10-K

2017

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 10-K

(Mark One)
ý	ANNUAL REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the fiscal year ended December 31, 2017
OR
o	TRANSITION REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

____________________________________________________________________________

Commission file number 1-815

E. I. DU PONT DE NEMOURS AND COMPANY

(Exact name of registrant as specified in its charter)

DELAWARE (State or Other Jurisdiction of Incorporation or Organization) 51-0014090 (I.R.S. Employer Identification No.)

974 Centre Road

Wilmington, Delaware 19805

(Address of principal executive offices)

Registrant's telephone number, including area code: 302-774-1000

Securities registered pursuant to Section 12(b) of the Act:

Title of each class	Name of exchange on which registered
Preferred Stock $4.50 Series, no par value, cumulative	New York Stock Exchange
Preferred Stock $3.50 Series, no par value, cumulative	New York Stock Exchange

No securities are registered pursuant to Section 12(g) of the Act.

_____________________________________________________

   Indicate by check mark whether the registrant is a well-known seasoned issuer (as defined in Rule 405 of the Securities Act).    

Yes ý       No o

        Indicate by check mark whether the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.    Yes o       No ý

        Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.    Yes ý        No o

        Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).    Yes ý        No o

        Indicate by check mark if disclosure of delinquent filers pursuant to Item 405 of Regulation S-K is not contained herein, and will not be contained, to the best of registrant's knowledge, in definitive proxy or information statements incorporated by reference in Part III of this Form 10-K or any amendment to this Form 10-K.  ý

        Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, or a non-accelerated filer. See definition of "accelerated filer and large accelerated filer" in Rule 12b-2 of the Exchange Act.

Large Accelerated Filer x	Accelerated Filer o
Non-Accelerated Filer o	Smaller reporting company o
	Emerging growth company o

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. o

        Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act).    Yeso Noý

        The aggregate market value of voting stock held by nonaffiliates of the registrant (excludes outstanding shares beneficially owned by directors and officers and treasury shares) as of June 30, 2017, was approximately $70.0 billion.

As of December 31, 2017, and as of the date of this filing, all of the company's issued and outstanding common stock, comprised of 100 shares, $0.30 par value per share, is held by DowDuPont Inc.

The Registrant meets the conditions set forth in General Instruction I(1)(a), (b) and (d) of Form 10-K (as modified by a grant of no-action relief dated February 12, 2018) and is therefore filing this form with reduced disclosure format.

E. I. du Pont de Nemours and Company

Form 10-K

Table of Contents

The terms "DuPont" or the "company" as used herein refer to E. I. du Pont de Nemours and Company and its consolidated subsidiaries, or to E. I. du Pont de Nemours and Company, as the context may indicate.

			Page
PART I
	Item 1.	Business	2
	Item 1A.	Risk Factors	9
	Item 1B.	Unresolved Staff Comments	16
	Item 2.	Properties	16
	Item 3.	Legal Proceedings	17
	Item 4.	Mine Safety Disclosures	17
PART II
	Item 5.	Market for Registrant's Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities	18
	Item 6.	Selected Financial Data	18
	Item 7.	Management's Discussion and Analysis of Financial Condition and Results of Operations	19
	Item 7A.	Quantitative and Qualitative Disclosures About Market Risk	43
	Item 8.	Financial Statements and Supplementary Data	44
	Item 9.	Changes in and Disagreements With Accountants on Accounting and Financial Disclosure	44
	Item 9A.	Controls and Procedures	44
	Item 9B.	Other Information	44
PART III
	Item 10.	Directors, Executive Officers and Corporate Governance	45
	Item 11.	Executive Compensation	45
	Item 12.	Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters	45
	Item 13.	Certain Relationships and Related Transactions, and Director Independence	45
	Item 14.	Principal Accountant Fees and Services	46
PART IV
	Item 15.	Exhibits and Financial Statement Schedules	47
SIGNATURES			50

1

Part I

ITEM 1.  BUSINESS

DuPont was founded in 1802 and was incorporated in Delaware in 1915. Today, DuPont is helping customers find solutions to capitalize on areas of growing global demand — enabling more, safer, nutritious food; creating high-performance, cost-effective and energy efficient materials for a wide range of industries; and increasingly delivering renewably sourced bio-based materials and fuels. Total worldwide employment at December 31, 2017 was about 44,000 people. The company has subsidiaries in about 90 countries worldwide and manufacturing operations in about 50 countries. The percentage of consolidated net sales made to customers outside the United States of America (U.S.) was 70 percent during the period September 1 through December 31, 2017 and 56 percent during the period January 1 through August 31, 2017. See Note 20 to the Consolidated Financial Statements for additional details on the location of the company's sales and property.

DowDuPont Merger of Equals

DowDuPont Inc. ("DowDuPont") was formed on December 9, 2015 to effect an all-stock, merger of equals strategic combination between The Dow Chemical Company ("Dow") and DuPont (the "Merger Transaction"). On August 31, 2017 at 11:59 pm ET, (the "Merger Effectiveness Time") pursuant to the Agreement and Plan of Merger, dated as of December 11, 2015, as amended on March 31, 2017 (the "Merger Agreement"), Dow and DuPont each merged with wholly owned subsidiaries of DowDuPont ("Mergers") and, as a result of the Mergers, Dow and DuPont became subsidiaries of DowDuPont (collectively, the "Merger"). Prior to the Merger, DowDuPont did not conduct any business activities other than those required for its formation and matters contemplated by the Merger Agreement. DowDuPont intends to pursue, subject to the receipt of approval by the Board of Directors of DowDuPont, the separation of the combined company's agriculture business, specialty products business and materials science business through a series of tax-efficient transactions (collectively, the "Intended Business Separations"). DowDuPont anticipates materials science separating by the end of the first quarter of 2019, and expects agriculture and specialty products to separate by June 1, 2019.

Upon completion of the Merger, (i) each share of common stock, par value $0.30 per share issued and outstanding immediately prior to the Merger Effectiveness Time, of the company (the “DuPont Common Stock”) was converted into the right to receive 1.2820 fully paid and non-assessable shares of DowDuPont common stock, par value $0.01 per share, ("DowDuPont Common Stock"), in addition to cash in lieu of any fractional shares of DowDuPont Common Stock, and (ii) each share of DuPont Preferred Stock—$4.50 Series and DuPont Preferred Stock—$3.50 Series (collectively, the “DuPont Preferred Stock”) issued and outstanding immediately prior to the Merger Effectiveness Time remains issued and outstanding and was unaffected by the Mergers.

As a condition of the regulatory approval for the Merger Transaction, the company was required to divest certain assets related to its Crop Protection business and research and development ("R&D") organization, specifically the company’s Cereal Broadleaf Herbicides and Chewing Insecticides portfolios, including Rynaxypyr^®, Cyazypyr^® , and Indoxacarb as well as the Crop Protection R&D pipeline and organization, excluding seed treatment, nematicides, and late-stage R&D programs (the "Divested Ag Business"). On March 31, 2017, the company entered into a definitive agreement (the "FMC Transaction Agreement") with FMC Corporation ("FMC"). Under the FMC Transaction Agreement, and effective upon the closing of the transaction on November 1, 2017, FMC acquired the Divested Ag Business that DuPont was required to divest in order to obtain European Commission ("EC") approval for the Merger Transaction, and DuPont acquired certain assets relating to FMC’s Health and Nutrition segment, excluding its Omega-3 products (the "H&N Business") (collectively, the "FMC Transactions"). See Note 3 and Note 4 for further information regarding the acquisition and divestiture, respectively. The assets and liabilities related to the Divested Ag Business for all periods are presented as held for sale in the Consolidated Balance Sheets. The sale of the Divested Ag Business meets the criteria for discontinued operations and as such, earnings are included within income from discontinued operations after income taxes in the Consolidated Statements of Operations for all periods presented.

Basis of Presentation

For purposes of DowDuPont's financial statement presentation, Dow was determined to be the accounting acquirer in the Merger and DuPont's assets and liabilities are reflected at fair value as of the Merger Effectiveness Time. In connection with the Merger and the related accounting determination, DuPont has elected to apply push-down accounting and reflect in its financial statements, the fair value of its assets and liabilities. DuPont's Consolidated Financial Statements for periods following the close of the Merger are labeled “Successor” and reflect DowDuPont’s basis in the fair values of the assets and liabilities of DuPont. All periods prior to the closing of the Merger reflect the historical accounting basis in DuPont's assets and liabilities and are labeled “Predecessor.” The Consolidated Financial Statements and Footnotes include a black line division between the columns titled "Predecessor" and "Successor" to signify that the amounts shown for the periods prior to and following the Merger are not comparable. See Note 3 for additional information on the Merger.

2

Part I

ITEM 1.  BUSINESS,continued

Tax Reform

On December 22, 2017, the Tax Cuts and Jobs Act (“The Act”) was enacted.  The Act reduces the US federal corporate income tax rate from 35 percent to 21 percent, requires companies to pay a one-time transition tax (“transition tax”) on earnings of foreign subsidiaries that were previously tax deferred, creates new provisions related to foreign sourced earnings, eliminates the domestic manufacturing deduction and moves to a territorial system. At December 31, 2017, the company had not completed its accounting for the tax effects of enactment of the Act; however, in the fourth quarter of 2017, the company recorded a net benefit in provision for taxes on continuing operations of $2,001 million, which consisted of a provisional net benefit of $2,716 million due to the reduction of the U.S. federal corporate income tax rate, partially offset by a provisional charge of $715 million due to the transition tax. Additional details related to The Act can be found in Item 7, Management’s Discussion and Analysis of Financial Condition and Results of Operations, on page 21 of this report and Note 7 to the Consolidated Financial Statements.

DowDuPont Cost Synergy Program

In September and November 2017, DowDuPont and the company approved post-merger restructuring actions to achieve targeted cost synergies under the DowDuPont Cost Synergy Program (the “Synergy Program”), adopted by the DowDuPont Board of Directors. The plan is designed to integrate and optimize the organization following the Merger and in preparation for the Intended Business Separations.  Based on all actions approved to date under the Synergy Program, DuPont expects to record total pre-tax restructuring charges of $430 million to $600 million, comprised of approximately $320 million to $360 million of severance and related benefits costs; $110 million to $140 million of costs related to contract terminations; and up to $100 million of asset related charges. The Synergy Program includes certain asset actions, including strategic decisions regarding the cellulosic biofuel unit reflected in the preliminary fair value measurement of DuPont’s assets as of the merger date. Current estimated total pre-tax restructuring charges could be impacted by future adjustments to the preliminary fair value of DuPont’s assets.

For the period September 1 through December 31, 2017, DuPont recorded a pre-tax charge of $187 million, consisting of severance and related benefit costs of $153 million, contract termination costs of $31 million and asset-related charges of $3 million. The charge for the period September 1 through December 31, 2017 was recognized in restructuring and asset related charges - net in the company's Consolidated Statements of Operations. Substantially all of the remaining restructuring charges are expected to be incurred in 2018 and the related actions, including employee separations, associated with this plan are expected to be substantially complete by the end of 2019.

Future cash payments related to this program are anticipated to be approximately $410 million to $480 million, primarily related to the payment of severance and related benefits and contract termination costs. It is possible that additional charges and future cash payments could occur in relation to the restructuring actions. The company anticipates including savings associated with these actions within DowDuPont's cost synergy commitment of $3.3 billion associated with the Merger Transaction. Additional details related to this plan can be found in Item 7, Management's Discussion and Analysis of Financial Condition and Results of Operations, on page 21 of this report and Note 5 to the Consolidated Financial Statements.

2017 Restructuring Program

During the first quarter 2017, DuPont committed to take actions to improve plant productivity and better position its product lines for productivity and growth before and after the anticipated closing of the Merger Transaction (the "2017 restructuring program"). In connection with these actions, the company incurred pre-tax charges of $313 million for the period January 1 through August 31, 2017 ("Predecessor" period) recognized in restructuring and asset related charges - net in the company's Consolidated Statements of Operations. The charge is comprised of $279 million of asset-related charges and $34 million in severance and related benefit costs. The charges primarily relate to the second quarter closure of the safety and construction product line at the Cooper River manufacturing site located near Charleston, South Carolina. The asset-related charges mainly consist of accelerated depreciation associated with the closure. The actions associated with this plan are substantially complete. The company anticipates including savings associated with these actions within the targeted cost synergies associated with the Merger Transaction. Additional details related to this plan can be found in Item 7, Management's Discussion and Analysis of Financial Condition and Results of Operations, on page 22 of this report and Note 5 to the Consolidated Financial Statements.

3

Part I

ITEM 1.  BUSINESS,continued

2016 Global Cost Savings and Restructuring Plan

On December 11, 2015, DuPont announced a 2016 global cost savings and restructuring plan designed to reduce $730 million in costs in 2016 compared with 2015. As part of the plan, the company committed to take structural actions across all product lines and staff functions globally to operate more efficiently by further consolidating product lines and aligning staff functions more closely with them.  In connection with the restructuring actions, the company recorded a pre-tax charge to earnings of $783 million in the fourth quarter 2015, comprised of $641 million of severance and related benefit costs, $109 million of asset related charges, and $33 million of contract termination costs. The restructuring actions associated with the charge are substantially complete and the plan delivered the target cost reductions in 2016 versus 2015. Additional details related to this plan can be found in Item 7, Management's Discussion and Analysis of Financial Condition and Results of Operations, on page 22 of this report and Note 5 to the Consolidated Financial Statements.

Acquisition of Granular, Inc.

On August 31, 2017, the company acquired Granular, Inc., a leading provider of software and analytics tools that help farms improve efficiency, profitability, and sustainability.  The purchase price was approximately $250 million and was primarily allocated to goodwill, developed technology and customer relationships.

Divestiture of Food Safety Diagnostic Business

In February 2017, the company completed the sale of the global food safety diagnostic business to Hygiena LLC.  The sale resulted in a pre-tax gain of $162 million ($86 million net of tax). The gain was recorded in sundry income - net in the company's Consolidated Statement of Operations for the period January 1 through August 31, 2017.

Settlement of PFOA MDL

As previously reported, approximately 3,550 lawsuits have been filed in various federal and state courts in Ohio and West Virginia alleging personal injury from exposure to perfluorooctanoic acid and its salts, including the ammonium salt ("PFOA"), in drinking water as a result of the historical manufacture or use of PFOA at the Washington Works' plant outside Parkersburg, West Virginia.  The plant operating units involved in the allegations are owned and operated by The Chemours Company ("Chemours").  These personal injury lawsuits were consolidated in multi-district litigation in the United States District Court for the Southern District of Ohio (the "MDL"). In February 2017, DuPont and plaintiffs’ counsel agreed to a settlement in principle of the MDL; the parties executed the definitive settlement agreements in March 2017. The total settlement amount is $670.7 million in cash, half of which was paid by Chemours and half by DuPont. The settlement was entered into solely by way of compromise and is not in any way an admission of liability or fault by DuPont or Chemours. The company recorded a pre-tax charge of $335 million ($214 million net of tax) to (loss) income from discontinued operations after income taxes in the company's Consolidated Statement of Operations for the period January 1 through August 31, 2017 for the remainder of the settlement not subject to indemnification by Chemours. See Note 14 to the Consolidated Financial Statements for additional information.

Spin-off of Performance Chemicals

On July 1, 2015, DuPont completed the separation of its Performance Chemicals segment through the spin-off of all of the issued and outstanding stock of The Chemours Company. In connection with the separation, the company and Chemours entered into a Separation Agreement and a Tax Matters Agreement as well as certain ancillary agreements. In accordance with generally accepted accounting principles in the U.S. ("GAAP"), the results of operations of its former Performance Chemicals segment are presented as discontinued operations and, as such, are included within (loss) income from discontinued operations after income taxes in the Consolidated Statements of Operations for all periods presented. Additional details regarding the separation and other related agreements can be found in Note 4 to the Consolidated Financial Statements.

Segment Information

Effective with the Merger, DuPont’s business activities are components of its parent company’s business operations. DuPont’s business activities, including the assessment of performance and allocation of resources, are reviewed and managed by DowDuPont. Information used by the chief operating decision maker of DuPont relates to the company in its entirety. Accordingly, there are no separate reportable business segments for DuPont under Accounting Standards Codification ("ASC") Topic 280 “Segment Reporting” and DuPont's business results are reported in this Form 10-K as a single operating segment. Prior year's segment information has been made to conform to the current presentation.

4

Part I

ITEM 1.  BUSINESS,continued

Principal Product Information

Subsidiaries and affiliates of DuPont conduct manufacturing, seed production and/or selling activities and some are distributors of products manufactured by the company. The following describes the company’s principal product lines including major brands and technologies:

Agriculture

The agriculture product line offers a broad portfolio of products and services that are specifically targeted to achieve gains in crop yields and productivity for the global production agriculture industry. The agriculture product line includes hybrid corn seed and soybean seed varieties, primarily under the Pioneer^® brand name, as well as canola, sunflower, sorghum, wheat and rice seed, silage inoculants, weed, insect and disease control products, as well as agronomic software. Pioneer seed sales amounted to 15 percent, 34 percent, 29 percent and 29 percent of the company's total consolidated net sales for the period September 1, 2017 through December 31, 2017, for the period January 1, 2017 through August 31, 2017 and for the years ended December 31, 2016 and 2015, respectively.

Packaging and Specialty Plastics

The packaging and specialty plastics product line specializes in resins and films used in packaging and industrial polymer applications, sealants and adhesives and sporting goods. Key brands and technologies include DuPont™ Surlyn^® ionomer resins, Bynel^® coextrudable adhesive resins, Elvax^® EVA resins, Nucrel^® Elvaloy^®polymer modifiers and Elvaloy^® copolymer resins.

Electronics and Imaging

The electronics and imaging product line supplies differentiated materials and systems for consumer electronics, photovoltaics ("PV"), displays and advanced printing that enable superior performance and lower total cost of ownership for customers. The company targets growth opportunities in circuit and semiconductor fabrication and packaging materials, PV materials, display materials, packaging graphics, and digital printing.

Industrial Biosciences

The industrial biosciences product line offers a broad portfolio of bio-based products, including enzymes that add value and functionality to processes and products across a broad range of markets such as animal nutrition, detergents, food manufacturing, ethanol production and industrial applications. The product line also includes DuPont™ Sorona^® PTT renewably sourced polymer for use in carpet and apparel fibers and clean technologies offerings to help reduce sulfur and other emissions, formulate cleaner fuels, and dispose of liquid waste.

Nutrition and Health

The nutrition and health product line offers a wide range of sustainable, bio-based ingredients, providing innovative solutions including the wide-range of DuPont™ Danisco® food ingredients such as cultures and probiotics, notably Howaru^®, pharmaceutical excipients, emulsifiers, texturants, natural sweeteners such as Xivia^® and Supro^® soy-based food ingredients. These ingredients hold leading market positions based on industry leading innovation, knowledge and experience, relevant product portfolios and close-partnering with the world's food manufacturers and pharmaceutical companies. The company has recently expanded the probiotics production capacity in the United States due to the rapidly growing global demand for probiotics.

Safety and Construction

The safety and construction product line offers innovation engineered products and integrated systems for a number of industry verticals including construction, worker safety, energy, oil and gas and transportation. The product line addresses the growing global needs of businesses, governments, and consumers for solutions that make life safer, healthier and better. Key brands and technologies include DuPont™ Kevlar^® fiber, DuPont™ Nomex^® fiber and paper, and DuPont™ Tyvek^® protective materials, DuPont™ Tychem^® protective suits and DuPont™ Corian^® solid and quartz surfaces.

5

Part I

ITEM 1.  BUSINESS,continued

Transportation and Advanced Polymers

The transportation and advanced polymers product line offers a broad range of polymer-based materials and expert application development assistance to enhance the performance, reduce the total system cost and optimize the sustainability of their products. The portfolio of high performance renewably-sourced and sustainable polymers includes engineering resins, adhesives, lubricants and parts used by customers to fabricate components for mechanical, chemical and electrical systems. Key brands and technologies include DuPont™ Zytel^® long chain nylon polymers, Zytel^® HTN nylon resins, Zytel^® nylon resins, Crastin^® PBT polymer resins, Rynite^® PET polymer resins, Delrin^® acetal resins, Hytrel^® polyester thermoplastic elastomer resins, Vespel^® parts and shapes, Vamac^® ethylene acrylic elastomer and Kalrez^® perfluoroelastomer.

See Note 20 to the Consolidated Financial Statements for net sales by major product line for the periods September 1 through December 31, 2017, the period January 1 through August 31, 2017 and for the years ended December 31, 2016 and 2015.

Sales by geographic region are included within Part II, Item 7 "Management's Discussion and Analysis of Financial Condition and Results of Operations", "Analysis of Operations".

Principal Markets

The company's principal markets include: agriculture, automotive and transportation, packaging for food and beverages, electrical/electronic components, material handling, healthcare, construction, semiconductor, aerospace/aircraft, dietary supplements, specialty food ingredients, food nutrition, health and safety, industrial, consumer electronics, photovoltaics, displays, consumer, military and law enforcement, aircraft, energy, animal nutrition, detergents, food and beverage, carpet and apparel fiber.

Sources and Availability of Major Raw Materials

The company utilizes numerous suppliers as well as internal sources to supply a wide range of raw materials, energy, supplies, services and equipment. To ensure availability, the company maintains multiple sources for fuels and many raw materials, including hydrocarbon feedstocks. Large volume purchases are generally procured under competitively priced supply contracts.

The following are the company's major commodities, raw materials and supplies:

Corn and soybean seeds, soy white flakes, soybean, adipic acid, hexamethylene diamine, meta-phenylene diamine, terephthaloyl chloride, thermoplastic polyester elastomer and thermoplastic copolyester elastomer.

Competition

As a science and technology based company, DuPont competes on a variety of factors such as product quality and performance or specifications, continuity of supply, price, customer service and breadth of product line, depending on the characteristics of the particular market involved and the product or service provided. The company competes globally with other seed and plant biotechnology companies on the basis of technology and trait leadership, price, quality and cost competitiveness. Key competitors for the company's agriculture product line include BASF, Bayer, Monsanto and Syngenta, as well as regional seed companies.

Distribution

Most products are marketed primarily through the company's sales organization, although in some regions, more emphasis is placed on sales through distributors. The company has a diverse worldwide network which markets and distributes the company's brands to customers globally. This network consists of the company's sales and marketing organization partnering with distributors, independent retailers and farmers, cooperatives and agents throughout the world. In the corn and soybean markets of the U.S. Corn Belt, the company sells Pioneer^® brand products primarily through a specialized force of independent sales representatives. Outside of North America, the company markets Pioneer^® brand products primarily through a network of subsidiaries, joint ventures and independent producer-distributors.

Seasonality

Sales of the company's agriculture product line are affected by the seasonality of global agriculture markets and weather patterns. Sales and earnings performance are significantly stronger in the first versus second half of the year, reflecting the northern hemisphere planting season. As a result of this seasonality, the agriculture product line inventory is at its highest level at the end of the calendar year and is sold down in the first and second quarters. Trade receivables for seeds are at a low point at year-end and increase through the northern hemisphere selling season to peak at the end of the second quarter.

6

Part I

ITEM 1.  BUSINESS,continued

Backlog

In general, the company does not manufacture its products against a backlog of orders and does not consider backlog to be a significant indicator of the level of future sales activity. Production and inventory levels are based on the level of incoming orders as well as projections of future demand. Therefore, the company believes that backlog information is not meaningful to understanding its overall business and should not be considered a reliable indicator of the company's ability to achieve any particular level of revenue or financial performance.

Intellectual Property

Trade secrets are an important element of the company's intellectual property. Many of the processes used to make DuPont products are kept as trade secrets which, from time to time, may be licensed to third parties. DuPont vigilantly protects all of its intellectual property including its trade secrets. When the company discovers that its trade secrets have been unlawfully taken, it reports the matter to governmental authorities for investigation and potential criminal action, as appropriate. In addition, the company takes measures to mitigate any potential impact, which may include civil actions seeking redress, restitution and/or damages based on loss to the company and/or unjust enrichment.

Patents & Trademarks: DuPont continually applies for and obtains U.S. and foreign patents and has access to a large patent portfolio, both owned and licensed. DuPont’s rights under these patents and licenses, as well as the products made and sold under them, are important to the company in the aggregate. The protection afforded by these patents varies based on country, scope of individual patent coverage, as well as the availability of legal remedies in each country. This significant patent estate may be leveraged to align with the company’s strategic priorities within and across product lines. At December 31, 2017, the company owned about 6,500 active U.S. patents and about 9,900 active patents outside of the U.S., which reflects the impact of the FMC Transactions. Information on the importance of intellectual property rights to the company’s agriculture product line is included in the Research and Development discussion below.

Remaining life of granted patents owned as of December 31, 2017:

	U.S.	Other Countries
Within 5 years	1,700	2,800
6 to 10 years	1,900	4,400
11 to 16 years	2,400	2,600
16 to 20 years	500	100
Total	6,500	9,900

In addition to its owned patents, the company owns over 7,000 patent applications.

The company owns or licenses many trademarks that have significant recognition at the consumer retail level and/or product line to product line level. Ownership rights in trademarks do not expire if the trademarks are continued in use and properly protected.

Research and Development

DuPont’s investment in research and development ("R&D") was $473 million for the period September 1 through December 31, 2017, $1,064 million for the period January 1 through August 31, 2017, $1,502 million in 2016 and $1,735 million in 2015. DuPont conducts R&D activities to renew its portfolio, create new product lines, and transform markets to deliver results in the short, mid and long term. The company protects its R&D investment through its intellectual property strategy.  See discussion under “Intellectual Property” above.

R&D expense related to the agriculture product line accounted for 53 percent and 56 percent of the company's total research and development expense for the periods from January 1 through August 31, 2017 and September 1 through December 31, 2017, respectively. R&D for the agriculture product line requires long-term commitment of resources, extensive regulatory efforts and collaborations, partnerships and business arrangements to successfully bring products to market. To protect its investment, the company employs the use of patents covering germplasm and native and biotechnology traits in accordance with country laws. The company holds multiple long-term biotechnology trait licenses from third parties as a normal course of business. The biotechnology traits licensed by the company from third parties are contained in a variety of Pioneer seeds, including corn hybrids and soybean varieties. The majority of Pioneer’s corn hybrids and soybean varieties sold to customers contain biotechnology traits licensed from third parties under these long-term licenses.

7

Part I

ITEM 1.  BUSINESS,continued

Environmental Matters

Information related to environmental matters is included in several areas of this report: (1) Environmental Proceedings beginning on page 17, (2) Management's Discussion and Analysis of Financial Condition and Results of Operations beginning on pages 34, 40-42 and (3) Notes 1 and 14 to the Consolidated Financial Statements.

Available Information

The company is subject to the reporting requirements under the Securities Exchange Act of 1934. Consequently, the company is required to file reports and information with the Securities and Exchange Commission ("SEC"), including reports on the following forms: annual report on Form 10-K, quarterly reports on Form 10-Q, current reports on Form 8-K, and amendments to those reports filed or furnished pursuant to Section 13(a) or 15(d) of the Securities Exchange Act of 1934.

The public may read and copy any materials the company files with the SEC at the SEC's Public Reference Room at 100 F Street, NE, Washington, DC 20549. The public may obtain information on the operation of the Public Reference Room by calling the SEC at 1-800-SEC-0330. The SEC also maintains an Internet site at http://www.sec.gov that contains reports, proxy and information statements, and other information regarding issuers that file electronically with the SEC.

The company's annual report on Form 10-K, quarterly reports on Form 10-Q, current reports on Form 8-K and amendments to those reports are also accessible on DowDuPont's website at http://www.dow-dupont.com/home by clicking on the section labeled "Investors", then on "DuPont SEC Filings." These reports are made available, without charge, as soon as is reasonably practicable after the company files or furnishes them electronically with the SEC.

8

Part I

ITEM 1A.  RISK FACTORS

The company's operations could be affected by various risks, many of which are beyond its control. Based on current information, the company believes that the following identifies the most significant risk factors that could affect its operations. Past financial performance may not be a reliable indicator of future performance and historical trends should not be used to anticipate results or trends in future periods.

The Benefits of the Merger May Not be Fully Realized. Combining the Businesses of DuPont and Dow May Be More Difficult, Costly or Time-Consuming than Expected, Which May Adversely Affect DuPont's Results.

The success of the Merger depends on, among other things, DowDuPont's ability to combine the DuPont and Dow businesses in a manner that facilitates the intended separation of the combined company's agriculture, materials science and specialty products businesses through one or more tax-efficient transactions (the "Intended Business Separations"), resulting in three independent, publicly traded companies, and realizes anticipated synergies.

DuPont expects to benefit from significant cost synergies at both the product line and corporate levels through the Synergy Program which is designed to integrate and optimize the organization following the Merger and in preparation for the Intended Business Separations, including through the achievement of production cost efficiencies, enhancement of the agricultural supply chain, elimination of duplicative agricultural research and development programs, optimization of the combined company’s global footprint across manufacturing, sales and research and development in the materials science business, optimizing manufacturing processes in the electronics space, the reduction of corporate and leveraged services costs, and the realization of significant procurement synergies. In connection with the Synergy Program, DuPont expects to record total pretax restructuring charges of $430 million to $600 million, comprised of approximately $320 million to $360 million of severance and related benefit costs; $110 million to $140 million of costs related to contract terminations; and up to $100 million of asset related charges.

Management also expects the combined company will achieve growth synergies and other meaningful savings and benefits as a result of the Intended Business Separations.

Combining DuPont and Dow's independent businesses and preparing for the Intended Business Separations are complex, costly and time-consuming processes and the management of DowDuPont may face significant implementation challenges, many of which may be beyond the control of management, including, without limitation:

• ongoing diversion of the attention of management from the operation of the combined company’s business as a result of the Intended Business Separations;

• impact of portfolio changes between materials science and specialty products on integration and separation preparation activities;

• difficulties in achieving anticipated cost savings, synergies, business opportunities and growth prospects;

• the possibility of faulty assumptions underlying expectations regarding the integration or separation process, including with respect to the intended tax efficient transactions;

• unanticipated issues in integrating, replicating or separating information technology, communications programs, financial procedures and operations, and other systems, procedures and policies;

• difficulties in managing a larger combined company, addressing differences in business culture and retaining key personnel;

• unanticipated changes in applicable laws and regulations;

• managing tax costs or inefficiencies associated with integrating the operations of the combined company and the intended tax efficient separation transactions; and

• coordinating geographically separate organizations.

Some of these factors will be outside of the control of DowDuPont, DuPont and Dow, and any one of them could result in increased costs and diversion of management’s time and energy, as well as decreases in the amount of expected revenue which could materially impact business, financial condition and results of operations. The integration and Intended Businesses Separation processes and other disruptions, including those from divestitures and acquisitions undertaken in connection with securing regulatory approval for the Merger, as well as those from the portfolio changes between the materials science and specialty products businesses, may also adversely affect the combined company’s relationships with employees, suppliers, customers, distributors, licensors and others with whom DuPont and Dow have business or other dealings, and difficulties in integrating the businesses or regulatory functions of DuPont and Dow could harm the reputation of DowDuPont, DuPont and Dow.

9

Part I

ITEM 1A.  RISK FACTORS,continued

If DowDuPont is not able to successfully combine the businesses of DuPont and Dow in an efficient, cost-effective and timely manner, the anticipated benefits and cost savings, including from the Synergy Program, of the Merger (including the Intended Business Separations) may not be realized fully, or at all, or may take longer to realize than expected, and the value of DowDuPont common stock, the revenues, levels of expenses and results of operations may be affected adversely. A variety of factors may adversely affect DowDuPont's ability to realize the currently expected synergies, savings and other benefits of the Merger, including failure to successfully optimize the combined company's facilities footprint, the failure to take advantage of the combined company's global supply chain, the failure to identify and eliminate duplicative programs, and the failure to otherwise integrate DuPont's or Dow's respective businesses, including their technology platforms.

DuPont Will Incur Significant Transaction Costs in Connection with the Integration of Dow and DuPont.

There are a large number of processes, policies, procedures, operations, technologies and systems that must be integrated in connection with the Merger and replicated, transferred or separated in connection with the Intended Business Separations. While DuPont has assumed a certain level of expenses, including in connection with the Synergy Program, would be incurred in connection with the Merger and the Intended Business Separations, there are many factors beyond the combined company’s control that could affect the total amount of, or the timing of, anticipated expenses with respect to the integration and implementation of the combined businesses.

There may also be additional unanticipated significant costs in connection with the Merger and the Intended Business Separations that DuPont may not recoup. These costs and expenses could reduce the benefits and additional income DuPont expects to achieve from the Merger. Although DuPont expects that these benefits will offset the transaction expenses and implementation costs over time, this net benefit may not be achieved in the near term or at all.

Inability to Access the Debt Capital Markets Could Impair DuPont's Liquidity, Business or Financial Condition.

DowDuPont’s primary sources of liquidity are through DuPont and Dow and their respective consolidated subsidiaries, (collectively, the “Subsidiaries”). Each of DuPont and Dow has relied and continues to rely on access to the debt capital markets to finance their day-to-day and long-term operations. In connection with the Merger, DowDuPont has not incurred debt obligations or guaranteed the debt obligations of Dow or DuPont. Any limitation on the part of either DuPont’s or Dow's ability to raise money in the debt markets could have a substantial negative effect on their respective liquidity and the liquidity of DowDuPont. Access to the debt capital markets in amounts adequate to finance each company’s activities could be impaired as a result of the existence of material nonpublic information about the Intended Business Separations and other potential factors, including factors that are not specific to the companies, such as a severe disruption of the financial markets and interest rate fluctuations.

Prior to the Intended Business Separations, if pursued, the level and quality of the respective earnings, operations, business and management, among other things, of each of DuPont and Dow will impact their respective credit ratings, costs and availability of financing and those of the combined company. A decrease in the ratings assigned to DuPont or Dow by the ratings agencies may negatively impact their access to the debt capital markets and increase the combined company’s cost of borrowing. There can be no assurance that DuPont and Dow will maintain their current credit worthiness or prospective credit ratings. Any actual or anticipated changes or downgrades in such credit ratings may have a negative impact on the liquidity, capital position or access to capital markets of DuPont and Dow and, therefore, DowDuPont.

The Costs of Complying with Evolving Regulatory Requirements Could Negatively Impact the Company's Financial Results. Actual or Alleged Violations of Environmental Laws or Permit Requirements Could Result in Restrictions or Prohibitions on Plant Operations, Substantial Civil or Criminal Sanctions, as well as the Assessment of Strict Liability and/or Joint and Several Liability.

The company is subject to extensive federal, state, local and foreign laws, regulations, rules and ordinances relating to pollution, protection of the environment, greenhouse gas emissions, and the generation, storage, handling, transportation, treatment, disposal and remediation of hazardous substances and waste materials. Costs and capital expenditures relating to environmental, health or safety matters are subject to evolving regulatory requirements and depend on the timing of the promulgation and enforcement of specific standards which impose the requirements. Moreover, changes in environmental regulations could inhibit or interrupt the company's operations, or require modifications to its facilities. Accordingly, environmental, health or safety regulatory matters could result in significant unanticipated costs or liabilities.

10

Part I

ITEM 1A.  RISK FACTORS,continued

Increased Concerns Regarding the Safe Use of Seeds with Biotechnology Traits, Crop Protection Products and Chemicals in General, in Commerce and their Potential Impact on the Environment as well as Perceived Impacts of Biotechnology on Health and the Environment, have Resulted in More Restrictive Regulations and could Lead to New Regulations.

Concerns and claims regarding the safe use of seeds with biotechnology traits, crop protection products, and chemicals in general, their potential impact on health and the environment, and the perceived impacts of biotechnology on health and the environment, reflect a growing trend in societal demands for increasing levels of product safety and environmental protection. These concerns and claims include those that increased use of crop protection products, related drift and volatilization, and of biotechnology traits to address resistance of weeds and pests to control by crop protection products, could increase such resistance and otherwise negatively impact health and the environment. These concerns could manifest themselves in stockholder proposals, preferred purchasing, delays or failures in obtaining or retaining regulatory approvals, delayed product launches, lack of market acceptance, product discontinuation, continued pressure for and adoption of more stringent regulatory intervention and litigation. These concerns could also influence public perceptions, the viability or continued sales of certain of the company's products, the company's reputation and the cost to comply with regulations. These concerns could have a negative impact on the company's results of operations.

In most jurisdictions, the company must test the safety, efficacy and environmental impact of its agricultural products to satisfy regulatory requirements and obtain the necessary approvals. In certain jurisdictions, the company must periodically renew its approvals which may require it to demonstrate compliance with then-current standards. The regulatory environment is lengthy, complex and in some markets unpredictable, with requirements that can vary by product, technology, industry and country. The regulatory environment may be impacted by the activities of non-governmental organizations and special interest groups and stakeholder reaction to actual or perceived impacts of new technology, products or processes on safety, health and the environment. Obtaining and maintaining regulatory approvals requires submitting a significant amount of information and data, which may require participation from technology providers. Regulatory standards and trial procedures are continuously changing. The pace of change together with the lack of regulatory harmony could result in unintended noncompliance.

Responding to these changes and meeting existing and new requirements may involve significant costs or capital expenditures or require changes in business practice that could result in reduced profitability. The failure to receive necessary permits or approvals could have near- and long-term effects on the company’s ability to produce and sell some current and future products.

To maintain its right to produce or sell existing products or to commercialize new products containing biotechnology traits, particularly seed products, the company must be able to demonstrate its ability to satisfy the requirements of regulatory agencies. Sales into and use of seeds with biotechnology traits in jurisdictions where cultivation has been approved could be impacted if key import markets have not approved the import of grains, food and food ingredients and other products derived from those seeds. If import of grains, food and food ingredients and other products derived from those seeds containing such biotechnology traits occurs in these markets, it could lead to disruption in trade and potential liability for the company.

In addition, the company’s regulatory compliance could be affected by the detection of low level presence of biotechnology traits in conventional seed or products produced from such seed. Furthermore, the detection of biotechnology traits not approved in the country of cultivation may affect the company’s ability to supply product and could affect exports of products produced from such seeds and even result in crop destruction or product recalls.

An Impairment of Goodwill or Intangibles Assets could Negatively Impact the company's Financial Results.

As a result of the Merger and the related accounting determination, DuPont elected to apply push-down accounting and has reflected the acquisition date fair value of assets and liabilities in its Successor Consolidated Financial Statements, including a significant amount of goodwill and intangible assets. The company assesses both goodwill and indefinite-lived intangible assets for impairment on an annual basis, or more frequently if conditions indicate that an impairment may have occurred. The company has the option to first perform qualitative testing to determine whether it is more likely than not that the fair value of a reporting unit is less than its carrying value. If the company chooses not to complete a qualitative assessment for a given reporting unit or if the initial assessment indicates that it is more likely than not that the estimated fair value of a reporting unit is less than its carrying value, additional quantitative testing is required. If quantitative testing indicates that the carrying value of a reporting unit exceeds its fair value, a goodwill impairment is recorded equal to the amount by which the carrying value of the reporting unit exceeds its fair value. Since the company utilizes a discounted cash flow methodology to calculate the fair value of its reporting units, continued weak demand for a specific product line could result in an impairment. As a result of the application of push-down accounting, the carrying value of the company’s assets approximates fair value therefore increasing the risk of impairments. Future impairments of goodwill or intangible assets could be recorded in results of operations due to changes in assumptions, estimates or circumstances and there can be no assurance that such impairments would be immaterial to the company.

11

Part I

ITEM 1A.  RISK FACTORS,continued

The Determination to Proceed with the Intended Business Separations is a Decision of the DowDuPont Board of Directors and the Expected Benefits of Such Transactions, if They Occur, Will Be Uncertain.

In the event that the DowDuPont board determines to proceed with the Intended Business Separations, it is currently anticipated that any such Intended Business Separation transaction would be effectuated through two pro-rata spin-off transactions, in which DowDuPont stockholders, at such time, would receive shares of capital stock in the resulting spin-off companies, resulting in three independent, public companies. The DowDuPont board may ultimately determine to abandon one or more of the Intended Business Separation transactions, and such determination could have an adverse impact on DowDuPont, DuPont, and Dow. There are many factors that could, prior to the determination by the DowDuPont board to proceed with the Intended Business Separations, impact the structure or timing of, the anticipated benefits from, or determination to ultimately proceed with, the Intended Business Separations, including, among others, global economic conditions, instability in credit markets, declining consumer and business confidence, fluctuating commodity prices and interest rates, volatile foreign currency exchange rates, tax considerations, and other challenges that could affect the global economy, specific market conditions in one or more of the industries of the businesses proposed to be separated, and changes in the regulatory or legal environment. Such changes could adversely impact the value of one or more of the Intended Business Separation transactions to the combined company’s stockholders. Additionally, to the extent the DowDuPont board determines to proceed with the Intended Business Separations, the consummation of such transactions is a complex, costly and time-consuming process, and there can be no guarantee that the intended benefits of such transactions will be achieved. An inability to realize the full extent of the anticipated benefits of the Intended Business Separations, as well as any delays encountered in the process, could have an adverse effect upon the revenues, level of expenses and operating results of the agriculture business, the specialty products business, the materials science business and/or the combined company.

The Company’s Operations Outside the United States are Subject to Risks and Restrictions, Which Could Negatively Affect Our Results of Operations, Financial Condition, and Cash Flows.

The company’s operations outside the United States are subject to risks and restrictions, including fluctuations in currency values and foreign-currency exchange rates; exchange control regulations; changes in local political or economic conditions; import and trade restrictions; import or export licensing requirements and trade policy and other potentially detrimental domestic and foreign governmental practices or policies affecting U.S. companies doing business abroad. Although DuPont has operations throughout the world, sales outside the U.S. in 2017 were principally to customers in Eurozone countries, China, Brazil, and Japan. Further, the company’s largest currency exposures are the European euro, the Chinese yuan, the Brazilian real, and the Japanese yen. Market uncertainty or an economic downturn in these geographic areas could reduce demand for the company’s products and result in decreased sales volume, which could have a negative impact on DuPont’s results of operations. In addition, changes in exchange rates may affect the company’s results from operations, financial condition and cash flows in future periods. The company actively manages currency exposures that are associated with net monetary asset positions, committed currency purchases and sales, foreign currency-denominated revenues and other assets and liabilities created in the normal course of business.

Volatility in Energy and Raw Materials Costs Could Have a Significant Impact on the Company's Sales and Earnings.

The company's manufacturing processes consume significant amounts of energy and raw materials, the costs of which are subject to worldwide supply and demand as well as other factors beyond the control of the company. Significant variations in the cost of energy, which primarily reflect market prices for oil, natural gas, and raw materials affect the company's operating results from period to period. Legislation to address climate change by reducing greenhouse gas emissions and establishing a price on carbon could create increases in energy costs and price volatility.

When possible, the company purchases raw materials through negotiated long-term contracts to minimize the impact of price fluctuations. Additionally, the company enters into over-the-counter and exchange traded derivative commodity instruments to hedge its exposure to price fluctuations on certain raw material purchases. The company takes actions to offset the effects of higher energy and raw material costs through selling price increases, productivity improvements and cost reduction programs. Success in offsetting higher raw material costs with price increases is largely influenced by competitive and economic conditions and could vary significantly depending on the market served. If the company is not able to fully offset the effects of higher energy and raw material costs, it could have a significant impact on the company's financial results.

12

Part I

ITEM 1A.  RISK FACTORS,continued

The Company's Results of Operations and Financial Condition Could be Seriously Impacted by Business Disruptions and Security Breaches, Including Cybersecurity Incidents.

Business and/or supply chain disruptions, plant and/or power outages and information technology system and/or network disruptions, regardless of cause including acts of sabotage, employee error or other actions, geo-political activity, weather events and natural disasters could seriously harm the company's operations as well as the operations of its customers and suppliers. In addition, terrorist attacks and natural disasters have increased stakeholder concerns about the security and safety of chemical production and distribution. Failure to effectively prevent, detect and recover from security breaches, including attacks on information technology and infrastructure by hackers; viruses; breaches due to employee error or actions; or other disruptions could result in misuse of the company's assets, business disruptions, loss of property including trade secrets and confidential business information, legal claims or proceedings, reporting errors, processing inefficiencies, negative media attention, loss of sales and interference with regulatory compliance. Like most major corporations, the company is the target of industrial espionage, including cyber-attacks, from time to time. The company has determined that these attacks have resulted, and could result in the future, in unauthorized parties gaining access to at least certain confidential business information. However, to date, the company has not experienced any material financial impact, changes in the competitive environment or business operations that it attributes to these attacks. Although management does not believe that the company has experienced any material losses to date related to security breaches, including cybersecurity incidents, there can be no assurance that it will not suffer such losses in the future. The company actively manages the risks within its control that could lead to business disruptions and security breaches. As these threats continue to evolve, particularly around cybersecurity, the company may be required to expend significant resources to enhance its control environment, processes, practices and other protective measures. Despite these efforts, such events could have a material adverse effect on the company's business, financial condition or results of operations.

Unpredictable Seasonal and Weather Factors Could Impact Sales and Earnings from the Company’s Agriculture Product Line.

The agriculture industry is subject to seasonal and weather factors, which can vary unpredictably from period to period. Weather factors can affect the presence of disease and pests on a regional basis and, accordingly, can positively or adversely affect the demand for crop protection products, including the mix of products used. The weather also can affect the quality, volume and cost of seed produced for sale as well as demand and product mix. Seed yields can be higher or lower than planned, which could lead to higher inventory and related write-offs and affect the ability to supply.

Inability to Discover, Develop and Protect New Technologies and Enforce the Company's Intellectual Property Rights, and to Respond to New Technologies Could Adversely Affect the Company's Financial Results.

The company competes with major global companies that have strong intellectual property rights, including rights supporting the use of biotechnology to enhance products, particularly agricultural and bio-based products. Speed in discovering, developing, protecting, and responding to new technologies, including new technology-based distribution channels that could impede the company's ability to engage with customers and end users, and bringing related products to market is a significant competitive advantage. Failure to predict and respond effectively could cause the company's existing or candidate products to become less competitive, adversely affecting sales. Competitors are increasingly challenging intellectual property positions and the outcomes can be highly uncertain. If challenges are resolved adversely, it could negatively impact the company's ability to obtain licenses on competitive terms, commercialize new products and generate sales from existing products.

Intellectual property rights, including patents, plant variety protection, trade secrets, confidential information, trademarks, tradenames and other forms of trade dress, are important to the company's business. The company endeavors to protect its intellectual property rights in jurisdictions in which its products are produced or used and in jurisdictions into which its products are imported. However, the company may be unable to obtain protection for its intellectual property in key jurisdictions. Further, changes in government policies and regulations, including changes made in reaction to pressure from non-governmental organizations, could impact the extent of intellectual property protection afforded by such jurisdictions.

The majority of the company’s corn hybrids and soybean varieties sold to customers contain biotechnology traits that are licensed from third parties under long-term licenses. If the company loses its rights under such licenses, it could negatively impact the company's ability to obtain future licenses on competitive terms, commercialize new products and generate sales from existing products.

13

Part I

ITEM 1A.  RISK FACTORS,continued

The company has designed and implemented internal controls to restrict access to and distribution of its intellectual property. Despite these precautions, the company's intellectual property is vulnerable to unauthorized access through employee error or actions, theft and cybersecurity incidents, and other security breaches. When unauthorized access and use or counterfeit products are discovered, the company reports such situations to governmental authorities for investigation, as appropriate, and takes measures to mitigate any potential impact. Protecting intellectual property related to biotechnology is particularly challenging because theft is difficult to detect and biotechnology can be self-replicating. Accordingly, the impact of such theft can be significant.

Failure to Effectively Manage Acquisitions, Divestitures, Alliances and Other Portfolio Actions Could Adversely Impact Our Future Results.

The company made certain divestitures, primarily related to its agriculture product line, in connection with obtaining regulatory approval for the Merger. In addition, the company had a recent acquisition and from time to time evaluates acquisition candidates that may strategically fit its business and/or growth objectives. If the company is unable to successfully integrate and develop acquired businesses, the company could fail to achieve anticipated synergies and cost savings, including any expected increases in revenues and operating results, which could have a material adverse effect on the company’s financial results. The company continually reviews its portfolio of assets for contributions to the company’s objectives and alignment with its growth strategy. However, the company may not be successful in separating underperforming or non-strategic assets and gains or losses on the divestiture of, or lost operating income from, such assets may affect the company’s earnings. Moreover, the company might incur asset impairment charges related to acquisitions or divestitures that reduce its earnings. In addition, if the execution or implementation of acquisitions, divestitures, alliances, joint ventures and other portfolio actions is not successful, it could adversely impact the company’s financial condition, cash flows and results of operations.

The Company's Business, Including its Results of Operations and Reputation, Could be Adversely Affected by Process Safety and Product Stewardship Issues.

Failure to appropriately manage safety, human health, product liability and environmental risks associated with the company's products, product life cycles and production processes could adversely impact employees, communities, stakeholders, the environment, the company's reputation and its results of operations. Public perception of the risks associated with the company's products and production processes could impact product acceptance and influence the regulatory environment in which the company operates. While the company has procedures and controls to manage process safety risks, issues could be created by events outside of its control including natural disasters, severe weather events, acts of sabotage and substandard performance by third parties with which the company collaborates.

DuPont’s Results of Operations Could Be Adversely Affected by Environmental, Litigation and Other Commitments and Contingencies.

The company is subject to various laws and regulations around the world governing the environment, including the discharge of pollutants and the management and disposal of hazardous substances. As a result of its operations, including its past operations and operations of divested businesses, the company could incur substantial costs, including remediation and restoration costs. The costs of complying with complex environmental laws and regulations, as well as internal voluntary programs, are significant and will continue to be so for the foreseeable future. The ultimate costs under environmental laws and the timing of these costs are difficult to predict. The company's accruals for such costs and liabilities may not be adequate because the estimates on which the accruals are based depend on a number of factors including the nature of the matter, the complexity of the site, site geology, the nature and extent of contamination, the type of remedy, the outcome of discussions with regulatory agencies and other Potentially Responsible Parties (PRPs) at multi-party sites and the number and financial viability of other PRPs.

At December 31, 2017, the company had accrued obligations of $433 million for probable environmental remediation and restoration costs, although it is reasonably possible that the ultimate cost could range up to $920 million above that amount. This includes matters with an aggregate estimated liability range from $242 up to $430 million above that amount for which the company is indemnified by Chemours. At December 31, 2017, the company had recognized a liability of $433 million and an indemnification asset of $242 million for environmental contingencies. If the company could no longer continue to recognize the related indemnification asset due to potential disputes related to recovery or solvency of Chemours, it could adversely impact DuPont’s financial position and results of operations.

14

Part I

ITEM 1A.  RISK FACTORS,continued

The company faces risks arising from various unasserted and asserted litigation matters, including, but not limited to, product liability, patent infringement, antitrust claims, and claims for third party property damage or personal injury stemming from alleged environmental torts. The company has noted a nationwide trend in purported class actions against chemical manufacturers generally seeking relief such as medical monitoring, property damages, off-site remediation and punitive damages arising from alleged environmental torts without claiming present personal injuries. The company also has noted a trend in public and private suits being filed on behalf of states, counties, cities and utilities alleging harm to the general public and the environment, including waterways and watersheds. An adverse outcome in any one or more of these matters could be material to the company's financial results. Various factors or developments can lead to changes in current estimates of liabilities such as a final adverse judgment, significant settlement or changes in applicable law. A future adverse ruling or unfavorable development could result in future charges that could have a material adverse effect on the company.

In the ordinary course of business, the company may make certain commitments, including representations, warranties and indemnities relating to current and past operations, including those related to divested businesses and issue guarantees of third party obligations. If the company were required to make payments as a result, they could exceed the amounts accrued, thereby adversely affecting the company's results of operations.

Pursuant to the Separation Agreement, Chemours indemnifies DuPont against certain litigation, environmental, workers' compensation and other liabilities that arose prior to the distribution. The term of this indemnification is indefinite and includes defense costs and expenses, as well as monetary and non-monetary settlements and judgments. If the company could no longer continue to recognize the related indemnification asset due to potential disputes related to recovery or solvency of Chemours, it could adversely impact DuPont’s financial position and results of operations.

See Note 14 to the Consolidated Financial Statements for additional information on environmental, litigation and other commitments and contingencies faced by the company.

15

Part I

ITEM 1B.  UNRESOLVED STAFF COMMENTS

None.

ITEM 2.  PROPERTIES

The company's corporate headquarters are located in Wilmington, Delaware. The company's manufacturing, processing, marketing and research and development facilities, as well as regional purchasing offices and distribution centers are located throughout the world. Additional information with respect to the company's property, plant and equipment and leases is contained in Notes 11, 14 and 20 to the Consolidated Financial Statements.

The company has investments in property, plant and equipment related to global manufacturing operations. The number of principal manufacturing sites by major geographic area around the world at December 31, 2017 is as follows:

	Number of Sites
Asia Pacific	62
EMEA 1	76
Latin America	37
U.S. & Canada	112
	287

^1. Europe, Middle East, and Africa ("EMEA").

The company's principal sites include facilities which, in the opinion of management, are suitable and adequate for their use and have sufficient capacity for the company's current needs and expected near-term growth. Properties are primarily owned by the company; however, certain properties are leased. No title examination of the properties has been made for the purpose of this report and certain properties are shared with other tenants under long-term leases.

16

Part I

ITEM 3.  LEGAL PROCEEDINGS

The company is subject to various litigation matters, including, but not limited to, product liability, patent infringement, antitrust claims, and claims for third party property damage or personal injury stemming from alleged environmental torts. Information regarding certain of these matters is set forth below and in Note 14 to the Consolidated Financial Statements.

Litigation

PFOA: Environmental and Litigation Proceedings

For purposes of this report, the term PFOA means collectively perfluorooctanoic acid and its salts, including the ammonium salt

and does not distinguish between the two forms. Information related to this matter is included in Note 14 to the Consolidated Financial Statements under the heading PFOA.

Fayetteville Works Facility, Fayetteville, North Carolina

In August 2017, the U.S. Attorney’s Office for the Eastern District of North Carolina served the company with a subpoena for testimony and the production of documents to a grand jury. In the fourth quarter of 2017, DuPont was served with additional subpoenas relating to the same issue. Information related to this matter is included in Note 14 to the Consolidated Financial Statements under the heading Fayetteville Works Facility, North Carolina.

La Porte Plant, La Porte, Texas - Crop Protection - Release Incident Investigations

On November 15, 2014, there was a release of methyl mercaptan at the company’s La Porte facility. The release occurred at the site’s Crop Protection unit resulting in four employee fatalities inside the unit. DuPont continues to cooperate with governmental agencies, including the U.S. Environmental Protection Agency ("EPA"), the Chemical Safety Board and the Department of Justice ("DOJ"), still conducting investigations. These investigations could result in sanctions and civil or criminal penalties against the company.

Environmental Proceedings

The company believes it is remote that the following matters will have a material impact on its financial position, liquidity or results of operations. The descriptions are included per Regulation S-K, Item 103(5)(c) of the Securities Exchange Act of 1934.

La Porte Plant, La Porte, Texas - EPA Multimedia Inspection

The EPA conducted a multimedia inspection at the La Porte facility in January 2008. DuPont, EPA and DOJ began discussions in the Fall 2011 relating to the management of certain materials in the facility's waste water treatment system, hazardous waste management, flare and air emissions. These discussions continue.

Sabine Plant, Orange, Texas - EPA Multimedia Inspection

In June 2012, DuPont began discussions with EPA and DOJ related to a multimedia inspection that EPA conducted at the Sabine facility in March 2009 and December 2015. The discussions involve the management of materials in the facility's waste water treatment system, hazardous waste management, flare and air emissions, including leak detection and repair. These discussions continue.

ITEM 4.  MINE SAFETY DISCLOSURES

Not applicable.

17

Part II

ITEM 5.  MARKET FOR REGISTRANT'S COMMON EQUITY, RELATED STOCKHOLDER MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES

Market for Registrant's Common Equity and Related Stockholder Matters

Prior to the Merger, shares of DuPont Common Stock were registered pursuant to Section 12(b) of the Securities Exchange Act of 1934, as amended and listed on the New York Stock Exchange (the “NYSE”). As a result of the Merger, on August 31, 2017, the company requested that the NYSE withdraw the shares of DuPont Common Stock from listing on the NYSE and filed a Form 25 with the U.S. Securities and Exchange Commission ("SEC") to report that DuPont Common Stock is no longer listed on the NYSE. The number of record holders of DuPont common stock was approximately 57,000 at August 31, 2017. The closing price of DuPont common stock on the NYSE on August 31, 2017 was $83.93. DowDuPont is the sole record holder of DuPont Common Stock. DuPont continues to have preferred stock outstanding and it remains listed on the NYSE. DowDuPont Common Stock is listed and trades on the NYSE, ticker symbol DWDP.

Prior to the Merger, holders of the company's common stock were entitled to receive dividends when they were declared by the Board of Directors. Dividends on common stock and preferred stock were historically declared in January, April, July and October. When dividends on common stock were declared, they were usually paid mid-March, June, September and December. The third quarter 2017 dividend on common stock was paid as of September 30, 2017. Preferred dividends are paid on or about the 25th of January, April, July and October. The Stock Transfer Agent and Registrar is Computershare Trust Company, N.A.

The information regarding the dividends per share of DuPont Common Stock based on declaration date for 2017 and 2016 is shown below.

2017	Per Share Dividend Declared
Third Quarter (July 1 through August 31, 2017)	$	0.38
Second Quarter	0.38
First Quarter	0.38
2016
Fourth Quarter	$	0.38
Third Quarter	0.38
Second Quarter	0.38
First Quarter	0.38

ITEM 6.  SELECTED FINANCIAL DATA

The Registrant meets the conditions set forth in General Instruction I(1)(a), (b) and (d) of Form 10-K (as modified by a grant of no-action relief dated February 12, 2018) and is therefore filing this form with the reduced disclosure format and has omitted the information called for by this Item pursuant to General Instruction I(2)(c) of Form 10-K.

18

Part II

ITEM 7.  MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

CAUTIONARY STATEMENTS ABOUT FORWARD-LOOKING STATEMENTS

This communication contains “forward-looking statements” within the meaning of the federal securities laws, including Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. In this context, forward-looking statements often address expected future business and financial performance and financial condition, and often contain words such as “expect,” “anticipate,” “intend,” “plan,” “believe,” “seek,” “see,” “will,” “would,” “target,” similar expressions, and variations or negatives of these words.

On December 11, 2015, The Dow Chemical Company (“Dow”) and E. I. du Pont de Nemours and Company (“DuPont”) announced entry into an Agreement and Plan of Merger, as amended on March 31, 2017, (the “Merger Agreement”) under which the companies would combine in an all-stock merger of equals transaction (the “Merger”). Effective August 31, 2017, the Merger was completed and each of Dow and DuPont became subsidiaries of DowDuPont Inc. (“DowDuPont”).

Forward-looking statements by their nature address matters that are, to varying degrees, uncertain, including the intended separation, subject to approval of the DowDuPont Board of Directors, of DowDuPont’s agriculture, materials science and specialty products businesses in one or more tax efficient transactions on anticipated terms (the “Intended Business Separations”). Forward-looking statements are not guarantees of future performance and are based on certain assumptions and expectations of future events which may not be realized. Forward-looking statements also involve risks and uncertainties, many of which are beyond the control of DuPont and its parent company. Some of the important factors that could cause DuPont’s actual results to differ materially from those projected in any such forward-looking statements include, but are not limited to: (i) costs to achieve and achieving the successful integration of the respective agriculture, materials science and specialty products businesses of Dow and DuPont, anticipated tax treatment, unforeseen liabilities, future capital expenditures, revenues, expenses, earnings, productivity actions, economic performance, indebtedness, financial condition, losses, future prospects, business and management strategies for the management, expansion and growth of the combined operations; (ii) costs to achieve and achievement of the anticipated synergies by the combined agriculture, materials science and specialty products businesses; (iii) risks associated with the Intended Business Separations, including conditions which could delay, prevent or otherwise adversely affect the proposed transactions, including possible issues or delays in obtaining required regulatory approvals or clearances related to the Intended Business Separations, associated cost, disruptions in the financial markets or other potential barriers; (iv) disruptions or business uncertainty, including from the Intended Business Separations, could adversely impact DuPont’s business or financial performance and its ability to retain and hire key personnel; and (v) risks to DuPont’s business, operations and results of operations from: the availability of and fluctuations in the cost of energy and raw materials; failure to develop and market new products and optimally manage product life cycles; ability, cost and impact on business operations, including the supply chain, of responding to changes in market acceptance, rules, regulations and policies and failure to respond to such changes; delays or failures in obtaining or retaining regulatory approvals, delayed product launches, lack of market acceptance, product discontinuation, changes in the regulatory environment and litigation resulting from concerns and claims regarding the safe use of seeds with biotechnology traits and crop protection products potential impact on health and the environment, and the perceived impacts of biotechnology on health and the environment; impact of unpredictable seasonal and weather factors could impact sales and earnings from agriculture products; outcome of significant litigation, environmental matters and other commitments and contingencies; failure to appropriately manage process safety and product stewardship issues; global economic and capital market conditions, including the continued availability of capital and financing, as well as inflation, interest and currency exchange rates; changes in political conditions, business or supply disruptions; security threats, such as acts of sabotage, terrorism or war, natural disasters and weather events and patterns which could result in a significant operational event for DuPont, adversely impact demand or production; ability to discover, develop and protect new technologies and to protect and enforce the DuPont’s intellectual property rights; failure to effectively manage acquisitions, divestitures, alliances, joint ventures and other portfolio changes; unpredictability and severity of catastrophic events, including, but not limited to, acts of terrorism or outbreak of war or hostilities, as well as management’s response to any of the aforementioned factors. While the list of factors presented here is, considered representative, no such list should be considered to be a complete statement of all potential risks and uncertainties. Unlisted factors may present significant additional obstacles to the realization of forward-looking statements. Consequences of material differences in results as compared with those anticipated in the forward-looking statements could include, among other things, business disruption, operational problems, financial loss, legal liability to third parties and similar risks, any of which could have a material adverse effect on DuPont’s consolidated financial condition, results of operations, credit rating or liquidity. DuPont does not assume any obligation to publicly provide revisions or updates to any forward-looking statements whether as a result of new information, future developments or otherwise, should circumstances change, except as otherwise required by securities and other applicable laws. A detailed discussion of some of the significant risks and uncertainties which may cause results and events to differ materially from such forward-looking statements is included in the section titled “Risk Factors” (Part I, Item 1A of this Form 10-K).

19

Part II

ITEM 7.  MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS, continued

Overview

DowDuPont Merger of Equals    On August 31, 2017 at 11:59 pm ET, (the "Merger Effectiveness Time") pursuant to the Merger Agreement, Dow and DuPont each merged with wholly owned subsidiaries of DowDuPont (the "Mergers") and, as a result of the Mergers, Dow and DuPont became subsidiaries of DowDuPont (collectively, the "Merger").

DowDuPont intends to pursue, subject to the receipt of approval by the Board of Directors of DowDuPont, the separation of the combined company's agriculture business, specialty products business and materials science business through a series of tax efficient transactions (collectively, the "Intended Business Separations"). DowDuPont anticipates materials science separating by the end of the first quarter of 2019, and expects agriculture and specialty products to separate by June 1, 2019.

During the period September 1 through December 31, 2017 and the period January 1 through August 31, 2017, the company incurred $314 million and $581 million, respectively, of costs in connection with the Merger and the Intended Business Separations, including costs relating to integration and separation planning. During the years ended December 31, 2016 and 2015, the company incurred $386 million and $10 million, respectively. These costs are recorded within integration and separation costs in the Successor period and the costs are recorded within selling, general and administrative expenses in the Predecessor periods within the company's Consolidated Statements of Operations. These costs have primarily consisted of financial advisory, information technology, legal, accounting, consulting and other professional advisory fees associated with the preparation and execution of activities related to the Merger and Intended Business Separations.

See the discussion of this report entitled DowDuPont Merger of Equals under Part 1, Item 1 Business; Part 1, Item 1A, Risk Factors; and Note 3 to the Consolidated Financial Statements for further details and a discussion of some of the risks related to the transaction.

Results  Net sales were $7.1 billion for the period September 1 through December 31, 2017 and $17.3 billion for the period January 1 through August 31, 2017, compared to $23.2 billion for the year ended December 31, 2016. The $1.1 billion increase was primarily driven by 4 percent higher sales volume as worldwide local price and currency were flat. (Loss) income from continuing operations before taxes was $(1.6) billion, $1.8 billion and $2.7 billion for the period September 1 through December 31, 2017, for the period January 1 through August 31, 2017 and for the year ended December 31, 2016, respectively. The period September 1 through December 31, 2017 results include $1.5 billion of amortization of inventory step-up, increased transaction costs related to the Merger and Intended Business Separations, higher depreciation related to the fair value step up of property, plant and equipment and lower gains from sales of businesses, partially offset by higher sales. Pension and other post employment benefits ("OPEB") (benefits) costs for the period of September 1 through December 31, 2017 and January 1 through August 31, 2017 were $(83) million and $373 million, respectively, as compared to $222 million in 2016.  Activity in the Successor period benefited from the absence of the amortization of net losses from accumulated other comprehensive loss ("AOCL").  Pension and OPEB costs for 2016 include a curtailment gain as a result of changes made to the U.S. Pension and OPEB benefits in 2016.

20

Part II

ITEM 7.  MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS, continued

Analysis of Operations

Note on Financial Presentation

In connection with the Merger Transaction, the company applied the acquisition method of accounting as of September 1, 2017 and the financial statements reflect the preliminary related adjustments. As a result, financial information for the period January 1 through August 31, 2017 ("Predecessor") and the period September 1 through December 31, 2017 ("Successor") are not comparable to the financial information for the years ended December 31, 2016 and 2015 ("Predecessor"). In addition, the company has elected to make certain changes in presentation to harmonize its accounting and reporting with that of DowDuPont in the Successor period. See Note 1 for further discussion of these changes and Note 3 for additional information regarding the Merger Transaction.

FMC Transactions

On March 31, 2017, the company and FMC Corporation ("FMC") entered into a definitive agreement (the "FMC Transaction Agreement"). Under the FMC Transaction Agreement, FMC would acquire the crop protection business and R&D assets that DuPont was required to divest in order to obtain EC approval of the Merger Agreement, (the "Divested Ag Business") and DuPont agreed to acquire certain assets relating to FMC’s Health and Nutrition segment, excluding its Omega-3 products (the "H&N Business") (collectively, the "FMC Transactions"). The sale of the Divested Ag Business meets the criteria for discontinued operations and as such, earnings are included within (loss) income from discontinued operations after income taxes for all periods presented.

On November 1, 2017, the company completed the FMC Transactions through the disposition of the Divested Ag Business and the acquisition of the H&N Business. The preliminary fair value as determined by the company of the H&N Business is $1,970 million. The FMC Transactions include a cash consideration payment to DuPont of approximately $1,200 million, which reflects the difference in value between the Divested Ag Business and the H&N Business, as well as favorable contracts with FMC of $495 million, subject to adjustments for inventory of the Divested Ag Business and net working capital of the H&N Business. Due to the proximity of the Merger and the closing of the sale, the carrying value of the Divested Ag Business approximates the fair value of the consideration received, thus no resulting gain or loss was recognized on the sale. Refer to Note 3 for further information on the H&N Business.

Tax Reform

On December 22, 2017, the Tax Cuts and Jobs Act (“The Act”) was enacted. The Act reduces the U.S. federal corporate income tax rate from 35 percent to 21 percent, requires companies to pay a one-time transition tax (“transition tax”) on earnings of foreign subsidiaries that were previously tax deferred, creates new provisions related to foreign sourced earnings, eliminates the domestic manufacturing deduction and moves to a territorial system. At December 31, 2017, the company had not completed its accounting for the tax effects of The Act; however, in the fourth quarter of 2017, the company recorded a net benefit in provision for income taxes on continuing operations of $2,001 million, which consisted of a provisional net benefit of $2,716 million due to the reduction of the U.S. federal corporate income tax rate partially offset by a provisional charge of $715 million due to the transition tax. The company expects that it will have sufficient available foreign tax credits to offset the tax liability associated with the one-time transition tax. See Note 7 for additional information.

DowDuPont Cost Synergy Program

In September and November 2017, DowDuPont and the company approved post-merger restructuring actions to achieve targeted cost synergies under the DowDuPont Cost Synergy Program (the “Synergy Program”), adopted by the DowDuPont Board of Directors. The plan is designed to integrate and optimize the organization following the Merger and in preparation for the Intended Business Separations.  Based on all actions approved to date under the Synergy Program, DuPont expects to record total pre-tax restructuring charges of $430 million to $600 million. Additional details related to this plan can be found on page 3 of this report and Note 5 to the Consolidated Financial Statements.

On February 1, 2018, DowDuPont announced an increase in its cost synergy commitment from $3 billion to $3.3 billion.

21

Part II

ITEM 7.  MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS, continued

2017 Restructuring Program

During the first quarter 2017, DuPont committed to take actions to improve plant productivity and better position its product lines for productivity and growth before and after the anticipated closing of the Merger Transaction (the "2017 restructuring program"). In connection with these actions, the company incurred pre-tax charges of $313 million during the period from January 1 through August 31, 2017 recognized in restructuring and asset related charges - net in the company's Consolidated Statements of Operations. The charges primarily relate to the second quarter closure of the safety and construction product line at the Cooper River manufacturing site located near Charleston, South Carolina. The actions associated with this plan are substantially complete as of December 31, 2017. Additional details related to this plan can be found on page 3 of this report and Note 5 to the Consolidated Financial Statements.

2016 Global Cost Savings and Restructuring Plan

On December 11, 2015, DuPont announced a 2016 global cost savings and restructuring plan designed to reduce $730 million in costs in 2016 compared with 2015. As part of the plan, the company committed to take structural actions across all product lines and staff functions globally to operate more efficiently by further consolidating product lines and aligning staff functions more closely with them.  In connection with the restructuring actions, the company recorded a pre-tax charge to earnings of $783 million in the fourth quarter 2015, comprised of $641 million of severance and related benefit costs, $109 million of asset related charges, and $33 million of contract termination costs. The restructuring actions associated with the charge are substantially complete and the plan delivered the target cost reductions in 2016 versus 2015. Additional details related to this plan can be found on page 4 of this report and Note 5 to the Consolidated Financial Statements.

Impact of 2017 Hurricanes

In 2017 Hurricane Harvey made landfall in Texas and Hurricane Maria made landfall in Puerto Rico, both causing widespread damage. The financial impact related to the hurricanes, including lost sales and repairs and maintenance, is not material to the Predecessor or Successor financial statements.

Separation of Performance Chemicals

In October 2013, DuPont announced its intention to separate its Performance Chemicals segment through a U.S. tax-free spin-off to shareholders, subject to customary closing conditions.  In July 2015, DuPont completed the separation of its Performance Chemicals segment through the spin-off of all of the issued and outstanding stock of The Chemours Company (Chemours).

Settlement of PFOA MDL

As previously reported, approximately 3,550 lawsuits have been filed in various federal and state courts in Ohio and West Virginia alleging personal injury from exposure to perfluorooctanoic acid and its salts, including the ammonium salt ("PFOA"), in drinking water as a result of the historical manufacture or use of PFOA at the Washington Works' plant outside Parkersburg, West Virginia.  The plant operating units involved in the allegations are owned and operated by The Chemours Company ("Chemours").  These personal injury lawsuits were consolidated in multi-district litigation in the United States District Court for the Southern District of Ohio (the "MDL"). In February 2017, DuPont and plaintiffs’ counsel agreed to a settlement in principle of the MDL; the parties executed the definitive settlement agreements in March 2017. The total settlement amount is $670.7 million in cash, half of which was paid by Chemours and half by DuPont. The settlement was entered into solely by way of compromise and is not in any way an admission of liability or fault by DuPont or Chemours. The company recorded a pre-tax charge of $335 million ($214 million net of tax) to (loss) income from discontinued operations after income taxes in the company's Consolidated Statement of Operations for the period January 1 through August 31, 2017 for the remainder of the settlement not subject to indemnification by Chemours. See Note 14 to the Consolidated Financial Statements for additional information.

22

Part II

ITEM 7.  MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS, continued

Net Sales

2017 versus 2016

Net sales were $7.1 billion for the period September 1 through December 31, 2017 and $17.3 billion for the period January 1 through August 31, 2017, compared to $23.2 billion for the year ended December 31, 2016. The $1.1 billion increase was primarily driven by 4 percent higher sales volume. In Asia Pacific sales volume increased 10 percent primarily driven by the electronics and imaging product line and the transportation and advanced polymers product line. In EMEA sales volume increased 5 percent driven by the agriculture product line and the safety and construction product line. In U.S. and Canada net sales increased 1 percent, principally reflecting volume growth in the agriculture product line. In Latin America net sales increased 4 percent, driven by a positive currency impact due to stronger Brazilian real, as well as higher volume, partially offset by lower local prices.

In the Consolidated Statement of Operations, royalty income is included within net sales in the Successor Period and is included in sundry income - net in the Predecessor Periods. Royalty income does not have a significant impact on any period presented. See Note 1 for further discussion of the changes in presentation.

2016 versus 2015

Net sales of $23.2 billion in 2016 were 2 percent below prior year net sales of $23.7 billion, reflecting a 1 percent reduction due to currency and a 1 percent decrease due to lower local prices. Negative currency impact was primarily due to the weaker European euro, Mexican peso, and Chinese yuan, partly offset by the stronger Japanese yen and Brazilian real. Worldwide lower local prices primarily reflect reductions for the transportation and advanced polymers product line and the electronic and imaging product line, as well as flat prices in the agriculture product line. Worldwide volume was flat.

	Successor			Predecessor
	For the Period September 1 through December 31, 2017			For the Period January 1 through August 31, 2017			For the Year Ended December 31, 2016			For the Year Ended December 31, 2015
	Net sales ($ billions)		% of Net sales	Net sales ($ billions)		% of Net sales	Net sales ($ billions)		% of Net sales	Net sales ($ billions)		% of Net sales
Worldwide	$	7.1	100.0	$	17.3	100.0	$	23.2	100.0	$	23.7	100.0
U.S. & Canada	2.2		31.0	8.1		47.0	10.1		43.8	10.5		44.4
Europe, Middle East & Africa (EMEA)	1.7		24.1	3.9		22.8	5.3		22.7	5.5		23.2
Asia Pacific	2.1		29.3	3.9		22.2	5.4		23.3	5.3		22.4
Latin America	1.1		15.6	1.4		8.0	2.4		10.2	2.4		10.0

Cost of Goods Sold ("COGS")

2017 versus 2016

COGS was $6.2 billion for the period September 1 through December 31, 2017 and $10.2 billion for the period January 1 through August 31, 2017 compared to $14.0 billion for the year ended December 31, 2016. The increase was primarily driven by the amortization of the inventory step-up of $1.5 billion for the period September 1 through December 31, 2017 as well as higher sales volume, increased expenses due to the elimination of the other operating charges financial statement line item in the Successor period, higher depreciation related to the fair value step up of property, plant and equipment and higher pension and OPEB costs due to the curtailment gains recognized in 2016 as a result of the changes made to the U.S. Pension and OPEB benefits.

COGS as a percentage of net sales was 87 percent, 59 percent, and 60 percent for the period September 1 through December 31, 2017, for the period January 1 through August 31, 2017 and for the year ended December 31, 2016, respectively. The amortization of the inventory step-up was 22 percent of net sales in the Successor period. The remaining COGS increase as a percentage of net sales in the Successor period is due to the items discussed above, partially offset with a pension and OPEB benefit as a result of the absence of the amortization of net losses from AOCL. The elimination of the other operating charges financial statement line item would have increased COGS as a percentage of net sales by 2 percent for the period January 1 through August 31, 2017 and for the year ended December 31, 2016.

See Note 3 for additional information regarding the Merger, including the valuation of inventory and see Note 1 for further discussion of the changes in presentation.

23

Part II

ITEM 7.  MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS, continued

2016 versus 2015

COGS decreased from $14.6 billion for the year ended December 31, 2015 to $14.0 billion for the year ended December 31, 2016. The decrease was primarily driven by lower raw material costs, lower pension and OPEB costs, and the strengthening of the U.S. dollar versus global currencies. COGS as a percentage of net sales decreased 2 percent, from 62 percent to 60 percent, principally due to lower raw material costs and lower pension and OPEB costs.

Other Operating Charges

2017 versus 2016

Other operating charges were $667 million for the year ended December 31, 2016 and $504 million for the period January 1 through August 31, 2017. In the Successor period, other operating charges are included primarily in cost of goods sold, as well as selling, general and administrative expenses and amortization of intangibles. See Note 1 for further discussion of the changes in presentation.

2016 versus 2015

Other operating charges increased from $434 million for the year ended December 31, 2015 to $667 million for the year ended December 31, 2016. The increase was primarily driven by a $152 million decrease in Imprelis^® herbicide insurance recoveries, and a $23 million reduction in the estimated liability related to Imprelis^® herbicide claims versus a $130 million accrual reduction in the prior year.

Research and Development Expense ("R&D")

2017 versus 2016

R&D expense was $473 million for the period September 1 through December 31, 2017, $1,064 million for the period January 1 through August 31, 2017, and $1,502 million for the year ended December 31, 2016. The change was primarily driven by an increase in R&D expense related to the agriculture product line and higher pension and OPEB costs due to the curtailment gains recognized in 2016 as a result of the changes made to the U.S. Pension and OPEB benefits in 2016, partially offset with lower costs related to the DowDuPont Cost Synergy Program.

R&D as a percentage of net sales was 7 percent, 6 percent, and 6 percent for the period September 1 through December 31, 2017, for the period January 1 through August 31, 2017 and for the year ended December 31, 2016, respectively. R&D as a percentage of net sales is slightly higher in the Successor period, primarily due to an increase in R&D for new product introductions and higher depreciation, partially offset with a pension and OPEB benefit, cost savings, and the absence of amortization expense.

2016 versus 2015

R&D expenses decreased from $1,735 million for the year ended December 31, 2015 to $1,502 million for the year ended December 31, 2016. The decrease was primarily due to lower costs related to the 2016 global cost savings and restructuring plan, a decrease in pension and OPEB costs and the strengthening of the U.S. dollar versus global currencies. R&D as a percentage of net sales decreased 1 percent, from 7 percent to 6 percent, principally due to cost savings and lower pension and OPEB costs.

Selling, General and Administrative Expenses ("SG&A")

2017 versus 2016

SG&A expenses were $1,101 million for the period September 1 through December 31, 2017, $3,306 million for the period January 1 through August 31, 2017, and $4,143 million for the year ended December 31, 2016. The change was primarily driven by higher transaction costs, increased selling expense and commissions, primarily for agriculture products, higher compensation and higher pension and OPEB costs, partially offset with lower costs related to the 2016 global cost savings and restructuring plan and the absence of amortization expense in the Successor period. In the Successor period, integration and separation costs and amortization of intangibles are presented as a line item on the Consolidated Statement of Operations. See Note 1 for further discussion of the changes in presentation. During the year ended December 31, 2016 and the period January 1 through August 31, 2017, the company incurred $386 million and $581 million, respectively, of transaction costs in connection with the merger with Dow and the Intended Business Separations.

24

Part II

ITEM 7.  MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS, continued

SG&A as a percentage of net sales was 16 percent, 19 percent, and 16 percent for the period September 1 through December 31, 2017, for the period January 1 through August 31, 2017 and for the year ended December 31, 2016, respectively. Transaction costs were 3 percent and 2 percent of net sales for the period January through August 31, 2017 and for the year ended December 31, 2016. The remaining net sales increase as a percentage of net sales in the Successor period is due to the items discussed above.

2016 versus 2015

SG&A expenses decreased from $4,428 million for the year ended December 31, 2015 to $4,143 million for the year ended December 31, 2016.  The $285 million decrease was primarily due to lower costs related to the 2016 global cost savings and restructuring plan, lower selling expense, and a decrease in pension and OPEB costs, partially offset by $386 million of transaction costs associated with the merger with Dow. SG&A expense as a percent of sales decreased by 1 percent, from 19 percent to 18 percent, primarily due to cost savings from the company’s 2016 global cost savings and restructuring plan and a decrease in pension and OPEB costs.

Amortization of Intangibles

Intangible asset amortization was $389 million for the period September 1 through December 31, 2017. In the Predecessor periods, amortization of intangibles was included within SG&A; other operating charges; R&D; and COGS. See Note 3 for further information regarding the Merger, including the valuation of intangible assets.

Restructuring and Asset Related Charges - Net

2017 versus 2016

Restructuring and asset related charges - net were $180 million for the period September 1 through December 31, 2017, $323 million for the period January 1 through August 31, 2017, and $556 million for the year ended December 31, 2016. The charge for period January 1 through August 31, 2017 is comprised of $279 million of asset-related charges and $44 million in severance and related benefit costs. The asset-related charges primarily relate to the second quarter closure of the safety and construction product line at the Cooper River manufacturing site located near Charleston, South Carolina as part of the 2017 restructuring program. For the period September 1 through December 31, 2017, DuPont recorded a pre-tax charge of $187 million, consisting of severance and related benefit costs of $153 million, contract termination costs of $31 million and asset related charges of $3 million related to the Synergy program described below. This charge was partially offset by a $7 million benefit related to the 2016 and 2014 restructuring plans for adjustments to recognized severance costs. See Note 5 for additional information.

In September and November 2017, DowDuPont and the company approved post-merger restructuring actions under the DowDuPont Cost Synergy Program (the “Synergy Program”), adopted by the DowDuPont Board of Directors. The plan is designed to integrate and optimize the organization following the Merger.  Based on all actions approved to date under the Synergy Program, DuPont expects to record total pre-tax restructuring charges of $430 million to $600 million, comprised of approximately $320 million to $360 million of severance and related benefits costs; $110 million to $140 million of costs related to contract terminations; and up to $100 million of asset related charges. The Synergy Program includes certain asset actions, including strategic decisions regarding the cellulosic biofuel unit reflected in the preliminary fair value measurement of DuPont’s assets as of the merger date. Current estimated total pre-tax restructuring charges could be impacted by future adjustments to the preliminary fair value of DuPont’s assets.

Substantially all of the remaining restructuring charges are expected to be incurred in 2018 and the related actions, including employee separations, associated with this plan are expected to be substantially complete by the end of 2019. Future cash payments related to this program are anticipated to be approximately $410 million to $480 million, primarily related to the payment of severance and related benefits and contract termination costs. It is possible that additional charges and future cash payments could occur in relation to the restructuring actions.

The $556 million charge for 2016 consisted of $593 million of asset related charges (discussed in the “Asset Impairment” section, below) and a $68 million charge related to the decision to not re-start the company's insecticide manufacturing facility at the La Porte site located in La Porte, Texas. These charges were partially offset by a net $84 million benefit related to the 2016 restructuring plan, primarily due to a reduction in severance and related benefit costs driven by the elimination of positions at a lower cost than expected, and a $21 million benefit related to the 2014 restructuring plan for adjustments to the previously recognized severance costs.

25

Part II

ITEM 7.  MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS, continued

2016 versus 2015

Restructuring and asset related charges - net decreased from $795 million for the year ended December 31, 2015 to $556 million for the year ended December 31, 2016. The charges for 2016 are discussed above. The $795 million in charges recorded during 2015 in restructuring and asset related charges - net consist of a pre-tax charge of $783 million related to the 2016 restructuring plan, consisting of $778 million of restructuring and asset related charges - net and $5 million in sundry income - net. The charges consisted of $641 million in severance and related benefit costs, $109 million in asset related charges, and $33 million in contract termination charges. In addition, the company recognized a $38 million impairment charge discussed below, partly offset by a $21 million net benefit related to the 2014 restructuring plan. The $21 million net benefit was recorded to adjust the estimated costs associated with the 2014 restructuring program due to lower than estimated individual severance costs and workforce reductions achieved through non-severance programs, offset by the identification of additional projects.

Asset Impairments

During 2016, the company recorded an asset impairment charge of $435 million related to its uncompleted enterprise resource planning (ERP) system.  Given the uncertainties related to timing of completion as well as potential developments and changes to technologies in the market place at the time of restart, use of the ERP system can no longer be considered probable. See Note 5 to the Consolidated Financial Statements for additional details related to this charge.

During 2016, the company recorded a $158 million impairment charge related to indefinite-lived intangible trade names as a result of the realignment of brand marketing strategies and a determination to phase out the use of certain acquired trade names.

During 2015, the company recorded an impairment charge of $38 million related to an impairment of a cost basis investment.

Integration and Separation Costs

Integration and separation costs were $314 million for the period September 1 through December 31, 2017. In the Predecessor periods, integration and separation costs were included within SG&A. See Note 1 for further discussion of the changes in presentation.

Sundry Income - Net

2017 versus 2016

Sundry income - net was $166 million and $90 million for the period January 1 through August 31, 2017 and for the period September 1 through December 31, 2017, respectively. Sundry income - net was $707 million for the year ended December 31, 2016. The period September 1 through December 31, 2017, the period January 1 through August 31, 2017 and the year ended December 31, 2016 includes a net exchange gain of $8 million, a net exchange loss of $394 million and a net exchange loss of $106 million, respectively. The period January 1 through August 31, 2017 included a pre-tax gain of $162 million associated with the sale of the global food safety diagnostic business. The year ended December 31, 2016 included a pre-tax gain of $369 million associated with the sale of DuPont (Shenzhen) Manufacturing Limited entity.

2016 versus 2015

Sundry income - net increased from $690 million for the year ended December 31, 2015 to $707 million for the year ended December 31, 2016. The $17 million increase was primarily due to gains on sales of businesses and other assets, including a $369 million gain on the sale of DuPont (Shenzhen) Manufacturing Limited, partially offset by an increase in pre-tax exchange losses and the absence of a $145 million gain associated with the company's settlement of a legal claim in the prior year. Pre-tax exchange losses increased $136 million compared to prior year. See Notes 6 and 18 to the Consolidated Financial Statements for further discussion of the company's policy of hedging the foreign currency-denominated monetary assets and liabilities.

See Note 6 to the Consolidated Financial Statements for additional information.

Interest Expense

2017 versus 2016

Interest expense was $107 million for the period September 1 through December 31, 2017, $254 million for the period January 1 through August 31, 2017, and $370 million for the year ended December 31, 2016. The change was primarily driven by amortization of the step-up of debt as a result of push-down accounting, partially offset by higher debt balances.

26

Part II

ITEM 7.  MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS, continued

2016 versus 2015

Interest expense increased from $342 million for the year ended December 31, 2015 to $370 million for the year ended December 31, 2016. The increase was primarily due to lower capitalized interest related to construction projects partially offset by lower interest on borrowings.

Provision for Income Taxes on Continuing Operations

2017 versus 2016

For the period September 1 through December 31, 2017, the company’s effective tax rate of 168.5 percent on pre-tax loss from continuing operations of $1,586 million was favorably impacted by a provisional net benefit of $2,001 million that the company recognized due to the enactment of the Act, a net benefit of $261 million related to an internal legal entity restructuring associated with the Intended Business Separations, as well as geographic mix of earnings. Those impacts were partially offset by the non-tax deductible amortization of the fair value step-up in DuPont’s inventories as a result of the Merger, certain net exchange losses recognized on the remeasurement of the net monetary asset positions which were not tax deductible in their local jurisdictions, as well as the tax impact of costs associated with the merger with Dow and restructuring and asset related charges.

For the period January 1 through August 31, 2017, the company’s effective tax rate was 8.3 percent on pre-tax income from continuing operations of $1,791 million.  For the period January 1 through August 31, 2017, the company’s effective tax rate was favorably impacted by geographic mix of earnings, certain net exchange gains recognized on the remeasurement of the net monetary asset positions which were not taxable in their local jurisdictions, net favorable tax consequences of the adoption of Financial Accounting Standards Board (FASB) Accounting Standards Update (ASU) No. 2016-09, Compensation - Stock Compensation (Topic 718), Improvements to Employee Share-Based Payment Accounting, tax benefits related to a reduction in the company’s unrecognized tax benefits due to the closure of various tax statutes of limitations, as well as tax benefits on costs associated with the merger with Dow and restructuring and asset related charges. Those tax benefits were partially offset by the unfavorable tax consequences of non-deductible goodwill associated with the gain on the sale of global food safety diagnostics in the first quarter 2017.

For the year ended December 31, 2016, the company’s effective tax rate of 23.5 percent on pre-tax income from continuing operations of $2,723 million was impacted by geographic mix of earnings as well as certain net exchange gains recognized on the remeasurement of the net monetary asset positions which were not taxable in their local jurisdictions. Those benefits were partially offset by the tax consequences of the gain on the sale of DuPont (Shenzhen) Manufacturing Limited in the first quarter 2016.

2016 versus 2015

For the year ended December 31, 2015, the company’s effective tax rate of 28.4 percent on pre-tax income from continuing operations of $2,022 million was impacted by the company's policy of hedging the foreign currency-denominated monetary assets and liabilities of its operations as well as increased tax benefits on restructuring and asset related charges.

Corporate Outlook

New products introductions in the agriculture product line are expected to contribute to growth in 2018. The company's 2018 results will be favorably impacted by the acquisition of the H&N Business.

In 2018, the company expects income from continuing operations will be negatively impacted by the amortization of the inventory step-up, incremental amortization and depreciation related to the fair value step up of intangible assets and property, plant and equipment, as well as transaction costs related to preparation for the Intended Business Separations, partially offset by realized synergy savings. A pension and OPEB benefit is expected in 2018 due to the absence of the amortization of net losses from accumulated other comprehensive loss. The company expects the US federal corporate tax rate reduction, from 35 percent to 21 percent, will have a positive impact on the 2018 effective tax rate.

Recent Accounting Pronouncements

See Note 2 to the Consolidated Financial Statements for a description of recent accounting pronouncements.

27

Part II

ITEM 7.  MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS, continued

Liquidity & Capital Resources

	Successor		Predecessor
(Dollars in millions)	December 31, 2017		December 31, 2016
Cash, cash equivalents and marketable securities	$	8,202	$	5,910
Total debt	13,070		8,536

The company continually reviews its sources of liquidity and debt portfolio and occasionally may make adjustments to one or both to ensure adequate liquidity and an optimum debt maturity schedule.

The company's credit ratings impact its access to the debt capital markets and cost of capital. The company remains committed to a strong financial position and strong investment-grade rating. The company's long-term and short-term credit ratings are as follows:

	Long-term	Short-term	Outlook
Standard & Poor's	A-	A-2	Stable
Moody’s Investors Service	A3	P-2	Negative
Fitch Ratings	A	F1	Rating Watch Negative

The company believes its ability to generate cash from operations and access to capital markets will be adequate to meet anticipated cash requirements to fund its working capital, capital spending, debt maturities as well as distributions and other intercompany transfers to DowDuPont which relies on DuPont and Dow to fund payment of its costs and expenses. DuPont’s current strong financial position, liquidity and credit ratings continue to provide access as needed to the capital markets. The company's liquidity needs can be met through a variety of sources, including cash provided by operating activities, cash and cash equivalents, marketable securities, commercial paper, syndicated credit lines, bilateral credit lines, long-term debt markets, bank financing, committed receivable repurchase facilities and asset sales.

The company has access to approximately $6.7 billion in committed and uncommitted unused credit lines with several major financial institutions including unused commitments of $3 billion under the Term Loan Facility described below and a $3 billion revolving credit facility to support its commercial paper program. These unused credit lines provide support to meet the company's short-term liquidity needs and for general corporate purposes which may include funding of discretionary and non-discretionary contributions to certain benefit plans, severance payments, repayment and refinancing of debt, working capital, capital expenditures and repurchases and redemptions of securities.

In May 2017, the company completed an underwritten public offering of $1.25 billion of the company's 2.20 percent Notes due 2020 and $750 million of the company's Floating Rate Notes due 2020 (the "May 2017 Debt Offering"). The proceeds of this offering were used to make a discretionary pension contribution to the company's principal U.S. pension plan, as discussed below.

The company's indenture covenants include customary limitations on liens, sale and leaseback transactions, and mergers and consolidations affecting manufacturing plants, mineral producing properties or research facilities located in the U.S. and the consolidated subsidiaries owning such plants, properties and facilities subject to certain limitations. The outstanding long-term debt also contains customary default provisions. In addition, the company will be required to redeem all of the Notes associated with the May 2017 Debt Offering at a redemption price equal to 100 percent of the aggregate principal amount plus any accrued and unpaid interest upon the announcement of the record date for the separation of either the agriculture or specialty products business, or the entry into an agreement to sell all or substantially all of the assets of either business to a third party.

28

Part II

ITEM 7.  MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS, continued

In March 2016, the company entered into a credit agreement that provides for a three-year, senior unsecured term loan facility in the aggregate principal amount of $4.5 billion (the "Term Loan Facility") under which DuPont may make up to seven term loan borrowings and amounts repaid or prepaid are not available for subsequent borrowings. The facility was amended in 2017 to extend the date on which the commitment to lend terminates to July 27, 2018. The proceeds from the borrowings under the Term Loan Facility will be used for the company's general corporate purposes including debt repayment, working capital and funding a portion of DowDuPont's costs and expenses. The Term Loan Facility matures in March 2019, unless extended by mutual agreement, at which time all outstanding borrowings, including accrued but unpaid interest, become immediately due and payable. As of December 31, 2017, the company had made three term loan borrowings in an aggregate principal amount of $1.5 billion and had unused commitments of $3 billion under the Term Loan Facility.

The Term Loan Facility and the amended revolving credit facility contain customary representations and warranties, affirmative and negative covenants, and events of default that are typical for companies with similar credit ratings and generally consistent with those applicable to DuPont’s long-term public debt. The Term Loan Facility and the amended revolving credit facility contain a financial covenant requiring that the ratio of Total Indebtedness to Total Capitalization for DuPont and its consolidated subsidiaries not exceed 0.6667. At December 31, 2017, the company was in compliance with this financial covenant.

The Term Loan Facility and the amended revolving credit facility impose additional affirmative and negative covenants on DuPont and its subsidiaries after the closing of the Merger, subject to certain limitations, including to:

• not sell, lease or otherwise convey to DowDuPont, its shareholders or its non-DuPont subsidiaries, any assets or properties of DuPont or its subsidiaries unless the aggregate amount of revenues attributable to all such assets and properties so conveyed after the merger does not exceed 30 percent of the consolidated revenues of DuPont and its subsidiaries as of December 31, 2015 (the Disposition Limitation); and

• not guarantee any indebtedness or other obligations of DowDuPont, Dow or their respective subsidiaries (other than of DuPont and its subsidiaries).

The Term Loan Facility and the amended revolving credit facility will terminate, and the loans and other amounts thereunder would become due and payable, upon the sale, transfer, lease or other disposition of all or substantially all of the assets of the agriculture product line to DowDuPont, its shareholders or any of its non-DuPont subsidiaries.

In January 2017, the company entered into a committed receivable repurchase facility of up to $1.3 billion (the "2017 Repurchase Facility") which expired on November 30, 2017. Under the facility, the company sold a portfolio of available and eligible outstanding customer notes receivables within the agriculture product line to participating institutions and simultaneously agreed to repurchase at a future date.

In February 2018, the company entered into a new committed receivable repurchase facility of up to $1.3 billion (the "2018 Repurchase Facility") which expires on December 15, 2018. The 2018 Repurchase Facility has substantially similar terms and conditions as the 2017 Repurchase Facility and includes the 2017 Repurchase Facility change of control language conformed to the Disposition Limitation covenant described above. See further discussion of the 2018 Repurchase Facility in Item 9B, Other Information and Note 22 to the Consolidated Financial Statements.

At the end of 2016, the company anticipated making contributions of approximately $230 million to its principal U.S. pension plan in 2017. During the period January 1 through August 31, 2017, the company made total contributions of $2.9 billion to its principal U.S pension plan, an increase of approximately $2.7 billion reflecting discretionary contributions. The discretionary contribution was funded through the May 2017 Debt Offering, as discussed above; short-term borrowings, including commercial paper issuance; and cash. The $2.9 billion contribution was taken as a deduction on the company’s 2016 federal tax return and resulted in a net operating loss for tax purposes.  This loss resulted in an overpayment of taxes paid of approximately $800 million.  A portion of the overpayment will be applied against the current year tax liability.  The remainder of the loss generated a refund of approximately $700 million which was received during the fourth quarter of 2017. 

29

Part II

ITEM 7.  MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS, continued

The company entered into a trust agreement in 2013 (as amended and restated in 2017) that established and requires DuPont to fund a trust (the "Trust") for cash obligations under certain nonqualified benefit and deferred compensation plans upon a change in control event as defined in the Trust agreement. Under the Trust agreement, the consummation of the Merger was a change in control event. As a result, in November 2017, the company contributed $571 million to the Trust. In the fourth quarter of 2017, $13 million was distributed to the company according to the Trust agreement and at December 31, 2017, the balance in the Trust was $558 million.

The company's cash, cash equivalents and marketable securities at December 31, 2017 and 2016 are $8.2 billion and $5.9 billion, respectively, of which $7.9 billion at December 31, 2017 and $5.7 billion at December 31, 2016 was held by subsidiaries in foreign countries, including United States territories. For each of its foreign subsidiaries, the company makes an assertion regarding the amount of earnings intended for permanent reinvestment, with the balance available to be repatriated to the United States.

The Tax Cuts and Jobs Act requires companies to pay a one-time transition tax on earnings of foreign subsidiaries, a majority of which were previously considered permanently reinvested by the company (see Note 7 for further details of the Tax Cuts and Jobs Act). The cash held by foreign subsidiaries for permanent reinvestment is generally used to finance the subsidiaries' operational activities and future foreign investments. A deferred tax liability has been accrued for the estimated U.S. Federal tax on all unrepatriated earnings as of December 31, 2017 in accordance with the Act. At December 31, 2017, management believed that sufficient liquidity is available in the United States. The company is currently evaluating the impact of the Act on its permanent reinvestment assertion. In the event that additional foreign funds are needed in the United States, the company has the ability to repatriate additional funds. The repatriation could result in an adjustment to the tax liability for foreign withholding taxes, foreign and/or U.S. state income taxes and the impact of foreign currency movements. As such, it is not practicable to calculate the unrecognized deferred tax liability on undistributed foreign earnings.

	Successor		Predecessor
(Dollars in millions)	For the Period September 1 through December 31, 2017		For the Period January 1 through August 31, 2017			2016		2015
Cash provided by (used for) operating activities	$	4,196	$	(3,949	)	$	3,357	$	2,422

Cash provided by operating activities was $4.2 billion for the period September 1 through December 31, 2017, primarily driven by seasonal cash flows related to the agriculture product line and a tax refund related to voluntary pension contributions made in the Predecessor period, partially offset by transaction costs and the PFOA multi-district litigation settlement, which was primarily paid in September. Cash used for operating activities was $3.9 billion for the period January 1 through August 31, 2017, primarily driven by pension contributions of $3.0 billion, seasonal cash flows related to the agriculture product line, transaction costs and tax payments, partially offset by earnings. Cash provided by operating activities was $3.4 billion for the year ended December 31, 2016, primarily due to earnings offset by tax payments, pension contributions and transaction costs.

Cash provided by operating activities increased $1.0 billion in 2016 compared to 2015 primarily due to a higher earnings contribution of approximately $0.5 billion, lower year-over-year income tax payments and lower working capital.

	Successor		Predecessor
(Dollars in millions)	For the Period September 1 through December 31, 2017		For the Period January 1 through August 31, 2017			2016			2015
Cash provided by (used for) investing activities	$	2,210	$	(2,382	)	$	(1,514	)	$	(1,828	)

Cash provided by investing activities was $2.2 billion for the period September 1 through December 31, 2017, primarily driven by $1.2 billion of cash received for the FMC transactions and net proceeds from investments, partially offset by the funding of the Rabbi Trust and capital expenditures. Cash used for investing activities was $2.4 billion for the period January 1 through August 31, 2017, primarily due to increased net purchases of investments, capital expenditures, payments for the acquisition of Granular and net payments from foreign currency contracts, partially offset by proceeds from the sale of property and businesses. Cash used for investing activities of $1.5 billion during the year ended December 31, 2016 was primarily due to $1.0 billion of capital expenditures, net purchases of investments and net payments from foreign currency contracts, partially offset by proceeds from the sale of property and businesses.

30

Part II

ITEM 7.  MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS, continued

Cash used for investing activities in 2016 increased by $0.3 billion compared to 2015. The change was primarily due to lower purchases of property, plant and equipment, lower net purchases of marketable securities and higher proceeds from sales of product lines and other assets. This is partially offset by cash outflows relating to foreign currency contract settlements. See Note 18 to the Consolidated Financial Statements for further discussion of marketable securities outstanding at December 31, 2016 and 2015.

Capital expenditures totaled $0.7 billion and $0.4 billion for the periods from January 1 through August 31, 2017 and September 1 through December 31, 2017, respectively, $1.0 billion in 2016, and $1.6 billion in 2015. The company expects 2018 capital expenditures to be about $1.7 billion, of which approximately $0.5 billion is related to the targeted cost synergies associated with the Merger and execution of the Intended Business Separations.

	Successor			Predecessor
(Dollars in millions)	For the Period September 1 through December 31, 2017			For the Period January 1 through August 31, 2017		2016			2015
Cash (used for) provided by financing activities	$	(3,227	)	$	5,632	$	(2,385	)	$	(1,929	)

Cash used for financing activities was $3.2 billion for the period September 1 through December 31, 2017, driven by a decrease in borrowings from commercial paper, distributions to DowDuPont and dividends paid to stockholders, partially offset by increased borrowings under the Term Loan. Cash provided by financing activities was $5.6 billion for the period January 1 through August 31, 2017, driven by the May 2017 Debt Offering as well as increased borrowings from commercial paper, the Repurchase Facility, and the Term Loan Facility, partially offset by dividends paid to stockholders. Cash used for financing activities of $2.4 billion during the year ended December 31, 2016 was driven by dividend payments to stockholders, repurchases of common stock, and repayments of long-term debt.

The $0.5 billion increase in cash used for financing activities in 2016 compared to 2015 was primarily due to lower borrowings as a result of the prior year distribution of approximately $3.9 billion which Chemours financed through external borrowings and paid to the company prior to its separation. This was partially offset by lower share repurchases and lower dividends paid to stockholders.

Dividend payments to shareholders of DuPont common and preferred stock totaled $0.3 billion during the period September 1 through December 31, 2017, which includes the third quarter dividend declared for common stockholders of record July 31, 2017 and paid in September 2017. Dividend payments to shareholders of DuPont common and preferred stock totaled $0.7 billion during the period January 1 through August 31, 2017, $1.3 billion in 2016, and $1.5 billion in 2015. Dividends per share of common stock were $1.14 for the period January 1 through August 31, 2017, $1.52 in 2016, and $1.72 in 2015.

In the first quarter 2015, DuPont announced its intention to buy back about $4 billion of shares of DuPont common stock using the distribution proceeds received from Chemours. During 2015, the company purchased and retired 35 million shares of DuPont common stock through a $2 billion accelerated share repurchase ("ASR") agreement and in 2016 purchased and retired 13.2 million shares in the open market at a cost of $916 million.

As of the consummation of the Merger, shares of DuPont common stock held publicly were redeemed and DuPont's common stock is owned solely by its parent company, DowDuPont. DuPont's preferred stock remains issued and outstanding, and DuPont continues to be responsible for dividends on its preferred stock; however, the obligation is not material to the company's liquidity. Dividend payments to shareholders of DuPont preferred stock totaled $3 million during the period September 1 through December 31, 2017, $7 million during the period January 1 through August 31, 2017, $10 million in 2016, and $10 million in 2015.

DowDuPont relies on distributions and other intercompany transfers from DuPont and Dow to fund payment of its costs and expenses. In November 2017, DowDuPont’s Board of Directors declared a fourth quarter dividend per share of DowDuPont common stock payable on December 15, 2017 and authorized an initial $4 billion share repurchase program to buy back shares of DowDuPont common stock. In the fourth quarter of 2017, DuPont declared and paid distributions in cash and in-kind to DowDuPont of $829 million, primarily to fund a portion of DowDuPont’s fourth quarter share repurchases and dividend payment.

See Note 15 to the Consolidated Financial Statements for additional information relating to the above share buyback plans.

31

Part II

ITEM 7.  MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS, continued

Critical Accounting Estimates

The company's significant accounting policies are more fully described in Note 1 to the Consolidated Financial Statements. Management believes that the application of these policies on a consistent basis enables the company to provide the users of the financial statements with useful and reliable information about the company's operating results and financial condition.

The preparation of the Consolidated Financial Statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts, including, but not limited to, receivable and inventory valuations, impairment of tangible and intangible assets, long-term employee benefit obligations, income taxes, restructuring liabilities, environmental matters and litigation. Management's estimates are based on historical experience, facts and circumstances available at the time and various other assumptions that are believed to be reasonable. The company reviews these matters and reflects changes in estimates as appropriate. Management believes that the following represents some of the more critical judgment areas in the application of the company's accounting policies which could have a material effect on the company's financial position, liquidity or results of operations.

Pension Plans and Other Post Employment Benefits

Accounting for employee benefit plans involves numerous assumptions and estimates. Discount rate and expected return on plan assets are two critical assumptions in measuring the cost and benefit obligation of the company's pension and other post employment benefit ("OPEB") plans. Management reviews these two key assumptions when plans are re-measured. These and other assumptions are updated periodically to reflect the actual experience and expectations on a plan specific basis as appropriate. As permitted by GAAP, actual results that differ from the assumptions are accumulated on a plan by plan basis and to the extent that such differences exceed 10 percent of the greater of the plan's benefit obligation or the applicable plan assets, the excess is amortized over the average remaining service period of active employees.

About 80 percent of the company's benefit obligation for pensions and essentially all of the company's OPEB obligations are attributable to the benefit plans in the U.S. In the U.S. the discount rate is developed by matching the expected cash flow of the benefit plans to a yield curve constructed from a portfolio of high quality fixed-income instruments provided by the plans' actuaries as of the measurement date. Effective in 2016, the company began to measure the service and interest cost components utilizing a full yield curve approach by applying the specific spot rates along the yield curve used in the determination of the benefit obligation to the relevant projected cash flows. The company made this change as it believes it is a more precise measurement of service and interest costs by improving the correlation between projected benefit cash flows to the corresponding spot yield curve rates. The company considers this a change in estimate, and, accordingly, has accounted for it on a prospective basis. This change does not affect the measure of the total benefit obligation. Historically, the service and interest cost components were estimated utilizing a single weighted-average discount rate derived from the yield curve and cash flow for measurement of the benefit obligation at the beginning of the period. For non-U.S. benefit plans, the company utilizes prevailing long-term high quality corporate bond indices to determine the discount rate, applicable to each country, at the measurement date.

Within the U.S., the company establishes strategic asset allocation percentage targets and appropriate benchmarks for significant asset classes with the aim of achieving a prudent balance between return and risk. Strategic asset allocations in other countries are selected in accordance with the laws and practices of those countries. Where appropriate, asset-liability studies are also taken into consideration. The long-term expected return on plan assets in the U.S. is based upon historical real returns (net of inflation) for the asset classes covered by the investment policy, expected performance, and projections of inflation and interest rates over the long-term period during which benefits are payable to plan participants. Consistent with prior years, the long-term expected return on plan assets in the U.S. reflects the asset allocation of the plan and the effect of the company's active management of the plan's assets. In connection with pension contributions of $2,900 million to its principal U.S. pension plan for the period of January 1, 2017 through August 31, 2017, an investment policy study was completed for the principal U.S. pension plan. The study resulted in new target asset allocations for the U.S. pension plan with resulting changes to the expected return on plan assets. The long-term rate of return on assets decreased from 8.00 percent for the Predecessor period to 6.25 percent for the Successor period in 2017.

32

Part II

ITEM 7.  MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS, continued

In determining annual expense for the principal U.S. pension plan, the company uses a market-related value of assets rather than its fair value. The market-related value of assets is calculated by averaging market returns over 36 months. Accordingly, there may be a lag in recognition of changes in market valuation. As a result, changes in the fair value of assets are not immediately reflected in the company's calculation of net periodic pension cost. The following table shows the market-related value and fair value of plan assets for the principal U.S. pension plan:

	Successor		Predecessor
(Dollars in billions)	December 31, 2017 1		December 31, 2016 1		December 31, 2015
Market-related value of assets	$	16.6	$	13.5	$	15.1
Fair value of plan assets	16.7		13.5		14.4

^1.  During the fourth quarter of 2017 and 2016, the plan's trust fund paid approximately $140 million and $550 million, respectively, to a group of separated, vested plan participants who elected a limited-time opportunity to receive a lump sum payout. See further discussion under "Long-term Employee Benefits" beginning on page 38.

For plans other than the principal U.S. pension plan, pension expense is determined using the fair value of assets.

The following table highlights the potential impact on the company's pre-tax earnings due to changes in certain key assumptions with respect to the company's pension and OPEB plans, based on assets and liabilities at December 31, 2017:

Pre-tax Earnings Benefit (Charge)	Successor
(Dollars in millions)	1/4 Percentage Point Increase			1/4 Percentage Point Decrease
Discount rate	$	(34	)	$	37
Expected rate of return on plan assets	49			(49		)

Additional information with respect to pension and OPEB expenses, liabilities and assumptions is discussed under "Long-term Employee Benefits" beginning on page 38 and in Note 16 to the Consolidated Financial Statements.

Environmental Matters

Accruals for environmental matters are recorded when it is probable that a liability has been incurred and the amount of the liability can be reasonably estimated. At December 31, 2017, the company had accrued obligations of $433 million for probable environmental remediation and restoration costs, including $67 million for the remediation of Superfund sites. As remediation activities vary substantially in duration and cost from site to site, it is difficult to develop precise estimates of future site remediation costs. The company's estimates are based on a number of factors, including the complexity of the geology, the nature and extent of contamination, the type of remedy, the outcome of discussions with regulatory agencies and other Potentially Responsible Parties (PRPs) at multi-party sites and the number of and financial viability of other PRPs. Therefore, considerable uncertainty exists with respect to environmental remediation and costs, and, under adverse changes in circumstances, it is reasonably possible that the ultimate cost with respect to these particular matters could range up to $900 million above that amount. Consequently, it is reasonably possible that environmental remediation and restoration costs in excess of amounts accrued could have a material impact on the company’s results of operations, financial condition and cash flows. It is the opinion of the company’s management, however, that the possibility is remote that costs in excess of the range disclosed will have a material impact on the company’s results of operations, financial condition or cash flows. For further discussion, see Environmental Matters in Management’s Discussion and Analysis of Financial Condition and Results of Operations and Notes 1 and 14 to the Consolidated Financial Statements.

33

Part II

ITEM 7.  MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS, continued

Legal Contingencies

The company's results of operations could be affected by significant litigation adverse to the company, including product liability claims, patent infringement and antitrust claims, and claims for third party property damage or personal injury stemming from alleged environmental torts. The company records accruals for legal matters when the information available indicates that it is probable that a liability has been incurred and the amount of the loss can be reasonably estimated. Management makes adjustments to these accruals to reflect the impact and status of negotiations, settlements, rulings, advice of counsel and other information and events that may pertain to a particular matter. Predicting the outcome of claims and lawsuits and estimating related costs and exposure involves substantial uncertainties that could cause actual costs to vary materially from estimates. In making determinations of likely outcomes of litigation matters, management considers many factors. These factors include, but are not limited to, the nature of specific claims including unasserted claims, the company's experience with similar types of claims, the jurisdiction in which the matter is filed, input from outside legal counsel, the likelihood of resolving the matter through alternative dispute resolution mechanisms, and the matter's current status. Considerable judgment is required in determining whether to establish a litigation accrual when an adverse judgment is rendered against the company in a court proceeding. In such situations, the company will not recognize a loss if, based upon a thorough review of all relevant facts and information, management believes that it is probable that the pending judgment will be successfully overturned on appeal. A detailed discussion of significant litigation matters is contained in Note 14 to the Consolidated Financial Statements.

Indemnification Assets

On July 1, 2015, DuPont completed the separation of its Performance Chemicals segment through the spin-off of all of the issued and outstanding stock of The Chemours Company (the "Separation"). In connection with the Separation, the company and The Chemours Company ("Chemours") entered into a Separation Agreement (the "Separation Agreement"). Pursuant to the Separation Agreement and the Amendment to the Separation Agreement discussed in Note 4 to the Consolidated Financial Statements, the company is indemnified by Chemours against certain litigation, environmental, workers' compensation, and other liabilities that arose prior to the separation. The term of this indemnification is indefinite and includes defense costs and expenses, as well as monetary and non-monetary settlements and judgments.  In connection with the recognition of liabilities related to these indemnified matters, the company records an indemnification asset when recovery is deemed probable.  In assessing the probability of recovery, the company considers the contractual rights under the Separation Agreement and the Amendment to the Separation Agreement and any potential credit risk.  Future events, such as potential disputes related to recovery as well as the solvency of Chemours, could cause the indemnification assets to have a lower value than anticipated and recorded. The company evaluates the recovery of the indemnification assets recorded when events or changes in circumstances indicate the carrying values may not be fully recoverable.  

Income Taxes

The breadth of the company's operations and the global complexity of tax regulations require assessments of uncertainties and judgments in estimating taxes the company will ultimately pay. The final taxes paid are dependent upon many factors, including negotiations with taxing authorities in various jurisdictions, outcomes of tax litigation and resolution of disputes arising from federal, state and international tax audits in the normal course of business. The resolution of these uncertainties may result in adjustments to the company's tax assets and tax liabilities. It is reasonably possible that changes to the company’s global unrecognized tax benefits could be significant; however, due to the uncertainty regarding the timing of completion of audits and possible outcomes, a current estimate of the range of increases or decreases that may occur within the next twelve months cannot be made.

Deferred income taxes result from differences between the financial and tax basis of the company's assets and liabilities and are adjusted for changes in tax rates and tax laws when changes are enacted. Valuation allowances are recorded to reduce deferred tax assets when it is more likely than not that a tax benefit will not be realized. Significant judgment is required in evaluating the need for and magnitude of appropriate valuation allowances against deferred tax assets. The realization of these assets is dependent on generating future taxable income, as well as successful implementation of various tax planning strategies. For example, changes in facts and circumstances that alter the probability that the company will realize deferred tax assets could result in recording a valuation allowance, thereby reducing the deferred tax asset and generating a deferred tax expense in the relevant period. In some situations these changes could be material.

34

Part II

ITEM 7.  MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS, continued

On December 22, 2017, the Act was enacted, making significant changes to the U.S. tax law (see Note 7 for further information). The SEC staff issued Staff Accounting Bulletin No. 118 (“SAB 118”), which provides guidance on accounting for the tax effects of the Act for which the accounting under Accounting Standards Codification 740 (“ASC 740”) is incomplete. To the extent that a company's accounting for certain income tax effects of the Act is incomplete but it is able to determine a reasonable estimate, it must record a provisional estimate in the financial statements. The provisional amounts, and adjustments identified in the measurement period, are recorded to the provision for income taxes on continuing operations in the period the amounts are determined. In accordance with Staff Accounting Bulletin 118 ("SAB 118"), during the measurement period, income tax effects of the Act may be refined upon obtaining, preparing, or analyzing additional information, and such changes could be material. During the measurement period, provisional amounts may be also be adjusted for the effects, if any, of interpretative guidance issued after December 31, 2017, by U.S. regulatory and standard-setting bodies. SAB 118 provides that the measurement period is complete when a company's accounting is complete and in no circumstances, should the measurement period extend beyond one year from the enactment date. If a company cannot determine a provisional estimate to be included in the financial statements, it should continue to apply ASC 740 on the basis of the provisions of the tax laws that were in effect immediately before enactment of the Act. Refer to Note 7 to the Consolidated Financial Statements for additional details related to the Act.

At December 31, 2017, the company had a net deferred tax liability balance of $5.4 billion, net of valuation allowance of $1.4 billion. Realization of deferred tax assets is expected to occur over an extended period of time. As a result, changes in tax laws, assumptions with respect to future taxable income, and tax planning strategies could result in adjustments to deferred tax assets. See Note 7 to the Consolidated Financial Statements for additional details related to the deferred tax liability balance.

Valuation of Assets and Impairment Considerations

The assets and liabilities of acquired businesses are measured at their estimated fair values at the dates of acquisition. The excess of the purchase price over the estimated fair value of the net assets acquired, including identified intangibles, is recorded as goodwill. The determination and allocation of fair value to the assets acquired and liabilities assumed is based on various assumptions and valuation methodologies requiring considerable management judgment, including estimates based on historical information, current market data and future expectations. The principal assumptions utilized in the company's valuation methodologies include revenue growth rates, operating margin estimates, royalty rates, and discount rates. Although the estimates are deemed reasonable by management based on information available at the dates of acquisition, those estimates are inherently uncertain.

Assessment of the potential impairment of goodwill, other intangible assets, property, plant and equipment, investments in nonconsolidated affiliates, and other assets is an integral part of the company's normal ongoing review of operations. Testing for potential impairment of these assets is significantly dependent on numerous assumptions and reflects management's best estimates at a particular point in time. The dynamic economic environments in which the company's diversified product lines operate, and key economic and product line assumptions with respect to projected selling prices, market growth and inflation rates, can significantly affect the outcome of impairment tests. Estimates based on these assumptions may differ significantly from actual results. Changes in factors and assumptions used in assessing potential impairments can have a significant impact on the existence and magnitude of impairments, as well as the time in which such impairments are recognized. In addition, the company continually reviews its diverse portfolio of assets to ensure they are achieving their greatest potential and are aligned with the company's growth strategy. Strategic decisions involving a particular group of assets may trigger an assessment of the recoverability of the related assets. Such an assessment could result in impairment losses.

The company performs goodwill impairment testing at the reporting unit level which is defined as the operating segment or one level below the operating segment. One level below the operating segment, or component, is a business in which discrete financial information is available and regularly reviewed by management. The company aggregates certain components into reporting units based on economic similarities. Subsequent to the Merger, the company identified nine reporting units.

For purposes of the annual goodwill impairment test, the company has the option to first perform qualitative testing to determine whether it is more likely than not that the fair value of a reporting unit is less than its carrying value. Qualitative factors assessed at the company level include, but are not limited to, GDP growth rates, long-term commodity prices, equity and credit market activity, discount rates, foreign exchange rates, and overall financial performance. Qualitative factors assessed at the reporting unit level include, but are not limited to, changes in industry and market structure, competitive environments, planned capacity and new product launches, cost factors such as raw material prices, and financial performance of the reporting unit. If the company chooses not to complete a qualitative assessment for a given reporting unit or if the initial assessment indicates that it is more likely than not that the carrying value of a reporting unit exceeds its estimated fair value, additional quantitative testing is required.

35

Part II

ITEM 7.  MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS, continued

In the predecessor period, the company completed the annual impairment test on July 1, 2017 when a quantitative assessment was performed on all reporting units that carry goodwill. Based on the results of the company's annual goodwill impairment test in the predecessor period, the company determined that the fair value of each of the reporting units exceeded its carrying value, and therefore there were no indications of impairment. The company's methodology for estimating the fair value of its reporting units is using the income approach based on the present value of future cash flows.

In connection with the Merger Transaction, the company adopted the policy of the parent company and performed its annual goodwill impairment test in the fourth quarter. In the fourth quarter of 2017, a qualitative assessment was performed on all reporting units that carry goodwill. For the qualitative assessments, management considered the factors discussed above at both the company level and the reporting unit level. Based on the qualitative assessment, management concluded it is not more likely than not that the carrying value of the reporting unit exceeds the fair value of the reporting unit. As discussed below, the company’s assets and liabilities were measured at fair value as of the date of the Merger, and as a result, any declines in projected cash flows could have a material, negative impact on the carrying value of the company's assets and therefore result in an impairment.

Purchase Accounting

Due to the Merger and the related accounting determination, DuPont has elected to apply the acquisition method of accounting, which requires that all assets and liabilities be remeasured to fair value as of the date of the Merger. Such fair values have been reflected in the company's financial statements following the push-down method of accounting. Estimates of fair value require a complex series of judgments about future events and uncertainties. The estimates and assumptions used to determine the preliminary estimated fair value assigned to each class of assets and liabilities, as well as asset lives, have a material impact to the company's consolidated financial statements, and are based upon assumptions believed to be reasonable but that are inherently uncertain. Third party valuation specialists were engaged to assist in the valuation of certain of these assets and liabilities.

36

Part II

ITEM 7.  MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS, continued

Off-Balance Sheet Arrangements

Certain Guarantee Contracts

Information with respect to the company's guarantees is included in Note 14 to the Consolidated Financial Statements. Historically, the company has not had to make significant payments to satisfy guarantee obligations; however, the company believes it has the financial resources to satisfy these guarantees.

Contractual Obligations

Information related to the company's significant contractual obligations is summarized in the following table:

			Payments Due In
(Dollars in millions)	Total at December 31, 2017		2018		2019-2020		2021-2022		2023 and beyond
Long-term debt and capital lease obligations1,2	$	11,113	$	1,286	$	5,010	$	1,507	$	3,310
Expected cumulative cash requirements      for interest payments through maturity	2,669		385		502		275		1,507
Operating leases	1,044		264		327		185		268
Purchase obligations3
Information technology infrastructure & services	163		93		64		6		—
Raw material obligations	1,630		530		546		527		27
Utility obligations	105		66		23		11		5
Other	90		70		12		8		—
Total purchase obligations	1,988		759		645		552		32
Other liabilities1,4
Pension and other post employment benefits	8,139		456		778		730		6,175
Workers' compensation	78		13		35		15		15
Environmental remediation	433		146		149		71		67
License agreements5	1,173		230		382		316		245
Other6	262		82		45		39		96
Total other long-term liabilities	10,085		927		1,389		1,171		6,598
Total contractual obligations7	$	26,899	$	3,621	$	7,873	$	3,690	$	11,715

^1.  Included in the Consolidated Financial Statements.

^2.  Excludes unamortized debt step-up premium of $492 million.

^3.  Represents enforceable and legally binding agreements in excess of $1 million to purchase goods or services that specify fixed or minimum quantities; fixed, minimum or variable price provisions; and the approximate timing of the agreement.

^4.  The company's contractual obligations do not reflect an offset for recoveries associated with indemnifications by Chemours in accordance with the Separation Agreement. Refer to Notes 4 and 14 to the Consolidated Financial Statements for additional detail related to the indemnifications.

^5.  Represents undiscounted remaining payments under DuPont Pioneer license agreements ($1,079 million on a discounted basis).

^6.  Primarily represents employee-related benefits other than pensions and other post employment benefits.

^7.  Due to uncertainty regarding the completion of tax audits and possible outcomes, the timing of certain payments of obligations related to unrecognized tax benefits cannot be made and have been excluded from the table above. See Note 7 to the Consolidated Financial Statements for additional detail.

The company expects to meet its contractual obligations through its normal sources of liquidity and believes it has the financial resources to satisfy these contractual obligations.

37

Part II

ITEM 7.  MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS, continued

Long-term Employee Benefits

The company has various obligations to its employees and retirees. The company maintains retirement-related programs in many countries that have a long-term impact on the company's earnings and cash flows. These plans are typically defined benefit pension plans, as well as medical, dental and life insurance benefits for pensioners and survivors and disability benefits for employees (other post employment benefits or OPEB plans). Approximately 80 percent of the company's worldwide benefit obligation for pensions and essentially all of the company's worldwide OPEB obligations are attributable to the U.S. benefit plans.

Pension coverage for employees of the company's non-U.S. consolidated subsidiaries is provided, to the extent deemed appropriate, through separate plans. The company regularly explores alternative solutions to meet its global pension obligations in the most cost effective manner possible as demographics, life expectancy and country-specific pension funding rules change. Where permitted by applicable law, the company reserves the right to change, modify or discontinue its plans that provide pension, medical, dental, life insurance and disability benefits.

Benefits under defined benefit pension plans are based primarily on years of service and employees' pay near retirement. In November 2016, the company announced changes to the U.S. pension and OPEB plans. The company will freeze the pay and service amounts used to calculate pension benefits for active employees who participate in the U.S. pension plans on November 30, 2018. Therefore, as of November 30, 2018, active employees participating in the U.S. pension plans will not accrue additional benefits for future service and eligible compensation received. In addition to the changes to the U.S. pension plans, OPEB eligible employees who will be under the age of 50 as of November 30, 2018 will not receive post-retirement medical, dental and life insurance benefits. As a result of these changes, the company recognized a pre-tax curtailment gain of $382 million during the fourth quarter of 2016. The majority of employees hired in the U.S. on or after January 1, 2007 are not eligible to participate in the pension and post-retirement medical, dental and life insurance plans, but receive benefits in the defined contribution plans.

In the fourth quarter 2016, about $550 million of lump-sum payments were made from the principal U.S. pension plan trust fund to a group of separated, vested plan participants who were extended a limited-time opportunity and voluntarily elected to receive their pension benefits in a single lump-sum payment. In the fourth quarter 2017, about $140 million of lump sum payments were made from the principal U.S. pension plan trust fund under a similar program.

Pension benefits are paid primarily from trust funds established to comply with applicable laws and regulations. Unless required by law, the company does not make contributions that are in excess of tax deductible limits. The actuarial assumptions and procedures utilized are reviewed periodically by the plans' actuaries to provide reasonable assurance that there will be adequate funds for the payment of benefits. The company contributed $2,900 million to the principal U.S. pension plan for the period January 1, 2017 through August 31, 2017. The company does not expect to make cash contributions to this plan in 2018.

Funding for each pension plan other than the principal U.S. pension plan is governed by the rules of the sovereign country in which it operates. Thus, there is not necessarily a direct correlation between pension funding and pension expense. In general, however, improvements in plans' funded status tends to moderate subsequent funding needs. The company contributed $34 million, $67 million, $121 million and $164 million to its funded pension plans other than the principal U.S. pension plan for the period September 1 through December 31, 2017, for the period January 1 through August 31, 2017, and for the years ended December 31, 2016 and 2015, respectively.

U.S. pension benefits that exceed federal limitations are covered by separate unfunded plans and these benefits are paid to pensioners and survivors from operating cash flows. The company's remaining pension plans with no plan assets are paid from operating cash flows. The company made benefit payments of $34 million, $57 million, $184 million and $144 million to its unfunded plans for the period September 1 through December 31, 2017, for the period January 1 through August 31, 2017, and for the years ended December 31, 2016 and 2015, respectively.

The company's OPEB plans are unfunded and the cost of the approved claims is paid from operating cash flows. Pre-tax cash requirements to cover actual net claims costs and related administrative expenses were $59 million, $166 million, $218 million, and $237 million for the period September 1 through December 31, 2017, for the period January 1 through August 31, 2017, and for the years ended December 31, 2016 and 2015, respectively. Changes in cash requirements reflect the net impact of higher per capita health care costs, demographic changes, plan amendments and changes in participant premiums, co-pays and deductibles.

In 2018, the company expects to contribute approximately $200 million to its funded pension plans other than the principal U.S. pension plan and its remaining plans with no plan assets, and about $250 million for its OPEB plans.

38

Part II

ITEM 7.  MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS, continued

The company's income can be significantly affected by pension and defined contribution benefits as well as OPEB costs. The following table summarizes the extent to which the company's income for the period September 1 through December 31, 2017, for the period January 1 through August 31, 2017 and for the years ended December 31, 2016 and 2015 was affected by pre-tax charges related to long-term employee benefits:

	Successor			Predecessor
	For the Period September 1 through December 31, 2017			For the Period January 1 through August 31, 2017		For the Year Ended December 31, 2016		For the Year Ended December 31, 2015
(Dollars in millions)
Long-term employee benefit plan (benefit) charges 1	$	(12	)	$	538	$	442	$	616

1. The long-term employee benefit plan (benefit) charges include discontinued operations of $2 million, $8 million, $6 million and ($233) million for the periods September 1 through December 31, 2017 and January 1 through August 31, 2017 and for the years ended December 31, 2016 and 2015, respectively.

The above (benefit) charges for pension and OPEB are determined as of the beginning of each period. Activity for the period September 1 through December 31, 2017 benefited from the absence of the amortization of net losses from AOCL.  Long-term employee benefit expense in 2016 include a $382 million curtailment gain as a result of changes made to the U.S. Pension and OPEB benefits in 2016 described above. See "Pension Plans and Other Post Employment Benefits" under the Critical Accounting Estimates section beginning on page 32 of this report for additional information on determining annual expense.

For 2018, long term employee benefit expense from continuing operations is expected to decrease by about $500 million. The decrease is mainly due to the absence of the amortization of net losses and prior service benefit from AOCL, which were $518 million during the period January 1 through August 31, 2017.

39

Part II

ITEM 7.  MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS, continued

Environmental Matters

The company operates global manufacturing, product handling and distribution facilities that are subject to a broad array of environmental laws and regulations. Such rules are subject to change by the implementing governmental agency, and the company monitors these changes closely. Company policy requires that all operations fully meet or exceed legal and regulatory requirements. In addition, the company implements voluntary programs to reduce air emissions, minimize the generation of hazardous waste, decrease the volume of water use and discharges, increase the efficiency of energy use and reduce the generation of persistent, bioaccumulative and toxic materials. Management has noted a global upward trend in the amount and complexity of proposed chemicals regulation. The costs to comply with complex environmental laws and regulations, as well as internal voluntary programs and goals, are significant and will continue to be significant for the foreseeable future.

Pre-tax environmental expenses charged to income from continuing operations are summarized below:

	Successor		Predecessor
(Dollars in millions)	For the Period Sep 1 - Dec 31, 2017		For the Period Jan 1 - Aug 31, 2017		Dec 31, 2016		Dec 31, 2015
Environmental operating costs	$	85	$	205	$	335	$	346
Environmental remediation costs	8		65		62		66
	$	93	$	270	$	397	$	412

About 66 percent of total pre-tax environmental expenses charged to income from continuing operations for the period September 1 through December 31, 2017 and for the period January 1 through August 31, 2017, respectively, resulted from operations in the U.S. Based on existing facts and circumstances, management does not believe that year over year changes, if any, in environmental expenses charged to current operations will have a material impact on the company's financial position, liquidity or results of operations. Annual expenditures in the near term are not expected to vary significantly from the range of such expenditures experienced in the past few years. Longer term, expenditures are subject to considerable uncertainty and may fluctuate significantly.

Environmental Operating Costs

As a result of its operations, the company incurs costs for pollution abatement activities including waste collection and disposal, installation and maintenance of air pollution controls and wastewater treatment, emissions testing and monitoring, and obtaining permits. The company also incurs costs related to environmental related research and development activities including environmental field and treatment studies as well as toxicity and degradation testing to evaluate the environmental impact of products and raw materials.

40

Part II

ITEM 7.  MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS, continued

Remediation Accrual

Changes in the remediation accrual balance are summarized below:

(Dollars in millions)
Balance at December 31, 2015 (Predecessor)	$	492
Remediation payments	(52		)
Net increase in remediation accrual 1	62
Net change, indemnification 2	(45		)
Balance at December 31, 2016	$	457
Remediation payments	(53		)
Net increase in remediation accrual 1	65
Net change, indemnification 2	14
Balance at August 31, 2017	$	483
Balance at September 1, 2017 (Successor)	483
Remediation payments	(40		)
Net increase in remediation accrual 1	8
Net change, indemnification 2	(18		)
Balance at December 31, 2017	$	433

1. Excludes indemnified remediation obligations.

2. Net change in indemnified remediation obligations. Pursuant to the Separation Agreement, as discussed below and in Note 4 to the Consolidated Financial Statements, DuPont is indemnified by Chemours for certain environmental matters.

Considerable uncertainty exists with respect to environmental remediation costs, and, under adverse changes in circumstances, the potential liability may range up to $920 million above the amount accrued as of December 31, 2017. However, based on existing facts and circumstances, management does not believe that any loss, in excess of amounts accrued, related to remediation activities at any individual site will have a material impact on the financial position, liquidity or results of operations of the company.

Pursuant to the Separation Agreement discussed in Note 4 to the Consolidated Financial Statements, the company is indemnified by Chemours for certain environmental matters, included in the liability of $433 million, that have an estimated liability of $242 million at December 31, 2017 and a potential exposure that ranges up to approximately $430 million above the amount accrued. As such, the company has recorded an indemnification asset of $242 million corresponding to the company's accrual balance related to these matters at December 31, 2017.

As of December 31, 2017, the company has been notified of potential liability under the Comprehensive Environmental Response, Compensation and Liability Act ("Superfund") or similar state laws at about 500 sites around the U.S., including approximately 100 sites for which DuPont does not believe it has liability based on current information. Active remediation is under way at 62 of these sites. In addition, the company has resolved its liability at approximately 200 sites, either by completing remedial actions with other PRPs or by participating in "de minimis buyouts" with other PRPs whose waste, like the company's, represented only a small fraction of the total waste present at a site. The company received notice of potential liability at 3 new sites during 2017 compared with single notices in both 2016 and 2015.

Environmental Capital Expenditures

Capital expenditures for environmental projects, either required by law or necessary to meet the company’s internal environmental goals, were $18 million and $35 million for the period September 1 through December 31, 2017 and for the period January 1 through August 31, 2017, respectively. The company currently estimates expenditures for environmental-related capital projects to be approximately $44 million in 2018.

41

Part II

ITEM 7.  MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS, continued

Climate Change

The company believes that climate change is an important global issue that presents risks and opportunities. Expanding upon significant global greenhouse gas (GHG) emissions and other environmental footprint reductions made in the period 1990-2010, in 2015, the company announced its 2020 Sustainability Goals, including a goal to achieve a 7 percent reduction in GHG emissions intensity (2015 baseline) and a 10 percent improvement in energy intensity (2010 baseline). As of 2016, the company achieved reductions of 1.3 percent in GHG emissions intensity against the goal baseline of 2015, and 8 percent since 2010. In addition, the company has achieved a 10.8 percent improvement in energy intensity since 2010. The company continuously evaluates opportunities for existing and new product and service offerings in light of the anticipated demands of a low-carbon economy.

The company is actively engaged in efforts to develop constructive public policies to reduce GHG emissions and encourage lower carbon forms of energy. Such policies may bring higher operating costs as well as greater revenue and margin opportunities. Legislative efforts to control or limit GHG emissions could affect the company's energy source and supply choices as well as increase the cost of energy and raw materials derived from fossil fuels. Such efforts are also anticipated to provide the business community with greater certainty for the regulatory future, help guide investment decisions, and drive growth in demand for low-carbon and energy-efficient products, technologies, and services. Similarly, demand is expected to grow for products that facilitate adaptation to a changing climate. However, the current unsettled policy environment in the U.S., where many company facilities are located, adds an element of uncertainty to business decisions, particularly those relating to long-term capital investments.

In addition, significant differences in regional or national approaches could present challenges in a global marketplace. An effective global climate policy framework will help drive the market changes that are needed to stimulate and efficiently deploy new innovations in science and technology, while maintaining open and competitive global markets.

42

Part II

ITEM 7A.  QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

The company’s global operations are exposed to financial market risks relating to fluctuations in foreign currency exchange rates, commodity prices, and interest rates. The company has established a variety of programs including the use of derivative instruments and other financial instruments to manage the exposure to financial market risks as to minimize volatility of financial results. In the ordinary course of business, the company enters into derivative instruments to hedge its exposure to foreign currency, interest rate and commodity price risks under established procedures and controls. For additional information on these derivatives and related exposures, see Note 18 to the Consolidated Financial Statements. Decisions regarding whether or not to hedge a given commitment are made on a case-by-case basis, taking into consideration the amount and duration of the exposure, market volatility and economic trends. Foreign currency exchange contracts are also used, from time to time, to manage near-term foreign currency cash requirements.

Foreign Currency Exchange Rate Risks

The company has significant international operations resulting in a large number of currency transactions that result from international sales, purchases, investments and borrowings. The primary currencies for which the company has an exchange rate exposure are the European euro (EUR), Chinese yuan, Brazilian real, and Japanese yen. The company uses forward exchange contracts to offset its net exposures, by currency, related to the foreign currency denominated monetary assets and liabilities of its operations. In addition to the contracts disclosed in Note 18 to the Consolidated Financial Statements, from time to time, the company will enter into foreign currency exchange contracts to establish with certainty the U.S. dollar (USD) amount of future firm commitments denominated in a foreign currency.

The following table illustrates the fair values of outstanding foreign currency contracts at December 31, 2017 and 2016, and the effect on fair values of a hypothetical adverse change in the foreign exchange rates that existed at December 31, 2017 and 2016. The sensitivities for foreign currency contracts are based on a 10 percent adverse change in foreign exchange rates.

	Fair Value (Liability)/Asset					Fair Value Sensitivity
	Successor			Predecessor		Successor			Predecessor
(Dollars in millions)	2017			2016		2017			2016
Foreign currency contracts	$	(33	)	$	61	$	(863	)	$	(567	)

Since the company's risk management programs are highly effective, the potential loss in value for each risk management portfolio described above would be largely offset by changes in the value of the underlying exposure.

Concentration of Credit Risk

The company maintains cash and cash equivalents, marketable securities, derivatives and certain other financial instruments with various financial institutions. These financial institutions are generally highly rated and geographically dispersed and the company has a policy to limit the dollar amount of credit exposure with any one institution.

As part of the company's financial risk management processes, it continuously evaluates the relative credit standing of all of the financial institutions that service DuPont and monitors actual exposures versus established limits. The company has not sustained credit losses from instruments held at financial institutions.

The company's sales are not materially dependent on any single customer. As of December 31, 2017, no one individual customer balance represented more than five percent of the company's total outstanding receivables balance. Credit risk associated with its receivables balance is representative of the geographic, industry and customer diversity associated with the company's global product lines.

The company also maintains strong credit controls in evaluating and granting customer credit. As a result, it may require that customers provide some type of financial guarantee in certain circumstances. Length of terms for customer credit varies by industry and region.

43

Part II

ITEM 8.  FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA

The financial statements and supplementary data required by this Item are included herein, commencing on page F-1 of this report.

ITEM 9.  CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND FINANCIAL DISCLOSURE

None.

ITEM 9A.  CONTROLS AND PROCEDURES

The company maintains a system of disclosure controls and procedures to give reasonable assurance that information required to be disclosed in the company's reports filed or submitted under the Securities Exchange Act of 1934 (Exchange Act) is recorded, processed, summarized and reported within the time periods specified in the rules and forms of the SEC. These controls and procedures also give reasonable assurance that information required to be disclosed in such reports is accumulated and communicated to management to allow timely decisions regarding required disclosures.

As of December 31, 2017, the company's Chief Executive Officer (CEO) and Chief Financial Officer (CFO), together with management, conducted an evaluation of the effectiveness of the company's disclosure controls and procedures pursuant to Rules 13a-15(e) and 15d-15(e) of the Exchange Act. Based on that evaluation, the CEO and CFO concluded that these disclosure controls and procedures are effective.

There has been no change in the company's internal control over financial reporting that occurred during the fourth quarter of 2017 that has materially affected, or is reasonably likely to materially affect, the company's internal control over financial reporting. The company has completed its evaluation of its internal controls and has concluded that the company's system of internal controls over financial reporting was effective as of December 31, 2017 (see page F-2).

The company completed its acquisition of the Health and Nutrition Business (the "H&N Business") from FMC Corporation on November 1, 2017. As a result, management has excluded this business from its assessment of internal control over financial reporting as of December 31, 2017. The total assets of the H&N Business that were excluded from the assessment represented less than two percent of the company's total assets as of December 31, 2017. The total net sales of the H&N Business that were excluded from the assessment represented less than two percent of the company's total sales for the period September 1 to December 31, 2017.

ITEM 9B.  OTHER INFORMATION

In February 2018, the company entered into a new committed receivable repurchase facility of up to $1,300 (the "2018 Repurchase Facility") which expires in December 2018. Under the 2018 Repurchase Facility, DuPont may sell a portfolio of available and eligible outstanding customer notes receivables within the agriculture product line to participating institutions and simultaneously agree to repurchase at a future date. The 2018 Repurchase Facility is considered a secured borrowing with the customer notes receivables, inclusive of those that are sold and repurchased, equal to 105 percent of the outstanding amounts borrowed utilized as collateral. Borrowings under the 2018 Repurchase Facility will have an interest rate of LIBOR + 0.75 percent.

44

Part III

ITEM 10.  DIRECTORS, EXECUTIVE OFFICERS AND CORPORATE GOVERNANCE

The Registrant meets the conditions set forth in General Instruction I(1)(a), (b) and (d) of Form 10-K (as modified by a grant of no-action relief dated February 12, 2018) and is therefore filing this form with the reduced disclosure format and has omitted the information called for by this Item pursuant to General Instruction I(2)(c) of Form 10-K.

ITEM 11.  EXECUTIVE COMPENSATION

The Registrant meets the conditions set forth in General Instruction I(1)(a), (b) and (d) of Form 10-K (as modified by a grant of no-action relief dated February 12, 2018) and is therefore filing this form with the reduced disclosure format and has omitted the information called for by this Item pursuant to General Instruction I(2)(c) of Form 10-K.

ITEM 12. SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED STOCKHOLDER MATTERS

The Registrant meets the conditions set forth in General Instruction I(1)(a), (b) and (d) of Form 10-K (as modified by a grant of no-action relief dated February 12, 2018) and is therefore filing this form with the reduced disclosure format and has omitted the information called for by this Item pursuant to General Instruction I(2)(c) of Form 10-K.

ITEM 13.  CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS, AND DIRECTOR INDEPENDENCE

The Registrant meets the conditions set forth in General Instruction I(1)(a), (b) and (d) of Form 10-K (as modified by a grant of no-action relief dated February 12, 2018) and is therefore filing this form with the reduced disclosure format and has omitted the information called for by this Item pursuant to General Instruction I(2)(c) of Form 10-K.

45

Part III

ITEM 14.  PRINCIPAL ACCOUNTANT FEES AND SERVICES

Independent Public Accountants

PricewaterhouseCoopers LLP ("PwC"), an independent registered public accounting firm, has served as the company’s independent accountants continuously since 1954. PwC has issued its reports, included in the company’s Form 10-K, on the audited consolidated financial statements of the Company and internal control over financial reporting for the period January 1 through August 31, 2017 (the "Predecessor" period) and the period September 1 through December 31, 2017 (the "Successor" period). The DuPont Audit Committee appointed PwC to be the independent auditor for fiscal year 2017, which was ratified by holders of DuPont Common Stock on May 24, 2017.

To assure that the audit and non-audit services performed by the independent registered public accounting firm do not impair its independence in appearance and/or fact, the committee established policies and procedures requiring its pre-approval of all such services and associated fees. These policies and procedures required the independent registered public accounting firm to submit a report annually regarding the audit, audit-related, tax and other services it expects to render in the following year and the associated, forecasted fees to the committee for its approval. Audit services include the audit of the company’s Consolidated Financial Statements, separate audits of its subsidiaries, services associated with regulatory filings and attestation services regarding the effectiveness of the company’s internal controls over financial reporting. Audit-related services are assurance services that are reasonably related to the audit of the company’s Consolidated Financial Statements or services traditionally provided by the independent registered public accounting firm. Audit-related services include employee benefit plan audits; audits of carve-out financial statements related to divestitures; due diligence services regarding potential acquisitions or dispositions, including tax-related due diligence; and agreed-upon or expanded audit procedures related to regulatory requirements. Tax services include selected non-U.S. tax compliance services, advice and recommendation with respect to issues such as tax audits and appeals, restructurings, mergers and acquisitions, and assistance regarding appropriate handling of items on the returns, required disclosures, elections and filing positions available to the company. Other services include non-financial attestation, assessment and advisory services.

In accordance with its pre-approval policies and procedures, the committee pre-approved all services rendered by and associated fees paid to PwC, including services related to the Merger Transaction and Intended Business Separations, for calendar years 2017 and 2016. These are shown by category in the following table.

(in millions)	2017		2016
Audit Fees1	$	26.6	$	14.5
Audit-Related Fees2	26.2		22.0
Tax Fees	—		0.2
All Other Fees	0.1		—
Total	$	52.9	$	36.7

1. Audit Fees paid to PwC in 2017 increased versus prior year primarily due to services related to (i) two audits being required in 2017 (Predecessor and Successor), and (ii) the Merger Transaction, including purchase accounting and other merger-related technical issues.

2. Audit-Related Fees paid to PwC in 2017 and 2016 primarily relate to the Intended Business Separations.

46

Part IV

ITEM 15.  EXHIBITS AND FINANCIAL STATEMENT SCHEDULES

(a) Financial Statements, Financial Statement Schedules and Exhibits:

1. Financial Statements (See the Index to the Consolidated Financial Statements on page F-1 of this report).

2. Financial Statement Schedules

Schedule II—Valuation and Qualifying Accounts

(Dollars in millions)

	Successor			Predecessor
	For the Period September 1 through December 31, 2017			For the Period January 1 through August 31, 2017			For the Year Ended December 31, 2016			For the Year Ended December 31, 2015
Accounts Receivable—Allowance for Doubtful Receivables
Balance at beginning of period	$	—		$	287		$	225		$	235
Additions charged to expenses	10			51			119			58
Deductions from reserves1	—			(33		)	(57		)	(68		)
Balance at end of period	$	10		$	305		$	287		$	225
Inventory—Obsolescence Reserve
Balance at beginning of period	$	—		$	214		$	237		$	179
Additions charged to expenses	89			241			275			391
Deductions from reserves2	(34		)	(181		)	(298		)	(333		)
Balance at end of period	$	55		$	274		$	214		$	237
Deferred Tax Assets—Valuation Allowance
Balance at beginning of period	$	1,323		$	1,308		$	1,529		$	1,704
Additions charged to expenses	84			95			74			40
Deductions from reserves	(29		)	(20		)	(295		)	(215		)
Balance at end of period	$	1,378		$	1,383		$	1,308		$	1,529

^1. Deductions include write-offs, recoveries and currency translation adjustments.

^2. Deductions include disposals and currency translation adjustments.

Financial Statement Schedules listed under SEC rules but not included in this report are omitted because they are not applicable or the required information is shown in the Consolidated Financial Statements or notes thereto incorporated by reference.

47

Part IV

ITEM 15.  EXHIBITS AND FINANCIAL STATEMENT SCHEDULES,continued

3. Exhibits

The following list of exhibits includes both exhibits submitted with this Form 10-K as filed with the SEC and those incorporated by reference to other filings:

Exhibit Number	Description
3.1	Company’s Amended and Restated Certificate of Incorporation (incorporated by reference to Exhibit 3.1 to the company’s Current Report on Form 8-K (Commission file number 1-815) dated September 1, 2017).
3.2	Company’s Amended and Restated Bylaws (incorporated by reference to Exhibit 3.2 to the company's Current Report on Form 8-K (Commission file number 1-815) for the period ended September 1, 2017).
4	The Company agrees to provide the Commission, on request, copies of instruments defining the rights of holders of long-term debt of the company and its subsidiaries.
10.1**	Separation Agreement by and between the Company and The Chemours Company (incorporated by reference to Exhibit 2.1 to the company's Current Report on Form 8-K (Commission file number 1-815) dated July 8, 2015).
10.2	Amendment No. 1 to Separation Agreement by and between the Company and The Chemours Company, dated August 24, 2017 (incorporated by reference to Exhibit 2.1 to the company's Current Report on Form 8-K (Commission file number 1-815) dated August 25, 2017).
10.3	Tax Matters Agreement by and between the Company and The Chemours Company (incorporated by reference to Exhibit 2.2 to the company's Current Report on Form 8-K (Commission file number 1-815) dated July 8, 2015).
10.4**	Master Repurchase Agreement by and among Cooperatieve Rabobank, U.A. (New York Branch), The Bank of Tokyo Mitsubishi UFJ Ltd. (New York Branch) and PHI Financial Services, Inc. dated as of February 13, 2018.
10.5**	Master Framework Agreement by and among Cooperatieve Rabobank, U.A. (New York Branch), The Bank of Tokyo Mitsubishi UFJ Ltd. (New York Branch) and PHI Financial Services, Inc. dated as of February 13, 2018.
10.6	Agreement and Plan of Merger by and between the Company and The Dow Chemical Company, dated as of December 11, 2015 (incorporated by reference to Exhibit 2.1 to the Company's Current Report on Form 8-K (Commission file number 1-815) dated December 11, 2015).
10.7	Amendment No. 1, dated March 31, 2017, to the Agreement and Plan of Merger, dated as of December 11, 2015 by and among the Company, The Dow Chemical Company, Diamond Merger Sub, Inc., Orion Merger Sub, Inc. and Diamond-Orion HoldCo, Inc. (n/k/a DowDuPont Inc.) (incorporated by reference to Exhibit 2.1 to the Company’s current report on Form 8-K (Commission file number 1-815) dated March 31, 2017).
10.8**	Transaction Agreement, dated as of March 31, 2017, by and between the Company and FMC Corporation (incorporated by reference to Exhibit 10.25 to the Company’s Quarterly Report on Form 10-Q (Commission file number 1-815) for the period ended March 31, 2017).
10.9**	Purchase Price Allocation Side Letter Agreement, dated as of May 12, 2017, by and between the Company and FMC Corporation (incorporated by reference to Exhibit 10.26 to the Company’s Quarterly Report on Form 10-Q (Commission file number 1-815) for the period ended June 30, 2017).
10.10	Employment Agreement by and between the Company and Edward D. Breen, dated as of August 31, 2017, (incorporated by reference to Exhibit 10.1 to the Company's Current Report on Form 8-K (Commission file number 1-815) dated September 1, 2017).
10.11*	The E. I. du Pont de Nemours and Company Equity Incentive Plan, incorporated by reference to Exhibit 4.1 to DowDuPont Inc. Registration Statement on Form S-8 filed September 1, 2017.
10.12*	The E. I. du Pont de Nemours and Company Stock Performance Plan, incorporated by reference to Exhibit 4.2 to DowDuPont Inc. Registration Statement on Form S-8 filed September 1, 2017.
10.13*	The E. I. du Pont de Nemours and Company Management Deferred Compensation Plan, incorporated by reference to Exhibit 4.3 to DowDuPont Inc. Registration Statement on Form S-8 filed September 1, 2017.
10.14*	The E. I. du Pont de Nemours and Company Stock Accumulation and Deferred Compensation Plan for Directors, incorporated by reference to Exhibit 4.4 to DowDuPont Inc. Registration Statement on Form S-8 filed September 1, 2017.
10.15*	DuPont’s Pension Restoration Plan, as last amended effective June 29, 2015 (incorporated by reference to Exhibit 10.3 to the Company’s Quarterly Report on Form 10-Q (Commission file number 1-815) for the period ended June 30, 2015).

48

Part IV

ITEM 15.  EXHIBITS AND FINANCIAL STATEMENT SCHEDULES,continued

10.16*	DuPont’s Supplemental Retirement Income Plan, as last amended effective December 18, 1996 (incorporated by reference to Exhibit 10.2 to the Company’s Annual Report on Form 10-K (Commission file number 1-815) for the year ended December 31, 2011).
10.17*	DuPont’s Rules for Lump Sum Payments, as last amended effective May 15, 2014 (incorporated by reference to Exhibit 10.4 to the Company’s Quarterly Report on Form 10-Q (Commission file number 1-815) for the period ended June 30, 2015).
10.18*	DuPont’s Retirement Savings Restoration Plan, as last amended effective May 15, 2014. (incorporated by reference to Exhibit 10.08 to the Company’s Quarterly Report on Form 10-Q (Commission file number 1-815) for the period ended June 30, 2014).
10.19*	DuPont’s Retirement Income Plan for Directors, as last amended January 2011 (incorporated by reference to Exhibit 10.9 to the Company’s Quarterly Report on Form 10-Q (Commission file number 1-815) for the period ended March 31, 2012).
10.20**	DuPont's Senior Executive Severance Plan, as amended and restated effective December 10, 2015 (incorporated by reference to Exhibit 10.10 to the Company’s Annual Report on Form 10-K (Commission file number 1-815) for the year ended December 31, 2015).
12	Computation of Ratio of Earnings to Fixed Charges.
21	Subsidiaries of the Registrant.
23	Consent of Independent Registered Public Accounting Firm.
31.1	Rule 13a-14(a)/15d-14(a) Certification of the company’s Principal Executive Officer.
31.2	Rule 13a-14(a)/15d-14(a) Certification of the company’s Principal Financial Officer.
32.1	Section 1350 Certification of the company’s Principal Executive Officer. The information contained in this Exhibit shall not be deemed filed with the Securities and Exchange Commission nor incorporated by reference in any registration statement filed by the registrant under the Securities Act of 1933, as amended.
32.2	Section 1350 Certification of the company’s Principal Financial Officer. The information contained in this Exhibit shall not be deemed filed with the Securities and Exchange Commission nor incorporated by reference in any registration statement filed by the registrant under the Securities Act of 1933, as amended.
101.INS	XBRL Instance Document
101.SCH	XBRL Taxonomy Extension Schema Document
101.CAL	XBRL Taxonomy Extension Calculation Linkbase Document
101.DEF	XBRL Taxonomy Extension Definition Linkbase Document
101.LAB	XBRL Taxonomy Extension Label Linkbase Document
101.PRE	XBRL Taxonomy Extension Presentation Linkbase Document

*	Management contract or compensatory plan or arrangement.
**	DuPont hereby undertakes to furnish supplementally a copy of any omitted schedule or exhibit to such agreement to the U.S. Securities and Exchange Commission upon request.

49

Signatures

Pursuant to the requirements of Section 13 of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

February 15, 2018
	E. I. DU PONT DE NEMOURS AND COMPANY
	By:	/s/ Nicholas C. Fanandakis
		Nicholas C. Fanandakis Executive Vice President and Chief Financial Officer (Principal Financial and Accounting Officer)

_____________________________________________

Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant in the capacities and on the dates indicated:

Signature	Title(s)	Date
/s/ E.D. Breen	Chair of the Board of Directors and Chief Executive Officer and Director (Principal Executive Officer)	February 15, 2018
E. D. Breen
/s/ N. C. Fanandakis	Director	February 15, 2018
N. C. Fanandakis

50

E.I. du Pont de Nemours and Company

Index to the Consolidated Financial Statements

	Page(s)
Consolidated Financial Statements:
Management's Reports on Responsibility for Financial Statements and Internal Control over Financial Reporting	F-2
Report of Independent Registered Public Accounting Firm - Successor	F-3
Report of Independent Registered Public Accounting Firm - Predecessor	F-5
Consolidated Statements of Operations for the period September 1 through December 31, 2017, the period January 1 through August 31, 2017, and the years ended December 31, 2016 and 2015	F-6
Consolidated Statements of Comprehensive Income for the period September 1 through December 31, 2017, the period January 1 through August 31, 2017, and the years ended December 31, 2016 and 2015	F-7
Consolidated Balance Sheets as of December 31, 2017 and December 31, 2016	F-8
Consolidated Statements of Cash Flows for the period September 1 through December 31, 2017, the period January 1 through August 31, 2017, and the years ended December 31, 2016 and 2015	F-9
Consolidated Statements of Equity for the period September 1 through December 31, 2017, the period January 1 through August 31, 2017, and the years ended December 31, 2016 and 2015	F-11
Notes to the Consolidated Financial Statements	F-12

F-1

Management's Reports on Responsibility for Financial Statements and

Internal Control over Financial Reporting

Management's Report on Responsibility for Financial Statements

Management is responsible for the Consolidated Financial Statements and the other financial information contained in this Annual Report on Form 10-K. The financial statements have been prepared in accordance with generally accepted accounting principles in the United States of America (GAAP) and are considered by management to present fairly the company's financial position, results of operations and cash flows. The financial statements include some amounts that are based on management's best estimates and judgments. The financial statements have been audited by the company's independent registered public accounting firm, PricewaterhouseCoopers LLP. The purpose of their audit is to express an opinion as to whether the Consolidated Financial Statements included in this Annual Report on Form 10-K present fairly, in all material respects, the company's financial position, results of operations and cash flows in conformity with GAAP. Their reports are presented on the following pages.

Management's Report on Internal Control over Financial Reporting

Management is responsible for establishing and maintaining an adequate system of internal control over financial reporting as defined in Rules 13a-15(f) and 15d-15(f) under the Securities Exchange Act of 1934. The company's internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with GAAP. The company's internal control over financial reporting includes those policies and procedures that:

i. pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the company;

ii. provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles and that receipts and expenditures of the company are being made only in accordance with authorization of management and directors of the company; and

iii. provide reasonable assurance regarding prevention or timely detection of unauthorized acquisitions, use or disposition of the company's assets that could have a material effect on the financial statements.

Internal control over financial reporting has certain inherent limitations which may not prevent or detect misstatements. In addition, changes in conditions and business practices may cause variation in the effectiveness of internal controls.

Management assessed the effectiveness of the company's internal control over financial reporting as of December 31, 2017, based on criteria set forth by the Committee of Sponsoring Organizations of the Treadway Commission (COSO) in Internal Control-Integrated Framework (2013). Based on its assessment and those criteria, management concluded that the company maintained effective internal control over financial reporting as of December 31, 2017.

The company completed its acquisition of the Health and Nutrition Business (the "H&N Business") from FMC Corporation on November 1, 2017. As a result, management has excluded this business from its assessment of internal control over financial reporting as of December 31, 2017. The total assets of the H&N Business that were excluded from the assessment represented less two percent of the company's total assets as of December 31, 2017. The total net sales of the H&N Business that were excluded from the assessment represented less than two percent of the company's total revenues for the period September 1 to December 31, 2017.

PricewaterhouseCoopers LLP, an independent registered public accounting firm, has audited the effectiveness of the company's internal control over financial reporting as of December 31, 2017, as stated in their reports, which are presented on the following pages.

Edward D. Breen Chair of the Board and Chief Executive Officer	Nicholas C. Fanandakis Executive Vice President and Chief Financial Officer

February 15, 2018

F-2

Report of Independent Registered Public Accounting Firm

To theStockholders and Board of Directors of

E.I. du Pont de Nemours and Company

Opinions on the Financial Statements and Internal Control over Financial Reporting

We have audited the accompanying consolidated balance sheet of E.I. du Pont de Nemours and Companyand its subsidiaries (Successor)(the “Company”)as of December 31, 2017,and the related consolidated statements of operations, comprehensive income, equity and cash flows for the period September 1, 2017 through December 31, 2017, including the related notes and financial statement schedule appearing under Item 15(a)(2) (collectively referred to as the “consolidated financial statements”). We also have audited the Company's internal control over financial reporting as of December 31, 2017, based on criteria established in Internal Control - Integrated Framework(2013)issued by the Committee of Sponsoring Organizations of the Treadway Commission (COSO).

In our opinion, the consolidatedfinancial statements referred to above present fairly, in all material respects, the financial position of the Company as of December 31, 2017, and the results of theiroperations and theircash flows for the period September 1, 2017 through December 31, 2017 in conformity with accounting principles generally accepted in the United States of America. Also in our opinion, the Company maintained, in all material respects, effective internal control over financial reporting as of December 31, 2017, based on criteria established in Internal Control - Integrated Framework(2013)issued by the COSO.

Basis for Opinions

The Company's management is responsible for these consolidated financial statements, for maintaining effective internal control over financial reporting, and for its assessment of the effectiveness of internal control over financial reporting, included inManagement's Report on Internal Control over Financial Reporting appearing on page F-2. Our responsibility is to express opinions on the Company’s consolidated financial statements and on the Company's internal control over financial reporting based on our audit. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) ("PCAOB") and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.

We conducted our audit in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the consolidatedfinancial statements are free of material misstatement, whether due to error or fraud, and whether effective internal control over financial reporting was maintained in all material respects.

Our audit of the consolidated financial statements included performing procedures to assess the risks of material misstatement of the consolidated financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the consolidated financial statements. Our audit also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the consolidatedfinancial statements. Our audit of internal control over financial reporting included obtaining an understanding of internal control over financial reporting, assessing the risk that a material weakness exists, and testing and evaluating the design and operating effectiveness of internal control based on the assessed risk. Our audit also included performing such other procedures as we considered necessary in the circumstances. We believe that our audit provides a reasonable basis for our opinions.

As described in Management’s Report on Internal Control over Financial Reporting, management has excluded the H&N Business from its assessment of internal control over financial reporting as of December 31, 2017 because it was acquired by the Company in a purchase business combination during 2017. We have also excluded the H&N Business from our audit of internal control over financial reporting. The H&N Business is a wholly-owned subsidiary whose total assets and total revenues excluded from management’s assessment and our audit of internal control over financial reporting represent less than two percent each of the related consolidated financial statement amounts as of December 31, 2017 and for the period September 1, 2017 through December 31, 2017.

F-3

Definition and Limitations of Internal Control over Financial Reporting

A company’s internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. A company’s internal control over financial reporting includes those policies and procedures that (i) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the company; (ii) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the company are being made only in accordance with authorizations of management and directors of the company; and (iii) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of the company’s assets that could have a material effect on the financial statements.

Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.

PricewaterhouseCoopers LLP

Philadelphia, Pennsylvania

February 15, 2018

We have served as the Company’s auditor since 1954.

F-4

Report of Independent Registered Public Accounting Firm

TotheStockholders and Board of Directors of

E.I. du Pont de Nemours and Company:

Opinion on the Financial Statements

We have audited the accompanying consolidatedbalance sheet of E.I. du Pont de Nemours and Company and its subsidiaries (Predecessor) as of December 31, 2016, and the related consolidated statements of operations, comprehensive income, equity and cash flowsfor the period January 1, 2017 through August 31, 2017, and for each of the two years in the period ended December 31, 2016, including the related notes and financial statement schedule appearing under Item 15(a)(2) (collectively referred to as the “consolidatedfinancial statements”). In our opinion, the consolidated financial statements present fairly, in all material respects, the financial position of the Companyas ofDecember 31, 2016, and the results of their operations and their cash flows for the period January 1, 2017 through August 31, 2017, and for each of the two years in the period ended December 31, 2016in conformity with accounting principles generally accepted in the United States of America.

Basis for Opinion

These consolidatedfinancial statements are the responsibility of the Company’s management. Our responsibility is to express an opinion on the Company’s consolidated financial statements based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (“PCAOB”) and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.

We conducted our audits of these consolidatedfinancial statements in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the consolidated financial statements are free of material misstatement, whether due to error or fraud.

Our audits included performing procedures to assess the risks of material misstatement of the consolidatedfinancial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the consolidatedfinancial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the consolidatedfinancial statements. We believe that our audits provide a reasonable basis for our opinion.

PricewaterhouseCoopers LLP

Philadelphia, Pennsylvania

February 15, 2018

We have served as the Company's auditor since 1954.

F-5

E. I. du Pont de Nemours and Company

Consolidated Financial Statements

CONSOLIDATED STATEMENTS OF OPERATIONS

	Successor			Predecessor
(In millions, except per share amounts)	For the Period September 1 through December 31, 2017			For the Period January 1 through August 31, 2017		For the Year Ended December 31, 2016		For the Year Ended December 31, 2015
Net sales	$	7,053		$	17,281	$	23,209	$	23,657
Cost of goods sold	6,165			10,205		13,955		14,591
Other operating charges				504		667		434
Research and development expense	473			1,064		1,502		1,735
Selling, general and administrative expenses	1,101			3,306		4,143		4,428
Amortization of intangibles	389
Restructuring and asset related charges - net	180			323		556		795
Integration and separation costs	314
Sundry income - net	90			166		707		690
Interest expense	107			254		370		342
(Loss) Income from continuing operations before income taxes	(1,586		)	1,791		2,723		2,022
(Benefit from) provision for income taxes on continuing operations	(2,673		)	149		641		575
Income from continuing operations after income taxes	1,087			1,642		2,082		1,447
(Loss) Income from discontinued operations after income taxes	(77		)	119		443		512
Net income	1,010			1,761		2,525		1,959
Net income attributable to noncontrolling interests	—			20		12		6
Net income attributable to DuPont	$	1,010		$	1,741	$	2,513	$	1,953
Basic earnings per share of common stock:
Basic earnings per share of common stock from continuing operations				$	1.86	$	2.36	$	1.60
Basic earnings per share of common stock from discontinued operations				0.13		0.51		0.57
Basic earnings per share of common stock				$	2.00	$	2.87	$	2.17
Diluted earnings per share of common stock:
Diluted earnings per share of common stock from continuing operations				$	1.85	$	2.35	$	1.59
Diluted earnings per share of common stock from discontinued operations				0.13		0.50		0.57
Diluted earnings per share of common stock				$	1.99	$	2.85	$	2.16
Dividends declared per share of common stock				$	1.14	$	1.52	$	1.72

See Notes to the Consolidated Financial Statements beginning on page F-13.

F-6

E. I. du Pont de Nemours and Company

Consolidated Financial Statements

CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME

	Successor			Predecessor
(In millions)	For the Period September 1 through December 31, 2017			For the Period January 1 through August 31, 2017			For the Year Ended December 31, 2016			For the Year Ended December 31, 2015
Net income	$	1,010		$	1,761		$	2,525		$	1,959
Other comprehensive (loss) income - net of tax:
Unrealized gains on investments	—			—			20			(19		)
Cumulative translation adjustments	(454		)	1,042			(510		)	(1,605		)
Adjustments to pension benefit plans	128			247			323			574
Adjustments to other benefit plans	(53		)	10			(379		)	(240		)
Derivative instruments	(2		)	(10		)	31			(18		)
Total other comprehensive (loss) income	(381		)	1,289			(515		)	(1,308		)
Comprehensive income	629			3,050			2,010			651
Comprehensive income attributable to noncontrolling interests - net of tax	—			20			12			6
Comprehensive income attributable to DuPont	$	629		$	3,030		$	1,998		$	645

See Notes to the Consolidated Financial Statements beginning on page F-13.

F-7

E. I. du Pont de Nemours and Company

Consolidated Financial Statements

CONSOLIDATED BALANCE SHEETS

	Successor			Predecessor
(In millions, except share amounts)	December 31, 2017			December 31, 2016
Assets
Current assets
Cash and cash equivalents	$	7,250		$	4,548
Marketable securities	952			1,362
Accounts and notes receivable - net	5,239			4,959
Inventories	8,633			5,350
Other current assets	981			505
Assets held for sale- current	—			789
Total current assets	23,055			17,513
Investment in nonconsolidated affiliates	1,595			649
Property, plant and equipment	12,878			23,015
Less: Accumulated depreciation	443			14,164
Net property, plant and equipment	12,435			8,851
Goodwill	45,589			4,169
Other intangible assets	27,726			3,664
Deferred income taxes	480			3,308
Other assets	2,084			1,810
Total Assets	$	112,964		$	39,964
Liabilities and Equity
Current liabilities
Short-term borrowings and capital lease obligations	$	2,779		$	429
Accounts payable	4,831			3,678
Income taxes payable	149			101
Accrued and other current liabilities	4,384			4,650
Liabilities held for sale - current	—			74
Total current liabilities	12,143			8,932
Long-Term Debt	10,291			8,107
Other Noncurrent Liabilities
Deferred income tax liabilities	5,836			425
Pension and other post employment benefits - noncurrent	7,787
Other noncurrent obligations	1,975			12,304
Total noncurrent liabilities	25,889			20,836
Commitments and contingent liabilities
Stockholders’ equity
Preferred stock, without par value – cumulative; 23,000,000 shares authorized;      issued at December 31, 2017 and December 31, 2016:
$4.50 Series – 1,673,000 shares (callable at $120)	169			167
$3.50 Series – 700,000 shares (callable at $102)	70			70
Common stock, $.30 par value; 1,800,000,000 shares authorized; issued at December 31, 2017 - 100 and December 31, 2016 – 950,044,000	—			285
Additional paid-in capital	74,727			11,190
Retained earnings	175			14,924
Accumulated other comprehensive loss	(381		)	(9,911		)
Common stock held in treasury, at cost (Shares: December 31, 2017 - 0; December 31, 2016 – 87,041,000)	—			(6,727		)
Total DuPont stockholders’ equity	74,760			9,998
Noncontrolling interests	172			198
Total equity	74,932			10,196
Total Liabilities and Equity	$	112,964		$	39,964

See Notes to the Consolidated Financial Statements beginning on page F-13.

F-8

E. I. du Pont de Nemours and Company Consolidated Financial Statements CONSOLIDATED STATEMENTS OF CASH FLOWS
	Successor			Predecessor
(In millions)	For the Period September 1 through December 31, 2017			For the Period January 1 through August 31, 2017			For the Year Ended December 31, 2016			For the Year Ended December 31, 2015
Operating activities
Net income	$	1,010		$	1,761		$	2,525		$	1,959
Adjustments to reconcile net income to cash used for operating activities:
Depreciation and amortization	815			749			1,258			1,466
Provision for deferred income tax	(3,015		)
Net periodic pension (benefit) cost	(111		)	295			572			591
Pension contributions	(68		)	(3,024		)	(535		)	(308		)
Net gain on sales of property, businesses, consolidated companies, and investments	(16		)	(204		)	(436		)	(59		)
Restructuring and asset related charges - net	180
Asset related charges				279			682			147
Amortization of inventory step-up	1,573
Other net loss	125			481			366			106
Changes in assets and liabilities, net of effects of acquired and divested companies:
Accounts and notes receivable	2,107			(2,269		)	(270		)	(448		)
Inventories	(1,010		)
Inventories and other operating assets				(202		)	(54		)	164
Accounts payable	934
Accounts payable and other operating liabilities				(1,555		)	(674		)	(1,031		)
Other assets and liabilities	1,672
Accrued interest and income taxes				(260		)	(77		)	(165		)
Cash provided by (used for) operating activities	4,196			(3,949		)	3,357			2,422
Investing activities
Capital expenditures	(426		)	(687		)	(1,019		)	(1,629		)
Proceeds from sales of property, businesses, and consolidated companies - net of cash divested	1,268			300			316			156
Payment into trust account	(571		)	—			—			—
Distribution from trust account	13			—			—			—
Acquisitions of businesses - net of cash acquired	3			(246		)	—			(152		)
Investments in and loans to nonconsolidated affiliates	(5		)	(22		)	(19		)	(76		)
Purchases of investments	(1,043		)	(5,457		)	(2,633		)	(1,897		)
Proceeds from sales and maturities of investments	2,938			3,977			2,181			1,121
Foreign currency exchange contract settlements				(206		)	(385		)	615
Other investing activities - net	33			(41		)	45			34
Cash provided by (used for) investing activities	2,210			(2,382		)	(1,514		)	(1,828		)
Financing activities
Change in short-term (less than 90 days) borrowings	(2,541		)	3,610			387			(1		)
Proceeds from issuance of long-term debt	499			2,734			813			3,679
Payments on long-term debt	(42		)	(229		)	(1,440		)	(1,537		)
Repurchase of common stock				—			(916		)	(2,353		)
Proceeds from exercise of stock options	30			235			154			200

F-9

E. I. du Pont de Nemours and Company Consolidated Financial Statements CONSOLIDATED STATEMENTS OF CASH FLOWS
Dividends paid to stockholders	(332		)	(666		)	(1,335		)	(1,546		)
Distributions to DowDuPont	(829		)
Cash transferred to Chemours at spin-off	—			—			—			(250		)
Other financing activities	(12		)	(52		)	(48		)	(121		)
Cash (used for) provided by financing activities	(3,227		)	5,632			(2,385		)	(1,929		)
Effect of exchange rate changes on cash	(22		)	187			(153		)	(275		)
Cash reclassified as held for sale	88			(31		)	15			22
Increase (decrease) in cash and cash equivalents	3,245			(543		)	(680		)	(1,588		)
Cash and cash equivalents at beginning of period	4,005			4,548			5,228			6,816
Cash and cash equivalents at end of period	$	7,250		$	4,005		$	4,548		$	5,228
Supplemental cash flow information
Cash paid (received) during the period for
Interest, net of amounts capitalized	$	76		$	331		$	386		$	341
Income taxes	(437		)	272			735			885

See Notes to the Consolidated Financial Statements beginning on page F-13.

F-10

E. I. du Pont de Nemours and Company

Consolidated Financial Statements

CONSOLIDATED STATEMENTS OF EQUITY

(In millions)	Preferred Stock		Common Stock			Additional Paid-in Capital			Retained Earnings			Accumulated Other Comp Loss			Treasury Stock			Non-controlling Interests			Total Equity
Predecessor
Balance at January 1, 2015	$	237	$	298		$	11,174		$	16,894		$	(8,556	)	(6,727		)	58			$	13,378
Net income									1,953									6			1,959
Other comprehensive loss												(1,308		)							(1,308		)
Common dividends ($1.72 per share)									(1,542		)							(4		)	(1,546		)
Preferred dividends									(10		)										(10		)
Common stock issued-compensation plans			2			359															361
Common stock repurchased															(2,353		)				(2,353		)
Common stock retired			(12		)	(451		)	(1,890		)				2,353						—
Spin-off of Chemours									(895		)	468						(4		)	(431		)
Consolidation of a joint venture						(1		)										151			150
Balance at December 31, 2015	$	237	$	288		$	11,081		$	14,510		$	(9,396	)	$	(6,727	)	$	207		$	10,200
Balance at January 1, 2016	$	237	$	288		$	11,081		$	14,510		$	(9,396	)	(6,727		)	207			$	10,200
Net income									2,513									12			2,525
Other comprehensive loss												(515		)							(515		)
Common dividends ($1.52 per share)									(1,331		)							(16		)	(1,347		)
Preferred dividends									(10		)										(10		)
Common stock issued-compensation plans			1			267															268
Common stock repurchased															(916		)				(916		)
Common stock retired			(4		)	(154		)	(758		)				916						—
Sale of a majority interest in a consolidated subsidiary						(4		)										(5		)	(9		)
Balance at December 31, 2016	$	237	$	285		$	11,190		$	14,924		$	(9,911	)	$	(6,727	)	$	198		$	10,196
Balance at January 1, 2017	$	237	$	285		$	11,190		$	14,924		$	(9,911	)	$	(6,727	)	$	198		10,196
Net income									1,741									20			1,761
Other comprehensive income												1,289									1,289
Common dividends ($1.14 per share)									(991		)							(4		)	(995		)
Preferred dividends									(7		)										(7		)
Common stock issued-compensation plans			2			273															275
Common stock retired			(26		)	(1,044		)	(5,657		)				6,727						—
Sale of majority interest in consolidated subsidiary																		(2		)	(2		)
Balance at August 31, 2017	$	237	$	261		$	10,419		$	10,010		$	(8,622	)	$	—		$	212		$	12,517
Successor
Balance at September 1, 2017 (remeasured upon Merger)	$	239	$	—		$	74,680		$	—		$	—		$	—		$	162		$	75,081
Net income									1,010									—			1,010
Other comprehensive loss												(381		)							(381		)
Preferred dividends									(3		)										(3		)
Distributions to DowDuPont									(829		)										(829		)
Issuance of DowDuPont stock						30															30
Stock-based compensation						36															36
Sale of a majority interest in a consolidated subsidiary																		(4		)	(4		)
Acquisition of a noncontrolling interest in a consolidated subsidiary																		3			3
Other						(19		)	(3		)							11			(11		)
Balance at December 31, 2017	$	239	$	—		$	74,727		$	175		$	(381	)	$	—		$	172		$	74,932

See Notes to the Consolidated Financial Statements beginning on page F-13.

F-11

E. I. du Pont de Nemours and Company

Notes to the Consolidated Financial Statements

Table of Contents

Note		Page
1	Summary of Significant Accounting Policies	F-13
2	Recent Accounting Guidance	F-20
3	Business Combinations	F-23
4	Divestitures and Other Transactions	F-29
5	Restructuring and Asset Related Charges	F-33
6	Supplementary Information	F-36
7	Income Taxes	F-37
8	Earnings Per Share of Common Stock	F-42
9	Accounts and Notes Receivable, Net	F-43
10	Inventories	F-43
11	Property, Plant and Equipment	F-44
12	Goodwill and Other Intangible Assets	F-44
13	Short-Term Borrowings, Long-Term Debt and Available Credit Facilities	F-46
14	Commitments and Contingent Liabilities	F-48
15	Stockholders' Equity	F-52
16	Pension Plans and Other Post Employment Benefits	F-56
17	Stock-Based Compensation	F-67
18	Financial Instruments	F-71
19	Fair Value Measurements	F-75
20	Geographic and Product Line Information	F-76
21	Selected Quarterly Financial Data	F-78
22	Subsequent Events	F-78

F-12

E. I. du Pont de Nemours and Company

Notes to the Consolidated Financial Statements (continued)

NOTE 1 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Principles of Consolidation and Basis of Presentation

The accompanying Consolidated Financial Statements of E. I. du Pont de Nemours and Company (“DuPont” or “the company”) were prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”). The significant accounting policies described below, together with the other notes that follow, are an integral part of the Consolidated Financial Statements.

DowDuPont Inc. ("DowDuPont") was formed on December 9, 2015 to effect an all-stock, merger of equals strategic combination between The Dow Chemical Company ("Dow") and DuPont (the "Merger Transaction"). On August 31, 2017 at 11:59 pm ET, (the "Merger Effectiveness Time") pursuant to the Agreement and Plan of Merger, dated as of December 11, 2015, as amended on March 31, 2017 (the "Merger Agreement"), Dow and DuPont each merged with wholly owned subsidiaries of DowDuPont ("Mergers") and, as a result of the Mergers, Dow and DuPont became subsidiaries of DowDuPont (collectively, the "Merger"). Prior to the Merger, DowDuPont did not conduct any business activities other than those required for its formation and matters contemplated by the Merger Agreement. DowDuPont intends to pursue, subject to the receipt of approval by the Board of Directors of DowDuPont, the separation of the combined company's agriculture business, specialty products business and materials science business through a series of tax-efficient transactions (collectively, the "Intended Business Separations").

For purposes of DowDuPont's financial statement presentation, Dow was determined to be the accounting acquirer in the Merger and DuPont's assets and liabilities are reflected at fair value as of the Merger Effectiveness Time. In connection with the Merger and the related accounting determination, DuPont has elected to apply push-down accounting and reflect in its financial statements the fair value of its assets and liabilities. DuPont's Consolidated Financial Statements for periods following the close of the Merger are labeled “Successor” and reflect DowDuPont’s basis in the fair values of the assets and liabilities of DuPont. All periods prior to the closing of the Merger reflect the historical accounting basis in DuPont's assets and liabilities and are labeled “Predecessor.” The Consolidated Financial Statements and footnotes include a black line division between the columns titled "Predecessor" and "Successor" to signify that the amounts shown for the periods prior to and following the Merger are not comparable. See Note 3 for additional information on the Merger.

Transactions between DowDuPont, DuPont, Dow and their affiliates and other associated companies are reflected in the Successor consolidated financial statements and disclosed as related party transactions when material. Related party transactions with DowDuPont are included in Note 6. Related party transactions with Dow and their affiliates were not material as of December 31, 2017 and for the period September 1 through December 31, 2017.

As a condition of the regulatory approval for the Merger Transaction, the company was required to divest certain assets related to its crop protection business and research and development ("R&D") organization, specifically the company’s Cereal Broadleaf Herbicides and Chewing Insecticides portfolios, including Rynaxypyr^®, Cyazypyr^® and Indoxacarb as well as the crop protection R&D pipeline and organization, excluding seed treatment, nematicides, and late-stage R&D programs. On March 31, 2017, the company entered into a definitive agreement (the "FMC Transaction Agreement") with FMC Corporation ("FMC"). Under the FMC Transaction Agreement, FMC would acquire the crop protection business and R&D assets that DuPont was required to divest in order to obtain European Commission ("EC") approval of the Merger Transaction as described above, (the "Divested Ag Business") and DuPont agreed to acquire certain assets relating to FMC’s Health and Nutrition segment, excluding its Omega-3 products (the "H&N Business") (collectively, the "FMC Transactions").

On November 1, 2017, the company completed the FMC Transactions through the disposition of the Divested Ag Business and the acquisition of the H&N Business. The sale of the Divested Ag Business meets the criteria for discontinued operations and as such, results of operations are presented as discontinued operations and have been excluded from continuing operations for all periods presented. The sum of the individual earnings per share amounts from continuing operations and discontinued operations may not equal the total company earnings per share amounts due to rounding. The assets and liabilities related to the Divested Ag Business for all periods are presented as assets and liabilities held for sale in the Consolidated Balance Sheets. The comprehensive income and cash flows related to the Divested Ag Business have not been segregated and are included in the Consolidated Statements of Comprehensive Income and Consolidated Statements of Cash Flows, respectively, for all periods presented. Amounts related to the Divested Ag Business are consistently included or excluded from the Notes to the Consolidated Financial Statements based on the respective financial statement line item. See Note 4 for additional information.

F-13

E. I. du Pont de Nemours and Company

Notes to the Consolidated Financial Statements (continued)

On July 1, 2015, the company completed the separation of its Performance Chemicals segment through the spin-off of all of the issued and outstanding stock of The Chemours Company ("Chemours"). In accordance with GAAP, the results of operations of the Performance Chemicals segment are presented as discontinued operations and, as such, have been excluded from continuing operations in the Consolidated Statements of Operations for all periods presented. See Note 4 for additional information.

Certain reclassifications of prior year's data have been made to conform to current year's presentation. As described in Note 2, effective January 1, 2017, the company adopted the Financial Accounting Standards Board (“FASB”) Accounting Standards Update ("ASU") No. 2016-09, Compensation - Stock Compensation (Topic 718), Improvements to Employee Share-Based Payment Accounting. In conjunction with the adoption of this ASU, the company retrospectively reclassified cash flows related to income tax impacts associated with employee share-based payments in the Consolidated Statements of Cash Flows, as described in Note 2.

The Consolidated Financial Statements include the accounts of the company and subsidiaries in which a controlling interest is maintained. For those consolidated subsidiaries in which the company's ownership is less than 100 percent, the outside stockholders' interests are shown as noncontrolling interests. Investments in affiliates over which the company has significant influence but not a controlling interest are accounted for under the equity method.

The company is also involved with certain joint ventures accounted for under the equity method of accounting that are variable interest entities ("VIEs"). The company is not the primary beneficiary, as the nature of the company's involvement with the VIEs does not provide it the power to direct the VIEs significant activities. Future events may require these VIEs to be consolidated if the company becomes the primary beneficiary. At December 31, 2017 and 2016, the maximum exposure to loss related to the nonconsolidated VIEs is not considered material to the Consolidated Financial Statements.

Use of Estimates in Financial Statement Preparation

The preparation of financial statements in accordance with U.S. GAAP requires the use of estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenues and expenses during the reporting period. The company’s consolidated financial statements include amounts that are based on management’s best estimates and judgments. Actual results could differ from those estimates. In connection with the Merger, DowDuPont has performed a preliminary allocation of the total consideration exchanged for the DuPont assets and liabilities it acquired using preliminary estimates. The estimates are subject to change as discussed in Note 3.

Changes in Accounting and Reporting

Within the Successor period, DuPont made the following changes in accounting and reporting to harmonize its accounting and reporting with DowDuPont.

Within the Successor period of the Consolidated Statements of Operations:

• Included royalty income within net sales. In the Predecessor periods, royalty income is included within sundry income - net.

• Eliminated the other operating charges line item. In the Successor period, a majority of these costs are included within cost of goods sold. These costs are also included in selling, general and administrative expenses and amortization of intangibles in the Successor period.

• Presented amortization of intangibles as a separate line item. In the Predecessor periods, amortization is included within cost of goods sold, selling, general and administrative expenses, other operating charges, and research and development expenses.

• Presented integration and separation costs as a separate line item. In the Predecessor periods, these costs are included within selling, general and administrative expenses.

• Included interest accrued related to unrecognized tax benefits within the (benefit from) provision for income taxes on continuing operations. In the Predecessor period, interest accrued related to unrecognized tax benefits is included within sundry income - net.

Within the Successor period of the Consolidated Balance Sheets:

• Included loans to nonconsolidated affiliates within other assets. In the Predecessor period, loans are included within investment in nonconsolidated affiliates.

• Included accrued discounts and rebates within accounts payable. In the Predecessor period, accrued discounts and rebates are included within accrued and other current liabilities.

• Included non-current pension liabilities within pension and other post employment benefits - noncurrent. In the Predecessor period, non-current pension liabilities are included within other noncurrent obligations.

F-14

E. I. du Pont de Nemours and Company

Notes to the Consolidated Financial Statements (continued)

Within the Successor period of the Consolidated Statements of Cash Flows:

• Included foreign currency exchange contract settlements within cash flows from operating activities, regardless of hedge accounting qualification. In the Predecessor period, DuPont reflected non-qualified hedge programs, specifically forward contracts, options and cash collateral activity, within cash flows from investing activities. In the Predecessor period, DuPont reflected cash flows from qualified programs within the line item it related to (i.e., revenue hedge cash flows presented within changes from accounts receivable).

• Aligned the line items within "changes in assets and liabilities, net of effects of acquired and divested companies" to the DowDuPont presentation, including accounts and notes receivable, inventories, accounts payable, and other assets and liabilities. In the Predecessor period, the line item "changes in assets and liabilities, net of effects of acquired and divested companies" includes accounts and notes receivable, inventories and other operating assets, accounts payable and other operating liabilities, and accrued interest and income taxes.

Cash and Cash Equivalents

Cash equivalents represent investments with maturities of three months or less from time of purchase. They are carried at cost plus accrued interest.

Restricted Cash

Restricted cash represents trust assets of $558 million as of December 31, 2017, and is included within other current assets on the Consolidated Balance Sheets. See Note 6 and Note 16 for further information.

Marketable Securities

Marketable securities represent investments in fixed and floating rate financial instruments with maturities greater than three months and up to twelve months at time of purchase. Investments classified as held-to-maturity are recorded at amortized cost. The carrying value approximates fair value due to the short-term nature of the investments. Investments classified as available-for-sale are carried at estimated fair value with unrealized gains and losses recorded as a component of accumulated other comprehensive income (loss). The cost of investments sold is determined by specific identification.

Fair Value Measurements

Under the accounting guidance for fair value measurements and disclosures, a fair value hierarchy was established that prioritizes the inputs to valuation techniques used to measure fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). A financial instrument's level within the fair value hierarchy is based on the lowest level of any input that is significant to the fair value measurement.

The company uses the following valuation techniques to measure fair value for its assets and liabilities:

Level 1	–	Quoted market prices in active markets for identical assets or liabilities;
Level 2	–	Significant other observable inputs (e.g. quoted prices for similar items in active markets, quoted prices for identical or similar items in markets that are not active, inputs other than quoted prices that are observable such as interest rate and yield curves, and market-corroborated inputs);
Level 3	–	Unobservable inputs for the asset or liability, which are valued based on management's estimates of assumptions that market participants would use in pricing the asset or liability.

Foreign Currency Translation

The company's worldwide operations utilize the U.S. dollar (USD) or local currency as the functional currency, where applicable. The company identifies its separate and distinct foreign entities and groups the foreign entities into two categories: 1) extension of the parent or foreign subsidiaries operating in a hyper-inflationary environment (USD functional currency) and 2) self-contained (local functional currency). If a foreign entity does not align with either category, factors are evaluated and a judgment is made to determine the functional currency. 

F-15

E. I. du Pont de Nemours and Company

Notes to the Consolidated Financial Statements (continued)

For foreign entities where the USD is the functional currency, all foreign currency-denominated asset and liability amounts are re-measured into USD at end-of-period exchange rates, except for inventories, prepaid expenses, property, plant and equipment, goodwill and other intangible assets, which are re-measured at historical rates. Foreign currency income and expenses are re-measured at average exchange rates in effect during the year, except for expenses related to balance sheet amounts re-measured at historical exchange rates. Exchange gains and losses arising from re-measurement of foreign currency-denominated monetary assets and liabilities are included in income in the period in which they occur.

For foreign entities where the local currency is the functional currency, assets and liabilities denominated in local currencies are translated into USD at end-of-period exchange rates and the resultant translation adjustments are reported, net of their related tax effects, as a component of accumulated other comprehensive loss in equity. Assets and liabilities denominated in other than the local currency are re-measured into the local currency prior to translation into USD and the resultant exchange gains or losses are included in income in the period in which they occur. Income and expenses are translated into USD at average exchange rates in effect during the period.

The company changes the functional currency of its separate and distinct foreign entities only when significant changes in economic facts and circumstances indicate clearly that the functional currency has changed.

Inventories

The company's inventories are valued at the lower of cost or net realizable value. Elements of cost in inventories include raw materials, direct labor and manufacturing overhead. Stores and supplies are valued at cost or net realizable value, whichever is lower; cost is generally determined by the average cost method.

As of December 31, 2017 approximately 60 percent, 30 percent, and 10 percent of the company's inventories were accounted for under the first-in, first-out ("FIFO"), average cost and the last-in, first-out ("LIFO") methods, respectively. As of December 31, 2016 approximately 55 percent, 30 percent, and 15 percent of the company's inventories were accounted for under the FIFO, average cost and LIFO methods, respectively. Inventories accounted for under the FIFO method are primarily comprised of products with shorter shelf lives such as seeds, certain food-ingredients and enzymes.

The company establishes allowances for obsolescence of inventory based upon quality considerations and assumptions about future demand and market conditions.

Property, Plant and Equipment

Property, plant and equipment are carried at cost less accumulated depreciation. In connection with the Merger, the preliminary estimated fair value of property, plant and equipment is determined using a market approach and a replacement cost approach. Refer to Note 3 for further information. Depreciation is based on the estimated service lives of depreciable assets and is calculated using the straight-line method. Fully depreciated assets are retained in property and accumulated depreciation accounts until they are removed from service. When assets are surrendered, retired, sold, or otherwise disposed of, their gross carrying values and related accumulated depreciation are removed from the Consolidated Balance Sheets and included in determining gain or loss on such disposals.

Goodwill and Other Intangible Assets

The company records goodwill when the purchase price of a business acquisition exceeds the estimated fair value of net identified tangible and intangible assets acquired. Goodwill is tested for impairment at the reporting unit level annually, or more frequently when events or changes in circumstances indicate that the fair value of a reporting unit has more likely than not declined below its carrying value. In connection with the Merger Transaction, the company adopted the policy of DowDuPont and performed an annual goodwill impairment test in the fourth quarter of 2017. In the Predecessor periods, the annual impairment test was performed in the third quarter.

When testing goodwill for impairment, the company has the option to first perform qualitative testing to determine whether it is more likely than not that the fair value of a reporting unit is less than its carrying value.  If the company chooses not to complete a qualitative assessment for a given reporting unit or if the initial assessment indicates that it is more likely than not that the carrying value of a reporting unit exceeds its estimated fair value, additional quantitative testing is required.  The company's fair value methodology is primarily based on discounted cash flow techniques.  See Note 12 for further information on goodwill.

Indefinite-lived intangible assets are tested for impairment at least annually; however, these tests are performed more frequently when events or changes in circumstances indicate that the asset may be impaired. Impairment exists when carrying value exceeds fair value. The company's fair value methodology is primarily based on discounted cash flow techniques.

F-16

E. I. du Pont de Nemours and Company

Notes to the Consolidated Financial Statements (continued)

Definite-lived intangible assets are amortized over their estimated useful lives, generally on a straight-line basis for periods ranging primarily from 1 to 23 years. The company continually evaluates the reasonableness of the useful lives of these assets. Once these assets are fully amortized, they are removed from the Consolidated Balance Sheets.

Impairment of Long-Lived Assets

The company evaluates the carrying value of long-lived assets to be held and used when events or changes in circumstances indicate the carrying value may not be recoverable. The carrying value of a long-lived asset group is considered impaired when the total projected undiscounted cash flows from the assets are separately identifiable and are less than its carrying value. In that event, a loss is recognized based on the amount by which the carrying value exceeds the fair value of the long-lived asset. The company's fair value methodology is an estimate of fair market value which is made based on prices of similar assets or other valuation methodologies including present value techniques. Long-lived assets to be disposed of by sale, if material, are classified as held for sale and reported at the lower of carrying amount or fair value less cost to sell, and depreciation is ceased. Long-lived assets to be disposed of other than by sale are classified as held and used until they are disposed of and reported at the lower of carrying amount or fair value. Depreciation is recognized over the remaining useful life of the assets.

Derivative Instruments

Derivative instruments are reported in the Consolidated Balance Sheets at their fair values. The company utilizes derivatives to manage exposures to foreign currency exchange rates and commodity prices. Changes in the fair values of derivative instruments that are not designated as hedges are recorded in current period earnings. For derivative instruments designated as cash flow hedges, the effective portion of any hedge is reported in accumulated other comprehensive loss until it is cleared to earnings during the same period in which the hedged item affects earnings. The ineffective portion of all hedges is recognized in current period earnings.

In the event that a derivative designated as a hedge of a firm commitment or an anticipated transaction is terminated prior to the maturation of the hedged transaction, gains or losses realized at termination are deferred and included in the measurement of the hedged transaction. If a hedged transaction matures, or is sold, extinguished, or terminated prior to the maturity of a derivative designated as a hedge of such transaction, gains or losses associated with the derivative through the date the transaction matured are included in the measurement of the hedged transaction and the derivative is reclassified as for trading purposes. Derivatives designated as hedges of anticipated transactions are reclassified as for trading purposes if the anticipated transaction is no longer probable.

In the Predecessor period, the company reflected non-qualified hedge programs, specifically forward contracts, options and cash collateral activity, within cash flows from investing activities. In the Predecessor period, the company reflected cash flows from qualified programs within the line item it related to (i.e., revenue hedge cash flows presented within changes from accounts receivable). In the Successor period, the company included foreign currency exchange contract settlements within cash flows from operating activities, regardless of hedge accounting qualification. See Note 18 for additional discussion regarding the company's objectives and strategies for derivative instruments.

Environmental Matters

Accruals for environmental matters are recorded when it is probable that a liability has been incurred and the amount of the liability can be reasonably estimated. These accruals are adjusted periodically as assessment and remediation efforts progress or as additional technical or legal information becomes available. Accruals for environmental liabilities are included in the Consolidated Balance Sheets in accrued and other current liabilities and other noncurrent obligations at undiscounted amounts. Accruals for related insurance or other third-party recoveries for environmental liabilities are recorded when it is probable that a recovery will be realized and are included in the consolidated balance sheets as accounts and notes receivable - net.

Environmental costs are capitalized if the costs extend the life of the property, increase its capacity, and/or mitigate or prevent contamination from future operations. Environmental costs are also capitalized in recognition of legal asset retirement obligations resulting from the acquisition, construction and/or normal operation of a long-lived asset. Costs related to environmental contamination treatment and cleanup are charged to expense. Estimated future incremental operations, maintenance and management costs directly related to remediation are accrued when such costs are probable and reasonably estimable.

F-17

E. I. du Pont de Nemours and Company

Notes to the Consolidated Financial Statements (continued)

Revenue Recognition

The company recognizes revenue when it is realized or realizable, and the earnings process is complete. The company's revenues are from the sale of a wide range of products to a diversified base of customers around the world. Revenue for product sales is recognized when title and risk of loss have been transferred, collectability is reasonably assured and pricing is fixed or determinable. A majority of product sales are sold FOB (free on board) shipping point or, with respect to non-United States of America (U.S.) customers, an equivalent basis. Accruals are made for sales returns and other allowances based on the company's experience. The company accounts for cash sales incentives as a reduction in sales and noncash sales incentives as a charge to cost of goods sold or selling expense, depending on the nature of the incentive. Amounts billed to customers for shipping and handling fees are included in net sales and costs incurred by the company for the delivery of goods are classified as cost of goods sold in the Consolidated Statements of Operations. Taxes on revenue-producing transactions are excluded from net sales.

The company periodically enters into prepayment contracts with the agriculture product line's customers and receives advance payments for product to be delivered in future periods. These advance payments are recorded as deferred revenue (classified as accrued and other current liabilities) or debt, depending on the nature of the program. Revenue associated with advance payments is recognized as shipments are made and title, ownership and risk of loss pass to the customer.

Licensing and royalty income is recognized in accordance with agreed upon terms, when performance obligations are satisfied, the amount is fixed or determinable and collectability is reasonably assured.

Royalty Expense

The company’s agriculture product line currently has certain third party biotechnology trait license agreements, which require up-front and variable payments subject to the licensor meeting certain conditions. These payments are reflected as other current assets and other assets and are amortized to cost of goods sold as seeds containing the respective trait technology are utilized over the life of the license. The company evaluates the carrying value of the prepaid royalties when events or changes in circumstances indicate the carrying value may not be recoverable.

Cost of Goods Sold

Successor periods - Cost of goods sold primarily includes the cost of manufacture and delivery, ingredients or raw materials, direct salaries, wages and benefits and overhead, non-capitalizable costs associated with capital projects and other operational expenses.  No amortization of intangibles is included within costs of goods sold.

Predecessor periods - Cost of goods sold primarily includes the cost of manufacture and delivery, ingredients or raw materials, direct salaries, wages and benefits and overhead.

Other Operating Charges

Predecessor periods - Other operating charges includes product claim charges and recoveries, non-capitalizable costs associated with capital projects and other operational expenses. 

Research and Development

Research and development costs are expensed as incurred. Research and development expense includes costs (primarily consisting of employee costs, materials, contract services, research agreements, and other external spend) relating to the discovery and development of new products, enhancement of existing products and regulatory approval of new and existing products.

Selling, General and Administrative Expenses

Successor periods - Selling, general and administrative expenses primarily include selling and marketing expenses, commissions, functional costs, and business management expenses.

Predecessor periods - Selling, general and administrative expenses primarily include selling and marketing expenses, commissions, functional costs, business management expenses and integration and separation costs.

Integration and Separation Costs

Successor periods - Integration and separation costs includes costs incurred to prepare for and close the Merger, post-Merger integration expenses and costs incurred to prepare for the Intended Business Separations. These costs primarily consist of financial advisory, information technology, legal, accounting, consulting and other professional advisory fees associated with preparation and execution of these activities.

F-18

E. I. du Pont de Nemours and Company

Notes to the Consolidated Financial Statements (continued)

Litigation

Accruals for legal matters are recorded when it is probable that a liability has been incurred and the amount of the liability can be reasonably estimated. Legal costs, such as outside counsel fees and expenses, are charged to expense in the period incurred.

Severance Costs

Severance benefits are provided to employees under the company's ongoing benefit arrangements. Severance costs are accrued when management commits to a plan of termination and it becomes probable that employees will be entitled to benefits at amounts that can be reasonably estimated.

Insurance/Self-Insurance

The company self-insures certain risks where permitted by law or regulation, including workers' compensation, vehicle liability and employee related benefits. Liabilities associated with these risks are estimated in part by considering historical claims experience, demographic factors and other actuarial assumptions. For other risks, the company uses a combination of insurance and self-insurance, reflecting comprehensive reviews of relevant risks. A receivable for an insurance recovery is generally recognized when the loss has occurred and collection is considered probable.

Income Taxes

The company accounts for income taxes using the asset and liability method. Under this method, deferred tax assets and liabilities are recognized for the future tax consequences of temporary differences between the carrying amounts and tax bases of assets and liabilities using enacted tax rates. The effect of a change in tax rates on deferred tax assets or liabilities is recognized in income in the period that includes the enactment date (see Note 7 for further information relating to the enactment of the Tax Cuts and Job Act).

The company recognizes the financial statement effects of an uncertain income tax position when it is more likely than not, based on the technical merits, that the position will be sustained upon examination. The company accrues for other tax contingencies when it is probable that a liability to a taxing authority has been incurred and the amount of the contingency can be reasonably estimated. The current portion of uncertain income tax positions is included in income taxes payable and the long-term portion is included in other noncurrent obligations in the Consolidated Balance Sheets.

Provision is made for taxes on undistributed earnings of foreign subsidiaries and related companies to the extent that such earnings are not deemed to be permanently invested. Income tax related penalties are included in the provision for income taxes in the Consolidated Statements of Operations. Interest accrued related to unrecognized tax benefits is included within the (benefit from) provision for income taxes from continuing operations in the Consolidated Statements of Operations in the Successor period. In the Predecessor period, interest accrued related to unrecognized tax benefits is included within sundry income - net in the Consolidated Statements of Operations.

Segments

Effective with the Merger, DuPont’s business activities are components of its parent company’s business operations. DuPont’s business activities, including the assessment of performance and allocation of resources, are reviewed and managed by DowDuPont. Information used by the chief operating decision maker of DuPont relates to the company in its entirety. Accordingly, there are no separate reportable business segments for DuPont under Accounting Standards Codification ("ASC") Topic 280 “Segment Reporting” and DuPont's business results are reported in this Form 10-K as a single operating segment. Prior year's segment information has been made to conform to the current presentation.

F-19

E. I. du Pont de Nemours and Company

Notes to the Consolidated Financial Statements (continued)

NOTE 2 - RECENT ACCOUNTING GUIDANCE

Recently Adopted Accounting Guidance

In March 2016, the FASB issued ASU No. 2016-09, Compensation - Stock Compensation (Topic 718), Improvements to Employee Share-Based Payment Accounting, which modifies the accounting for certain aspects of share-based payments to employees. The new guidance requires excess tax benefits and tax deficiencies to be recorded in the income statement when stock awards vest or are settled. In addition, cash flows related to excess tax benefits will no longer be separately classified as a financing activity apart from other income tax cash flows. The standard also allows the company to repurchase more of an employee’s vested shares for tax withholding purposes without triggering liability accounting, and clarifies that all cash payments made to tax authorities on an employee’s behalf for withheld shares should be presented as a financing activity on the statement of cash flows. The company adopted this standard as of January 1, 2017.

The primary impact of adoption was the recognition of excess tax benefits in the company's provision for income taxes rather than additional paid-in capital, which is applied prospectively in accordance with the guidance. Adoption of the new standard resulted in the recognition of $2 million and $30 million of excess tax benefits in the company's provision for income taxes rather than additional paid-in capital for the period September 1 through December 31, 2017 and the period January 1 through August 31, 2017, respectively.

The company elected to apply the presentation requirements for cash flows related to excess tax benefits retrospectively to all periods presented, which resulted in an increase to both net cash provided by operating activities and net cash used for financing activities of $27 million and $74 million for the years ended December 31, 2016 and 2015, respectively. The presentation requirements for cash flows related to employee taxes paid for withheld shares resulted in an increase to both net cash provided by operating activities and net cash used for financing activities of $30 million and $32 million for the years ended December 31, 2016 and 2015, respectively.

The remaining updates required by this standard did not have a material impact to the company’s Consolidated Financial Statements.

In January 2017, the FASB issued ASU No. 2017-04, Intangibles - Goodwill and Other (Topic 350), Simplifying the Test for Goodwill Impairment. The new guidance eliminates the requirement to determine the fair value of individual assets and liabilities of a reporting unit to measure goodwill impairment. Under the amendments in the new ASU, goodwill impairment testing will be performed by comparing the fair value of the reporting unit with its carrying amount and recognizing an impairment charge for the amount by which the carrying amount exceeds the reporting unit’s fair value. The new standard is effective for annual and interim goodwill impairment tests in fiscal years beginning after December 15, 2019, and should be applied on a prospective basis. Early adoption is permitted for annual or interim goodwill impairment testing performed after January 1, 2017. In connection with the Merger Transaction, the company adopted the policy of the parent company and performed its annual goodwill impairment test in the fourth quarter. Previously, the annual impairment test was performed in the third quarter. The company early adopted the new guidance for the annual goodwill impairment test that was performed in the fourth quarter of 2017. See Note 12 for additional information.

Accounting Guidance Issued But Not Adopted as of December 31, 2017

In August 2017, the FASB issued ASU No. 2017-12, Derivatives and Hedging (Topic 815), Targeted Improvements to Accounting for Hedging Activities. The new guidance expands and refines hedge accounting for both nonfinancial and financial risk components and aligns the recognition and presentation of the effects of the hedging instrument and the hedged items in the financial statements. For cash flow and net investment hedges existing as of the date of adoption, an entity should apply a cumulative-effect adjustment related to eliminating the separate measurement of ineffectiveness to accumulated other comprehensive income with a corresponding adjustment to the opening balance of retained earnings as of the beginning of the fiscal year in which an entity adopts. Presentation and disclosure guidance is required to be adopted prospectively. The new standard is effective for fiscal years beginning after December 15, 2018 and interim periods within those fiscal years. Early adoption is permitted in any interim period. All transition requirements and elections should be applied to hedging relationships existing (that is, hedging relationships in which the hedging instrument has not expired, been sold, terminated, or exercised or the entity has not removed the designation of the hedging relationship) on the date of adoption. The effect of adoption should be reflected as of the beginning of the fiscal year of adoption. The company is currently evaluating the impact this guidance will have on the Consolidated Financial Statements and related disclosures.

F-20

E. I. du Pont de Nemours and Company

Notes to the Consolidated Financial Statements (continued)

In March 2017, the FASB issued ASU No. 2017-07, Compensation - Retirement Benefits (Topic 715), Improving the Presentation of Net Periodic Pension Cost and Net Periodic Postretirement Benefit Cost. The new guidance requires registrants to present the service cost component of net periodic benefit cost in the same income statement line item or items as other employee compensation costs arising from services rendered during the period. In addition, only the service cost component will be eligible for capitalization in assets. Registrants will present the other components of net periodic benefit cost separately from the service cost component; and, the line item or items used in the income statement to present the other components of net periodic benefit cost must be disclosed. The guidance is effective for annual reporting periods beginning after December 15, 2017, including interim periods within those fiscal years. Early adoption is permitted as of the beginning of an annual period. The new standard must be adopted retrospectively for the presentation of the service cost component and the other components of net periodic benefit cost in the income statement, and prospectively for the capitalization of the service cost component of net periodic benefit cost in assets. The company plans to adopt this guidance in the first quarter of 2018 and is currently evaluating the impact on the Consolidated Financial Statements and related disclosures. The company anticipates approximately half the costs will be reclassified from cost of goods sold, with the remainder reclassified from selling, general and administrative expenses and research and development expense, to sundry income - net in the Consolidated Statements of Operations. See Note 16 for the components of net periodic benefit cost.

In January 2017, the FASB issued ASU No. 2017-01, Business Combinations (Topic 805), Clarifying the Definition of a Business. The new guidance narrows the existing definition of a business and provides a framework for evaluating whether a transaction should be accounted for as an acquisition (or disposal) of assets or a business. The guidance requires an entity to evaluate if substantially all of the fair value of the gross assets acquired is concentrated in a single identifiable asset or a group of similar identifiable assets; if so, the set of transferred assets and activities (collectively, the "set") is not a business. To be considered a business, the set would need to include an input and a substantive process that together significantly contribute to the ability to create outputs, as defined by the ASU. The guidance is effective for annual reporting periods beginning after December 15, 2017, including interim periods within those annual reporting periods, and should be applied prospectively. Early adoption is permitted. The company adopted this standard on January 1, 2018 and will apply it prospectively to all applicable transactions after the adoption date.

In November 2016, the FASB issued ASU 2016-18, Statement of Cash Flows (Topic 230): Restricted Cash (a consensus of the FASB Emerging Issues Task Force), which clarifies how entities should present restricted cash and restricted cash equivalents in the statement of cash flows, and, as a result, entities will no longer present transfers between cash and cash equivalents and restricted cash and restricted cash equivalents in the statement of cash flows. An entity with a material balance of restricted cash and restricted cash equivalents must disclose information about the nature of the restrictions. The new standard is effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2017. Early adoption is permitted and the new guidance must be applied retrospectively to all periods presented. The new guidance will change the presentation of restricted cash in the Consolidated Statements of Cash Flows and will be applied retrospectively in the first quarter of 2018.

In October 2016, the FASB issued ASU No. 2016-16, Income Taxes (Topic 740), Intra-Entity Transfers of Assets Other Than Inventory. The new guidance requires that entities recognize the income tax consequences of an intra-entity transfer of an asset other than inventory when the transfer occurs, rather than when the asset is sold to an outside party. The guidance is effective for annual reporting periods beginning after December 15, 2017, including interim periods within those annual reporting periods. Early adoption is permitted as of the beginning of an annual reporting period. The new guidance requires adoption on a modified retrospective basis through a cumulative-effect adjustment directly to retained earnings as of the beginning of the period of adoption. The company plans to adopt this guidance in the first quarter of 2018 with the expectation that this guidance will have an immaterial impact on the Consolidated Financial Statements and related disclosures.

In August 2016, the FASB issued ASU No. 2016-15, Statement of Cash Flows (Topic 230), Classification of Certain Cash Receipts and Cash Payments. The new guidance makes eight targeted changes to how cash receipts and cash payments are presented and classified in the statement of cash flows. The guidance is effective for fiscal years beginning after December 15, 2017, and interim periods within those fiscal years. The new guidance requires adoption on a retrospective basis unless it is impracticable to apply, in which case the company would be required to apply the amendments prospectively as of the earliest date practicable. The company is currently evaluating the impact this guidance will have on the Consolidated Financial Statements and related disclosures, but does not expect there to be a significant impact.

F-21

E. I. du Pont de Nemours and Company

Notes to the Consolidated Financial Statements (continued)

In February 2016, the FASB issued ASU No. 2016-02, Leases (Topic 842). The amendments under the new guidance will require lessees to recognize almost all leases on their balance sheet as a right-of-use asset and a lease liability, other than leases that meet the definition of a short-term lease. For income statement purposes, the FASB retained a dual model, requiring leases to be classified as either operating or finance. Classification will be based on criteria that are largely similar to those applied in current lease accounting. Lessor accounting is similar to the current model, but updated to align with certain changes to the lessee model and the new revenue recognition standard. The new leasing standard will be effective for fiscal years beginning after December 15, 2018, and interim periods within those fiscal years. Early adoption is permitted. The new standard must be adopted using a modified retrospective transition, requiring application at the beginning of the earliest comparative period presented. The company is currently evaluating the impact of adopting this guidance on the Consolidated Financial Statements and related disclosures. The company is the lessee under various agreements for facilities and equipment that are currently accounted for as operating leases. A discussion of these leases is included in Note 14, "Commitments and Contingent Liabilities."

In May 2014, the FASB issued ASU No. 2014-09, Revenue from Contracts with Customers (Topic 606), which was further updated in March, April, May and December 2016, as well as September and November 2017.  The new guidance clarifies the principles for recognizing revenue and develops a common revenue standard for GAAP.  The core principle of the guidance is that an entity should recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods and services.  The new standard also will result in additional disclosure requirements to describe the nature, amount, timing and uncertainty of revenue and cash flows arising from contracts with customers.  In July 2015, the FASB approved a deferral of the ASU effective date from annual and interim periods beginning after December 15, 2016 to annual and interim periods beginning after December 15, 2017. The standard permits the use of either the retrospective or modified retrospective (cumulative-effect) transition method of adoption.  The company will adopt the standard in the first quarter of 2018 under the modified retrospective transition method.  The company has substantially completed its evaluation of the impact of the new standard on the Consolidated Financial Statements and has determined that the transition adjustment to be recorded upon adoption is not material and the company does not expect material changes in the timing of revenue recognition.  The company continues to evaluate the impact of the new standard on its disclosures.

F-22

E. I. du Pont de Nemours and Company

Notes to the Consolidated Financial Statements (continued)

Note 3 - BUSINESS COMBINATIONS

Acquisition of Granular, Inc.

On August 31, 2017, the company acquired Granular, Inc., a leading provider of software and analytics tools that help farms improve efficiency, profitability, and sustainability.  The purchase price was approximately $250 million and was primarily allocated to goodwill, developed technology, and customer relationships. The fair value of the acquired assets related to Granular, Inc. are included in the fair value measurement of DuPont’s assets and liabilities, discussed below. 

Merger with Dow

Upon completion of the Merger, (i) each share of common stock, par value $0.30 per share, of the company (the "DuPont Common Stock") was converted into the right to receive 1.2820 fully paid and non-assessable shares of DowDuPont common stock, par value $0.01 per share, ("DowDuPont Common Stock"), in addition to cash in lieu of any fractional shares of DowDuPont Common Stock, and (ii) each share of DuPont Preferred Stock— $4.50 Series and DuPont Preferred Stock— $3.50 Series (collectively "DuPont Preferred Stock") issued and outstanding immediately prior to the Merger Effectiveness Time remains issued and outstanding and was unaffected by the Merger.

As provided in the Merger Agreement, at the Merger Effectiveness Time, all options relating to shares of DuPont Common Stock that were outstanding immediately prior to the effective time of the Merger were generally automatically converted into options relating to shares of DowDuPont Common Stock and all restricted stock units and performance based restricted stock units relating to shares of DuPont Common Stock that were outstanding immediately prior to the effective time of the Mergers were generally automatically converted into restricted stock units relating to shares of DowDuPont Common Stock, in each case, after giving effect to appropriate adjustments to reflect the Mergers and otherwise generally on the same terms and conditions as applied under the applicable plans and award agreements immediately prior to the Merger Effectiveness Time. See Note 17 for further discussion.

Prior to the Merger, shares of DuPont Common Stock were registered pursuant to Section 12(b) of the Securities Exchange Act of 1934, as amended and listed on the New York Stock Exchange (the “NYSE”). As a result of the Merger, on August 31, 2017, the company requested that the NYSE withdraw the shares of DuPont Common Stock from listing on the NYSE and filed a Form 25 with the U.S. Securities and Exchange Commission ("SEC") to report that DuPont Common Stock is no longer listed on the NYSE. DuPont continues to have preferred stock outstanding and it remains listed on the NYSE. DowDuPont Common Stock is listed and trades on the NYSE, ticker symbol DWDP.

As a condition of the regulatory approval of the Merger, DuPont was required to divest a portion of its crop protection product line, including certain research and development capabilities. See Note 4 for additional information.

DuPont and Dow intend to pursue, subject to the receipt of approval by the Board of Directors of DowDuPont, the separation of the combined company’s agriculture, specialty products and materials science businesses through a series of tax-efficient transactions (collectively, the "Intended Business Separations").

Preliminary Allocation of Purchase Price

Based on an evaluation of the provisions of ASC 805, "Business Combinations," ("ASC 805") Dow was determined to be the accounting acquirer in the Merger. DowDuPont has applied the acquisition method of accounting with respect to the assets and liabilities of DuPont, which have been measured at fair value as of the date of the Merger. In connection with the Merger and the related accounting determination, DuPont has elected to apply push-down accounting and reflect in its financial statements the fair value of assets and liabilities. Such fair values have been reflected in the Successor Consolidated Financial Statements.

DuPont's assets and liabilities were measured at estimated fair values as of the Merger Effectiveness Time, primarily using Level 3 inputs. Estimates of fair value represent management's best estimate which require a complex series of judgments about future events and uncertainties. Third-party valuation specialists were engaged to assist in the valuation of these assets and liabilities.

The total fair value of consideration transferred for the Merger was $74,680 million. Total consideration is comprised of the equity value of the DowDuPont shares as of the Merger Effectiveness Time that were issued in exchange for DuPont shares, the cash value for fractional shares, and the portion of DuPont's share awards and share options earned as of the Merger Effectiveness Time. Share awards and share options converted to DowDuPont equity instruments, but not vested, were $144 million as of August 31, 2017, which will be expensed over the remaining future vesting period.

F-23

E. I. du Pont de Nemours and Company

Notes to the Consolidated Financial Statements (continued)

The following table summarizes the fair value of consideration exchanged as a result of the Merger:

(In millions, except exchange ratio)
DuPont Common Stock outstanding as of the Merger Effectiveness Time	868.3
DuPont exchange ratio	1.2820
DowDuPont Common Stock issued in exchange for DuPont Common Stock	1,113.2
Fair value of DowDuPont Common Stock issued 1	$	74,195
Fair value of DowDuPont equity awards issued in exchange for outstanding DuPont equity awards 2	485
Total consideration	$	74,680

1. Amount was determined based on the price per share of Dow Common Stock of $66.65 on August 31, 2017.

2. Represents the fair value of replacement awards issued for DuPont's equity awards outstanding immediately before the Merger and attributable to the service periods prior to the Merger. The previous DuPont equity awards were converted into the right to receive 1.2820 shares of DowDuPont Common Stock.

The acquisition method of accounting requires, among other things, that identifiable assets acquired and liabilities assumed be recognized on the balance sheet at the fair values as of the acquisition date. In determining the fair value, DowDuPont utilized various forms of the income, cost and market approaches depending on the asset or liability being fair valued. The estimation of fair value required significant judgments related to future net cash flows (including net sales, cost of products sold, selling and marketing costs, and working capital/contributory asset charges), discount rates reflecting the risk inherent in each cash flow stream, competitive trends, market comparables and other factors. Inputs were generally determined by taking into account historical data, supplemented by current and anticipated market conditions, and growth rates.

F-24

E. I. du Pont de Nemours and Company

Notes to the Consolidated Financial Statements (continued)

The table below presents the preliminary fair value that was allocated to DuPont's assets and liabilities based upon fair values as determined by DowDuPont. The valuation process to determine the fair values is not yet complete. DuPont estimated the preliminary fair value of acquired assets and liabilities as of the date of acquisition based on information currently available and continues to adjust those estimates upon refinement of market participant assumptions for integrating businesses, finalization of tax returns in the pre-merger period and application of push-down accounting at the subsidiary level. The preliminary fair values are substantially complete with the exception of identifiable intangible assets, property, plant, and equipment, income taxes and goodwill. As DuPont finalizes the fair value of assets acquired and liabilities assumed, additional purchase price adjustments may be recorded during the measurement period, but no later than one year from the date of the acquisition. DuPont will reflect measurement period adjustments, if any, in the period in which the adjustments are recognized. Final determination of the fair values may result in further adjustments to the values presented in the following table.

	Estimated fair value as previously reported 1		Measurement period adjustments2			Estimated fair value adjusted
(In millions)
Fair Value of Assets as of the Merger Effectiveness Time
Cash and cash equivalents	$	4,005	$	—		$	4,005
Marketable securities	2,849		—			2,849
Accounts and notes receivable	7,851		—			7,851
Inventories	8,886		(79		)	8,807
Other current assets	360		—			360
Investment in nonconsolidated affiliates	1,685		(31		)	1,654
Assets held for sale - current	3,184		564			3,748
Property, plant and equipment	12,122		(181		)	11,941
Goodwill 3	45,501		(396		)	45,105
Other intangible assets 3	27,844		(623		)	27,221
Deferred income tax assets	487		(203		)	284
Other assets	2,076		—			2,076
Total Assets	$	116,850	$	(949	)	$	115,901
Fair Value of Liabilities
Short-term borrowings and capital lease obligations	$	5,319	$	—		$	5,319
Accounts payable	3,283		—			3,283
Income taxes payable	140		—			140
Accrued and other current liabilities	3,517		—			3,517
Liabilities held for sale - current	104		11			115
Long-term debt	9,878		—			9,878
Deferred income tax liabilities	9,408		(940		)	8,468
Pension and other post employment benefits - noncurrent	8,092		(36		)	8,056
Other noncurrent obligations	2,028		—			2,028
Total Liabilities	$	41,769	$	(965	)	$	40,804
Noncontrolling interests	162		16			178
Preferred stock	239		—			239
Fair Value of Net Assets (Consideration for the Merger)	$	74,680	$	—		$	74,680

1. As previously reported in the company’s Quarterly Report on Form 10-Q for the period ended September 30, 2017.

2. DuPont recorded measurement period adjustments in the fourth quarter of 2017 to reflect facts and circumstances in existence as of the Merger Effectiveness Time. These measurement period adjustments primarily related to changes in preliminary valuation assumptions, including market participant estimates of cash flows and estimates of asset useful lives, as well as other initial estimates. All measurement period adjustments were offset against goodwill.

3. See Note 12 for additional information.

F-25

E. I. du Pont de Nemours and Company

Notes to the Consolidated Financial Statements (continued)

The significant fair value adjustments included in the preliminary allocation of purchase price are discussed below.

Inventories

Inventory is primarily comprised of finished products of $4,929 million, semi-finished products of $3,055 million and raw materials and stores and supplies of $823 million. The fair value of finished goods was calculated as the estimated selling price, adjusted for costs of the selling effort and a reasonable profit allowance relating to the selling effort. The fair value of semi-finished inventory was primarily calculated as the estimated selling price, adjusted for estimated costs to complete the manufacturing, estimated costs of the selling effort, as well as a reasonable profit margin on the remaining manufacturing and selling effort. The fair value of raw materials and stores and supplies was determined to approximate the historical carrying value. For inventory accounted for under the FIFO method and average cost method, the preliminary fair value step-up of inventory will be recognized in costs of goods sold as the inventory is sold. For inventory accounted for under the LIFO method, the preliminary fair value of inventory becomes the LIFO base layer inventory. The pre-tax amount of inventory step-up recognized for the period September 1 through December 31, 2017, was $1,538 million, of which $1,434 million was reflected in costs of goods sold within loss from continuing operations before income taxes and $104 million is reflected in loss from discontinued operations after income taxes in the Consolidated Statements of Operations.

Property, Plant & Equipment

Property, plant and equipment is comprised of machinery and equipment of $7,466 million, buildings of $2,583 million, construction in progress of $980 million and land and land improvements of $912 million. The preliminary estimated fair value of property and equipment was primarily determined using a market approach for land and certain types of equipment, and a replacement cost approach for other property and equipment. The market approach for certain types of equipment represents a sales comparison that measures the value of an asset through an analysis of sales and offerings of comparable assets. The replacement cost approach used for all other depreciable property and equipment measures the value of an asset by estimating the cost to acquire or construct comparable assets and adjusts for age and condition of the asset.

Goodwill

The excess of the consideration for the Merger over the preliminary net fair value of assets and liabilities was recorded as goodwill. The Merger resulted in the recognition of $45,105 million of goodwill, none of which is deductible. Goodwill largely consists of expected cost synergies resulting from the Merger and the Intended Business Separations, the assembled workforce of DuPont, and future technology and customers.

Other Intangible Assets

Other intangible assets primarily consist of acquired customer related assets, developed technology, trademarks and tradenames, and germplasm. The preliminary customer-related value was determined using the excess earnings method while the preliminary developed technology, trademarks and trade names, and germplasm values were primarily determined utilizing the relief from royalty method. Both the excess earnings and relief from royalty methods are forms of the income approach. Refer to Note 12 for further information on other intangible assets.

Deferred Income Tax Assets and Liabilities

The deferred income tax assets and liabilities include the expected future federal, state, and foreign tax consequences associated with temporary differences between the preliminary fair values of the assets acquired and liabilities assumed and the respective tax bases. Tax rates utilized in calculating deferred income taxes generally represent the enacted statutory tax rates at the Merger Effectiveness Time in the jurisdictions in which legal title of the underlying asset or liability resides. Refer to Note 7 for further information related to the remeasurement of deferred income tax assets and liabilities as a result of the enactment of the U.S. Tax Cuts and Jobs Act in December 2017.

The preliminary fair value of deferred income tax assets includes a $172 million adjustment to derecognize a valuation allowance for certain historical net operating losses that will not be fully realized as a result of the Merger.  Included in the fair value adjustment related to deferred income tax liabilities is a $546 million adjustment reflecting a change in determination as to the reinvestment strategy of certain foreign operations of the company.

F-26

E. I. du Pont de Nemours and Company

Notes to the Consolidated Financial Statements (continued)

Integration and Separation Costs

Integration and separation costs have been and are expected to be significant. These costs to date primarily have consisted of financial advisory, information technology, legal, accounting, consulting, and other professional advisory fees associated with the preparation and execution of activities related to the Merger and the Intended Business Separations. These costs are recorded within integration and separation costs in the Successor period and the costs are recorded within selling, general and administrative expenses in the Predecessor periods within the Consolidated Statements of Operations.

	Successor		Predecessor
(In millions)	For the Period September 1 through December 31, 2017		For the Period January 1 through August 31, 2017		For the Year Ended December 31, 2016		For the Year Ended December 31, 2015
Integration and separation costs	$	314
Selling, general and administrative expenses			$	581	$	386	$	10

H&N Business

On November 1, 2017, the company completed the FMC Transactions through the acquisition of the H&N Business and the disposition of the Divested Ag Business. The acquisition will be integrated into the nutrition and health product line to enhance DuPont’s position as a leading provider of sustainable, bio-based food ingredients and allow for expanded capabilities in the pharma excipients space. The company accounted for the acquisition in accordance with ASC 805, which requires the assets acquired and liabilities assumed to be recognized on the balance sheet at their fair values as of the acquisition date.

The following table summarizes the fair value of consideration exchanged as a result of the FMC Transactions:

(In millions)
Fair Value of Divested Ag Business 1	$	3,665
Less: Cash received 2	1,200
Less: Favorable contracts 3	495
Fair Value of H&N Business	$	1,970

1. Refer to Note 4 for additional information.

2. The FMC Transactions include a cash consideration payment to DuPont of approximately $1,200 million, which reflects the difference in value between the Divested Ag Business and the H&N Business, subject to certain customary inventory and net working capital adjustments.

3. Upon closing and pursuant to the terms of the FMC Transaction Agreement, DuPont entered into favorable supply contracts with FMC. DuPont recorded these contracts as intangible assets recognized at the fair value of off-market contracts. Refer to Notes 4 and 12 for additional information.

F-27

E. I. du Pont de Nemours and Company

Notes to the Consolidated Financial Statements (continued)

The table below presents the preliminary fair value that was allocated to the assets acquired and liabilities assumed. The purchase accounting and purchase price allocation for the H&N Business are substantially complete. However, the company continues to refine the preliminary valuation of certain acquired assets, such as inventories, intangibles, deferred income taxes, and property plant and equipment, which could impact the amount of residual goodwill recorded. The company will finalize the amounts recognized as it obtains the information necessary to complete the analysis, but no later than one year from the date of the acquisition. Final determination of the fair values may result in further adjustments to the values presented in the following table.

	Successor
(In millions)	November 1, 2017
Fair Value of Assets
Cash and cash equivalents	$	16
Accounts and notes receivable	144
Inventories	314
Property, plant and equipment	505
Goodwill	718
Other intangible assets	435
Other current and non-current assets	16
Total Assets	$	2,148
Fair Value of Liabilities
Accounts payable and other accrued liabilities	$	70
Deferred income tax liabilities	108
Total Liabilities	$	178
Fair Value of Net Assets (Consideration for the H&N Business)	$	1,970

The significant fair value adjustments included in the preliminary allocation of purchase price are discussed below.

Inventories

Acquired inventory is comprised of finished goods of $153 million, semi-finished products of $85 million and raw materials and stores and supplies of $76 million. Fair value of inventory was calculated using a net realizable value approach for finished goods and semi-finished products and a replacement cost approach for raw materials and stores and supplies. The preliminary fair value step-up of inventory of $100 million will be recognized in costs of goods sold as the inventory is sold. The pre-tax amount recognized during the period ending November 1 through December 31, 2017, was $35 million, which was reflected in cost of goods sold within loss from continuing operations before income taxes in the Consolidated Statements of Operations.

Property, Plant & Equipment

Property, plant and equipment is comprised of machinery and equipment of $372 million, buildings of $63 million, land and land improvements of $39 million, and construction in progress of $31 million. The preliminary estimated fair values were determined using a combination of a market approach and replacement cost approach.

Goodwill

The excess of the consideration for the H&N Business over the preliminary net fair value of assets acquired and liabilities assumed resulted in the recognition of $718 million of goodwill, of which $208 million is tax-deductible. Goodwill is attributable to the H&N Business’s workforce and expected cost synergies in procurement, production and market access.

Other Intangible Assets

Other intangible assets includes customer-related intangible assets of $268 million, developed technology of $130 million, and trademarks and tradenames of $37 million. The preliminary customer-related fair value was determined using the excess earnings method while the preliminary developed technology, trademarks and tradenames fair values were primarily determined utilizing the relief from royalty method.

F-28

E. I. du Pont de Nemours and Company

Notes to the Consolidated Financial Statements (continued)

Results of Operations

The following table provides net sales and (loss) income from continuing operations before income taxes of the H&N Business included in the company's results since the acquisition.

	Successor
(In millions)	For the Period November 1 through December 31, 2017
Net sales	$	102
Loss from continuing operations before income taxes	$	(12	)

The H&N Business results include $35 million that was recognized in cost of goods sold as inventory was sold related to the fair value step-up of inventories in the Consolidated Statements of Operations, for the period of November 1 through December 31, 2017.

The company evaluated the disclosure requirements under ASC 805 and determined the H&N Business was not considered a material business combination for purposes of disclosing supplemental pro forma information.

NOTE 4 - DIVESTITURES AND OTHER TRANSACTIONS

Merger Remedy - Divested Ag Business

On March 31, 2017, the company and FMC entered into the FMC Transaction Agreement. Under the FMC Transaction Agreement, FMC acquired the Divested Ag Business that DuPont was required to divest in order to obtain EC approval of the Merger Transaction as described in Note 1 and DuPont agreed to acquire the H&N Business. The sale of the Divested Ag Business meets the criteria for discontinued operations and as such, earnings are included within "(Loss) Income from discontinued operations after income taxes" for all periods presented.

On November 1, 2017, the company completed the FMC Transactions through the disposition of the Divested Ag Business and the acquisition of the H&N Business. The preliminary fair value as determined by the company of the H&N Business is $1,970 million. The FMC Transactions include a cash consideration payment to DuPont of approximately $1,200 million, which reflects the difference in value between the Divested Ag Business and the H&N Business, as well as favorable contracts with FMC of $495 million, subject to adjustments for inventory of the Divested Ag Business and net working capital of the H&N Business. Due to the proximity of the Merger and the closing of the sale, the carrying value of the Divested Ag Business approximated the fair value of the consideration received, thus no resulting gain or loss was recognized on the sale. Refer to Note 3 for further information on the H&N Business.

F-29

E. I. du Pont de Nemours and Company

Notes to the Consolidated Financial Statements (continued)

The results of operations of the Divested Ag Business are presented as discontinued operations as summarized below:

	Successor			Predecessor
(In millions)	For the Period September 1 through December 31, 20171			For the Period January 1 through August 31, 2017		For the Year Ended December 31, 2016			For the Year Ended December 31, 2015
Net sales	$	199		$	1,068	$	1,385		$	1,473
Cost of goods sold	194			412		514			521
Other operating charges				17		19			25
Research and development expenses	30			95		139			163
Selling, general and administrative expenses2	102			146		176			187
Restructuring and asset related charges - net	(1		)	—		(4		)	15
Sundry (expense) income - net	(1		)	7		1			7
(Loss) Income from discontinued operations before income taxes	(127		)	405		542			569
(Benefit from) Provision for income taxes	(50		)	79		103			121
(Loss) Income from discontinued operations after income taxes	$	(77	)	$	326	$	439		$	448

^1.  Includes results of operations for the period September 1 through October 31, 2017, as the Divested Ag Business was disposed of on November 1, 2017.

^2.  Successor period includes $44 million of transaction costs associated with the disposal of the Divested Ag Business.

The following table presents depreciation and capital expenditures of the discontinued operations related to the Divested Ag Business:

	Successor		Predecessor
(In millions)	For the Period September 1 through December 31, 2017		For the Period January 1 through August 31, 2017		For the Year Ended December 31, 2016		For the Year Ended December 31, 2015
Depreciation	$	—	$	21	$	32	$	30
Capital expenditures	$	5	$	8	$	40	$	77

The carrying amount of major classes of assets and liabilities classified as assets and liabilities of discontinued operations at December 31, 2016 related to the Divested Ag Business consist of the following:

	Predecessor
(In millions)	December 31, 2016
Cash and cash equivalents	$	57
Accounts and notes receivable - net	12
Inventories	323
Other current assets	1
Property, plant and equipment - net	380
Goodwill	11
Other assets	5
Assets held for sale	$	789
Accounts payable	27
Accrued and other current liabilities	12
Deferred income tax liabilities	6
Other noncurrent obligations	29
Liabilities held for sale	$	74

F-30

E. I. du Pont de Nemours and Company

Notes to the Consolidated Financial Statements (continued)

Upon closing and pursuant to the terms of the FMC Transaction Agreement, DuPont and FMC entered into favorable supply agreements and certain ancillary agreements, including manufacturing service agreements and transition service agreements.  Under the terms of the favorable supply agreements, FMC will supply product to DuPont at cost for a period of up to five years and, as a result, DuPont recorded an intangible asset of $495 million upon closing that will amortize over a period of five years.

Food Safety Diagnostic Sale

In February 2017, the company completed the sale of global food safety diagnostics to Hygiena LLC.  The sale resulted in a pre-tax gain of $162 million ($86 million net of tax). The gain was recorded in sundry income - net in the company's Consolidated Statement of Operations for the period January 1 through August 31, 2017.

DuPont (Shenzhen) Manufacturing Limited

In March 2016, the company recognized the sale of its 100 percent ownership interest in DuPont (Shenzhen) Manufacturing Limited to the Feixiang Group. The sale of the entity, which held certain buildings and other assets, resulted in a pre-tax gain of $369 million ($214 million net of tax). The gain was recorded in sundry income - net in the company's Consolidated Statement of Operations for the year ended December 31, 2016.

Performance Chemicals

On July 1, 2015, DuPont completed the separation of its Performance Chemicals segment through the spin-off of all of the issued and outstanding stock of The Chemours Company (the "Separation"). In connection with the Separation, the company and The Chemours Company ("Chemours") entered into a Separation Agreement (the "Separation Agreement"), discussed below, and a Tax Matters Agreement and certain ancillary agreements, including an employee matters agreement, agreements related to transition and site services, and intellectual property cross licensing arrangements. In addition, the companies have entered into certain supply agreements.

Separation Agreement

The company and Chemours entered into a Separation Agreement that sets forth, among other things, the agreements between the company and Chemours regarding the principal transactions necessary to effect the Separation and also sets forth ancillary agreements that govern certain aspects of the company’s relationship with Chemours after the separation. Among other matters, the Separation Agreement and the ancillary agreements provide for the allocation between DuPont and Chemours of assets, employees, liabilities and obligations (including investments, property and employee benefits and tax-related assets and liabilities) attributable to periods prior to, at and after the completion of the Separation.

Pursuant to the Separation Agreement and the Amendment to the Separation Agreement, as discussed below, Chemours indemnifies DuPont against certain litigation, environmental, workers' compensation and other liabilities that arose prior to the distribution. The term of this indemnification is generally indefinite and includes defense costs and expenses, as well as monetary and non-monetary settlements and judgments. In 2017, DuPont and Chemours amended the Separation Agreement to provide for a limited sharing of potential future PFOA liabilities for a period of five years beginning July 6, 2017. In connection with the recognition of liabilities related to these matters, the company records an indemnification asset when recovery is deemed probable. At December 31, 2017, the indemnified assets are $80 million within accounts and notes receivable - net and $340 million within other assets along with the corresponding liabilities of $80 million within accrued and other current liabilities and $340 million within other noncurrent obligations on the Condensed Consolidated Balance Sheet. See Note 14 for further discussion of the amendment to the Separation Agreement and certain litigation and environmental matters indemnified by Chemours.

F-31

E. I. du Pont de Nemours and Company

Notes to the Consolidated Financial Statements (continued)

The results of operations of the Performance Chemicals segment are presented as discontinued operations as summarized below:

	Predecessor
(In millions)	For the Period January 1 through August 31, 2017			For the Year Ended December 31, 2016			For the Year Ended December 31, 2015
Net sales	$	—		$	—		$	2,810
Cost of goods sold	—			—			2,215
Other operating charges	335			36			386
Research and development expense	—			—			40
Selling, general and administrative expenses	—			—			(87		)
Restructuring and asset related charges - net	—			—			59
Sundry income - net	3			3			27
Interest expense	—			—			32
(Loss) income from discontinued operations before income taxes	(332		)	(33		)	192
(Benefit from) provision for income taxes	(125		)	(28		)	106
(Loss) income from discontinued operations after income taxes	$	(207	)	$	(5	)	$	86

Income (loss) from discontinued operations after income taxes for the period January 1 through August 31, 2017 includes a charge of $335 million ($214 million net of tax) in connection with the perfluorooctanoic acid (“PFOA”) multi-district litigation settlement.

During the years ended December 31, 2016 and 2015, the company incurred $35 million and $306 million of costs, respectively, in connection with the separation primarily related to professional fees associated with preparation of regulatory filings and separation activities within finance, tax, legal, and information system functions. (Loss) income from discontinued operations during the years ended December 31, 2016 and 2015, includes $35 million and $260 million of these costs, respectively. Income from continuing operations during the year ended December 31, 2015 includes $26 million of these costs, recorded in other operating charges in the company's Consolidated Statements of Operations. Income from continuing operations during the year ended December 31, 2015 also included $20 million of transaction costs incurred for a premium associated with the early retirement of DuPont debt. The company exchanged notes received from Chemours in May 2015 (as part of a dividend payment) for DuPont debt that it then retired. These costs were reported in interest expense in the company's Consolidated Statements of Operations.

In connection with the separation, income from discontinued operations during the year ended December 31, 2015 included pension and other post employment benefit plan curtailment gain of $281 million. In addition, income from discontinued operations during the year ended December 31, 2015, included a restructuring charge of $59 million, consisting of severance and related benefit costs associated with the Performance Chemicals segment to achieve fixed cost and operational productivity improvements for Chemours post-spin.

In connection with the spin-off, the company received a dividend from Chemours in May 2015 of $3,923 million comprised of a cash distribution of $3,416 million and a distribution in-kind of $507 million of 7 percent senior unsecured notes due 2025 (Chemours Notes Received). Chemours financed the dividend payment through issuance of approximately $4,000 million of debt, including the Chemours Notes Received (Chemours' Debt). Net assets of $431 million were transferred to Chemours on July 1, 2015, including the $4,000 million of Chemours' Debt.

The following table presents the depreciation, amortization and purchases of property, plant and equipment of the discontinued operations related to Performance Chemicals:

(In millions)	Predecessor
For the year ended December 31,	2015
Depreciation	$	126
Amortization of intangible assets	2
Capital Expenditures	235

F-32

E. I. du Pont de Nemours and Company

Notes to the Consolidated Financial Statements (continued)

NOTE 5 - RESTRUCTURING AND ASSET RELATED CHARGES - NET

DowDuPont Cost Synergy Program

In September and November 2017, DowDuPont and the company approved post-merger restructuring actions under the DowDuPont Cost Synergy Program (the “Synergy Program”), adopted by the DowDuPont Board of Directors. The plan is designed to integrate and optimize the organization following the Merger and in preparation for the Intended Business Separations.  Based on all actions approved to date under the Synergy Program, DuPont expects to record total pre-tax restructuring charges of $430 million to $600 million, comprised of approximately $320 million to $360 million of severance and related benefits costs; $110 million to $140 million of costs related to contract terminations; and up to $100 million of asset related charges. The Synergy Program includes certain asset actions, including strategic decisions regarding the cellulosic biofuel unit reflected in the preliminary fair value measurement of DuPont’s assets as of the merger date. Current estimated total pre-tax restructuring charges could be impacted by future adjustments to the preliminary fair value of DuPont’s assets.

For the period September 1 through December 31, 2017, DuPont recorded a pre-tax charge of $187 million, consisting of severance and related benefit costs of $153 million, contract termination costs of $31 million and asset-related charges of $3 million. The charge for the period September 1 through December 31, 2017 was recognized in restructuring and asset related charges - net in the company's Consolidated Statements of Operations. Substantially all of the remaining restructuring charges are expected to be incurred in 2018 and the related actions, including employee separations, associated with this plan are expected to be substantially complete by the end of 2019.

DuPont account balances and activity for the DowDuPont Cost Synergy Program are summarized below:

(In millions)	Severance and Related Benefit Costs			Other Non-Personnel Charges1			Asset-Related Charges			Total
Charges to income from continuing operations for the period September 1 through December 31, 2017 (Successor)	$	153		$	31		$	3		$	187
Payments	(13		)	(3		)	—			(16		)
Asset write-offs	—			—			(3		)	(3		)
Non-cash compensation	(7		)	—			—			(7		)
Balance as of December 31, 2017	$	133		$	28		$	—		$	161

1. Other non-personnel charges consist of contractual obligation costs.

2017 Restructuring Program

During the first quarter 2017, DuPont committed to take actions to improve plant productivity and better position its product lines for productivity and growth before and after the anticipated closing of the Merger Transaction (the "2017 restructuring program"). In connection with these actions, the company incurred pre-tax charges of $313 million during the period from January 1 through August 31, 2017 ("Predecessor" period) recognized in restructuring and asset related charges - net in the company's Consolidated Statements of Operations. The charge is comprised of $279 million of asset-related charges and $34 million in severance and related benefit costs. The charges primarily relate to the second quarter closure of the safety and construction product line at the Cooper River manufacturing site located near Charleston, South Carolina. The asset-related charges mainly consist of accelerated depreciation associated with the closure. The actions associated with this plan are substantially complete as of December 31, 2017.

F-33

E. I. du Pont de Nemours and Company

Notes to the Consolidated Financial Statements (continued)

Account balances and activity for the 2017 restructuring program are summarized below:

(In millions)	Severance and Related Benefit Costs			Asset Related Charges1			Total
Charges to income from continuing operations for the period January 1 through August 31, 2017 (Predecessor)	$	34		$	279		$	313
Payments	(8		)	—			(8		)
Asset write-offs	—			(279		)	$	(279	)
Balance as of August 31, 2017	$	26		$	—		$	26
Charges to income from continuing operations for the period September 1 through December 31, 2017 (Successor)	$	—		$	—		$	—
Payments	(7		)	—			(7		)
Balance as of December 31, 2017	$	19		$	—		$	19

^1.  Includesaccelerated depreciation related to site closure. Charge for accelerated depreciation represents the difference between the depreciation expense to be recognized over the revised useful life of the site, based upon the anticipated date the site will be closed and depreciation expense as determined utilizing the useful life prior to the restructuring action.

La Porte Plant, La Porte, Texas

In March 2016, DuPont announced its decision to not re-start its insecticide manufacturing facility at the La Porte site located in La Porte, Texas.  The facility manufactured Lannate^® and Vydate^® insecticides and has been shut down since November 2014.  As a result of this decision, during the year ended December 31, 2016, a pre-tax charge of $68 million was recorded in restructuring and asset related charges - net in the company's Consolidated Statement of Operations which included $41 million of asset related charges, $16 million of employee severance and related benefit costs, and $11 million of contract termination costs.                

2016 Global Cost Savings and Restructuring Plan

In December 2015, DuPont committed to take structural actions across all product lines and staff functions globally to operate more efficiently by further consolidating product lines and aligning staff functions more closely with them as part of a 2016 global cost savings and restructuring plan. As a result, during the year ended December 31, 2015, a pre-tax charge of $783 million was recorded, consisting of $778 million of restructuring and asset related charges - net and $5 million in sundry income - net in the company's Consolidated Statement of Operations. The charges consisted of $641 million in severance and related benefit costs, $109 million in asset related charges, and $33 million in contract termination charges.

During the year ended December 31, 2016, in connection with the restructuring actions, the company recorded a net pre-tax benefit to earnings of $(81) million, consisting of $(84) million in restructuring and asset related charges - net and $3 million in sundry income - net in the company's Consolidated Statement of Operations. The net benefit was comprised of a reduction of $(150) million in severance and related benefit costs, offset by $53 million of asset related charges, and $16 million of contract termination costs. This was primarily due to a reduction in severance and related benefit costs partially offset by the identification of additional projects. The reduction in severance and related benefit costs was driven by elimination of positions at a lower cost than expected as a result of redeployments and attrition as well as lower than estimated individual severance costs.

The company incurred pre-tax charges of $10 million during the period January 1 through August 31, 2017, recognized in restructuring and asset related charges - net in the company’s Consolidated Statement of Operations. This was due to additional severance payments owed to previously terminated executives that became probable during the period. The company incurred a pre-tax benefit of $(5) million for the period from September 1 through December 31, 2017. The reduction in severance and related benefit costs was driven by the elimination of positions at a lower cost than expected.

F-34

E. I. du Pont de Nemours and Company

Notes to the Consolidated Financial Statements (continued)

Account balances and activity for the restructuring program are summarized below:

(In millions)	Severance and Related Benefit Costs			Other Non-Personnel Charges1			Total
Balance at December 31, 2016 (Predecessor)	$	100		$	22		$	122
Payments	(76		)	(11		)	(87		)
Net translation adjustment	2			—			2
Other adjustments	10			—			10
Balance as of August 31, 2017	$	36		$	11		$	47
Balance at September 1, 2017 (Successor)	$	36		$	11		$	47
Payments	(18		)	(2		)	(20		)
Other adjustments	(5		)	—			(5		)
Balance as of December 31, 2017	$	13		$	9		$	22

1. Other non-personnel charges consist of contractual obligation costs.

2014 Restructuring Program

In June 2014, DuPont announced its global, multi-year initiative to redesign its global organization and operating model to reduce costs and improve productivity and agility across all product lines and functions. During the period from September 1 through December 31, 2017, and the years ended December 31, 2016 and 2015, benefits of $(2) million, $(21) million and $(21) million were recorded, respectively, in restructuring and asset related charges - net in the company's Consolidated Statements of Operations to reduce the accrual for severance costs associated with this program.

Asset Impairment

In the fourth quarter 2015, the company elected to defer further testing and deployment of a multi-year, phased implementation of an enterprise resource planning (ERP) system; which had not been placed in service as of year-end.  At December 31, 2016, the company had capitalized costs associated with the ERP system of $435 million.  In connection with IT strategy reviews conducted during the fourth quarter of 2016, the company reviewed considerations around the timing of restarting testing and deployment of the ERP system.  As a result, the company concluded it intended to complete and place in service the ERP system, however, given the uncertainties related to implementation timing as well as potential developments and changes to technologies in the market place at the time of restart, use of this ERP system could no longer be considered probable. As a result, due to the specificity of the design related to the ERP system, the company determined that the uncompleted ERP system had a fair value of zero and recorded a pre-tax charge of $435 million in restructuring and asset related charges - net in the company's Consolidated Statement of Operations during the year ended December 31, 2016. 

The company recognized a $158 million pre-tax impairment charge in restructuring and asset related charges - net in the company's Consolidated Statement of Operations during the year ended December 31, 2016 related to indefinite-lived intangible trade names. In connection with the company's strategy reviews and brand realignment conducted during the third quarter 2016, the company decided to phase out the use of certain acquired trade names resulting in a change from an indefinite life to a finite useful life for these assets. As a result of these changes, the carrying value of the trade name assets exceeded the fair value.

The basis of the fair value for the charges was calculated utilizing an income approach (relief from royalty method) using Level 3 inputs within the fair value hierarchy, as described in Note 1. The key assumptions used in the calculation included projected revenue, royalty rates and discount rates. These key assumptions involve management judgment and estimates relating to future operating performance and economic conditions that may differ from actual cash flows. After the recognition of the impairment charge, the remaining net book value of the trade names was $28 million, which represented fair value.

During the first quarter 2015, a $38 million pre-tax impairment charge was recorded in restructuring and asset related charges - net in the company's Consolidated Statement of Operations. The majority relates to a cost basis investment in which the assessment resulted from the venture's revised operating plan reflecting underperformance of its European wheat based ethanol facility and deteriorating European ethanol market conditions. One of the primary investors communicated that they would not fund the revised operating plan of the investee. As a result, the carrying value of DuPont's 6 percent cost basis investment in this venture exceeds its fair value by $37 million, such that an impairment charge was recorded.

F-35

E. I. du Pont de Nemours and Company

Notes to the Consolidated Financial Statements (continued)

NOTE 6 - SUPPLEMENTARY INFORMATION

Sundry Income - Net	Successor		Predecessor
(In millions)	For the Period September 1 through December 31, 2017		For the Period January 1 through August 31, 2017			For the Year Ended December 31, 2016			For the Year Ended December 31, 2015
Royalty income1			$	84		$	170		$	138
Interest income	$	41	83			102			124
Equity in earnings of affiliates - net	1		55			99			49
Net gain on sales of businesses and other assets2,3	16		205			435			92
Net exchange gains (losses)	8		(394		)	(106		)	30
Miscellaneous income and expenses - net4	24		133			7			257
Sundry income - net	$	90	$	166		$	707		$	690

^1.  In the Successor period, royalty income of $60 million is included in Net Sales.

^2.   Includes a pre-tax gain of $162 million ($86 million net of tax) for the period January 1 through August 31, 2017 related to the sale of global food safety diagnostics. See Note 4 for additional information.

^3.   Includes a pre-tax gain of $369 million ($214 million net of tax) for the year ended December 31, 2016 related to the sale of DuPont (Shenzhen) Manufacturing Limited. See Note 4 for additional information.

^4.   Miscellaneous income and expenses - net, includes interest items (in the Predecessor period only), gains (losses) on available for sale securities, gains related to litigation settlements, licensing income, gains on purchases, and other items.

The following table summarizes the impacts of the company's foreign currency hedging program on the company's results of operations. The company routinely uses foreign currency exchange contracts to offset its net exposures, by currency, related to the foreign currency-denominated monetary assets and liabilities. The objective of this program is to maintain an approximately balanced position in foreign currencies in order to minimize, on an after-tax basis, the effects of exchange rate changes on net monetary asset positions. The hedging program gains (losses) are largely taxable (tax deductible) in the United States (U.S.), whereas the offsetting exchange gains (losses) on the remeasurement of the net monetary asset positions are often not taxable (tax deductible) in their local jurisdictions. The net pre-tax exchange gains (losses) are recorded in sundry income - net and the related tax impact is recorded in provision for income taxes on continuing operations in the Consolidated Statements of Operations.

	Successor			Predecessor
(In millions)	For the Period September 1 through December 31, 2017			For the Period January 1 through August 31, 2017			For the Year Ended December 31, 2016			For the Year Ended December 31, 2015
Subsidiary Monetary Position (Loss) Gain
Pre-tax exchange (loss) gain	$	(83	)	$	37		$	198		$	(404	)
Local tax (expenses) benefits	(3		)	217			(126		)	(61		)
Net after-tax impact from subsidiary exchange (loss) gain	$	(86	)	$	254		$	72		$	(465	)
Hedging Program Gain (Loss)
Pre-tax exchange gain (loss)	$	91		$	(431	)	$	(304	)	$	434
Tax (expenses) benefits	(33		)	155			110			(157		)
Net after-tax impact from hedging program exchange gain (loss)	$	58		$	(276	)	$	(194	)	$	277
Total Exchange Gain (Loss)
Pre-tax exchange gain (loss)	$	8		$	(394	)	$	(106	)	$	30
Tax (expenses) benefits	(36		)	372			(16		)	(218		)
Net after-tax exchange (loss) gain	$	(28	)	$	(22	)	$	(122	)	$	(188	)

Other current assets

Other current assets includes approximately $558 million of restricted cash related to the Rabbi Trust as of December 31, 2017. See Note 16 for additional information.

F-36

E. I. du Pont de Nemours and Company

Notes to the Consolidated Financial Statements (continued)

Accrued and other current liabilities

Accrued and other current liabilities were $4,384 million at December 31, 2017 and $4,650 million at December 31, 2016. Deferred revenue and compensation and other employee-related costs, which are components of accrued and other current liabilities, were $2,014 million and $857 million at December 31, 2017, respectively and $2,217 million and $807 million at December 31, 2016, respectively. No other components of accrued and other current liabilities were more than 5 percent of total current liabilities.

Other noncurrent obligations

Other noncurrent obligations were $1,975 million at December 31, 2017 and $12,304 million at December 31, 2016. Accrued pension benefit costs and accrued other post employment benefit costs, which are components of other noncurrent obligations in the Predecessor period, were $8,092 million and $2,554 million at December 31, 2016, respectively. In the Successor period, accrued pension benefit costs and accrued other post employment benefit costs are included in the line item, pension and other post employment benefits - noncurrent in the Consolidated Balance Sheets. See Note 1 for discussion of reclassification adjustments. No other components of other noncurrent obligations were more than 5 percent of total liabilities.

Related Parties

Transactions with DowDuPont

DowDuPont relies on distributions and other intercompany transfers from DuPont and Dow to fund payment of its costs and expenses. In November 2017, DowDuPont’s Board of Directors declared a fourth quarter dividend per share of DowDuPont common stock payable on December 15, 2017 and authorized an initial $4,000 million share repurchase program to buy back shares of DowDuPont common stock. In the fourth quarter of 2017, DuPont declared and paid distributions in cash and in-kind to DowDuPont of $829 million, primarily to fund a portion of DowDuPont’s fourth quarter share repurchases and dividend payment.

In addition, at December 31, 2017, DuPont had a payable to DowDuPont of $354 million, included in accounts payable in the Consolidated Balance Sheets related to its estimated 2017 tax liability. See Note 7 for additional information.

NOTE 7 - INCOME TAXES

On December 22, 2017, the Tax Cuts and Jobs Act (“The Act”) was enacted. The Act reduces the U.S. federal corporate income tax rate from 35 percent to 21 percent, requires companies to pay a one-time transition tax (“transition tax”) on earnings of foreign subsidiaries that were previously tax deferred, creates new provisions related to foreign sourced earnings, eliminates the domestic manufacturing deduction and moves to a territorial system. At December 31, 2017, the company had not completed its accounting for the tax effects of The Act; however, as described below, the company has made a reasonable estimate of the effects on its existing deferred tax balances and the one-time transition tax. In accordance with Staff Accounting Bulletin 118 ("SAB 118"), during the measurement period, income tax effects of the Act may be refined upon obtaining, preparing, or analyzing additional information, and such changes could be material. During the measurement period, provisional amounts may be also be adjusted for the effects, if any, of interpretative guidance issued after December 31, 2017, by U.S. regulatory and standard-setting bodies.

• As a result of The Act, the company remeasured its U.S. federal deferred income tax assets and liabilities based on the rates at which they are expected to reverse in the future, which is generally 21 percent. However, the company is still analyzing certain aspects of The Act and refining its calculations, which could potentially affect the measurement of these balances or potentially give rise to new deferred tax amounts. The provisional amount recorded related to the remeasurement of the company’s deferred income tax balance was $(2,716) million and was recorded as a benefit to the provision for income taxes on continuing operations.

• The Act requires a mandatory deemed repatriation of post-1986 undistributed foreign earnings and profits (“E&P”), which results in a one-time transition tax. As a result, the company has recorded a provisional amount for the transition tax liability for its foreign subsidiaries of $715 million, recorded as a charge to the provision for income taxes on continuing operations. The company has not yet completed its calculation of the total post-1986 foreign E&P for its foreign subsidiaries as E&P will not be finalized until the Federal income tax return is filed. Further, the transition tax is based in part on the amount of those earnings held in cash and other specified assets which is a defined term under The Act.

F-37

E. I. du Pont de Nemours and Company

Notes to the Consolidated Financial Statements (continued)

• For tax years beginning after December 31, 2017, The Act introduces new provisions for U.S. taxation of certain global intangible low-taxed income (“GILTI”). Due to its complexity and a current lack of guidance as to how to calculate the tax, the company is not yet able to determine a reasonable estimate for the impact of the incremental tax liability. When additional guidance is available, the company will make a policy election on whether the additional liability will be recorded in the period in which it is incurred or recognized for the basis differences that would be expected to reverse in future years.

Geographic Allocation of Income and Provision for Income Taxes	Successor			Predecessor
(In millions)	For the Period September 1 through December 31, 2017			For the Period January 1 through August 31, 2017			Year Ended 2016			Year Ended 2015
(Loss) Income from continuing operations before income taxes
Domestic	$	(811	)	$	409		$	1,415		$	1,301
Foreign	(775		)	1,382			1,308			721
(Loss) Income from continuing operations before income taxes	$	(1,586	)	$	1,791		$	2,723		$	2,022
Current tax expense (benefit)
Federal	$	216		$	(563	)	$	4		$	155
State and local	22			(11		)	9			2
Foreign	187			282			539			420
Total current tax expense (benefit)	$	425		$	(292	)	$	552		$	577
Deferred tax (benefit) expense
Federal	$	(2,790	)	$	476		$	22		$	135
State and local	(48		)	(8		)	(29		)	4
Foreign	(260		)	(27		)	96			(141		)
Total deferred tax (benefit) expense	$	(3,098	)	$	441		$	89		$	(2	)
(Benefit from) Provision for income taxes on continuing operations	(2,673		)	149			641			575
Net Income from continuing operations	$	1,087		$	1,642		$	2,082		$	1,447

International pre-tax (loss) earnings from continuing operations was $(775) million, $1,382 million, $1,308 million, and $721 million for the period September 1 through December 31, 2017, the period January 1 through August 31, 2017, and the years ended December 31, 2016 and 2015, respectively. In connection with the Merger, pre-tax earnings from continuing operations for the period September 1 through December 31, 2017 includes depreciation and amortization associated with the fair value that was allocated to the company’s tangible and intangible assets as well as costs of $1,469 million recognized in cost of goods sold related to the fair value step-up of inventories (See Note 3 and 10 for further information).

The U.S. pre-tax earnings from continuing operations for the period January 1 through August 31, 2017 includes transaction costs associated with the Merger and restructuring and asset related charges (which are mostly incurred in the US). These decreases were partially offset by the gain on the sale of the company's food safety diagnostics business in the first quarter 2017.

The increase in pre-tax earnings from continuing operations from 2015 to 2016 is primarily driven by the gain on the sale of DuPont (Shenzhen) Manufacturing Limited in 2016 in addition to the absence of 2015 restructuring and asset related charges - net.

F-38

E. I. du Pont de Nemours and Company

Notes to the Consolidated Financial Statements (continued)

Reconciliation to U.S. Statutory Rate	Successor		Predecessor
	For the Period September 1 through December 31, 2017		For the Period January 1 through August 31, 2017		Year Ended 2016		Year Ended 2015
Statutory U.S. federal income tax rate	35.0	%	35.0	%	35.0	%	35.0	%
Equity earning effect	0.9		(0.5	)	(0.8	)	(0.7	)
Lower effective tax rates on international operations - net	(9.5	)	(11.4	)	(9.2	)	(9.7	)
Acquisitions, divestitures and ownership restructuring activities 1, 2	15.8		5.2		1.9		(0.2	)
U.S. research and development credit	0.4		(0.8	)	(0.7	)	(1.5	)
Exchange gains/losses 3	(1.8	)	(12.9	)	1.9		10.2
Impact of U.S. Tax Reform	126.1
Excess tax benefits from stock compensation4	0.1		(1.7	)
Tax settlements and expiration of statute of limitations5	—		(3.8	)	(1.1	)	(1.5	)
Other - net	1.5		(0.8	)	(3.5	)	(3.2	)
Effective tax rate	168.5	%	8.3	%	23.5	%	28.4	%

1. See Notes 3 and 4 for additional information.

2. Includes a net tax benefit of $261 million related to an internal legal entity restructuring associated with the Intended Business Separations.

3. Principally reflects the impact of foreign exchange gains and losses on net monetary assets for which no corresponding tax impact is realized. Further information about the company's foreign currency hedging program is included in Note 6 and Note 18 under the heading Foreign Currency Risk.

4. Reflects the impact of the adoption of Accounting Standards Update ("ASU") 2016-09, which resulted in the recognition of excess tax benefits related to equity compensation in the (benefit from) provision for income taxes on continuing operations. See Note 2 for additional information.

5. The period January 1 through August 31, 2017 includes a tax benefit of $53 million for accrued interest reversals (recorded in sundry income - net).

Deferred Tax Balances at December 31	2017 (Successor)					2016 (Predecessor)
(In millions)	Assets			Liabilities		Assets			Liabilities
Property	$	—		$	1,160	$	—		$	742
Tax loss and credit carryforwards	1,690			—		1,808			—
Accrued employee benefits	1,988			68		4,529			410
Other accruals and reserves	333			39		617			222
Intangibles	284			6,286		210			1,345
Inventory	130			597		163			138
Long-term debt	109			—		—			—
Investments	23			453		126			230
Unrealized exchange gains/losses	—			71		—			346
Other – net	260			121		257			86
Subtotal	$	4,817		$	8,795	$	7,710		$	3,519
Valuation allowances	(1,378		)	—		(1,308		)	—
Total	$	3,439		$	8,795	$	6,402		$	3,519
Net Deferred Tax (Liability) Asset	$	(5,356	)			$	2,883

F-39

E. I. du Pont de Nemours and Company

Notes to the Consolidated Financial Statements (continued)

Operating Loss and Tax Credit Carryforwards	Deferred Tax Asset
(In millions)	2017 (Successor)		2016 (Predecessor)
Operating loss carryforwards
Expire within 5 years	$	42	$	41
Expire after 5 years or indefinite expiration	1,483		1,482
Total operating loss carryforwards	$	1,525	$	1,523
Tax credit carryforwards
Expire within 5 years	$	10	$	10
Expire after 5 years or indefinite expiration	155		275
Total tax credit carryforwards	$	165	$	285
Total Operating Loss and Tax Credit Carryforwards	$	1,690	$	1,808

Total Gross Unrecognized Tax Benefits	Successor			Predecessor
	For the Period September 1 through December 31, 2017			For the Period January 1 through August 31, 2017			Year Ended 2016			Year Ended 2015
(In millions)
Total unrecognized tax benefits as of beginning of period	$	436		$	348		$	558		$	735
Decreases related to positions taken on items from prior years	(2		)	(19		)	(41		)	(98		)
Increases related to positions taken on items from prior years	9			3			32			13
Increases related to positions taken in the current year	19			19			32			32
Settlement of uncertain tax positions with tax authorities	1			(6		)	(205		)	(58		)
Decreases due to expiration of statutes of limitations	(5		)	(81		)	(30		)	(30		)
Exchange loss (gain)	1			1			2			(36		)
Total unrecognized tax benefits as of end of period	$	459		$	265		$	348		$	558
Total unrecognized tax benefits that, if recognized, would impact the effective tax rate	$	76		$	188		$	253		$	386
Total amount of interest and penalties (benefit) recognized in Provision for income taxes on continuing operations	$	1		$	(27	)	$	10		$	(14	)
Total accrual for interest and penalties associated with unrecognized tax benefits	$	25		$	22		$	71		$	88

Each year the company files hundreds of tax returns in the various national, state and local income taxing jurisdictions in which it operates. These tax returns are subject to examination and possible challenge by the tax authorities. Positions challenged by the tax authorities may be settled or appealed by the company. As a result, there is an uncertainty in income taxes recognized in the company's financial statements in accordance with accounting for income taxes and accounting for uncertainty in income taxes. It is reasonably possible that changes to the company’s global unrecognized tax benefits could be significant; however, due to the uncertainty regarding the timing of completion of audits and possible outcomes, a current estimate of the range of increases or decreases that may occur within the next twelve months cannot be made.

F-40

E. I. du Pont de Nemours and Company

Notes to the Consolidated Financial Statements (continued)

Tax years that remain subject to examination for the company’s major tax jurisdictions are shown below:

Tax Years Subject to Examination by Major Tax Jurisdiction at Dec 31,	Earliest Open Year
Jurisdiction
Brazil	2012
Canada	2011
China	2014
Denmark	2003
Germany	2006
India	2001
The Netherlands	2014
Switzerland	2012
United States:
Federal income tax	2012
State and local income tax	2004

Undistributed earnings of foreign subsidiaries and related companies that are deemed to be permanently invested amounted to $15,408 million at December 31, 2017, $17,380 million at December 31, 2016 and $16,053 million at December 31, 2015. The Act imposed U.S. tax on all foreign unrepatriated earnings. These undistributed earnings are still subject to certain taxes upon repatriation, primarily foreign withholding taxes. It is not practicable to calculate the unrecognized deferred tax liability on undistributed earnings.

DuPont and its subsidiaries are included in DowDuPont's consolidated federal income tax group and consolidated tax return.  Generally, the consolidated tax liability of the DowDuPont U.S. tax group for each year will be apportioned among the members of the consolidated group based on each member’s separate taxable income.  DuPont and Dow intend that to the extent Federal and/or State corporate income tax liabilities are reduced through the utilization of tax attributes of the other, settlement of any receivable and payable generated from the use of the other party’s sub-group attributes will be in accordance with a tax sharing agreement and/or tax matters agreement.

F-41

E. I. du Pont de Nemours and Company

Notes to the Consolidated Financial Statements (continued)

NOTE 8 - EARNINGS PER SHARE OF COMMON STOCK

Upon completion of the Merger, each share of DuPont Common Stock was converted into the right to receive 1.2820 fully paid and non-assessable shares of DowDuPont Common Stock, in addition to cash in lieu of any fractional shares of DowDuPont Common Stock issued and therefore earnings per share of common stock information is not presented for the Successor period.

Set forth below is a reconciliation of the numerator and denominator for basic and diluted earnings per share calculations for the Predecessor periods indicated below:

	Predecessor
(In millions, except share amounts)	For the Period January 1 through August 31, 2017			For the Year Ended December 31, 2016			For the Year Ended December 31, 2015
Numerator:
Income from continuing operations after income taxes attributable to DuPont	$	1,624		$	2,072		$	1,443
Preferred dividends	(7		)	(10		)	(10		)
Income from continuing operations after income taxes available to DuPont common stockholders	$	1,617		$	2,062		$	1,433
Income from discontinued operations after income taxes available to DuPont common stockholders	117			441			510
Net income available to common stockholders	$	1,734		$	2,503		$	1,943
Denominator:
Weighted-average number of common shares outstanding - Basic	867,888,000			872,560,000			893,992,000
Dilutive effect of the company’s employee compensation plans1	4,532,000			4,476,000			5,535,000
Weighted-average number of common shares outstanding - Diluted1	872,420,000			877,036,000			899,527,000

^1.  Diluted earnings per share considers the impact of potentially dilutive securities except in periods in which there is a loss because the inclusion of the potential common shares would have an anti-dilutive effect.

The following average number of stock options were antidilutive, and therefore not included in the dilutive earnings per share calculations:

	Predecessor
	For the Period January 1 through August 31, 2017	For the Year Ended December 31, 2016	For the Year Ended December 31, 2015
Average number of stock options	1,906	4,794,000	4,715,000

F-42

E. I. du Pont de Nemours and Company

Notes to the Consolidated Financial Statements (continued)

NOTE 9 - ACCOUNTS AND NOTES RECEIVABLE, NET

	Successor		Predecessor
(In millions)	December 31, 2017		December 31, 2016
Accounts receivable – trade1	$	3,777	$	3,601
Notes receivable – trade2	199		206
Other3	1,263		1,152
Total accounts and notes receivable - net	$	5,239	$	4,959

^1.  Accounts receivable – trade is net of allowances of $10 millionat December 31, 2017 and $287 million at December 31, 2016. Allowances are equal to the estimated uncollectible amounts. That estimate is based on historical collection experience, current economic and market conditions, and review of the current status of customers' accounts.

^2.  Notes receivable – trade primarily consists of receivables within the agriculture product line for deferred payment loan programs for the sale of seed products to customers. These loans have terms of one year or less and are primarily concentrated in North America. The company maintains a rigid pre-approval process for extending credit to customers in order to manage overall risk and exposure associated with credit losses. As of December 31, 2017 and 2016, there were no significant past due notes receivable, nor were there any significant impairments related to current loan agreements.

^3.  Other includes receivables in relation to fair value of derivative instruments, indemnification assets, value added tax, general sales tax and other taxes. No individual group represents more than ten percent of total receivables.

Accounts and notes receivable are carried at amounts that approximate fair value.

NOTE 10 - INVENTORIES

	Successor		Predecessor
(In millions)	December 31, 2017		December 31, 2016
Finished products	$	4,500	$	2,961
Semi-finished products	2,769		1,877
Raw materials	371		292
Stores and supplies	447		398
Total	$	8,087	$	5,528
Adjustment of inventories to a LIFO basis	546		(178		)
Total inventories	$	8,633	$	5,350

As a result of the Merger, a fair value step-up of $3,842 million was recorded for inventories. Of this amount, $1,434 million has been recognized in costs of goods sold within loss from continuing operations for the period September 1, 2017 through December 31, 2017. See Note 3 for additional information regarding the Merger.

F-43

E. I. du Pont de Nemours and Company

Notes to the Consolidated Financial Statements (continued)

NOTE 11 - PROPERTY, PLANT AND EQUIPMENT

	Successor			Predecessor
(In millions)	December 31, 2017			December 31, 2016
Land and land improvements	$	913		$	501
Buildings	2,747			4,224
Machinery and equipment	8,104			16,909
Construction in progress	1,114			1,381
Total property, plant and equipment	12,878			23,015
Accumulated depreciation	(443		)	(14,164		)
Total property, plant and equipment - net	$	12,435		$	8,851

As a result of the Merger, a fair value step-up of $3,200 million was recorded for property, plant and equipment. See Note 3 for additional information regarding the Merger.

Buildings, machinery and equipment and land improvements are depreciated over useful lives on a straight-line basis ranging from 1 to 25 years. Capitalizable costs associated with computer software for internal use are amortized on a straight-line basis over 1 to 8 years.

	Successor		Predecessor
(In millions)	For the Period September 1 through December 31, 2017		For the Period January 1 through August 31, 2017		For the Year Ended December 31, 2016		For the Year Ended December 31, 2015
Depreciation expense	$	426	$	589	$	907	$	948

NOTE 12 - GOODWILL AND OTHER INTANGIBLE ASSETS

Goodwill

The following table summarizes changes in the carrying amount of goodwill for the period September 1 through December 31, 2017, the period January 1 through August 31, 2017, and the year ended December 31, 2016:

(In millions)
Balance as of December 31, 2015 (Predecessor)	$	4,238
Currency Translation Adjustment	(68		)
Other Goodwill Adjustments and Acquisitions	(1		)
Balance as of December 31, 2016 (Predecessor)	4,169
Currency Translation Adjustment	176
Other Goodwill Adjustments and Acquisitions	198
Balance as of August 31, 2017 (Predecessor)	$	4,543
Balance at September 1, 2017 (Successor)	$	45,105
Currency Translation Adjustment	(234		)
Goodwill Recognized for H&N Acquisition	718
Balance as of December 31, 2017 (Successor)	$	45,589

In 2017and 2016, the company performed impairment tests for goodwill and determined that no goodwill impairments existed.

F-44

E. I. du Pont de Nemours and Company

Notes to the Consolidated Financial Statements (continued)

Other Intangible Assets

The gross carrying amounts and accumulated amortization of other intangible assets by major class are as follows: 

	Successor							Predecessor
(In millions)	December 31, 2017							December 31, 2016
	Gross		Accumulated Amortization			Net		Gross		Accumulated Amortization			Net
Intangible assets subject to amortization (Definite-lived):
Customer-related	$	9,502	$	(186	)	$	9,316	$	1,574	$	(586	)	$	988
Developed technology	4,364		(144		)	4,220		1,410		(838		)	572
Trademarks/trade names	1,117		(26		)	1,091		53		(15		)	38
Favorable supply contracts1	495		(17		)	478
Microbial cell factories2	397		(6		)	391
Other3	459		(10		)	449		171		(82		)	89
Total other intangible assets with finite lives	16,334		(389		)	15,945		3,208		(1,521		)	1,687
Intangible assets not subject to amortization (Indefinite-lived):
In-process research and development ("IPR&D")	660		—			660		73		—			73
Microbial cell factories2								306		—			306
Germplasm4	6,265		—			6,265		1,053		—			1,053
Trademarks / trade names	4,856		—			4,856		545		—			545
Total other intangible assets	11,781		—			11,781		1,977		—			1,977
Total	$	28,115	$	(389	)	$	27,726	$	5,185	$	(1,521	)	$	3,664

^1.  Upon closing and pursuant to the terms of the FMC Transaction Agreement, DuPont entered into favorable supply contracts with FMC. DuPont recorded these contracts as intangible assets recognized at the fair value of off-market contracts. Refer to Notes 3 and 4 for additional information.

^2.  Microbial cell factories, derived from natural microbes, are used to sustainably produce enzymes, peptides and chemicals using natural metabolic processes. The company recognized the microbial cell factories as intangible assets upon the acquisition of Danisco. As a result of the valuation as part of the Merger, it was determined that this intangible asset now has a definite life and therefore it has been moved from indefinite-lived to definite-lived as of September 1, 2017.

^3.  Primarily consists of sales and farmer networks, marketing and manufacturing alliances and noncompetition agreements.

^4.  Pioneer germplasm is the pool of genetic source material and body of knowledge gained from the development and delivery stage of plant breeding. The company recognized germplasm as an intangible asset upon the acquisition of Pioneer. This intangible asset is expected to contribute to cash flows beyond the foreseeable future and there are no legal, regulatory, contractual, or other factors which limit its useful life.

In connection with the Merger, the company recorded $27,221 million of intangible assets, as shown in the table below, representing the preliminary fair values at the Merger date. See Note 3 for additional information regarding the Merger.

Intangible Assets	Gross Carrying Amount		Weighted-average Amortization Period (years)
(In millions)
Intangible assets with finite lives:
Customer-related	$	9,264	17
Developed technology	4,239		12
Trademarks/trade names	1,080		15
Microbial cell factories	400		23
Other	453		17
Total other intangible assets with finite lives	$	15,436
Intangible assets with indefinite lives:
IPR&D	$	660
Germplasm	6,263
Trademarks/trade names	4,862
Total intangible assets	$	27,221

F-45

E. I. du Pont de Nemours and Company

Notes to the Consolidated Financial Statements (continued)

The aggregate pre-tax amortization expense from continuing operations for definite-lived intangible assets was $389 million for the period September 1 through December 31, 2017 and $139 million for the period January 1 through August 31, 2017. The aggregate pre-tax amortization expense from continuing operations for definite-lived intangible assets was $319 million and $362 million for 2016 and 2015, respectively.

Total estimated amortization expense for the next five fiscal years is as follows:

(In millions)
2018	$	1,266
2019	$	1,254
2020	$	1,244
2021	$	1,228
2022	$	1,221

NOTE 13 - SHORT-TERM BORROWINGS, LONG-TERM DEBT AND AVAILABLE CREDIT FACILITIES

The following tables summarize the company's short-term borrowings and capital lease obligations and long-term debt:

Short-term borrowings and capital lease obligations	Successor		Predecessor
(In millions)	December 31, 2017		December 31, 2016
Commercial paper	$	1,436	$	386
Other loans - various currencies	28		39
Long-term debt payable within one year	1,315		4
Total short-term borrowings and capital lease obligations	$	2,779	$	429

The estimated fair value of the company's short-term borrowings, including interest rate financial instruments, was determined using Level 2 inputs within the fair value hierarchy, as described in Note 1 and Note 19. Based on quoted market prices for the same or similar issues, or on current rates offered to the company for debt of the same remaining maturities, the fair value of the company's short-term borrowings and capital lease obligations was $2,780 million and $430 million at December 31, 2017 and 2016, respectively.

The weighted-average interest rate on short-term borrowings outstanding at December 31, 2017 and 2016 was 1.8 percent and 2.2 percent, respectively. The decrease in the interest rate for 2017 was primarily due to lower effective interest on long-term debt payable within one year.

F-46

E. I. du Pont de Nemours and Company

Notes to the Consolidated Financial Statements (continued)

Long Term Debt	Successor1				Predecessor
	December 31, 2017				December 31, 2016
(In millions)	Amount		Weighted Average Rate		Amount
Promissory notes and debentures:
Final maturity 2018	$	1,280	1.59	%	$	1,290
Final maturity 2019	521		2.23	%	500
Final maturity 2020	3,070		1.79	%	999
Final maturity 2021	1,580		2.07	%	1,498
Final maturity 2023 and thereafter	3,492		3.32	%	3,188
Other facilities:
Term loan due 2019	1,500		2.35	%	500
Other loans	18		4.32	%	22
Foreign currency loans, various rates and maturities	30		2.85	%	29
Medium-term notes, varying maturities through 2043	110		1.22	%	111
Capital lease obligations	5				9
Less: Unamortized debt discount and issuance costs	—				35
Less: Long-term debt due within one year	1,315				4
Total	$	10,291			$	8,107

^1.  The Successor period includes the reflection of debt at fair value at the date of the Merger. See Note 3 for additional information regarding the Merger.

Principal payments of long-term debt for the next five years are as follows:

Maturities of Long-Term Debt For Next Five Years1
(In millions)
2018	$	1,286
2019	$	2,005
2020	$	3,005
2021	$	1,505
2022	$	2

^1.  Excludes unamortized debt step-up premium.

The estimated fair value of the company's long-term borrowings, was determined using Level 2 inputs within the fair value hierarchy, as described in Note 1 and Note 19. Based on quoted market prices for the same or similar issues, or on current rates offered to the company for debt of the same remaining maturities, the fair value of the company's long-term borrowings, not including long-term debt due within one year, was $10,250 million and $8,460 million at December 31, 2017 and 2016, respectively.

Available Committed Credit Facilities

The following table summarizes the company's credit facilities:

Committed and Available Credit Facilities at December 31, 2017 (Successor)
(In millions)	Effective Date	Committed Credit		Credit Available		Maturity Date	Interest
Revolving Credit Facility	March 2016	$	3,000	$	2,950	May 2019	Floating Rate
Term Loan Facility	March 2016	4,500		3,000		March 2019	Floating Rate
Total Committed and Available Credit Facilities		$	7,500	$	5,950

F-47

E. I. du Pont de Nemours and Company

Notes to the Consolidated Financial Statements (continued)

Debt Offering

In May 2017, the company completed an underwritten public offering of $1,250 million of the company's 2.20 percent Notes due 2020 and $750 million of the company's Floating Rate Notes due 2020 (the "May 2017 Debt Offering"). The proceeds of this offering were used to make a discretionary pension contribution to the company's principal U.S. pension plan. See Note 16 for further discussion regarding this contribution.

Term Loan Facility

In March 2016, the company entered into a credit agreement that provides for a three-year, senior unsecured term loan facility in the aggregate principal amount of $4,500 million (the "Term Loan Facility") under which DuPont may make up to seven term loan borrowings and amounts repaid or prepaid are not available for subsequent borrowings. The facility was amended in 2017 to extend the date on which the commitment to lend terminates to July 27, 2018. The proceeds from the borrowings under the Term Loan Facility will be used for the company's general corporate purposes including debt repayment, working capital and funding a portion of DowDuPont's costs and expenses. The Term Loan Facility matures in March 2019 at which time all outstanding borrowings, including accrued but unpaid interest, become immediately due and payable. As of December 31, 2017, the company had made three term loan borrowings in an aggregate principal amount of $1,500 million and had unused commitments of $3,000 million under the Term Loan Facility.

Uncommitted Credit Facilities and Outstanding Letters of Credit

Unused bank credit lines on uncommitted credit facilities were approximately $731 million at December 31, 2017. These lines are available to support short-term liquidity needs and general corporate purposes including letters of credit. Outstanding letters of credit were $177 million at December 31, 2017. These letters of credit support commitments made in the ordinary course of business.

NOTE 14 - COMMITMENTS AND CONTINGENT LIABILITIES

Guarantees

Indemnifications

In connection with acquisitions and divestitures as of December 31, 2017, the company has indemnified respective parties against certain liabilities that may arise in connection with these transactions and business activities prior to the completion of the transactions. The term of these indemnifications, which typically pertain to environmental, tax and product liabilities, is generally indefinite. In addition, the company indemnifies its duly elected or appointed directors and officers to the fullest extent permitted by Delaware law, against liabilities incurred as a result of their activities for the company, such as adverse judgments relating to litigation matters. If the indemnified party were to incur a liability or have a liability increase as a result of a successful claim, pursuant to the terms of the indemnification, the company would be required to reimburse the indemnified party. The maximum amount of potential future payments is generally unlimited.

Obligations for Equity Affiliates & Others

The company has directly guaranteed various debt obligations under agreements with third parties related to equity affiliates, customers and suppliers. At December 31, 2017 and December 31, 2016, the company had directly guaranteed $297 million and $388 million, respectively, of such obligations. These amounts represent the maximum potential amount of future (undiscounted) payments that the company could be required to make under the guarantees. The company would be required to perform on these guarantees in the event of default by the guaranteed party.

The company assesses the payment/performance risk by assigning default rates based on the duration of the guarantees. These default rates are assigned based on the external credit rating of the counterparty or through internal credit analysis and historical default history for counterparties that do not have published credit ratings. For counterparties without an external rating or available credit history, a cumulative average default rate is used.

In certain cases, the company has recourse to assets held as collateral, as well as personal guarantees from customers and suppliers. Assuming liquidation, these assets are estimated to cover approximately 23 percent of the $89 million of guaranteed obligations of customers and suppliers. Set forth below are the company's guaranteed obligations at December 31, 2017.

F-48

E. I. du Pont de Nemours and Company

Notes to the Consolidated Financial Statements (continued)

The following tables provide a summary of the final expiration and maximum future payments for each type of guarantee:

Guarantees at December 31, 2017 (Successor)	Final Expiration	Maximum Future Payments
(In millions)
Obligations for customers and suppliers1:
Bank borrowings	2022	$	89
Obligations for non-consolidated affiliates2:
Bank borrowings	2018	161
Obligations for Chemours3:
Chemours' purchase obligations	2018	10
Residual value guarantees4	2029	37
Total guarantees		$	297

1. Existing guarantees for customers and suppliers, as part of contractual agreements.

2.    Existing guarantees for non-consolidated affiliates' liquidity needs in normal operations.

3. Guarantee for Chemours' raw material purchase obligations under agreement with third party supplier.

4. The company provides guarantees related to leased assets specifying the residual value that will be available to the lessor at lease termination through sale of the assets to the lessee or third parties.

Operating Leases

The company uses various leased facilities and equipment in its operations. The terms for these leased assets vary depending on the lease agreement.

Future minimum lease payments (including residual value guarantee amounts) under non-cancelable operating leases are $264 million, $190 million, $137 million, $104 million and $81 million for the years 2018, 2019, 2020, 2021 and 2022, respectively, and $268 million for subsequent years and are not reduced by non-cancelable minimum sublease rentals due in the future in the amount of $3 million. Net rental expense under operating leases was $105 million, $179 million, $242 million and $266 million for the period September 1 through December 31, 2017, for the period January 1 through August 31, 2017, and for the years ended December 31, 2016 and 2015, respectively.

Litigation

The company is subject to various legal proceedings arising out of the normal course of its current and former business operations, including product liability, intellectual property, commercial, environmental and antitrust lawsuits. It is not possible to predict the outcome of these various proceedings. Although considerable uncertainty exists, management does not anticipate that the ultimate disposition of these matters will have a material adverse effect on the company's results of operations, consolidated financial position or liquidity.  However, the ultimate liabilities could be material to results of operations in the period recognized.

PFOA

DuPont used PFOA (collectively, perfluorooctanoic acids and its salts, including the ammonium salt), as a processing aid to manufacture some fluoropolymer resins at various sites around the world including its Washington Works' plant in West Virginia. Pursuant to the Separation Agreement discussed in Note 4, the company is indemnified by Chemours for the PFOA matters discussed below and has recorded a total indemnification asset of $15 million.

U.S. Environmental Protection Agency (“EPA") and New Jersey department of Environmental Protection (“NJDEP”)

DuPont is obligated under agreements with EPA, including a 2009 consent decree to which Chemours was added in 2017, and has made voluntary commitments to NJDEP. These obligations and voluntary commitments include surveying, sampling and testing drinking water in and around certain company sites and offering treatment or an alternative supply of drinking water if tests indicate the presence of PFOA in drinking water at or greater than the national health advisory level established from time to time by the EPA. At December 31, 2017, the company had an accrual of $15 million related to these obligations and voluntary commitments. The company recorded an indemnification asset corresponding to the accrual balance at December 31, 2017.

F-49

E. I. du Pont de Nemours and Company

Notes to the Consolidated Financial Statements (continued)

Leach v. DuPont

In August 2001, a class action, captioned Leach v. DuPont, was filed in West Virginia state court alleging that residents living near the Washington Works facility had suffered, or may suffer, deleterious health effects from exposure to PFOA in drinking water. A settlement was reached in 2004 that binds approximately 80,000 residents, (the "Leach Settlement".) In addition to paying $23 million to plaintiff’s attorneys for fees and expenses and $70 million to fund a community health project, the company is obligated to fund up to $235 million for a medical monitoring program for eligible class members and to pay administrative costs and fees associated with the program. In January 2012, the company put $1 million into an escrow account to fund medical monitoring as required by the settlement agreement. As of December 31, 2017, less than $1 million has been disbursed from the account. The company also must continue to provide water treatment designed to reduce the level of PFOA in water to six area water districts, including the Little Hocking Water Association, and private well users. While it is probable that the company will incur liabilities related to funding the medical monitoring program and providing water treatment, the company does not expect any such liabilities to be material.

Under the Leach Settlement, the company funded a series of health studies which were completed in October 2012 by an independent science panel of experts (the "C8 Science Panel".) The C8 Science Panel found probable links, as defined in the Leach Settlement, between exposure to PFOA and pregnancy-induced hypertension, including preeclampsia; kidney cancer; testicular cancer; thyroid disease; ulcerative colitis; and diagnosed high cholesterol.

Multi-District Litigation

Leach class members may pursue personal injury claims against DuPont only for the six human diseases for which the C8 Science Panel determined a probable link exists. Following the Leach Settlement, approximately 3,550 lawsuits alleging personal injury claims were filed in various federal and state courts in Ohio and West Virginia. These lawsuits are consolidated in multi-district litigation ("MDL") in the U.S. District Court for the Southern District of Ohio.

In the first quarter of 2017, the MDL was settled for $670.7 million in cash (the "MDL Settlement"), half of which was to be paid by Chemours and half paid by DuPont. At December 31, 2017, all payments under the settlement agreement have been made by both companies. DuPont’s payment is not subject to indemnification or reimbursement by Chemours.  In exchange for that payment, DuPont and Chemours receive releases of all claims by the settling plaintiffs. The MDL Settlement was entered into solely by way of compromise and settlement and is not in any way an admission of liability or fault by DuPont or Chemours. All of the MDL plaintiffs participated and resolved their claims within the MDL Settlement.

New Items

At December 31, 2017, five lawsuits had been filed against the company in West Virginia and four in Ohio alleging personal injury from exposure to PFOA in drinking water.

In addition, three lawsuits are pending in federal court in New York on behalf of five individuals who are residents of Hoosick Falls, New York. The plaintiffs claim personal injuries, including kidney cancer, thyroid disease and ulcerative colitis, from alleged exposure to PFOA discharged into the air and water from nearby manufacturing facilities owned and operated by defendant third parties. Plaintiffs claim that PFOA used at the facilities was purchased from or manufactured by the company and co-defendant, 3M Company. An action is pending in Alabama state court filed by a municipal water utility. The plaintiff alleges contamination from wastewater from defendant carpet manufacturers’ operations using perfluorinated chemicals and compounds, including PFOA, (“PFCs”). Plaintiff alleges that the PFCs used in defendant manufacturers’ operations were supplied by the company and co-defendant 3M Company.

While it is reasonably possible that the company could incur liabilities related to these actions, it does not expect any such liabilities would be material. Chemours is defending and indemnifying the company in these matters in accordance with the amendment to the Separation Agreement discussed below.

F-50

E. I. du Pont de Nemours and Company

Notes to the Consolidated Financial Statements (continued)

Amendment to Separation Agreement

Concurrent with the MDL Settlement, DuPont and Chemours amended the Separation Agreement to provide for a limited sharing of potential future PFOA liabilities (i.e., indemnifiable losses, as defined in the Separation Agreement) for a period of five years beginning July 6, 2017. During that five-year period, Chemours will annually pay future PFOA liabilities up to $25 million and, if such amount is exceeded, DuPont would pay any excess amount up to the next $25 million (which payment will not be subject to indemnification by Chemours), with Chemours annually bearing any further excess liabilities. After the five-year period, this limited sharing agreement will expire, and Chemours’ indemnification obligations under the Separation Agreement will continue unchanged.  There have been no charges incurred by DuPont under this arrangement through December 31, 2017. Chemours has also agreed that it will not contest its liability to DuPont under the Separation Agreement for PFOA liabilities on the basis of ostensible defenses generally applicable to the indemnification provisions under the Separation Agreement, including defenses relating to punitive damages, fines or penalties or attorneys’ fees, and waives any such defenses with respect to PFOA liabilities.  Chemours has, however, retained defenses as to whether any particular PFOA claim is within the scope of the indemnification provisions of the Separation Agreement.

It is possible that new lawsuits could be filed against DuPont related to PFOA that may not be within the scope of the MDL Settlement. Any such new litigation would be subject to indemnification by Chemours under the Separation Agreement, as amended.

Fayetteville Works Facility, North Carolina

Prior to the separation of Chemours, the company introduced GenX as a polymerization processing aid and a replacement for PFOA at the Fayetteville Works facility. The facility is now owned and operated by Chemours which continues to manufacture and use GenX. Chemours is responding to ongoing inquiries and investigations from federal, state and local investigators, regulators and other governmental authorities as well as inquiries from the media and local community stakeholders. These inquiries and investigations involve the discharge of GenX and certain similar compounds from the Chemours’ facility at Fayetteville Works into the Cape Fear River in Bladen County, North Carolina.

In August 2017, the U.S. Attorney’s Office for the Eastern District of North Carolina served the company with a subpoena for testimony and the production of documents to a grand jury. In the fourth quarter 2017, DuPont was served with additional subpoenas relating to the same issue. The subpoenas seek documents and testimony related to alleged discharges of PFOA and/or GenX from the Fayetteville Works facility into the Cape Fear River. It is possible that these ongoing inquiries and investigations, including the grand jury subpoena, could result in penalties or sanctions, or that additional litigation will be instituted against Chemours and/or the company.

At December 31, 2017, several actions, filed on behalf of putative classes of property owners and residents in areas near or who draw drinking water from the Cape Fear River, are pending in federal court against Chemours, the company and one also names DowDuPont. These actions relate to the alleged discharge of certain perflourinated chemicals into the river from the operations and wastewater treatment at the Fayetteville Works facility. The three purported class actions, filed in the fourth quarter 2017 and now consolidated into a single purported class action, seek various relief including medical monitoring, property damages and injunctive relief. Separate actions pending at December 31, 2017 were filed by the Cape Fear Public Utility Authority and Brunswick County, NC seeking actual and punitive damages as well as injunctive relief. These actions have since been consolidated and two additional North Carolina water authorities have joined the action. Management believes the probability of loss with respect to these actions is remote.

The company has an indemnification claim against Chemours with respect to current and future inquiries and claims, including lawsuits, related to the foregoing. At December 31, 2017, Chemours is defending and indemnifying the company in the pending civil actions.

F-51

E. I. du Pont de Nemours and Company

Notes to the Consolidated Financial Statements (continued)

Environmental

Accruals for environmental matters are recorded when it is probable that a liability has been incurred and the amount of the liability can be reasonably estimated based on current law and existing technologies. At December 31, 2017, the company had accrued obligations of $433 million for probable environmental remediation and restoration costs, including $67 million for the remediation of Superfund sites. These obligations are included in "Accrued and other current liabilities" and "Other noncurrent obligations" in the Consolidated Balance Sheets. This is management’s best estimate of the costs for remediation and restoration with respect to environmental matters for which the company has accrued liabilities, although it is reasonably possible that the ultimate cost with respect to these particular matters could range up to $920 million above the amount accrued at December 31, 2017. Consequently, it is reasonably possible that environmental remediation and restoration costs in excess of amounts accrued could have a material impact on the company’s results of operations, financial condition and cash flows. It is the opinion of the company’s management, however, that the possibility is remote that costs in excess of the range disclosed will have a material impact on the company’s results of operations, financial condition or cash flows. Inherent uncertainties exist in these estimates primarily due to unknown conditions, changing governmental regulations and legal standards regarding liability, and emerging remediation technologies for handling site remediation and restoration. At December 31, 2016, the company had accrued obligations of $457 million for probable environmental remediation and restoration costs, including $50 million for the remediation of Superfund sites.

Pursuant to the DuPont and Chemours Separation Agreement, the company is indemnified by Chemours for certain environmental matters, included in the liability of $433 million, that have an estimated liability of $242 million as of December 31, 2017, and a potential exposure that ranges up to approximately $430 million above the amount accrued. As such, the company has recorded an indemnification asset of $242 million corresponding to the company’s accrual balance related to these matters at December 31, 2017, including $47 million related to the Superfund sites.

NOTE 15 - STOCKHOLDERS' EQUITY

Share Repurchase Program

2015 Share Buyback Plan

In the first quarter 2015, DuPont announced its intention to buy back shares of about $4,000 million using the distribution proceeds received from Chemours. In connection with the completion of the spin-off of Chemours, the Board of Directors authorized the use of the distribution proceeds to buy back shares of the company's common stock as follows: $2,000 million to be purchased and retired by December 31, 2015, which was completed during 2015, with the remainder to be purchased and retired by December 31, 2016. There were no share repurchases under this plan in the first and second quarters of 2016. The company had limited opportunity to repurchase shares in 2016, primarily due to the planned merger with Dow. However, during the second half of 2016, the company purchased and retired 13.2 million shares in the open market for a total cost of $916 million.  As of December 31, 2016, in aggregate, the company paid $2,916 million and received and retired 48.2 million shares. The authorization under this buyback program expired as of January 1, 2017.

2014 Share Buyback Plan

In January 2014, the company's Board of Directors authorized a $5,000 million share buyback plan that replaced the 2011 plan. During 2015, the company repurchased and retired 4.6 million shares in the open market for a total cost of $353 million. There were no share repurchases under this plan during 2016 and 2017. The authorization under this buyback program expired upon Merger. As of August 31, 2017, in aggregate, the company purchased 34.7 million shares at a total cost of $2,353 million under the plan.

Treasury Stock

Immediately prior to the closing of the Merger Transaction, all 87 million shares of DuPont common stock that were held in treasury were automatically canceled and retired for no consideration. Common stock held in treasury was recorded at cost. When retired, the excess of the cost of treasury stock over its par value was allocated between retained earnings ($5,657 million) and additional paid-in capital ($1,044 million).

F-52

E. I. du Pont de Nemours and Company

Notes to the Consolidated Financial Statements (continued)

Set forth below is a reconciliation of common stock share activity for the years ended December 31, 2017, 2016 and 2015:

Shares of common stock	Issued		Held In Treasury
Balance January 1, 2015 (Predecessor)	992,020,000		(87,041,000	)
Issued	5,932,000		—
Repurchased	—		(39,564,000	)
Retired	(39,564,000	)	39,564,000
Balance December 31, 2015 (Predecessor)	958,388,000		(87,041,000	)
Issued	4,808,000		—
Repurchased	—		(13,152,000	)
Retired	(13,152,000	)	13,152,000
Balance December 31, 2016 (Predecessor)	950,044,000		(87,041,000	)
Issued	5,335,000		—
Retired	(87,041,000	)	87,041,000
Balance August 31, 2017 (Predecessor)	868,338,000		—
Balance September 1 and December 31, 2017 (Successor)1	100		—

^1.  All of the company's issued and outstanding common stock at September 1, 2017 is held by the DowDuPont Inc.

F-53

E. I. du Pont de Nemours and Company

Notes to the Consolidated Financial Statements (continued)

Other Comprehensive Income (Loss)

The changes and after-tax balances of components comprising accumulated other comprehensive loss are summarized below:

(In millions)	Cumulative Translation Adjustment1			Derivative Instruments			Pension Benefit Plans2			Other Benefit Plans			Unrealized Gain (Loss) on Investments			Total
2015
Balance January 1, 2015 (Predecessor)	$	(919	)	$	(6	)	$	(7,895	)	$	262		$	2		$	(8,556	)
Other comprehensive (loss) income before reclassifications	(1,605		)	(25		)	39			3			(17		)	(1,605		)
Amounts reclassified from accumulated other comprehensive income (loss)	—			7			535			(243		)	(2		)	297
Net other comprehensive (loss) income	(1,605		)	(18		)	574			(240		)	(19		)	(1,308		)
Spin-off of Chemours	$	191		$	—		$	278		$	—		$	(1	)	$	468
Balance December 31, 2015 (Predecessor)	$	(2,333	)	$	(24	)	$	(7,043	)	$	22		$	(18	)	$	(9,396	)
2016
Other comprehensive (loss) income before reclassifications	(510		)	20			(271		)	(81		)	(8		)	(850		)
Amounts reclassified from accumulated other comprehensive income (loss)	—			11			594			(298		)	28			335
Net other comprehensive (loss) income	(510		)	31			323			(379		)	20			(515		)
Balance December 31, 2016 (Predecessor)	$	(2,843	)	$	7		$	(6,720	)	$	(357	)	$	2		$	(9,911	)
2017
Other comprehensive income (loss) before reclassifications	1,042			3			(78		)	—			1			968
Amounts reclassified from accumulated other comprehensive income (loss)	—			(13		)	325			10			(1		)	321
Net other comprehensive income (loss)	1,042			(10		)	247			10			—			1,289
Balance August 31, 2017 (Predecessor)	$	(1,801	)	$	(3	)	$	(6,473	)	$	(347	)	$	2		$	(8,622	)
Balance September 1, 2017 (Successor)3	$	—		$	—		$	—		$	—		$	—		$	—
Other comprehensive income (loss) before reclassifications	(454		)	(2		)	128			(53		)	—			(381		)
Amounts reclassified from accumulated other comprehensive income (loss)	—			—			—			—			—			—
Net other comprehensive (loss) income	(454		)	(2		)	128			(53		)	—			(381		)
Balance December 31, 2017 (Successor)	$	(454	)	$	(2	)	$	128		$	(53	)	$	—		$	(381	)

^1.  The cumulative translation adjustment loss for the period September 1 through December 31, 2017 is primarily driven by the strengthening of the U.S dollar (USD) against the European Euro (EUR) and the Brazilian real (BRL). The cumulative translation adjustment gain for the period January 1 through August 31, 2017 is primarily driven by the weakening of the USD against the EUR. The currency translation loss for the year ended December 31, 2016 is primarily driven by the strengthening of the USD against the EUR partially offset by the weakening of the USD against the BRL. The currency translation loss for the year ended December 31, 2015 is driven by the strengthening USD against primarily the EUR and BRL.

^2.  The Pension Benefit Plans loss recognized in other comprehensive (loss) income during the year ended December 31, 2016 includes the impact of the remeasurement of the principal U.S. pension plan as of June 30, 2016. See Note 16 for additional information.

^3.  In connection with the Merger, balances in accumulated other comprehensive loss at Merger Effectiveness Time were eliminated as a result of reflecting the balance sheet at fair value as of the date of the Merger. See Note 3 and 16 for further information regarding the Merger and pension and OPEB plans, respectively.

F-54

E. I. du Pont de Nemours and Company

Notes to the Consolidated Financial Statements (continued)

The tax (expense) benefit on the net activity related to each component of other comprehensive income (loss) were as follows:

	Successor			Predecessor
(In millions)	For the Period September 1 through December 31, 2017			For the Period January 1 through August 31, 2017			For the Year Ended December 31, 2016			For the Year Ended December 31, 2015
Derivative instruments	$	1		$	6		$	(19	)	$	7
Pension benefit plans - net	(37		)	(145		)	(163		)	(317		)
Other benefit plans - net	15			(5		)	194			135
(Provision for) benefit from income taxes related to other comprehensive income (loss) items	$	(21	)	$	(144	)	$	12		$	(175	)

A summary of the reclassifications out of accumulated other comprehensive loss is provided as follows:

	Successor		Predecessor									Income Classification
(In millions)	For the Period September 1 through December 31, 2017		For the Period January 1 through August 31, 2017			For the Year Ended December 31, 2016			For the Year Ended December 31, 2015
Derivative Instruments:	$	—	$	(21	)	$	18		$	12		(1)
Tax expense (benefit)	—		8			(7		)	(5		)	(2)
After-tax	$	—	$	(13	)	$	11		$	7
Amortization of pension benefit plans:
Prior service benefit	—		(3		)	(6		)	(9		)	(3)
Actuarial losses	—		506			822			768			(3)
Curtailment gain (loss)	—		—			40			(6		)	(3)
Settlement loss	—		—			62			76			(3)
Total before tax	$	—	$	503		$	918		$	829
Tax benefit	—		(178		)	(324		)	(294		)	(2)
After-tax	$	—	$	325		$	594		$	535
Amortization of other benefit plans:
Prior service benefit	—		(46		)	(134		)	(182		)	(3)
Actuarial losses	—		61			78			78			(3)
Curtailment gain	—		—			(392		)	(274		)	(3)
Total before tax	$	—	$	15		$	(448	)	$	(378	)
Tax (benefit) expense	—		(5		)	150			135			(2)
After-tax	$	—	$	10		$	(298	)	$	(243	)
Net realized (losses) gains on investments, before tax:	—		(1		)	28			(2		)	(4)
Tax expense	—		—			—			—			(2)
After-tax	$	—	$	(1	)	$	28		$	(2	)
Total reclassifications for the period, after-tax	$	—	$	321		$	335		$	297

^1.  Cost of goods sold.

^2.  Provision for income taxes from continuing operations.

^3.  These accumulated other comprehensive loss components are included in the computation of net periodic benefit cost of the company's pension and other benefit plans. See Note 16 for additional information.

^4.  Sundry income - net.

F-55

E. I. du Pont de Nemours and Company

Notes to the Consolidated Financial Statements (continued)

The tax benefit (expense) recorded in Stockholders' Equity was $33 million and $(138) million for the years ended December 31, 2016 and 2015, respectively. Included in these amounts were tax benefits of $21 million and $37 million for the years ended December 31, 2016 and 2015, respectively, associated with stock compensation programs. The remainder consists of amounts recorded within other comprehensive loss as shown in the table above.

NOTE 16 - PENSION PLANS AND OTHER POST EMPLOYMENT BENEFITS

The company offers various long-term benefits to its employees. Where permitted by applicable law, the company reserves the right to change, modify or discontinue the plans.

As a result of the Merger, the company re-measured its pension and OPEB plans. The remeasurement of the company’s pension and OPEB plans are included in the fair value measurement of DuPont’s assets and liabilities as a result of the application of purchase accounting in connection with the Merger. In addition, net losses and prior service benefits recognized in accumulated other comprehensive loss were eliminated. Dow and DuPont did not merge their pension plans and other post employment benefit plans as a result of the Merger. See Note 3 for details on the Merger.

Defined Benefit Pension Plans

The company has both funded and unfunded noncontributory defined benefit pension plans covering a majority of the U.S. employees and a number of other countries. The principal U.S. pension plan is the largest pension plan held by DuPont. Most employees hired on or after January 1, 2007 are not eligible to participate in the U.S. defined benefit pension plans. The benefits under these plans are based primarily on years of service and employees' pay near retirement. In November 2016, the company announced that it will freeze the pay and service amounts used to calculate pension benefits for active employees who participate in the U.S. pension plans on November 30, 2018. Therefore, as of November 30, 2018, active employees participating in the U.S. pension plans will not accrue additional benefits for future service and eligible compensation received. These changes resulted in a $527 million decline in the projected benefit obligation, which is reflected in actuarial loss (gain) in the change in projected benefit obligations table on page F-60, and recognition of a $25 million pre-tax curtailment gain during the fourth quarter of 2016. The decline in the projected benefit obligation is primarily due to the decrease in expected future compensation.

The company's funding policy is consistent with the funding requirements of federal laws and regulations. Pension coverage for employees of the company's non-U.S. consolidated subsidiaries is provided, to the extent deemed appropriate, through separate plans. Obligations under such plans are funded by depositing funds with trustees, covered by insurance contracts, or remain unfunded. The company did not make any contributions to its principal U.S. pension plan for the period September 1 through December 31, 2017. During the period January 1 through August 31, 2017, the company made total contributions of $2,900 million to its principal U.S. pension plan funded through the May 2017 Debt Offering; short-term borrowings, including commercial paper issuance; and cash flow from operations. See Note 13 for further discussion related to the May 2017 Debt Offering. The company contributed $230 million to the principal U.S. pension plan in 2016. No contributions were made to its principal U.S. pension plan in 2015. The company does not expect to make cash contributions to this plan in 2018.

The company made total contributions of $34 million, $67 million, $121 million and $164 million to its funded pension plans other than the principal U.S. pension plan for the periods September 1 through December 31, 2017 and January 1 through August 31, 2017 and the years ended December 31, 2016 and 2015, respectively. Additionally, the company made total contributions of $34 million, $57 million, $184 million and $144 million to its remaining plans with no plan assets for the periods September 1 through December 31, 2017 and January 1 through August 31, 2017 and the years ended December 31, 2016 and 2015, respectively. DuPont expects to contribute approximately $200 million to its funded pension plans other than the principal U.S. pension plan and its remaining plans with no plan assets in 2018.

The company’s remeasurement of its pension plans at the Merger Effectiveness Time resulted in an increase in the underfunded status of $560 million. In connection with the remeasurement, the company updated the weighted average discount rate to 3.42 percent at August 31, 2017 from 3.80 percent as of December 31, 2016.

The workforce reductions in 2016 related to a 2016 global cost savings and restructuring plan triggered curtailments for certain of the company's pension plans, including the principal U.S. pension plan. For the principal U.S. pension plan, the company recorded curtailment losses of $63 million during the year ended December 31, 2016. The curtailment losses were driven by the changes in the benefit obligation based on the demographics of the terminated positions partially offset by accelerated recognition of a portion of the prior service benefit.

F-56

E. I. du Pont de Nemours and Company

Notes to the Consolidated Financial Statements (continued)

In the fourth quarter 2016, about $550 million of lump-sum payments were made from the principal U.S. pension plan trust fund to a group of separated, vested plan participants who were extended a limited-time opportunity and voluntarily elected to receive their pension benefits in a single lump-sum payment. In the fourth quarter 2017, about $140 million of lump-sum payments were made from the principal U.S. pension plan trust fund under a similar program. Since the company recognizes pension settlements only when the lump-sum payments exceed the sum of the plan's service and interest cost components of net periodic pension cost for the year, these lump-sum payments did not result in the recognition of a pension settlement charge.

The weighted-average assumptions used to determine pension plan obligations for all pension plans are summarized in the table below:

Weighted-Average Assumptions used to Determine Benefit Obligations	Successor		Predecessor
	December 31, 2017		December 31, 2016
Discount rate	3.37	%	3.80	%
Rate of increase in future compensation levels 1	4.04	%	3.80	%

1. The rate of compensation increase represents the single annual effective salary increase that an average plan participant would receive during the participant's entire career at the company.

The weighted-average assumptions used to determine net periodic benefit costs for all pension plans are summarized in the two tables below:

Weighted-Average Assumptions used to Determine Net Periodic Benefit Cost	Successor		Predecessor
	For the Period September 1 through December 31, 2017		For the Period January 1 through August 31, 2017		For the Year Ended December 31, 2016		For the Year Ended December 31, 2015
Discount rate	3.42	%	3.80	%	3.77	%	3.93	%
Rate of increase in future compensation levels	3.80	%	3.80	%	3.96	%	4.01	%
Expected long-term rate of return on plan assets	6.24	%	7.66	%	7.74	%	8.10	%

The weighted-average assumptions used to determine net periodic benefit costs for U.S. plans are summarized in the table below:

Weighted- Average Assumptions used to Determine Net Periodic Benefit Cost	Successor		Predecessor
	For the Period September 1 through December 31, 2017		For the Period January 1 through August 31, 2017		For the Year Ended December 31, 2016		For the Year Ended December 31, 2015
Discount rate	3.73	%	4.16	%	4.04	%	4.29	%
Rate of increase in future compensation levels	3.95	%	3.95	%	4.15	%	4.20	%
Expected long-term rate of return on plan assets	6.25	%	8.00	%	8.00	%	8.50	%

Other Post Employment Benefits

The company provides medical, dental and life insurance benefits to certain pensioners and survivors. The associated plans for retiree benefits are unfunded and the cost of the approved claims is paid from company funds. Essentially all of the cost and liabilities for these retiree benefit plans are attributable to the U.S. benefit plans. The non-Medicare eligible retiree medical plan is contributory with pensioners and survivors' contributions adjusted annually to achieve a 50/50 target for sharing of cost increases between the company and pensioners and survivors. In addition, limits are applied to DuPont's portion of the retiree medical cost coverage. For Medicare eligible pensioners and survivors, DuPont provides a company-funded Health Reimbursement Arrangement (HRA). In November 2016, the company announced that eligible employees who will be under the age of 50 as of November 30, 2018 will not receive post-retirement medical, dental and life insurance benefits. As a result of these changes, the company recognized a pre-tax curtailment gain of $357 million during the fourth quarter of 2016. Beginning January 1, 2015, eligible employees who retire on and after that date will receive the same life insurance benefit payment, regardless of employee's age or pay. The majority of U.S. employees hired on or after January 1, 2007 are not eligible to participate in the post-retirement medical, dental and life insurance plans.

The company also provides disability benefits to employees. Employee disability benefit plans are insured in many countries. However, primarily in the U.S., such plans are generally self-insured. Obligations and expenses for self-insured plans are reflected in the change in projected benefit obligations table on page F-60.

F-57

E. I. du Pont de Nemours and Company

Notes to the Consolidated Financial Statements (continued)

The company’s remeasurement of its OPEB plans at the Merger Effectiveness Time resulted in an increase in the benefit obligation of $41 million. In connection with the remeasurement, the company lowered the weighted average discount rate to 3.62 percent as of August 31, 2017 from 4.03 percent as of December 31, 2016.

As a result of the workforce reductions related to a 2016 global cost savings and restructuring plan, a curtailment was triggered for the company's other post employment benefit plans. The company recorded curtailment gains of $35 million during the year ended December 31, 2016. The curtailment gains were driven by accelerated recognition of a portion of the prior service benefit partially offset by the change in the benefit obligation based on the demographics of the terminated positions.

The company's OPEB plans are unfunded and the cost of the approved claims is paid from operating cash flows. Pre-tax cash requirements to cover actual net claims costs and related administrative expenses were $59 million, $166 million, $218 million, and $237 million for the periods September 1 through December 31, 2017 and January 1 through August 31, 2017 and for the years ended December 31, 2016 and 2015, respectively. Changes in cash requirements reflect the net impact of higher per capita health care costs, demographic changes, plan amendments and changes in participant premiums, co-pays and deductibles. In 2018, the company expects to contribute about $250 million for its OPEB plans.

The weighted-average assumptions used to determine benefit obligations for OPEB plans are summarized in the table below:

Weighted-Average Assumptions used to Determine Benefit Obligations	Successor		Predecessor
	December 31, 2017		December 31, 2016
Discount rate	3.56	%	4.03	%

The weighted-average assumptions used to determine net periodic benefit costs for the OPEB plans are summarized in the two tables below:

Weighted-Average Assumptions used to Determine Net Periodic Benefit Cost	Successor		Predecessor
	For the Period September 1 through December 31, 2017		For the Period January 1 through August 31, 2017		For the Year Ended December 31, 2016		For the Year Ended December 31, 2015
Discount rate	3.62	%	4.03	%	3.87	%	4.13	%

Assumed Health Care Cost Trend Rates	Successor		Predecessor
	December 31, 2017		December 31, 2016
Health care cost trend rate assumed for next year	6.40	%	7.00	%
Rate to which the cost trend rate is assumed to decline (the ultimate health care trend rate)	5.00	%	5.00	%
Year that the rate reached the ultimate health care cost trend rate	2023		2023

Assumed health care cost trend rates have a modest effect on the amounts reported for the health care plans. A one percentage point change in assumed health care cost trend rates would have an immaterial impact on service and interest cost and the postretirement benefit obligation.

Assumptions

Within the U.S., the company determines the expected long-term rate of return on plan assets by performing a detailed analysis of key economic and market factors driving historical returns for each asset class and formulating a projected return based on factors in the current environment. Factors considered include, but are not limited to, inflation, real economic growth, interest rate yield, interest rate spreads, and other valuation measures and market metrics. The expected long-term rate of return for each asset class is then weighted based on the strategic asset allocation approved by the governing body for each plan. The company's historical experience with the pension fund asset performance is also considered. For non-U.S. plans, assumptions reflect economic assumptions applicable to each country.

F-58

E. I. du Pont de Nemours and Company

Notes to the Consolidated Financial Statements (continued)

Effective 2016, DuPont elected to adopt a spot rate approach to determine the discount rate utilized to measure the service cost and interest cost components of net periodic pension and other post employment benefit costs for its U.S. plans. Under the spot rate approach, the company calculates service costs and interest costs by applying individual spot rates from a yield curve (based on high-quality corporate bond yields) to the separate expected cash flows components of service cost and interest cost. Service cost and interest cost for all other plans are determined on the basis of the single equivalent discount rates derived in determining those plan obligations. The company changed to the new method to provide a more precise measure of interest and service costs for certain plans by improving the correlation between projected benefit cash flows and the discrete spot yield curves. The company has accounted for this change as a change in accounting estimate and it was applied prospectively starting in 2016. For non-U.S. benefit plans, the company utilizes prevailing long-term high quality corporate bond indices to determine the discount rate applicable to each country at the measurement date.

The discount rates utilized to measure the pension and other post employment obligations are based on the yield on high-quality corporate fixed income investments at the measurement date. Future expected actuarially determined cash flows are individually discounted at the spot rates under Aon Hewitt AA_Above Median yield curve (based on high-quality corporate bond yields) to arrive at the plan’s obligations as of the measurement date. For non-U.S. benefit plans, the company utilizes prevailing long-term high quality corporate bond indices to determine the discount rate applicable to each country at the measurement date.

In October 2014, the U.S. Society of Actuaries ("SOA") released final reports of new mortality tables and a mortality improvement scale for measurement of retirement program obligations in the U.S. The SOA publishes updated mortality improvement scales on an annual basis. The company has adopted the 2016 and 2017 SOA mortality improvement scale in measuring its U.S. pension and other postretirement obligations for the years ended December 31, 2016 and 2017, respectively. The effect of these adoptions is amortized into net periodic benefit cost for the years following the adoption.

F-59

E. I. du Pont de Nemours and Company

Notes to the Consolidated Financial Statements (continued)

Summarized information on the company's pension and other post employment benefit plans is as follows:

Change in Projected Benefit Obligations, Plan Assets and Funded Status
	Defined Benefit Pension Plans									Other Post Employment Benefits
	Successor			Predecessor						Successor			Predecessor
(In millions)	For the Period September 1 through December 31, 2017 1			For the Period January 1 through August 31, 2017			For the Year Ended December 31, 2016			For the Period September 1 through December 31, 2017 1			For the Period January 1 through August 31, 2017			For the Year Ended December 31, 2016
Change in benefit obligations:
Benefit obligation at beginning of the period	$	26,036		$	24,831		$	26,094		$	2,772		$	2,829		$	2,758
Service cost	49			92			174			3			6			11
Interest cost	247			524			800			26			60			87
Plan participants' contributions	6			8			18			12			26			36
Actuarial (gain) loss	(23		)	—			460			68			—			153
Benefits paid2	(730		)	(1,118		)	(2,374		)	(71		)	(192		)	(254		)
Plan amendments	—			—			—			—			—			(28		)
Net effects of acquisitions / divestitures / other	22			—			7			—			—			65
Effect of foreign exchange rates	(57		)	429			(348		)	—			2			1
Benefit obligations at end of the period	$	25,550		$	24,766		$	24,831		$	2,810		$	2,731		$	2,829
Change in plan assets:
Fair value of plan assets at beginning of the period	$	20,395		$	16,656		$	17,497		$	—		$	—		$	—
Actual return on plan assets	549			846			1,219			—			—			—
Employer contributions	68			3,024			535			59			166			218
Plan participants' contributions	6			8			18			12			26			36
Benefits paid2	(730		)	(1,118		)	(2,374		)	(71		)	(192		)	(254		)
Net effects of acquisitions / divestitures / other	29			—			—			—			—			—
Effect of foreign exchange rates	(33		)	269			(239		)	—			—			—
Fair value of plan assets at end of the period	$	20,284		$	19,685		$	16,656		$	—		$	—		$	—
Funded status
U.S. plan with plan assets	$	(3,628	)	$	(3,277	)	$	(6,391	)	$	—		$	—		$	—
Non-U.S. plans with plan assets	(447		)	(609		)	(674		)	—			—			—
All other plans 3, 4	(1,191		)	(1,187		)	(1,102		)	(2,810		)	(2,731		)	(2,829		)
Plans of discontinued operations	—			(8		)	(8		)	—			—			—
Funded status at end of the period	$	(5,266	)	$	(5,081	)	$	(8,175	)	$	(2,810	)	$	(2,731	)	$	(2,829	)

1. The benefit obligation and the fair value of plan assets at the beginning of the period September 1 through December 31, 2017, reflects the remeasurement of the plans at the Merger Effectiveness Time.

2. In the fourth quarter of 2016, about $550 million of lump-sum payments were made from the principal U.S. pension plan trust fund to a group of separated, vested plan participants who were extended a limited-time opportunity and voluntarily elected to receive their pension benefits in a single lump-sum payment. In the fourth quarter of 2017, about $140 million of lump-sum payments were made from the principal U.S. pension plan trust fund under a similar program.

3. As of December 31, 2017, $389 million of the benefit obligations are supported by funding under the Trust agreement, defined in the "Trust Assets" section below.

4. Includes pension plans maintained around the world where funding is not customary.

F-60

E. I. du Pont de Nemours and Company

Notes to the Consolidated Financial Statements (continued)

	Defined Benefit Pension Plans						Other Post Employment Benefits
(In millions)	Successor			Predecessor			Successor			Predecessor
	December 31, 2017			December 31, 2016			December 31, 2017			December 31, 2016
Amounts recognized in the Consolidated Balance Sheets:
Other Assets	$	47		$	3		$	—		$	—
Accrued and other current liabilities	(86		)	(78		)	(250		)	(275		)
Liabilities held for sale - current	—			(8		)	—			—
Pension and other post employment benefits - noncurrent 1	(5,227		)				(2,560		)
Other noncurrent obligations 1	—			(8,092		)	—			(2,554		)
Net amount recognized	$	(5,266	)	$	(8,175	)	$	(2,810	)	$	(2,829	)
Pretax amounts recognized in accumulated other comprehensive (income) loss:
Net (gain) loss	$	(165	)	$	10,280		$	68		$	830
Prior service benefit	—			(17		)	—			(281		)
Pretax balance in accumulated other comprehensive (income) loss at end of year	$	(165	)	$	10,263		$	68		$	549

1. In the Successor Period, non-current pension and OPEB liabilities are included within pension and other post employment benefits - noncurrent in the Consolidated Balance Sheets.  In the Predecessor period, these liabilities are included within other noncurrent obligations. 

The accumulated benefit obligation for all pensions plans was $25.1 billion and $24.3 billion at December 31, 2017 and 2016, respectively.

Pension Plans with Projected Benefit Obligations in Excess of Plan Assets	Successor		Predecessor
(In millions)	December 31, 2017		December 31, 2016
Projected benefit obligations	$	25,254	$	24,779
Accumulated benefit obligations	24,864		24,297
Fair value of plan assets	19,941		16,601

Pension Plans with Accumulated Benefit Obligations in Excess of Plan Assets	Successor		Predecessor
(In millions)	December 31, 2017		December 31, 2016
Projected benefit obligations	$	24,625	$	23,946
Accumulated benefit obligations	24,315		23,591
Fair value of plan assets	19,335		15,838

F-61

E. I. du Pont de Nemours and Company

Notes to the Consolidated Financial Statements (continued)

	Defined Benefit Pension Plans												Other Post Employment Benefits
(In millions)	Successor			Predecessor									Successor		Predecessor
Components of net periodic benefit cost (credit) and amounts recognized in other comprehensive loss	For the Period September 1 through December 31, 2017			For the Period January 1 through August 31, 2017			For the Year Ended December 31, 2016			For the Year Ended December 31, 2015			For the Period September 1 through December 31, 2017		For the Period January 1 through August 31, 2017			For the Year Ended December 31, 2016			For the Year Ended December 31, 2015
Net Periodic Benefit Cost:
Service cost	$	49		$	92		$	174		$	232		$	3	$	6		$	11		$	15
Interest cost	247			524			800			1,084			26		60			87			112
Expected return on plan assets	(407		)	(824		)	(1,320		)	(1,554		)	—		—			—			—
Amortization of unrecognized loss	—			506			822			768			—		61			78			78
Amortization of prior service benefit	—			(3		)	(6		)	(9		)	—		(46		)	(134		)	(182		)
Curtailment loss (gain)	—			—			40			(6		)	—		—			(392		)	(274		)
Settlement loss	—			—			62			76			—		—			—			—
Net periodic (credit) benefit cost - Total	$	(111	)	$	295		$	572		$	591		$	29	$	81		$	(350	)	$	(251	)
Less: Discontinued operations	1			3			—			—			—		—			—			(272		)
Net periodic (credit) benefit cost - Continuing operations	$	(112	)	$	292		$	572		$	591		$	29	$	81		$	(350	)	$	21
Changes in plan assets and benefit obligations recognized in other comprehensive (income) loss:
Net (gain) loss	$	(165	)	$	(22	)	$	570		$	57		$	68	$	—		$	153		$	(4	)
Amortization of unrecognized loss	—			(506		)	(822		)	(768		)	—		(61		)	(78		)	(78		)
Prior service benefit	—			—			—			—			—		—			(28		)	—
Amortization of prior service benefit	—			3			6			9			—		46			134			182
Curtailment (loss) gain	—			—			(40		)	6			—		—			392			274
Settlement loss	—			—			(62		)	(76		)	—		—			—			—
Effect of foreign exchange rates	—			133			(138		)	(119		)	—		—			—			1
Spin-off of Chemours	—			—			—			(382		)	—		—			—			—
Total (benefit) loss recognized in other comprehensive loss, attributable to DuPont	$	(165	)	$	(392	)	$	(486	)	$	(1,273	)	$	68	$	(15	)	$	573		$	375
Total recognized in net periodic benefit cost and other comprehensive (income) loss	$	(276	)	$	(97	)	$	86		$	(682	)	$	97	$	66		$	223		$	124

The estimated pretax net gain for the defined benefit pensions plans that will be amortized from accumulated other comprehensive (income) loss into net periodic benefit cost during 2018 is $1 million.

F-62

E. I. du Pont de Nemours and Company

Notes to the Consolidated Financial Statements (continued)

Estimated Future Benefit Payments

The estimated future benefit payments, reflecting expected future service, as appropriate, are presented in the following table:

Estimated Future Benefit Payments at December 31, 2017 (Successor)	Defined Benefit Pension Plans		Other Post Employment Benefits
(In millions)
2018	$	1,636	$	250
2019	1,614		243
2020	1,600		236
2021	1,587		227
2022	1,568		218
Years 2023-2027	7,533		906
Total	15,538		2,080

Plan Assets

All pension plan assets in the U.S. are invested through a single master trust fund. The strategic asset allocation for this trust fund is approved by management. The general principles guiding U.S. pension asset investment policies are those embodied in the Employee Retirement Income Security Act of 1974 (ERISA). These principles include discharging DuPont's investment responsibilities for the exclusive benefit of plan participants and in accordance with the "prudent expert" standard and other ERISA rules and regulations. DuPont establishes strategic asset allocation percentage targets and appropriate benchmarks for significant asset classes with the aim of achieving a prudent balance between return and risk. Strategic asset allocations in other countries are selected in accordance with the laws and practices of those countries. Where appropriate, asset liability studies are utilized in this process. U.S. plan assets and a portion of non-U.S. plan assets are managed by investment professionals employed by DuPont. The remaining assets are managed by professional investment firms unrelated to the company. DuPont's pension investment professionals have discretion to manage the assets within established asset allocation ranges approved by management of the company. Additionally, pension trust funds are permitted to enter into certain contractual arrangements generally described as "derivatives". Derivatives are primarily used to reduce specific market risks, hedge currency and adjust portfolio duration and asset allocation in a cost-effective manner.

In connection with pension contributions of $2,900 million to its principal U.S. pension plan during the period of January 1, 2017 through August 31, 2017, an investment policy study was completed for the principal U.S. pension plan. The study resulted in new target asset allocations being approved for the U.S. pension plan with resulting changes to the expected return on plan assets. The long-term rate of return on assets decreased from 8 percent to 6.25 percent.

The weighted-average target allocation for plan assets of the company's pension plans is summarized as follows:

Target Allocation for Plan Assets	Successor		Predecessor
Asset Category	December 31, 2017		December 31, 2016
U.S. equity securities	17	%	27	%
Non-U.S. equity securities	18		24
Fixed income securities	50		33
Hedge funds	2		2
Private market securities	8		8
Real estate	3		4
Cash and cash equivalents	2		2
Total	100	%	100	%

Global equity securities include varying market capitalization levels. U.S. equity investments are primarily large-cap companies. Global fixed income investments include corporate-issued, government-issued and asset-backed securities. Corporate debt investments include a range of credit risk and industry diversification. U.S. fixed income investments are weighted heavier than non-U.S. fixed income securities. Other investments include cash and cash equivalents, hedge funds, real estate and private market securities such as interests in private equity and venture capital partnerships.

F-63

E. I. du Pont de Nemours and Company

Notes to the Consolidated Financial Statements (continued)

Fair value calculations may not be indicative of net realizable value or reflective of future fair values. Furthermore, although the company believes its valuation methods are appropriate and consistent with other market participants, the use of different methodologies or assumptions to determine the fair value of certain financial instruments could result in a different fair value measurement at the reporting date.

For pension plan assets classified as Level 1 measurements (measured using quoted prices in active markets), total fair value is either the price of the most recent trade at the time of the market close or the official close price, as defined by the exchange on which the asset is most actively traded on the last trading day of the period, multiplied by the number of units held without consideration of transaction costs.

For pension or other post employment benefit plan assets classified as Level 2 measurements, where the security is frequently traded in less active markets, fair value is based on the closing price at the end of the period; where the security is less frequently traded, fair value is based on the price a dealer would pay for the security or similar securities, adjusted for any terms specific to that asset or liability. Market inputs are obtained from well-established and recognized vendors of market data and subjected to tolerance and quality checks. For derivative assets and liabilities, standard industry models are used to calculate the fair value of the various financial instruments based on significant observable market inputs, such as foreign exchange rates, commodity prices, swap rates, interest rates and implied volatilities obtained from various market sources.

For pension plan assets classified as Level 3 measurements, total fair value is based on significant unobservable inputs including assumptions where there is little, if any, market activity for the investment. Investment managers or fund managers provide valuations of the investment on a monthly or quarterly basis. These valuations are reviewed for reasonableness based on applicable sector, benchmark and company performance. Adjustments to valuations are made where appropriate. Where available, audited financial statements are obtained and reviewed for the investments as support for the manager’s investment valuation.

The tables below present the fair values of the company's pension assets by level within the fair value hierarchy, as described in Note 1:

Basis of Fair Value Measurements
For the year ended December 31, 2017 (Successor)
(In millions)	Total			Level 1		Level 2			Level 3
Cash and cash equivalents	$	3,057		$	3,057	$	—		$	—
U.S. equity securities 1	4,043			4,012		14			17
Non-U.S. equity securities	3,064			2,866		195			3
Debt – government-issued	3,263			497		2,766			—
Debt – corporate-issued	3,181			270		2,884			27
Debt – asset-backed	706			17		687			2
Hedge funds	85			—		83			2
Private market securities	14			—		—			14
Real estate	342			239		7			96
Derivatives – asset position	24			3		21			—
Derivatives – liability position	(16		)	—		(16		)	—
Other	2			—		2			—
Subtotal	$	17,765		$	10,961	$	6,643		$	161
Investments measured at net asset value
Hedge funds	747
Private market securities	1,383
Real estate funds	437
Total investments measured at net asset value	$	2,567
Other items to reconcile to fair value of plan assets
Pension trust receivables 2	127
Pension trust payables 3	(175		)
Total	$	20,284

1. The DuPont pension plans directly held $910 million (4 percent of total plan assets) of DowDuPont common stock at December 31, 2017.

2. Primarily receivables for investments securities sold.

3. Primarily payables for investment securities purchased

F-64

E. I. du Pont de Nemours and Company

Notes to the Consolidated Financial Statements (continued)

Basis of Fair Value Measurements
For the year ended December 31, 2016 (Predecessor)
(In millions)	Total			Level 1		Level 2			Level 3
Cash and cash equivalents	$	1,505		$	1,480	$	25		$	—
U.S. equity securities1	4,071			4,033		20			18
Non-U.S. equity securities	3,278			3,126		151			1
Debt – government-issued	2,067			864		1,203			—
Debt – corporate-issued	2,475			273		2,163			39
Debt – asset-backed	721			39		682			—
Hedge funds	1			—		1			—
Private market securities	67			—		25			42
Real estate	275			175		2			98
Derivatives – asset position	53			7		46			—
Derivatives – liability position	(47		)	—		(47		)	—
Other	4			—		4			—
Subtotal	$	14,470		$	9,997	$	4,275		$	198
Investments measured at net asset value
Hedge funds	434
Private market securities	1,416
Real estate funds	444
Total investments measured at net asset value	$	2,294
Other items to reconcile to fair value of plan assets
Pension trust receivables2	264
Pension trust payables3	(372		)
Total	$	16,656

1. The DuPont pension plans directly held $732 million (4 percent of total plan assets) of DuPont common stock at December 31, 2016.

2. Primarily receivables for investments securities sold.

3. Primarily payables for investment securities purchased.

F-65

E. I. du Pont de Nemours and Company

Notes to the Consolidated Financial Statements (continued)

The following table summarizes the changes in fair value of Level 3 pension plan assets for the year ended December 31, 2016 and for the periods January 1 through August 31, 2017 and September 1 through December 31, 2017:

Fair Value Measurement of Level 3 Pension Plan Assets	U.S. equity securities			Non-U.S. equity securities			Debt – corporate-issued			Debt- asset- backed			Hedge funds		Private market securities			Real estate			Total
(In millions)
Predecessor
Balance at January 1, 2016	$	20		$	2		$	34		$	1		$	—	$	37		$	144		$	238
Actual return on assets:
Relating to assets sold during the year ended December 31, 2016	(3		)	—			(25		)	—			—		—			—			(28		)
Relating to assets held at December 31, 2016	1			(1		)	27			—			—		2			(10		)	19
Purchases, sales and settlements, net	—			—			(3		)	(1		)	—		3			(36		)	(37		)
Transfers in Level 3, net	—			—			6			—			—		—			—			6
Balance at December 31, 2016	$	18		$	1		$	39		$	—		$	—	$	42		$	98		$	198
Actual return on assets:
Relating to assets sold during the period January 1 through August 31, 2017	(1		)	2			(20		)	—			—		—			—			(19		)
Relating to assets held at August 31, 2017	(7		)	(2		)	22			—			—		(5		)	7			15
Purchases, sales and settlements, net	6			1			(1		)	—			—		1			(7		)	—
Transfers in (out) of Level 3, net	—			—			6			2			—		(21		)	—			(13		)
Balance at August 31, 2017	$	16		$	2		$	46		$	2		$	—	$	17		$	98		$	181
Successor
Balance at September 1, 2017	$	16		$	2		$	46		$	2		$	—	$	17		$	98		$	181
Actual return on assets:
Relating to assets sold during the period September 1 through December 31, 2017	—			—			(3		)	—			—		—			—			(3		)
Relating to assets held at December 31, 2017	1			(1		)	5			—			—		(3		)	4			6
Purchases, sales and settlements, net	—			2			(21		)	—			2		—			(6		)	(23		)
Balance at December 31, 2017	$	17		$	3		$	27		$	2		$	2	$	14		$	96		$	161

The following table presents additional information about the pension plan assets valued using net asset value as a practical expedient:

(In millions)	Successor				Predecessor
	December 31, 2017				December 31, 2016
	Fair Value		Unfunded Commitments		Fair Value		Unfunded Commitments		Redemption Frequency	Redemption Notice Period Range
Hedge funds 1	747		—		434		—		Monthly, Quarterly	Ranges from 15-45 days monthly, 10-185 days quarterly
Private market securities 2	1,383		797		1,416		693		Not applicable	Not applicable
Real estate funds 2	437		371		444		244		Not applicable	Not applicable
Total	$	2,567	$	1,168	$	2,294	$	937

1. Less than 5 percent of hedge funds have gates in place at the investor level for year-end redemptions. Hedge funds also contain either no lock up or a lock up period of less than 1 year.

2. The remaining life of private market securities and real estate funds is an average of 15 years per investment.

F-66

E. I. du Pont de Nemours and Company

Notes to the Consolidated Financial Statements (continued)

Trust Assets

DuPont entered into a trust agreement in 2013 (as amended and restated in 2017) that established and requires DuPont to fund a trust (the "Trust") for cash obligations under certain non-qualified benefit and deferred compensation plans upon a change in control event as defined in the Trust agreement. Under the Trust agreement, the consummation of the Merger was a change in control event. As a result, in November 2017, DuPont contributed $571 million to the Trust. In the fourth quarter of 2017, $13 million was distributed to DuPont according to the Trust agreement and at December 31, 2017, the balance in the Trust was $558 million.

Defined Contribution Plans

DuPont provides defined contribution benefits to its employees. The most significant is the U.S. Retirement Savings Plan ("the Plan"), which covers all U.S. full-service employees. This Plan includes a non-leveraged Employee Stock Ownership Plan ("ESOP"). Employees are not required to participate in the ESOP and those who do are free to diversify out of the ESOP. The purpose of the Plan is to provide retirement savings benefits for employees and to provide employees an opportunity to become stockholders of the company. The Plan is a tax qualified contributory profit sharing plan, with cash or deferred arrangement and any eligible employee of DuPont may participate. Currently, DuPont contributes 100 percent of the first 6 percent of the employee's contribution election and also contributes 3 percent of each eligible employee's eligible compensation regardless of the employee's contribution.

DuPont's contributions to the Plan were $53 million, $129 million, $187 million and $219 million for the periods September 1 through December 31, 2017 and January 1 through August 31, 2017 and the years ended December 31, 2016 and 2015, respectively. DuPont's matching contributions vest immediately upon contribution. The 3 percent nonmatching company contribution vests after employees complete three years of service. In addition, DuPont made contributions to other defined contribution plans of $17 million, $33 million, $33 million and $57 million for the periods September 1 through December 31, 2017 and January 1 through August 31, 2017 and the years ended December 31, 2016 and 2015, respectively. Included in DuPont's contributions are amounts related to discontinued operations of $1 million, $5 million, $6 million and $39 million for the periods September 1 through December 31, 2017 and January 1 through August 31, 2017 and the years ended December 31, 2016 and 2015, respectively.

NOTE 17 - STOCK-BASED COMPENSATION

The company's Equity Incentive Plan ("EIP"), as amended and restated effective August 31, 2017, provides for equity-based and cash incentive awards to certain employees, directors, and consultants. All outstanding DuPont equity awards as of the Merger date were converted into equity awards with respect to DowDuPont Common Stock. The previous DuPont equity awards were converted into the right to receive 1.2820 shares of DowDuPont Common Stock and had a fair value of approximately $629 million at the Merger closing date, which was included in the total consideration exchanged. The converted DuPont equity awards were measured at their fair value and included $485 million as consideration exchanged and $144 million (includes $23 million of incremental expense as a result of the conversion) that will be amortized to stock compensation expense over the remaining vesting period of the awards. The fair values of the converted awards were based on valuation assumptions developed by management and other information including, but not limited to, historical volatility and dividend yield of DuPont and Dow. DuPont and Dow did not merge their equity and incentive plans as a result of the Merger.

Under the amended EIP, the maximum number of shares reserved for the grant or settlement of awards is 110 million shares, provided that each share in excess of 30 million that is issued with respect to any award that is not an option or stock appreciation right will be counted against the 110 million share limit as four and one-half shares. At December 31, 2017, approximately 34 million shares were authorized for future grants under the EIP. The company satisfies stock option exercises and vesting of time-vested restricted stock units ("RSUs") and performance-based restricted stock units ("PSUs") with newly issued shares of DowDuPont Common Stock.

The total stock-based compensation cost included in continuing operations within the Consolidated Statement of Operations was $33 million, $85 million, $118 million and $127 million for the period September 1 through December 31, 2017, the period January 1 through August 31, 2017, and the years ended December 31, 2016 and 2015, respectively. The income tax benefits related to stock-based compensation arrangements were $11 million, $29 million, $39 million and $42 million for the period September 1 through December 31, 2017, the period January 1 through August 31, 2017, and the years ended December 31, 2016 and 2015, respectively.

The compensation committee determines the long-term incentive mix, including stock options, RSUs and PSUs and may authorize new grants annually. The company estimates expected forfeitures.

F-67

E. I. du Pont de Nemours and Company

Notes to the Consolidated Financial Statements (continued)

Stock Options

The exercise price of shares subject to option is equal to the market price of DowDuPont's stock on the date of grant. All options vest serially over a three-year period. Stock option awards granted between 2010 and 2015 expire seven years after the grant date and options granted in 2016 and 2017 expire ten years after the grant date. The plan allows retirement-eligible employees to retain any granted awards upon retirement provided the employee has rendered at least six months of service following grant date.

The weighted-average grant-date fair value of options granted in the period September 1 through December 31, 2017, the period January 1 through August 31, 2017, and the years ended December 31, 2016 and 2015 was $28.56, $16.65, $13.40, and $11.57, respectively.

To measure the fair value of the awards on the date of grant, the company used the Black-Scholes option pricing model and the following assumptions:

Weighted-Average Assumptions	Successor		Predecessor
	For the Period September 1 through December 31, 2017		For the Period January 1 through August 31, 2017		For the Year Ended December 31, 2016		For the Year Ended December 31, 2015
Dividend yield	2.2	%	2.0	%	2.6	%	2.5	%
Expected volatility	23.59	%	23.21	%	28.27	%	22.52	%
Risk-free interest rate	2.1	%	2.3	%	1.8	%	1.4	%
Expected life of stock options granted during period (years)	7.2		7.2		7.2		5.3

In the Successor period, the company determined the dividend yield by dividing the annualized dividend on DowDuPont's Common Stock by the option exercise price. In the Predecessor periods, the company determined the dividend yield by dividing the annual dividend on DuPont's stock by the option exercise price. A historical daily measurement of volatility is determined based on the expected life of the option granted. In the Successor period, the measurement of volatility used DowDuPont stock information after the Merger date, and a weighted average of Dow and DuPont stock information prior to Merger date. In the Predecessor periods, the measurement of volatility used DuPont stock information. 

The risk-free interest rate is determined by reference to the yield on an outstanding U.S. Treasury note with a term equal to the expected life of the option granted. Expected life is determined by reference to the company's historical experience.

F-68

E. I. du Pont de Nemours and Company

Notes to the Consolidated Financial Statements (continued)

The following table summarizes stock option activity for 2017 under the EIP:

Stock Options	2017
	Number of Shares (in thousands)		Weighted Average Exercise Price (per share)		Weighted Average Remaining Contractual Term (years)	Aggregate Intrinsic Value (in thousands)
Outstanding at January 1, 2017 (Predecessor)	15,696		$	58.11
Granted	1,626		76.18
Exercised	(4,356	)	54.52
Forfeited/Expired	(136	)	60.93
Outstanding at August 31, 20171	12,830		$	61.84	4.71	$	283,365
Exercisable at August 31, 2017	8,441		$	57.78	3.37	$	220,716
Outstanding at September 1, 2017 (Successor)1	16,447		$	48.24
Granted	174		45.29
Exercised	(702	)	43.07
Forfeited/Expired	(30	)	54.83
Outstanding at December 31, 2017	15,889		$	48.43	3.74	$	362,088
Exercisable at December 31, 2017	10,881		$	45.75	3.06	$	277,163

^1.  As a result of the Merger, all previous DuPont equity awards were converted into the right to receive 1.2820 shares of DowDuPont Common Stock, as discussed above. As a result, the number of shares outstanding at September 1, 2017 represents the shares as of August 31, 2017 multiplied by the conversion factor.

The aggregate intrinsic values in the table above represent the total pre-tax intrinsic value (the difference between the closing stock price on the last trading day of the period and the exercise price, multiplied by the number of in-the-money options) that would have been received by the option holders had all option holders exercised their in-the-money options at period end. Total intrinsic value of options exercised for the period September 1 through December 31, 2017, for the period January 1 through August 31, 2017, and for the years ended December 31, 2016 and 2015 were $19 million, $108 million, $86 million and $160 million, respectively. For the period September 1 through December 31, 2017 and for the period January 1 through August 31, 2017, the company realized tax benefits from options exercised of $6 million and $36 million, respectively.

As of December 31, 2017, $24 million of total unrecognized pre-tax compensation expense related to non-vested stock options is expected to be recognized over a weighted-average period of 1.86 years.

Restricted Stock Units and Performance Deferred Stock

The company issues non-vested RSUs that serially vest over a three-year period and, upon vesting, convert one-for-one to DowDuPont Common Stock. A retirement-eligible employee retains any granted awards upon retirement provided the employee has rendered at least six months of service following the grant date. Additional RSUs are also granted periodically to key senior management employees. These RSUs generally vest over periods ranging from two to five years. The fair value of all stock-settled RSUs is based upon the market price of the underlying common stock as of the grant date. The awards have the same terms and conditions as were applicable to such equity awards immediately prior to the Merger closing date.

The company grants PSUs to senior leadership. As a result of the Merger, the EIP provisions required PSUs to be converted into RSUs based on the number of PSUs that would vest by assuming that target levels of performance are achieved. Service requirements for vesting in the RSUs replicate those inherent in the exchanged PSUs.

F-69

E. I. du Pont de Nemours and Company

Notes to the Consolidated Financial Statements (continued)

Vesting for PSUs granted in 2016 and for the period January 1, 2017 through August 31, 2017 is based upon total shareholder return ("TSR") relative to peer companies. Vesting for PSUs granted in 2015 is equally based upon change in operating net income relative to target and TSR relative to peer companies. Operating net income is net income attributable to DuPont excluding income from discontinued operations after taxes, significant after tax benefits (charges), and non-operating pension and OPEB costs. Non-operating pension and OPEB costs includes all of the components of net periodic benefit cost from continuing operations with the exception of the service cost component. Performance and payouts are determined independently for each metric. The actual award, delivered as DowDuPont Common Stock, can range from zero percent to 200 percent of the original grant. The weighted-average grant-date fair value of PSUs granted for the period January 1 through August 31, 2017, subject to the TSR metric, was $91.56, and estimated using a Monte Carlo simulation. The weighted-average grant-date fair value of the PSUs, subject to the revenue metric, was based upon the market price of the underlying common stock as of the grant date.

In accordance with the Merger Agreement, PSUs converted to RSUs based on an assessment of the underlying market conditions in the PSUs at the greater of target or actual performance levels as of the closing date. As the actual performance levels were not in excess of target as of the closing date, all PSUs converted to RSUs based on target and there was no incremental benefit from the Merger Agreement when compared to DuPont’s EIP.

In November 2017, DowDuPont granted PSUs to senior leadership that vest partially based on the realization of cost savings in connection with DowDuPont Cost Synergy Program, as well as DowDuPont’s ability to complete the Intended Business Separations. Performance and payouts are determined independently for each metric. The actual award, delivered in DowDuPont Common Stock, can range from zero percent to 200 percent of the original grant. The weighted-average grant date fair value of the PSUs granted in November 2017 of $71.16 was based upon the market price of the underlying common stock as of the grant date.

Nonvested awards of RSUs and PSUs are shown below.

	2017
	Number of Shares (in thousands)		Weighted Average Grant Date Fair Value (per share)
Nonvested at December 31, 2016 (Predecessor)	3,390		$	63.11
Granted	1,124		76.41
Vested	(1,332	)	63.08
Forfeited	(104	)	70.69
Nonvested at August 31, 20171	3,078		$	67.53
Nonvested at September 1, 2017 (Successor)1	3,948		$	67.06
Granted	412		70.02
Vested	(139	)	67.67
Forfeited	(23	)	66.65
Nonvested at December 31, 2017	4,198		$	68.28

^1.  As a result of the Merger, all previous DuPont equity awards were converted into the right to receive 1.2820 shares of DowDuPont Common Stock, as discussed above. As a result, the number of shares outstanding at September 1, 2017 represents the shares as of August 31, 2017 multiplied by the conversion factor.

The total fair value of stock units vested during for the period September 1 through December 31, 2017, the period January 1 through August 31, 2017, and the years ended December 31, 2016 and 2015 was $9 million, $84 million, $83 million and $64 million, respectively. The weighted-average grant-date fair value of stock units granted for the period September 1 through December 31, 2017, for the period January 1 through August 31, 2017, and for the years ended December 31, 2016 and 2015 was $70.02, $76.41, $59.50, and $71.66, respectively.

As of December 31, 2017, $113 million of total unrecognized pre-tax compensation expense related to RSUs and PSUs is expected to be recognized over a weighted average period of 1.73 years.

Other Cash-based Awards

Other cash-based awards resulted in compensation expense of $83 million, $264 million, $295 million and $179 million for the period September 1 through December 31, 2017, for the period January 1 through August 31, 2017, and for the years ended December 31, 2016 and 2015, respectively, included in income from continuing operations within the Consolidated Statement of Operations.

F-70

E. I. du Pont de Nemours and Company

Notes to the Consolidated Financial Statements (continued)

NOTE 18 - FINANCIAL INSTRUMENTS

At December 31, 2017, the company had $5,205 million ($2,713 million at December 31, 2016) of held-to-maturity securities (primarily time deposits and money market funds) classified as cash equivalents, as these securities had maturities of three months or less at the time of purchase; and $952 million ($1,362 million at December 31, 2016) of held-to-maturity securities (primarily time deposits) classified as marketable securities as these securities had maturities of more than three months to less than 1 year at the time of purchase. The company’s investments in held-to-maturity securities are held at amortized cost, which approximates fair value. These securities are included in cash and cash equivalents, marketable securities, and other current assets in the consolidated balance sheets.

Available-for-sale securities are reported at estimated fair value with unrealized gains and losses reported as a component of accumulated other comprehensive loss. There were no sales of available-for-sale securities for the period September 1 through December 31, 2017 or for the period January 1 through August 31, 2017. The proceeds from the sale of available-for-sale securities for the year ended December 31, 2016 were $788 million.

Derivative Instruments

Objectives and Strategies for Holding Derivative Instruments

In the ordinary course of business, the company enters into contractual arrangements (derivatives) to reduce its exposure to foreign currency, interest rate and commodity price risks. The company has established a variety of derivative programs to be utilized for financial risk management. These programs reflect varying levels of exposure coverage and time horizons based on an assessment of risk.

Derivative programs have procedures and controls and are approved by the Corporate Financial Risk Management Committee, consistent with the company's financial risk management policies and guidelines. Derivative instruments used are forwards, options, futures and swaps. The company has not designated any nonderivatives as hedging instruments.

The company's financial risk management procedures also address counterparty credit approval, limits and routine exposure monitoring and reporting. The counterparties to these contractual arrangements are major financial institutions and major commodity exchanges. The company is exposed to credit loss in the event of nonperformance by these counterparties. The company utilizes collateral support annex agreements with certain counterparties to limit its exposure to credit losses. The company anticipates performance by counterparties to these contracts and therefore no material loss is expected. Market and counterparty credit risks associated with these instruments are regularly reported to management.

The notional amounts of the company's derivative instruments were as follows:

Notional Amounts	Successor		Predecessor
(In millions)	December 31, 2017		December 31, 2016
Derivatives designated as hedging instruments:
Commodity contracts	$	587	$	422
Derivatives not designated as hedging instruments:
Foreign currency contracts	10,454		9,896
Commodity contracts	6		7

Foreign Currency Risk

The company's objective in managing exposure to foreign currency fluctuations is to reduce earnings and cash flow volatility associated with foreign currency rate changes. Accordingly, the company enters into various contracts that change in value as foreign exchange rates change to protect the value of its existing foreign currency-denominated assets, liabilities, commitments and cash flows.

F-71

E. I. du Pont de Nemours and Company

Notes to the Consolidated Financial Statements (continued)

The company routinely uses forward exchange contracts to offset its net exposures, by currency, related to the foreign currency denominated monetary assets and liabilities of its operations. The primary business objective of this hedging program is to maintain an approximately balanced position in foreign currencies so that exchange gains and losses resulting from exchange rate changes, net of related tax effects, are minimized. The company also uses foreign currency exchange contracts to offset a portion of the company's exposure to certain foreign currency-denominated revenues so that gains and losses on these contracts offset changes in the USD value of the related foreign currency-denominated revenues. The objective of the hedge program is to reduce earnings and cash flow volatility related to changes in foreign currency exchange rates.

Commodity Price Risk

Commodity price risk management programs serve to reduce exposure to price fluctuations on purchases of inventory such as corn, soybeans, soybean oil and soybean meal. The company enters into over-the-counter and exchange-traded derivative commodity instruments to hedge the commodity price risk associated with agricultural commodity exposures.

Derivatives Designated as Cash Flow Hedges

Foreign Currency Contracts

The company uses foreign currency exchange instruments such as forwards and options to offset a portion of the company's exposure to certain foreign currency-denominated revenues so that gains and losses on these contracts offset changes in the USD value of the related foreign currency-denominated revenues. In addition, the company occasionally uses forward exchange contracts to offset a portion of the company’s exposure to certain foreign currency-denominated transactions such as capital expenditures.

Commodity Contracts

The company enters into over-the-counter and exchange-traded derivative commodity instruments, including options, futures and swaps, to hedge the commodity price risk associated with agriculture commodity exposures.

While each risk management program has a different time maturity period, most programs currently do not extend beyond the next two-year period. Cash flow hedge results are reclassified into earnings during the same period in which the related exposure impacts earnings. Reclassifications are made sooner if it appears that a forecasted transaction is not probable of occurring.

The following table summarizes the after-tax effect of cash flow hedges on accumulated other comprehensive loss:

	Successor			Predecessor
(In millions)	For the Period September 1 - December 31, 2017			For the Period Jan. 1 - August 31, 2017			Year Ended December 31, 2016
Beginning balance	$	—		$	7		$	(24	)
Additions and revaluations of derivatives designated as cash flow hedges	(2		)	3			20
Clearance of hedge results to earnings	—			(13		)	11
Ending balance	$	(2	)	$	(3	)	$	7

At December 31, 2017, an after-tax net loss of $(6) million is expected to be reclassified from accumulated other comprehensive loss into earnings over the next twelve months.

Derivatives not Designated in Hedging Relationships

Foreign Currency Contracts

The company routinely uses forward exchange contracts to reduce its net exposure, by currency, related to foreign currency-denominated monetary assets and liabilities of its operations so that exchange gains and losses resulting from exchange rate changes are minimized. The netting of such exposures precludes the use of hedge accounting; however, the required revaluation of the forward contracts and the associated foreign currency-denominated monetary assets and liabilities intends to achieve a minimal earnings impact, after taxes. The company also uses foreign currency exchange contracts to offset a portion of the company's exposure to certain foreign currency-denominated revenues so that gains and losses on the contracts offset changes in the USD value of the related foreign currency-denominated revenues.

F-72

E. I. du Pont de Nemours and Company

Notes to the Consolidated Financial Statements (continued)

Commodity Contracts

The company utilizes options, futures and swaps that are not designated as hedging instruments to reduce exposure to commodity price fluctuations on purchases of inventory such as corn, soybeans, soybean oil and soybean meal.

Fair Value of Derivative Instruments

During the Predecessor period, the company's derivative assets and liabilities are reported on a gross basis in the Consolidated Balance Sheets. During the Successor period, to conform with DowDuPont's presentation post-merger, asset and liability derivatives subject to an enforceable master netting arrangement with the same counterparty are presented on a net basis in the Consolidated Balance Sheets. The presentation of the company's derivative assets and liabilities is as follows:

		Successor
		December 31, 2017
(In millions)	Balance Sheet Location	Gross		Counterparty and Cash Collateral Netting1			Net Amounts Included in the Condensed Consolidated Balance Sheet
Asset derivatives:
Derivatives not designated as hedging instruments:
Foreign currency contracts	Other current assets	$	46	$	(37	)	$	9
Total asset derivatives		$	46	$	(37	)	$	9
Liability derivatives:
Derivatives not designated as hedging instruments:
Foreign currency contracts	Accrued and other current liabilities	$	79	$	(32	)	$	47
Total liability derivatives		$	79	$	(32	)	$	47

^1.  Counterparty and cash collateral amounts represent the estimated net settlement amount when applying netting and set-off rights included in master netting arrangements between the company and its counterparties and the payable or receivable for cash collateral held or placed with the same counterparty. The company held cash collateral of $5 million as of December 31, 2017.

		Predecessor
(In millions)	Balance Sheet Location	December 31, 2016
Asset derivatives:
Derivatives not designated as hedging instruments:
Foreign currency contracts1	Accounts and notes receivable - net	$	182
Total asset derivatives2		$	182
Cash collateral1	Accrued and other current liabilities	$	52
Liability derivatives:
Derivatives not designated as hedging instruments:
Foreign currency contracts	Accrued and other current liabilities	$	121
Total liability derivatives2		$	121

^1.  Cash collateral held as of December 31, 2016 is related to foreign currency derivatives not designated as hedging instruments.

^2.  The company's derivative assets and liabilities subject to enforceable master netting arrangements totaled $114 million at December 31, 2016.

F-73

E. I. du Pont de Nemours and Company

Notes to the Consolidated Financial Statements (continued)

Effect of Derivative Instruments

	Amount of Gain (Loss) Recognized in OCI1 (Effective Portion) - Pre Tax
	Successor		Predecessor
(In millions)	For the Period September 1 - December 31, 2017		For the Period Jan. 1 - August 31, 2017		Year Ended December 31, 2016		Year Ended December 31, 2015
Derivatives designated as hedging instruments:
Cash flow hedges:
Foreign currency contracts	$	—	—		—		(2		)
Commodity contracts	3		5		32		(35		)
Total derivatives designated as hedging instruments	$	3	$	5	$	32	$	(37	)
Total derivatives	$	3	$	5	$	32	$	(37	)

1. OCI is defined as other comprehensive income (loss).

	Amount of Gain (Loss) Recognized in Income - Pre Tax1
	Successor		Predecessor
(In millions)	For the Period September 1 - December 31, 2017		For the Period Jan. 1 - August 31, 2017			Year Ended December 31, 2016			Year Ended December 31, 2015
Derivatives designated as hedging instruments:
Fair value hedges:
Interest rate swaps2	$	—	$	—		$	—		$	(1	)
Cash flow hedges:
Foreign currency contracts3	—		—			—			10
Commodity contracts2	—		21			(18		)	(22		)
Total derivatives designated as hedging instruments	$	—	$	21		$	(18	)	$	(13	)
Derivatives not designated as hedging instruments:
Foreign currency contracts4	91		(431		)	(304		)	434
Foreign currency contracts3	—		—			(12		)	(3		)
Commodity contracts2	—		2			(11		)	(2		)
Total derivatives not designated as hedging instruments	91		(429		)	(327		)	429
Total derivatives	$	91	$	(408	)	$	(345	)	$	416

1. For cash flow hedges, this represents the effective portion of the gain (loss) reclassified from accumulated OCI into income during the period. There was no material ineffectiveness with regard to the company's cash flow hedges during the period.

2. Recorded in cost of goods sold.

3. Recorded in net sales.

4. Gain recognized in sundry income - net was partially offset by the related gain on the foreign currency-denominated monetary assets and liabilities of the company's operations. See Note 6 for additional information.

F-74

E. I. du Pont de Nemours and Company

Notes to the Consolidated Financial Statements (continued)

NOTE 19 - FAIR VALUE MEASUREMENTS

The following tables summarize the bases used to measure certain assets and liabilities at fair value on a recurring basis:

December 31, 2017 (Successor)	Significant Other Observable Inputs (Level 2)
(In millions)
Assets at fair value:
Cash equivalents1	$	5,205
Marketable securities	$	952
Derivatives relating to:2
Foreign currency	46
Total assets at fair value	$	6,203
Liabilities at fair value:
Long-term debt3	$	11,560
Derivatives relating to:2
Foreign currency	79
Total liabilities at fair value	$	11,639

1. Time deposits included in "Cash and cash equivalents" and money market funds included in "Other current assets" in the consolidated balance sheets are held at amortized cost, which approximates fair value.

2. See Note 18 for the classification of derivatives in the consolidated balance sheets.

3. See Note 13 for information on fair value measurements of long-term debt.

December 31, 2016 (Predecessor)	Significant Other Observable Inputs (Level 2)
(In millions)
Assets at fair value:
Cash equivalents1	$	2,713
Marketable securities	$	1,362
Derivatives relating to:2
Foreign currency	182
Total assets at fair value	$	4,257
Liabilities at fair value:
Long-term debt3	$	8,464
Derivatives relating to:2
Foreign currency	121
Total liabilities at fair value	$	8,585

1. Time deposits included in "Cash and cash equivalents" and money market funds included in "Other current assets" in the consolidated balance sheets are held at amortized cost, which approximates fair value.

2. See Note 18 for the classification of derivatives in the consolidated balance sheets.

3. See Note 13 for information on fair value measurements of long-term debt.

For assets and liabilities classified as Level 1 measurements (measured using quoted prices in active markets), total fair value is either the price of the most recent trade at the time of the market close or the official close price, as defined by the exchange on which the asset is most actively traded on the last trading day of the period, multiplied by the number of units held without consideration of transaction costs.

For assets and liabilities classified as Level 2 measurements, where the security is frequently traded in less active markets, fair value is based on the closing price at the end of the period; where the security is less frequently traded, fair value is based on the price a dealer would pay for the security or similar securities, adjusted for any terms specific to that asset or liability, or by using observable market data points of similar, more liquid securities to imply the price. For time deposits classified as held-to-maturity investments and reported at amortized cost, fair value is based on an observable interest rate for similar securities. Market inputs are obtained from well-established and recognized vendors of market data and subjected to tolerance and quality checks. 

F-75

E. I. du Pont de Nemours and Company

Notes to the Consolidated Financial Statements (continued)

For derivative assets and liabilities, standard industry models are used to calculate the fair value of the various financial instruments based on significant observable market inputs, such as foreign exchange rates, commodity prices, swap rates, interest rates and implied volatilities obtained from various market sources. Market inputs are obtained from well-established and recognized vendors of market data and subjected to tolerance/quality checks.

For all other assets and liabilities for which observable inputs are used, fair value is derived through the use of fair value models, such as a discounted cash flow model or other standard pricing models. See Note 18 for further information on the types of instruments used by the company for risk management.

There were no transfers between Levels 1 and 2 during the years ended December 31, 2017 and December 31, 2016.

For assets classified as Level 3 measurements, the fair value is based on significant unobservable inputs including assumptions where there is little, if any, market activity. The fair value of the company’s interests held in trade receivable conduits is determined by calculating the expected amount of cash to be received using the key input of anticipated credit losses in the portfolio of receivables sold that have not yet been collected. Given the short-term nature of the underlying receivables, discount rate and prepayments are not factors in determining the fair value of the interests.

NOTE 20 - GEOGRAPHIC AND PRODUCT LINE INFORMATION

Sales are attributed to geographic areas based on customer location; long-lived assets are attributed to geographic areas based on asset location.

	Net Sales
	Successor		Predecessor
(In millions)	Sept 1 - Dec 31, 2017		Jan 1 - Aug 31, 2017		Year Ended Dec 31, 2016		Year Ended Dec 31, 2015
United States	$	2,086	$	7,535	$	9,500	$	9,812
Canada	139		583		669		692
EMEA1	1,689		3,927		5,251		5,483
Asia Pacific2	2,047		3,844		5,407		5,292
Latin America	1,092		1,392		2,382		2,378
Total	$	7,053	$	17,281	$	23,209	$	23,657

^1.  Europe, Middle East, and Africa (EMEA).

^2.  Net sales for China in the Successor period were $818 million. Net sales for China were less than 10 percent of consolidated net sales in all Predecessor periods.

	Net Property
	Successor		Predecessor
(In millions)	2017		2016		2015
United States	$	7,708	$	5,951	$	6,458
Canada	170		124		128
EMEA1	2,867		1,550		1,582
Asia Pacific	1,120		797		854
Latin America	570		429		392
Total	$	12,435	$	8,851	$	9,414

^1.  Europe, Middle East, and Africa (EMEA).

F-76

E. I. du Pont de Nemours and Company

Notes to the Consolidated Financial Statements (continued)

Net Sales by Principal Product Line

Effective with the Merger, DuPont’s business activities are components of its parent company’s business operations. DuPont’s business activities, including the assessment of performance and allocation of resources, are reviewed and managed by DowDuPont. Information used by the chief operating decision maker of DuPont relates to the company in its entirety. Accordingly, there are no separate reportable business segments for DuPont under ASC Topic 280 “Segment Reporting” and DuPont's business results are reported in this Form 10-K as a single operating segment. Prior year's segment information has been made to conform to the current presentation.

The company has one reportable segment with the following principal product lines: agriculture, packaging and specialty plastics, electronics and imaging, nutrition and health, industrial biosciences, transportation and advanced polymers and safety and construction. Net sales by principal product line are included below:

Net Sales	Successor		Predecessor
(In millions)	For the Period September 1 through December 31, 2017		For the Period January 1 through August 31, 2017		For the Year Ended December 31, 2016		For the Year Ended December 31, 2015
Agriculture	$	1,596	$	6,894	$	8,131	$	8,327
Packaging and Specialty Plastics	544		1,072		1,651		1,715
Electronics and Imaging	743		1,422		1,960		2,070
Nutrition and Health	1,165		2,129		3,268		3,256
Industrial Biosciences	573		1,022		1,500		1,478
Transportation and Advanced Polymers	1,355		2,608		3,599		3,591
Safety and Construction	1,074		2,134		3,099		3,220
Other	3		—		1		—
Total	$	7,053	$	17,281	$	23,209	$	23,657

F-77

E. I. du Pont de Nemours and Company

Notes to the Consolidated Financial Statements (continued)

NOTE 21 - QUARTERLY FINANCIAL DATA

	2017
	Predecessor										Successor
In millions, except per share amounts (unaudited)	First			Second			July 1 - Aug 31				Sept 1 - Sept 30				Fourth
Net sales	$	7,319		$	6,971		$	2,991			$	1,735			$	5,318
Cost of goods sold	4,209			4,021			1,975				1,511			2	4,654		2
Restructuring and asset related charges - net1	152			160			11				40				140
Net income (loss)	1,121		3,4,5	869		3	(229		)	3	(295		)	1,3	1,305		1,3,6
Net income (loss) attributable to DuPont	1,113			862			(234		)		(293		)		1,303
Earnings per common share, continuing operations - basic9	1.35			0.82			(0.30		)
Earnings per common share, continuing operations - diluted9	1.34			0.82			(0.30		)

	2016
	Predecessor
In millions, except per share amounts (unaudited)	First			Second				Third				Fourth
Net sales	$	7,014		$	6,646			$	4,646			$	4,903
Cost of goods sold	4,103			3,823				2,997				3,032
Restructuring and asset related charges - net1	78			(88		)		172				394
Net income (loss)	1,232		7,8	1,024			7	6			7	263		7
Net income (loss) attributable to DuPont	1,226			1,020				2				265
Earnings per common share, continuing operations - basic9	1.23			1.03				(0.08		)		0.19
Earnings per common share, continuing operations - diluted9	1.22			1.02				(0.08		)		0.19

1. See Note 5 for additional information.

2. Includes charges of $(360) million and $(1,109) million during the period September 1 - September 30, 2017 and the fourth quarter 2017, respectively, related to the amortization of inventory step-up as a result of the Merger and the acquisition of the H&N Business, which was included in cost of goods sold. See Note 3 for additional information.

3. Includes charges of $(170) million, $(201) million, $(210) million, $(71) million, and $(243) million in the first quarter 2017, second quarter 2017, the period July 1 - August 31, 2017, the period September 1 - September 30, 2017, and the fourth quarter 2017, respectively, related to transaction costs associated with the Merger. Predecessor costs are recorded in selling, general and administrative expenses; Successor costs are recoded in integration and separation costs. See Note 3 for additional information.

4. First quarter 2017 included a gain of $162 million recorded in sundry income - net associated with the sale of the company's global food safety diagnostic business. See Note 4 for additional information.

5. First quarter 2017 included a tax benefit of $53 million, as well as a $47 million benefit on associated accrued interest reversals (recorded in sundry income - net), related to a reduction in the company’s unrecognized tax benefits due to the closure of various tax statutes of limitations.

6. Includes a tax benefit of $2,262 million in the fourth quarter 2017 related to the Tax Cuts and Jobs Act and a benefit related to an internal entity restructuring associated with the Intended Business Separations. See Note 7 for additional information.

7. First, second, third and fourth quarter 2016 included charges of $(24) million, $(76) million, $(122) million, and $(164) million, respectively, recorded in selling, general and administrative expenses related to transaction costs associated with the Merger. See Note 3 for additional information.

8. First quarter 2016 included a gain of $369 million recorded in sundry income - net associated with the sale of the DuPont (Shenzhen) Manufacturing Limited entity, which held certain buildings and other assets. See Note 4 for additional information.

9. Due to quarterly changes in the share count and the allocation of income to participating securities, the sum of the four quarters may not equal the earnings per share amount calculated for the year.

NOTE 22 - SUBSEQUENT EVENTS

In February 2018, the company entered into a new committed receivable repurchase facility of up to $1,300 million (the 2018 Repurchase Facility) which expires in December 2018. Under the 2018 Repurchase Facility, DuPont may sell a portfolio of available and eligible outstanding customer notes receivables within the agriculture product line to participating institutions and simultaneously agree to repurchase at a future date. The 2018 Repurchase Facility is considered a secured borrowing with the customer notes receivables inclusive of those that are sold and repurchased, equal to 105 percent of the outstanding amounts borrowed utilized as collateral. Borrowings under the 2018 Repurchase Facility will have an interest rate of LIBOR + 0.75 percent.

F-78

EX-10.4

Master Repurchase

Agreement

September 1996 Version

Dated as of	February 13, 2018
Between:	Coöperatieve Rabobank, U.A., New York Branch The Bank of Tokyo-Mitsubishi UFJ, Ltd., New York Branch
and	PHI Financial Services, Inc.

1. Applicability

From time to time the parties hereto may enter into transactions in which one party (“Seller”) agrees to transfer to the other (“Buyer”) securities or other assets (“Securities”) against the transfer of funds by Buyer, with a simultaneous agreement by Buyer to transfer to Seller such Securities at a date certain or on demand, against the transfer of funds by Seller. Each such transaction shall be referred to herein as a “Transaction” and, unless otherwise agreed in writing, shall be governed by this Agreement, including any supplemental terms or conditions contained in Annex I hereto and in any other annexes identified herein or therein as applicable hereunder.

2. Definitions

(a) “Act of Insolvency”, with respect to any party, (i) the commencement by such party as debtor of any case or proceeding under any bankruptcy, insolvency, reorganization, liquidation, moratorium, dissolution, delinquency or similar law, or such party seeking the appointment or election of a receiver, conservator, trustee, custodian or similar official for such party or any substantial part of its property, or the convening of any meeting of creditors for purposes of commencing any such case or proceeding or seeking such an appointment or election, (ii) the commencement of any such case or proceeding against such party, or another seeking such an appointment or election, or the filing against a party of an application for a protective decree under the provisions of the Securities Investor Protection Act of 1970, which (A) is consented to or not timely contested by such party, (B) results in the entry of an order for relief, such an appointment or election, the issuance of such a protective decree or the entry of an order having a similar effect, or (C) is not dismissed within 15 days, (iii) the making by such party of a general assignment for the benefit of creditors, or (iv) the admission in writing by such party of such party’s inability to pay such party’s debts as they become due;

1¡ September 1996 ¡ Master Repurchase Agreement

(b) “Additional Purchased Securities”, Securities provided by Seller to Buyer pursuant to Paragraph 4(a) hereof;

(c) “Buyer’s Margin Amount”, with respect to any Transaction as of any date, the amount obtained by application of the Buyer’s Margin Percentage to the Repurchase Price for such Transaction as of such date;

(d) “Buyer’s Margin Percentage”, with respect to any Transaction as of any date, a percentage (which may be equal to the Seller’s Margin Percentage) agreed to by Buyer and Seller or, in the absence of any such agreement, the percentage obtained by dividing the Market Value of the Purchased Securities on the Purchase Date by the Purchase Price on the Purchase Date for such Transaction;

(e) “Confirmation”, the meaning specified in Paragraph 3(b) hereof;

(f) “Income”, with respect to any Security at any time, any principal thereof and all interest, dividends or other distributions thereon;

(g) “Margin Deficit”, the meaning specified in Paragraph 4(a) hereof;

(h) “Margin Excess”, the meaning specified in Paragraph 4(b) hereof;

(i) “Margin Notice Deadline”, the time agreed to by the parties in the relevant Confirmation, Annex I hereto or otherwise as the deadline for giving notice requiring same-day satisfaction of margin maintenance obligations as provided in Paragraph 4 hereof (or, in the absence of any such agreement, the deadline for such purposes established in accordance with market practice);

(j) “Market Value”, with respect to any Securities as of any date, the price for such Securities on such date obtained from a generally recognized source agreed to by the parties or the most recent closing bid quotation from such a source, plus accrued Income to the extent not included therein (other than any Income credited or transferred to, or applied to the obligations of, Seller pursuant to Paragraph 5 hereof) as of such date (unless contrary to market practice for such Securities);

(k) “Price Differential”, with respect to any Transaction as of any date, the aggregate amount obtained by daily application of the Pricing Rate for such Transaction to the Purchase Price for such Transaction on a 360 day per year basis for the actual number of days during the period commencing on (and including) the Purchase Date for such Transaction and ending on (but excluding) the date of determination (reduced by any amount of such Price Differential previously paid by Seller to Buyer with respect to such Transaction);

(l) “Pricing Rate”, the per annum percentage rate for determination of the Price Differential;

2¡ September 1996 ¡ Master Repurchase Agreement

(m) “Prime Rate”, the prime rate of U.S. commercial banks as published in The Wall Street Journal (or, if more than one such rate is published, the average of such rates);

(n) “Purchase Date”, the date on which Purchased Securities are to be transferred by Seller to Buyer;

(o) “Purchase Price”, (i) on the Purchase Date, the price at which Purchased Securities are transferred by Seller to Buyer, and (ii) thereafter, except where Buyer and Seller agree oth-erwise, such price increased by the amount of any cash transferred by Buyer to Seller pur-suant to Paragraph 4(b) hereof and decreased by the amount of any cash transferred by Seller to Buyer pursuant to Paragraph 4(a) hereof or applied to reduce Seller’s obligations under clause (ii) of Paragraph 5 hereof;

(p) “Purchased Securities”, the Securities transferred by Seller to Buyer in a Transaction here-under, and any Securities substituted therefor in accordance with Paragraph 9 hereof. The term “Purchased Securities” with respect to any Transaction at any time also shall include Additional Purchased Securities delivered pursuant to Paragraph 4(a) hereof and shall exclude Securities returned pursuant to Paragraph 4(b) hereof;

(q) “Repurchase Date”, the date on which Seller is to repurchase the Purchased Securities from Buyer, including any date determined by application of the provisions of Paragraph 3(c) or 11 hereof;

(r) “Repurchase Price”, the price at which Purchased Securities are to be transferred from Buyer to Seller upon termination of a Transaction, which will be determined in each case (including Transactions terminable upon demand) as the sum of the Purchase Price and the Price Differential as of the date of such determination;

(s) “Seller’s Margin Amount”, with respect to any Transaction as of any date, the amount obtained by application of the Seller’s Margin Percentage to the Repurchase Price for such Transaction as of such date;

(t) “Seller’s Margin Percentage”, with respect to any Transaction as of any date, a percentage (which may be equal to the Buyer’s Margin Percentage) agreed to by Buyer and Seller or, in the absence of any such agreement, the percentage obtained by dividing the Market Value of the Purchased Securities on the Purchase Date by the Purchase Price on the Purchase Date for such Transaction.

3. Initiation; Confirmation; Termination

(a) An agreement to enter into a Transaction may be made orally or in writing at the initiation of either Buyer or Seller. On the Purchase Date for the Transaction, the Purchased Securities shall be transferred to Buyer or its agent against the transfer of the Purchase Price to an account of Seller.

3¡ September 1996 ¡ Master Repurchase Agreement

(b) Upon agreeing to enter into a Transaction hereunder, Buyer or Seller (or both), as shall be agreed, shall promptly deliver to the other party a written confirmation of each Transaction (a “Confirmation”). The Confirmation shall describe the Purchased Securities (including CUSIP number, if any), identify Buyer and Seller and set forth (i) the Purchase Date, (ii) the Purchase Price, (iii) the Repurchase Date, unless the Transaction is to be terminable on demand, (iv) the Pricing Rate or Repurchase Price applicable to the Transaction, and (v) any additional terms or conditions of the Transaction not inconsistent with this Agreement. The Confirmation, together with this Agreement, shall constitute conclusive evidence of the terms agreed between Buyer and Seller with respect to the Transaction to which the Confirmation relates, unless with respect to the Confirmation specific objection is made promptly after receipt thereof. In the event of any conflict between the terms of such Confirmation and this Agreement, this Agreement shall prevail.

(c) In the case of Transactions terminable upon demand, such demand shall be made by Buyer or Seller, no later than such time as is customary in accordance with market practice, by telephone or otherwise on or prior to the business day on which such termination will be effective. On the date specified in such demand, or on the date fixed for termination in the case of Transactions having a fixed term, termination of the Transaction will be effected by transfer to Seller or its agent of the Purchased Securities and any Income in respect thereof received by Buyer (and not previously credited or transferred to, or applied to the obligations of, Seller pursuant to Paragraph 5 hereof) against the transfer of the Repurchase Price to an account of Buyer.

4. Margin Maintenance

(a) If at any time the aggregate Market Value of all Purchased Securities subject to all Transactions in which a particular party hereto is acting as Buyer is less than the aggregate Buyer’s Margin Amount for all such Transactions (a “Margin Deficit”), then Buyer may by notice to Seller require Seller in such Transactions, at Seller’s option, to transfer to Buyer cash or additional Securities reasonably acceptable to Buyer (“Additional Purchased Securities”), so that the cash and aggregate Market Value of the Purchased Securities, including any such Additional Purchased Securities, will thereupon equal or exceed such aggregate Buyer’s Margin Amount (decreased by the amount of any Margin Deficit as of such date arising from any Transactions in which such Buyer is acting as Seller).

(b) If at any time the aggregate Market Value of all Purchased Securities subject to all Transactions in which a particular party hereto is acting as Seller exceeds the aggregate Seller’s Margin Amount for all such Transactions at such time (a “Margin Excess”), then Seller may by notice to Buyer require Buyer in such Transactions, at Buyer’s option, to transfer cash or Purchased Securities to Seller, so that the aggregate Market Value of the Purchased Securities, after deduction of any such cash or any Purchased Securities so transferred, will thereupon not exceed such aggregate Seller’s Margin Amount (increased

4¡ September 1996 ¡ Master Repurchase Agreement

by the amount of any Margin Excess as of such date arising from any Transactions in which such Seller is acting as Buyer).

(c) If any notice is given by Buyer or Seller under subparagraph (a) or (b) of this Paragraph at or before the Margin Notice Deadline on any business day, the party receiving such notice shall transfer cash or Additional Purchased Securities as provided in such subparagraph no later than the close of business in the relevant market on such day. If any such notice is given after the Margin Notice Deadline, the party receiving such notice shall transfer such cash or Securities no later than the close of business in the relevant market on the next business day following such notice.

(d) Any cash transferred pursuant to this Paragraph shall be attributed to such Transactions as shall be agreed upon by Buyer and Seller.

(e) Seller and Buyer may agree, with respect to any or all Transactions hereunder, that the respective rights of Buyer or Seller (or both) under subparagraphs (a) and (b) of this Paragraph may be exercised only where a Margin Deficit or Margin Excess, as the case may be, exceeds a specified dollar amount or a specified percentage of the Repurchase Prices for such Transactions (which amount or percentage shall be agreed to by Buyer and Seller prior to entering into any such Transactions).

(f) Seller and Buyer may agree, with respect to any or all Transactions hereunder, that the respective rights of Buyer and Seller under subparagraphs (a) and (b) of this Paragraph to require the elimination of a Margin Deficit or a Margin Excess, as the case may be, may be exercised whenever such a Margin Deficit or Margin Excess exists with respect to any single Transaction hereunder (calculated without regard to any other Transaction outstanding under this Agreement).

5. Income Payments

Seller shall be entitled to receive an amount equal to all Income paid or distributed on or in respect of the Securities that is not otherwise received by Seller, to the full extent it would be so entitled if the Securities had not been sold to Buyer. Buyer shall, as the parties may agree with respect to any Transaction (or, in the absence of any such agreement, as Buyer shall reasonably determine in its discretion), on the date such Income is paid or distributed either (i) transfer to or credit to the account of Seller such Income with respect to any Purchased Securities subject to such Transaction or (ii) with respect to Income paid in cash, apply the Income payment or payments to reduce the amount, if any, to be transferred to Buyer by Seller upon termination of such Transaction. Buyer shall not be obligated to take any action pursuant to the preceding sentence (A) to the extent that such action would result in the creation of a Margin Deficit, unless prior thereto or simultaneously therewith Seller transfers to Buyer cash or Additional Purchased Securities sufficient to eliminate such Margin Deficit, or (B) if an Event of Default with respect to Seller has occurred and is then continuing at the time such Income is paid or distributed.

5¡ September 1996 ¡ Master Repurchase Agreement

6. Security Interest

Although the parties intend that all Transactions hereunder be sales and purchases and not loans, in the event any such Transactions are deemed to be loans, Seller shall be deemed to have pledged to Buyer as security for the performance by Seller of its obligations under each such Transaction, and shall be deemed to have granted to Buyer a security interest in, all of the Purchased Securities with respect to all Transactions hereunder and all Income thereon and other proceeds thereof.

7. Payment and Transfer

Unless otherwise mutually agreed, all transfers of funds hereunder shall be in immediately available funds. All Securities transferred by one party hereto to the other party (i) shall be in suitable form for transfer or shall be accompanied by duly executed instruments of transfer or assignment in blank and such other documentation as the party receiving possession may reasonably request, (ii) shall be transferred on the book-entry system of a Federal Reserve Bank, or (iii) shall be transferred by any other method mutually acceptable to Seller and Buyer.

September 1996 ¡ Master Repurchase Agreement ¡ 5

8. Segregation of Purchased Securities

To the extent required by applicable law, all Purchased Securities in the possession of Seller shall be segregated from other securities in its possession and shall be identified as subject to this Agreement. Segregation may be accomplished by appropriate identification on the books and records of the holder, including a financial or securities intermediary or a clearing corporation. All of Seller’s interest in the Purchased Securities shall pass to Buyer on the Purchase Date and, unless otherwise agreed by Buyer and Seller, nothing in this Agreement shall preclude Buyer from engaging in repurchase transactions with the Purchased Securities or otherwise selling, transferring, pledging or hypothecating the Purchased Securities, but no such transaction shall relieve Buyer of its obligations to transfer Purchased Securities to Seller pursuant to Paragraph 3, 4 or 11 hereof, or of Buyer’s obligation to credit or pay Income to, or apply Income to the obligations of, Seller pursuant to Paragraph 5 hereof.

6¡ September 1996 ¡ Master Repurchase Agreement

Required Disclosure for Transactions in Which the Seller
Retains Custody of the Purchased Securities

Seller is not permitted to substitute other securities for those subject to this Agreement and therefore must keep Buyer’s securities segregated at all times, unless in this Agreement Buyer grants Seller the right to substitute other securities. If Buyer grants the right to substitute, this means that Buyer’s securities will likely be commingled with Seller’s own securities during the trading day. Buyer is advised that, during any trading day that Buyer’s securities are commingled with Seller’s securities, they [will]* [may]** be subject to liens granted by Seller to [its clearing bank]* [third parties]** and may be used by Seller for deliveries on other securities transactions. Whenever the securities are commingled, Seller’s ability to resegregate substitute securities for Buyer will be subject to Seller’s ability to satisfy [the clearing]* [any]** lien or to obtain substitute securities.

* Language to be used under 17 C.F.R. ß403.4(e) if Seller is a government securities broker

or dealer other than a financial institution.

** Language to be used under 17 C.F.R. ß403.5(d) if Seller is a financial institution.

9. Substitution

(a) Seller may, subject to agreement with and acceptance by Buyer, substitute other Securities for any Purchased Securities. Such substitution shall be made by transfer to Buyer of such other Securities and transfer to Seller of such Purchased Securities. After substitution, the substituted Securities shall be deemed to be Purchased Securities.

(b) In Transactions in which Seller retains custody of Purchased Securities, the parties expressly agree that Buyer shall be deemed, for purposes of subparagraph (a) of this Paragraph, to have agreed to and accepted in this Agreement substitution by Seller of other Securities for Purchased Securities; provided, however, that such other Securities shall have a Market Value at least equal to the Market Value of the Purchased Securities for which they are substituted.

10. Representations

Each of Buyer and Seller represents and warrants to the other that (i) it is duly authorized to execute and deliver this Agreement, to enter into Transactions contemplated hereunder and to perform its obligations hereunder and has taken all necessary action to authorize such execution, delivery and performance, (ii) it will engage in such Transactions as principal (or, if agreed in writing, in the form of an annex hereto or otherwise, in advance of any Transaction by the other party hereto, as agent for a disclosed principal), (iii) the person signing this Agreement on its behalf is duly authorized to do so on its behalf (or on behalf of any such disclosed principal), (iv) it has obtained all authorizations of any governmental body required in connection with this Agreement and the Transactions hereunder and such authorizations are in full force and effect and (v) the execution, delivery and performance of this Agreement and the Transactions hereunder will not violate any law, ordinance, charter, bylaw or rule applicable to it or any

7¡ September 1996 ¡ Master Repurchase Agreement

agreement by which it is bound or by which any of its assets are affected. On the Purchase Date for any Transaction Buyer and Seller shall each be deemed to repeat all the foregoing representations made by it.

11. Events of Default

In the event that (i) Seller fails to transfer or Buyer fails to purchase Purchased Securities upon the applicable Purchase Date, (ii) Seller fails to repurchase or Buyer fails to transfer Purchased Securities upon the applicable Repurchase Date, (iii) Seller or Buyer fails to comply with Paragraph 4 hereof, (iv) Buyer fails, after one business day’s notice, to comply with Paragraph 5 hereof, (v) an Act of Insolvency occurs with respect to Seller or Buyer, (vi) any representation made by Seller or Buyer shall have been incorrect or untrue in any material respect when made or repeated or deemed to have been made or repeated, or (vii) Seller or Buyer shall admit to the other its inability to, or its intention not to, perform any of its obligations hereunder (each an “Event of Default”):

(a) The nondefaulting party may, at its option (which option shall be deemed to have been exercised immediately upon the occurrence of an Act of Insolvency), declare an Event of Default to have occurred hereunder and, upon the exercise or deemed exercise of such option, the Repurchase Date for each Transaction hereunder shall, if it has not already occurred, be deemed immediately to occur (except that, in the event that the Purchase Date for any Transaction has not yet occurred as of the date of such exercise or deemed exercise, such Transaction shall be deemed immediately canceled). The nondefaulting party shall (except upon the occurrence of an Act of Insolvency) give notice to the defaulting party of the exercise of such option as promptly as practicable.

(b) In all Transactions in which the defaulting party is acting as Seller, if the nondefaulting party exercises or is deemed to have exercised the option referred to in subparagraph (a) of this Paragraph, (i) the defaulting party’s obligations in such Transactions to repurchase all Purchased Securities, at the Repurchase Price therefor on the Repurchase Date determined in accordance with subparagraph (a) of this Paragraph, shall thereupon become immediately due and payable, (ii) all Income paid after such exercise or deemed exercise shall be retained by the nondefaulting party and applied to the aggregate unpaid Repurchase Prices and any other amounts owing by the defaulting party hereunder, and (iii) the defaulting party shall immediately deliver to the nondefaulting party any Purchased Securities subject to such Transactions then in the defaulting party’s possession or control.

(c) In all Transactions in which the defaulting party is acting as Buyer, upon tender by the nondefaulting party of payment of the aggregate Repurchase Prices for all such Transactions, all right, title and interest in and entitlement to all Purchased Securities subject to such Transactions shall be deemed transferred to the nondefaulting party, and the defaulting party shall deliver all such Purchased Securities to the nondefaulting party.

8¡ September 1996 ¡ Master Repurchase Agreement

(d) If the nondefaulting party exercises or is deemed to have exercised the option referred to in subparagraph (a) of this Paragraph, the nondefaulting party, without prior notice to the defaulting party, may:

(i) as to Transactions in which the defaulting party is acting as Seller, (A) immediately sell, in a recognized market (or otherwise in a commercially reasonable manner) at such price or prices as the nondefaulting party may reasonably deem satisfactory, any or all Purchased Securities subject to such Transactions and apply the proceeds thereof to the aggregate unpaid Repurchase Prices and any other amounts owing by the defaulting party hereunder or (B) in its sole discretion elect, in lieu of selling all or a portion of such Purchased Securities, to give the defaulting party credit for such Purchased Securities in an amount equal to the price therefor on such date, obtained from a generally recognized source or the most recent closing bid quotation from such a source, against the aggregate unpaid Repurchase Prices and any other amounts owing by the defaulting party hereunder; and

(ii) as to Transactions in which the defaulting party is acting as Buyer, (A) immediately purchase, in a recognized market (or otherwise in a commercially reasonable manner) at such price or prices as the nondefaulting party may reasonably deem satisfactory, securities (“Replacement Securities”) of the same class and amount as any Purchased Securities that are not delivered by the defaulting party to the nondefaulting party as required hereunder or (B) in its sole discretion elect, in lieu of purchasing Replacement Securities, to be deemed to have purchased Replacement Securities at the price therefor on such date, obtained from a generally recognized source or the most recent closing offer quotation from such a source.

Unless otherwise provided in Annex I, the parties acknowledge and agree that (1) the Securities subject to any Transaction hereunder are instruments traded in a recognized market, (2) in the absence of a generally recognized source for prices or bid or offer quotations for any Security, the nondefaulting party may establish the source therefor in its sole discretion and (3) all prices, bids and offers shall be determined together with accrued Income (except to the extent contrary to market practice with respect to the relevant Securities).

(e) As to Transactions in which the defaulting party is acting as Buyer, the defaulting party shall be liable to the nondefaulting party for any excess of the price paid (or deemed paid) by the nondefaulting party for Replacement Securities over the Repurchase Price for the Purchased Securities replaced thereby and for any amounts payable by the defaulting party under Paragraph 5 hereof or otherwise hereunder.

(f) For purposes of this Paragraph 11, the Repurchase Price for each Transaction hereunder in respect of which the defaulting party is acting as Buyer shall not increase above the amount of such Repurchase Price for such Transaction determined as of the date of the exercise or

9¡ September 1996 ¡ Master Repurchase Agreement

deemed exercise by the nondefaulting party of the option referred to in sub-paragraph (a) of this Paragraph.

(g) The defaulting party shall be liable to the nondefaulting party for (i) the amount of all reasonable legal or other expenses incurred by the nondefaulting party in connection with or as a result of an Event of Default, (ii) damages in an amount equal to the cost (including all fees, expenses and commissions) of entering into replacement transactions and entering into or terminating hedge transactions in connection with or as a result of an Event of Default, and (iii) any other loss, damage, cost or expense directly arising or resulting from the occurrence of an Event of Default in respect of a Transaction.

(h) To the extent permitted by applicable law, the defaulting party shall be liable to the non-defaulting party for interest on any amounts owing by the defaulting party hereunder, from the date the defaulting party becomes liable for such amounts hereunder until such amounts are (i) paid in full by the defaulting party or (ii) satisfied in full by the exercise of the nondefaulting party’s rights hereunder. Interest on any sum payable by the defaulting party to the nondefaulting party under this Paragraph 11(h) shall be at a rate equal to the greater of the Pricing Rate for the relevant Transaction or the Prime Rate.

(i) The nondefaulting party shall have, in addition to its rights hereunder, any rights otherwise available to it under any other agreement or applicable law.

12. Single Agreement

Buyer and Seller acknowledge that, and have entered hereinto and will enter into each Transaction hereunder in consideration of and in reliance upon the fact that, all Transactions hereunder constitute a single business and contractual relationship and have been made in consideration of each other. Accordingly, each of Buyer and Seller agrees (i) to perform all of its obligations in respect of each Transaction hereunder, and that a default in the performance of any such obligations shall constitute a default by it in respect of all Transactions hereunder, (ii) that each of them shall be entitled to set off claims and apply property held by them in respect of any Transaction against obligations owing to them in respect of any other Transactions hereunder and (iii) that payments, deliveries and other transfers made by either of them in respect of any Transaction shall be deemed to have been made in consideration of payments, deliveries and other transfers in respect of any other Transactions hereunder, and the obligations to make any such payments, deliveries and other transfers may be applied against each other and netted.

13. Notices and Other Communications

Any and all notices, statements, demands or other communications hereunder may be given by a party to the other by mail, facsimile, telegraph, messenger or otherwise to the address specified in Annex II hereto, or so sent to such party at any other place specified in a notice of change of address hereafter received by the other. All notices, demands and requests hereunder may be

10¡ September 1996 ¡ Master Repurchase Agreement

made orally, to be confirmed promptly in writing, or by other communication as specified in the preceding sentence.

14. Entire Agreement; Severability

This Agreement shall supersede any existing agreements between the parties containing general terms and conditions for repurchase transactions. Each provision and agreement herein shall be treated as separate and independent from any other provision or agreement herein and shall be enforceable notwithstanding the unenforceability of any such other provision or agreement.

15. Non-assignability; Termination

(a) The rights and obligations of the parties under this Agreement and under any Transaction shall not be assigned by either party without the prior written consent of the other party, and any such assignment without the prior written consent of the other party shall be null and void. Subject to the foregoing, this Agreement and any Transactions shall be binding upon and shall inure to the benefit of the parties and their respective successors and assigns. This Agreement may be terminated by either party upon giving written notice to the other, except that this Agreement shall, notwithstanding such notice, remain applicable to any Transactions then outstanding.

(b) Subparagraph (a) of this Paragraph 15 shall not preclude a party from assigning, charging or otherwise dealing with all or any part of its interest in any sum payable to it under Paragraph 11 hereof.

16. Governing Law

This Agreement shall be governed by the laws of the State of New York without giving effect to the conflict of law principles thereof.

17. No Waivers, Etc.

No express or implied waiver of any Event of Default by either party shall constitute a waiver of any other Event of Default and no exercise of any remedy hereunder by any party shall constitute a waiver of its right to exercise any other remedy hereunder. No modification or waiver of any provision of this Agreement and no consent by any party to a departure here-from shall be effective unless and until such shall be in writing and duly executed by both of the parties hereto. Without limitation on any of the foregoing, the failure to give a notice pursuant to Paragraph 4(a) or 4(b) hereof will not constitute a waiver of any right to do so at a later date.

11¡ September 1996 ¡ Master Repurchase Agreement

18. Use of Employee Plan Assets

(a) If assets of an employee benefit plan subject to any provision of the Employee Retirement Income Security Act of 1974 (“ERISA”) are intended to be used by either party hereto (the “Plan Party”) in a Transaction, the Plan Party shall so notify the other party prior to the Transaction. The Plan Party shall represent in writing to the other party that the Transaction does not constitute a prohibited transaction under ERISA or is otherwise exempt therefrom, and the other party may proceed in reliance thereon but shall not be required so to proceed.

(b) Subject to the last sentence of subparagraph (a) of this Paragraph, any such Transaction shall proceed only if Seller furnishes or has furnished to Buyer its most recent available audited statement of its financial condition and its most recent subsequent unaudited statement of its financial condition.

(c) By entering into a Transaction pursuant to this Paragraph, Seller shall be deemed (i) to represent to Buyer that since the date of Seller’s latest such financial statements, there has been no material adverse change in Seller’s financial condition which Seller has not dis-closed to Buyer, and (ii) to agree to provide Buyer with future audited and unaudited statements of its financial condition as they are issued, so long as it is a Seller in any out-standing Transaction involving a Plan Party.

19. Intent

(a) The parties recognize that each Transaction is a “repurchase agreement” as that term is defined in Section 101 of Title 11 of the United States Code, as amended (except insofar as the type of Securities subject to such Transaction or the term of such Transaction would render such definition inapplicable), and a “securities contract” as that term is defined in Section 741 of Title 11 of the United States Code, as amended (except insofar as the type of assets subject to such Transaction would render such definition inapplicable).

(b) It is understood that either party’s right to liquidate Securities delivered to it in connection with Transactions hereunder or to exercise any other remedies pursuant to Paragraph 11 hereof is a contractual right to liquidate such Transaction as described in Sections 555 and 559 of Title 11 of the United States Code, as amended.

(c) The parties agree and acknowledge that if a party hereto is an “insured depository institution,” as such term is defined in the Federal Deposit Insurance Act, as amended (“FDIA”), then each Transaction hereunder is a “qualified financial contract,” as that term is defined in FDIA and any rules, orders or policy statements thereunder (except insofar as the type of assets subject to such Transaction would render such definition inapplicable).

(d) It is understood that this Agreement constitutes a “netting contract” as defined in and subject to Title IV of the Federal Deposit Insurance Corporation Improvement Act of 1991 (“FDICIA”) and each payment entitlement and payment obligation under any Transaction

12¡ September 1996 ¡ Master Repurchase Agreement

hereunder shall constitute a “covered contractual payment entitlement” or “covered contractual payment obligation”, respectively, as defined in and subject to FDI-CIA (except insofar as one or both of the parties is not a “financial institution” as that term is defined in FDICIA).

20. Disclosure Relating to Certain Federal Protections

The parties acknowledge that they have been advised that:

(a) in the case of Transactions in which one of the parties is a broker or dealer registered with the Securities and Exchange Commission (“SEC”) under Section 15 of the Securities Exchange Act of 1934 (“1934 Act”), the Securities Investor Protection Corporation has taken the position that the provisions of the Securities Investor Protection Act of 1970 (“SIPA”) do not protect the other party with respect to any Transaction hereunder.

(b) in the case of Transactions in which one of the parties is a government securities broker or a government securities dealer registered with the SEC under Section 15C of the 1934 Act, SPA will not provide protection to the other party with respect to any Transaction hereunder; and

(c) in the case of Transactions in which one of the parties is a financial institution, funds held by the financial institution pursuant to a Transaction hereunder are not a deposit and therefore are not insured by the Federal Deposit Insurance Corporation or the National Credit Union Share Insurance Fund, as applicable.

[Signature Pages Follow]

13¡ September 1996 ¡ Master Repurchase Agreement

COÖPERATIEVE RABOBANK, U.A., NEW YORK BRANCH

By:	/s/ Vikram Malkani
Name:	Vikram Malkani
Title:	Managing Director
Date:	February 13, 2018

By:	/s/Chris G. Kortlandt
Name:	Chris G. Kortlandt
Title:	Managing Director
Date:	February 13, 2018

[SIGNATURE PAGES CONTINUE ON FOLLOWING PAGE]

[Signature Page to 1996 SIFMA Master Repurchase Agreement]

14¡ September 1996 ¡ Master Repurchase Agreement

THE BANK OF TOKYO-MITSUBISHI UFJ, LTD., NEW YORK BRANCH

By:	/s/ Thomas Giuntini
Name:	Thomas Giuntini
Title:	Director
Date:	February 13, 2018

[SIGNATURE PAGES CONTINUE ON FOLLOWING PAGE]

[Signature Page to 1996 SIFMA Master Repurchase Agreement]

15¡ September 1996 ¡ Master Repurchase Agreement

PHI FINANCIAL SERVICES, INC.

By:	/s/ Andrew Girardi
Name:	Andrew Girardi
Title:	President
Date:	February 13, 2018

[Signature Page to 1996 SIFMA Master Repurchase Agreement]

16¡ September 1996 ¡ Master Repurchase Agreement

Annex I

Supplemental Terms and Conditions

This Annex I forms a part of the 1996 SIFMA Master Repurchase Agreement dated as of February 13, 2018 (the “SIFMA Master,” and as amended by this Annex I, this or the “Agreement”) among PHI Financial Services, Inc., Coöperatieve Rabobank, U.A., New York Branch (“Rabobank”) and each of the other Buyers from time to time Party thereto. Subject to the provisions of Paragraph 1 of this Annex I, (a) capitalized terms used but not defined in this Annex I shall have the meanings ascribed to them in the SIFMA Master, and (b) aside from this Annex I, including all exhibits and schedules attached hereto and thereto, no other Annexes or Schedules thereto shall form a part of the SIFMA Master or be applicable thereunder.

Applicability; Parties; Framework.

Framework Agreement. This Agreement is being entered into in accordance with that certain Master Framework Agreement, dated as of February 13, 2018 (the “Framework Agreement”), among Seller, each of the “Buyers” thereunder and Rabobank, as agent for the Buyers (the “Agent”). Capitalized terms used but not defined in this Agreement or in any Confirmations shall have the meanings set forth in the Framework Agreement (including Schedule 1 thereto). In the event of any inconsistency between this Agreement and the Framework Agreement, the Framework Agreement shall govern.

Seller. PHI Financial Services, Inc. will act as Seller with respect to all Transactions entered into hereunder.

Buyers. All references to “Buyer” in this Agreement shall refer collectively to the “Buyers” party to the Framework Agreement, each as represented for purposes of this Agreement by Rabobank, as Agent. Each such Buyer shall be deemed a party to this Agreement, and upon entry into any Transaction, each such Buyer shall acquire an undivided fractional interest in the Purchased Securities for such Transaction (pro-rata in accordance with its Undivided Funding Percentage) in accordance with Section 4.2(b) of the Framework Agreement until such Purchased Securities are repurchased by Seller pursuant to this Agreement (at which point such undivided fractional interests shall be collectively reconveyed to Seller) or otherwise disposed of hereunder. Subject to the terms and conditions of the Framework Agreement, all powers of Buyers hereunder, including the execution and delivery of Confirmations hereunder or any other matters involving consent or discretion, shall be exercised solely by Agent on behalf of such Buyers. The parties agree that any remedies to be exercised against Seller, Guarantor or the Collateral shall be exercised solely through Agent and not by any Buyer individually.

Securities. All Securities under this Agreement shall consist of Eligible Farmer Loans. Only Eligible Farmer Loans shall be recognized as Securities for purposes of any Transactions hereunder.

Entire Agreement. The first sentence of Paragraph 14 of the SIFMA Master is subject to, and superseded by, Section 9.3 of the Framework Agreement.

Definitions.

Added Definitions. For purposes of this Agreement, the following additional terms shall have the following meanings:

17¡ September 1996 ¡ Master Repurchase Agreement

(i)     “Breakage Amount”, with respect to any Breakage Event pertaining to any outstanding Transaction, an amount “X” to be calculated as follows:

X = (A - B) * (C - D) * E

where:

A refers to the Purchase Price for such Transaction immediately prior to such Breakage Event;

B refers to (x) in the case of a Breakage Event of the type specified in clause (1) of the definition thereof, the Purchase Price for any new Transaction entered into hereunder having a Purchase Date coinciding with the date on which such outstanding Transaction is terminated or (y) in the case of a Breakage Event of the type described in clause (2) of the definition thereof, the excess (if any) of (I) the Purchase Price for such outstanding Transaction immediately prior to such Breakage Event over (II) the amount of cash transferred by Seller to Buyer;

C refers to the Pricing Rate for such outstanding Transaction;

D refers to LIBID for the Breakage Period plus 0.75%; and

E refers to the actual number of days in the Breakage Period divided by 360.

(ii)    “Breakage Event”, with respect to any Transaction, (1) the termination of such Transaction by Seller before the Repurchase Date specified in the Confirmation for such Transaction in accordance with Paragraph 3(c)(ii) of the SIFMA Master, as amended by this Annex I, or (2) the transfer of any cash by Seller to Buyer during the Transaction Period for such Transaction as required pursuant to Paragraph 4(a) of the SIFMA Master, as amended by this Annex I, or as permitted in accordance with Paragraph 4(f) of this Annex I;

(iii)    “Breakage Period”, with respect to any Breakage Event, the period commencing on (and including) (x) in the case of a Breakage Event of the type described in clause (1) of the definition thereof, the effective date of Seller’s termination of the applicable Transaction or (y) in the case of a Breakage Event of the type described in clause (2) of the definition thereof, the date on which such cash is transferred by Seller to Buyer, and, in each case, ending on (but excluding) the next succeeding Monthly Date;

(iv)    “Framework Agreement”, the meaning set forth in Paragraph 1(a) of this Annex I;

(v)    “LIBID”, with respect to any Breakage Period, London Interbank Bid Rate for deposits in U.S. Dollars which appears on the Bloomberg Screen LIBOR Rates Page (or any successor source) as of 11:00 a.m., London time, on the day that is two (2) London Banking Days preceding the first day of such Breakage Period, for a period equal to such Breakage Period; provided, that if the Breakage Period is not equal to a period specified on such page, the rate shall be calculated using Linear Interpolation;

“LIBOR”, with respect to any Transaction Period or Breakage Period, the rate for deposits in U.S. Dollars for a period equal to such Transaction Period or such Breakage Period which appears on the Bloomberg Screen LIBOR Rates Page (or any successor source) as of 11:00 a.m., London time, on the day that is two (2) London Banking Days preceding the first day of the Transaction Period or such Breakage Period; provided that if the Transaction Period or such Breakage Period is not

18¡ September 1996 ¡ Master Repurchase Agreement

equal to a period specified on such page, the rate shall be calculated using Linear Interpolation; provided, further, that in the event that such rate is not available at such time for any reason, then the LIBOR Rate for such Transaction Period or such Breakage Period shall be the rate at which U.S. Dollar deposits in an amount comparable to the Purchase Price and for a maturity comparable to such Transaction Period or such Breakage Period are offered by the principal London office of Coöperatieve Rabobank, U.A. to leading banks in immediately available funds in the London interbank market at approximately 11:00 a.m., London time, on the day that is two (2) London Banking Days preceding the first day of the Transaction Period or such Breakage Period;

(vi)    “Linear Interpolation” , straight-line interpolation by reference to two rates, one of which shall be determined as if the applicable Transaction Period (or Breakage Period, if applicable) were the period of time for which rates are available next shorter than the length of such Transaction Period (or Breakage Period) and the other of which shall be determined as if such Transaction Period (or Breakage Period) were the period of time for which rates are available next longer than the length of such Transaction Period (or Breakage Period); such determinations to be made by Agent;

(vii)    “London Banking Day”, any day other than (i) a Saturday or Sunday or (ii) a day on which banking institutions located in City of London are permitted or required by applicable Law or regulation to remain closed.

(viii)    “Portfolio Schedule”, the meaning set forth in Paragraph 3(b) of this Annex I;

(ix)    “Roll-Over Securities”, with respect to any expiring Transaction, any Purchased Securities under such Transaction which, in lieu of being transferred back to Seller, become Purchased Securities under a new Transaction (as set forth on the Portfolio Schedule for such Transaction) with a Purchase Date coinciding with the Repurchase Date of such expiring Transaction.

Revised Definitions. For purposes of this Agreement, and notwithstanding anything in Paragraph 2 of the SIFMA Master to the contrary, the following terms shall have the following amended and restated meanings:

(x)    “Buyer’s Margin Amount”, with respect to any Transaction as of any date, the amount obtained by application of the Buyer’s Margin Percentage to the Purchase Price for such Transaction as of such date;

(xi)    “Buyer’s Margin Percentage”, with respect to any Transaction as of any date, one hundred and five percent (105%);

(xii)    “Defaulted Farmer Loan”, any Eligible Farmer Loan with respect to which an Act of Insolvency has occurred with respect to the applicable Debtor or with respect to which any of the Asset Representations, Warranties or Covenants has been breached;

(xiii)    “Market Value”, as of any date with respect to the Securities comprising the Transaction Portfolio for an outstanding Transaction, an amount equal to the sum of the Book Values of all Eligible Farmer Loans comprising such Transaction Portfolio (as set forth in the applicable Portfolio Schedule) as of such date; provided; that the Book Value of any Defaulted Farmer Loan shall be deemed to be zero;

19¡ September 1996 ¡ Master Repurchase Agreement

(xiv)    “Price Differential”, with respect to any Transaction as of any date, the sum of the aggregate amount obtained by daily application of the Pricing Rate for such Transaction to the Purchase Price for such Transaction on a 360 day per year basis for the actual number of days during the period commencing on (and including) the Purchase Date for such Transaction and ending on (but excluding) the date of determination (reduced by any amount of such Price Differential previously paid by Seller to Buyer with respect to such Transaction); provided, that upon the occurrence of any Breakage Event with respect to such Transaction, such Price Differential shall be (x) be increased by an amount equal to the absolute value of the applicable Breakage Amount for such Breakage Event if such amount is a positive number or (y) be reduced by an amount equal to the absolute value of the applicable Breakage Amount for such Breakage Event if such Breakage Amount is a negative number, in each case determined as of the date on which such Breakage Event occurs;

(xv)    “Pricing Rate”, the per annum percentage rate for determination of the Price Differential, determined for each Transaction (unless otherwise specified in the Confirmation) as being equal to the sum of (A) LIBOR as of the applicable Purchase Date plus (B) 0.75%; provided, that if Seller elects to terminate an outstanding Transaction before the Repurchase Date specified in the Confirmation for such Transaction in accordance with Paragraph 3(c)(ii) of the SIFMA Master (as amended by this Annex I), the Pricing Rate for any new Transaction entered into hereunder having a Purchase Date coinciding with the date on which such outstanding Transaction is terminated shall be equal to the Pricing Rate for the Transaction terminated on such date.

(xvi)    “Repurchase Date”, the date on which Seller is to repurchase the Purchased Securities from Buyer, which shall be the earliest of (i) the next Monthly Date immediately succeeding the applicable Purchase Date, (ii) the Facility Expiration Date and (iii) any date determined by application of the provisions of Paragraph 3(c) or 11 of this Annex I; and

(xvii)    “Repurchase Price”, the price at which Purchased Securities are to be transferred from Buyer to Seller upon termination of a Transaction, which will be determined in each case (including Transactions terminable upon demand) as the sum of (A) the Purchase Price for such Transaction plus (B) the accrued and unpaid Price Differential as of the date of such determination (it being understood that all such accrued and unpaid Price Differential shall be payable when and as set forth in Paragraph 12 of this Annex I).

Initiation; Confirmation; Termination. Notwithstanding anything to the contrary in Paragraph 3 of the SIFMA Master, the following shall apply:

No Oral Agreements. All agreements to enter into Transactions hereunder shall be in writing in accordance with Article 4 of the Framework Agreement.

Confirmations; Priority. All Confirmations with respect to Transactions hereunder shall be substantially in the form attached as Exhibit A to this Annex I, and shall be accompanied by a schedule substantially in the form attached as Exhibit B to this Annex I (a “Portfolio Schedule”) setting forth the Eligible Farmer Loans comprising the Purchased Securities for such Transaction. In the event of any conflict between the terms of a Confirmation and this Agreement, the Confirmation shall prevail.

20¡ September 1996 ¡ Master Repurchase Agreement

Termination. Paragraph 3(c) of the SIFMA Master is hereby amended and restated as follows:

“Subject in each case to Section 4.1(c) of the Framework Agreement, Transactions hereunder shall terminate upon the earlier of (i) the date determined pursuant to the definition of Repurchase Date (without regard to this Paragraph 3(c)) or (ii) a date specified upon demand by Seller, which demand shall be made by Seller in writing no later than 5:00 p.m. on the third Business Day prior to the Business Day on which such termination will be effective; provided, that specification of an early termination date pursuant to the foregoing clause (ii) shall be permitted with respect to no more than ten (10) Transactions during the Facility Term (it being understood any specification of an early termination date which is subsequently voided pursuant to Section 4.1(c) of the Framework Agreement shall not be counted towards such maximum). On such earlier date, termination of the Transaction will be effected by transfer to Seller or its agent of the related Purchased Securities (other than any Roll-Over Securities) against the payment of the related Repurchase Price by Seller (which may be netted against the Purchase Price payable in respect of any new Transaction) in accordance with the Framework Agreement.”

Outstanding Transactions; Continuity. Notwithstanding anything in this Agreement to the contrary, the Parties agree that no more than one Transaction hereunder shall be outstanding at any given time. It is the intention of the Parties that during the Facility Term, and subject to fulfillment of the applicable conditions set forth in the Framework Agreement with respect to Buyers’ entry into Transactions, the expiration of each Transaction hereunder on the applicable Repurchase Date shall coincide with the entry into a subsequent Transaction with a concurrent Purchase Date in accordance with the procedures set forth in the Framework Agreement. The Parties further intend that, pursuant to Paragraph 12 of the SIFMA Master and to the extent permitted under Paragraph 12 of this Annex I, the Repurchase Price payable by Seller with respect to each such expiring Transaction shall be netted to the extent applicable against the Purchase Price payable by Buyers with respect to such subsequent Transaction.

Margin Maintenance. Notwithstanding anything to the contrary in Paragraph 4 of the SIFMA Master, the following shall apply:

Option to Substitute. In the case of any Margin Deficit with respect to any Transaction, Seller may, in lieu of transferring cash or Additional Purchased Securities in accordance with Paragraph 4(a) of the SIFMA Master, as amended by this Annex I, effect a substitution of Purchased Securities in accordance with Paragraph 9 of the SIFMA Master, as amended by this Annex I, so long as the resulting Market Value of the Purchased Securities (including the substituted Securities) will thereupon exceed the Buyer’s Margin Amount with respect to such Transaction.

Margin Excess Inapplicable. The provisions of Paragraph 4(b) of the SIFMA Master shall not apply to Transactions under this Agreement, and all references thereto or to “Margin Excess” in the SIFMA Master shall be disregarded; provided, that in the event the Market Value of any Transaction exceeds the Buyer’s Margin Amount with respect to such Transaction by more than $10 million, Seller shall be entitled to deliver an amended and restated Portfolio Schedule reflecting a Market Value for such Transaction at least equal to the Buyer’s Margin Amount.

21¡ September 1996 ¡ Master Repurchase Agreement

(b)    Margin Deficit Cures. Paragraph 4(c) of the SIFMA Master is hereby amended and restated in its entirety to read as follows:

“If any notice is given (or deemed given) by Buyer under subparagraph (a) of this Paragraph, Seller shall transfer cash or Additional Purchased Securities as provided in such subparagraph no later than (x) three Business Days following its receipt (or deemed receipt) of such notice in the case of notices received (or deemed received) prior to the Farmer Loan Maturity Date or (y) one Business Day following its receipt (or deemed receipt) of such notice in the case of notices received (or deemed received) on or after the Farmer Loan Maturity Date.”

Evidence of Additional Purchased Securities. Any transfer of Additional Purchased Securities in accordance with Paragraph 4(a) of the SIFMA Master, as amended by this Annex I, with respect to a Transaction shall be evidenced by an amendment and restatement of the Portfolio Schedule for such Transaction.

Threshold. In accordance with Paragraph 4(e) of the SIFMA Master, as amended by this Annex I, the Parties agree that the rights of Buyer under Paragraph 4(a) of the SIFMA Master, as amended by this Annex I, to require the elimination of any Margin Deficit may be exercised only where such Margin Deficit exceeds $10 million.

Margin Prepayments. Seller may, at its discretion in connection with any Transaction, elect to transfer cash to Buyer prior to (and in anticipation of) any Margin Deficit arising or the exercise by Buyer of its rights under Paragraph 4(a) of the SIFMA Master, as amended by this Annex I, and such cash shall be treated for all purposes under this Agreement in the same manner as cash transferred by Seller pursuant to the aforementioned Paragraph 4(a); provided, that (i) Seller must provide Buyer with written notice of any such transfer at least three (3) Business Days in advance thereof, (ii) the amount to be transferred on any such occasion must be at least $10 million and (iii) the remaining Purchase Price of the outstanding Transaction after giving effect to any such transfer must be at least $10 million.

Treatment of Margin Payments. For purposes of Paragraph 4(d) of the SIFMA Master, as amended by this Annex I, any cash transferred in respect of Seller’s margin obligations with respect to any Transaction (including any prepayments contemplated by Paragraph 4(f) of this Annex I) shall be applied to reduce the Purchase Price of such Transaction.

Reporting of Margin Deficits. Seller shall provide Agent with the notices required pursuant to Section 5.3(o) of the Framework Agreement and, to the extent any such notice relates to a Margin Deficit in excess of the threshold specified in Paragraph 4(e) of this Annex I, Buyer shall be automatically deemed to have delivered a concurrent notice to Seller exercising its rights under Paragraph 4(a) of the SIFMA Master, as amended by this Annex I, to require the elimination of such Margin Deficit.

Income Payments. Notwithstanding anything to the contrary in Paragraph 5 of the SIFMA Master, unless an Event of Default with respect to Seller shall have occurred and (i) such Event of Default is continuing and (ii) Agent, on behalf of Buyers, has exercised remedies with respect to the Purchased Securities under Paragraph 11(d) of the SIFMA Master, as amended by this Annex I, Seller shall service the Purchased Securities, and be entitled to receive and retain all Income paid or distributed

22¡ September 1996 ¡ Master Repurchase Agreement

on or in respect of such Securities. All references in this Agreement to Income received by Buyer prior to such an Event of Default shall be disregarded.

Security Interest. Paragraph 6 of the SIFMA Master is hereby amended and restated in its entirety to read as follows:

“(a) Seller hereby grants to Agent, for the benefit of the Buyers, a first priority security interest in all of Seller’s right, title and interest in and to all loans identified in the Portfolio Schedule applicable to each Transaction entered into under this Agreement, all rights to payment arising thereunder, all instruments that may from time to time evidence such loans and all rights arising under the loan agreements governing such loans, whether now existing or hereafter arising, and all proceeds thereof (collectively, the “Collateral”), to secure the Seller’s obligations under the Transaction Agreements (the “Secured Obligations”). This Agreement shall create a continuing security interest in the Collateral (notwithstanding any deemed repurchase by Seller under an expiring Transaction and simultaneous deemed purchase by Buyers under a subsequent Transaction of any Roll-Over Securities) and shall remain in full force and effect until such security interest is released pursuant to (and to the extent provided in) Paragraph 6(c) below or until all unpaid Repurchase Price with respect to outstanding Transactions under this Agreement have been indefeasibly paid in full (without application of any set off or netting). Agent (for the benefit of the Buyers) shall have, with respect to all the Collateral, in addition to all other rights and remedies available to Agent (for the benefit of the Buyers) under the Transaction Agreements, all the rights and remedies of a secured party under the Uniform Commercial Code as in effect in any applicable jurisdiction.

(b) Seller hereby authorizes Agent to file such financing statements (and continuation statements with respect to such financing statements when applicable) as may be necessary to perfect the security interest granted pursuant to the foregoing Paragraph 6(a) under the Uniform Commercial Code of the relevant jurisdiction (which financing statements may describe the collateral as “All of Debtor’s right, title and interest in and to all loans identified in the schedule (as such schedule is amended and restated from time to time, each a “Portfolio Schedule”) applicable to each transaction entered into under the 1996 SIFMA Master Repurchase Agreement dated as of February 13, 2018 (the “Repurchase Agreement”), between Debtor, Coöperatieve Rabobank, U.A., New York Branch and the other Buyers from time to time party thereto, including Annex I thereto (and as amended thereby), all rights to payment arising thereunder, all instruments that may from time to time evidence such loans and all rights arising under the loan agreements governing such loans, whether now existing or hereafter arising, and all proceeds thereof.”).

(c) The security interest granted pursuant to the foregoing Paragraph 6(a) is released by Agent and the Buyers (i) upon payment of the Repurchase Price for any Transaction (including by application of set off or netting in accordance with Paragraph 12 of this Agreement (but subject to Paragraph 12 of Annex I hereto)), without further action by any Person, but solely with respect to the Purchased Securities in respect of such Transaction that are not Roll-Over Securities with respect to such Transaction, and (ii) upon any amendment and restatement of the Portfolio Schedule with respect to a Transaction in accordance with the terms hereof,

23¡ September 1996 ¡ Master Repurchase Agreement

without further action by any Person, but solely with respect to Purchased Securities previously identified in the existing Portfolio Schedule for such Transaction that are no longer identified in the amended and restated Portfolio Schedule for such Transaction. Agent hereby agrees, at Seller’s expense, to (x) file appropriate financing statement amendments to reflect such release and (y) agree to take such additional actions, as Seller may reasonably request to better evidence such release.”

Payment and Transfer. Notwithstanding anything in Paragraph 7 of the SIFMA Master to the contrary, all transfers of Securities by one party to the other party shall be evidenced by the Portfolio Schedule attached to each Confirmation and any amendments thereto made in accordance with this Agreement; it being understood that upon Seller’s payment in full of the Repurchase Price with respect to a Transaction on any Repurchase Date (including as a result of netting), all Purchased Securities (other than Roll-Over Securities) shall be automatically deemed to be transferred and assigned from Buyer to Seller without further evidence thereof.

Rehypothecation of Purchased Securities. Paragraph 8 of the SIFMA Master is hereby amended and restated in its entirety to read as follows:

“Notwithstanding anything herein to the contrary, unless an Event of Default shall have occurred with respect to Seller, Buyer shall be prohibited from engaging in repurchase transactions with the Purchased Securities or otherwise selling, transferring, pledging or hypothecating the Purchased Securities.”

Substitution. Notwithstanding anything to the contrary in Paragraph 9 of the SIFMA Master, all substitutions of Purchased Securities pursuant to Paragraph 9 of the SIFMA Master, as amended by this Annex I, respect to any Transaction shall be evidenced by an amendment and restatement of the Portfolio Schedule for such Transaction.

Representations. The representations and warranties of Seller set forth in Paragraph 10 of the SIFMA Master are hereby replaced with the representations and warranties set forth in Section 5.1 of the Framework Agreement. It is acknowledged that Seller is also making the representations and warranties set forth in Section 5.2 of the Framework Agreement with respect to the Purchased Securities.

Events of Default.

Replacement Events of Default. The Events of Default applicable to Seller set forth in Paragraph 11 of the SIFMA Master are hereby replaced with the Events of Default set forth in the definition thereof in the Framework Agreement.

Remedies. Paragraph 11(d) of the SIFMA Master is hereby amended and restated in its entirety to read as follows:

“If the nondefaulting party is the Buyer and exercises or is deemed to have exercised the option referred to in subparagraph (a) of this Paragraph, Agent on behalf of the Buyers may, at its discretion and with such notice to the defaulting party as may be required by applicable law, immediately (i) take possession of and any or all Purchased Securities subject to any outstanding Transactions, at its discretion, (ii) subject to the requirements of applicable law, sell any or all such Purchased

24¡ September 1996 ¡ Master Repurchase Agreement

Securities, at such price or prices as Agent may reasonably deem satisfactory, and apply the proceeds thereof to the aggregate unpaid Repurchase Prices and any other amounts owing by the defaulting party hereunder or under any of the other Transaction Agreements (it being understood, for the avoidance of doubt, that the defaulting party shall remain liable to the nondefaulting party for the excess of such aggregate unpaid Repurchase Prices and other amounts owing over any sale proceeds so applied); and (iii) generally exercise any and all rights afforded to a secured party under the Uniform Commercial Code or other applicable law.”

Replacement Securities Inapplicable. The provisions of Paragraph 11(e) of the SIFMA Master shall not apply to Transactions under this Agreement, and all references thereto or to “Replacement Securities” shall be disregarded.

Single Agreement. With respect to any Transaction under this Agreement, and notwithstanding anything in this Agreement to the contrary, the portion of the Repurchase Price for such Transaction consisting of the Price Differential shall, in all circumstances, be paid by Seller by wire transfer of immediately available funds to the account of Agent set forth in Schedule 2 to the Framework Agreement on the Repurchase Date for such Transaction (or, if such Repurchase Date is not a Monthly Date, on the earlier of (i) next succeeding Monthly Date to occur following such Repurchase Date or (ii) the Facility Expiration Date), and such payment of the Price Differential shall not be subject to any setoff, netting or other application by Seller against other amounts, whether pursuant to Paragraph 12 of the SIFMA Master or otherwise.

Miscellaneous.

Termination of Agreement. The last sentence of Paragraph 15(a) of the SIFMA Master is hereby amended and restated to read as follows:

“This Agreement shall terminate on the Facility Expiration Date, except that this Agreement shall, notwithstanding such termination, remain applicable to any Transactions then outstanding.”

Other Inapplicable Provisions. Paragraphs 18, 19 and 20 of the SIFMA Master shall not be applicable to Transactions under this Agreement, and all terms and provisions thereof and references thereto shall be disregarded for purposes of this Agreement.

25¡ September 1996 ¡ Master Repurchase Agreement

EX-10.5

Execution Version

MASTER FRAMEWORK AGREEMENT

This MASTER FRAMEWORK AGREEMENT (this “Framework Agreement”), is made and entered into as of February 13, 2018 (the “Effective Date”), by and among:

Coöperatieve Rabobank, U.A., New York Branch, a Dutch coöperatieve acting through its New York Branch (“Rabobank”) and The Bank of Tokyo-Mitsubishi UFJ, Ltd., New York Branch, a Japanese banking corporation acting through its New York Branch (“BTMU”), as purchasers (collectively, the “Buyers”);

Rabobank, as Buyers’ agent (in such capacity, “Agent”); and

PHI Financial Services, Inc., an Iowa corporation (“Seller”).

Each of Agent, Buyers and Seller may also be referred to herein individually as a “Party”, and collectively as the “Parties”.

RECITALS

WHEREAS, Buyers have agreed to provide Seller with a facility under which Buyers and Seller will enter into certain sale and repurchase agreements with respect to Eligible Farmer Loans owned by Seller.

AGREEMENT

NOW, THEREFORE, in consideration of the mutual covenants, agreements and conditions set forth herein, and for other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the Parties agree as follows:

1.    Interpretation.

1.1    Definitions. All capitalized terms used in this Framework Agreement (including its recitals and Schedules) shall, unless defined herein, have the respective meanings set forth in Schedule 1 hereto.

1.2    Construction.

(a)    The headings and sub-headings in this Framework Agreement shall not affect its interpretation. References in this Framework Agreement to Sections and Schedules shall, unless the context otherwise requires, be references to Sections of, and Schedules to, this Framework Agreement.

(b)    Words denoting the singular number only shall include the plural number also and vice versa; words denoting one gender only shall include the other genders and words denoting persons shall include firms and corporations and vice versa.

(c)    References to a Person are also to its permitted successors or assigns.

(d)    References in this Framework Agreement to any agreement or other document shall be deemed also to refer to such agreement or document as amended or varied or novated from time to time.

(e)    References to an amendment include a supplement, novation, restatement or re-enactment and amend and amended (or any of their derivative forms) will be construed accordingly.

(f)    Reference to a time of day is a reference to New York City time.

(g)    “Include”, “includes” and “including” shall be deemed to be followed by the words “without limitation.”

(h)    “Hereof”, “hereto”, “herein” and “hereunder” and words of similar import when used in this Framework Agreement refer to this Framework Agreement as a whole and not to any particular provision of this Framework Agreement.

(i)    References to a “writing” or “written” include any text transmitted or made available on paper or through electronic means.

(j)    References to “$”, U.S. Dollars or otherwise to dollar amounts refer to the lawful currency of the United States.

(k)    References to a law include any amendment or modification to such law and any rules and regulations issued thereunder, whether such amendment or modification is made, or issuance of such rules and regulations occurs, before or after the Effective Date.

2.    Transaction Agreements.

2.1    Agreements to be Executed at the Closing.Concurrently with this Framework Agreement, the Parties intend to execute the following additional agreements (together with this Framework Agreement and each subsequent Confirmation entered into during the Facility Term subsequent to the Closing, the “Transaction Agreements”) to which they are party:

(a)    the Master Repurchase Agreement among Seller and the Buyers;

(b)    the Fee Letter among Seller and Buyers;

(c)    the Side Letter between Seller and Agent; and

(d)    the Guaranty.

2.2    Definitions. When used in any Transaction Agreement, capitalized terms not otherwise defined therein will, to the extent defined herein, have the meanings set forth in this Framework Agreement (including Schedule 1).

2

3.    Closing; Closing Deliveries.

3.1    Closing. Subject to the terms and conditions of this Framework Agreement, the transactions contemplated in this Framework Agreement to occur concurrently with the execution hereof (other than the entry into any Confirmations) will take place at a closing (the “Closing”) to be held on the Effective Date at a mutually agreeable location or by the exchange of electronic documentation.

3.2    Seller Closing Deliverables. At the Closing or prior to the Closing, Seller will deliver, or cause to be delivered, to each Buyer:

(a)    an executed counterpart to each of the Transaction Agreements (other than any Confirmations) to which it is a party;

(b)    an executed counterpart of Guarantor to the Guaranty;

(c)    a certificate of the Secretary or an Assistant Secretary of Seller, dated the Effective Date, certifying as to (i) the incumbency of the officers of Seller executing the Transaction Agreements, (ii) attached copies of Seller’s articles of incorporation and bylaws; and (iii) copies of all corporate approvals and consents of Seller that are required by it in connection with entering into, and the exercise of its rights and the performance of its obligations under, the Transaction Agreements;

(d)    a certificate of the Secretary or an Assistant Secretary of Guarantor, dated the Effective Date, certifying as to (i) the incumbency of the officer(s) of Guarantor executing the Guaranty, (ii) attached copies of Guarantor’s certificate of incorporation and bylaws; and (iii) copies of all corporate approvals and consents of Guarantor that are required by it in connection with entering into, and the exercise of its rights and the performance of its obligations under, the Guaranty;

(e)    a customary legal opinion or opinions with respect to Seller opining on existence, due authorization and execution, absence of conflicts with Organizational Documents, binding nature of obligations, absence of violations of Law and no consents under Law; and

(f)    a customary legal opinion or opinions with respect to Guarantor opining on existence, due authorization and execution, absence of conflicts with Organizational Documents, binding nature of obligations, absence of violations of Law and no consents under Law.

3.3    Buyer Closing Deliverables. At the Closing or prior to the Closing, each Buyer will deliver to Seller and each other Buyer an executed counterpart to each of the Transaction Agreements (other than any Confirmations) to which it is a party.

3.4    Agent Closing Deliverables. At the Closing or prior to the Closing, Agent shall provide to Seller, an executed copy of IRS Form W-8IMY, indicating on Part VI that Agent is a U.S. branch of a foreign bank described in United States Department of Treasury Regulations section 1.1441-1(b)(2)(iv)(A) agreeing to be treated as a U.S. person for purposes of withholding on payments under the Transaction Agreements.

3

3.5    Seller Initial Transaction Deliverables. On or prior to the Purchase Date for the initial Transaction hereunder, Seller will deliver, or cause to be delivered, to each Buyer:

(a)    results of a UCC lien search with respect to Seller for the State of Iowa as of a date not more than seven (7) days prior to the Closing;

(b)    fully prepared UCC-1 financing statements reflecting the Security Interests granted by Seller under the Master Repurchase Agreement; and

(c)    a customary legal opinion or opinions, in form and substance reasonably satisfactory to Agent, with respect to creation and perfection of security interests.

4.    Transactions.

4.1    Requests for Transactions.

(a)    Transaction Notices. Seller may, from time to time during the Facility Term, deliver a written notice, substantially in the form attached hereto as Exhibit A and including a fully-completed proposed Portfolio Schedule (a “Transaction Notice”) to Agent requesting that Buyers enter into a Transaction on a Monthly Date (or, if Seller elects to terminate a Transaction pursuant to Paragraph 3(c)(ii) of Annex I to the Master Repurchase Agreement, on the effective date of such termination). Such notice shall be delivered to Agent not less than four (4) Business Days prior to the proposed Purchase Date for such proposed Transaction (or such later date as may be consented to by Agent, which consent may be conditioned on the consent of the Buyers). Subject to the terms and conditions set forth herein and in the other Transaction Agreements, each Buyer agrees severally, and not jointly, to enter into such Transactions with Seller up to its respective Individual Commitment Amount as of the applicable Purchase Date.

(b)    Confirmation Process. Within one (1) Business Day of its receipt of a Transaction Notice, Agent shall deliver a fully completed draft Confirmation with respect to the proposed Transaction, attaching the related proposed Portfolio Schedule provided by Seller pursuant to Section 4.1(a). In the event Seller and Agent disagree with respect to any portion of the draft Confirmation or the proposed Portfolio Schedule or in the event Agent determines in good faith that any applicable Transaction Conditions are not, or will not be, satisfied as of the relevant Purchase Date, Seller or Agent (as applicable) shall promptly notify the other of the same, and Seller and Agent shall cooperate expeditiously and in good faith to resolve any such matters (to the extent the same are capable of being resolved). If the applicable Transaction Conditions are (or will be) satisfied as of the applicable Purchase Date, then Agent shall, on behalf of the Buyers and subject to the provisions of Section 4.5, enter into the proposed Transaction with Seller on the terms set forth in the draft Confirmation (as may be modified as agreed between Seller and Agent in accordance with the preceding sentence) by executing and delivering to Seller, on behalf of each such Buyer, a Confirmation evidencing such Transaction in accordance with the Master Repurchase Agreement.

(c)    Failed Closings. If, on any proposed Purchase Date, the entry into a proposed Transaction on such date would otherwise fail to occur due to:

4

(i)    any failure of Seller and Agent to agree on the Confirmation or the Portfolio Schedule for such proposed Transaction in accordance with the foregoing Section 4.1(b) on or before such proposed Purchase Date;

(ii)    any failure as of such proposed Purchase Date of any applicable Transaction Condition to be satisfied with respect to such proposed Transaction;

(iii)    any unforeseen circumstance or event, such as a disruption in wire transfers, power or other mechanical or technological failures or interruptions, computer viruses, communications disruptions, work stoppages, natural disasters, fire, war, terrorism, riots, rebellions, or any circumstance beyond the control of the Parties; or

(iv)    any other reason (other than the failure of a Deemed Roll-Over Condition to be satisfied);

then, notwithstanding any provision to the contrary in any Transaction Agreement,

(x)     if the proposed Purchase Date is not a Monthly Date and any Current Transaction was specified for early termination on such proposed Purchase Date pursuant to Paragraph 3(c)(ii) of Annex I to the Master Repurchase Agreement, then notwithstanding such specification, such Current Transaction shall continue without termination on such proposed Purchase Date and no new Transaction shall be entered into on such proposed Purchase Date, and

(y)    if the proposed Purchase Date is a Monthly Date, then so long as the Deemed Roll-Over Conditions are satisfied as of such Monthly Date, and notwithstanding the failure of any Additional Funding Condition or Roll-Over Condition (which condition, in each case, is not also a Deemed Roll-Over Condition) to be satisfied as of such Monthly Date, Seller and Buyers shall be deemed to have entered into a new Roll-Over Transaction (a “Deemed Roll-Over Transaction”) on such Monthly Date in accordance with Section 4.1(d) below.

(d)    Deemed Roll-Over Transactions. In the event the Parties are deemed to have entered into a Deemed Roll-Over Transaction on any Monthly Date pursuant to the foregoing Section 4.1(c), such Deemed Roll-Over Transaction shall be deemed to be entered into on the same terms as those set forth in the final form of Confirmation (including the Portfolio Schedule thereto) governing the Transaction expiring on such Monthly Date, subject to the following modifications:

(A) the Purchase Date shall be the applicable Monthly Date on which such Deemed Roll-Over Transaction is deemed to have been entered into, and the applicable Pricing Rate shall be updated accordingly;

(B) the Repurchase Date shall be the earlier of the Facility Expiration Date or the next applicable Monthly Date following the Purchase Date;

(C) the Portfolio Schedule applicable to the Deemed Roll-Over Transaction shall be: (i) in the event Seller has delivered to Agent a Portfolio Schedule by such Purchase

5

Date designated for use in connection with entry into a Transaction on such Purchase Date and which satisfies clauses (vi) through (ix) of Section 4.3(a), such delivered Portfolio Schedule; and (ii) otherwise, the Portfolio Schedule for the prior Transaction expiring on such Monthly Date (the Portfolio Schedule described in this clause (ii), a “Roll-Over Portfolio Schedule”);

(D) if the Purchase Price set forth in the Confirmation for the expiring Transaction exceeds the Aggregate Commitment Amount applicable to such Deemed Roll-Over Transaction, the Purchase Price for such Deemed Roll-Over Transaction shall be reduced so as to be equal to such applicable Aggregate Commitment Amount, and Seller shall pay to Agent for the account of the Buyers any Funded Repurchase Price required to be paid by it as a result of such reduction; and

(E) in addition to any Funded Repurchase Price required to be paid by Seller on such Monthly Date in accordance with the terms hereof, Seller may, at its election, pay to Agent for the account of the Buyers an additional amount by wire transfer of immediately available funds to the account of Agent specified in Schedule 2 by or before 5:00 p.m. on such Monthly Date, which additional payment shall (i) reduce the Purchase Price for such Deemed Roll-Over Transaction and (ii) be treated as the payment of additional Funded Repurchase Price for all purposes hereunder and under the other Transaction Agreements; provided, that the Price Differential through the first two (2) Business Days of the Transaction Period for such Deemed Roll-Over Transaction shall be calculated as though the corresponding reduction of Purchase Price did not occur.

Promptly after entry into any Deemed Roll-Over Transaction, Seller and Agent shall cooperate expeditiously and in good faith to prepare, execute and deliver a Confirmation and Portfolio Schedule which, if treated as having been delivered in a timely manner in connection with a proposed Roll-Over Transaction to be entered into on the Purchase Date for such Deemed Roll-Over Transaction, would satisfy the applicable Roll-Over Conditions (excluding the condition described in Section 4.3(a)(iii), which need not be satisfied for purposes of this paragraph) as of such Purchase Date, to evidence and definitively document such Deemed Roll-Over Transaction, with the terms of such Confirmation, and if applicable, updated Portfolio Schedule, amending, restating and superseding any deemed terms specified in the preceding sentence as of the applicable Purchase Date, notwithstanding such later execution and delivery of such definitive documentation.

4.2    Funding of Transaction Purchase Prices.

(a)    Funding Notices. In the event Agent receives a Transaction Notice for a proposed Transaction in accordance with Section 4.1(a), Agent shall deliver to each other Buyer a written notice concerning such Transaction (a “Funding Notice”) not later than 10:00 a.m. on the date that is two (2) Business Days prior to the date of the proposed Transaction. Such notice shall (i) set forth the Purchase Date for the proposed Transaction, the amount of any Funded Purchase Price anticipated to be paid or Funded Repurchase Price anticipated to be received in connection with such Transaction, any Funding Amount payable by or Distribution Amount anticipated to be distributed to each Buyer in connection with the Transaction, any adjustments and related calculations made pursuant to Section 4.5 and the anticipated Aggregate Buyer Balance after giving

6

effect to such Transaction, and (ii) be accompanied by a copy of the substantially final form of Confirmation to be entered into in connection with such Transaction.

(b)    Funding of Purchase Prices. Following receipt of any Funding Notice concerning a proposed Transaction, each Buyer shall fund its respective Funding Amount (if any) for such proposed Transaction by wire transfer of immediately available funds to the account of Agent specified in Schedule 2 no later than 11:00 a.m. on the Purchase Date for such Transaction (or such later time as Agent may determine with the consent of Seller (such consent not to be unreasonably withheld so long as the Funded Purchase Price is received for value on such Purchase Date)). Agent shall, subject to satisfaction of the Additional Funding Conditions, use such funds to pay the Funded Purchase Price for the Transaction on behalf of each of the Buyers in accordance with terms of the Master Repurchase Agreement and applicable Confirmation, upon which Seller will sell and assign, and Buyers will purchase, the Transaction Portfolio for such Transaction, with each Buyer receiving a fractional undivided interest in such Transaction Portfolio in accordance with its respective Undivided Funding Percentage as of the time of such purchase (after giving effect to the funding of such Funding Amounts and payment of such Funded Purchase Price). The closing of such Transaction and payment of such Funded Purchase Price shall occur at 12:00 noon on the Purchase Date (or such later time on such Purchase Date as Agent may determine with the consent of Seller (such consent not to be unreasonably withheld for so long as the Funded Purchase Price is received for value on such Purchase Date)).

(c)    Advance Payment of Funded Purchase Price. Notwithstanding the provisions of Section 4.2(b) above, Agent may, at its sole discretion, on any Purchase Date for a Transaction in respect of which it anticipates receiving Funding Amounts from Buyers, transfer in advance any Funded Purchase Price anticipated to be payable in respect of such Transaction to Seller on such Purchase Date prior to Agent’s actual receipt of such Funding Amounts; provided, that if Agent does not receive all such Funding Amounts from Buyers by or before 5:00 p.m. on such Purchase Date, then subject to and in accordance with Section 4.5(a)(iii), Seller and each applicable Defaulting Buyer severally agree to pay to Agent forthwith on demand the amount of Funded Purchase Price transferred in advance corresponding to the Funding Amounts not received, with interest thereon at a rate reasonably determined by Agent in accordance with banking industry rules on interbank compensation.

(d)    Return of Excess Funding Amounts. In the event any Buyer has funded its respective Funding Amount on any proposed Purchase Date for an Additional Funding Transaction in accordance with Section 4.2(b), and either (i) Seller and Buyers fail to enter into such Additional Funding Transaction on such proposed Purchase Date or (ii) Seller and Buyers enter into an Additional Funding Transaction on such Purchase Date with respect to which less than all of the amount funded by such Buyer is actually applied to the payment of Funded Purchase Price on such Purchase Date, then Agent shall, promptly following either such event, refund to such Buyer the unused portion of such funded amount.

7

4.3    Transaction Conditions.

(a)    The obligation of Buyers to enter into any Additional Funding Transaction shall be subject to satisfaction of the following conditions (in each case, as of the Purchase Date) (together, the “Additional Funding Conditions”):

(i)    with respect to the initial Transaction, each of the items required to be delivered by Seller in connection with such initial Transaction pursuant to Section 3.5 shall have been delivered in accordance with the terms hereof;

(ii)    all amounts then due and owing by Seller under Section 9.2, the Fee Letter and the Side Letter shall have been paid in full;

(iii)    the Transaction Notice, including the proposed Portfolio Schedule required to be attached thereto, shall have been delivered to Agent in accordance with Section 4.1;

(iv)    Seller shall have delivered to Agent a duly executed counterpart to the applicable Confirmation;

(v)    each of the representations and warranties of Seller and Guarantor (as applicable) set forth in the Transaction Agreements (excluding any representations or warranties set forth in the Asset Representations, Warranties and Covenants) shall be true and correct in all material respects;

(vi)    the aggregate Market Value of the Transaction Portfolio for such Transaction (as set forth in the Portfolio Schedule to the Confirmation provided by Seller) shall be equal to or greater than 105% of the Purchase Price for such Transaction;

(vii)    all of the loans included in the Transaction Portfolio for such Transaction (as set forth in the Portfolio Schedule to the Confirmation provided by Seller) shall be Eligible Farmer Loans;

(viii)    the Weighted Average CBR Score with respect to the Transaction Portfolio for such Transaction shall be equal to or greater than 675;

(ix)    no less than seventy percent (70%) of the Eligible Farmer Loans comprising the Transaction Portfolio for such Transaction (based on their respective Book Values) shall have been made to Debtors that are natural persons;

(x)    the Purchase Date for such Transaction shall be at least ten (10) days prior to the Farmer Loan Maturity Date;

(xi)    the payment of the proposed Purchase Price would not cause (x) the Aggregate Buyer Balance (after giving effect to such payment) to exceed the Aggregate Commitment Amount applicable to such Transaction or (y) any Buyer’s Individual Buyer Balance (after giving effect to such payment) to exceed such Buyer’s applicable Individual Commitment Amount with respect to such Transaction;

8

(xii)    no Potential Event of Default or Event of Default shall have occurred and be continuing which has not been waived; and

(xiii)    no “Event of Default” shall have occurred and be continuing under the Revolver which has not been waived.

(b)    The obligation of Buyers to enter into any Roll-Over Transaction (other than a Deemed Roll-Over Transaction) shall be subject to satisfaction of the following conditions (in each case, as of the Purchase Date) (together, the “Roll-Over Conditions”):

(i)    each of the conditions set forth in clauses (iii), (iv), and (vi) through (xi) of Section 4.3(a) shall have been satisfied; and

(ii)    no Event of Default shall have occurred and be continuing which has not been waived.

(c)    The deemed entry by Buyers into any Deemed Roll-Over Transaction shall be subject to satisfaction of the following conditions (in each case, as of the Purchase Date) (together, the “Deemed Roll-Over Conditions”):

(i)    the aggregate Market Value of the Transaction Portfolio for such Deemed Roll-Over Transaction (as set forth in the applicable Portfolio Schedule for such Deemed Roll-Over Transaction determined in accordance with Section 4.1(d)(C)) shall be equal to or greater than (x) 100% of the Purchase Price for such Transaction, if the applicable Portfolio Schedule for such Deemed Roll-Over Transaction is a Roll-Over Portfolio Schedule, or (y) 105% of the Purchase Price for such Transaction, in all other cases;

(ii)    each of the conditions set forth in clauses (vii) through (xi) of Section 4.3(a), as applied mutatis mutandis to the applicable terms of such Deemed Roll-Over Transaction and to the Transaction Portfolio set forth on the Portfolio Schedule for such Deemed Roll-Over Transaction, shall have been satisfied;

(iii)    if the prior Transaction expiring on such Purchase Date is a Deemed Roll-Over Transaction, Seller shall have executed and delivered definitive documentation evidencing such prior Deemed Roll-Over Transaction in accordance with the last sentence of Section 4.1(d) on or before the Business Day immediately preceding such Purchase Date; and

(iv)    no Event of Default shall have occurred and be continuing which has not been waived.

4.4    Funding of Transaction Repurchase Prices.

(a)    Seller’s Payment of Funded Repurchase Price. On each Repurchase Date for a Transaction on which Funded Repurchase Price (other than Funded Repurchase Price on account of accrued but unpaid Price Differential) is payable by Seller pursuant to the Transaction Agreements (including, for the avoidance of doubt, on the Facility Expiration Date and each Commitment Reduction Date), Seller shall fund the Funded Repurchase Price for such Transaction

9

by wire transfer of immediately available funds to the account of Agent specified in Schedule 2, no later than 5:00 p.m. on such Repurchase Date (or such later time as Seller may determine with the consent of Agent (such consent not to be unreasonably withheld so long as such Funded Repurchase Price is received for value on such Repurchase Date)).

(b)    Distribution of Amounts Received by Agent. On any Business Day when Agent receives any Funded Repurchase Price or Margin Payment from Seller for any Transaction, Agent shall distribute to each Buyer such Buyer’s Distribution Amount in respect of such Funded Repurchase Price or Margin Payment by wire transfer of immediately available funds to the account of such Buyer set forth on Schedule 2 hereto (i) on the same Business Day if such Funded Repurchase Price or Margin Payment is received from Seller prior to 2:00 p.m. on such Business Day or (ii) otherwise, on the next succeeding Business Day.

(c)     Advances of Funded Repurchase Price. Notwithstanding the foregoing Section 4.4(b), Agent may, at its discretion, on any Repurchase Date when it anticipates receiving any Funded Repurchase Price from Seller, transfer in advance to each Buyer its anticipated Distribution Amount in respect of such anticipated Funded Repurchase Price on such Repurchase Date prior to Agent’s actual receipt of such Funded Repurchase Price; provided, that if Agent does not receive such Funded Repurchase Price from Seller by 5:00 p.m. on such Repurchase Date, each Buyer shall be required to promptly refund to Agent any such anticipated Distribution Amounts transferred in advance.

4.5    Defaulting Buyers.

(a)     Adjustment for Reduced Funding. Notwithstanding anything in this Article IV to the contrary, in the event that, on any Purchase Date on which Agent has entered into, or is obligated to enter into, an Additional Funding Transaction with respect to which any Funded Purchase Price is to be paid in accordance with Section 4.2(b), one or more Buyers (any such Buyer, a “Defaulting Buyer”) fails to fund its respective Funding Amount on such Purchase Date when and as required by Section 4.2(b), then Agent shall promptly give notice of such failure to Seller and each other Buyer. Upon Agent’s giving of such notice:

(i)    the Confirmation for such Additional Funding Transaction shall be amended (or, if already executed and delivered by Seller prior to Agent’s giving of such notice, shall be deemed to have been amended) so as to reduce the Purchase Price for such Additional Funding Transaction by the applicable Funding Amounts such Defaulting Buyers have failed to fund;

(ii)    when and as required pursuant to Section 4.2(b), and subject to the satisfaction of the Additional Funding Conditions otherwise applicable to such Additional Funding Transaction, Agent shall pay to Seller, on behalf of the Buyers (other than the Defaulting Buyer), any remaining unpaid Funded Purchase Price payable in respect of such Additional Funding Transaction (after giving effect to the reduction in Purchase Price pursuant to the foregoing Section 4.5(a)(i));

10

(iii)    to the extent Agent has advanced any amounts to Seller pursuant to Section 4.2(c) on such Purchase Date in excess of the Funded Purchase Price payable in respect of such Additional Funding Transaction (after giving effect to the reduction in Purchase Price pursuant to the foregoing Section 4.5(a)(i)), Seller shall refund any such excess when and as required pursuant to Section accordance with Section 4.2(c);

(iv)    following such Purchase Date, Seller shall be entitled to exercise its rights under Paragraph 4(b) of Annex I to the Master Repurchase Agreement to address the excess Market Value of the Transaction Portfolio which may result from the failure of such Defaulting Buyer to fund.

(b)    Replacement of Buyers. Seller may, at its sole expense and effort, upon notice to any Defaulting Buyer and Agent, require such Defaulting Buyer to assign, without recourse, all of its rights and obligations under the Transaction Agreements (including its Individual Buyer Balance, Individual Commitment Amount and any undivided fractional interest it may own with respect to any Transaction Portfolio) to one or more existing Buyers or new Buyers that is willing to assume such obligations; provided that (i) Seller shall have received the prior written consent of Agent with respect to any new Buyer, which consent shall not unreasonably be withheld, (ii) such Defaulting Buyer shall have received payment of an amount equal to its Individual Buyer Balance and accrued and unpaid Price Differential, fees and all other amounts payable to it under the Transaction Agreements (which may be paid by the applicable assignee and/or by Seller) and (iii) such assignment does not conflict with applicable Law. No Buyer shall be required to make any such assignment if prior thereto, such Buyer shall have ceased to be a Defaulting Buyer in accordance with Section 4.5(c). Each Party agrees that an assignment required pursuant to this Section 4.5(b) may be effected pursuant to assignment documentation executed by Seller, Agent and the assignee and that the Defaulting Buyer required to make such assignment need not be a party thereto. In connection with any such assignment, each assignee of the Defaulting Buyer agrees to purchase (at par) Individual Buyer Balances of other non-Defaulting Buyers (together with corresponding portions of such other non-Defaulting Buyers’ undivided fractional interests in any Transaction Portfolio) as Agent may determine necessary to cause each non-Defaulting Buyer’s Undivided Funding Percentage in connection with the applicable Current Transaction to equal its Undivided Commitment Percentage with respect to such Current Transaction (in each case, after giving effect to such assignment and with such adjustments as Agent may deem appropriate to take into account any Buyers that remain Defaulting Buyers).

(c)    Reinstatement of Defaulting Buyers. In the event that Agent and Seller agree that a Defaulting Buyer has adequately remedied all matters that caused such Buyer to be a Defaulting Buyer, then such Buyer shall cease to be a Defaulting Buyer for all purposes hereof. In connection with any such reinstatement of a Defaulting Buyer, such Defaulting Buyer agrees to purchase (at par) Individual Buyer Balances of other non-Defaulting Buyers as Agent may determine necessary to cause each non-Defaulting Buyer’s Undivided Funding Percentage in connection with the applicable Current Transaction to equal its Undivided Commitment Percentage with respect to such Current Transaction (in each case, after giving effect to such reinstatement and with such adjustments as Agent may deem appropriate to take into account any Buyers that remain Defaulting Buyers).

11

(d)    Replacement of Agent. In the event that Agent or any Affiliate thereof is a Defaulting Buyer, Buyers having more than 50% of the aggregate amount of Individual Commitment Amounts of all Buyers (excluding all Individual Commitment Amounts or Individual Buyer Balances of any Defaulting Buyer) may, to the extent permitted by applicable law, by notice in writing to Seller and Agent, remove Agent in its capacity as such, and subject to Seller’s approval (not to be unreasonably withheld), appoint a successor. Upon the acceptance of its appointment as Agent hereunder by a successor, such successor shall succeed to and become vested with all the rights, powers, privileges and duties of the removed Agent and the removed Agent shall be discharged from its duties and obligations hereunder and under the other Transaction Agreements. The fees payable by Seller to a successor Agent shall be the same as those payable to its predecessor unless otherwise agreed between Seller and such successor. Removed Agent agrees to execute such additional documents and perform such further acts as may be reasonably required or desirable to carry out or perform the foregoing provisions of this Section; provided that, to the extent removed Agent fails to promptly execute such additional documents and or to perform such further acts, successor Agent may, on behalf of removed Agent, execute such additional documents or perform such further acts.

(e)    Calculations. All calculations with respect to adjustments in the Undivided Commitment Percentages and Undivided Funding Percentages of, Funding Amounts owed by, or Distribution Amounts payable to, any Buyers resulting from any Buyer becoming a Defaulting Buyer or any actions taken by Agent pursuant to this Section 4.5 shall be made by Agent and communicated to Buyers in appropriate Funding Notices or other written notices (in all cases, with copies to Seller).

5.    Representations and Warranties; Certain Covenants.

5.1    Representations and Warranties of Seller. Seller represents to Agent and each Buyer that:

(a)    Organization and Authority. Seller is a corporation duly organized, validly existing, and in good standing under the Laws of the State of Iowa. Seller has full corporate power and authority to enter into the Transaction Agreements to which it is a party, to carry out its obligations thereunder, and to consummate the transactions contemplated thereby. The execution and delivery by Seller of the Transaction Agreements to which it is a party and the performance by Seller of its obligations thereunder have been duly authorized by all requisite corporate action on the part of Seller. The Transaction Agreements to which Seller is a party have been duly executed and delivered by Seller, and (assuming due authorization, execution, and delivery by each other Party) the Transaction Agreements to which Seller is a party constitute a legal, valid, and binding obligation of Seller enforceable against Seller in accordance with their terms, subject to applicable bankruptcy, insolvency, fraudulent conveyance, reorganization, moratorium and similar Laws affecting creditors’ rights generally and subject, as to enforceability, to general principles of equity.

(b)    No Conflicts; Consents. The execution, delivery and performance by Seller of each of the Transaction Agreements and the consummation of the transactions contemplated by the Transaction Agreements do not and will not: (A) conflict with or result in a violation or breach of, or default under, any provision of the Organizational Documents of Seller; (B) conflict with or

12

result in a violation or breach of any provision of any Law or Governmental Order applicable to Seller except as would not reasonably be expected to have a Material Adverse Effect; or (C) require the consent, notice or other action by any Person pursuant to, or result in a default or event of default under, any Contract to which Seller is a party, except: (1) as expressly set forth in the applicable Transaction Agreement, (2) as shall have been obtained by Seller as of the Effective Date or (3) as would not reasonably be expected to have a Material Adverse Effect. No consent, approval, Permit, Governmental Order, declaration or filing with, or notice to, any Governmental Authority is required by or with respect to Seller in connection with the execution and delivery of the Transaction Agreements and the consummation of the transactions contemplated by the Transaction Agreements except as shall have been obtained by Seller or except as would not reasonably be expected to have a Material Adverse Effect.

(c)    Legal Proceedings. There are no Actions pending or, to Seller’s knowledge, threatened against or by Seller or any Affiliate of Seller that challenge or seek to prevent, enjoin, or otherwise delay the transactions contemplated by the Transaction Agreements.

(d)    Compliance with Laws. Seller is in compliance with all applicable Laws in connection with the performance of obligations or exercise of rights under the Transaction Agreements, except where the failure to be so would not reasonably be expected to have a Material Adverse Effect.

(e)    No Defaults. No Event of Default under this Framework Agreement has occurred and is continuing that has not been waived. Except as disclosed to Agent, no Potential Event of Default under this Framework Agreement has occurred and is continuing that has not been waived.

(f)    No Change of Control. None of the events described in clauses (a) though (d) of the proviso to the definition of Change of Control set forth in Schedule 1 to this Agreement occurred or was continuing at any time during the period from the effective date of the DowDuPont Merger through the Effective Date.

5.2    Asset Representations and Warranties. Seller represents or covenants, as applicable, to Agent and each Buyer with respect to each Eligible Farmer Loan included in the Transaction Portfolio for any outstanding Transaction that:

(a)    Accuracy of Information. The information regarding such Eligible Farmer Loan set forth on the Portfolio Schedule to the Confirmation for such Transaction (as corrected in accordance with Section 4.1(d), in the case of any Deemed Roll-Over Transaction) is true and correct in all material respects as of the Purchase Date for such Transaction.

(b)    Form of Loan Agreement. The Loan Agreement for such Eligible Farmer Loan is substantially in the form of one of the Deferred Payment Loan Agreements attached to Schedule 3 hereto or any other form of Loan Agreement provided to and deemed satisfactory by Agent.

13

(c)    Enforceability. Such Eligible Farmer Loan and related Loan Agreement has been duly authorized, executed and delivered by all parties thereto, and constitutes a legal, valid, and binding obligation of each such party enforceable against such party in accordance with its terms, subject to applicable bankruptcy, insolvency, fraudulent conveyance, reorganization, moratorium and similar Laws affecting creditors’ rights generally and subject, as to enforceability, to general principles of equity.

(d)    No Conflicts; Consents. The execution, delivery and performance by Seller and each applicable Debtor under such Eligible Farmer Loan of the Loan Agreement and the consummation of the transactions contemplated thereby do not and will not conflict with or result in a violation or breach of any provision of any Law or Governmental Order applicable to Seller except as would not reasonably be expected to have a Material Adverse Effect, and no consent, approval, Permit, Governmental Order, declaration or filing with, or notice to, any Governmental Authority is required by or with respect to Seller or any Affiliate of Seller in connection with the execution and delivery of the Loan Agreement and the consummation of the transactions contemplated thereby except as shall have been obtained by Seller or such Affiliate as of the date of such Loan Agreement or except as would not reasonably be expected to have a Material Adverse Effect.

(e)    No Modifications. Except in accordance with its ordinary servicing practices (so long as the related modification, alteration or amendment would not (i) cause such loan to cease to be an Eligible Farmer Loan, (ii) breach any of the other Asset Representations, Warranties and Covenants, (iii) reduce the amount payable under the Eligible Farmer Loan (other than as a result of a prepayment), (iv) extend the stated maturity date of such Eligible Farmer Loan or (v) reasonably be expected to have a Material Adverse Effect) or as consented to by Agent, Seller is not a party to any Contract or other legally binding arrangement with any Debtor in relation to such Eligible Farmer Loan that modifies, alters or amends any of the terms in the related Loan Agreement.

(f)    Compliance with Laws.

(i)    Seller and its Affiliates are in compliance with all applicable Laws with respect to the making of such Eligible Farmer Loan (including all applicable “know your customer” Laws), except where the failure to be so would not reasonably be expected to have a Material Adverse Effect.

(ii)    None of Seller, any of its Subsidiaries or, to the knowledge of Seller, any Affiliate of Seller or any director, officer, agent or other person acting on behalf of Seller or any of its Subsidiaries (i) is a Sanctioned Person, (ii) transacts with, or has any investments in, any Sanctioned Country or Sanctioned Person or (iii) is the subject of any action or investigation under any Sanctions Laws or Anti-Money Laundering Laws.

(iii)    None of Seller, any of its Subsidiaries nor, to the knowledge of Seller, any director, officer, agent or other person acting on behalf of Seller or any of its Subsidiaries has taken any action, directly or indirectly, that would result in a violation by such persons of Anti-Corruption Laws; and Seller has instituted and maintains policies and procedures designed to ensure continued compliance therewith.

14

(g)    Legal Proceedings. There is no Action pending or, to the knowledge of Seller, threatened against Seller relating to such Eligible Farmer Loan or which seeks the issuance of an order restraining, enjoining or otherwise prohibiting or making illegal the consummation of any of the transactions contemplated by the Loan Agreement, except as would not reasonably be expected to have a Material Adverse Effect.

(h)    Segregation of Eligible Farmer Loans. All Eligible Farmer Loans included in the Portfolio Schedule for the Current Transaction that are in the possession of Seller shall be segregated from other securities in its possession and shall be identified as subject to the Transaction Agreements. Segregation may be accomplished by appropriate identification on the books and records of Seller.

5.3    Certain Covenants. Seller covenants with Agent and each Buyer as follows:

(a)    Taxes. Subject to the provisions of Section 6.8 and the provision by each Buyer of any relevant IRS forms and related documentation confirming its exemption from withholding Taxes, Seller will pay all relevant Taxes and make all relevant returns in respect of Taxes in relation to any Purchased Securities and Seller shall indemnify and hold each Buyer harmless from and against any such Taxes. Without limiting the generality of the foregoing, Seller shall remit all Direct Taxes to the applicable Governmental Authority relating to the Purchased Securities as and when due and Seller shall indemnify and hold Buyer harmless from and against any such Taxes.

(b)    Performance of Loan Agreements. Seller shall perform and comply with each Loan Agreement governing an Eligible Farmer Loan included in the Transaction Portfolio for the Current Transaction in such a way as would not (or would not reasonably be expected to) materially affect the entitlement and/or ability to receive and/or to recover and/or enforce and/or collect payment of the full amount of such Eligible Farmer Loan, and the exercise by Agent of its rights under this Framework Agreement and the other Transaction Agreements shall not relieve Seller of such obligations.

(c)    Indemnification. Seller will indemnify and keep indemnified Agent, each Buyer, their Affiliates, and their respective officers, directors, employees and agents and their successors and assigns (each, an “Indemnified Party”) against any cost, claim, loss, expense, liability or damages (including reasonable legal costs and out-of-pocket expenses) arising out of or involving a claim or demand made by any Person (other than by Seller, any of its Affiliates or any Indemnified Party) against such Indemnified Party (each a “Claim”) and incurred or suffered by it in connection with:

(i)    any representation or warranty made by Seller under or in connection with any Transaction Agreement (including with respect to any Portfolio Schedule delivered by Seller pursuant hereto) that shall have been false or incorrect when made or deemed made (without regard to any knowledge, materiality or Material Adverse Effect qualifiers contained therein);

15

(ii)    the failure by Seller, to comply with any applicable Law with respect to any Eligible Farmer Loan included in any Transaction Portfolio, or the nonconformity of any such Eligible Farmer Loan included therein or any related Contract with any such applicable Law, rule or regulation or any failure of Seller to keep or perform any of its obligations, express or implied, with respect to any Contract;

(iii)    any failure of Seller to perform its duties, covenants or other obligations in accordance with the provisions of any Transaction Agreement;

(iv)    any products liability, personal injury or damage, suit or other similar claim arising out of or in connection with merchandise, insurance or services that are the subject of any Eligible Farmer Loan in which any Indemnified Party becomes involved as a result of any of the Transactions contemplated hereby;

(v)    any investigation, litigation or proceeding related to or arising from any Transaction Agreement, the Transactions contemplated hereby, Seller’s use of the proceeds of such Transactions, the ownership of the Eligible Farmer Loans originated by Seller or any other investigation, litigation or proceeding relating to Seller in which any Indemnified Party becomes involved as a result of any of the Transactions contemplated hereby;

(vi)    any action or omission by Seller which reduces or impairs the rights of Buyer with respect to any Eligible Farmer Loan or the value of any such Eligible Farmer Loan; and

(vii)    any civil penalty or fine assessed by OFAC or any other Governmental Authority administering any Sanctions Law or Anti-Money Laundering Law against, and all reasonable costs and expenses (including counsel fees and disbursements) incurred in connection with defense thereof by any Buyer as a result of any action of Seller;

provided, that notwithstanding the foregoing, in no event shall Seller be liable hereunder to any Indemnified Party or any other Person for (A) any special, indirect, consequential or punitive damages, even if Seller has been advised of the likelihood of such loss or damage and regardless of the form of action or (B) Claims to the extent arising from any Indemnified Party’s breach, bad faith, gross negligence or willful misconduct.

(d)    Approvals and Filings. Except as would not (or would not reasonably be expected to) materially affect the entitlement and/or ability to receive and/or to recover and/or enforce and/or collect payment of the full amount in the Eligible Farmer Loans, Seller shall maintain such Permits and make such filings, registrations and submissions as are necessary or advisable for the performance of its obligations under the Loan Agreements relating to the Eligible Farmer Loans.

(e)    Books and Records. Seller shall keep all its books, records and documents evidencing or relating to the Eligible Farmer Loans in accordance with its practice and procedures

16

from time to time. Seller shall, but only upon Agent’s reasonable request in advance of the same, during normal business hours at reasonably accessible offices in the continental United States designated by Seller, and subject to Seller’s normal security and confidentiality procedures, permit Agent or any of its agents or representatives to examine and make copies of and abstracts from the records, books of account and documents (including computer tapes and disks) of Seller, visit the properties of Seller for the purpose of examining or obtaining access to such records, books of account and documents, and discuss the affairs, finances and accounts of Seller relating to the Eligible Farmer Loans with any of its officers, and Seller shall be obligated to reimburse Agent for the costs and expenses of one such examination during the Facility Term.

(f)    No Sales, Liens. Seller (i) shall not sell, assign or grant any Security Interest on or otherwise encumber any Eligible Farmer Loan subject to a Transaction or any Loan Agreement under which such Eligible Farmer Loan arises except as expressly contemplated by the Transaction Agreements, (ii) shall not permit any Security Interest to exist on or with respect to, any such Eligible Farmer Loan or Loan Agreement except as expressly contemplated by the Transaction Agreements, and (iii) will defend the right, title and interest of the Buyers in, to and under any of the foregoing.

(g)    No Waivers, Amendments. Except to the extent arising in the ordinary course of business and except as required by Section 5.3(h), Seller shall not (x) cancel, terminate, amend, modify or waive any term or condition of any Loan Agreement for an Eligible Farmer Loan subject to a Transaction (including reducing the amount of such Eligible Farmer Loan) or (y) take any other action that, in each case, may materially affect any entitlement and/or ability to receive and/or recover and/or enforce and/or collect payment in full of the full amount of the Eligible Farmer Loan, or otherwise prejudice any Buyer’s interest in any Eligible Farmer Loan in any material respect.

(h)    Ordinary Course. Seller shall follow its credit and collection procedures with respect to the Eligible Farmer Loans in accordance with its ordinary course of dealing as in effect from time to time without regard to the Transactions contemplated hereby, and shall use the same standards it would follow with respect to Eligible Farmer Loans which are owned by Seller.

(i)    Notice of Certain Events. Seller shall provide Agent with prompt notice upon becoming aware of (x) any Event of Default or Potential Event of Default or (y) any Change of Control with respect to Seller or Guarantor.

(j)    Changes in Credit and Collection Procedures. Seller shall provide Agent with prompt notice, and in all instances at least sixty (60) days prior to the effectiveness of any material change in or material amendment to the credit and collection procedures (other than any such change or amendment required by applicable Law, in which case Seller shall provide notice to Agent of such change or amendment as promptly as practicable), a copy of the credit and collection procedures then in effect and a notice indicating such proposed change or amendment.

(k)    Information Required by Governmental Authorities. Subject to applicable Laws prohibiting or limiting such disclosure or provision of such information, documents, records or reports, Seller shall provide each Buyer promptly, from time to time upon request, such information, documents, records or reports relating to the Eligible Farmer Loans or Seller as such Buyer (or its assigns) may be required by a Governmental Authority to obtain;provided, that each

17

such Buyer shall use commercially reasonable efforts to maintain the confidentiality of such information, documents, records or reports to the extent consistent with applicable Law, Seller’s normal privacy and confidentiality procedures, the terms of the Data Transfer Agreement and any confidentiality provisions or restrictions contained therein.

(l)    Accounting. Seller shall comply with all required accounting and Tax disclosures related to the Transactions in accordance with GAAP and applicable Law, except where the failure to do so would not reasonably be expected to have a Material Adverse Effect.

(m)    Changes Concerning Seller. Seller will not undergo a Change of Control or change its (i) jurisdiction of organization, (ii) name, (iii) identity or structure (within the meaning of Article 9 of the UCC), unless it shall have notified Agent of the same and delivered to Agent all financing statement amendments and other documents necessary to maintain the perfection of the Security Interests granted by Seller under the Transaction Agreements in connection with such change, relocation or Change of Control.

(n)    Compliance. Seller will not directly or indirectly use, and shall not permit its Subsidiaries and its or their respective directors, officers, employees and, to the knowledge of Seller and to the extent commercially reasonable, agents to directly or indirectly use, the proceeds of any Transaction (i) in furtherance of an offer, payment, promise to pay, or authorization of the payment or giving of money, or anything else of value, to any Person in violation of any Anti-Money Laundering Laws or Anti-Corruption Laws, (ii) for the purpose of funding, financing or facilitating any activities, business or transaction of or with any Sanctioned Person, or in any Sanctioned Country, in violation of Sanctions Laws, or (iii) in any manner that would result in the violation of any Sanctions or Sanctions Laws by any Person (including any Party hereto). Seller shall, and cause each of its Subsidiaries to, use commercially reasonable efforts to ensure that no funds used to pay the obligations under any Transaction Agreement (i) constitute the property of, or are beneficially owned, directly or indirectly, by any Sanctioned Person, (ii) are derived from any transactions or business with any Sanctioned Person or Sanctioned Country, or (iii) are derived from any unlawful activity, including activity in violation of Anti-Money Laundering Laws or Anti-Corruption Laws. Seller will maintain in effect policies and procedures designed to promote compliance by Seller, its Subsidiaries, and their respective directors, officers, employees, and agents with Anti-Corruption Laws.

(o)    Margin Compliance During Final Two Months. On each Recalculation Date, Seller shall recalculate the aggregate Market Value of the Transaction Portfolio for the Current Transaction as of the close of business on the Business Day that is (x) three (3) Business Days before such Recalculation Date in the case of Recalculation Dates occurring prior to the Farmer Loan Maturity Date or (y) one (1) Business Day before such Recalculation Date in the case of Recalculation Dates occurring after the Farmer Loan Maturity Date, and based on such recalculations, shall notify Agent in writing (i) no later than the second Business Day following such Recalculation Date if the aggregate Market Value of such Transaction Portfolio decreases to an extent sufficient to result in a Margin Deficit exceeding fifty percent (50%) of the applicable threshold specified in Paragraph 4(e) of Annex I to the Master Repurchase Agreement and (ii) promptly if the aggregate Market Value of such Transaction Portfolio decreases to an extent sufficient

18

to result in a Margin Deficit exceeding the applicable threshold specified in Paragraph 4(e) of Annex I to the Master Repurchase Agreement.

(p)    Servicing Information. In the event that Agent reasonably determines, with notice to Seller, that the likelihood of an Event of Default occurring has increased by an amount that it deems material, Seller shall within ten (10) Business Days following receipt of such notice, provide Agent with an updated Portfolio Schedule for the Current Transaction, which updated Portfolio Schedule shall include, for each Debtor with respect to each Eligible Farmer Loan listed on the Portfolio Schedule, the name, address, phone number, email address of, and principal contact at, each such Debtor and each Portfolio Schedule delivered hereunder thereafter shall contain such additional information; provided, that, for the avoidance of doubt, any removal by Seller of Eligible Farmer Loans from the applicable Transaction Portfolio prior to or in connection with the delivery of such updated Portfolio Schedule and other documents must comply with the applicable requirements of this Framework Agreement and the Master Repurchase Agreement. If an Event of Default shall have occurred and be continuing, Seller, upon a written request from Agent, provide to Agent (i) within ten (10) Business Days following receipt of such request with a list of all invoices provided to the Debtors under the Eligible Farmer Loans comprising the Transaction Portfolio, (ii) within four weeks following receipt of such request, copies of all Loan Agreements with and invoices pertaining to, such Debtors and corresponding Eligible Farmer Loans, which delivery shall be effected at an approximate rate of 25% of such Loan Agreements and invoices per week, it being understood that delivery at a faster rate in earlier weeks may result in a smaller percentage being delivered in later weeks and (iii) as promptly as practicable following receipt of such request, any other documents which may be necessary or appropriate to enforce Seller’s rights in connection with such Eligible Farmer Loans.

6.    Agent.

Appointment and Authority.

(a)    Each of the Buyers hereby irrevocably appoints Rabobank to act on its behalf as Agent hereunder and under the other Transaction Agreements and authorizes Agent to take such actions on its behalf and to exercise such powers as are delegated to Agent by the terms hereof or thereof (including the power to execute and deliver Confirmations on behalf of such Buyer in accordance with Sections 4.1 and 4.5 of this Framework Agreement and the Master Repurchase Agreement), together with such actions and powers as are reasonably incidental thereto. The provisions of this Article VI (other than the proviso to the first sentence of Section 6.5) are solely for the benefit of Agent, and neither Seller nor Guarantor shall have rights as a third party beneficiary of any of such provisions.

(b)    Each of the Buyers hereby irrevocably appoints and authorizes Agent to act as the agent of such Buyer for purposes of acquiring, holding and enforcing any and all Security Interests on Purchased Securities granted by Seller under the Transaction Agreements, including the filing in Agent’s name of any financing statements on behalf of Buyers, together with such powers and discretion as are reasonably incidental thereto. Each Buyer hereby authorizes Agent to exercise any rights and remedies on its behalf hereunder or under the other Transaction Agreements in respect of such Security Interests.

19

(c)    Agent hereby agrees that it will promptly deliver to each Buyer copies of each Confirmation and Portfolio Schedule and any notices or written information received by Agent from Seller or Guarantor in connection with any Transaction Agreement (other than the Side Letter).

Rights as a Buyer. The Person serving as Agent hereunder shall have the same rights and powers in its capacity as a Buyer as any other Buyer and may exercise the same as though it were not Agent and the term “Buyer” or “Buyers” shall, unless otherwise expressly indicated or unless the context otherwise requires, include the Person serving as Agent hereunder in its individual capacity. Such Person and its Affiliates may accept deposits from, lend money to, act as the financial advisor or in any other advisory capacity for and generally engage in any kind of business with Seller, Guarantor or any of their Affiliates as if such Person were not Agent hereunder and without any duty to account therefor to the Buyers.

Exculpatory Provisions. The Agent shall not have any duties or obligations except those expressly set forth herein and in the other Transaction Agreements. Without limiting the generality of the foregoing, Agent:

(i)    shall not be subject to any fiduciary or other implied duties, regardless of whether an Event of Default has occurred and is continuing;

(ii)    shall not have any duty to take any discretionary action or exercise any discretionary powers; and

(iii)    shall not, except as expressly set forth herein or in the other Transaction Agreements, have any duty to disclose, and shall not be liable for the failure to disclose, any information relating to any Seller, Guarantor or any of their Affiliates that is communicated to or obtained by the Person serving as Agent or any of its Affiliates in any capacity.

Agent shall not be liable for any action taken or not taken by it in the absence of its own gross negligence or willful misconduct. Agent shall be deemed not to have knowledge of any Event of Default unless and until notice describing such Event of Default as such is given to Agent by Seller, Guarantor or a Buyer.

Agent shall not be responsible for or have any duty to ascertain or inquire into (i) any statement, warranty or representation made in or in connection with this Framework Agreement or any other Transaction Agreement, (ii) the contents of any certificate, report or other document delivered hereunder or thereunder or in connection herewith or therewith, (iii) the performance or observance of any of the covenants, agreements or other terms or conditions set forth herein or therein or the occurrence of any Event of Default, (iv) the validity, enforceability, effectiveness or genuineness of this Framework Agreement, any other Transaction Agreement or any other agreement, instrument or document, (v) the value or the sufficiency of any Purchased Securities or (vi) the satisfaction of any condition set forth in Article III, Section 4.3 or elsewhere herein, other than to confirm receipt of items expressly required to be delivered to Agent.

Reliance by Agent. Agent shall be entitled to rely upon, and shall not incur any liability for relying upon, any notice, request, certificate, consent, statement, instrument, document or other

20

writing (including any electronic message, Internet or intranet website posting or other distribution) believed by it to be genuine and to have been signed, sent or otherwise authenticated by the proper Person. Agent also may rely upon any statement made to it orally or by telephone and believed by it to have been made by the proper Person, and shall not incur any liability for relying thereon. Agent may consult with legal counsel, independent accountants and other experts selected by it, and shall not be liable for any action taken or not taken by it in accordance with the advice of any such counsel, accountants or experts.

Delegation of Duties. Agent may perform any and all of its duties and exercise its rights and powers hereunder or under any other Transaction Agreement by or through any one or more sub-agents appointed by Agent; provided, that with respect to any sub-agents taking actions with respect to, or receiving information in respect of, Eligible Farmer Loans that are not wholly-owned Subsidiaries of Agent and could reasonably be considered a competitor of Seller, but only insofar as no Event of Default has occurred and is continuing, Agent shall have first obtained the prior written consent of Seller. Agent and any such sub-agent may perform any and all of its duties and exercise its rights and powers by or through their respective Related Parties. The exculpatory provisions of this Article shall apply to any such sub-agent and to the Related Parties of Agent and any such sub-agent.

6.6    Non-Reliance on Agent and Other Buyers. Each Buyer acknowledges that it has, independently and without reliance upon Agent or any other Buyer or any of their Related Parties and based on such documents and information as it has deemed appropriate, made its own credit analysis and decision to enter into this Framework Agreement and the other Transaction Agreements. Each Buyer also acknowledges that it will, independently and without reliance upon Agent or any other Buyer or any of their Related Parties and based on such documents and information as it shall from time to time deem appropriate, continue to make its own decisions in taking or not taking action under or based upon this Framework Agreement, any other Transaction Agreement or any related agreement or any document furnished hereunder or thereunder.

Agent May File Proofs of Claim. In case of the pendency of any proceeding under any bankruptcy or insolvency Law or any other judicial proceeding relative to Seller or Guarantor, Agent shall be entitled and empowered, by intervention in such proceeding or otherwise:

(i)    to file and prove a claim for the whole amount of any amounts that are owing by Seller or Guarantor under any Transaction Agreement and unpaid and to file such other documents as may be necessary or advisable in order to have the claims of the Buyers and Agent (including any claim for the reasonable compensation, expenses, disbursements and advances of the Buyers, Agent and their respective agents and counsel and all other amounts due to the Buyers and Agent under any Transaction Agreement) allowed in such judicial proceeding; and

(ii)    to collect and receive any monies or other property payable or deliverable on any such claims and to distribute the same;

and any custodian, curator, receiver, assignee, trustee, liquidator, sequestrator or other similar official in any such judicial proceeding is hereby authorized by each Buyer to make such payments to Agent

21

and, in the event that Agent shall consent to the making of such payments directly to the Buyers, to pay to Agent any amount due for the reasonable compensation, expenses, disbursements and advances of Agents and their respective agents and counsel, and any other amounts due to Agent hereunder or under any Transaction Agreement.

Nothing contained herein shall be deemed to authorize Agent to authorize or consent to or accept or adopt on behalf of any Buyer any plan of reorganization, arrangement, adjustment or composition affecting the obligations of Seller or Guarantor under any Transaction Agreement or the rights of any Buyer or to authorize Agent to vote in respect of the claim of any Buyer in any such proceeding.

Withholding Tax. To the extent required by any applicable Law, Agent may withhold from any payment to any Buyer an amount equal to any applicable withholding Tax; provided, that Agent shall ensure that the withholding does not exceed the minimum amount legally required and Agent shall pay the amount withheld to the relevant Governmental Authority in accordance with applicable law. If the IRS or any other authority of the United States or other jurisdiction asserts a claim that Agent did not properly withhold Tax from any amount paid to or for the account of any Buyer for any reason (including because the appropriate form was not delivered or was not properly executed, or because such Buyer failed to notify Agent of a change in circumstances that rendered the exemption from, or reduction of, withholding Tax ineffective), such Buyer shall indemnify and hold harmless Agent (to the extent that Agent has not already been reimbursed by Seller or Guarantor and without limiting or expanding the obligation of Seller or Guarantor to do so) for all amounts paid, directly or indirectly, by Agent as Tax or otherwise, including any penalties, additions to Tax or interest thereon, together with all expenses incurred, including legal expenses and any out-of-pocket expenses, whether or not such Tax was correctly or legally imposed or asserted by the relevant Governmental Authority; provided, that Buyer shall not be required to indemnify Agent for penalties, addition to Tax or interest thereon, or any expenses incurred, to the extent the failure to withhold results from Agent’s gross negligence or willful misconduct. A certificate as to the amount of such payment or liability delivered to any Buyer by Agent shall be conclusive absent manifest error. Each Buyer hereby authorizes Agent to set off and apply any and all amounts at any time owing to such Buyer under this Framework Agreement or any other Transaction Agreement against any amount due to Agent under this Article VI. The agreements in this Article VI shall survive any assignment of rights by, or the replacement of, a Buyer, the expiration of the Facility Term and the repayment, satisfaction or discharge of all obligations under this Framework Agreement and the other Transaction Agreements. Unless required by applicable Laws, at no time shall Agent have any obligation to file for or otherwise pursue on behalf of a Buyer any refund of Taxes withheld or deducted from funds paid for the account of such Buyer.

7.    Payment To Agent; Several Obligations And Certain Calculations.

7.1    Payments to Agent.Notwithstanding anything to the contrary contained herein, all amounts payable to any Buyer in connection with any Transaction shall be paid to Agent, and Agent shall distribute such payments to the Buyers in accordance with Section 4.4. As between Seller and the Buyers, any payment of such amounts to Agent shall be treated as payments to the Buyers

22

and neither Seller nor Guarantor shall have any liability for the failure of Agent to comply with the preceding sentence.

7.2    Several Obligations.The obligations of the Buyers hereunder are several, and no Buyer shall have any obligation or liability for the failure of any other Buyer to perform its obligations hereunder.

7.3    Certain Calculations.Agent shall calculate the Undivided Commitment Percentages, Undivided Funding Percentages, Funded Purchase Prices, Funding Amounts, Distribution Amounts, Aggregate Commitment Amount, Aggregate Buyer Balance, Individual Commitment Amounts, Individual Buyer Balances, Breakage Amounts, the amounts of any fees payable under the Fee Letter or the Side Letter and all other amounts to be calculated under the Transaction Agreements, as well as any adjustments thereto, which calculations shall be conclusive absent manifest error. Upon the reasonable request of Seller, any Buyer or Guarantor for any such calculations, Agent shall promptly provide such calculations to such Person.

8.    Confidentiality.

8.1    Duty to Preserve Confidentiality. Except as otherwise provided herein, each Receiving Party agrees, for a period of two (2) years following the termination or expiration of this Framework Agreement, to hold in confidence all Confidential Information furnished by the Disclosing Party, to not disclose any Confidential Information to any third party, and to use Confidential Information solely for purposes of the transactions contemplated by this Framework Agreement and the other Transaction Agreements; provided, that such Confidential Information may be disclosed to Representatives of such Receiving Party as reasonably necessary in connection with the transactions contemplated by this Framework Agreement and the other Transaction Agreements, so long as such Representatives are similarly bound by an obligation of confidentiality (including by means of applicable policies of the Receiving Party).

8.2    Permitted Disclosure. Notwithstanding the foregoing Section, a Receiving Party shall be permitted to disclose Confidential Information of a Disclosing Party if the Receiving Party is required by applicable Law or other legal process or requested by any Governmental Authority asserting jurisdiction over the Receiving Party or its Affiliates, or as necessary or appropriate to enforce its rights under the Transaction Agreements. Such Receiving Party agrees that in the event of any such disclosure (other than as a result of an examination by a Governmental Authority or other regulatory authority), it will notify the Disclosing Party as soon as practicable, unless such notification shall be prohibited by applicable Law. Such Receiving Party shall disclose only that portion of the Confidential Information that, in the reasonable judgment of such Receiving Party and its Representatives, is legally required (or, in the case of request by a Governmental Authority or other regulatory authority, that portion ordinarily disclosed in accordance with the Receiving Party’s usual practice with respect to such requests) and shall disclose the Confidential Information in a manner reasonably designed to preserve its confidential nature.

8.3    Return of Confidential Information. Unless otherwise specified in writing, all Confidential Information shall remain the property of the Disclosing Party. Upon request of the Disclosing Party, the Receiving Party agrees to return or destroy all Confidential Information

23

received from the Disclosing Party; provided, that (i) the Receiving Party and its Representatives may retain Confidential Information to the extent required by any applicable Law, by any supervisory or regulatory body or by its internal record retention policy, and (ii) the Receiving Party and its Representatives shall in no event be required to erase, destroy or return any information from computer systems or hard drives, tapes, memory or other electronic forms of information retention processes, materials or equipment. All Confidential Information so retained shall remain subject to the confidentiality obligations set forth herein.

8.4    Data Transfer Agreement. In addition to the confidentiality provisions set forth in Section 8.1, but subject to the provisions of Sections 8.2 and 8.3 concerning permitted disclosures and retention, each Buyer agrees to be bound by the provisions of the Data Transfer Agreement that are applicable to the “Company” thereunder as though such Buyer were a signatory to such Data Transfer Agreement as the “Company” thereunder.

9.    Miscellaneous.

Except as otherwise expressly set forth in a Transaction Agreement, the following will apply to all Transaction Agreements:

9.1    Copies of Records; Further Assurances. Each Party will promptly provide, upon the other Party’s written request, copies of the other Party’s records in a Party’s or any of its Subsidiaries’ possession or control. Each Party will promptly execute, or cause its Subsidiaries to promptly execute, such other documents and instruments, and provide such other assurances, as reasonably necessary to carry out the purpose and intent of the Transaction Agreements.

9.2    Expenses. Upon and as a condition to the Closing, Seller shall reimburse Rabobank for all reasonable and sufficiently detailed documented out-of-pocket expenses (including fees, charges and disbursements of counsel) up to an aggregate of $125,000 incurred by Rabobank in connection with the negotiation, preparation, execution and delivery of the Transaction Agreements and any related documentation and the consummation of the transactions contemplated thereby. Except as otherwise set forth in the preceding sentence or in any Transaction Agreement, all costs and expenses, including fees and disbursements of counsel, financial advisors, and accountants, incurred in connection with any Transaction Agreement will be paid by the Party incurring those costs and expenses.

9.3    Entire Agreement. This Framework Agreement, together with the other Transaction Agreements, constitutes the entire agreement between the Parties and supersedes all prior oral and written negotiations, communications, discussions, and correspondence pertaining to the subject matter of the Transaction Agreements.

9.4    Order of Precedence. If there is a conflict between this Framework Agreement and any other Transaction Agreement, this Framework Agreement will control unless the conflicting provision of the other Transaction Agreement specifically references the provision of this Framework Agreement to be superseded.

24

9.5    Amendments and Waivers. The Transaction Agreements may only be amended or modified (including any waiver of or exception to any obligation or covenant under a Transaction Agreement) by an instrument in writing signed by each Party hereto. For the avoidance of doubt, Agent is not authorized to sign any waiver or amendment on behalf of any Buyer without the consent of such Buyer.

9.6    Binding Effect. The Transaction Agreements will be binding upon and inure to the benefit of the Parties and their respective heirs, legal representatives, successors, and permitted assigns.

9.7    Assignment. Except as provided in this Framework Agreement or any other Transaction Agreement, neither this Framework Agreement nor any other Transaction Agreement, respectively, may be assigned or otherwise transferred, nor may any right or obligation hereunder or under another Transaction Agreement be assigned or transferred by any Party without the consent of the other Parties. Any permitted assignee shall assume all obligations of its assignor under this Framework Agreement; provided, that in the event of any assignment by a Defaulting Buyer required pursuant to Section 4.5(b), any indemnity obligations owed to or by such Defaulting Buyer under the Transaction Agreements shall survive such assignment. This Framework Agreement is binding upon the permitted successors and assigns of the Parties. Any attempted assignment not in accordance with this Section 9.7 shall be void.

9.8    Notices. All notices, requests, demands, and other communications required or permitted to be given under any of the Transaction Agreements by either Party must be in writing delivered to the applicable Party at the following address:

If to Rabobank or Agent:    

Coöperatieve Rabobank, U.A., New York Branch
245 Park Avenue
New York, New York 10167
Attention:	Vikram Malkani
E-Mail:	Vikram.Malkani@rabobank.com

With copy to:

Coöperatieve Rabobank, U.A., New York Branch
245 Park Avenue
New York, New York 10167
Attention:	Chris Kortlandt
E-Mail:	Chris.Kortlandt@rabobank.com

25

If to BTMU:    

The Bank of Tokyo-Mitsubishi UFJ, Ltd.
1251 Avenue of the Americas
New York, New York 10020-1104
Attention:	Robert Wenzel
E-Mail:	RWenzel@us.mufg.jp

With copy to:

The Bank of Tokyo-Mitsubishi UFJ, Ltd.
1251 Avenue of the Americas
New York, NY 10020-1104
Attention:	Thomas Giuntini
E-Mail:	TGiuntini@us.mufg.jp

If to Seller:    

PHI Financial Services, Inc.
7100 NW 62nd Avenue
P.O. Box 1050
Johnston, Iowa 50131
Attention:	Secretary
E-Mail:	mike.wineland@pioneer.com

With a copy to:    

E. I. du Pont de Nemours and Company
974 Centre Road
Chestnut Run Plaza 730/5218
Wilmington, Delaware 19805
Attention:	Treasury Consultant and Corporate Secretary
E-Mails:	james.p.donaghey@dupont.com
	erik.t.hoover@dupont.com

or to such other address as any Party may designate by written notice to the other Party. Each notice, request, demand, or other communication will be deemed given and effective, as follows: (i) if sent by hand delivery, upon delivery; (ii) if sent by first-class U.S. Mail, postage prepaid, upon the earlier to occur of receipt or three (3) days after deposit in the U.S. Mail; (iii) if sent by a recognized prepaid overnight courier service, one (1) Business Day after the date it is given to such service; (iv) if sent

26

by facsimile, upon receipt of confirmation of successful transmission by the facsimile machine; and (v) if sent by email, upon acknowledgement of receipt by the recipient.

9.9    GOVERNING LAW. THIS FRAMEWORK AGREEMENT SHALL BE GOVERNED BY AND CONSTRUED IN ACCORDANCE WITH THE LAWS OF THE STATE OF NEW YORK WITHOUT GIVING EFFECT TO THE CONFLICTS OF LAW PROVISIONS THEREOF OTHER THAN SECTIONS 5-1401 AND 5-1402 OF THE NEW YORK GENERAL OBLIGATIONS LAW.

9.10    Jurisdiction. Each Party hereby irrevocably and unconditionally:

(a)    submits for itself and its property in any legal action or proceeding relating to this Framework Agreement, or for recognition and enforcement of any judgment in respect thereof, to the non-exclusive general jurisdiction of the courts of the State of New York located in the Borough of Manhattan in the City of New York, the courts of the United States of America for the Southern District of New York and appellate courts from any thereof;

(b)    consents that any such action or proceeding may be brought in such courts and waives any objection that it may now or hereafter have to the venue of any such action or proceeding in any such court or that such action or proceeding was brought in an inconvenient court and agrees not to plead or claim the same;

(c)    agrees that service of process in any such action or proceeding may be effected by mailing a copy thereof by registered or certified mail (or any substantially similar form of mail), postage prepaid, to the applicable party at its respective address set forth in Section 9.8 or at such other address which has been designated in accordance therewith; and

(d)    agrees that nothing herein shall affect the right to effect service of process in any other manner permitted by Law or shall limit the right to sue in any other jurisdiction.

9.11    WAIVER OF JURY TRIAL. EACH PARTY HEREBY WAIVES ITS RIGHTS TO A TRIAL BY JURY OF ANY CLAIM OR CAUSE OF ACTION BASED UPON OR ARISING OUT OF OR RELATED TO ANY OF THE TRANSACTION AGREEMENTS OR THE TRANSACTIONS CONTEMPLATED BY THE TRANSACTION AGREEMENTS, IN ANY ACTION, PROCEEDING OR OTHER LITIGATION OF ANY TYPE BROUGHT BY EITHER PARTY AGAINST THE OTHER, WHETHER WITH RESPECT TO CONTRACT CLAIMS, TORT CLAIMS, OR OTHERWISE. EACH PARTY HEREBY AGREES THAT ANY SUCH CLAIM OR CAUSE OF ACTION WILL BE TRIED BY A COURT TRIAL WITHOUT A JURY. WITHOUT LIMITING THE PREVIOUS SENTENCE, THE PARTIES FURTHER AGREE THAT THEIR RESPECTIVE RIGHTS TO A TRIAL BY JURY IS WAIVED BY OPERATION OF THIS SECTION AS TO ANY ACTION, COUNTERCLAIM, OR OTHER PROCEEDING THAT SEEKS, IN WHOLE OR IN PART, TO CHALLENGE THE VALIDITY OR ENFORCEABILITY OF ANY PORTION OF ANY TRANSACTION AGREEMENTS. THIS WAIVER WILL APPLY TO ANY SUBSEQUENT AMENDMENT, RENEWAL, SUPPLEMENT, OR MODIFICATION TO ANY OF THE TRANSACTION AGREEMENTS.

27

9.12    Severability. If any provision of a Transaction Agreement is held by a court of competent jurisdiction to be invalid, unenforceable, or void, that provision will be enforced to the fullest extent permitted by applicable Law, and the remainder of the applicable Transaction Agreement will remain in full force and effect. If the time period or scope of any provision is declared by a court of competent jurisdiction to exceed the maximum time period or scope that that court deems enforceable, then that court will reduce the time period or scope to the maximum time period or scope permitted by Law.

9.13    Survival. The provisions of Section 5.3(c), Article VI, Article VII, Article VIII and this Article IX shall survive any termination or expiration of this Framework Agreement and any of the other Transaction Agreements.

9.14    Counterparts. The Transaction Agreements and any document related to the Transaction Agreements may be executed by the Parties on any number of separate counterparts, by facsimile or email, and all of those counterparts taken together will be deemed to constitute one and the same instrument; signature pages may be detached from multiple separate counterparts and attached to a single counterpart so that all signatures are physically attached to the same document. A facsimile, portable document format (“.pdf”) or other electronic format signature page will constitute an original for the purposes of this Section 9.14 (including with respect to each of the Transaction Agreements and related documents).

[SIGNATURE PAGES FOLLOW]

28

IN WITNESS WHEREOF, the Parties have executed this Master Framework Agreement as of the date first written above.

Buyer and Agent:

Coöperatieve Rabobank, U.A., New York Branch
By:	/s/ Vikram Malkani
Name:	Vikram Malkani
Title:	Managing Director
By:	/s/ Chris G. Kortlandt
Name:	Chris G. Kortlandt
Title:	Managing Director

[SIGNATURE PAGES CONTINUE ON FOLLOWING PAGE]

[Signature Page to Master Framework Agreement]

IN WITNESS WHEREOF, the Parties have executed this Master Framework Agreement as of the date first written above.

Buyer:

The Bank of Tokyo-Mitsubishi UFJ, Ltd., New York Branch
By:	/s/ Thomas Giuntini
Name:	Thomas Giuntini
Title:	Director

[SIGNATURE PAGES CONTINUE ON FOLLOWING PAGE]

[Signature Page to Master Framework Agreement]

IN WITNESS WHEREOF, the Parties have executed this Master Framework Agreement as of the date first written above.

Seller:

PHI Financial Services, Inc.
By:	/s/ Andrew Girardi
Name:	Andrew Girardi
Title:	President

[Signature Page to Master Framework Agreement]

SCHEDULE 1

DEFINITIONS

As used in the Transaction Agreements, the following terms have the following meanings unless otherwise defined in any Transaction Agreement:

“Action” means any suit in equity, action at law or other judicial or administrative proceeding conducted or presided over by any Governmental Authority.

“Additional Funding Conditions” has the meaning set forth in Section 4.3(a).

“Additional Funding Transaction” means a Transaction with respect to which any Funded Purchase Price is to be paid, whether pursuant to Section 4.2(b) or Section 4.5(a)(ii).

“Affiliate” of a Party means any Person that directly or indirectly, through one or more intermediaries, controls, is controlled by, or is under common control with, that Party. The term “control” (including the terms “controlled by” and “under common control with”) means the possession, directly or indirectly, of the power to direct or cause the direction of the management and policies of a Person, whether through the ownership of voting securities, by contract, or otherwise.

“Agent” has the meaning set forth in the Preamble.

“Aggregate Commitment Amount” means, as of any date of determination with respect to any Transaction or proposed Transaction, the sum of the applicable Individual Commitment Amounts for each of the Buyers as of such date of determination.

“Aggregate Buyer Balance” means, as of any time of determination, the aggregate Purchase Price with respect to the applicable Current Transaction.

“Anti-Corruption Laws” means the Foreign Corrupt Practices Act of 1977, the UK Bribery Act of 2010, and the rules and regulations promulgated thereunder, and all other laws, rules, and regulations of any jurisdiction applicable to Seller or any of its Subsidiaries concerning or relating to bribery or corruption.

“Anti-Money Laundering Laws” means the Patriot Act, the Money Laundering Control Act of 1986, the Bank Secrecy Act, and the rules and regulations promulgated thereunder, and corresponding laws of the jurisdictions in which Seller or any of its Subsidiaries operates or in which Seller or any of its Subsidiaries will use the proceeds of the Transactions.

“Asset Representations, Warranties and Covenants” means, collectively, the representations, warranties and covenants set forth in Section 5.2, Section 5.3(b), Section 5.3(d), Section 5.3(f), Section 5.3(g) and Section 5.3(h).

“Book Value” means, with respect to any Eligible Farmer Loan as of any date of determination, the outstanding principal amount of such Eligible Farmer Loan as of such date of determination.

Schedule 1 to Master Framework Agreement

“Breakage Amount” has the meaning set forth in the Master Repurchase Agreement.

“Business Day” means any day other than (i) a Saturday or Sunday or (ii) a day on which banking institutions located in New York City are permitted or required by applicable Law or regulation to remain closed.

“Buyer” has the meaning set forth in the Preamble.

“CBR Score” means, with respect to any Debtor that is a natural person as of any date of determination, the most recent numerical FICO score issued by Equifax, Experian or TransUnion with respect to such Debtor obtained by Seller and maintained in its records in accordance with its underwriting procedures for the 2018 season; provided, that any such Debtor for which Seller does not have a FICO score in its records as of such date of determination (with respect to which the most recent FICO score in Seller’s records was issued more than three (3) years prior to such date of determination) shall be deemed to have a FICO score of zero.

“Change of Control” means with respect to any Person, the acquisition of ownership, directly or indirectly, beneficially or of record, by any Person or group (within the meaning of the Securities Exchange Act of 1934 and the rules of the Securities and Exchange Commission thereunder as in effect on the date hereof), of voting equity securities representing more than 50% of the aggregate ordinary voting power represented by the issued and outstanding voting equity securities of such Person; provided, that the occurrence of any of the following shall also be treated as a Change of Control with respect to Seller:

(a)    Topco ceases to own, directly or indirectly, 100% of the issued and outstanding equity interests in Guarantor (other than, unless redeemed or otherwise extinguished, the Preferred Stock - $4.50 Series and the Preferred Stock - $3.50 Series of Guarantor outstanding on March 22, 2016);

(b)    Guarantor violates the provisions of Sections 5.09, 6.01 or 6.05 of the Revolver, as amended from time to time;

(c)    Guarantor violates the provisions of Section 6.02 of the Revolver, as amended from time to time, replacing the reference to a “Default” thereunder with an Event of Default under this Framework Agreement; or

(d)    Seller ceases to be a direct or indirect wholly-owned Subsidiary of Guarantor.

“Code”means the Internal Revenue Code of 1986, as amended.

“Commitment Reduction Date” means the each of the Monthly Dates occurring in October, 2018 and November, 2018.

“Confidential Information” means any and all information, know-how and data, technical or non-technical, disclosed or provided by one Party to another Party concerning any of the Transaction Agreements, the subject matter thereof or any of the transactions contemplated thereby, whether

Schedule 1 to Master Framework Agreement

disclosed or provided in oral, written, graphic, photographic, electronic, or any other form, but excluding any such information to the extent that such information:

(a)    is or becomes generally known or available to the public without breach of this Framework Agreement;

(b)    is known to the Receiving Party or any of its Representatives at the time of disclosure, as evidenced by written records of the Receiving Party;

(c)    is independently developed by the Receiving Party or any of its Representatives, as evidenced by written records of the Receiving Party; or

(d)    is disclosed to the Receiving Party by a third party who, to the knowledge of the Receiving Party, is not bound by any duty of confidentiality to the Disclosing Party.

“Confirmation” has the meaning set forth in the Master Repurchase Agreement.

“Contract” means contracts, leases, deeds, mortgages, licenses, instruments, notes, commitments, undertakings, indentures, joint ventures and all other agreements, commitments, and legally binding arrangements, whether written or oral.

“Current Transaction” means, as of any time of determination, the Transaction, if any, outstanding at such time of determination.

“Data Transfer Agreement” means that certain Data Transfer Agreement dated as of September 15, 2015, between Agent and Guarantor, as set forth on Schedule 4.

“Debtor” means, with respect to any Eligible Farmer Loan, each of the Persons designated as a “borrower” under the applicable Loan Agreement.

“Deemed Roll-Over Conditions” has the meaning set forth in Section 4.3(c).

“Deemed Roll-Over Transaction” has the meaning set forth in Section 4.1(c).

“Defaulting Buyer” has the meaning set forth in Section 4.5.

“Direct Taxes” means sales, use, excise, gross receipts, fuel, value added, export/import, acquisition, transfer and similar Taxes, or any inspection fees, environmental fees and similar amounts imposed on or with respect to any Eligible Farmer Loan or any Contracts related thereto.

“Disclosing Party” means the Party who provides (by any means, including indirectly through Agent or any third party or third party application or website) any Confidential Information to the Receiving Party.

“Distribution Amount” means, for any Buyer with respect to any Funded Repurchase Price or Margin Payment paid by Seller in connection with any Transaction, an amount equal to the product of

Schedule 1 to Master Framework Agreement

such Funded Repurchase Price or Margin Payment, multiplied by such Buyer’s Undivided Funding Percentage as of the date such Funded Repurchase Price or Margin Payment was paid by Seller to Agent.

“DowDuPont Merger” means that certain merger of equals transaction completed as of August 31, 2017 pursuant to and as contemplated by the Agreement and Plan of Merger, dated as of December 11, 2015, by and among The Dow Chemical Company, DowDuPont Inc. (f/k/a Diamond-Orion Holdco, Inc.), Diamond Merger Sub, Inc., Orion Merger Sub, Inc. and Guarantor, as supplemented by the Orion Disclosure Letter thereto and the Diamond Disclosure Letter thereto, each dated as of the same time, and as subsequently amended on March 31, 2017.

“Eligible Farmer Loan” means any outstanding loan made by Seller to a customer of Seller or its Affiliates in connection with Seller’s Pioneer Deferred Payment Plan program with a stated final maturity date of December 1, 2018 (the “Farmer Loan Maturity Date”).

“ERISA Event” has the meaning ascribed to such term in the Revolver.

“Event of Default” means any of the following:

(a)    Seller or Guarantor shall have failed to pay any margin payment required to be paid under Paragraph 4(a) of the Master Repurchase Agreement or any Repurchase Price due and payable on the Scheduled Facility Expiration Date or on any Commitment Reduction Date, in each case, when and as the same shall become due and payable;

(b)    Seller or Guarantor shall have failed to pay any Repurchase Price (other than any Repurchase Price payable on the Scheduled Facility Expiration Date or any Commitment Reduction Date), Price Differential, any fee required to be paid under the Fee Letter or the Side Letter, any amount required to be refunded pursuant to Section 4.5(a)(iii) hereof, or any other amounts owing under any Transaction Agreement (other than amounts specified in clause (a) of this definition), in each case, when and as the same shall become due and payable, and such failure shall continue unremedied for a period of three (3) or more Business Days;

(c)    Seller shall fail to perform any covenant set forth in Section 5.3(f)(i) or Section 5.3(o);

(d)    Seller or Guarantor shall fail to observe or perform any covenant, condition or agreement contained in this Framework Agreement or any other Transaction Agreement (excluding (i) any covenants, conditions or agreements contained in the Asset Representations, Warranties and Covenants unless the failure to observe such covenants, conditions and agreements would, individually or in the aggregate, have a Material Adverse Effect and (ii) any covenants, conditions or agreements specified in clauses (a), (b) or (c) of this definition) and such failure shall continue unremedied for a period of 30 or more days;

(e)    any representation or warranty made or deemed made by or on behalf of Seller or Guarantor in or in connection with this Framework Agreement, any other Transaction Agreement or

Schedule 1 to Master Framework Agreement

any amendment or modification hereof or thereof, shall prove to have been incorrect in any material respect when made or deemed made (excluding any representations or warranties contained in the Asset Representations, Warranties and Covenants unless the failure of such representations and warranties would, individually or in the aggregate, have a Material Adverse Effect), and such failure to be correct shall continue unremedied for a period of 30 or more days;

(f)    an involuntary proceeding shall be commenced or an involuntary petition shall be filed seeking (i) liquidation, reorganization or other relief in respect of either of Seller or Guarantor or its debts, or of a substantial part of the assets thereof, under any Federal, state or foreign bankruptcy, insolvency, receivership or similar law now or hereafter in effect or (ii) the appointment of a receiver, trustee, custodian, sequestrator, conservator or similar official for either of Seller or Guarantor or for a substantial part of its assets, and in any such case, such proceeding or petition shall continue undismissed for a period of 60 or more days or an order or decree approving or ordering any of the foregoing shall be entered;

(g)    Seller or Guarantor shall (i) voluntarily commence any proceeding or file any petition seeking liquidation, reorganization or other relief under any Federal, state or foreign bankruptcy, insolvency, receivership or similar law now or hereafter in effect, (ii) consent to the institution of, or fail to contest in a timely and appropriate manner, any proceeding or petition described in clause (f) of this definition, (iii) apply for or consent to the appointment of a receiver, trustee, custodian, sequestrator, conservator or similar official for Seller or for a substantial part of its assets, (iv) file an answer admitting the material allegations of a petition filed against it in any such proceeding, (v) make a general assignment for the benefit of creditors or (vi) take any action for the purpose of effecting any of the foregoing;

(h)    Seller or Guarantor shall become unable, admit in writing its inability or fail generally to pay its debts as they become due;

(i)    one or more judgments for the payment of money in an aggregate amount (to the extent not covered by insurance) in excess of $100,000,000 shall be rendered against Seller, Guarantor or any Material Subsidiaries of Guarantor or any combination thereof, and the same shall remain undischarged for a period of thirty (30) or more consecutive days during which execution shall not be effectively stayed, vacated or bonded pending appeal;

(j)    an ERISA Event shall have occurred that, in the reasonable determination of Agent, when taken together with all other ERISA Events that have occurred, could reasonably be expected to result in a Material Adverse Effect; and

(k)    the Guaranty shall cease to be in full force and effect, or its validity or enforceability shall be disputed by Seller or Guarantor.

“Facility Expiration Date” means the Scheduled Facility Expiration Date; provided, that on any Business Day following the occurrence of a Change of Control with respect to Guarantor or Seller, Agent may deliver a written notice to Seller terminating the Facility Term, in which case the Facility Expiration Date shall be the first Monthly Date to occur that is at least five (5) Business Days following the date of such delivery.

Schedule 1 to Master Framework Agreement

“Facility Term” means the period beginning on the Effective Date and ending on the Facility Expiration Date.

“Farmer Loan Maturity Date” has the meaning set forth in the definition of Eligible Farmer Loan.

“Fee Letter” means that certain Fee Letter Agreement dated as of the Effective Date, by and between Seller, Agent and the Buyers.

“Framework Agreement” has the meaning set forth in the Preamble.

“Funded Purchase Price” means, with respect to any Transaction entered into (or proposed to be entered into) on any Purchase Date, the excess of (a) Purchase Price for such Transaction over (y) the amount of Repurchase Price under the Transaction (if any) whose Repurchase Date coincides with such Purchase Date which is netted against such Purchase Price in accordance with Paragraph 12 of the Master Repurchase Agreement (any such netting being subject to Paragraph 12 of Annex I to the Master Repurchase Agreement).

“Funded Repurchase Price” means, with respect to any Transaction expiring on any Repurchase Date, the Repurchase Price for such Transaction minus the amount of any Purchase Price under any other Transaction whose Purchase Date coincides with such Repurchase Date which is netted against such Repurchase Price in accordance with Paragraph 12 of the Master Repurchase Agreement (any such netting being subject to Paragraph 12 of Annex I to the Master Repurchase Agreement).

“Funding Amount” means, with respect to any Buyer in connection with any proposed Additional Funding Transaction, an amount equal to the product of (x) the Funded Purchase Price anticipated to be payable with respect to such Additional Funding Transaction (as specified in the relevant Funding Notice and without regard to any subsequent reduction thereof) multiplied by (y) such Buyer’s Undivided Commitment Percentage with respect to such Additional Funding Transaction; provided, that if one or more Buyers are Defaulting Buyers as of the date on which Agent delivers (or is required to deliver) the relevant Funding Notice in connection with such proposed Additional Funding Transaction pursuant to Section 4.2(a), then solely for purposes of calculating the applicable Funding Amounts for each Buyer in connection with such proposed Additional Funding Transaction, (i) the Undivided Commitment Percentage of each such existing Defaulting Buyer with respect to such Additional Funding Transaction shall be deemed to be zero, and (ii) the Undivided Commitment Percentages of the remaining Buyers shall be deemed to be proportionately increased (as calculated by Agent and indicated in the relevant Funding Notice for such proposed Additional Funding Transaction) such that the sum of the Undivided Commitment Percentages of such remaining Buyers equals 100%.

“Funding Notice” has the meaning set forth in Section 4.2(a).

“GAAP”means generally accepted accounting principles as applied in the United States.

“Governmental Authority” means any federal, state, local or foreign government or political subdivision thereof, or any agency or instrumentality of such government or political subdivision, or

Schedule 1 to Master Framework Agreement

any agency, authority, instrumentality, regulatory body, court, central bank or other entity exercising executive, legislative, judicial, taxing, regulatory or administrative powers or functions of or pertaining to government (including any supranational bodies such as the European Union or the European Central Bank).

“Governmental Order” means any order, writ, judgment, injunction, decree, stipulation, determination or award entered by or with any Governmental Authority.

“Guarantor” means E. I. du Pont de Nemours and Company, a Delaware corporation.

“Guaranty” means that certain Guaranty, dated as of the Effective Date, executed by Guarantor in favor of Buyers.

“Individual Buyer Balance” means, for any Buyer as of any time of determination, the excess, if any, of (x) the aggregate amount of Funded Purchase Price funded by such Buyer and applied to Purchase Price over (y) the aggregate Distribution Amounts allocated to such Buyer with respect to amounts of Funded Repurchase Price or Margin Payments paid by Seller (excluding any such amounts of Funded Repurchase Price attributable to payments of Price Differential), in each case, in connection with the Current Transaction and all prior Transactions as of such time of determination, subject to transfer or adjustment in accordance with the terms hereof.

“Individual Commitment Amount” means, with respect to each Buyer in connection with any outstanding or proposed Transaction, the amount set forth in Schedule 5 to this Framework Agreement for such Buyer corresponding to the calendar month in which the Purchase Date for such Transaction occurs, subject to transfer or adjustment in accordance with the terms hereof.

“Law” means any statute, law, ordinance, regulation, rule, code, order, constitution, treaty, common law, judgment, decree, other requirement or rule of law of any Governmental Authority.

“Loan Agreement” means, with respect to each Eligible Farmer Loan, the Contract governing such loan, as amended.

“Margin Deficit” has the meaning set forth in the Master Repurchase Agreement.

“Margin Payment” means any cash transferred by Seller to Agent as required pursuant to Paragraph 4(a) of the Master Repurchase Agreement or as permitted under Paragraph 4(f) of Annex I to the Master Repurchase Agreement.

“Market Value” has the meaning set forth in the Master Repurchase Agreement.

“Master Repurchase Agreement” means that certain 1996 SIFMA Master Repurchase Agreement dated as of February 13, 2018, between Seller and Buyers, including Annex I thereto (and as amended thereby).

“Material Adverse Effect” means a material adverse effect on (a) the Eligible Farmer Loans, taken as a whole, (b) the ability of Seller to perform any of its obligations under the Transaction

Schedule 1 to Master Framework Agreement

Agreements to which it is a party or (c) the rights of or benefits available to the Buyers under the Transaction Agreements.

“Material Subsidiary” has the meaning ascribed to such term in the Revolver.

“Monthly Date” means each of (i) February 23, 2018 and (ii) the eleventh (11^th) Business Day of each subsequent calendar month occurring during the Facility Term.

“OFAC” means the Office of Foreign Assets Control of the U.S. Department of the Treasury.

“Organizational Documents” means a Party’s articles or certificate of incorporation and its by-laws or similar governing instruments required by the laws of its jurisdiction of formation or organization.

“Party” and “Parties” have the meaning set forth in the Preamble.

“Permits” means all permits, licenses, franchises, approvals, authorizations, registrations, certificates, variances and similar rights obtained, or required to be obtained, from Governmental Authorities.

“Person” means an individual, corporation, partnership, joint venture, limited liability company, Governmental Authority, unincorporated organization, trust, association, or other entity.

“Portfolio Schedule” has the meaning set forth in the Master Repurchase Agreement.

“Potential Event of Default” means the occurrence of any event that, with the giving of notice or lapse of time, would become an Event of Default.

“Price Differential” has the meaning set forth in the Master Repurchase Agreement.

“Pricing Rate” has the meaning set forth in the Master Repurchase Agreement.

“Purchase Date” has the meaning set forth in the Master Repurchase Agreement.

“Purchase Price” has the meaning set forth in the Master Repurchase Agreement.

“Purchased Securities” has the meaning set forth in the Master Repurchase Agreement.

“Rabobank” has the meaning set forth in the Preamble.

“Recalculation Date” means each of October 29, 2018, November 26, 2018, December 4, 2018 and December 11, 2018, as each such date may be adjusted at the request of Seller with the consent of Agent.

“Receiving Party” means the Party to whom any Confidential Information is provided (by any means, including indirectly through Agent or any third party or third party application or website) by the Disclosing Party.

Schedule 1 to Master Framework Agreement

“Related Parties” means, with respect to any Person, such Person’s Affiliates and the partners, directors, officers, employees, agents, sub-agents, trustees and advisors of such Person and of such Person’s Affiliates.

“Representatives” means, with respect to any Person, its Affiliates, and the respective directors, officers, employees, consultants, representatives, attorneys, accountants, auditors, professional advisors and agents of such Person and each such Affiliate.

“Repurchase Date” has the meaning set forth in the Master Repurchase Agreement.

“Repurchase Price” has the meaning set forth in the Master Repurchase Agreement.

“Revolver” means that certain Credit Agreement dated as of May 21, 2014, as amended and restated as of March 22, 2016, among Guarantor, as Borrower, the Lenders from time to time party thereto, and JPMorgan Chase Bank, N.A., as Administrative Agent (as such agreement may be amended, restated or otherwise modified from time to time).

“Roll-Over Conditions” has the meaning set forth in Section 4.3(b).

“Roll-Over Portfolio Schedule” has the meaning set forth in Section 4.1(d)(C).

“Roll-Over Transaction” means any Transaction other than an Additional Funding Transaction.

“Sanctioned Country” means, at any time, a country or territory that is the target of comprehensive, country-wide or territory-wide Sanctions.

“Sanctioned Person” means, at any time, (a) any Person that is the target of any Sanctions, (b) listed in any Sanctions-related list of designated Persons maintained by any U.S. Governmental Authority (including OFAC), Her Majesty’s Treasury of the United Kingdom, the United Nations Security Council, the European Union or the Netherlands, (c) any Person organized or resident in a Sanctioned Country or (d) any Person that is fifty-percent or more owned, directly or indirectly, in the aggregate by, or is otherwise controlled by (within the meaning of applicable Sanctions Laws), any Person referred to in clauses (a), (b) or (c) above.

“Sanctions” means the economic or financial sanctions, trade embargoes or anti-terrorism programs implemented by Sanctions Laws.

“Sanctions Laws” means the laws, rules, regulations and executive orders promulgated or administered to implement economic or financial sanctions, trade embargoes or anti-terrorism programs by (a) any U.S. Governmental Authority (including OFAC), including Executive Order 13224, the Patriot Act, the Trading with the Enemy Act, the International Emergency Economic Powers Act; (b) Her Majesty’s Treasury of the United Kingdom; (c) the United Nations Security Council; (d) the European Union; or (e) the Netherlands.

“Scheduled Facility Expiration Date” means December 17, 2018.

Schedule 1 to Master Framework Agreement

“Security Interest” means any pledge, charge, lien, assignment by way of security, retention of title and any other encumbrance or security interest whatsoever created or arising under any relevant law, as well as any other agreement or arrangement having the effect of or performing the economic function of the same.

“Seller” has the meaning set forth in the Preamble.

“Side Letter” means that certain Side Letter Agreement dated as of the Effective Date, by and between Seller and Rabobank.

“Subsidiary” of any Person means any corporation, partnership, limited liability company, association, trust, unincorporated association or other legal entity of which such Person (either alone or through or together with any other Subsidiary), (i) owns, directly or indirectly, fifty percent (50%) or more of the shares of capital stock or other equity interests that are generally entitled to vote for the election of the board of directors or other governing body of such corporation or other legal entity; or (ii) has the contractual or other power to designate a majority of the board of directors or other governing body (and, where the context permits, includes any predecessor of such an entity).

“Tax” means all taxes, levies, imposts, duties, deductions, withholdings (including backup withholding), assessments, fees or other charges payable to or imposed by any Governmental Authority, including any sales, use, excise or similar taxes and inclusive of any interest, additions to tax, penalties or fines applicable thereto.

“Topco” means DowDuPont Inc., a Delaware corporation.

“Transaction” has the meaning set forth in the Master Repurchase Agreement.

“Transaction Agreements” has the meaning set forth in Section 2.1.

“Transaction Conditions” means (i) in the case of any Additional Funding Transaction, the Additional Funding Conditions, (ii) in the case of any Roll-Over Transaction, the Roll-Over Conditions and (iii) in the case of any Deemed Roll-Over Transaction, the Deemed Roll-Over Conditions.

“Transaction Notice” has the meaning set forth in Section 4.1.

“Transaction Period” means, with respect to any Transaction, the period commencing on (and including) the Purchase Date for such Transaction and expiring on (but excluding) the Repurchase Date for such Transaction.

“Transaction Portfolio” means, with respect to any Transaction, the portfolio of Eligible Farmer Loans comprising the Purchased Securities acquired by Buyers in connection with such Transaction, as such portfolio may be modified from time to time during the Transaction Period for such Transaction in accordance with the terms of the Master Repurchase Agreement and applicable Confirmation.

“Undivided Commitment Percentage” means, with respect to any Buyer as of any date of determination or in connection with any Transaction or proposed Transaction, a fraction (expressed as

Schedule 1 to Master Framework Agreement

a percentage) (a) the numerator of which is the Individual Commitment Amount of such Buyer applicable to such Transaction as of such date of determination and (b) the denominator of which is the Aggregate Commitment Amount in connection with such Transaction as of such date of determination.

“Undivided Funding Percentage” means, with respect to any Buyer as of any date of determination in connection with any Transaction, a fraction (expressed as a percentage), (a) the numerator of which is the Individual Buyer Balance of such Buyer as of such date of determination and (b) the denominator of which is the Aggregate Buyer Balance as of such date of determination.

“Weighted Average CBR Score” means, with respect to any Transaction Portfolio, the average of the CBR Scores for the applicable Debtors with respect to all Eligible Farmer Loans included in such Transaction Portfolio made to Debtors who are natural persons, weighted in accordance with the respective Book Values of such Eligible Farmer Loans.

Schedule 1 to Master Framework Agreement

SCHEDULE 5

INDIVIDUAL COMMITMENT AMOUNTS

($ in millions)

	Rabobank		BTMU
February 2018		$50		$50
March 2018		$150		$150
April 2018		$300		$300
May 2018		$550		$550
June 2018		$650		$650
July 2018		$650		$650
August 2018		$650		$650
September 2018		$650		$650
October 2018		$550		$550
November 2018		$400		$400

Schedule 5 to Master Framework Agreement

EX-12

Exhibit 12

E. I. DU PONT DE NEMOURS AND COMPANY

COMPUTATION OF RATIO OF EARNINGS TO FIXED CHARGES

(Dollars in millions)

	Successor			Predecessor
	9/1/17-12/31/17			1/1/17-8/31/17			2016			2015			2014			2013
(Loss) Income from continuing operations before income taxes	$	(1,586	)	$	1,791		$	2,723		$	2,022		$	3,564		$	1,857
Adjustment for companies accounted for by the    equity method	33			(42		)	(23		)	39			150			63
Less: Capitalized interest	(6		)	(18		)	(25		)	(70		)	(56		)	(39		)
Add: Amortization of capitalized interest	—			18			51			32			36			36
	(1,559		)	1,749			2,726			2,023			3,694			1,917
Fixed charges:
Interest and debt expense	107			254			370			322			377			448
Capitalized interest	6			18			25			70			56			39
Rental expense representative of interest factor	32			42			70			101			99			93
	145			314			465			493			532			580
Total adjusted earnings available for payment of     fixed charges	$	(1,414	)	$	2,063		$	3,191		$	2,516		$	4,226		$	2,497
Number of times fixed charges earned	N/A1			6.6			6.9			5.1			7.9			4.3

¹ The ratio coverage for the period September 1 to December 31, 2017 is less than 1:1. DuPont would need to generate additional earnings of approximately $1,559 million to achieve coverage of 1:1 for the period September 1 to December 31, 2017.

EX-21

Exhibit 21

SUBSIDIARIES OF THE REGISTRANT

Set forth below are certain subsidiaries of

E. I. du Pont de Nemours and Company

Name	Organized Under Laws Of
Belco Technologies Corporation	Delaware
DPC (Luxembourg) SARL	Luxembourg
DPNL BV	The Netherlands
Du Pont (Australia) PTY LTD.	Australia
Du Pont Agricultural Chemicals Ltd., Shanghai	China
Du Pont China Limited (US)	Delaware
Du Pont de Nemours (Belgium) BVBA	Belgium
Du Pont de Nemours Italiana S.r.l.	Italy
Du Pont Feedstocks Company	Delaware
DuPont (China) Research & Development and Management Co., Ltd.	China
DuPont (Korea) Inc.	Korea
DuPont (Thailand) Limited	Thailand
DuPont (U.K.) Industrial Limited	United Kingdom
DuPont (U.K.) Limited	United Kingdom
DuPont (U.K.) Ltd.	United Kingdom
DuPont Acquisition (Luxembourg) S.a.r.l.	Luxembourg
DuPont Acquisition, LLC	Delaware
DuPont Apollo (Shenzhen) Limited	China
DuPont Argentina S.R.L.	Argentina
DuPont Asturias, S.L.	Spain
DuPont Belgium North America Finance Company	Belgium
DuPont BVco BV	The Netherlands
DuPont Capital Management Corporation	Delaware
DuPont Chemical and Energy Operations, Inc.	Delaware
DuPont China Holding Company Ltd.	China
DuPont China Limited	Hong Kong
DuPont Company (Singapore) Pte Ltd.	Singapore
DuPont Contern (Luxembourg) SARL	Luxembourg
DuPont Coordination Center N.V.	Belgium
DuPont DACI Beteiligungs-GmbH	Austria
DuPont de Nemours (Deutschland) GmbH	Germany
DuPont de Nemours (France) S.A.S.	France
DuPont de Nemours (Luxembourg) S.a.r.l.	Luxembourg
DuPont de Nemours (Luxembourg) SARL	Luxembourg
DuPont de Nemours (Nederland) B.V.	The Netherlands
DuPont de Nemours Groupe SAS	France
DuPont de Nemours Holding Sarl (LLC)	Switzerland
DuPont de Nemours International S.a.r.l.	Switzerland
DuPont de Nemours International Sarl	Switzerland
DuPont Denmark Holding ApS	Denmark
DuPont Deutschland Holding GmbH & Co. KG	Germany
DuPont do Brasil S.A.	Brazil
DuPont Eastern Europe BV	The Netherlands
DuPont Electronic Polymers LP	Delaware
DuPont Electronics Microcircuits Industries, Ltd.	Bermuda
DuPont Energy Company, LLC	Delaware
DuPont Global Operations, Inc.	Delaware
DuPont Iberica, S.L.	Spain
DuPont International (Luxembourg) SCA	Luxembourg

DuPont International B.V.	The Netherlands
DuPont International Operations S.a r.l.	Switzerland
DuPont Kabushiki Kaisha	Japan
DuPont KGA B.V.	The Netherlands
DuPont Mexico S.A. de C.V.	Mexico
DuPont Nutrition Biosciences ApS	Denmark
DuPont Nutrition USA, Inc.	Delaware
DuPont Operations Worldwide, Inc.	Delaware
DuPont Operations, Inc.	Delaware
DuPont Products (Luxembourg) SARL	Luxembourg
DuPont Science (Luxembourg) S.a r.l.	Luxembourg
DuPont Solutions (Luxembourg) SARL	Luxembourg
DuPont Specialty Products Kabushiki Kaisha	Japan
DuPont Taiwan Limited	Taiwan
DuPont Technology (Luxembourg) S.a.r.l.	Luxembourg
DuPont Teijin Films China LTD.	Hong Kong
DuPont Trading (Shanghai) Co., Ltd.	China
DuPont Xingda Filaments Company Limited	China
E.I. DuPont Canada Company	Canada
E.I. DuPont Canada- Thetford Inc.	Canada
E.I. DuPont India Private Limited	India
EKC Technology, Inc.	California
FCC Acquisition Corporation	California
FMC Biopolymer AS	Norway
FMC Manufacturing Limited	Ireland
Hickory Holdings, Inc.	Delaware
Howson Algraphy BV	The Netherlands
MECS Inc.	Delaware
Pioneer Hi-Bred International, Inc.	Iowa
Shenzhen DuPont Performance Materials Investment Co., Ltd.	China
Solae L.L.C.	Delaware
SP EMEA Holding 7 B.V.	The Netherlands
SP Luxembourg, LLC	Delaware
Spruance Genco, LLC	Delaware

Subsidiaries not listed would not, if considered in the aggregate as a single subsidiary, constitute a significant subsidiary.

EX-23

Exhibit 23

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

We hereby consent to the incorporation by reference in the Registration Statement on FormS‑3 (No.333-215864) of E.I. du Pont de Nemours and Company of our Successor report dated February 15, 2018, relating to the financial statements, financial statement schedule and the effectiveness of internal control over financial reporting, as well as our Predecessor report dated February 15, 2018, relating to the financial statements and financial statement schedule, which appear in this Form 10‑K.

/s/ PricewaterhouseCoopers LLP

Philadelphia, Pennsylvania

February 15, 2018

EX-31.1

Exhibit 31.1

CERTIFICATIONS

I, Edward D. Breen, certify that:

1. I have reviewed this report on Form 10-K for the period ended December 31, 2017 of E. I. du Pont de Nemours and Company;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c) Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d) Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

5. The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

Date:	February 15, 2018
By:	/s/ Edward D. Breen
	Edward D. Breen
	Chief Executive Officer and Chair of the Board

EX-31.2

Exhibit 31.2

CERTIFICATIONS

I, Nicholas C. Fanandakis, certify that:

1. I have reviewed this report on Form 10-K for the period ended December 31, 2017 of E. I. du Pont de Nemours and Company;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c) Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d) Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

5. The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

Date:	February 15, 2018
By:	/s/ Nicholas C. Fanandakis
	Nicholas C. Fanandakis
	Executive Vice President and Chief Financial Officer

EX-32.1

Exhibit 32.1

Certification of CEO Pursuant to

18 U.S.C. Section 1350,

As Adopted Pursuant to

Section 906 of the Sarbanes-Oxley Act of 2002

In connection with the Annual Report of E. I. du Pont de Nemours and Company (the "Company") on Form 10-K for the period ending December 31, 2017 as filed with the Securities and Exchange Commission on the date hereof (the "Report"), Edward D. Breen, as Chief Executive Officer of the Company, hereby certifies, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

(1)The Report fully complies with the requirements of Section 13(a) or Section 15(d) of the Securities Exchange Act of 1934; and

(2)The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

/s/ Edward D. Breen

Edward D. Breen

Chief Executive Officer

February 15, 2018

EX-32.2

Exhibit 32.2

Certification of CFO Pursuant to

18 U.S.C. Section 1350,

As Adopted Pursuant to

Section 906 of the Sarbanes-Oxley Act of 2002

In connection with the Annual Report of E. I. du Pont de Nemours and Company (the "Company") on Form 10-K for the period ending December 31, 2017 as filed with the Securities and Exchange Commission on the date hereof (the "Report"), Nicholas C. Fanandakis, as Chief Financial Officer of the Company, hereby certifies, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

(1)The Report fully complies with the requirements of Section 13(a) or Section 15(d) of the Securities Exchange Act of 1934; and

(2)The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

/s/ Nicholas C. Fanandakis

Nicholas C. Fanandakis

Chief Financial Officer

February 15, 2018

XML

DEI Document - USD ($) $ in Billions	12 Months Ended
	Dec. 31, 2017	Jun. 30, 2017
Document and Entity Information [Abstract]
Document Type	10-K
Amendment Flag	false
Document Period End Date	Dec. 31, 2017
Entity Registrant Name	DUPONT E I DE NEMOURS & CO
Entity Central Index Key	0000030554
Current Fiscal Year End Date	--12-31
Document Fiscal Year Focus	2017
Document Fiscal Period Focus	FY
Entity Well-known Seasoned Issuer	Yes
Entity Voluntary Filers	No
Entity Current Reporting Status	Yes
Entity Filer Category	Large Accelerated Filer
Entity Public Float		$ 70.0
Entity Common Stock, Shares Outstanding	100

XML

Consolidated Statements of Income - USD ($) $ in Millions	4 Months Ended	8 Months Ended	12 Months Ended
	Dec. 31, 2017	Aug. 31, 2017	Dec. 31, 2016	Dec. 31, 2015
Successor [Member]
Net Sales	$ 7,053
Cost of Goods Sold	6,165
Research and Development Expense	473
Selling, General and Administrative Expense	1,101
Amortization of Intangible Assets	389
Restructuring and Asset Related Charges - Net	180
Integration and Separation Costs	314
Sundry income - net	90
Interest Expense	107
(Loss) Income from continuing operations before income taxes	(1,586)
(Benefit from) provision for income taxes on continuing operations	(2,673)
Income from continuing operations after income taxes	1,087
(Loss) Income from discontinued operations after income taxes	(77)
Net income	1,010
Net income attributable to noncontrolling interests	0
Net income attributable to DuPont	$ 1,010
Predecessor [Member]
Net Sales		$ 17,281	$ 23,209	$ 23,657
Cost of Goods Sold		10,205	13,955	14,591
Other Operating Charges		504	667	434
Research and Development Expense		1,064	1,502	1,735
Selling, General and Administrative Expense		3,306	4,143	4,428
Amortization of Intangible Assets		139	319	362
Restructuring and Asset Related Charges - Net		323	556	795
Integration and Separation Costs		581	386	10
Sundry income - net		166	707	690
Interest Expense		254	370	342
(Loss) Income from continuing operations before income taxes		1,791	2,723	2,022
(Benefit from) provision for income taxes on continuing operations		149	641	575
Income from continuing operations after income taxes		1,642	2,082	1,447
(Loss) Income from discontinued operations after income taxes		119	443	512
Net income		1,761	2,525	1,959
Net income attributable to noncontrolling interests		20	12	6
Net income attributable to DuPont		$ 1,741	$ 2,513	$ 1,953
Basic earnings per share of common stock from continuing operations		$ 1.86	$ 2.36	$ 1.60
Basic earnings per share of common stock from discontinued operations		0.13	0.51	0.57
Basic earnings per share of common stock		2.00	2.87	2.17
Diluted earnings per share of common stock from continuing operations		1.85	2.35	1.59
Diluted earnings per share of common stock from discontinued operations		0.13	0.50	0.57
Diluted earnings per share of common stock		1.99	2.85	2.16
Dividends declared per share of common stock		$ 1.14	$ 1.52	$ 1.72

XML

Consolidated Statements of Comprehensive Income - USD ($) $ in Millions	4 Months Ended	8 Months Ended	12 Months Ended
	Dec. 31, 2017	Aug. 31, 2017	Dec. 31, 2016	Dec. 31, 2015
Predecessor [Member]
Net income		$ 1,761	$ 2,525	$ 1,959
Unrealized gains on Investments		0	20	(19)
Cumulative Translation Adjustments		1,042	(510)	(1,605)
Derivatives Instruments		(10)	31	(18)
Other Comprehensive Income (Loss), Net of Tax		1,289	(515)	(1,308)
Comprehensive Income		3,050	2,010	651
Comprehensive Income Attributable to Noncontrolling Interest		20	12	6
Comprehensive Income Attributable to DuPont		3,030	1,998	645
Successor [Member]
Net income	$ 1,010
Unrealized gains on Investments	0
Cumulative Translation Adjustments	(454)
Derivatives Instruments	(2)
Other Comprehensive Income (Loss), Net of Tax	(381)
Comprehensive Income	629
Comprehensive Income Attributable to Noncontrolling Interest	0
Comprehensive Income Attributable to DuPont	629
Pension Plan | Predecessor [Member]
Adjustments to benefit plans		247	323	574
Pension Plan | Successor [Member]
Adjustments to benefit plans	128
Other Benefit Plans | Predecessor [Member]
Adjustments to benefit plans		$ 10	$ (379)	$ (240)
Other Benefit Plans | Successor [Member]
Adjustments to benefit plans	$ (53)

XML

Consolidated Balance Sheets - USD ($) $ in Millions		Dec. 31, 2017	Dec. 31, 2016
Successor [Member]
Cash and Cash Equivalents		$ 7,250
Marketable Securities		952
Accounts and notes receivable - net		5,239
Inventories		8,633
Other current assets		981
Assets held for sale- current		0
Total current assets		23,055
Investments in nonconsolidated affiliates		1,595
Property, Plant and Equipment, Gross		12,878
Accumulated Depreciation		443
Property, Plant and Equipment, Net		12,435
Goodwill		45,589
Other intangible assets		27,726
Deferred Income Taxes		480
Other Assets		2,084
Total Assets		112,964
Short-term borrowings and capital lease obligations		2,779
Accounts Payable		4,831
Income Taxes Payable		149
Accrued and other current liabilities		4,384
Liabilities held for sale - current		0
Total current liabilities		12,143
Long-term Debt	[1]	10,291
Deferred Income Tax Liabilities		5,836
Pension and other post employment benefits - noncurrent		7,787
Other noncurrent obligations		1,975
Liabilities, Noncurrent		25,889
Common Stock, Value, Issued		0
Additional Paid in Capital		74,727
Retained earnings		175
Accumulated other comprehensive loss		(381)
Treasury Stock, Value		0
Total DuPont Stockholders' Equity		74,760
Noncontrolling Interests		172
Total Stockholders' Equity		74,932
Total Liabilities and Equity		112,964
Successor [Member] | $4.50 Series Preferred Stock [Member]
Preferred Stock, Value		169
Successor [Member] | $3.50 Series Preferred Stock [Member]
Preferred Stock, Value		$ 70
Predecessor [Member]
Cash and Cash Equivalents			$ 4,548
Marketable Securities			1,362
Accounts and notes receivable - net			4,959
Inventories			5,350
Other current assets			505
Assets held for sale- current			789
Total current assets			17,513
Investments in nonconsolidated affiliates			649
Property, Plant and Equipment, Gross			23,015
Accumulated Depreciation			14,164
Property, Plant and Equipment, Net			8,851
Goodwill			4,169
Other intangible assets			3,664
Deferred Income Taxes			3,308
Other Assets			1,810
Total Assets			39,964
Short-term borrowings and capital lease obligations			429
Accounts Payable			3,678
Income Taxes Payable			101
Accrued and other current liabilities			4,650
Liabilities held for sale - current			74
Total current liabilities			8,932
Long-term Debt			8,107
Deferred Income Tax Liabilities			425
Other noncurrent obligations			12,304
Liabilities, Noncurrent			20,836
Common Stock, Value, Issued			285
Additional Paid in Capital			11,190
Retained earnings			14,924
Accumulated other comprehensive loss			(9,911)
Treasury Stock, Value			(6,727)
Total DuPont Stockholders' Equity			9,998
Noncontrolling Interests			198
Total Stockholders' Equity			10,196
Total Liabilities and Equity			39,964
Predecessor [Member] | $4.50 Series Preferred Stock [Member]
Preferred Stock, Value			167
Predecessor [Member] | $3.50 Series Preferred Stock [Member]
Preferred Stock, Value			$ 70

[1] The Successor period includes the reflection of debt at fair value at the date of the Merger. See Note 3 for additional information regarding the Merger.

XML

Consolidated Balance Sheets (Parentheticals) - USD ($)	Dec. 31, 2017	Dec. 31, 2016
Successor [Member]
Common Stock, Par or Stated Value Per Share	$ 0.30
Common Stock, Shares Authorized	1,800,000,000
Common Stock, Shares, Issued	100
Treasury Stock, Shares	0
Successor [Member] | $4.50 Series Preferred Stock [Member]
Preferred Stock, Par Value	$ 0
Preferred Stock, Shares Authorized	23,000,000
Preferred Stock, Shares Issued	1,673,000
Preferred Stock, Redemption Amount	$ 120
Successor [Member] | $3.50 Series Preferred Stock [Member]
Preferred Stock, Par Value	$ 0.00
Preferred Stock, Shares Authorized	23,000,000
Preferred Stock, Shares Issued	700,000
Preferred Stock, Redemption Amount	$ 102
Predecessor [Member]
Common Stock, Par or Stated Value Per Share		$ 0.30
Common Stock, Shares Authorized		1,800,000,000
Common Stock, Shares, Issued		950,044,000
Treasury Stock, Shares		87,041,000
Predecessor [Member] | $4.50 Series Preferred Stock [Member]
Preferred Stock, Par Value		$ 0
Preferred Stock, Shares Authorized		23,000,000
Preferred Stock, Shares Issued		1,673,000
Preferred Stock, Redemption Amount		$ 120
Predecessor [Member] | $3.50 Series Preferred Stock [Member]
Preferred Stock, Par Value		$ 0.00
Preferred Stock, Shares Authorized		23,000,000
Preferred Stock, Shares Issued		700,000
Preferred Stock, Redemption Amount		$ 102

XML

Consolidated Statements of Cash Flows - USD ($) $ in Millions	4 Months Ended	8 Months Ended	12 Months Ended
	Dec. 31, 2017	Aug. 31, 2017	Dec. 31, 2016	Dec. 31, 2015
Successor [Member]
Net income	$ 1,010
Depreciation and Amortization	815
Provision for Deferred Income Tax	(3,015)
Net Periodic Pension (Benefit) Cost	(111)
Pension Contributions	(68)
Net gain on sales of property, businesses, consolidated companies, and investments	(16)
Restructuring and Asset Related Charges - Net	180
Amortization of inventory step-up	1,573
Other net loss	125
Accounts and Notes Receivable	2,107
Inventories	(1,010)
Accounts Payable	934
Other Assets and Liabilities, Net	1,672
Cash provided by (used for) operating activities	4,196
Capital expenditures	(426)
Proceeds from the sale of property, businesses, and consolidated companies, net of cash divested	1,268
Payment into a trust account	(571)
Distribution from trust account	13
Acquisitions of businesses - Net of Cash Acquired	3
Investments in and loans to nonconsolidated affiliates	(5)
Purchases of investments	(1,043)
Proceeds from Sale and Maturities of Investments	2,938
Other investing activities - net	33
Cash provided by (used for) investing activities	2,210
Change in short-term (less than 90 days) borrowings	(2,541)
Proceeds from Issuance of Long-term Debt	499
Repayments of Long-term Debt	(42)
Proceeds from Stock Options Exercised	30
Payments of Dividends to Stockholders	(332)
Distributions to DowDuPont	(829)
Cash Transferred to Chemours at Spinoff	0
Other financing activities	(12)
Cash (used for) provided by financing activities	(3,227)
Effect of Exchange Rate Changes on Cash	(22)
Cash reclassified as held for sale	88
Increase (Decrease) in Cash and Cash Equivalents	3,245
Cash and Cash Equivalents at beginning of period	4,005
Cash and Cash Equivalents at end of period	7,250	$ 4,005
Interest, net of amounts capitalized	76
Income Taxes	(437)
Predecessor [Member]
Net income		1,761	$ 2,525	$ 1,959
Depreciation and Amortization		749	1,258	1,466
Net Periodic Pension (Benefit) Cost		295	572	591
Pension Contributions		(3,024)	(535)	(308)
Net gain on sales of property, businesses, consolidated companies, and investments		(204)	(436)	(59)
Restructuring and Asset Related Charges - Net		323	556	795
Asset related charges		279	682	147
Other net loss		481	366	106
Accounts and Notes Receivable		(2,269)	(270)	(448)
Inventories and Other Operating Assets		(202)	(54)	164
Accounts Payable and Other Operating Liabilities		(1,555)	(674)	(1,031)
Accrued Interest and Income Taxes		(260)	(77)	(165)
Cash provided by (used for) operating activities		(3,949)	3,357	2,422
Capital expenditures		(687)	(1,019)	(1,629)
Proceeds from the sale of property, businesses, and consolidated companies, net of cash divested		300	316	156
Payment into a trust account		0	0	0
Distribution from trust account		0	0	0
Acquisitions of businesses - Net of Cash Acquired		(246)	0	(152)
Investments in and loans to nonconsolidated affiliates		(22)	(19)	(76)
Purchases of investments		(5,457)	(2,633)	(1,897)
Proceeds from Sale and Maturities of Investments		3,977	2,181	1,121
Foreign currency exchange contract settlements		(206)	(385)	615
Other investing activities - net		(41)	45	34
Cash provided by (used for) investing activities		(2,382)	(1,514)	(1,828)
Change in short-term (less than 90 days) borrowings		3,610	387	(1)
Proceeds from Issuance of Long-term Debt		2,734	813	3,679
Repayments of Long-term Debt		(229)	(1,440)	(1,537)
Repurchase of Common Stock		0	(916)	(2,353)
Proceeds from Stock Options Exercised		235	154	200
Payments of Dividends to Stockholders		(666)	(1,335)	(1,546)
Cash Transferred to Chemours at Spinoff		0	0	(250)
Other financing activities		(52)	(48)	(121)
Cash (used for) provided by financing activities		5,632	(2,385)	(1,929)
Effect of Exchange Rate Changes on Cash		187	(153)	(275)
Cash reclassified as held for sale		(31)	15	22
Increase (Decrease) in Cash and Cash Equivalents		(543)	(680)	(1,588)
Cash and Cash Equivalents at beginning of period	$ 4,005	4,548	5,228	6,816
Cash and Cash Equivalents at end of period		4,005	4,548	5,228
Interest, net of amounts capitalized		331	386	341
Income Taxes		$ 272	$ 735	$ 885

XML

Consolidated Statements of Equity - USD ($) $ in Millions	Total	Preferred Stock [Member]	Common Stock [Member]	Additional Paid-in Capital [Member]	Retained Earnings [Member]	AOCI Attributable to Parent		Treasury Stock [Member]	Noncontrolling Interest [Member]	Parent Company [Member] Retained Earnings [Member]
Beginning Balance (Predecessor [Member]) at Dec. 31, 2014	$ 13,378	$ 237	$ 298	$ 11,174	$ 16,894	$ (8,556)		$ (6,727)	$ 58
Net income | Predecessor [Member]	1,959				1,953				6
Net other comprehensive income (loss) | Predecessor [Member]	(1,308)					(1,308)
Dividends, Common Stock | Predecessor [Member]	(1,546)				(1,542)				(4)
Dividends, Preferred Stock | Predecessor [Member]	(10)				(10)
Stock Issued During Period, Value, Share-Based Compensation and Adjustments to APIC, Share-Based Compensation | Predecessor [Member]	361		2	359
Common stock repurchased | Predecessor [Member]	(2,353)							(2,353)
Common stock retired | Predecessor [Member]	0		(12)	(451)	(1,890)			2,353
Spin-off of Chemours | Predecessor [Member]	(431)				(895)	468			(4)
Consolidation of a joint venture | Predecessor [Member]	150			(1)					151
Ending Balance (Predecessor [Member]) at Dec. 31, 2015	10,200	237	288	11,081	14,510	(9,396)		(6,727)	207
Net income | Predecessor [Member]	2,525				2,513				12
Net other comprehensive income (loss) | Predecessor [Member]	(515)					(515)
Dividends, Common Stock | Predecessor [Member]	(1,347)				(1,331)				(16)
Dividends, Preferred Stock | Predecessor [Member]	(10)				(10)
Stock Issued During Period, Value, Share-Based Compensation and Adjustments to APIC, Share-Based Compensation | Predecessor [Member]	268		1	267
Common stock repurchased | Predecessor [Member]	(916)							(916)
Common stock retired | Predecessor [Member]	0		(4)	(154)	(758)			916
Sale of a majority interest in consolidated subsidiary | Predecessor [Member]	(9)			(4)					(5)
Ending Balance (Predecessor [Member]) at Dec. 31, 2016	10,196	237	285	11,190	14,924	(9,911)		(6,727)	198
Net income | Predecessor [Member]	1,761				1,741				20
Net other comprehensive income (loss) | Predecessor [Member]	1,289					1,289
Dividends, Common Stock | Predecessor [Member]	(995)				(991)				(4)
Dividends, Preferred Stock | Predecessor [Member]	(7)				(7)
Stock Issued During Period, Value, Share-Based Compensation and Adjustments to APIC, Share-Based Compensation | Predecessor [Member]	275		2	273
Common stock retired | Predecessor [Member]	0		(26)	(1,044)	(5,657)			6,727
Sale of a majority interest in consolidated subsidiary | Predecessor [Member]	(2)								(2)
Ending Balance (Predecessor [Member]) at Aug. 31, 2017	12,517	237	261	10,419	10,010	(8,622)		0	212
Ending Balance (Successor [Member]) at Aug. 31, 2017	75,081	239	0	74,680	0	0	[1]	0	162
Net income | Successor [Member]	1,010				1,010				0
Net other comprehensive income (loss) | Successor [Member]	(381)					(381)
Dividends, Preferred Stock | Successor [Member]	(3)				(3)
Distributions to DowDuPont | Successor [Member]	(829)									$ (829)
Issuance of DowDuPont stock | Successor [Member]	30			30
Stock-based compensation | Successor [Member]	36			36
Stockholders' Equity, Other | Successor [Member]	(11)			(19)	(3)				11
Sale of a majority interest in consolidated subsidiary | Successor [Member]	(4)								(4)
Consolidation of a joint venture | Successor [Member]	3								3
Ending Balance (Successor [Member]) at Dec. 31, 2017	$ 74,932	$ 239	$ 0	$ 74,727	$ 175	$ (381)		$ 0	$ 172

[1] In connection with the Merger, balances in accumulated other comprehensive loss at Merger Effectiveness Time were eliminated as a result of reflecting the balance sheet at fair value as of the date of the Merger. See Note 3 and 16 for further information regarding the Merger and pension and OPEB plans, respectively.

XML

Consolidated Statements of Equity (Parentheticals) - $ / shares	8 Months Ended	12 Months Ended
	Aug. 31, 2017	Dec. 31, 2016	Dec. 31, 2015
Predecessor [Member]
Dividends declared	$ 1.14	$ 1.52	$ 1.72

XML

Summary of Significant Accounting Policies

12 Months Ended

Dec. 31, 2017

Accounting Policies [Abstract]

Significant Accounting Policies [Text Block]

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Principles of Consolidation and Basis of Presentation

The accompanying Consolidated Financial Statements of E. I. du Pont de Nemours and Company (“DuPont” or “the company”) were prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”). The significant accounting policies described below, together with the other notes that follow, are an integral part of the Consolidated Financial Statements.

DowDuPont Inc. ("DowDuPont") was formed on December 9, 2015 to effect an all-stock, merger of equals strategic combination between The Dow Chemical Company ("Dow") and DuPont (the "Merger Transaction"). On August 31, 2017 at 11:59 pm ET, (the "Merger Effectiveness Time") pursuant to the Agreement and Plan of Merger, dated as of December 11, 2015, as amended on March 31, 2017 (the "Merger Agreement"), Dow and DuPont each merged with wholly owned subsidiaries of DowDuPont ("Mergers") and, as a result of the Mergers, Dow and DuPont became subsidiaries of DowDuPont (collectively, the "Merger"). Prior to the Merger, DowDuPont did not conduct any business activities other than those required for its formation and matters contemplated by the Merger Agreement. DowDuPont intends to pursue, subject to the receipt of approval by the Board of Directors of DowDuPont, the separation of the combined company's agriculture business, specialty products business and materials science business through a series of tax-efficient transactions (collectively, the "Intended Business Separations").

For purposes of DowDuPont's financial statement presentation, Dow was determined to be the accounting acquirer in the Merger and DuPont's assets and liabilities are reflected at fair value as of the Merger Effectiveness Time. In connection with the Merger and the related accounting determination, DuPont has elected to apply push-down accounting and reflect in its financial statements the fair value of its assets and liabilities. DuPont's Consolidated Financial Statements for periods following the close of the Merger are labeled “Successor” and reflect DowDuPont’s basis in the fair values of the assets and liabilities of DuPont. All periods prior to the closing of the Merger reflect the historical accounting basis in DuPont's assets and liabilities and are labeled “Predecessor.” The Consolidated Financial Statements and footnotes include a black line division between the columns titled "Predecessor" and "Successor" to signify that the amounts shown for the periods prior to and following the Merger are not comparable. See Note 3 for additional information on the Merger.

Transactions between DowDuPont, DuPont, Dow and their affiliates and other associated companies are reflected in the Successor consolidated financial statements and disclosed as related party transactions when material. Related party transactions with DowDuPont are included in Note 6. Related party transactions with Dow and their affiliates were not material as of December 31, 2017 and for the period September 1 through December 31, 2017.

As a condition of the regulatory approval for the Merger Transaction, the company was required to divest certain assets related to its crop protection business and research and development ("R&D") organization, specifically the company’s Cereal Broadleaf Herbicides and Chewing Insecticides portfolios, including Rynaxypyr^®, Cyazypyr^® and Indoxacarb as well as the crop protection R&D pipeline and organization, excluding seed treatment, nematicides, and late-stage R&D programs. On March 31, 2017, the company entered into a definitive agreement (the "FMC Transaction Agreement") with FMC Corporation ("FMC"). Under the FMC Transaction Agreement, FMC would acquire the crop protection business and R&D assets that DuPont was required to divest in order to obtain European Commission ("EC") approval of the Merger Transaction as described above, (the "Divested Ag Business") and DuPont agreed to acquire certain assets relating to FMC’s Health and Nutrition segment, excluding its Omega-3 products (the "H&N Business") (collectively, the "FMC Transactions").

On November 1, 2017, the company completed the FMC Transactions through the disposition of the Divested Ag Business and the acquisition of the H&N Business. The sale of the Divested Ag Business meets the criteria for discontinued operations and as such, results of operations are presented as discontinued operations and have been excluded from continuing operations for all periods presented. The sum of the individual earnings per share amounts from continuing operations and discontinued operations may not equal the total company earnings per share amounts due to rounding. The assets and liabilities related to the Divested Ag Business for all periods are presented as assets and liabilities held for sale in the Consolidated Balance Sheets. The comprehensive income and cash flows related to the Divested Ag Business have not been segregated and are included in the Consolidated Statements of Comprehensive Income and Consolidated Statements of Cash Flows, respectively, for all periods presented. Amounts related to the Divested Ag Business are consistently included or excluded from the Notes to the Consolidated Financial Statements based on the respective financial statement line item. See Note 4 for additional information.

On July 1, 2015, the company completed the separation of its Performance Chemicals segment through the spin-off of all of the issued and outstanding stock of The Chemours Company ("Chemours"). In accordance with GAAP, the results of operations of the Performance Chemicals segment are presented as discontinued operations and, as such, have been excluded from continuing operations in the Consolidated Statements of Operations for all periods presented. See Note 4 for additional information.

Certain reclassifications of prior year's data have been made to conform to current year's presentation. As described in Note 2, effective January 1, 2017, the company adopted the Financial Accounting Standards Board (“FASB”) Accounting Standards Update ("ASU") No. 2016-09, Compensation - Stock Compensation (Topic 718), Improvements to Employee Share-Based Payment Accounting. In conjunction with the adoption of this ASU, the company retrospectively reclassified cash flows related to income tax impacts associated with employee share-based payments in the Consolidated Statements of Cash Flows, as described in Note 2.

The Consolidated Financial Statements include the accounts of the company and subsidiaries in which a controlling interest is maintained. For those consolidated subsidiaries in which the company's ownership is less than 100 percent, the outside stockholders' interests are shown as noncontrolling interests. Investments in affiliates over which the company has significant influence but not a controlling interest are accounted for under the equity method.

The company is also involved with certain joint ventures accounted for under the equity method of accounting that are variable interest entities ("VIEs"). The company is not the primary beneficiary, as the nature of the company's involvement with the VIEs does not provide it the power to direct the VIEs significant activities. Future events may require these VIEs to be consolidated if the company becomes the primary beneficiary. At December 31, 2017 and 2016, the maximum exposure to loss related to the nonconsolidated VIEs is not considered material to the Consolidated Financial Statements.

Use of Estimates in Financial Statement Preparation

The preparation of financial statements in accordance with U.S. GAAP requires the use of estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenues and expenses during the reporting period. The company’s consolidated financial statements include amounts that are based on management’s best estimates and judgments. Actual results could differ from those estimates. In connection with the Merger, DowDuPont has performed a preliminary allocation of the total consideration exchanged for the DuPont assets and liabilities it acquired using preliminary estimates. The estimates are subject to change as discussed in Note 3.

Changes in Accounting and Reporting

Within the Successor period, DuPont made the following changes in accounting and reporting to harmonize its accounting and reporting with DowDuPont.

Within the Successor period of the Consolidated Statements of Operations:

• Included royalty income within net sales. In the Predecessor periods, royalty income is included within sundry income - net.

• Eliminated the other operating charges line item. In the Successor period, a majority of these costs are included within cost of goods sold. These costs are also included in selling, general and administrative expenses and amortization of intangibles in the Successor period.

• Presented amortization of intangibles as a separate line item. In the Predecessor periods, amortization is included within cost of goods sold, selling, general and administrative expenses, other operating charges, and research and development expenses.

• Presented integration and separation costs as a separate line item. In the Predecessor periods, these costs are included within selling, general and administrative expenses.

• Included interest accrued related to unrecognized tax benefits within the (benefit from) provision for income taxes on continuing operations. In the Predecessor period, interest accrued related to unrecognized tax benefits is included within sundry income - net.

Within the Successor period of the Consolidated Balance Sheets:

• Included loans to nonconsolidated affiliates within other assets. In the Predecessor period, loans are included within investment in nonconsolidated affiliates.

• Included accrued discounts and rebates within accounts payable. In the Predecessor period, accrued discounts and rebates are included within accrued and other current liabilities.

• Included non-current pension liabilities within pension and other post employment benefits - noncurrent. In the Predecessor period, non-current pension liabilities are included within other noncurrent obligations.

Within the Successor period of the Consolidated Statements of Cash Flows:

• Included foreign currency exchange contract settlements within cash flows from operating activities, regardless of hedge accounting qualification. In the Predecessor period, DuPont reflected non-qualified hedge programs, specifically forward contracts, options and cash collateral activity, within cash flows from investing activities. In the Predecessor period, DuPont reflected cash flows from qualified programs within the line item it related to (i.e., revenue hedge cash flows presented within changes from accounts receivable).

• Aligned the line items within "changes in assets and liabilities, net of effects of acquired and divested companies" to the DowDuPont presentation, including accounts and notes receivable, inventories, accounts payable, and other assets and liabilities. In the Predecessor period, the line item "changes in assets and liabilities, net of effects of acquired and divested companies" includes accounts and notes receivable, inventories and other operating assets, accounts payable and other operating liabilities, and accrued interest and income taxes.

Cash and Cash Equivalents

Cash equivalents represent investments with maturities of three months or less from time of purchase. They are carried at cost plus accrued interest.

Restricted Cash

Restricted cash represents trust assets of $558 million as of December 31, 2017, and is included within other current assets on the Consolidated Balance Sheets. See Note 6 and Note 16 for further information.

Marketable Securities

Marketable securities represent investments in fixed and floating rate financial instruments with maturities greater than three months and up to twelve months at time of purchase. Investments classified as held-to-maturity are recorded at amortized cost. The carrying value approximates fair value due to the short-term nature of the investments. Investments classified as available-for-sale are carried at estimated fair value with unrealized gains and losses recorded as a component of accumulated other comprehensive income (loss). The cost of investments sold is determined by specific identification.

Fair Value Measurements

Under the accounting guidance for fair value measurements and disclosures, a fair value hierarchy was established that prioritizes the inputs to valuation techniques used to measure fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). A financial instrument's level within the fair value hierarchy is based on the lowest level of any input that is significant to the fair value measurement.

The company uses the following valuation techniques to measure fair value for its assets and liabilities:

Level 1	–	Quoted market prices in active markets for identical assets or liabilities;
Level 2	–	Significant other observable inputs (e.g. quoted prices for similar items in active markets, quoted prices for identical or similar items in markets that are not active, inputs other than quoted prices that are observable such as interest rate and yield curves, and market-corroborated inputs);
Level 3	–	Unobservable inputs for the asset or liability, which are valued based on management's estimates of assumptions that market participants would use in pricing the asset or liability.

Foreign Currency Translation

The company's worldwide operations utilize the U.S. dollar (USD) or local currency as the functional currency, where applicable. The company identifies its separate and distinct foreign entities and groups the foreign entities into two categories: 1) extension of the parent or foreign subsidiaries operating in a hyper-inflationary environment (USD functional currency) and 2) self-contained (local functional currency). If a foreign entity does not align with either category, factors are evaluated and a judgment is made to determine the functional currency. 

For foreign entities where the USD is the functional currency, all foreign currency-denominated asset and liability amounts are re-measured into USD at end-of-period exchange rates, except for inventories, prepaid expenses, property, plant and equipment, goodwill and other intangible assets, which are re-measured at historical rates. Foreign currency income and expenses are re-measured at average exchange rates in effect during the year, except for expenses related to balance sheet amounts re-measured at historical exchange rates. Exchange gains and losses arising from re-measurement of foreign currency-denominated monetary assets and liabilities are included in income in the period in which they occur.

For foreign entities where the local currency is the functional currency, assets and liabilities denominated in local currencies are translated into USD at end-of-period exchange rates and the resultant translation adjustments are reported, net of their related tax effects, as a component of accumulated other comprehensive loss in equity. Assets and liabilities denominated in other than the local currency are re-measured into the local currency prior to translation into USD and the resultant exchange gains or losses are included in income in the period in which they occur. Income and expenses are translated into USD at average exchange rates in effect during the period.

The company changes the functional currency of its separate and distinct foreign entities only when significant changes in economic facts and circumstances indicate clearly that the functional currency has changed.

Inventories

The company's inventories are valued at the lower of cost or net realizable value. Elements of cost in inventories include raw materials, direct labor and manufacturing overhead. Stores and supplies are valued at cost or net realizable value, whichever is lower; cost is generally determined by the average cost method.

As of December 31, 2017 approximately 60 percent, 30 percent, and 10 percent of the company's inventories were accounted for under the first-in, first-out ("FIFO"), average cost and the last-in, first-out ("LIFO") methods, respectively. As of December 31, 2016 approximately 55 percent, 30 percent, and 15 percent of the company's inventories were accounted for under the FIFO, average cost and LIFO methods, respectively. Inventories accounted for under the FIFO method are primarily comprised of products with shorter shelf lives such as seeds, certain food-ingredients and enzymes.

The company establishes allowances for obsolescence of inventory based upon quality considerations and assumptions about future demand and market conditions.

Property, Plant and Equipment

Property, plant and equipment are carried at cost less accumulated depreciation. In connection with the Merger, the preliminary estimated fair value of property, plant and equipment is determined using a market approach and a replacement cost approach. Refer to Note 3 for further information. Depreciation is based on the estimated service lives of depreciable assets and is calculated using the straight-line method. Fully depreciated assets are retained in property and accumulated depreciation accounts until they are removed from service. When assets are surrendered, retired, sold, or otherwise disposed of, their gross carrying values and related accumulated depreciation are removed from the Consolidated Balance Sheets and included in determining gain or loss on such disposals.

Goodwill and Other Intangible Assets

The company records goodwill when the purchase price of a business acquisition exceeds the estimated fair value of net identified tangible and intangible assets acquired. Goodwill is tested for impairment at the reporting unit level annually, or more frequently when events or changes in circumstances indicate that the fair value of a reporting unit has more likely than not declined below its carrying value. In connection with the Merger Transaction, the company adopted the policy of DowDuPont and performed an annual goodwill impairment test in the fourth quarter of 2017. In the Predecessor periods, the annual impairment test was performed in the third quarter.

When testing goodwill for impairment, the company has the option to first perform qualitative testing to determine whether it is more likely than not that the fair value of a reporting unit is less than its carrying value.  If the company chooses not to complete a qualitative assessment for a given reporting unit or if the initial assessment indicates that it is more likely than not that the carrying value of a reporting unit exceeds its estimated fair value, additional quantitative testing is required.  The company's fair value methodology is primarily based on discounted cash flow techniques.  See Note 12 for further information on goodwill.

Indefinite-lived intangible assets are tested for impairment at least annually; however, these tests are performed more frequently when events or changes in circumstances indicate that the asset may be impaired. Impairment exists when carrying value exceeds fair value. The company's fair value methodology is primarily based on discounted cash flow techniques.

Definite-lived intangible assets are amortized over their estimated useful lives, generally on a straight-line basis for periods ranging primarily from 1 to 23 years. The company continually evaluates the reasonableness of the useful lives of these assets. Once these assets are fully amortized, they are removed from the Consolidated Balance Sheets.

Impairment of Long-Lived Assets

The company evaluates the carrying value of long-lived assets to be held and used when events or changes in circumstances indicate the carrying value may not be recoverable. The carrying value of a long-lived asset group is considered impaired when the total projected undiscounted cash flows from the assets are separately identifiable and are less than its carrying value. In that event, a loss is recognized based on the amount by which the carrying value exceeds the fair value of the long-lived asset. The company's fair value methodology is an estimate of fair market value which is made based on prices of similar assets or other valuation methodologies including present value techniques. Long-lived assets to be disposed of by sale, if material, are classified as held for sale and reported at the lower of carrying amount or fair value less cost to sell, and depreciation is ceased. Long-lived assets to be disposed of other than by sale are classified as held and used until they are disposed of and reported at the lower of carrying amount or fair value. Depreciation is recognized over the remaining useful life of the assets.

Derivative Instruments

Derivative instruments are reported in the Consolidated Balance Sheets at their fair values. The company utilizes derivatives to manage exposures to foreign currency exchange rates and commodity prices. Changes in the fair values of derivative instruments that are not designated as hedges are recorded in current period earnings. For derivative instruments designated as cash flow hedges, the effective portion of any hedge is reported in accumulated other comprehensive loss until it is cleared to earnings during the same period in which the hedged item affects earnings. The ineffective portion of all hedges is recognized in current period earnings.

In the event that a derivative designated as a hedge of a firm commitment or an anticipated transaction is terminated prior to the maturation of the hedged transaction, gains or losses realized at termination are deferred and included in the measurement of the hedged transaction. If a hedged transaction matures, or is sold, extinguished, or terminated prior to the maturity of a derivative designated as a hedge of such transaction, gains or losses associated with the derivative through the date the transaction matured are included in the measurement of the hedged transaction and the derivative is reclassified as for trading purposes. Derivatives designated as hedges of anticipated transactions are reclassified as for trading purposes if the anticipated transaction is no longer probable.

In the Predecessor period, the company reflected non-qualified hedge programs, specifically forward contracts, options and cash collateral activity, within cash flows from investing activities. In the Predecessor period, the company reflected cash flows from qualified programs within the line item it related to (i.e., revenue hedge cash flows presented within changes from accounts receivable). In the Successor period, the company included foreign currency exchange contract settlements within cash flows from operating activities, regardless of hedge accounting qualification. See Note 18 for additional discussion regarding the company's objectives and strategies for derivative instruments.

Environmental Matters

Accruals for environmental matters are recorded when it is probable that a liability has been incurred and the amount of the liability can be reasonably estimated. These accruals are adjusted periodically as assessment and remediation efforts progress or as additional technical or legal information becomes available. Accruals for environmental liabilities are included in the Consolidated Balance Sheets in accrued and other current liabilities and other noncurrent obligations at undiscounted amounts. Accruals for related insurance or other third-party recoveries for environmental liabilities are recorded when it is probable that a recovery will be realized and are included in the consolidated balance sheets as accounts and notes receivable - net.

Environmental costs are capitalized if the costs extend the life of the property, increase its capacity, and/or mitigate or prevent contamination from future operations. Environmental costs are also capitalized in recognition of legal asset retirement obligations resulting from the acquisition, construction and/or normal operation of a long-lived asset. Costs related to environmental contamination treatment and cleanup are charged to expense. Estimated future incremental operations, maintenance and management costs directly related to remediation are accrued when such costs are probable and reasonably estimable.

Revenue Recognition

The company recognizes revenue when it is realized or realizable, and the earnings process is complete. The company's revenues are from the sale of a wide range of products to a diversified base of customers around the world. Revenue for product sales is recognized when title and risk of loss have been transferred, collectability is reasonably assured and pricing is fixed or determinable. A majority of product sales are sold FOB (free on board) shipping point or, with respect to non-United States of America (U.S.) customers, an equivalent basis. Accruals are made for sales returns and other allowances based on the company's experience. The company accounts for cash sales incentives as a reduction in sales and noncash sales incentives as a charge to cost of goods sold or selling expense, depending on the nature of the incentive. Amounts billed to customers for shipping and handling fees are included in net sales and costs incurred by the company for the delivery of goods are classified as cost of goods sold in the Consolidated Statements of Operations. Taxes on revenue-producing transactions are excluded from net sales.

The company periodically enters into prepayment contracts with the agriculture product line's customers and receives advance payments for product to be delivered in future periods. These advance payments are recorded as deferred revenue (classified as accrued and other current liabilities) or debt, depending on the nature of the program. Revenue associated with advance payments is recognized as shipments are made and title, ownership and risk of loss pass to the customer.

Licensing and royalty income is recognized in accordance with agreed upon terms, when performance obligations are satisfied, the amount is fixed or determinable and collectability is reasonably assured.

Royalty Expense

The company’s agriculture product line currently has certain third party biotechnology trait license agreements, which require up-front and variable payments subject to the licensor meeting certain conditions. These payments are reflected as other current assets and other assets and are amortized to cost of goods sold as seeds containing the respective trait technology are utilized over the life of the license. The company evaluates the carrying value of the prepaid royalties when events or changes in circumstances indicate the carrying value may not be recoverable.

Cost of Goods Sold

Successor periods - Cost of goods sold primarily includes the cost of manufacture and delivery, ingredients or raw materials, direct salaries, wages and benefits and overhead, non-capitalizable costs associated with capital projects and other operational expenses.  No amortization of intangibles is included within costs of goods sold.

Predecessor periods - Cost of goods sold primarily includes the cost of manufacture and delivery, ingredients or raw materials, direct salaries, wages and benefits and overhead.

Other Operating Charges

Predecessor periods - Other operating charges includes product claim charges and recoveries, non-capitalizable costs associated with capital projects and other operational expenses. 

Research and Development

Research and development costs are expensed as incurred. Research and development expense includes costs (primarily consisting of employee costs, materials, contract services, research agreements, and other external spend) relating to the discovery and development of new products, enhancement of existing products and regulatory approval of new and existing products.

Selling, General and Administrative Expenses

Successor periods - Selling, general and administrative expenses primarily include selling and marketing expenses, commissions, functional costs, and business management expenses.

Predecessor periods - Selling, general and administrative expenses primarily include selling and marketing expenses, commissions, functional costs, business management expenses and integration and separation costs.

Integration and Separation Costs

Successor periods - Integration and separation costs includes costs incurred to prepare for and close the Merger, post-Merger integration expenses and costs incurred to prepare for the Intended Business Separations. These costs primarily consist of financial advisory, information technology, legal, accounting, consulting and other professional advisory fees associated with preparation and execution of these activities.

Litigation

Accruals for legal matters are recorded when it is probable that a liability has been incurred and the amount of the liability can be reasonably estimated. Legal costs, such as outside counsel fees and expenses, are charged to expense in the period incurred.

Severance Costs

Severance benefits are provided to employees under the company's ongoing benefit arrangements. Severance costs are accrued when management commits to a plan of termination and it becomes probable that employees will be entitled to benefits at amounts that can be reasonably estimated.

Insurance/Self-Insurance

The company self-insures certain risks where permitted by law or regulation, including workers' compensation, vehicle liability and employee related benefits. Liabilities associated with these risks are estimated in part by considering historical claims experience, demographic factors and other actuarial assumptions. For other risks, the company uses a combination of insurance and self-insurance, reflecting comprehensive reviews of relevant risks. A receivable for an insurance recovery is generally recognized when the loss has occurred and collection is considered probable.

Income Taxes

The company accounts for income taxes using the asset and liability method. Under this method, deferred tax assets and liabilities are recognized for the future tax consequences of temporary differences between the carrying amounts and tax bases of assets and liabilities using enacted tax rates. The effect of a change in tax rates on deferred tax assets or liabilities is recognized in income in the period that includes the enactment date (see Note 7 for further information relating to the enactment of the Tax Cuts and Job Act).

The company recognizes the financial statement effects of an uncertain income tax position when it is more likely than not, based on the technical merits, that the position will be sustained upon examination. The company accrues for other tax contingencies when it is probable that a liability to a taxing authority has been incurred and the amount of the contingency can be reasonably estimated. The current portion of uncertain income tax positions is included in income taxes payable and the long-term portion is included in other noncurrent obligations in the Consolidated Balance Sheets.

Provision is made for taxes on undistributed earnings of foreign subsidiaries and related companies to the extent that such earnings are not deemed to be permanently invested. Income tax related penalties are included in the provision for income taxes in the Consolidated Statements of Operations. Interest accrued related to unrecognized tax benefits is included within the (benefit from) provision for income taxes from continuing operations in the Consolidated Statements of Operations in the Successor period. In the Predecessor period, interest accrued related to unrecognized tax benefits is included within sundry income - net in the Consolidated Statements of Operations.

Segments

Effective with the Merger, DuPont’s business activities are components of its parent company’s business operations. DuPont’s business activities, including the assessment of performance and allocation of resources, are reviewed and managed by DowDuPont. Information used by the chief operating decision maker of DuPont relates to the company in its entirety. Accordingly, there are no separate reportable business segments for DuPont under Accounting Standards Codification ("ASC") Topic 280 “Segment Reporting” and DuPont's business results are reported in this Form 10-K as a single operating segment. Prior year's segment information has been made to conform to the current presentation.

XML

Recent Accounting Guidance

12 Months Ended

Dec. 31, 2017

Accounting Changes and Error Corrections [Abstract]

Recent Accounting Guidance

RECENT ACCOUNTING GUIDANCE

Recently Adopted Accounting Guidance

In March 2016, the FASB issued ASU No. 2016-09, Compensation - Stock Compensation (Topic 718), Improvements to Employee Share-Based Payment Accounting, which modifies the accounting for certain aspects of share-based payments to employees. The new guidance requires excess tax benefits and tax deficiencies to be recorded in the income statement when stock awards vest or are settled. In addition, cash flows related to excess tax benefits will no longer be separately classified as a financing activity apart from other income tax cash flows. The standard also allows the company to repurchase more of an employee’s vested shares for tax withholding purposes without triggering liability accounting, and clarifies that all cash payments made to tax authorities on an employee’s behalf for withheld shares should be presented as a financing activity on the statement of cash flows. The company adopted this standard as of January 1, 2017.

The primary impact of adoption was the recognition of excess tax benefits in the company's provision for income taxes rather than additional paid-in capital, which is applied prospectively in accordance with the guidance. Adoption of the new standard resulted in the recognition of $2 million and $30 million of excess tax benefits in the company's provision for income taxes rather than additional paid-in capital for the period September 1 through December 31, 2017 and the period January 1 through August 31, 2017, respectively.

The company elected to apply the presentation requirements for cash flows related to excess tax benefits retrospectively to all periods presented, which resulted in an increase to both net cash provided by operating activities and net cash used for financing activities of $27 million and $74 million for the years ended December 31, 2016 and 2015, respectively. The presentation requirements for cash flows related to employee taxes paid for withheld shares resulted in an increase to both net cash provided by operating activities and net cash used for financing activities of $30 million and $32 million for the years ended December 31, 2016 and 2015, respectively.

The remaining updates required by this standard did not have a material impact to the company’s Consolidated Financial Statements.

In January 2017, the FASB issued ASU No. 2017-04, Intangibles - Goodwill and Other (Topic 350), Simplifying the Test for Goodwill Impairment. The new guidance eliminates the requirement to determine the fair value of individual assets and liabilities of a reporting unit to measure goodwill impairment. Under the amendments in the new ASU, goodwill impairment testing will be performed by comparing the fair value of the reporting unit with its carrying amount and recognizing an impairment charge for the amount by which the carrying amount exceeds the reporting unit’s fair value. The new standard is effective for annual and interim goodwill impairment tests in fiscal years beginning after December 15, 2019, and should be applied on a prospective basis. Early adoption is permitted for annual or interim goodwill impairment testing performed after January 1, 2017. In connection with the Merger Transaction, the company adopted the policy of the parent company and performed its annual goodwill impairment test in the fourth quarter. Previously, the annual impairment test was performed in the third quarter. The company early adopted the new guidance for the annual goodwill impairment test that was performed in the fourth quarter of 2017. See Note 12 for additional information.

Accounting Guidance Issued But Not Adopted as of December 31, 2017

In August 2017, the FASB issued ASU No. 2017-12, Derivatives and Hedging (Topic 815), Targeted Improvements to Accounting for Hedging Activities. The new guidance expands and refines hedge accounting for both nonfinancial and financial risk components and aligns the recognition and presentation of the effects of the hedging instrument and the hedged items in the financial statements. For cash flow and net investment hedges existing as of the date of adoption, an entity should apply a cumulative-effect adjustment related to eliminating the separate measurement of ineffectiveness to accumulated other comprehensive income with a corresponding adjustment to the opening balance of retained earnings as of the beginning of the fiscal year in which an entity adopts. Presentation and disclosure guidance is required to be adopted prospectively. The new standard is effective for fiscal years beginning after December 15, 2018 and interim periods within those fiscal years. Early adoption is permitted in any interim period. All transition requirements and elections should be applied to hedging relationships existing (that is, hedging relationships in which the hedging instrument has not expired, been sold, terminated, or exercised or the entity has not removed the designation of the hedging relationship) on the date of adoption. The effect of adoption should be reflected as of the beginning of the fiscal year of adoption. The company is currently evaluating the impact this guidance will have on the Consolidated Financial Statements and related disclosures.

In March 2017, the FASB issued ASU No. 2017-07, Compensation - Retirement Benefits (Topic 715), Improving the Presentation of Net Periodic Pension Cost and Net Periodic Postretirement Benefit Cost. The new guidance requires registrants to present the service cost component of net periodic benefit cost in the same income statement line item or items as other employee compensation costs arising from services rendered during the period. In addition, only the service cost component will be eligible for capitalization in assets. Registrants will present the other components of net periodic benefit cost separately from the service cost component; and, the line item or items used in the income statement to present the other components of net periodic benefit cost must be disclosed. The guidance is effective for annual reporting periods beginning after December 15, 2017, including interim periods within those fiscal years. Early adoption is permitted as of the beginning of an annual period. The new standard must be adopted retrospectively for the presentation of the service cost component and the other components of net periodic benefit cost in the income statement, and prospectively for the capitalization of the service cost component of net periodic benefit cost in assets. The company plans to adopt this guidance in the first quarter of 2018 and is currently evaluating the impact on the Consolidated Financial Statements and related disclosures. The company anticipates approximately half the costs will be reclassified from cost of goods sold, with the remainder reclassified from selling, general and administrative expenses and research and development expense, to sundry income - net in the Consolidated Statements of Operations. See Note 16 for the components of net periodic benefit cost.

In January 2017, the FASB issued ASU No. 2017-01, Business Combinations (Topic 805), Clarifying the Definition of a Business. The new guidance narrows the existing definition of a business and provides a framework for evaluating whether a transaction should be accounted for as an acquisition (or disposal) of assets or a business. The guidance requires an entity to evaluate if substantially all of the fair value of the gross assets acquired is concentrated in a single identifiable asset or a group of similar identifiable assets; if so, the set of transferred assets and activities (collectively, the "set") is not a business. To be considered a business, the set would need to include an input and a substantive process that together significantly contribute to the ability to create outputs, as defined by the ASU. The guidance is effective for annual reporting periods beginning after December 15, 2017, including interim periods within those annual reporting periods, and should be applied prospectively. Early adoption is permitted. The company adopted this standard on January 1, 2018 and will apply it prospectively to all applicable transactions after the adoption date.

In November 2016, the FASB issued ASU 2016-18, Statement of Cash Flows (Topic 230): Restricted Cash (a consensus of the FASB Emerging Issues Task Force), which clarifies how entities should present restricted cash and restricted cash equivalents in the statement of cash flows, and, as a result, entities will no longer present transfers between cash and cash equivalents and restricted cash and restricted cash equivalents in the statement of cash flows. An entity with a material balance of restricted cash and restricted cash equivalents must disclose information about the nature of the restrictions. The new standard is effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2017. Early adoption is permitted and the new guidance must be applied retrospectively to all periods presented. The new guidance will change the presentation of restricted cash in the Consolidated Statements of Cash Flows and will be applied retrospectively in the first quarter of 2018.

In October 2016, the FASB issued ASU No. 2016-16, Income Taxes (Topic 740), Intra-Entity Transfers of Assets Other Than Inventory. The new guidance requires that entities recognize the income tax consequences of an intra-entity transfer of an asset other than inventory when the transfer occurs, rather than when the asset is sold to an outside party. The guidance is effective for annual reporting periods beginning after December 15, 2017, including interim periods within those annual reporting periods. Early adoption is permitted as of the beginning of an annual reporting period. The new guidance requires adoption on a modified retrospective basis through a cumulative-effect adjustment directly to retained earnings as of the beginning of the period of adoption. The company plans to adopt this guidance in the first quarter of 2018 with the expectation that this guidance will have an immaterial impact on the Consolidated Financial Statements and related disclosures.

In August 2016, the FASB issued ASU No. 2016-15, Statement of Cash Flows (Topic 230), Classification of Certain Cash Receipts and Cash Payments. The new guidance makes eight targeted changes to how cash receipts and cash payments are presented and classified in the statement of cash flows. The guidance is effective for fiscal years beginning after December 15, 2017, and interim periods within those fiscal years. The new guidance requires adoption on a retrospective basis unless it is impracticable to apply, in which case the company would be required to apply the amendments prospectively as of the earliest date practicable. The company is currently evaluating the impact this guidance will have on the Consolidated Financial Statements and related disclosures, but does not expect there to be a significant impact.

In February 2016, the FASB issued ASU No. 2016-02, Leases (Topic 842). The amendments under the new guidance will require lessees to recognize almost all leases on their balance sheet as a right-of-use asset and a lease liability, other than leases that meet the definition of a short-term lease. For income statement purposes, the FASB retained a dual model, requiring leases to be classified as either operating or finance. Classification will be based on criteria that are largely similar to those applied in current lease accounting. Lessor accounting is similar to the current model, but updated to align with certain changes to the lessee model and the new revenue recognition standard. The new leasing standard will be effective for fiscal years beginning after December 15, 2018, and interim periods within those fiscal years. Early adoption is permitted. The new standard must be adopted using a modified retrospective transition, requiring application at the beginning of the earliest comparative period presented. The company is currently evaluating the impact of adopting this guidance on the Consolidated Financial Statements and related disclosures. The company is the lessee under various agreements for facilities and equipment that are currently accounted for as operating leases. A discussion of these leases is included in Note 14, "Commitments and Contingent Liabilities."

In May 2014, the FASB issued ASU No. 2014-09, Revenue from Contracts with Customers (Topic 606), which was further updated in March, April, May and December 2016, as well as September and November 2017.  The new guidance clarifies the principles for recognizing revenue and develops a common revenue standard for GAAP.  The core principle of the guidance is that an entity should recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods and services.  The new standard also will result in additional disclosure requirements to describe the nature, amount, timing and uncertainty of revenue and cash flows arising from contracts with customers.  In July 2015, the FASB approved a deferral of the ASU effective date from annual and interim periods beginning after December 15, 2016 to annual and interim periods beginning after December 15, 2017. The standard permits the use of either the retrospective or modified retrospective (cumulative-effect) transition method of adoption.  The company will adopt the standard in the first quarter of 2018 under the modified retrospective transition method.  The company has substantially completed its evaluation of the impact of the new standard on the Consolidated Financial Statements and has determined that the transition adjustment to be recorded upon adoption is not material and the company does not expect material changes in the timing of revenue recognition.  The company continues to evaluate the impact of the new standard on its disclosures.

XML

Business Combinations

12 Months Ended

Dec. 31, 2017

Business Combinations [Abstract]

Business Combination Disclosure [Text Block]

BUSINESS COMBINATIONS

Acquisition of Granular, Inc.

On August 31, 2017, the company acquired Granular, Inc., a leading provider of software and analytics tools that help farms improve efficiency, profitability, and sustainability.  The purchase price was approximately $250 million and was primarily allocated to goodwill, developed technology, and customer relationships. The fair value of the acquired assets related to Granular, Inc. are included in the fair value measurement of DuPont’s assets and liabilities, discussed below. 

Merger with Dow

Upon completion of the Merger, (i) each share of common stock, par value $0.30 per share, of the company (the "DuPont Common Stock") was converted into the right to receive 1.2820 fully paid and non-assessable shares of DowDuPont common stock, par value $0.01 per share, ("DowDuPont Common Stock"), in addition to cash in lieu of any fractional shares of DowDuPont Common Stock, and (ii) each share of DuPont Preferred Stock— $4.50 Series and DuPont Preferred Stock— $3.50 Series (collectively "DuPont Preferred Stock") issued and outstanding immediately prior to the Merger Effectiveness Time remains issued and outstanding and was unaffected by the Merger.

As provided in the Merger Agreement, at the Merger Effectiveness Time, all options relating to shares of DuPont Common Stock that were outstanding immediately prior to the effective time of the Merger were generally automatically converted into options relating to shares of DowDuPont Common Stock and all restricted stock units and performance based restricted stock units relating to shares of DuPont Common Stock that were outstanding immediately prior to the effective time of the Mergers were generally automatically converted into restricted stock units relating to shares of DowDuPont Common Stock, in each case, after giving effect to appropriate adjustments to reflect the Mergers and otherwise generally on the same terms and conditions as applied under the applicable plans and award agreements immediately prior to the Merger Effectiveness Time. See Note 17 for further discussion.

Prior to the Merger, shares of DuPont Common Stock were registered pursuant to Section 12(b) of the Securities Exchange Act of 1934, as amended and listed on the New York Stock Exchange (the “NYSE”). As a result of the Merger, on August 31, 2017, the company requested that the NYSE withdraw the shares of DuPont Common Stock from listing on the NYSE and filed a Form 25 with the U.S. Securities and Exchange Commission ("SEC") to report that DuPont Common Stock is no longer listed on the NYSE. DuPont continues to have preferred stock outstanding and it remains listed on the NYSE. DowDuPont Common Stock is listed and trades on the NYSE, ticker symbol DWDP.

As a condition of the regulatory approval of the Merger, DuPont was required to divest a portion of its crop protection product line, including certain research and development capabilities. See Note 4 for additional information.

DuPont and Dow intend to pursue, subject to the receipt of approval by the Board of Directors of DowDuPont, the separation of the combined company’s agriculture, specialty products and materials science businesses through a series of tax-efficient transactions (collectively, the "Intended Business Separations").

Preliminary Allocation of Purchase Price

Based on an evaluation of the provisions of ASC 805, "Business Combinations," ("ASC 805") Dow was determined to be the accounting acquirer in the Merger. DowDuPont has applied the acquisition method of accounting with respect to the assets and liabilities of DuPont, which have been measured at fair value as of the date of the Merger. In connection with the Merger and the related accounting determination, DuPont has elected to apply push-down accounting and reflect in its financial statements the fair value of assets and liabilities. Such fair values have been reflected in the Successor Consolidated Financial Statements.

DuPont's assets and liabilities were measured at estimated fair values as of the Merger Effectiveness Time, primarily using Level 3 inputs. Estimates of fair value represent management's best estimate which require a complex series of judgments about future events and uncertainties. Third-party valuation specialists were engaged to assist in the valuation of these assets and liabilities.

The total fair value of consideration transferred for the Merger was $74,680 million. Total consideration is comprised of the equity value of the DowDuPont shares as of the Merger Effectiveness Time that were issued in exchange for DuPont shares, the cash value for fractional shares, and the portion of DuPont's share awards and share options earned as of the Merger Effectiveness Time. Share awards and share options converted to DowDuPont equity instruments, but not vested, were $144 million as of August 31, 2017, which will be expensed over the remaining future vesting period.

The following table summarizes the fair value of consideration exchanged as a result of the Merger:

(In millions, except exchange ratio)
DuPont Common Stock outstanding as of the Merger Effectiveness Time	868.3
DuPont exchange ratio	1.2820
DowDuPont Common Stock issued in exchange for DuPont Common Stock	1,113.2
Fair value of DowDuPont Common Stock issued 1	$	74,195
Fair value of DowDuPont equity awards issued in exchange for outstanding DuPont equity awards 2	485
Total consideration	$	74,680

1. Amount was determined based on the price per share of Dow Common Stock of $66.65 on August 31, 2017.

2. Represents the fair value of replacement awards issued for DuPont's equity awards outstanding immediately before the Merger and attributable to the service periods prior to the Merger. The previous DuPont equity awards were converted into the right to receive 1.2820 shares of DowDuPont Common Stock.

The acquisition method of accounting requires, among other things, that identifiable assets acquired and liabilities assumed be recognized on the balance sheet at the fair values as of the acquisition date. In determining the fair value, DowDuPont utilized various forms of the income, cost and market approaches depending on the asset or liability being fair valued. The estimation of fair value required significant judgments related to future net cash flows (including net sales, cost of products sold, selling and marketing costs, and working capital/contributory asset charges), discount rates reflecting the risk inherent in each cash flow stream, competitive trends, market comparables and other factors. Inputs were generally determined by taking into account historical data, supplemented by current and anticipated market conditions, and growth rates.

The table below presents the preliminary fair value that was allocated to DuPont's assets and liabilities based upon fair values as determined by DowDuPont. The valuation process to determine the fair values is not yet complete. DuPont estimated the preliminary fair value of acquired assets and liabilities as of the date of acquisition based on information currently available and continues to adjust those estimates upon refinement of market participant assumptions for integrating businesses, finalization of tax returns in the pre-merger period and application of push-down accounting at the subsidiary level. The preliminary fair values are substantially complete with the exception of identifiable intangible assets, property, plant, and equipment, income taxes and goodwill. As DuPont finalizes the fair value of assets acquired and liabilities assumed, additional purchase price adjustments may be recorded during the measurement period, but no later than one year from the date of the acquisition. DuPont will reflect measurement period adjustments, if any, in the period in which the adjustments are recognized. Final determination of the fair values may result in further adjustments to the values presented in the following table.

	Estimated fair value as previously reported 1		Measurement period adjustments2			Estimated fair value adjusted
(In millions)
Fair Value of Assets as of the Merger Effectiveness Time
Cash and cash equivalents	$	4,005	$	—		$	4,005
Marketable securities	2,849		—			2,849
Accounts and notes receivable	7,851		—			7,851
Inventories	8,886		(79		)	8,807
Other current assets	360		—			360
Investment in nonconsolidated affiliates	1,685		(31		)	1,654
Assets held for sale - current	3,184		564			3,748
Property, plant and equipment	12,122		(181		)	11,941
Goodwill 3	45,501		(396		)	45,105
Other intangible assets 3	27,844		(623		)	27,221
Deferred income tax assets	487		(203		)	284
Other assets	2,076		—			2,076
Total Assets	$	116,850	$	(949	)	$	115,901
Fair Value of Liabilities
Short-term borrowings and capital lease obligations	$	5,319	$	—		$	5,319
Accounts payable	3,283		—			3,283
Income taxes payable	140		—			140
Accrued and other current liabilities	3,517		—			3,517
Liabilities held for sale - current	104		11			115
Long-term debt	9,878		—			9,878
Deferred income tax liabilities	9,408		(940		)	8,468
Pension and other post employment benefits - noncurrent	8,092		(36		)	8,056
Other noncurrent obligations	2,028		—			2,028
Total Liabilities	$	41,769	$	(965	)	$	40,804
Noncontrolling interests	162		16			178
Preferred stock	239		—			239
Fair Value of Net Assets (Consideration for the Merger)	$	74,680	$	—		$	74,680

1. As previously reported in the company’s Quarterly Report on Form 10-Q for the period ended September 30, 2017.

2. DuPont recorded measurement period adjustments in the fourth quarter of 2017 to reflect facts and circumstances in existence as of the Merger Effectiveness Time. These measurement period adjustments primarily related to changes in preliminary valuation assumptions, including market participant estimates of cash flows and estimates of asset useful lives, as well as other initial estimates. All measurement period adjustments were offset against goodwill.

3. See Note 12 for additional information.

The significant fair value adjustments included in the preliminary allocation of purchase price are discussed below.

Inventories

Inventory is primarily comprised of finished products of $4,929 million, semi-finished products of $3,055 million and raw materials and stores and supplies of $823 million. The fair value of finished goods was calculated as the estimated selling price, adjusted for costs of the selling effort and a reasonable profit allowance relating to the selling effort. The fair value of semi-finished inventory was primarily calculated as the estimated selling price, adjusted for estimated costs to complete the manufacturing, estimated costs of the selling effort, as well as a reasonable profit margin on the remaining manufacturing and selling effort. The fair value of raw materials and stores and supplies was determined to approximate the historical carrying value. For inventory accounted for under the FIFO method and average cost method, the preliminary fair value step-up of inventory will be recognized in costs of goods sold as the inventory is sold. For inventory accounted for under the LIFO method, the preliminary fair value of inventory becomes the LIFO base layer inventory. The pre-tax amount of inventory step-up recognized for the period September 1 through December 31, 2017, was $1,538 million, of which $1,434 million was reflected in costs of goods sold within loss from continuing operations before income taxes and $104 million is reflected in loss from discontinued operations after income taxes in the Consolidated Statements of Operations.

Property, Plant & Equipment

Property, plant and equipment is comprised of machinery and equipment of $7,466 million, buildings of $2,583 million, construction in progress of $980 million and land and land improvements of $912 million. The preliminary estimated fair value of property and equipment was primarily determined using a market approach for land and certain types of equipment, and a replacement cost approach for other property and equipment. The market approach for certain types of equipment represents a sales comparison that measures the value of an asset through an analysis of sales and offerings of comparable assets. The replacement cost approach used for all other depreciable property and equipment measures the value of an asset by estimating the cost to acquire or construct comparable assets and adjusts for age and condition of the asset.

Goodwill

The excess of the consideration for the Merger over the preliminary net fair value of assets and liabilities was recorded as goodwill. The Merger resulted in the recognition of $45,105 million of goodwill, none of which is deductible. Goodwill largely consists of expected cost synergies resulting from the Merger and the Intended Business Separations, the assembled workforce of DuPont, and future technology and customers.

Other Intangible Assets

Other intangible assets primarily consist of acquired customer related assets, developed technology, trademarks and tradenames, and germplasm. The preliminary customer-related value was determined using the excess earnings method while the preliminary developed technology, trademarks and trade names, and germplasm values were primarily determined utilizing the relief from royalty method. Both the excess earnings and relief from royalty methods are forms of the income approach. Refer to Note 12 for further information on other intangible assets.

Deferred Income Tax Assets and Liabilities

The deferred income tax assets and liabilities include the expected future federal, state, and foreign tax consequences associated with temporary differences between the preliminary fair values of the assets acquired and liabilities assumed and the respective tax bases. Tax rates utilized in calculating deferred income taxes generally represent the enacted statutory tax rates at the Merger Effectiveness Time in the jurisdictions in which legal title of the underlying asset or liability resides. Refer to Note 7 for further information related to the remeasurement of deferred income tax assets and liabilities as a result of the enactment of the U.S. Tax Cuts and Jobs Act in December 2017.

The preliminary fair value of deferred income tax assets includes a $172 million adjustment to derecognize a valuation allowance for certain historical net operating losses that will not be fully realized as a result of the Merger.  Included in the fair value adjustment related to deferred income tax liabilities is a $546 million adjustment reflecting a change in determination as to the reinvestment strategy of certain foreign operations of the company.

Integration and Separation Costs

Integration and separation costs have been and are expected to be significant. These costs to date primarily have consisted of financial advisory, information technology, legal, accounting, consulting, and other professional advisory fees associated with the preparation and execution of activities related to the Merger and the Intended Business Separations. These costs are recorded within integration and separation costs in the Successor period and the costs are recorded within selling, general and administrative expenses in the Predecessor periods within the Consolidated Statements of Operations.

	Successor		Predecessor
(In millions)	For the Period September 1 through December 31, 2017		For the Period January 1 through August 31, 2017		For the Year Ended December 31, 2016		For the Year Ended December 31, 2015
Integration and separation costs	$	314
Selling, general and administrative expenses			$	581	$	386	$	10

H&N Business

On November 1, 2017, the company completed the FMC Transactions through the acquisition of the H&N Business and the disposition of the Divested Ag Business. The acquisition will be integrated into the nutrition and health product line to enhance DuPont’s position as a leading provider of sustainable, bio-based food ingredients and allow for expanded capabilities in the pharma excipients space. The company accounted for the acquisition in accordance with ASC 805, which requires the assets acquired and liabilities assumed to be recognized on the balance sheet at their fair values as of the acquisition date.

The following table summarizes the fair value of consideration exchanged as a result of the FMC Transactions:

(In millions)
Fair Value of Divested Ag Business 1	$	3,665
Less: Cash received 2	1,200
Less: Favorable contracts 3	495
Fair Value of H&N Business	$	1,970

1. Refer to Note 4 for additional information.

2. The FMC Transactions include a cash consideration payment to DuPont of approximately $1,200 million, which reflects the difference in value between the Divested Ag Business and the H&N Business, subject to certain customary inventory and net working capital adjustments.

3. Upon closing and pursuant to the terms of the FMC Transaction Agreement, DuPont entered into favorable supply contracts with FMC. DuPont recorded these contracts as intangible assets recognized at the fair value of off-market contracts. Refer to Notes 4 and 12 for additional information.

The table below presents the preliminary fair value that was allocated to the assets acquired and liabilities assumed. The purchase accounting and purchase price allocation for the H&N Business are substantially complete. However, the company continues to refine the preliminary valuation of certain acquired assets, such as inventories, intangibles, deferred income taxes, and property plant and equipment, which could impact the amount of residual goodwill recorded. The company will finalize the amounts recognized as it obtains the information necessary to complete the analysis, but no later than one year from the date of the acquisition. Final determination of the fair values may result in further adjustments to the values presented in the following table.

	Successor
(In millions)	November 1, 2017
Fair Value of Assets
Cash and cash equivalents	$	16
Accounts and notes receivable	144
Inventories	314
Property, plant and equipment	505
Goodwill	718
Other intangible assets	435
Other current and non-current assets	16
Total Assets	$	2,148
Fair Value of Liabilities
Accounts payable and other accrued liabilities	$	70
Deferred income tax liabilities	108
Total Liabilities	$	178
Fair Value of Net Assets (Consideration for the H&N Business)	$	1,970

The significant fair value adjustments included in the preliminary allocation of purchase price are discussed below.

Inventories

Acquired inventory is comprised of finished goods of $153 million, semi-finished products of $85 million and raw materials and stores and supplies of $76 million. Fair value of inventory was calculated using a net realizable value approach for finished goods and semi-finished products and a replacement cost approach for raw materials and stores and supplies. The preliminary fair value step-up of inventory of $100 million will be recognized in costs of goods sold as the inventory is sold. The pre-tax amount recognized during the period ending November 1 through December 31, 2017, was $35 million, which was reflected in cost of goods sold within loss from continuing operations before income taxes in the Consolidated Statements of Operations.

Property, Plant & Equipment

Property, plant and equipment is comprised of machinery and equipment of $372 million, buildings of $63 million, land and land improvements of $39 million, and construction in progress of $31 million. The preliminary estimated fair values were determined using a combination of a market approach and replacement cost approach.

Goodwill

The excess of the consideration for the H&N Business over the preliminary net fair value of assets acquired and liabilities assumed resulted in the recognition of $718 million of goodwill, of which $208 million is tax-deductible. Goodwill is attributable to the H&N Business’s workforce and expected cost synergies in procurement, production and market access.

Other Intangible Assets

Other intangible assets includes customer-related intangible assets of $268 million, developed technology of $130 million, and trademarks and tradenames of $37 million. The preliminary customer-related fair value was determined using the excess earnings method while the preliminary developed technology, trademarks and tradenames fair values were primarily determined utilizing the relief from royalty method.

Results of Operations

The following table provides net sales and (loss) income from continuing operations before income taxes of the H&N Business included in the company's results since the acquisition.

	Successor
(In millions)	For the Period November 1 through December 31, 2017
Net sales	$	102
Loss from continuing operations before income taxes	$	(12	)

The H&N Business results include $35 million that was recognized in cost of goods sold as inventory was sold related to the fair value step-up of inventories in the Consolidated Statements of Operations, for the period of November 1 through December 31, 2017.

The company evaluated the disclosure requirements under ASC 805 and determined the H&N Business was not considered a material business combination for purposes of disclosing supplemental pro forma information.

XML

Divestitures and Other Transactions

12 Months Ended

Dec. 31, 2017

Discontinued Operations and Disposal Groups [Abstract]

Disposal Groups, Including Discontinued Operations, Disclosure [Text Block]

DIVESTITURES AND OTHER TRANSACTIONS

Merger Remedy - Divested Ag Business

On March 31, 2017, the company and FMC entered into the FMC Transaction Agreement. Under the FMC Transaction Agreement, FMC acquired the Divested Ag Business that DuPont was required to divest in order to obtain EC approval of the Merger Transaction as described in Note 1 and DuPont agreed to acquire the H&N Business. The sale of the Divested Ag Business meets the criteria for discontinued operations and as such, earnings are included within "(Loss) Income from discontinued operations after income taxes" for all periods presented.

On November 1, 2017, the company completed the FMC Transactions through the disposition of the Divested Ag Business and the acquisition of the H&N Business. The preliminary fair value as determined by the company of the H&N Business is $1,970 million. The FMC Transactions include a cash consideration payment to DuPont of approximately $1,200 million, which reflects the difference in value between the Divested Ag Business and the H&N Business, as well as favorable contracts with FMC of $495 million, subject to adjustments for inventory of the Divested Ag Business and net working capital of the H&N Business. Due to the proximity of the Merger and the closing of the sale, the carrying value of the Divested Ag Business approximated the fair value of the consideration received, thus no resulting gain or loss was recognized on the sale. Refer to Note 3 for further information on the H&N Business.

The results of operations of the Divested Ag Business are presented as discontinued operations as summarized below:

	Successor			Predecessor
(In millions)	For the Period September 1 through December 31, 20171			For the Period January 1 through August 31, 2017		For the Year Ended December 31, 2016			For the Year Ended December 31, 2015
Net sales	$	199		$	1,068	$	1,385		$	1,473
Cost of goods sold	194			412		514			521
Other operating charges				17		19			25
Research and development expenses	30			95		139			163
Selling, general and administrative expenses2	102			146		176			187
Restructuring and asset related charges - net	(1		)	—		(4		)	15
Sundry (expense) income - net	(1		)	7		1			7
(Loss) Income from discontinued operations before income taxes	(127		)	405		542			569
(Benefit from) Provision for income taxes	(50		)	79		103			121
(Loss) Income from discontinued operations after income taxes	$	(77	)	$	326	$	439		$	448

^1.  Includes results of operations for the period September 1 through October 31, 2017, as the Divested Ag Business was disposed of on November 1, 2017.

^2.  Successor period includes $44 million of transaction costs associated with the disposal of the Divested Ag Business.

The following table presents depreciation and capital expenditures of the discontinued operations related to the Divested Ag Business:

	Successor		Predecessor
(In millions)	For the Period September 1 through December 31, 2017		For the Period January 1 through August 31, 2017		For the Year Ended December 31, 2016		For the Year Ended December 31, 2015
Depreciation	$	—	$	21	$	32	$	30
Capital expenditures	$	5	$	8	$	40	$	77

The carrying amount of major classes of assets and liabilities classified as assets and liabilities of discontinued operations at December 31, 2016 related to the Divested Ag Business consist of the following:

	Predecessor
(In millions)	December 31, 2016
Cash and cash equivalents	$	57
Accounts and notes receivable - net	12
Inventories	323
Other current assets	1
Property, plant and equipment - net	380
Goodwill	11
Other assets	5
Assets held for sale	$	789
Accounts payable	27
Accrued and other current liabilities	12
Deferred income tax liabilities	6
Other noncurrent obligations	29
Liabilities held for sale	$	74

Upon closing and pursuant to the terms of the FMC Transaction Agreement, DuPont and FMC entered into favorable supply agreements and certain ancillary agreements, including manufacturing service agreements and transition service agreements.  Under the terms of the favorable supply agreements, FMC will supply product to DuPont at cost for a period of up to five years and, as a result, DuPont recorded an intangible asset of $495 million upon closing that will amortize over a period of five years.

Food Safety Diagnostic Sale

In February 2017, the company completed the sale of global food safety diagnostics to Hygiena LLC.  The sale resulted in a pre-tax gain of $162 million ($86 million net of tax). The gain was recorded in sundry income - net in the company's Consolidated Statement of Operations for the period January 1 through August 31, 2017.

DuPont (Shenzhen) Manufacturing Limited

In March 2016, the company recognized the sale of its 100 percent ownership interest in DuPont (Shenzhen) Manufacturing Limited to the Feixiang Group. The sale of the entity, which held certain buildings and other assets, resulted in a pre-tax gain of $369 million ($214 million net of tax). The gain was recorded in sundry income - net in the company's Consolidated Statement of Operations for the year ended December 31, 2016.

Performance Chemicals

On July 1, 2015, DuPont completed the separation of its Performance Chemicals segment through the spin-off of all of the issued and outstanding stock of The Chemours Company (the "Separation"). In connection with the Separation, the company and The Chemours Company ("Chemours") entered into a Separation Agreement (the "Separation Agreement"), discussed below, and a Tax Matters Agreement and certain ancillary agreements, including an employee matters agreement, agreements related to transition and site services, and intellectual property cross licensing arrangements. In addition, the companies have entered into certain supply agreements.

Separation Agreement

The company and Chemours entered into a Separation Agreement that sets forth, among other things, the agreements between the company and Chemours regarding the principal transactions necessary to effect the Separation and also sets forth ancillary agreements that govern certain aspects of the company’s relationship with Chemours after the separation. Among other matters, the Separation Agreement and the ancillary agreements provide for the allocation between DuPont and Chemours of assets, employees, liabilities and obligations (including investments, property and employee benefits and tax-related assets and liabilities) attributable to periods prior to, at and after the completion of the Separation.

Pursuant to the Separation Agreement and the Amendment to the Separation Agreement, as discussed below, Chemours indemnifies DuPont against certain litigation, environmental, workers' compensation and other liabilities that arose prior to the distribution. The term of this indemnification is generally indefinite and includes defense costs and expenses, as well as monetary and non-monetary settlements and judgments. In 2017, DuPont and Chemours amended the Separation Agreement to provide for a limited sharing of potential future PFOA liabilities for a period of five years beginning July 6, 2017. In connection with the recognition of liabilities related to these matters, the company records an indemnification asset when recovery is deemed probable. At December 31, 2017, the indemnified assets are $80 million within accounts and notes receivable - net and $340 million within other assets along with the corresponding liabilities of $80 million within accrued and other current liabilities and $340 million within other noncurrent obligations on the Condensed Consolidated Balance Sheet. See Note 14 for further discussion of the amendment to the Separation Agreement and certain litigation and environmental matters indemnified by Chemours.

The results of operations of the Performance Chemicals segment are presented as discontinued operations as summarized below:

	Predecessor
(In millions)	For the Period January 1 through August 31, 2017			For the Year Ended December 31, 2016			For the Year Ended December 31, 2015
Net sales	$	—		$	—		$	2,810
Cost of goods sold	—			—			2,215
Other operating charges	335			36			386
Research and development expense	—			—			40
Selling, general and administrative expenses	—			—			(87		)
Restructuring and asset related charges - net	—			—			59
Sundry income - net	3			3			27
Interest expense	—			—			32
(Loss) income from discontinued operations before income taxes	(332		)	(33		)	192
(Benefit from) provision for income taxes	(125		)	(28		)	106
(Loss) income from discontinued operations after income taxes	$	(207	)	$	(5	)	$	86

Income (loss) from discontinued operations after income taxes for the period January 1 through August 31, 2017 includes a charge of $335 million ($214 million net of tax) in connection with the perfluorooctanoic acid (“PFOA”) multi-district litigation settlement.

During the years ended December 31, 2016 and 2015, the company incurred $35 million and $306 million of costs, respectively, in connection with the separation primarily related to professional fees associated with preparation of regulatory filings and separation activities within finance, tax, legal, and information system functions. (Loss) income from discontinued operations during the years ended December 31, 2016 and 2015, includes $35 million and $260 million of these costs, respectively. Income from continuing operations during the year ended December 31, 2015 includes $26 million of these costs, recorded in other operating charges in the company's Consolidated Statements of Operations. Income from continuing operations during the year ended December 31, 2015 also included $20 million of transaction costs incurred for a premium associated with the early retirement of DuPont debt. The company exchanged notes received from Chemours in May 2015 (as part of a dividend payment) for DuPont debt that it then retired. These costs were reported in interest expense in the company's Consolidated Statements of Operations.

In connection with the separation, income from discontinued operations during the year ended December 31, 2015 included pension and other post employment benefit plan curtailment gain of $281 million. In addition, income from discontinued operations during the year ended December 31, 2015, included a restructuring charge of $59 million, consisting of severance and related benefit costs associated with the Performance Chemicals segment to achieve fixed cost and operational productivity improvements for Chemours post-spin.

In connection with the spin-off, the company received a dividend from Chemours in May 2015 of $3,923 million comprised of a cash distribution of $3,416 million and a distribution in-kind of $507 million of 7 percent senior unsecured notes due 2025 (Chemours Notes Received). Chemours financed the dividend payment through issuance of approximately $4,000 million of debt, including the Chemours Notes Received (Chemours' Debt). Net assets of $431 million were transferred to Chemours on July 1, 2015, including the $4,000 million of Chemours' Debt.

The following table presents the depreciation, amortization and purchases of property, plant and equipment of the discontinued operations related to Performance Chemicals:

(In millions)	Predecessor
For the year ended December 31,	2015
Depreciation	$	126
Amortization of intangible assets	2
Capital Expenditures	235

XML

Restructuring and Asset Related Charges

12 Months Ended

Dec. 31, 2017

Restructuring and Related Activities [Abstract]

Restructuring and Related Activities Disclosure [Text Block]

RESTRUCTURING AND ASSET RELATED CHARGES - NET

DowDuPont Cost Synergy Program

In September and November 2017, DowDuPont and the company approved post-merger restructuring actions under the DowDuPont Cost Synergy Program (the “Synergy Program”), adopted by the DowDuPont Board of Directors. The plan is designed to integrate and optimize the organization following the Merger and in preparation for the Intended Business Separations.  Based on all actions approved to date under the Synergy Program, DuPont expects to record total pre-tax restructuring charges of $430 million to $600 million, comprised of approximately $320 million to $360 million of severance and related benefits costs; $110 million to $140 million of costs related to contract terminations; and up to $100 million of asset related charges. The Synergy Program includes certain asset actions, including strategic decisions regarding the cellulosic biofuel unit reflected in the preliminary fair value measurement of DuPont’s assets as of the merger date. Current estimated total pre-tax restructuring charges could be impacted by future adjustments to the preliminary fair value of DuPont’s assets.

For the period September 1 through December 31, 2017, DuPont recorded a pre-tax charge of $187 million, consisting of severance and related benefit costs of $153 million, contract termination costs of $31 million and asset-related charges of $3 million. The charge for the period September 1 through December 31, 2017 was recognized in restructuring and asset related charges - net in the company's Consolidated Statements of Operations. Substantially all of the remaining restructuring charges are expected to be incurred in 2018 and the related actions, including employee separations, associated with this plan are expected to be substantially complete by the end of 2019.

DuPont account balances and activity for the DowDuPont Cost Synergy Program are summarized below:

(In millions)	Severance and Related Benefit Costs			Other Non-Personnel Charges1			Asset-Related Charges			Total
Charges to income from continuing operations for the period September 1 through December 31, 2017 (Successor)	$	153		$	31		$	3		$	187
Payments	(13		)	(3		)	—			(16		)
Asset write-offs	—			—			(3		)	(3		)
Non-cash compensation	(7		)	—			—			(7		)
Balance as of December 31, 2017	$	133		$	28		$	—		$	161

1. Other non-personnel charges consist of contractual obligation costs.

2017 Restructuring Program

During the first quarter 2017, DuPont committed to take actions to improve plant productivity and better position its product lines for productivity and growth before and after the anticipated closing of the Merger Transaction (the "2017 restructuring program"). In connection with these actions, the company incurred pre-tax charges of $313 million during the period from January 1 through August 31, 2017 ("Predecessor" period) recognized in restructuring and asset related charges - net in the company's Consolidated Statements of Operations. The charge is comprised of $279 million of asset-related charges and $34 million in severance and related benefit costs. The charges primarily relate to the second quarter closure of the safety and construction product line at the Cooper River manufacturing site located near Charleston, South Carolina. The asset-related charges mainly consist of accelerated depreciation associated with the closure. The actions associated with this plan are substantially complete as of December 31, 2017.

Account balances and activity for the 2017 restructuring program are summarized below:

(In millions)	Severance and Related Benefit Costs			Asset Related Charges1			Total
Charges to income from continuing operations for the period January 1 through August 31, 2017 (Predecessor)	$	34		$	279		$	313
Payments	(8		)	—			(8		)
Asset write-offs	—			(279		)	$	(279	)
Balance as of August 31, 2017	$	26		$	—		$	26
Charges to income from continuing operations for the period September 1 through December 31, 2017 (Successor)	$	—		$	—		$	—
Payments	(7		)	—			(7		)
Balance as of December 31, 2017	$	19		$	—		$	19

^1.  Includesaccelerated depreciation related to site closure. Charge for accelerated depreciation represents the difference between the depreciation expense to be recognized over the revised useful life of the site, based upon the anticipated date the site will be closed and depreciation expense as determined utilizing the useful life prior to the restructuring action.

La Porte Plant, La Porte, Texas

In March 2016, DuPont announced its decision to not re-start its insecticide manufacturing facility at the La Porte site located in La Porte, Texas.  The facility manufactured Lannate^® and Vydate^® insecticides and has been shut down since November 2014.  As a result of this decision, during the year ended December 31, 2016, a pre-tax charge of $68 million was recorded in restructuring and asset related charges - net in the company's Consolidated Statement of Operations which included $41 million of asset related charges, $16 million of employee severance and related benefit costs, and $11 million of contract termination costs.                

2016 Global Cost Savings and Restructuring Plan

In December 2015, DuPont committed to take structural actions across all product lines and staff functions globally to operate more efficiently by further consolidating product lines and aligning staff functions more closely with them as part of a 2016 global cost savings and restructuring plan. As a result, during the year ended December 31, 2015, a pre-tax charge of $783 million was recorded, consisting of $778 million of restructuring and asset related charges - net and $5 million in sundry income - net in the company's Consolidated Statement of Operations. The charges consisted of $641 million in severance and related benefit costs, $109 million in asset related charges, and $33 million in contract termination charges.

During the year ended December 31, 2016, in connection with the restructuring actions, the company recorded a net pre-tax benefit to earnings of $(81) million, consisting of $(84) million in restructuring and asset related charges - net and $3 million in sundry income - net in the company's Consolidated Statement of Operations. The net benefit was comprised of a reduction of $(150) million in severance and related benefit costs, offset by $53 million of asset related charges, and $16 million of contract termination costs. This was primarily due to a reduction in severance and related benefit costs partially offset by the identification of additional projects. The reduction in severance and related benefit costs was driven by elimination of positions at a lower cost than expected as a result of redeployments and attrition as well as lower than estimated individual severance costs.

The company incurred pre-tax charges of $10 million during the period January 1 through August 31, 2017, recognized in restructuring and asset related charges - net in the company’s Consolidated Statement of Operations. This was due to additional severance payments owed to previously terminated executives that became probable during the period. The company incurred a pre-tax benefit of $(5) million for the period from September 1 through December 31, 2017. The reduction in severance and related benefit costs was driven by the elimination of positions at a lower cost than expected.

Account balances and activity for the restructuring program are summarized below:

(In millions)	Severance and Related Benefit Costs			Other Non-Personnel Charges1			Total
Balance at December 31, 2016 (Predecessor)	$	100		$	22		$	122
Payments	(76		)	(11		)	(87		)
Net translation adjustment	2			—			2
Other adjustments	10			—			10
Balance as of August 31, 2017	$	36		$	11		$	47
Balance at September 1, 2017 (Successor)	$	36		$	11		$	47
Payments	(18		)	(2		)	(20		)
Other adjustments	(5		)	—			(5		)
Balance as of December 31, 2017	$	13		$	9		$	22

1. Other non-personnel charges consist of contractual obligation costs.

2014 Restructuring Program

In June 2014, DuPont announced its global, multi-year initiative to redesign its global organization and operating model to reduce costs and improve productivity and agility across all product lines and functions. During the period from September 1 through December 31, 2017, and the years ended December 31, 2016 and 2015, benefits of $(2) million, $(21) million and $(21) million were recorded, respectively, in restructuring and asset related charges - net in the company's Consolidated Statements of Operations to reduce the accrual for severance costs associated with this program.

Asset Impairment

In the fourth quarter 2015, the company elected to defer further testing and deployment of a multi-year, phased implementation of an enterprise resource planning (ERP) system; which had not been placed in service as of year-end.  At December 31, 2016, the company had capitalized costs associated with the ERP system of $435 million.  In connection with IT strategy reviews conducted during the fourth quarter of 2016, the company reviewed considerations around the timing of restarting testing and deployment of the ERP system.  As a result, the company concluded it intended to complete and place in service the ERP system, however, given the uncertainties related to implementation timing as well as potential developments and changes to technologies in the market place at the time of restart, use of this ERP system could no longer be considered probable. As a result, due to the specificity of the design related to the ERP system, the company determined that the uncompleted ERP system had a fair value of zero and recorded a pre-tax charge of $435 million in restructuring and asset related charges - net in the company's Consolidated Statement of Operations during the year ended December 31, 2016. 

The company recognized a $158 million pre-tax impairment charge in restructuring and asset related charges - net in the company's Consolidated Statement of Operations during the year ended December 31, 2016 related to indefinite-lived intangible trade names. In connection with the company's strategy reviews and brand realignment conducted during the third quarter 2016, the company decided to phase out the use of certain acquired trade names resulting in a change from an indefinite life to a finite useful life for these assets. As a result of these changes, the carrying value of the trade name assets exceeded the fair value.

The basis of the fair value for the charges was calculated utilizing an income approach (relief from royalty method) using Level 3 inputs within the fair value hierarchy, as described in Note 1. The key assumptions used in the calculation included projected revenue, royalty rates and discount rates. These key assumptions involve management judgment and estimates relating to future operating performance and economic conditions that may differ from actual cash flows. After the recognition of the impairment charge, the remaining net book value of the trade names was $28 million, which represented fair value.

During the first quarter 2015, a $38 million pre-tax impairment charge was recorded in restructuring and asset related charges - net in the company's Consolidated Statement of Operations. The majority relates to a cost basis investment in which the assessment resulted from the venture's revised operating plan reflecting underperformance of its European wheat based ethanol facility and deteriorating European ethanol market conditions. One of the primary investors communicated that they would not fund the revised operating plan of the investee. As a result, the carrying value of DuPont's 6 percent cost basis investment in this venture exceeds its fair value by $37 million, such that an impairment charge was recorded.

XML

Supplementary Information

12 Months Ended

Dec. 31, 2017

Supplementary Information [Abstract]

Additional Financial Information Disclosure [Text Block]

SUPPLEMENTARY INFORMATION

Sundry Income - Net	Successor		Predecessor
(In millions)	For the Period September 1 through December 31, 2017		For the Period January 1 through August 31, 2017			For the Year Ended December 31, 2016			For the Year Ended December 31, 2015
Royalty income1			$	84		$	170		$	138
Interest income	$	41	83			102			124
Equity in earnings of affiliates - net	1		55			99			49
Net gain on sales of businesses and other assets2,3	16		205			435			92
Net exchange gains (losses)	8		(394		)	(106		)	30
Miscellaneous income and expenses - net4	24		133			7			257
Sundry income - net	$	90	$	166		$	707		$	690

^1.  In the Successor period, royalty income of $60 million is included in Net Sales.

^2.   Includes a pre-tax gain of $162 million ($86 million net of tax) for the period January 1 through August 31, 2017 related to the sale of global food safety diagnostics. See Note 4 for additional information.

^3.   Includes a pre-tax gain of $369 million ($214 million net of tax) for the year ended December 31, 2016 related to the sale of DuPont (Shenzhen) Manufacturing Limited. See Note 4 for additional information.

^4.   Miscellaneous income and expenses - net, includes interest items (in the Predecessor period only), gains (losses) on available for sale securities, gains related to litigation settlements, licensing income, gains on purchases, and other items.

The following table summarizes the impacts of the company's foreign currency hedging program on the company's results of operations. The company routinely uses foreign currency exchange contracts to offset its net exposures, by currency, related to the foreign currency-denominated monetary assets and liabilities. The objective of this program is to maintain an approximately balanced position in foreign currencies in order to minimize, on an after-tax basis, the effects of exchange rate changes on net monetary asset positions. The hedging program gains (losses) are largely taxable (tax deductible) in the United States (U.S.), whereas the offsetting exchange gains (losses) on the remeasurement of the net monetary asset positions are often not taxable (tax deductible) in their local jurisdictions. The net pre-tax exchange gains (losses) are recorded in sundry income - net and the related tax impact is recorded in provision for income taxes on continuing operations in the Consolidated Statements of Operations.

	Successor			Predecessor
(In millions)	For the Period September 1 through December 31, 2017			For the Period January 1 through August 31, 2017			For the Year Ended December 31, 2016			For the Year Ended December 31, 2015
Subsidiary Monetary Position (Loss) Gain
Pre-tax exchange (loss) gain	$	(83	)	$	37		$	198		$	(404	)
Local tax (expenses) benefits	(3		)	217			(126		)	(61		)
Net after-tax impact from subsidiary exchange (loss) gain	$	(86	)	$	254		$	72		$	(465	)
Hedging Program Gain (Loss)
Pre-tax exchange gain (loss)	$	91		$	(431	)	$	(304	)	$	434
Tax (expenses) benefits	(33		)	155			110			(157		)
Net after-tax impact from hedging program exchange gain (loss)	$	58		$	(276	)	$	(194	)	$	277
Total Exchange Gain (Loss)
Pre-tax exchange gain (loss)	$	8		$	(394	)	$	(106	)	$	30
Tax (expenses) benefits	(36		)	372			(16		)	(218		)
Net after-tax exchange (loss) gain	$	(28	)	$	(22	)	$	(122	)	$	(188	)

Other current assets

Other current assets includes approximately $558 million of restricted cash related to the Rabbi Trust as of December 31, 2017. See Note 16 for additional information.

Accrued and other current liabilities

Accrued and other current liabilities were $4,384 million at December 31, 2017 and $4,650 million at December 31, 2016. Deferred revenue and compensation and other employee-related costs, which are components of accrued and other current liabilities, were $2,014 million and $857 million at December 31, 2017, respectively and $2,217 million and $807 million at December 31, 2016, respectively. No other components of accrued and other current liabilities were more than 5 percent of total current liabilities.

Other noncurrent obligations

Other noncurrent obligations were $1,975 million at December 31, 2017 and $12,304 million at December 31, 2016. Accrued pension benefit costs and accrued other post employment benefit costs, which are components of other noncurrent obligations in the Predecessor period, were $8,092 million and $2,554 million at December 31, 2016, respectively. In the Successor period, accrued pension benefit costs and accrued other post employment benefit costs are included in the line item, pension and other post employment benefits - noncurrent in the Consolidated Balance Sheets. See Note 1 for discussion of reclassification adjustments. No other components of other noncurrent obligations were more than 5 percent of total liabilities.

Related Parties

Transactions with DowDuPont

DowDuPont relies on distributions and other intercompany transfers from DuPont and Dow to fund payment of its costs and expenses. In November 2017, DowDuPont’s Board of Directors declared a fourth quarter dividend per share of DowDuPont common stock payable on December 15, 2017 and authorized an initial $4,000 million share repurchase program to buy back shares of DowDuPont common stock. In the fourth quarter of 2017, DuPont declared and paid distributions in cash and in-kind to DowDuPont of $829 million, primarily to fund a portion of DowDuPont’s fourth quarter share repurchases and dividend payment.

In addition, at December 31, 2017, DuPont had a payable to DowDuPont of $354 million, included in accounts payable in the Consolidated Balance Sheets related to its estimated 2017 tax liability. See Note 7 for additional information.

XML

Income Taxes

12 Months Ended

Dec. 31, 2017

Income Tax Disclosure [Abstract]

Income Tax Disclosure [Text Block]

INCOME TAXES

On December 22, 2017, the Tax Cuts and Jobs Act (“The Act”) was enacted. The Act reduces the U.S. federal corporate income tax rate from 35 percent to 21 percent, requires companies to pay a one-time transition tax (“transition tax”) on earnings of foreign subsidiaries that were previously tax deferred, creates new provisions related to foreign sourced earnings, eliminates the domestic manufacturing deduction and moves to a territorial system. At December 31, 2017, the company had not completed its accounting for the tax effects of The Act; however, as described below, the company has made a reasonable estimate of the effects on its existing deferred tax balances and the one-time transition tax. In accordance with Staff Accounting Bulletin 118 ("SAB 118"), during the measurement period, income tax effects of the Act may be refined upon obtaining, preparing, or analyzing additional information, and such changes could be material. During the measurement period, provisional amounts may be also be adjusted for the effects, if any, of interpretative guidance issued after December 31, 2017, by U.S. regulatory and standard-setting bodies.

• As a result of The Act, the company remeasured its U.S. federal deferred income tax assets and liabilities based on the rates at which they are expected to reverse in the future, which is generally 21 percent. However, the company is still analyzing certain aspects of The Act and refining its calculations, which could potentially affect the measurement of these balances or potentially give rise to new deferred tax amounts. The provisional amount recorded related to the remeasurement of the company’s deferred income tax balance was $(2,716) million and was recorded as a benefit to the provision for income taxes on continuing operations.

• The Act requires a mandatory deemed repatriation of post-1986 undistributed foreign earnings and profits (“E&P”), which results in a one-time transition tax. As a result, the company has recorded a provisional amount for the transition tax liability for its foreign subsidiaries of $715 million, recorded as a charge to the provision for income taxes on continuing operations. The company has not yet completed its calculation of the total post-1986 foreign E&P for its foreign subsidiaries as E&P will not be finalized until the Federal income tax return is filed. Further, the transition tax is based in part on the amount of those earnings held in cash and other specified assets which is a defined term under The Act.

• For tax years beginning after December 31, 2017, The Act introduces new provisions for U.S. taxation of certain global intangible low-taxed income (“GILTI”). Due to its complexity and a current lack of guidance as to how to calculate the tax, the company is not yet able to determine a reasonable estimate for the impact of the incremental tax liability. When additional guidance is available, the company will make a policy election on whether the additional liability will be recorded in the period in which it is incurred or recognized for the basis differences that would be expected to reverse in future years.

Geographic Allocation of Income and Provision for Income Taxes	Successor			Predecessor
(In millions)	For the Period September 1 through December 31, 2017			For the Period January 1 through August 31, 2017			Year Ended 2016			Year Ended 2015
(Loss) Income from continuing operations before income taxes
Domestic	$	(811	)	$	409		$	1,415		$	1,301
Foreign	(775		)	1,382			1,308			721
(Loss) Income from continuing operations before income taxes	$	(1,586	)	$	1,791		$	2,723		$	2,022
Current tax expense (benefit)
Federal	$	216		$	(563	)	$	4		$	155
State and local	22			(11		)	9			2
Foreign	187			282			539			420
Total current tax expense (benefit)	$	425		$	(292	)	$	552		$	577
Deferred tax (benefit) expense
Federal	$	(2,790	)	$	476		$	22		$	135
State and local	(48		)	(8		)	(29		)	4
Foreign	(260		)	(27		)	96			(141		)
Total deferred tax (benefit) expense	$	(3,098	)	$	441		$	89		$	(2	)
(Benefit from) Provision for income taxes on continuing operations	(2,673		)	149			641			575
Net Income from continuing operations	$	1,087		$	1,642		$	2,082		$	1,447

International pre-tax (loss) earnings from continuing operations was $(775) million, $1,382 million, $1,308 million, and $721 million for the period September 1 through December 31, 2017, the period January 1 through August 31, 2017, and the years ended December 31, 2016 and 2015, respectively. In connection with the Merger, pre-tax earnings from continuing operations for the period September 1 through December 31, 2017 includes depreciation and amortization associated with the fair value that was allocated to the company’s tangible and intangible assets as well as costs of $1,469 million recognized in cost of goods sold related to the fair value step-up of inventories (See Note 3 and 10 for further information).

The U.S. pre-tax earnings from continuing operations for the period January 1 through August 31, 2017 includes transaction costs associated with the Merger and restructuring and asset related charges (which are mostly incurred in the US). These decreases were partially offset by the gain on the sale of the company's food safety diagnostics business in the first quarter 2017.

The increase in pre-tax earnings from continuing operations from 2015 to 2016 is primarily driven by the gain on the sale of DuPont (Shenzhen) Manufacturing Limited in 2016 in addition to the absence of 2015 restructuring and asset related charges - net.

Reconciliation to U.S. Statutory Rate	Successor		Predecessor
	For the Period September 1 through December 31, 2017		For the Period January 1 through August 31, 2017		Year Ended 2016		Year Ended 2015
Statutory U.S. federal income tax rate	35.0	%	35.0	%	35.0	%	35.0	%
Equity earning effect	0.9		(0.5	)	(0.8	)	(0.7	)
Lower effective tax rates on international operations - net	(9.5	)	(11.4	)	(9.2	)	(9.7	)
Acquisitions, divestitures and ownership restructuring activities 1, 2	15.8		5.2		1.9		(0.2	)
U.S. research and development credit	0.4		(0.8	)	(0.7	)	(1.5	)
Exchange gains/losses 3	(1.8	)	(12.9	)	1.9		10.2
Impact of U.S. Tax Reform	126.1
Excess tax benefits from stock compensation4	0.1		(1.7	)
Tax settlements and expiration of statute of limitations5	—		(3.8	)	(1.1	)	(1.5	)
Other - net	1.5		(0.8	)	(3.5	)	(3.2	)
Effective tax rate	168.5	%	8.3	%	23.5	%	28.4	%

1. See Notes 3 and 4 for additional information.

2. Includes a net tax benefit of $261 million related to an internal legal entity restructuring associated with the Intended Business Separations.

3. Principally reflects the impact of foreign exchange gains and losses on net monetary assets for which no corresponding tax impact is realized. Further information about the company's foreign currency hedging program is included in Note 6 and Note 18 under the heading Foreign Currency Risk.

4. Reflects the impact of the adoption of Accounting Standards Update ("ASU") 2016-09, which resulted in the recognition of excess tax benefits related to equity compensation in the (benefit from) provision for income taxes on continuing operations. See Note 2 for additional information.

5. The period January 1 through August 31, 2017 includes a tax benefit of $53 million for accrued interest reversals (recorded in sundry income - net).

Deferred Tax Balances at December 31	2017 (Successor)					2016 (Predecessor)
(In millions)	Assets			Liabilities		Assets			Liabilities
Property	$	—		$	1,160	$	—		$	742
Tax loss and credit carryforwards	1,690			—		1,808			—
Accrued employee benefits	1,988			68		4,529			410
Other accruals and reserves	333			39		617			222
Intangibles	284			6,286		210			1,345
Inventory	130			597		163			138
Long-term debt	109			—		—			—
Investments	23			453		126			230
Unrealized exchange gains/losses	—			71		—			346
Other – net	260			121		257			86
Subtotal	$	4,817		$	8,795	$	7,710		$	3,519
Valuation allowances	(1,378		)	—		(1,308		)	—
Total	$	3,439		$	8,795	$	6,402		$	3,519
Net Deferred Tax (Liability) Asset	$	(5,356	)			$	2,883

Operating Loss and Tax Credit Carryforwards	Deferred Tax Asset
(In millions)	2017 (Successor)		2016 (Predecessor)
Operating loss carryforwards
Expire within 5 years	$	42	$	41
Expire after 5 years or indefinite expiration	1,483		1,482
Total operating loss carryforwards	$	1,525	$	1,523
Tax credit carryforwards
Expire within 5 years	$	10	$	10
Expire after 5 years or indefinite expiration	155		275
Total tax credit carryforwards	$	165	$	285
Total Operating Loss and Tax Credit Carryforwards	$	1,690	$	1,808

Total Gross Unrecognized Tax Benefits	Successor			Predecessor
	For the Period September 1 through December 31, 2017			For the Period January 1 through August 31, 2017			Year Ended 2016			Year Ended 2015
(In millions)
Total unrecognized tax benefits as of beginning of period	$	436		$	348		$	558		$	735
Decreases related to positions taken on items from prior years	(2		)	(19		)	(41		)	(98		)
Increases related to positions taken on items from prior years	9			3			32			13
Increases related to positions taken in the current year	19			19			32			32
Settlement of uncertain tax positions with tax authorities	1			(6		)	(205		)	(58		)
Decreases due to expiration of statutes of limitations	(5		)	(81		)	(30		)	(30		)
Exchange loss (gain)	1			1			2			(36		)
Total unrecognized tax benefits as of end of period	$	459		$	265		$	348		$	558
Total unrecognized tax benefits that, if recognized, would impact the effective tax rate	$	76		$	188		$	253		$	386
Total amount of interest and penalties (benefit) recognized in Provision for income taxes on continuing operations	$	1		$	(27	)	$	10		$	(14	)
Total accrual for interest and penalties associated with unrecognized tax benefits	$	25		$	22		$	71		$	88

Each year the company files hundreds of tax returns in the various national, state and local income taxing jurisdictions in which it operates. These tax returns are subject to examination and possible challenge by the tax authorities. Positions challenged by the tax authorities may be settled or appealed by the company. As a result, there is an uncertainty in income taxes recognized in the company's financial statements in accordance with accounting for income taxes and accounting for uncertainty in income taxes. It is reasonably possible that changes to the company’s global unrecognized tax benefits could be significant; however, due to the uncertainty regarding the timing of completion of audits and possible outcomes, a current estimate of the range of increases or decreases that may occur within the next twelve months cannot be made.

Tax years that remain subject to examination for the company’s major tax jurisdictions are shown below:

Tax Years Subject to Examination by Major Tax Jurisdiction at Dec 31,	Earliest Open Year
Jurisdiction
Brazil	2012
Canada	2011
China	2014
Denmark	2003
Germany	2006
India	2001
The Netherlands	2014
Switzerland	2012
United States:
Federal income tax	2012
State and local income tax	2004

Undistributed earnings of foreign subsidiaries and related companies that are deemed to be permanently invested amounted to $15,408 million at December 31, 2017, $17,380 million at December 31, 2016 and $16,053 million at December 31, 2015. The Act imposed U.S. tax on all foreign unrepatriated earnings. These undistributed earnings are still subject to certain taxes upon repatriation, primarily foreign withholding taxes. It is not practicable to calculate the unrecognized deferred tax liability on undistributed earnings.

DuPont and its subsidiaries are included in DowDuPont's consolidated federal income tax group and consolidated tax return.  Generally, the consolidated tax liability of the DowDuPont U.S. tax group for each year will be apportioned among the members of the consolidated group based on each member’s separate taxable income.  DuPont and Dow intend that to the extent Federal and/or State corporate income tax liabilities are reduced through the utilization of tax attributes of the other, settlement of any receivable and payable generated from the use of the other party’s sub-group attributes will be in accordance with a tax sharing agreement and/or tax matters agreement.

XML

Earnings Per Share of Common Stock

12 Months Ended

Dec. 31, 2017

Earnings Per Share [Abstract]

Earnings Per Share [Text Block]

EARNINGS PER SHARE OF COMMON STOCK

Upon completion of the Merger, each share of DuPont Common Stock was converted into the right to receive 1.2820 fully paid and non-assessable shares of DowDuPont Common Stock, in addition to cash in lieu of any fractional shares of DowDuPont Common Stock issued and therefore earnings per share of common stock information is not presented for the Successor period.

Set forth below is a reconciliation of the numerator and denominator for basic and diluted earnings per share calculations for the Predecessor periods indicated below:

	Predecessor
(In millions, except share amounts)	For the Period January 1 through August 31, 2017			For the Year Ended December 31, 2016			For the Year Ended December 31, 2015
Numerator:
Income from continuing operations after income taxes attributable to DuPont	$	1,624		$	2,072		$	1,443
Preferred dividends	(7		)	(10		)	(10		)
Income from continuing operations after income taxes available to DuPont common stockholders	$	1,617		$	2,062		$	1,433
Income from discontinued operations after income taxes available to DuPont common stockholders	117			441			510
Net income available to common stockholders	$	1,734		$	2,503		$	1,943
Denominator:
Weighted-average number of common shares outstanding - Basic	867,888,000			872,560,000			893,992,000
Dilutive effect of the company’s employee compensation plans1	4,532,000			4,476,000			5,535,000
Weighted-average number of common shares outstanding - Diluted1	872,420,000			877,036,000			899,527,000

^1.  Diluted earnings per share considers the impact of potentially dilutive securities except in periods in which there is a loss because the inclusion of the potential common shares would have an anti-dilutive effect.

The following average number of stock options were antidilutive, and therefore not included in the dilutive earnings per share calculations:

	Predecessor
	For the Period January 1 through August 31, 2017	For the Year Ended December 31, 2016	For the Year Ended December 31, 2015
Average number of stock options	1,906	4,794,000	4,715,000

XML

Accounts and Notes Receivable, Net

12 Months Ended

Dec. 31, 2017

Receivables [Abstract]

Accounts and Notes Receivables, Net

ACCOUNTS AND NOTES RECEIVABLE, NET

	Successor		Predecessor
(In millions)	December 31, 2017		December 31, 2016
Accounts receivable – trade1	$	3,777	$	3,601
Notes receivable – trade2	199		206
Other3	1,263		1,152
Total accounts and notes receivable - net	$	5,239	$	4,959

^1.  Accounts receivable – trade is net of allowances of $10 millionat December 31, 2017 and $287 million at December 31, 2016. Allowances are equal to the estimated uncollectible amounts. That estimate is based on historical collection experience, current economic and market conditions, and review of the current status of customers' accounts.

^2.  Notes receivable – trade primarily consists of receivables within the agriculture product line for deferred payment loan programs for the sale of seed products to customers. These loans have terms of one year or less and are primarily concentrated in North America. The company maintains a rigid pre-approval process for extending credit to customers in order to manage overall risk and exposure associated with credit losses. As of December 31, 2017 and 2016, there were no significant past due notes receivable, nor were there any significant impairments related to current loan agreements.

^3.  Other includes receivables in relation to fair value of derivative instruments, indemnification assets, value added tax, general sales tax and other taxes. No individual group represents more than ten percent of total receivables.

Accounts and notes receivable are carried at amounts that approximate fair value.

XML

Inventories

12 Months Ended

Dec. 31, 2017

Inventory Disclosure [Abstract]

Inventory Disclosure [Text Block]

INVENTORIES

	Successor		Predecessor
(In millions)	December 31, 2017		December 31, 2016
Finished products	$	4,500	$	2,961
Semi-finished products	2,769		1,877
Raw materials	371		292
Stores and supplies	447		398
Total	$	8,087	$	5,528
Adjustment of inventories to a LIFO basis	546		(178		)
Total inventories	$	8,633	$	5,350

As a result of the Merger, a fair value step-up of $3,842 million was recorded for inventories. Of this amount, $1,434 million has been recognized in costs of goods sold within loss from continuing operations for the period September 1, 2017 through December 31, 2017. See Note 3 for additional information regarding the Merger.

XML

Property, Plant and Equipment

12 Months Ended

Dec. 31, 2017

Property, Plant and Equipment [Abstract]

Property, Plant and Equipment Disclosure [Text Block]

PROPERTY, PLANT AND EQUIPMENT

	Successor			Predecessor
(In millions)	December 31, 2017			December 31, 2016
Land and land improvements	$	913		$	501
Buildings	2,747			4,224
Machinery and equipment	8,104			16,909
Construction in progress	1,114			1,381
Total property, plant and equipment	12,878			23,015
Accumulated depreciation	(443		)	(14,164		)
Total property, plant and equipment - net	$	12,435		$	8,851

As a result of the Merger, a fair value step-up of $3,200 million was recorded for property, plant and equipment. See Note 3 for additional information regarding the Merger.

Buildings, machinery and equipment and land improvements are depreciated over useful lives on a straight-line basis ranging from 1 to 25 years. Capitalizable costs associated with computer software for internal use are amortized on a straight-line basis over 1 to 8 years.

	Successor		Predecessor
(In millions)	For the Period September 1 through December 31, 2017		For the Period January 1 through August 31, 2017		For the Year Ended December 31, 2016		For the Year Ended December 31, 2015
Depreciation expense	$	426	$	589	$	907	$	948

XML

Goodwill and Other Intangible Assets

12 Months Ended

Dec. 31, 2017

Goodwill and Intangible Assets Disclosure [Abstract]

Goodwill and Intangible Assets Disclosure [Text Block]

GOODWILL AND OTHER INTANGIBLE ASSETS

Goodwill

The following table summarizes changes in the carrying amount of goodwill for the period September 1 through December 31, 2017, the period January 1 through August 31, 2017, and the year ended December 31, 2016:

(In millions)
Balance as of December 31, 2015 (Predecessor)	$	4,238
Currency Translation Adjustment	(68		)
Other Goodwill Adjustments and Acquisitions	(1		)
Balance as of December 31, 2016 (Predecessor)	4,169
Currency Translation Adjustment	176
Other Goodwill Adjustments and Acquisitions	198
Balance as of August 31, 2017 (Predecessor)	$	4,543
Balance at September 1, 2017 (Successor)	$	45,105
Currency Translation Adjustment	(234		)
Goodwill Recognized for H&N Acquisition	718
Balance as of December 31, 2017 (Successor)	$	45,589

In 2017and 2016, the company performed impairment tests for goodwill and determined that no goodwill impairments existed.

Other Intangible Assets

The gross carrying amounts and accumulated amortization of other intangible assets by major class are as follows: 

	Successor							Predecessor
(In millions)	December 31, 2017							December 31, 2016
	Gross		Accumulated Amortization			Net		Gross		Accumulated Amortization			Net
Intangible assets subject to amortization (Definite-lived):
Customer-related	$	9,502	$	(186	)	$	9,316	$	1,574	$	(586	)	$	988
Developed technology	4,364		(144		)	4,220		1,410		(838		)	572
Trademarks/trade names	1,117		(26		)	1,091		53		(15		)	38
Favorable supply contracts1	495		(17		)	478
Microbial cell factories2	397		(6		)	391
Other3	459		(10		)	449		171		(82		)	89
Total other intangible assets with finite lives	16,334		(389		)	15,945		3,208		(1,521		)	1,687
Intangible assets not subject to amortization (Indefinite-lived):
In-process research and development ("IPR&D")	660		—			660		73		—			73
Microbial cell factories2								306		—			306
Germplasm4	6,265		—			6,265		1,053		—			1,053
Trademarks / trade names	4,856		—			4,856		545		—			545
Total other intangible assets	11,781		—			11,781		1,977		—			1,977
Total	$	28,115	$	(389	)	$	27,726	$	5,185	$	(1,521	)	$	3,664

^1.  Upon closing and pursuant to the terms of the FMC Transaction Agreement, DuPont entered into favorable supply contracts with FMC. DuPont recorded these contracts as intangible assets recognized at the fair value of off-market contracts. Refer to Notes 3 and 4 for additional information.

^2.  Microbial cell factories, derived from natural microbes, are used to sustainably produce enzymes, peptides and chemicals using natural metabolic processes. The company recognized the microbial cell factories as intangible assets upon the acquisition of Danisco. As a result of the valuation as part of the Merger, it was determined that this intangible asset now has a definite life and therefore it has been moved from indefinite-lived to definite-lived as of September 1, 2017.

^3.  Primarily consists of sales and farmer networks, marketing and manufacturing alliances and noncompetition agreements.

^4.  Pioneer germplasm is the pool of genetic source material and body of knowledge gained from the development and delivery stage of plant breeding. The company recognized germplasm as an intangible asset upon the acquisition of Pioneer. This intangible asset is expected to contribute to cash flows beyond the foreseeable future and there are no legal, regulatory, contractual, or other factors which limit its useful life.

In connection with the Merger, the company recorded $27,221 million of intangible assets, as shown in the table below, representing the preliminary fair values at the Merger date. See Note 3 for additional information regarding the Merger.

Intangible Assets	Gross Carrying Amount		Weighted-average Amortization Period (years)
(In millions)
Intangible assets with finite lives:
Customer-related	$	9,264	17
Developed technology	4,239		12
Trademarks/trade names	1,080		15
Microbial cell factories	400		23
Other	453		17
Total other intangible assets with finite lives	$	15,436
Intangible assets with indefinite lives:
IPR&D	$	660
Germplasm	6,263
Trademarks/trade names	4,862
Total intangible assets	$	27,221

The aggregate pre-tax amortization expense from continuing operations for definite-lived intangible assets was $389 million for the period September 1 through December 31, 2017 and $139 million for the period January 1 through August 31, 2017. The aggregate pre-tax amortization expense from continuing operations for definite-lived intangible assets was $319 million and $362 million for 2016 and 2015, respectively.

Total estimated amortization expense for the next five fiscal years is as follows:

(In millions)
2018	$	1,266
2019	$	1,254
2020	$	1,244
2021	$	1,228
2022	$	1,221

XML

Short-Term Borrowings, Long-Term Debt and Available Credit Facilities

12 Months Ended

Dec. 31, 2017

Debt Disclosure [Abstract]

Debt Disclosure [Text Block]

SHORT-TERM BORROWINGS, LONG-TERM DEBT AND AVAILABLE CREDIT FACILITIES

The following tables summarize the company's short-term borrowings and capital lease obligations and long-term debt:

Short-term borrowings and capital lease obligations	Successor		Predecessor
(In millions)	December 31, 2017		December 31, 2016
Commercial paper	$	1,436	$	386
Other loans - various currencies	28		39
Long-term debt payable within one year	1,315		4
Total short-term borrowings and capital lease obligations	$	2,779	$	429

The estimated fair value of the company's short-term borrowings, including interest rate financial instruments, was determined using Level 2 inputs within the fair value hierarchy, as described in Note 1 and Note 19. Based on quoted market prices for the same or similar issues, or on current rates offered to the company for debt of the same remaining maturities, the fair value of the company's short-term borrowings and capital lease obligations was $2,780 million and $430 million at December 31, 2017 and 2016, respectively.

The weighted-average interest rate on short-term borrowings outstanding at December 31, 2017 and 2016 was 1.8 percent and 2.2 percent, respectively. The decrease in the interest rate for 2017 was primarily due to lower effective interest on long-term debt payable within one year.

Long Term Debt	Successor1				Predecessor
	December 31, 2017				December 31, 2016
(In millions)	Amount		Weighted Average Rate		Amount
Promissory notes and debentures:
Final maturity 2018	$	1,280	1.59	%	$	1,290
Final maturity 2019	521		2.23	%	500
Final maturity 2020	3,070		1.79	%	999
Final maturity 2021	1,580		2.07	%	1,498
Final maturity 2023 and thereafter	3,492		3.32	%	3,188
Other facilities:
Term loan due 2019	1,500		2.35	%	500
Other loans	18		4.32	%	22
Foreign currency loans, various rates and maturities	30		2.85	%	29
Medium-term notes, varying maturities through 2043	110		1.22	%	111
Capital lease obligations	5				9
Less: Unamortized debt discount and issuance costs	—				35
Less: Long-term debt due within one year	1,315				4
Total	$	10,291			$	8,107

^1.  The Successor period includes the reflection of debt at fair value at the date of the Merger. See Note 3 for additional information regarding the Merger.

Principal payments of long-term debt for the next five years are as follows:

Maturities of Long-Term Debt For Next Five Years1
(In millions)
2018	$	1,286
2019	$	2,005
2020	$	3,005
2021	$	1,505
2022	$	2

^1.  Excludes unamortized debt step-up premium.

The estimated fair value of the company's long-term borrowings, was determined using Level 2 inputs within the fair value hierarchy, as described in Note 1 and Note 19. Based on quoted market prices for the same or similar issues, or on current rates offered to the company for debt of the same remaining maturities, the fair value of the company's long-term borrowings, not including long-term debt due within one year, was $10,250 million and $8,460 million at December 31, 2017 and 2016, respectively.

Available Committed Credit Facilities

The following table summarizes the company's credit facilities:

Committed and Available Credit Facilities at December 31, 2017 (Successor)
(In millions)	Effective Date	Committed Credit		Credit Available		Maturity Date	Interest
Revolving Credit Facility	March 2016	$	3,000	$	2,950	May 2019	Floating Rate
Term Loan Facility	March 2016	4,500		3,000		March 2019	Floating Rate
Total Committed and Available Credit Facilities		$	7,500	$	5,950

Debt Offering

In May 2017, the company completed an underwritten public offering of $1,250 million of the company's 2.20 percent Notes due 2020 and $750 million of the company's Floating Rate Notes due 2020 (the "May 2017 Debt Offering"). The proceeds of this offering were used to make a discretionary pension contribution to the company's principal U.S. pension plan. See Note 16 for further discussion regarding this contribution.

Term Loan Facility

In March 2016, the company entered into a credit agreement that provides for a three-year, senior unsecured term loan facility in the aggregate principal amount of $4,500 million (the "Term Loan Facility") under which DuPont may make up to seven term loan borrowings and amounts repaid or prepaid are not available for subsequent borrowings. The facility was amended in 2017 to extend the date on which the commitment to lend terminates to July 27, 2018. The proceeds from the borrowings under the Term Loan Facility will be used for the company's general corporate purposes including debt repayment, working capital and funding a portion of DowDuPont's costs and expenses. The Term Loan Facility matures in March 2019 at which time all outstanding borrowings, including accrued but unpaid interest, become immediately due and payable. As of December 31, 2017, the company had made three term loan borrowings in an aggregate principal amount of $1,500 million and had unused commitments of $3,000 million under the Term Loan Facility.

Uncommitted Credit Facilities and Outstanding Letters of Credit

Unused bank credit lines on uncommitted credit facilities were approximately $731 million at December 31, 2017. These lines are available to support short-term liquidity needs and general corporate purposes including letters of credit. Outstanding letters of credit were $177 million at December 31, 2017. These letters of credit support commitments made in the ordinary course of business.

XML

Commitments and Contingent Liabilities

12 Months Ended

Dec. 31, 2017

Commitments and Contingencies Disclosure [Abstract]

Commitments and Contingencies Disclosure [Text Block]

COMMITMENTS AND CONTINGENT LIABILITIES

Guarantees

Indemnifications

In connection with acquisitions and divestitures as of December 31, 2017, the company has indemnified respective parties against certain liabilities that may arise in connection with these transactions and business activities prior to the completion of the transactions. The term of these indemnifications, which typically pertain to environmental, tax and product liabilities, is generally indefinite. In addition, the company indemnifies its duly elected or appointed directors and officers to the fullest extent permitted by Delaware law, against liabilities incurred as a result of their activities for the company, such as adverse judgments relating to litigation matters. If the indemnified party were to incur a liability or have a liability increase as a result of a successful claim, pursuant to the terms of the indemnification, the company would be required to reimburse the indemnified party. The maximum amount of potential future payments is generally unlimited.

Obligations for Equity Affiliates & Others

The company has directly guaranteed various debt obligations under agreements with third parties related to equity affiliates, customers and suppliers. At December 31, 2017 and December 31, 2016, the company had directly guaranteed $297 million and $388 million, respectively, of such obligations. These amounts represent the maximum potential amount of future (undiscounted) payments that the company could be required to make under the guarantees. The company would be required to perform on these guarantees in the event of default by the guaranteed party.

The company assesses the payment/performance risk by assigning default rates based on the duration of the guarantees. These default rates are assigned based on the external credit rating of the counterparty or through internal credit analysis and historical default history for counterparties that do not have published credit ratings. For counterparties without an external rating or available credit history, a cumulative average default rate is used.

In certain cases, the company has recourse to assets held as collateral, as well as personal guarantees from customers and suppliers. Assuming liquidation, these assets are estimated to cover approximately 23 percent of the $89 million of guaranteed obligations of customers and suppliers. Set forth below are the company's guaranteed obligations at December 31, 2017.

The following tables provide a summary of the final expiration and maximum future payments for each type of guarantee:

Guarantees at December 31, 2017 (Successor)	Final Expiration	Maximum Future Payments
(In millions)
Obligations for customers and suppliers1:
Bank borrowings	2022	$	89
Obligations for non-consolidated affiliates2:
Bank borrowings	2018	161
Obligations for Chemours3:
Chemours' purchase obligations	2018	10
Residual value guarantees4	2029	37
Total guarantees		$	297

1. Existing guarantees for customers and suppliers, as part of contractual agreements.

2.    Existing guarantees for non-consolidated affiliates' liquidity needs in normal operations.

3. Guarantee for Chemours' raw material purchase obligations under agreement with third party supplier.

4. The company provides guarantees related to leased assets specifying the residual value that will be available to the lessor at lease termination through sale of the assets to the lessee or third parties.

Operating Leases

The company uses various leased facilities and equipment in its operations. The terms for these leased assets vary depending on the lease agreement.

Future minimum lease payments (including residual value guarantee amounts) under non-cancelable operating leases are $264 million, $190 million, $137 million, $104 million and $81 million for the years 2018, 2019, 2020, 2021 and 2022, respectively, and $268 million for subsequent years and are not reduced by non-cancelable minimum sublease rentals due in the future in the amount of $3 million. Net rental expense under operating leases was $105 million, $179 million, $242 million and $266 million for the period September 1 through December 31, 2017, for the period January 1 through August 31, 2017, and for the years ended December 31, 2016 and 2015, respectively.

Litigation

The company is subject to various legal proceedings arising out of the normal course of its current and former business operations, including product liability, intellectual property, commercial, environmental and antitrust lawsuits. It is not possible to predict the outcome of these various proceedings. Although considerable uncertainty exists, management does not anticipate that the ultimate disposition of these matters will have a material adverse effect on the company's results of operations, consolidated financial position or liquidity.  However, the ultimate liabilities could be material to results of operations in the period recognized.

PFOA

DuPont used PFOA (collectively, perfluorooctanoic acids and its salts, including the ammonium salt), as a processing aid to manufacture some fluoropolymer resins at various sites around the world including its Washington Works' plant in West Virginia. Pursuant to the Separation Agreement discussed in Note 4, the company is indemnified by Chemours for the PFOA matters discussed below and has recorded a total indemnification asset of $15 million.

U.S. Environmental Protection Agency (“EPA") and New Jersey department of Environmental Protection (“NJDEP”)

DuPont is obligated under agreements with EPA, including a 2009 consent decree to which Chemours was added in 2017, and has made voluntary commitments to NJDEP. These obligations and voluntary commitments include surveying, sampling and testing drinking water in and around certain company sites and offering treatment or an alternative supply of drinking water if tests indicate the presence of PFOA in drinking water at or greater than the national health advisory level established from time to time by the EPA. At December 31, 2017, the company had an accrual of $15 million related to these obligations and voluntary commitments. The company recorded an indemnification asset corresponding to the accrual balance at December 31, 2017.

Leach v. DuPont

In August 2001, a class action, captioned Leach v. DuPont, was filed in West Virginia state court alleging that residents living near the Washington Works facility had suffered, or may suffer, deleterious health effects from exposure to PFOA in drinking water. A settlement was reached in 2004 that binds approximately 80,000 residents, (the "Leach Settlement".) In addition to paying $23 million to plaintiff’s attorneys for fees and expenses and $70 million to fund a community health project, the company is obligated to fund up to $235 million for a medical monitoring program for eligible class members and to pay administrative costs and fees associated with the program. In January 2012, the company put $1 million into an escrow account to fund medical monitoring as required by the settlement agreement. As of December 31, 2017, less than $1 million has been disbursed from the account. The company also must continue to provide water treatment designed to reduce the level of PFOA in water to six area water districts, including the Little Hocking Water Association, and private well users. While it is probable that the company will incur liabilities related to funding the medical monitoring program and providing water treatment, the company does not expect any such liabilities to be material.

Under the Leach Settlement, the company funded a series of health studies which were completed in October 2012 by an independent science panel of experts (the "C8 Science Panel".) The C8 Science Panel found probable links, as defined in the Leach Settlement, between exposure to PFOA and pregnancy-induced hypertension, including preeclampsia; kidney cancer; testicular cancer; thyroid disease; ulcerative colitis; and diagnosed high cholesterol.

Multi-District Litigation

Leach class members may pursue personal injury claims against DuPont only for the six human diseases for which the C8 Science Panel determined a probable link exists. Following the Leach Settlement, approximately 3,550 lawsuits alleging personal injury claims were filed in various federal and state courts in Ohio and West Virginia. These lawsuits are consolidated in multi-district litigation ("MDL") in the U.S. District Court for the Southern District of Ohio.

In the first quarter of 2017, the MDL was settled for $670.7 million in cash (the "MDL Settlement"), half of which was to be paid by Chemours and half paid by DuPont. At December 31, 2017, all payments under the settlement agreement have been made by both companies. DuPont’s payment is not subject to indemnification or reimbursement by Chemours.  In exchange for that payment, DuPont and Chemours receive releases of all claims by the settling plaintiffs. The MDL Settlement was entered into solely by way of compromise and settlement and is not in any way an admission of liability or fault by DuPont or Chemours. All of the MDL plaintiffs participated and resolved their claims within the MDL Settlement.

New Items

At December 31, 2017, five lawsuits had been filed against the company in West Virginia and four in Ohio alleging personal injury from exposure to PFOA in drinking water.

In addition, three lawsuits are pending in federal court in New York on behalf of five individuals who are residents of Hoosick Falls, New York. The plaintiffs claim personal injuries, including kidney cancer, thyroid disease and ulcerative colitis, from alleged exposure to PFOA discharged into the air and water from nearby manufacturing facilities owned and operated by defendant third parties. Plaintiffs claim that PFOA used at the facilities was purchased from or manufactured by the company and co-defendant, 3M Company. An action is pending in Alabama state court filed by a municipal water utility. The plaintiff alleges contamination from wastewater from defendant carpet manufacturers’ operations using perfluorinated chemicals and compounds, including PFOA, (“PFCs”). Plaintiff alleges that the PFCs used in defendant manufacturers’ operations were supplied by the company and co-defendant 3M Company.

While it is reasonably possible that the company could incur liabilities related to these actions, it does not expect any such liabilities would be material. Chemours is defending and indemnifying the company in these matters in accordance with the amendment to the Separation Agreement discussed below.

Amendment to Separation Agreement

Concurrent with the MDL Settlement, DuPont and Chemours amended the Separation Agreement to provide for a limited sharing of potential future PFOA liabilities (i.e., indemnifiable losses, as defined in the Separation Agreement) for a period of five years beginning July 6, 2017. During that five-year period, Chemours will annually pay future PFOA liabilities up to $25 million and, if such amount is exceeded, DuPont would pay any excess amount up to the next $25 million (which payment will not be subject to indemnification by Chemours), with Chemours annually bearing any further excess liabilities. After the five-year period, this limited sharing agreement will expire, and Chemours’ indemnification obligations under the Separation Agreement will continue unchanged.  There have been no charges incurred by DuPont under this arrangement through December 31, 2017. Chemours has also agreed that it will not contest its liability to DuPont under the Separation Agreement for PFOA liabilities on the basis of ostensible defenses generally applicable to the indemnification provisions under the Separation Agreement, including defenses relating to punitive damages, fines or penalties or attorneys’ fees, and waives any such defenses with respect to PFOA liabilities.  Chemours has, however, retained defenses as to whether any particular PFOA claim is within the scope of the indemnification provisions of the Separation Agreement.

It is possible that new lawsuits could be filed against DuPont related to PFOA that may not be within the scope of the MDL Settlement. Any such new litigation would be subject to indemnification by Chemours under the Separation Agreement, as amended.

Fayetteville Works Facility, North Carolina

Prior to the separation of Chemours, the company introduced GenX as a polymerization processing aid and a replacement for PFOA at the Fayetteville Works facility. The facility is now owned and operated by Chemours which continues to manufacture and use GenX. Chemours is responding to ongoing inquiries and investigations from federal, state and local investigators, regulators and other governmental authorities as well as inquiries from the media and local community stakeholders. These inquiries and investigations involve the discharge of GenX and certain similar compounds from the Chemours’ facility at Fayetteville Works into the Cape Fear River in Bladen County, North Carolina.

In August 2017, the U.S. Attorney’s Office for the Eastern District of North Carolina served the company with a subpoena for testimony and the production of documents to a grand jury. In the fourth quarter 2017, DuPont was served with additional subpoenas relating to the same issue. The subpoenas seek documents and testimony related to alleged discharges of PFOA and/or GenX from the Fayetteville Works facility into the Cape Fear River. It is possible that these ongoing inquiries and investigations, including the grand jury subpoena, could result in penalties or sanctions, or that additional litigation will be instituted against Chemours and/or the company.

At December 31, 2017, several actions, filed on behalf of putative classes of property owners and residents in areas near or who draw drinking water from the Cape Fear River, are pending in federal court against Chemours, the company and one also names DowDuPont. These actions relate to the alleged discharge of certain perflourinated chemicals into the river from the operations and wastewater treatment at the Fayetteville Works facility. The three purported class actions, filed in the fourth quarter 2017 and now consolidated into a single purported class action, seek various relief including medical monitoring, property damages and injunctive relief. Separate actions pending at December 31, 2017 were filed by the Cape Fear Public Utility Authority and Brunswick County, NC seeking actual and punitive damages as well as injunctive relief. These actions have since been consolidated and two additional North Carolina water authorities have joined the action. Management believes the probability of loss with respect to these actions is remote.

The company has an indemnification claim against Chemours with respect to current and future inquiries and claims, including lawsuits, related to the foregoing. At December 31, 2017, Chemours is defending and indemnifying the company in the pending civil actions.

Environmental

Accruals for environmental matters are recorded when it is probable that a liability has been incurred and the amount of the liability can be reasonably estimated based on current law and existing technologies. At December 31, 2017, the company had accrued obligations of $433 million for probable environmental remediation and restoration costs, including $67 million for the remediation of Superfund sites. These obligations are included in "Accrued and other current liabilities" and "Other noncurrent obligations" in the Consolidated Balance Sheets. This is management’s best estimate of the costs for remediation and restoration with respect to environmental matters for which the company has accrued liabilities, although it is reasonably possible that the ultimate cost with respect to these particular matters could range up to $920 million above the amount accrued at December 31, 2017. Consequently, it is reasonably possible that environmental remediation and restoration costs in excess of amounts accrued could have a material impact on the company’s results of operations, financial condition and cash flows. It is the opinion of the company’s management, however, that the possibility is remote that costs in excess of the range disclosed will have a material impact on the company’s results of operations, financial condition or cash flows. Inherent uncertainties exist in these estimates primarily due to unknown conditions, changing governmental regulations and legal standards regarding liability, and emerging remediation technologies for handling site remediation and restoration. At December 31, 2016, the company had accrued obligations of $457 million for probable environmental remediation and restoration costs, including $50 million for the remediation of Superfund sites.

Pursuant to the DuPont and Chemours Separation Agreement, the company is indemnified by Chemours for certain environmental matters, included in the liability of $433 million, that have an estimated liability of $242 million as of December 31, 2017, and a potential exposure that ranges up to approximately $430 million above the amount accrued. As such, the company has recorded an indemnification asset of $242 million corresponding to the company’s accrual balance related to these matters at December 31, 2017, including $47 million related to the Superfund sites.

XML

Stockholders' Equity

12 Months Ended

Dec. 31, 2017

Equity [Abstract]

Stockholders' Equity Note Disclosure [Text Block]

STOCKHOLDERS' EQUITY

Share Repurchase Program

2015 Share Buyback Plan

In the first quarter 2015, DuPont announced its intention to buy back shares of about $4,000 million using the distribution proceeds received from Chemours. In connection with the completion of the spin-off of Chemours, the Board of Directors authorized the use of the distribution proceeds to buy back shares of the company's common stock as follows: $2,000 million to be purchased and retired by December 31, 2015, which was completed during 2015, with the remainder to be purchased and retired by December 31, 2016. There were no share repurchases under this plan in the first and second quarters of 2016. The company had limited opportunity to repurchase shares in 2016, primarily due to the planned merger with Dow. However, during the second half of 2016, the company purchased and retired 13.2 million shares in the open market for a total cost of $916 million.  As of December 31, 2016, in aggregate, the company paid $2,916 million and received and retired 48.2 million shares. The authorization under this buyback program expired as of January 1, 2017.

2014 Share Buyback Plan

In January 2014, the company's Board of Directors authorized a $5,000 million share buyback plan that replaced the 2011 plan. During 2015, the company repurchased and retired 4.6 million shares in the open market for a total cost of $353 million. There were no share repurchases under this plan during 2016 and 2017. The authorization under this buyback program expired upon Merger. As of August 31, 2017, in aggregate, the company purchased 34.7 million shares at a total cost of $2,353 million under the plan.

Treasury Stock

Immediately prior to the closing of the Merger Transaction, all 87 million shares of DuPont common stock that were held in treasury were automatically canceled and retired for no consideration. Common stock held in treasury was recorded at cost. When retired, the excess of the cost of treasury stock over its par value was allocated between retained earnings ($5,657 million) and additional paid-in capital ($1,044 million).

Set forth below is a reconciliation of common stock share activity for the years ended December 31, 2017, 2016 and 2015:

Shares of common stock	Issued		Held In Treasury
Balance January 1, 2015 (Predecessor)	992,020,000		(87,041,000	)
Issued	5,932,000		—
Repurchased	—		(39,564,000	)
Retired	(39,564,000	)	39,564,000
Balance December 31, 2015 (Predecessor)	958,388,000		(87,041,000	)
Issued	4,808,000		—
Repurchased	—		(13,152,000	)
Retired	(13,152,000	)	13,152,000
Balance December 31, 2016 (Predecessor)	950,044,000		(87,041,000	)
Issued	5,335,000		—
Retired	(87,041,000	)	87,041,000
Balance August 31, 2017 (Predecessor)	868,338,000		—
Balance September 1 and December 31, 2017 (Successor)1	100		—

^1.  All of the company's issued and outstanding common stock at September 1, 2017 is held by the DowDuPont Inc.

Other Comprehensive Income (Loss)

The changes and after-tax balances of components comprising accumulated other comprehensive loss are summarized below:

(In millions)	Cumulative Translation Adjustment1			Derivative Instruments			Pension Benefit Plans2			Other Benefit Plans			Unrealized Gain (Loss) on Investments			Total
2015
Balance January 1, 2015 (Predecessor)	$	(919	)	$	(6	)	$	(7,895	)	$	262		$	2		$	(8,556	)
Other comprehensive (loss) income before reclassifications	(1,605		)	(25		)	39			3			(17		)	(1,605		)
Amounts reclassified from accumulated other comprehensive income (loss)	—			7			535			(243		)	(2		)	297
Net other comprehensive (loss) income	(1,605		)	(18		)	574			(240		)	(19		)	(1,308		)
Spin-off of Chemours	$	191		$	—		$	278		$	—		$	(1	)	$	468
Balance December 31, 2015 (Predecessor)	$	(2,333	)	$	(24	)	$	(7,043	)	$	22		$	(18	)	$	(9,396	)
2016
Other comprehensive (loss) income before reclassifications	(510		)	20			(271		)	(81		)	(8		)	(850		)
Amounts reclassified from accumulated other comprehensive income (loss)	—			11			594			(298		)	28			335
Net other comprehensive (loss) income	(510		)	31			323			(379		)	20			(515		)
Balance December 31, 2016 (Predecessor)	$	(2,843	)	$	7		$	(6,720	)	$	(357	)	$	2		$	(9,911	)
2017
Other comprehensive income (loss) before reclassifications	1,042			3			(78		)	—			1			968
Amounts reclassified from accumulated other comprehensive income (loss)	—			(13		)	325			10			(1		)	321
Net other comprehensive income (loss)	1,042			(10		)	247			10			—			1,289
Balance August 31, 2017 (Predecessor)	$	(1,801	)	$	(3	)	$	(6,473	)	$	(347	)	$	2		$	(8,622	)
Balance September 1, 2017 (Successor)3	$	—		$	—		$	—		$	—		$	—		$	—
Other comprehensive income (loss) before reclassifications	(454		)	(2		)	128			(53		)	—			(381		)
Amounts reclassified from accumulated other comprehensive income (loss)	—			—			—			—			—			—
Net other comprehensive (loss) income	(454		)	(2		)	128			(53		)	—			(381		)
Balance December 31, 2017 (Successor)	$	(454	)	$	(2	)	$	128		$	(53	)	$	—		$	(381	)

^1.  The cumulative translation adjustment loss for the period September 1 through December 31, 2017 is primarily driven by the strengthening of the U.S dollar (USD) against the European Euro (EUR) and the Brazilian real (BRL). The cumulative translation adjustment gain for the period January 1 through August 31, 2017 is primarily driven by the weakening of the USD against the EUR. The currency translation loss for the year ended December 31, 2016 is primarily driven by the strengthening of the USD against the EUR partially offset by the weakening of the USD against the BRL. The currency translation loss for the year ended December 31, 2015 is driven by the strengthening USD against primarily the EUR and BRL.

^2.  The Pension Benefit Plans loss recognized in other comprehensive (loss) income during the year ended December 31, 2016 includes the impact of the remeasurement of the principal U.S. pension plan as of June 30, 2016. See Note 16 for additional information.

^3.  In connection with the Merger, balances in accumulated other comprehensive loss at Merger Effectiveness Time were eliminated as a result of reflecting the balance sheet at fair value as of the date of the Merger. See Note 3 and 16 for further information regarding the Merger and pension and OPEB plans, respectively.

The tax (expense) benefit on the net activity related to each component of other comprehensive income (loss) were as follows:

	Successor			Predecessor
(In millions)	For the Period September 1 through December 31, 2017			For the Period January 1 through August 31, 2017			For the Year Ended December 31, 2016			For the Year Ended December 31, 2015
Derivative instruments	$	1		$	6		$	(19	)	$	7
Pension benefit plans - net	(37		)	(145		)	(163		)	(317		)
Other benefit plans - net	15			(5		)	194			135
(Provision for) benefit from income taxes related to other comprehensive income (loss) items	$	(21	)	$	(144	)	$	12		$	(175	)

A summary of the reclassifications out of accumulated other comprehensive loss is provided as follows:

	Successor		Predecessor									Income Classification
(In millions)	For the Period September 1 through December 31, 2017		For the Period January 1 through August 31, 2017			For the Year Ended December 31, 2016			For the Year Ended December 31, 2015
Derivative Instruments:	$	—	$	(21	)	$	18		$	12		(1)
Tax expense (benefit)	—		8			(7		)	(5		)	(2)
After-tax	$	—	$	(13	)	$	11		$	7
Amortization of pension benefit plans:
Prior service benefit	—		(3		)	(6		)	(9		)	(3)
Actuarial losses	—		506			822			768			(3)
Curtailment gain (loss)	—		—			40			(6		)	(3)
Settlement loss	—		—			62			76			(3)
Total before tax	$	—	$	503		$	918		$	829
Tax benefit	—		(178		)	(324		)	(294		)	(2)
After-tax	$	—	$	325		$	594		$	535
Amortization of other benefit plans:
Prior service benefit	—		(46		)	(134		)	(182		)	(3)
Actuarial losses	—		61			78			78			(3)
Curtailment gain	—		—			(392		)	(274		)	(3)
Total before tax	$	—	$	15		$	(448	)	$	(378	)
Tax (benefit) expense	—		(5		)	150			135			(2)
After-tax	$	—	$	10		$	(298	)	$	(243	)
Net realized (losses) gains on investments, before tax:	—		(1		)	28			(2		)	(4)
Tax expense	—		—			—			—			(2)
After-tax	$	—	$	(1	)	$	28		$	(2	)
Total reclassifications for the period, after-tax	$	—	$	321		$	335		$	297

^1.  Cost of goods sold.

^2.  Provision for income taxes from continuing operations.

^3.  These accumulated other comprehensive loss components are included in the computation of net periodic benefit cost of the company's pension and other benefit plans. See Note 16 for additional information.

^4.  Sundry income - net.

The tax benefit (expense) recorded in Stockholders' Equity was $33 million and $(138) million for the years ended December 31, 2016 and 2015, respectively. Included in these amounts were tax benefits of $21 million and $37 million for the years ended December 31, 2016 and 2015, respectively, associated with stock compensation programs. The remainder consists of amounts recorded within other comprehensive loss as shown in the table above.

XML

Pension Plans and Other Post Employment Benefit Plans

12 Months Ended

Dec. 31, 2017

Retirement Benefits [Abstract]

Pension and Other Postretirement Benefits Disclosure [Text Block]

PENSION PLANS AND OTHER POST EMPLOYMENT BENEFITS

The company offers various long-term benefits to its employees. Where permitted by applicable law, the company reserves the right to change, modify or discontinue the plans.

As a result of the Merger, the company re-measured its pension and OPEB plans. The remeasurement of the company’s pension and OPEB plans are included in the fair value measurement of DuPont’s assets and liabilities as a result of the application of purchase accounting in connection with the Merger. In addition, net losses and prior service benefits recognized in accumulated other comprehensive loss were eliminated. Dow and DuPont did not merge their pension plans and other post employment benefit plans as a result of the Merger. See Note 3 for details on the Merger.

Defined Benefit Pension Plans

The company has both funded and unfunded noncontributory defined benefit pension plans covering a majority of the U.S. employees and a number of other countries. The principal U.S. pension plan is the largest pension plan held by DuPont. Most employees hired on or after January 1, 2007 are not eligible to participate in the U.S. defined benefit pension plans. The benefits under these plans are based primarily on years of service and employees' pay near retirement. In November 2016, the company announced that it will freeze the pay and service amounts used to calculate pension benefits for active employees who participate in the U.S. pension plans on November 30, 2018. Therefore, as of November 30, 2018, active employees participating in the U.S. pension plans will not accrue additional benefits for future service and eligible compensation received. These changes resulted in a $527 million decline in the projected benefit obligation, which is reflected in actuarial loss (gain) in the change in projected benefit obligations table on page F-60, and recognition of a $25 million pre-tax curtailment gain during the fourth quarter of 2016. The decline in the projected benefit obligation is primarily due to the decrease in expected future compensation.

The company's funding policy is consistent with the funding requirements of federal laws and regulations. Pension coverage for employees of the company's non-U.S. consolidated subsidiaries is provided, to the extent deemed appropriate, through separate plans. Obligations under such plans are funded by depositing funds with trustees, covered by insurance contracts, or remain unfunded. The company did not make any contributions to its principal U.S. pension plan for the period September 1 through December 31, 2017. During the period January 1 through August 31, 2017, the company made total contributions of $2,900 million to its principal U.S. pension plan funded through the May 2017 Debt Offering; short-term borrowings, including commercial paper issuance; and cash flow from operations. See Note 13 for further discussion related to the May 2017 Debt Offering. The company contributed $230 million to the principal U.S. pension plan in 2016. No contributions were made to its principal U.S. pension plan in 2015. The company does not expect to make cash contributions to this plan in 2018.

The company made total contributions of $34 million, $67 million, $121 million and $164 million to its funded pension plans other than the principal U.S. pension plan for the periods September 1 through December 31, 2017 and January 1 through August 31, 2017 and the years ended December 31, 2016 and 2015, respectively. Additionally, the company made total contributions of $34 million, $57 million, $184 million and $144 million to its remaining plans with no plan assets for the periods September 1 through December 31, 2017 and January 1 through August 31, 2017 and the years ended December 31, 2016 and 2015, respectively. DuPont expects to contribute approximately $200 million to its funded pension plans other than the principal U.S. pension plan and its remaining plans with no plan assets in 2018.

The company’s remeasurement of its pension plans at the Merger Effectiveness Time resulted in an increase in the underfunded status of $560 million. In connection with the remeasurement, the company updated the weighted average discount rate to 3.42 percent at August 31, 2017 from 3.80 percent as of December 31, 2016.

The workforce reductions in 2016 related to a 2016 global cost savings and restructuring plan triggered curtailments for certain of the company's pension plans, including the principal U.S. pension plan. For the principal U.S. pension plan, the company recorded curtailment losses of $63 million during the year ended December 31, 2016. The curtailment losses were driven by the changes in the benefit obligation based on the demographics of the terminated positions partially offset by accelerated recognition of a portion of the prior service benefit.

In the fourth quarter 2016, about $550 million of lump-sum payments were made from the principal U.S. pension plan trust fund to a group of separated, vested plan participants who were extended a limited-time opportunity and voluntarily elected to receive their pension benefits in a single lump-sum payment. In the fourth quarter 2017, about $140 million of lump-sum payments were made from the principal U.S. pension plan trust fund under a similar program. Since the company recognizes pension settlements only when the lump-sum payments exceed the sum of the plan's service and interest cost components of net periodic pension cost for the year, these lump-sum payments did not result in the recognition of a pension settlement charge.

The weighted-average assumptions used to determine pension plan obligations for all pension plans are summarized in the table below:

Weighted-Average Assumptions used to Determine Benefit Obligations	Successor		Predecessor
	December 31, 2017		December 31, 2016
Discount rate	3.37	%	3.80	%
Rate of increase in future compensation levels 1	4.04	%	3.80	%

1. The rate of compensation increase represents the single annual effective salary increase that an average plan participant would receive during the participant's entire career at the company.

The weighted-average assumptions used to determine net periodic benefit costs for all pension plans are summarized in the two tables below:

Weighted-Average Assumptions used to Determine Net Periodic Benefit Cost	Successor		Predecessor
	For the Period September 1 through December 31, 2017		For the Period January 1 through August 31, 2017		For the Year Ended December 31, 2016		For the Year Ended December 31, 2015
Discount rate	3.42	%	3.80	%	3.77	%	3.93	%
Rate of increase in future compensation levels	3.80	%	3.80	%	3.96	%	4.01	%
Expected long-term rate of return on plan assets	6.24	%	7.66	%	7.74	%	8.10	%

The weighted-average assumptions used to determine net periodic benefit costs for U.S. plans are summarized in the table below:

Weighted- Average Assumptions used to Determine Net Periodic Benefit Cost	Successor		Predecessor
	For the Period September 1 through December 31, 2017		For the Period January 1 through August 31, 2017		For the Year Ended December 31, 2016		For the Year Ended December 31, 2015
Discount rate	3.73	%	4.16	%	4.04	%	4.29	%
Rate of increase in future compensation levels	3.95	%	3.95	%	4.15	%	4.20	%
Expected long-term rate of return on plan assets	6.25	%	8.00	%	8.00	%	8.50	%

Other Post Employment Benefits

The company provides medical, dental and life insurance benefits to certain pensioners and survivors. The associated plans for retiree benefits are unfunded and the cost of the approved claims is paid from company funds. Essentially all of the cost and liabilities for these retiree benefit plans are attributable to the U.S. benefit plans. The non-Medicare eligible retiree medical plan is contributory with pensioners and survivors' contributions adjusted annually to achieve a 50/50 target for sharing of cost increases between the company and pensioners and survivors. In addition, limits are applied to DuPont's portion of the retiree medical cost coverage. For Medicare eligible pensioners and survivors, DuPont provides a company-funded Health Reimbursement Arrangement (HRA). In November 2016, the company announced that eligible employees who will be under the age of 50 as of November 30, 2018 will not receive post-retirement medical, dental and life insurance benefits. As a result of these changes, the company recognized a pre-tax curtailment gain of $357 million during the fourth quarter of 2016. Beginning January 1, 2015, eligible employees who retire on and after that date will receive the same life insurance benefit payment, regardless of employee's age or pay. The majority of U.S. employees hired on or after January 1, 2007 are not eligible to participate in the post-retirement medical, dental and life insurance plans.

The company also provides disability benefits to employees. Employee disability benefit plans are insured in many countries. However, primarily in the U.S., such plans are generally self-insured. Obligations and expenses for self-insured plans are reflected in the change in projected benefit obligations table on page F-60.

The company’s remeasurement of its OPEB plans at the Merger Effectiveness Time resulted in an increase in the benefit obligation of $41 million. In connection with the remeasurement, the company lowered the weighted average discount rate to 3.62 percent as of August 31, 2017 from 4.03 percent as of December 31, 2016.

As a result of the workforce reductions related to a 2016 global cost savings and restructuring plan, a curtailment was triggered for the company's other post employment benefit plans. The company recorded curtailment gains of $35 million during the year ended December 31, 2016. The curtailment gains were driven by accelerated recognition of a portion of the prior service benefit partially offset by the change in the benefit obligation based on the demographics of the terminated positions.

The company's OPEB plans are unfunded and the cost of the approved claims is paid from operating cash flows. Pre-tax cash requirements to cover actual net claims costs and related administrative expenses were $59 million, $166 million, $218 million, and $237 million for the periods September 1 through December 31, 2017 and January 1 through August 31, 2017 and for the years ended December 31, 2016 and 2015, respectively. Changes in cash requirements reflect the net impact of higher per capita health care costs, demographic changes, plan amendments and changes in participant premiums, co-pays and deductibles. In 2018, the company expects to contribute about $250 million for its OPEB plans.

The weighted-average assumptions used to determine benefit obligations for OPEB plans are summarized in the table below:

Weighted-Average Assumptions used to Determine Benefit Obligations	Successor		Predecessor
	December 31, 2017		December 31, 2016
Discount rate	3.56	%	4.03	%

The weighted-average assumptions used to determine net periodic benefit costs for the OPEB plans are summarized in the two tables below:

Weighted-Average Assumptions used to Determine Net Periodic Benefit Cost	Successor		Predecessor
	For the Period September 1 through December 31, 2017		For the Period January 1 through August 31, 2017		For the Year Ended December 31, 2016		For the Year Ended December 31, 2015
Discount rate	3.62	%	4.03	%	3.87	%	4.13	%

Assumed Health Care Cost Trend Rates	Successor		Predecessor
	December 31, 2017		December 31, 2016
Health care cost trend rate assumed for next year	6.40	%	7.00	%
Rate to which the cost trend rate is assumed to decline (the ultimate health care trend rate)	5.00	%	5.00	%
Year that the rate reached the ultimate health care cost trend rate	2023		2023

Assumed health care cost trend rates have a modest effect on the amounts reported for the health care plans. A one percentage point change in assumed health care cost trend rates would have an immaterial impact on service and interest cost and the postretirement benefit obligation.

Assumptions

Within the U.S., the company determines the expected long-term rate of return on plan assets by performing a detailed analysis of key economic and market factors driving historical returns for each asset class and formulating a projected return based on factors in the current environment. Factors considered include, but are not limited to, inflation, real economic growth, interest rate yield, interest rate spreads, and other valuation measures and market metrics. The expected long-term rate of return for each asset class is then weighted based on the strategic asset allocation approved by the governing body for each plan. The company's historical experience with the pension fund asset performance is also considered. For non-U.S. plans, assumptions reflect economic assumptions applicable to each country.

Effective 2016, DuPont elected to adopt a spot rate approach to determine the discount rate utilized to measure the service cost and interest cost components of net periodic pension and other post employment benefit costs for its U.S. plans. Under the spot rate approach, the company calculates service costs and interest costs by applying individual spot rates from a yield curve (based on high-quality corporate bond yields) to the separate expected cash flows components of service cost and interest cost. Service cost and interest cost for all other plans are determined on the basis of the single equivalent discount rates derived in determining those plan obligations. The company changed to the new method to provide a more precise measure of interest and service costs for certain plans by improving the correlation between projected benefit cash flows and the discrete spot yield curves. The company has accounted for this change as a change in accounting estimate and it was applied prospectively starting in 2016. For non-U.S. benefit plans, the company utilizes prevailing long-term high quality corporate bond indices to determine the discount rate applicable to each country at the measurement date.

The discount rates utilized to measure the pension and other post employment obligations are based on the yield on high-quality corporate fixed income investments at the measurement date. Future expected actuarially determined cash flows are individually discounted at the spot rates under Aon Hewitt AA_Above Median yield curve (based on high-quality corporate bond yields) to arrive at the plan’s obligations as of the measurement date. For non-U.S. benefit plans, the company utilizes prevailing long-term high quality corporate bond indices to determine the discount rate applicable to each country at the measurement date.

In October 2014, the U.S. Society of Actuaries ("SOA") released final reports of new mortality tables and a mortality improvement scale for measurement of retirement program obligations in the U.S. The SOA publishes updated mortality improvement scales on an annual basis. The company has adopted the 2016 and 2017 SOA mortality improvement scale in measuring its U.S. pension and other postretirement obligations for the years ended December 31, 2016 and 2017, respectively. The effect of these adoptions is amortized into net periodic benefit cost for the years following the adoption.

Summarized information on the company's pension and other post employment benefit plans is as follows:

Change in Projected Benefit Obligations, Plan Assets and Funded Status
	Defined Benefit Pension Plans									Other Post Employment Benefits
	Successor			Predecessor						Successor			Predecessor
(In millions)	For the Period September 1 through December 31, 2017 1			For the Period January 1 through August 31, 2017			For the Year Ended December 31, 2016			For the Period September 1 through December 31, 2017 1			For the Period January 1 through August 31, 2017			For the Year Ended December 31, 2016
Change in benefit obligations:
Benefit obligation at beginning of the period	$	26,036		$	24,831		$	26,094		$	2,772		$	2,829		$	2,758
Service cost	49			92			174			3			6			11
Interest cost	247			524			800			26			60			87
Plan participants' contributions	6			8			18			12			26			36
Actuarial (gain) loss	(23		)	—			460			68			—			153
Benefits paid2	(730		)	(1,118		)	(2,374		)	(71		)	(192		)	(254		)
Plan amendments	—			—			—			—			—			(28		)
Net effects of acquisitions / divestitures / other	22			—			7			—			—			65
Effect of foreign exchange rates	(57		)	429			(348		)	—			2			1
Benefit obligations at end of the period	$	25,550		$	24,766		$	24,831		$	2,810		$	2,731		$	2,829
Change in plan assets:
Fair value of plan assets at beginning of the period	$	20,395		$	16,656		$	17,497		$	—		$	—		$	—
Actual return on plan assets	549			846			1,219			—			—			—
Employer contributions	68			3,024			535			59			166			218
Plan participants' contributions	6			8			18			12			26			36
Benefits paid2	(730		)	(1,118		)	(2,374		)	(71		)	(192		)	(254		)
Net effects of acquisitions / divestitures / other	29			—			—			—			—			—
Effect of foreign exchange rates	(33		)	269			(239		)	—			—			—
Fair value of plan assets at end of the period	$	20,284		$	19,685		$	16,656		$	—		$	—		$	—
Funded status
U.S. plan with plan assets	$	(3,628	)	$	(3,277	)	$	(6,391	)	$	—		$	—		$	—
Non-U.S. plans with plan assets	(447		)	(609		)	(674		)	—			—			—
All other plans 3, 4	(1,191		)	(1,187		)	(1,102		)	(2,810		)	(2,731		)	(2,829		)
Plans of discontinued operations	—			(8		)	(8		)	—			—			—
Funded status at end of the period	$	(5,266	)	$	(5,081	)	$	(8,175	)	$	(2,810	)	$	(2,731	)	$	(2,829	)

1. The benefit obligation and the fair value of plan assets at the beginning of the period September 1 through December 31, 2017, reflects the remeasurement of the plans at the Merger Effectiveness Time.

2. In the fourth quarter of 2016, about $550 million of lump-sum payments were made from the principal U.S. pension plan trust fund to a group of separated, vested plan participants who were extended a limited-time opportunity and voluntarily elected to receive their pension benefits in a single lump-sum payment. In the fourth quarter of 2017, about $140 million of lump-sum payments were made from the principal U.S. pension plan trust fund under a similar program.

3. As of December 31, 2017, $389 million of the benefit obligations are supported by funding under the Trust agreement, defined in the "Trust Assets" section below.

4. Includes pension plans maintained around the world where funding is not customary.

	Defined Benefit Pension Plans						Other Post Employment Benefits
(In millions)	Successor			Predecessor			Successor			Predecessor
	December 31, 2017			December 31, 2016			December 31, 2017			December 31, 2016
Amounts recognized in the Consolidated Balance Sheets:
Other Assets	$	47		$	3		$	—		$	—
Accrued and other current liabilities	(86		)	(78		)	(250		)	(275		)
Liabilities held for sale - current	—			(8		)	—			—
Pension and other post employment benefits - noncurrent 1	(5,227		)				(2,560		)
Other noncurrent obligations 1	—			(8,092		)	—			(2,554		)
Net amount recognized	$	(5,266	)	$	(8,175	)	$	(2,810	)	$	(2,829	)
Pretax amounts recognized in accumulated other comprehensive (income) loss:
Net (gain) loss	$	(165	)	$	10,280		$	68		$	830
Prior service benefit	—			(17		)	—			(281		)
Pretax balance in accumulated other comprehensive (income) loss at end of year	$	(165	)	$	10,263		$	68		$	549

1. In the Successor Period, non-current pension and OPEB liabilities are included within pension and other post employment benefits - noncurrent in the Consolidated Balance Sheets.  In the Predecessor period, these liabilities are included within other noncurrent obligations. 

The accumulated benefit obligation for all pensions plans was $25.1 billion and $24.3 billion at December 31, 2017 and 2016, respectively.

Pension Plans with Projected Benefit Obligations in Excess of Plan Assets	Successor		Predecessor
(In millions)	December 31, 2017		December 31, 2016
Projected benefit obligations	$	25,254	$	24,779
Accumulated benefit obligations	24,864		24,297
Fair value of plan assets	19,941		16,601

Pension Plans with Accumulated Benefit Obligations in Excess of Plan Assets	Successor		Predecessor
(In millions)	December 31, 2017		December 31, 2016
Projected benefit obligations	$	24,625	$	23,946
Accumulated benefit obligations	24,315		23,591
Fair value of plan assets	19,335		15,838

	Defined Benefit Pension Plans												Other Post Employment Benefits
(In millions)	Successor			Predecessor									Successor		Predecessor
Components of net periodic benefit cost (credit) and amounts recognized in other comprehensive loss	For the Period September 1 through December 31, 2017			For the Period January 1 through August 31, 2017			For the Year Ended December 31, 2016			For the Year Ended December 31, 2015			For the Period September 1 through December 31, 2017		For the Period January 1 through August 31, 2017			For the Year Ended December 31, 2016			For the Year Ended December 31, 2015
Net Periodic Benefit Cost:
Service cost	$	49		$	92		$	174		$	232		$	3	$	6		$	11		$	15
Interest cost	247			524			800			1,084			26		60			87			112
Expected return on plan assets	(407		)	(824		)	(1,320		)	(1,554		)	—		—			—			—
Amortization of unrecognized loss	—			506			822			768			—		61			78			78
Amortization of prior service benefit	—			(3		)	(6		)	(9		)	—		(46		)	(134		)	(182		)
Curtailment loss (gain)	—			—			40			(6		)	—		—			(392		)	(274		)
Settlement loss	—			—			62			76			—		—			—			—
Net periodic (credit) benefit cost - Total	$	(111	)	$	295		$	572		$	591		$	29	$	81		$	(350	)	$	(251	)
Less: Discontinued operations	1			3			—			—			—		—			—			(272		)
Net periodic (credit) benefit cost - Continuing operations	$	(112	)	$	292		$	572		$	591		$	29	$	81		$	(350	)	$	21
Changes in plan assets and benefit obligations recognized in other comprehensive (income) loss:
Net (gain) loss	$	(165	)	$	(22	)	$	570		$	57		$	68	$	—		$	153		$	(4	)
Amortization of unrecognized loss	—			(506		)	(822		)	(768		)	—		(61		)	(78		)	(78		)
Prior service benefit	—			—			—			—			—		—			(28		)	—
Amortization of prior service benefit	—			3			6			9			—		46			134			182
Curtailment (loss) gain	—			—			(40		)	6			—		—			392			274
Settlement loss	—			—			(62		)	(76		)	—		—			—			—
Effect of foreign exchange rates	—			133			(138		)	(119		)	—		—			—			1
Spin-off of Chemours	—			—			—			(382		)	—		—			—			—
Total (benefit) loss recognized in other comprehensive loss, attributable to DuPont	$	(165	)	$	(392	)	$	(486	)	$	(1,273	)	$	68	$	(15	)	$	573		$	375
Total recognized in net periodic benefit cost and other comprehensive (income) loss	$	(276	)	$	(97	)	$	86		$	(682	)	$	97	$	66		$	223		$	124

The estimated pretax net gain for the defined benefit pensions plans that will be amortized from accumulated other comprehensive (income) loss into net periodic benefit cost during 2018 is $1 million.

Estimated Future Benefit Payments

The estimated future benefit payments, reflecting expected future service, as appropriate, are presented in the following table:

Estimated Future Benefit Payments at December 31, 2017 (Successor)	Defined Benefit Pension Plans		Other Post Employment Benefits
(In millions)
2018	$	1,636	$	250
2019	1,614		243
2020	1,600		236
2021	1,587		227
2022	1,568		218
Years 2023-2027	7,533		906
Total	15,538		2,080

Plan Assets

All pension plan assets in the U.S. are invested through a single master trust fund. The strategic asset allocation for this trust fund is approved by management. The general principles guiding U.S. pension asset investment policies are those embodied in the Employee Retirement Income Security Act of 1974 (ERISA). These principles include discharging DuPont's investment responsibilities for the exclusive benefit of plan participants and in accordance with the "prudent expert" standard and other ERISA rules and regulations. DuPont establishes strategic asset allocation percentage targets and appropriate benchmarks for significant asset classes with the aim of achieving a prudent balance between return and risk. Strategic asset allocations in other countries are selected in accordance with the laws and practices of those countries. Where appropriate, asset liability studies are utilized in this process. U.S. plan assets and a portion of non-U.S. plan assets are managed by investment professionals employed by DuPont. The remaining assets are managed by professional investment firms unrelated to the company. DuPont's pension investment professionals have discretion to manage the assets within established asset allocation ranges approved by management of the company. Additionally, pension trust funds are permitted to enter into certain contractual arrangements generally described as "derivatives". Derivatives are primarily used to reduce specific market risks, hedge currency and adjust portfolio duration and asset allocation in a cost-effective manner.

In connection with pension contributions of $2,900 million to its principal U.S. pension plan during the period of January 1, 2017 through August 31, 2017, an investment policy study was completed for the principal U.S. pension plan. The study resulted in new target asset allocations being approved for the U.S. pension plan with resulting changes to the expected return on plan assets. The long-term rate of return on assets decreased from 8 percent to 6.25 percent.

The weighted-average target allocation for plan assets of the company's pension plans is summarized as follows:

Target Allocation for Plan Assets	Successor		Predecessor
Asset Category	December 31, 2017		December 31, 2016
U.S. equity securities	17	%	27	%
Non-U.S. equity securities	18		24
Fixed income securities	50		33
Hedge funds	2		2
Private market securities	8		8
Real estate	3		4
Cash and cash equivalents	2		2
Total	100	%	100	%

Global equity securities include varying market capitalization levels. U.S. equity investments are primarily large-cap companies. Global fixed income investments include corporate-issued, government-issued and asset-backed securities. Corporate debt investments include a range of credit risk and industry diversification. U.S. fixed income investments are weighted heavier than non-U.S. fixed income securities. Other investments include cash and cash equivalents, hedge funds, real estate and private market securities such as interests in private equity and venture capital partnerships.

Fair value calculations may not be indicative of net realizable value or reflective of future fair values. Furthermore, although the company believes its valuation methods are appropriate and consistent with other market participants, the use of different methodologies or assumptions to determine the fair value of certain financial instruments could result in a different fair value measurement at the reporting date.

For pension plan assets classified as Level 1 measurements (measured using quoted prices in active markets), total fair value is either the price of the most recent trade at the time of the market close or the official close price, as defined by the exchange on which the asset is most actively traded on the last trading day of the period, multiplied by the number of units held without consideration of transaction costs.

For pension or other post employment benefit plan assets classified as Level 2 measurements, where the security is frequently traded in less active markets, fair value is based on the closing price at the end of the period; where the security is less frequently traded, fair value is based on the price a dealer would pay for the security or similar securities, adjusted for any terms specific to that asset or liability. Market inputs are obtained from well-established and recognized vendors of market data and subjected to tolerance and quality checks. For derivative assets and liabilities, standard industry models are used to calculate the fair value of the various financial instruments based on significant observable market inputs, such as foreign exchange rates, commodity prices, swap rates, interest rates and implied volatilities obtained from various market sources.

For pension plan assets classified as Level 3 measurements, total fair value is based on significant unobservable inputs including assumptions where there is little, if any, market activity for the investment. Investment managers or fund managers provide valuations of the investment on a monthly or quarterly basis. These valuations are reviewed for reasonableness based on applicable sector, benchmark and company performance. Adjustments to valuations are made where appropriate. Where available, audited financial statements are obtained and reviewed for the investments as support for the manager’s investment valuation.

The tables below present the fair values of the company's pension assets by level within the fair value hierarchy, as described in Note 1:

Basis of Fair Value Measurements
For the year ended December 31, 2017 (Successor)
(In millions)	Total			Level 1		Level 2			Level 3
Cash and cash equivalents	$	3,057		$	3,057	$	—		$	—
U.S. equity securities 1	4,043			4,012		14			17
Non-U.S. equity securities	3,064			2,866		195			3
Debt – government-issued	3,263			497		2,766			—
Debt – corporate-issued	3,181			270		2,884			27
Debt – asset-backed	706			17		687			2
Hedge funds	85			—		83			2
Private market securities	14			—		—			14
Real estate	342			239		7			96
Derivatives – asset position	24			3		21			—
Derivatives – liability position	(16		)	—		(16		)	—
Other	2			—		2			—
Subtotal	$	17,765		$	10,961	$	6,643		$	161
Investments measured at net asset value
Hedge funds	747
Private market securities	1,383
Real estate funds	437
Total investments measured at net asset value	$	2,567
Other items to reconcile to fair value of plan assets
Pension trust receivables 2	127
Pension trust payables 3	(175		)
Total	$	20,284

1. The DuPont pension plans directly held $910 million (4 percent of total plan assets) of DowDuPont common stock at December 31, 2017.

2. Primarily receivables for investments securities sold.

3. Primarily payables for investment securities purchased

Basis of Fair Value Measurements
For the year ended December 31, 2016 (Predecessor)
(In millions)	Total			Level 1		Level 2			Level 3
Cash and cash equivalents	$	1,505		$	1,480	$	25		$	—
U.S. equity securities1	4,071			4,033		20			18
Non-U.S. equity securities	3,278			3,126		151			1
Debt – government-issued	2,067			864		1,203			—
Debt – corporate-issued	2,475			273		2,163			39
Debt – asset-backed	721			39		682			—
Hedge funds	1			—		1			—
Private market securities	67			—		25			42
Real estate	275			175		2			98
Derivatives – asset position	53			7		46			—
Derivatives – liability position	(47		)	—		(47		)	—
Other	4			—		4			—
Subtotal	$	14,470		$	9,997	$	4,275		$	198
Investments measured at net asset value
Hedge funds	434
Private market securities	1,416
Real estate funds	444
Total investments measured at net asset value	$	2,294
Other items to reconcile to fair value of plan assets
Pension trust receivables2	264
Pension trust payables3	(372		)
Total	$	16,656

1. The DuPont pension plans directly held $732 million (4 percent of total plan assets) of DuPont common stock at December 31, 2016.

2. Primarily receivables for investments securities sold.

3. Primarily payables for investment securities purchased.

The following table summarizes the changes in fair value of Level 3 pension plan assets for the year ended December 31, 2016 and for the periods January 1 through August 31, 2017 and September 1 through December 31, 2017:

Fair Value Measurement of Level 3 Pension Plan Assets	U.S. equity securities			Non-U.S. equity securities			Debt – corporate-issued			Debt- asset- backed			Hedge funds		Private market securities			Real estate			Total
(In millions)
Predecessor
Balance at January 1, 2016	$	20		$	2		$	34		$	1		$	—	$	37		$	144		$	238
Actual return on assets:
Relating to assets sold during the year ended December 31, 2016	(3		)	—			(25		)	—			—		—			—			(28		)
Relating to assets held at December 31, 2016	1			(1		)	27			—			—		2			(10		)	19
Purchases, sales and settlements, net	—			—			(3		)	(1		)	—		3			(36		)	(37		)
Transfers in Level 3, net	—			—			6			—			—		—			—			6
Balance at December 31, 2016	$	18		$	1		$	39		$	—		$	—	$	42		$	98		$	198
Actual return on assets:
Relating to assets sold during the period January 1 through August 31, 2017	(1		)	2			(20		)	—			—		—			—			(19		)
Relating to assets held at August 31, 2017	(7		)	(2		)	22			—			—		(5		)	7			15
Purchases, sales and settlements, net	6			1			(1		)	—			—		1			(7		)	—
Transfers in (out) of Level 3, net	—			—			6			2			—		(21		)	—			(13		)
Balance at August 31, 2017	$	16		$	2		$	46		$	2		$	—	$	17		$	98		$	181
Successor
Balance at September 1, 2017	$	16		$	2		$	46		$	2		$	—	$	17		$	98		$	181
Actual return on assets:
Relating to assets sold during the period September 1 through December 31, 2017	—			—			(3		)	—			—		—			—			(3		)
Relating to assets held at December 31, 2017	1			(1		)	5			—			—		(3		)	4			6
Purchases, sales and settlements, net	—			2			(21		)	—			2		—			(6		)	(23		)
Balance at December 31, 2017	$	17		$	3		$	27		$	2		$	2	$	14		$	96		$	161

The following table presents additional information about the pension plan assets valued using net asset value as a practical expedient:

(In millions)	Successor				Predecessor
	December 31, 2017				December 31, 2016
	Fair Value		Unfunded Commitments		Fair Value		Unfunded Commitments		Redemption Frequency	Redemption Notice Period Range
Hedge funds 1	747		—		434		—		Monthly, Quarterly	Ranges from 15-45 days monthly, 10-185 days quarterly
Private market securities 2	1,383		797		1,416		693		Not applicable	Not applicable
Real estate funds 2	437		371		444		244		Not applicable	Not applicable
Total	$	2,567	$	1,168	$	2,294	$	937

1. Less than 5 percent of hedge funds have gates in place at the investor level for year-end redemptions. Hedge funds also contain either no lock up or a lock up period of less than 1 year.

2. The remaining life of private market securities and real estate funds is an average of 15 years per investment.

Trust Assets

DuPont entered into a trust agreement in 2013 (as amended and restated in 2017) that established and requires DuPont to fund a trust (the "Trust") for cash obligations under certain non-qualified benefit and deferred compensation plans upon a change in control event as defined in the Trust agreement. Under the Trust agreement, the consummation of the Merger was a change in control event. As a result, in November 2017, DuPont contributed $571 million to the Trust. In the fourth quarter of 2017, $13 million was distributed to DuPont according to the Trust agreement and at December 31, 2017, the balance in the Trust was $558 million.

Defined Contribution Plans

DuPont provides defined contribution benefits to its employees. The most significant is the U.S. Retirement Savings Plan ("the Plan"), which covers all U.S. full-service employees. This Plan includes a non-leveraged Employee Stock Ownership Plan ("ESOP"). Employees are not required to participate in the ESOP and those who do are free to diversify out of the ESOP. The purpose of the Plan is to provide retirement savings benefits for employees and to provide employees an opportunity to become stockholders of the company. The Plan is a tax qualified contributory profit sharing plan, with cash or deferred arrangement and any eligible employee of DuPont may participate. Currently, DuPont contributes 100 percent of the first 6 percent of the employee's contribution election and also contributes 3 percent of each eligible employee's eligible compensation regardless of the employee's contribution.

DuPont's contributions to the Plan were $53 million, $129 million, $187 million and $219 million for the periods September 1 through December 31, 2017 and January 1 through August 31, 2017 and the years ended December 31, 2016 and 2015, respectively. DuPont's matching contributions vest immediately upon contribution. The 3 percent nonmatching company contribution vests after employees complete three years of service. In addition, DuPont made contributions to other defined contribution plans of $17 million, $33 million, $33 million and $57 million for the periods September 1 through December 31, 2017 and January 1 through August 31, 2017 and the years ended December 31, 2016 and 2015, respectively. Included in DuPont's contributions are amounts related to discontinued operations of $1 million, $5 million, $6 million and $39 million for the periods September 1 through December 31, 2017 and January 1 through August 31, 2017 and the years ended December 31, 2016 and 2015, respectively.

XML

Stock-Based Compensation

12 Months Ended

Dec. 31, 2017

Disclosure of Compensation Related Costs, Share-based Payments [Abstract]

Disclosure of Compensation Related Costs, Share-based Payments [Text Block]

STOCK-BASED COMPENSATION

The company's Equity Incentive Plan ("EIP"), as amended and restated effective August 31, 2017, provides for equity-based and cash incentive awards to certain employees, directors, and consultants. All outstanding DuPont equity awards as of the Merger date were converted into equity awards with respect to DowDuPont Common Stock. The previous DuPont equity awards were converted into the right to receive 1.2820 shares of DowDuPont Common Stock and had a fair value of approximately $629 million at the Merger closing date, which was included in the total consideration exchanged. The converted DuPont equity awards were measured at their fair value and included $485 million as consideration exchanged and $144 million (includes $23 million of incremental expense as a result of the conversion) that will be amortized to stock compensation expense over the remaining vesting period of the awards. The fair values of the converted awards were based on valuation assumptions developed by management and other information including, but not limited to, historical volatility and dividend yield of DuPont and Dow. DuPont and Dow did not merge their equity and incentive plans as a result of the Merger.

Under the amended EIP, the maximum number of shares reserved for the grant or settlement of awards is 110 million shares, provided that each share in excess of 30 million that is issued with respect to any award that is not an option or stock appreciation right will be counted against the 110 million share limit as four and one-half shares. At December 31, 2017, approximately 34 million shares were authorized for future grants under the EIP. The company satisfies stock option exercises and vesting of time-vested restricted stock units ("RSUs") and performance-based restricted stock units ("PSUs") with newly issued shares of DowDuPont Common Stock.

The total stock-based compensation cost included in continuing operations within the Consolidated Statement of Operations was $33 million, $85 million, $118 million and $127 million for the period September 1 through December 31, 2017, the period January 1 through August 31, 2017, and the years ended December 31, 2016 and 2015, respectively. The income tax benefits related to stock-based compensation arrangements were $11 million, $29 million, $39 million and $42 million for the period September 1 through December 31, 2017, the period January 1 through August 31, 2017, and the years ended December 31, 2016 and 2015, respectively.

The compensation committee determines the long-term incentive mix, including stock options, RSUs and PSUs and may authorize new grants annually. The company estimates expected forfeitures.

Stock Options

The exercise price of shares subject to option is equal to the market price of DowDuPont's stock on the date of grant. All options vest serially over a three-year period. Stock option awards granted between 2010 and 2015 expire seven years after the grant date and options granted in 2016 and 2017 expire ten years after the grant date. The plan allows retirement-eligible employees to retain any granted awards upon retirement provided the employee has rendered at least six months of service following grant date.

The weighted-average grant-date fair value of options granted in the period September 1 through December 31, 2017, the period January 1 through August 31, 2017, and the years ended December 31, 2016 and 2015 was $28.56, $16.65, $13.40, and $11.57, respectively.

To measure the fair value of the awards on the date of grant, the company used the Black-Scholes option pricing model and the following assumptions:

Weighted-Average Assumptions	Successor		Predecessor
	For the Period September 1 through December 31, 2017		For the Period January 1 through August 31, 2017		For the Year Ended December 31, 2016		For the Year Ended December 31, 2015
Dividend yield	2.2	%	2.0	%	2.6	%	2.5	%
Expected volatility	23.59	%	23.21	%	28.27	%	22.52	%
Risk-free interest rate	2.1	%	2.3	%	1.8	%	1.4	%
Expected life of stock options granted during period (years)	7.2		7.2		7.2		5.3

In the Successor period, the company determined the dividend yield by dividing the annualized dividend on DowDuPont's Common Stock by the option exercise price. In the Predecessor periods, the company determined the dividend yield by dividing the annual dividend on DuPont's stock by the option exercise price. A historical daily measurement of volatility is determined based on the expected life of the option granted. In the Successor period, the measurement of volatility used DowDuPont stock information after the Merger date, and a weighted average of Dow and DuPont stock information prior to Merger date. In the Predecessor periods, the measurement of volatility used DuPont stock information. 

The risk-free interest rate is determined by reference to the yield on an outstanding U.S. Treasury note with a term equal to the expected life of the option granted. Expected life is determined by reference to the company's historical experience.

The following table summarizes stock option activity for 2017 under the EIP:

Stock Options	2017
	Number of Shares (in thousands)		Weighted Average Exercise Price (per share)		Weighted Average Remaining Contractual Term (years)	Aggregate Intrinsic Value (in thousands)
Outstanding at January 1, 2017 (Predecessor)	15,696		$	58.11
Granted	1,626		76.18
Exercised	(4,356	)	54.52
Forfeited/Expired	(136	)	60.93
Outstanding at August 31, 20171	12,830		$	61.84	4.71	$	283,365
Exercisable at August 31, 2017	8,441		$	57.78	3.37	$	220,716
Outstanding at September 1, 2017 (Successor)1	16,447		$	48.24
Granted	174		45.29
Exercised	(702	)	43.07
Forfeited/Expired	(30	)	54.83
Outstanding at December 31, 2017	15,889		$	48.43	3.74	$	362,088
Exercisable at December 31, 2017	10,881		$	45.75	3.06	$	277,163

^1.  As a result of the Merger, all previous DuPont equity awards were converted into the right to receive 1.2820 shares of DowDuPont Common Stock, as discussed above. As a result, the number of shares outstanding at September 1, 2017 represents the shares as of August 31, 2017 multiplied by the conversion factor.

The aggregate intrinsic values in the table above represent the total pre-tax intrinsic value (the difference between the closing stock price on the last trading day of the period and the exercise price, multiplied by the number of in-the-money options) that would have been received by the option holders had all option holders exercised their in-the-money options at period end. Total intrinsic value of options exercised for the period September 1 through December 31, 2017, for the period January 1 through August 31, 2017, and for the years ended December 31, 2016 and 2015 were $19 million, $108 million, $86 million and $160 million, respectively. For the period September 1 through December 31, 2017 and for the period January 1 through August 31, 2017, the company realized tax benefits from options exercised of $6 million and $36 million, respectively.

As of December 31, 2017, $24 million of total unrecognized pre-tax compensation expense related to non-vested stock options is expected to be recognized over a weighted-average period of 1.86 years.

Restricted Stock Units and Performance Deferred Stock

The company issues non-vested RSUs that serially vest over a three-year period and, upon vesting, convert one-for-one to DowDuPont Common Stock. A retirement-eligible employee retains any granted awards upon retirement provided the employee has rendered at least six months of service following the grant date. Additional RSUs are also granted periodically to key senior management employees. These RSUs generally vest over periods ranging from two to five years. The fair value of all stock-settled RSUs is based upon the market price of the underlying common stock as of the grant date. The awards have the same terms and conditions as were applicable to such equity awards immediately prior to the Merger closing date.

The company grants PSUs to senior leadership. As a result of the Merger, the EIP provisions required PSUs to be converted into RSUs based on the number of PSUs that would vest by assuming that target levels of performance are achieved. Service requirements for vesting in the RSUs replicate those inherent in the exchanged PSUs.

Vesting for PSUs granted in 2016 and for the period January 1, 2017 through August 31, 2017 is based upon total shareholder return ("TSR") relative to peer companies. Vesting for PSUs granted in 2015 is equally based upon change in operating net income relative to target and TSR relative to peer companies. Operating net income is net income attributable to DuPont excluding income from discontinued operations after taxes, significant after tax benefits (charges), and non-operating pension and OPEB costs. Non-operating pension and OPEB costs includes all of the components of net periodic benefit cost from continuing operations with the exception of the service cost component. Performance and payouts are determined independently for each metric. The actual award, delivered as DowDuPont Common Stock, can range from zero percent to 200 percent of the original grant. The weighted-average grant-date fair value of PSUs granted for the period January 1 through August 31, 2017, subject to the TSR metric, was $91.56, and estimated using a Monte Carlo simulation. The weighted-average grant-date fair value of the PSUs, subject to the revenue metric, was based upon the market price of the underlying common stock as of the grant date.

In accordance with the Merger Agreement, PSUs converted to RSUs based on an assessment of the underlying market conditions in the PSUs at the greater of target or actual performance levels as of the closing date. As the actual performance levels were not in excess of target as of the closing date, all PSUs converted to RSUs based on target and there was no incremental benefit from the Merger Agreement when compared to DuPont’s EIP.

In November 2017, DowDuPont granted PSUs to senior leadership that vest partially based on the realization of cost savings in connection with DowDuPont Cost Synergy Program, as well as DowDuPont’s ability to complete the Intended Business Separations. Performance and payouts are determined independently for each metric. The actual award, delivered in DowDuPont Common Stock, can range from zero percent to 200 percent of the original grant. The weighted-average grant date fair value of the PSUs granted in November 2017 of $71.16 was based upon the market price of the underlying common stock as of the grant date.

Nonvested awards of RSUs and PSUs are shown below.

	2017
	Number of Shares (in thousands)		Weighted Average Grant Date Fair Value (per share)
Nonvested at December 31, 2016 (Predecessor)	3,390		$	63.11
Granted	1,124		76.41
Vested	(1,332	)	63.08
Forfeited	(104	)	70.69
Nonvested at August 31, 20171	3,078		$	67.53
Nonvested at September 1, 2017 (Successor)1	3,948		$	67.06
Granted	412		70.02
Vested	(139	)	67.67
Forfeited	(23	)	66.65
Nonvested at December 31, 2017	4,198		$	68.28

^1.  As a result of the Merger, all previous DuPont equity awards were converted into the right to receive 1.2820 shares of DowDuPont Common Stock, as discussed above. As a result, the number of shares outstanding at September 1, 2017 represents the shares as of August 31, 2017 multiplied by the conversion factor.

The total fair value of stock units vested during for the period September 1 through December 31, 2017, the period January 1 through August 31, 2017, and the years ended December 31, 2016 and 2015 was $9 million, $84 million, $83 million and $64 million, respectively. The weighted-average grant-date fair value of stock units granted for the period September 1 through December 31, 2017, for the period January 1 through August 31, 2017, and for the years ended December 31, 2016 and 2015 was $70.02, $76.41, $59.50, and $71.66, respectively.

As of December 31, 2017, $113 million of total unrecognized pre-tax compensation expense related to RSUs and PSUs is expected to be recognized over a weighted average period of 1.73 years.

Other Cash-based Awards

Other cash-based awards resulted in compensation expense of $83 million, $264 million, $295 million and $179 million for the period September 1 through December 31, 2017, for the period January 1 through August 31, 2017, and for the years ended December 31, 2016 and 2015, respectively, included in income from continuing operations within the Consolidated Statement of Operations.

XML

Financial Instruments

12 Months Ended

Dec. 31, 2017

Derivative Instruments and Hedging Activities Disclosure [Abstract]

Financial Instruments Disclosure [Text Block]

FINANCIAL INSTRUMENTS

At December 31, 2017, the company had $5,205 million ($2,713 million at December 31, 2016) of held-to-maturity securities (primarily time deposits and money market funds) classified as cash equivalents, as these securities had maturities of three months or less at the time of purchase; and $952 million ($1,362 million at December 31, 2016) of held-to-maturity securities (primarily time deposits) classified as marketable securities as these securities had maturities of more than three months to less than 1 year at the time of purchase. The company’s investments in held-to-maturity securities are held at amortized cost, which approximates fair value. These securities are included in cash and cash equivalents, marketable securities, and other current assets in the consolidated balance sheets.

Available-for-sale securities are reported at estimated fair value with unrealized gains and losses reported as a component of accumulated other comprehensive loss. There were no sales of available-for-sale securities for the period September 1 through December 31, 2017 or for the period January 1 through August 31, 2017. The proceeds from the sale of available-for-sale securities for the year ended December 31, 2016 were $788 million.

Derivative Instruments

Objectives and Strategies for Holding Derivative Instruments

In the ordinary course of business, the company enters into contractual arrangements (derivatives) to reduce its exposure to foreign currency, interest rate and commodity price risks. The company has established a variety of derivative programs to be utilized for financial risk management. These programs reflect varying levels of exposure coverage and time horizons based on an assessment of risk.

Derivative programs have procedures and controls and are approved by the Corporate Financial Risk Management Committee, consistent with the company's financial risk management policies and guidelines. Derivative instruments used are forwards, options, futures and swaps. The company has not designated any nonderivatives as hedging instruments.

The company's financial risk management procedures also address counterparty credit approval, limits and routine exposure monitoring and reporting. The counterparties to these contractual arrangements are major financial institutions and major commodity exchanges. The company is exposed to credit loss in the event of nonperformance by these counterparties. The company utilizes collateral support annex agreements with certain counterparties to limit its exposure to credit losses. The company anticipates performance by counterparties to these contracts and therefore no material loss is expected. Market and counterparty credit risks associated with these instruments are regularly reported to management.

The notional amounts of the company's derivative instruments were as follows:

Notional Amounts	Successor		Predecessor
(In millions)	December 31, 2017		December 31, 2016
Derivatives designated as hedging instruments:
Commodity contracts	$	587	$	422
Derivatives not designated as hedging instruments:
Foreign currency contracts	10,454		9,896
Commodity contracts	6		7

Foreign Currency Risk

The company's objective in managing exposure to foreign currency fluctuations is to reduce earnings and cash flow volatility associated with foreign currency rate changes. Accordingly, the company enters into various contracts that change in value as foreign exchange rates change to protect the value of its existing foreign currency-denominated assets, liabilities, commitments and cash flows.

The company routinely uses forward exchange contracts to offset its net exposures, by currency, related to the foreign currency denominated monetary assets and liabilities of its operations. The primary business objective of this hedging program is to maintain an approximately balanced position in foreign currencies so that exchange gains and losses resulting from exchange rate changes, net of related tax effects, are minimized. The company also uses foreign currency exchange contracts to offset a portion of the company's exposure to certain foreign currency-denominated revenues so that gains and losses on these contracts offset changes in the USD value of the related foreign currency-denominated revenues. The objective of the hedge program is to reduce earnings and cash flow volatility related to changes in foreign currency exchange rates.

Commodity Price Risk

Commodity price risk management programs serve to reduce exposure to price fluctuations on purchases of inventory such as corn, soybeans, soybean oil and soybean meal. The company enters into over-the-counter and exchange-traded derivative commodity instruments to hedge the commodity price risk associated with agricultural commodity exposures.

Derivatives Designated as Cash Flow Hedges

Foreign Currency Contracts

The company uses foreign currency exchange instruments such as forwards and options to offset a portion of the company's exposure to certain foreign currency-denominated revenues so that gains and losses on these contracts offset changes in the USD value of the related foreign currency-denominated revenues. In addition, the company occasionally uses forward exchange contracts to offset a portion of the company’s exposure to certain foreign currency-denominated transactions such as capital expenditures.

Commodity Contracts

The company enters into over-the-counter and exchange-traded derivative commodity instruments, including options, futures and swaps, to hedge the commodity price risk associated with agriculture commodity exposures.

While each risk management program has a different time maturity period, most programs currently do not extend beyond the next two-year period. Cash flow hedge results are reclassified into earnings during the same period in which the related exposure impacts earnings. Reclassifications are made sooner if it appears that a forecasted transaction is not probable of occurring.

The following table summarizes the after-tax effect of cash flow hedges on accumulated other comprehensive loss:

	Successor			Predecessor
(In millions)	For the Period September 1 - December 31, 2017			For the Period Jan. 1 - August 31, 2017			Year Ended December 31, 2016
Beginning balance	$	—		$	7		$	(24	)
Additions and revaluations of derivatives designated as cash flow hedges	(2		)	3			20
Clearance of hedge results to earnings	—			(13		)	11
Ending balance	$	(2	)	$	(3	)	$	7

At December 31, 2017, an after-tax net loss of $(6) million is expected to be reclassified from accumulated other comprehensive loss into earnings over the next twelve months.

Derivatives not Designated in Hedging Relationships

Foreign Currency Contracts

The company routinely uses forward exchange contracts to reduce its net exposure, by currency, related to foreign currency-denominated monetary assets and liabilities of its operations so that exchange gains and losses resulting from exchange rate changes are minimized. The netting of such exposures precludes the use of hedge accounting; however, the required revaluation of the forward contracts and the associated foreign currency-denominated monetary assets and liabilities intends to achieve a minimal earnings impact, after taxes. The company also uses foreign currency exchange contracts to offset a portion of the company's exposure to certain foreign currency-denominated revenues so that gains and losses on the contracts offset changes in the USD value of the related foreign currency-denominated revenues.

Commodity Contracts

The company utilizes options, futures and swaps that are not designated as hedging instruments to reduce exposure to commodity price fluctuations on purchases of inventory such as corn, soybeans, soybean oil and soybean meal.

Fair Value of Derivative Instruments

During the Predecessor period, the company's derivative assets and liabilities are reported on a gross basis in the Consolidated Balance Sheets. During the Successor period, to conform with DowDuPont's presentation post-merger, asset and liability derivatives subject to an enforceable master netting arrangement with the same counterparty are presented on a net basis in the Consolidated Balance Sheets. The presentation of the company's derivative assets and liabilities is as follows:

		Successor
		December 31, 2017
(In millions)	Balance Sheet Location	Gross		Counterparty and Cash Collateral Netting1			Net Amounts Included in the Condensed Consolidated Balance Sheet
Asset derivatives:
Derivatives not designated as hedging instruments:
Foreign currency contracts	Other current assets	$	46	$	(37	)	$	9
Total asset derivatives		$	46	$	(37	)	$	9
Liability derivatives:
Derivatives not designated as hedging instruments:
Foreign currency contracts	Accrued and other current liabilities	$	79	$	(32	)	$	47
Total liability derivatives		$	79	$	(32	)	$	47

^1.  Counterparty and cash collateral amounts represent the estimated net settlement amount when applying netting and set-off rights included in master netting arrangements between the company and its counterparties and the payable or receivable for cash collateral held or placed with the same counterparty. The company held cash collateral of $5 million as of December 31, 2017.

		Predecessor
(In millions)	Balance Sheet Location	December 31, 2016
Asset derivatives:
Derivatives not designated as hedging instruments:
Foreign currency contracts1	Accounts and notes receivable - net	$	182
Total asset derivatives2		$	182
Cash collateral1	Accrued and other current liabilities	$	52
Liability derivatives:
Derivatives not designated as hedging instruments:
Foreign currency contracts	Accrued and other current liabilities	$	121
Total liability derivatives2		$	121

^1.  Cash collateral held as of December 31, 2016 is related to foreign currency derivatives not designated as hedging instruments.

^2.  The company's derivative assets and liabilities subject to enforceable master netting arrangements totaled $114 million at December 31, 2016.

Effect of Derivative Instruments

	Amount of Gain (Loss) Recognized in OCI1 (Effective Portion) - Pre Tax
	Successor		Predecessor
(In millions)	For the Period September 1 - December 31, 2017		For the Period Jan. 1 - August 31, 2017		Year Ended December 31, 2016		Year Ended December 31, 2015
Derivatives designated as hedging instruments:
Cash flow hedges:
Foreign currency contracts	$	—	—		—		(2		)
Commodity contracts	3		5		32		(35		)
Total derivatives designated as hedging instruments	$	3	$	5	$	32	$	(37	)
Total derivatives	$	3	$	5	$	32	$	(37	)

1. OCI is defined as other comprehensive income (loss).

	Amount of Gain (Loss) Recognized in Income - Pre Tax1
	Successor		Predecessor
(In millions)	For the Period September 1 - December 31, 2017		For the Period Jan. 1 - August 31, 2017			Year Ended December 31, 2016			Year Ended December 31, 2015
Derivatives designated as hedging instruments:
Fair value hedges:
Interest rate swaps2	$	—	$	—		$	—		$	(1	)
Cash flow hedges:
Foreign currency contracts3	—		—			—			10
Commodity contracts2	—		21			(18		)	(22		)
Total derivatives designated as hedging instruments	$	—	$	21		$	(18	)	$	(13	)
Derivatives not designated as hedging instruments:
Foreign currency contracts4	91		(431		)	(304		)	434
Foreign currency contracts3	—		—			(12		)	(3		)
Commodity contracts2	—		2			(11		)	(2		)
Total derivatives not designated as hedging instruments	91		(429		)	(327		)	429
Total derivatives	$	91	$	(408	)	$	(345	)	$	416

1. For cash flow hedges, this represents the effective portion of the gain (loss) reclassified from accumulated OCI into income during the period. There was no material ineffectiveness with regard to the company's cash flow hedges during the period.

2. Recorded in cost of goods sold.

3. Recorded in net sales.

4. Gain recognized in sundry income - net was partially offset by the related gain on the foreign currency-denominated monetary assets and liabilities of the company's operations. See Note 6 for additional information.

XML

Fair Value Measurements

12 Months Ended

Dec. 31, 2017

Fair Value Disclosures [Abstract]

Fair Value Disclosures [Text Block]

FAIR VALUE MEASUREMENTS

The following tables summarize the bases used to measure certain assets and liabilities at fair value on a recurring basis:

December 31, 2017 (Successor)	Significant Other Observable Inputs (Level 2)
(In millions)
Assets at fair value:
Cash equivalents1	$	5,205
Marketable securities	$	952
Derivatives relating to:2
Foreign currency	46
Total assets at fair value	$	6,203
Liabilities at fair value:
Long-term debt3	$	11,560
Derivatives relating to:2
Foreign currency	79
Total liabilities at fair value	$	11,639

1. Time deposits included in "Cash and cash equivalents" and money market funds included in "Other current assets" in the consolidated balance sheets are held at amortized cost, which approximates fair value.

2. See Note 18 for the classification of derivatives in the consolidated balance sheets.

3. See Note 13 for information on fair value measurements of long-term debt.

December 31, 2016 (Predecessor)	Significant Other Observable Inputs (Level 2)
(In millions)
Assets at fair value:
Cash equivalents1	$	2,713
Marketable securities	$	1,362
Derivatives relating to:2
Foreign currency	182
Total assets at fair value	$	4,257
Liabilities at fair value:
Long-term debt3	$	8,464
Derivatives relating to:2
Foreign currency	121
Total liabilities at fair value	$	8,585

1. Time deposits included in "Cash and cash equivalents" and money market funds included in "Other current assets" in the consolidated balance sheets are held at amortized cost, which approximates fair value.

2. See Note 18 for the classification of derivatives in the consolidated balance sheets.

3. See Note 13 for information on fair value measurements of long-term debt.

For assets and liabilities classified as Level 1 measurements (measured using quoted prices in active markets), total fair value is either the price of the most recent trade at the time of the market close or the official close price, as defined by the exchange on which the asset is most actively traded on the last trading day of the period, multiplied by the number of units held without consideration of transaction costs.

For assets and liabilities classified as Level 2 measurements, where the security is frequently traded in less active markets, fair value is based on the closing price at the end of the period; where the security is less frequently traded, fair value is based on the price a dealer would pay for the security or similar securities, adjusted for any terms specific to that asset or liability, or by using observable market data points of similar, more liquid securities to imply the price. For time deposits classified as held-to-maturity investments and reported at amortized cost, fair value is based on an observable interest rate for similar securities. Market inputs are obtained from well-established and recognized vendors of market data and subjected to tolerance and quality checks. 

For derivative assets and liabilities, standard industry models are used to calculate the fair value of the various financial instruments based on significant observable market inputs, such as foreign exchange rates, commodity prices, swap rates, interest rates and implied volatilities obtained from various market sources. Market inputs are obtained from well-established and recognized vendors of market data and subjected to tolerance/quality checks.

For all other assets and liabilities for which observable inputs are used, fair value is derived through the use of fair value models, such as a discounted cash flow model or other standard pricing models. See Note 18 for further information on the types of instruments used by the company for risk management.

There were no transfers between Levels 1 and 2 during the years ended December 31, 2017 and December 31, 2016.

For assets classified as Level 3 measurements, the fair value is based on significant unobservable inputs including assumptions where there is little, if any, market activity. The fair value of the company’s interests held in trade receivable conduits is determined by calculating the expected amount of cash to be received using the key input of anticipated credit losses in the portfolio of receivables sold that have not yet been collected. Given the short-term nature of the underlying receivables, discount rate and prepayments are not factors in determining the fair value of the interests.

XML

Geographic and Product Line Information

12 Months Ended

Dec. 31, 2017

Geographical Reporting [Abstract]

Geographic and Principal Product Group Information [Text Block]

GEOGRAPHIC AND PRODUCT LINE INFORMATION

Sales are attributed to geographic areas based on customer location; long-lived assets are attributed to geographic areas based on asset location.

	Net Sales
	Successor		Predecessor
(In millions)	Sept 1 - Dec 31, 2017		Jan 1 - Aug 31, 2017		Year Ended Dec 31, 2016		Year Ended Dec 31, 2015
United States	$	2,086	$	7,535	$	9,500	$	9,812
Canada	139		583		669		692
EMEA1	1,689		3,927		5,251		5,483
Asia Pacific2	2,047		3,844		5,407		5,292
Latin America	1,092		1,392		2,382		2,378
Total	$	7,053	$	17,281	$	23,209	$	23,657

^1.  Europe, Middle East, and Africa (EMEA).

^2.  Net sales for China in the Successor period were $818 million. Net sales for China were less than 10 percent of consolidated net sales in all Predecessor periods.

	Net Property
	Successor		Predecessor
(In millions)	2017		2016		2015
United States	$	7,708	$	5,951	$	6,458
Canada	170		124		128
EMEA1	2,867		1,550		1,582
Asia Pacific	1,120		797		854
Latin America	570		429		392
Total	$	12,435	$	8,851	$	9,414

^1.  Europe, Middle East, and Africa (EMEA).

Net Sales by Principal Product Line

Effective with the Merger, DuPont’s business activities are components of its parent company’s business operations. DuPont’s business activities, including the assessment of performance and allocation of resources, are reviewed and managed by DowDuPont. Information used by the chief operating decision maker of DuPont relates to the company in its entirety. Accordingly, there are no separate reportable business segments for DuPont under ASC Topic 280 “Segment Reporting” and DuPont's business results are reported in this Form 10-K as a single operating segment. Prior year's segment information has been made to conform to the current presentation.

The company has one reportable segment with the following principal product lines: agriculture, packaging and specialty plastics, electronics and imaging, nutrition and health, industrial biosciences, transportation and advanced polymers and safety and construction. Net sales by principal product line are included below:

Net Sales	Successor		Predecessor
(In millions)	For the Period September 1 through December 31, 2017		For the Period January 1 through August 31, 2017		For the Year Ended December 31, 2016		For the Year Ended December 31, 2015
Agriculture	$	1,596	$	6,894	$	8,131	$	8,327
Packaging and Specialty Plastics	544		1,072		1,651		1,715
Electronics and Imaging	743		1,422		1,960		2,070
Nutrition and Health	1,165		2,129		3,268		3,256
Industrial Biosciences	573		1,022		1,500		1,478
Transportation and Advanced Polymers	1,355		2,608		3,599		3,591
Safety and Construction	1,074		2,134		3,099		3,220
Other	3		—		1		—
Total	$	7,053	$	17,281	$	23,209	$	23,657

XML

Quaterly Financial Data

12 Months Ended

Dec. 31, 2017

Quarterly Financial Information Disclosure [Abstract]

Quarterly Financial Information [Text Block]

QUARTERLY FINANCIAL DATA

	2017
	Predecessor										Successor
In millions, except per share amounts (unaudited)	First			Second			July 1 - Aug 31				Sept 1 - Sept 30				Fourth
Net sales	$	7,319		$	6,971		$	2,991			$	1,735			$	5,318
Cost of goods sold	4,209			4,021			1,975				1,511			2	4,654		2
Restructuring and asset related charges - net1	152			160			11				40				140
Net income (loss)	1,121		3,4,5	869		3	(229		)	3	(295		)	1,3	1,305		1,3,6
Net income (loss) attributable to DuPont	1,113			862			(234		)		(293		)		1,303
Earnings per common share, continuing operations - basic9	1.35			0.82			(0.30		)
Earnings per common share, continuing operations - diluted9	1.34			0.82			(0.30		)

	2016
	Predecessor
In millions, except per share amounts (unaudited)	First			Second				Third				Fourth
Net sales	$	7,014		$	6,646			$	4,646			$	4,903
Cost of goods sold	4,103			3,823				2,997				3,032
Restructuring and asset related charges - net1	78			(88		)		172				394
Net income (loss)	1,232		7,8	1,024			7	6			7	263		7
Net income (loss) attributable to DuPont	1,226			1,020				2				265
Earnings per common share, continuing operations - basic9	1.23			1.03				(0.08		)		0.19
Earnings per common share, continuing operations - diluted9	1.22			1.02				(0.08		)		0.19

1. See Note 5 for additional information.

2. Includes charges of $(360) million and $(1,109) million during the period September 1 - September 30, 2017 and the fourth quarter 2017, respectively, related to the amortization of inventory step-up as a result of the Merger and the acquisition of the H&N Business, which was included in cost of goods sold. See Note 3 for additional information.

3. Includes charges of $(170) million, $(201) million, $(210) million, $(71) million, and $(243) million in the first quarter 2017, second quarter 2017, the period July 1 - August 31, 2017, the period September 1 - September 30, 2017, and the fourth quarter 2017, respectively, related to transaction costs associated with the Merger. Predecessor costs are recorded in selling, general and administrative expenses; Successor costs are recoded in integration and separation costs. See Note 3 for additional information.

4. First quarter 2017 included a gain of $162 million recorded in sundry income - net associated with the sale of the company's global food safety diagnostic business. See Note 4 for additional information.

5. First quarter 2017 included a tax benefit of $53 million, as well as a $47 million benefit on associated accrued interest reversals (recorded in sundry income - net), related to a reduction in the company’s unrecognized tax benefits due to the closure of various tax statutes of limitations.

6. Includes a tax benefit of $2,262 million in the fourth quarter 2017 related to the Tax Cuts and Jobs Act and a benefit related to an internal entity restructuring associated with the Intended Business Separations. See Note 7 for additional information.

7. First, second, third and fourth quarter 2016 included charges of $(24) million, $(76) million, $(122) million, and $(164) million, respectively, recorded in selling, general and administrative expenses related to transaction costs associated with the Merger. See Note 3 for additional information.

8. First quarter 2016 included a gain of $369 million recorded in sundry income - net associated with the sale of the DuPont (Shenzhen) Manufacturing Limited entity, which held certain buildings and other assets. See Note 4 for additional information.

9. Due to quarterly changes in the share count and the allocation of income to participating securities, the sum of the four quarters may not equal the earnings per share amount calculated for the year.

XML

Subsequent Events (Notes)

12 Months Ended

Dec. 31, 2017

Subsequent Events [Abstract]

Subsequent Events [Text Block]

SUBSEQUENT EVENTS

In February 2018, the company entered into a new committed receivable repurchase facility of up to $1,300 million (the 2018 Repurchase Facility) which expires in December 2018. Under the 2018 Repurchase Facility, DuPont may sell a portfolio of available and eligible outstanding customer notes receivables within the agriculture product line to participating institutions and simultaneously agree to repurchase at a future date. The 2018 Repurchase Facility is considered a secured borrowing with the customer notes receivables inclusive of those that are sold and repurchased, equal to 105 percent of the outstanding amounts borrowed utilized as collateral. Borrowings under the 2018 Repurchase Facility will have an interest rate of LIBOR + 0.75 percent.

XML

Schedule II - Valuation and Qualifying Accounts (Other)

12 Months Ended

Dec. 31, 2017

Valuation and Qualifying Accounts [Abstract]

Schedule of Valuation and Qualifying Accounts Disclosure [Text Block]

Schedule II—Valuation and Qualifying Accounts

(Dollars in millions)

	Successor			Predecessor
	For the Period September 1 through December 31, 2017			For the Period January 1 through August 31, 2017			For the Year Ended December 31, 2016			For the Year Ended December 31, 2015
Accounts Receivable—Allowance for Doubtful Receivables
Balance at beginning of period	$	—		$	287		$	225		$	235
Additions charged to expenses	10			51			119			58
Deductions from reserves1	—			(33		)	(57		)	(68		)
Balance at end of period	$	10		$	305		$	287		$	225
Inventory—Obsolescence Reserve
Balance at beginning of period	$	—		$	214		$	237		$	179
Additions charged to expenses	89			241			275			391
Deductions from reserves2	(34		)	(181		)	(298		)	(333		)
Balance at end of period	$	55		$	274		$	214		$	237
Deferred Tax Assets—Valuation Allowance
Balance at beginning of period	$	1,323		$	1,308		$	1,529		$	1,704
Additions charged to expenses	84			95			74			40
Deductions from reserves	(29		)	(20		)	(295		)	(215		)
Balance at end of period	$	1,378		$	1,383		$	1,308		$	1,529

^1. Deductions include write-offs, recoveries and currency translation adjustments.

^2. Deductions include disposals and currency translation adjustments.

XML

Summary of Significant Accounting Policies (Policies)

12 Months Ended

Dec. 31, 2017

Accounting Policies [Abstract]

Principles of Consolidation and Basis of Presentation

Principles of Consolidation and Basis of Presentation

The accompanying Consolidated Financial Statements of E. I. du Pont de Nemours and Company (“DuPont” or “the company”) were prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”). The significant accounting policies described below, together with the other notes that follow, are an integral part of the Consolidated Financial Statements.

DowDuPont Inc. ("DowDuPont") was formed on December 9, 2015 to effect an all-stock, merger of equals strategic combination between The Dow Chemical Company ("Dow") and DuPont (the "Merger Transaction"). On August 31, 2017 at 11:59 pm ET, (the "Merger Effectiveness Time") pursuant to the Agreement and Plan of Merger, dated as of December 11, 2015, as amended on March 31, 2017 (the "Merger Agreement"), Dow and DuPont each merged with wholly owned subsidiaries of DowDuPont ("Mergers") and, as a result of the Mergers, Dow and DuPont became subsidiaries of DowDuPont (collectively, the "Merger"). Prior to the Merger, DowDuPont did not conduct any business activities other than those required for its formation and matters contemplated by the Merger Agreement. DowDuPont intends to pursue, subject to the receipt of approval by the Board of Directors of DowDuPont, the separation of the combined company's agriculture business, specialty products business and materials science business through a series of tax-efficient transactions (collectively, the "Intended Business Separations").

For purposes of DowDuPont's financial statement presentation, Dow was determined to be the accounting acquirer in the Merger and DuPont's assets and liabilities are reflected at fair value as of the Merger Effectiveness Time. In connection with the Merger and the related accounting determination, DuPont has elected to apply push-down accounting and reflect in its financial statements the fair value of its assets and liabilities. DuPont's Consolidated Financial Statements for periods following the close of the Merger are labeled “Successor” and reflect DowDuPont’s basis in the fair values of the assets and liabilities of DuPont. All periods prior to the closing of the Merger reflect the historical accounting basis in DuPont's assets and liabilities and are labeled “Predecessor.” The Consolidated Financial Statements and footnotes include a black line division between the columns titled "Predecessor" and "Successor" to signify that the amounts shown for the periods prior to and following the Merger are not comparable. See Note 3 for additional information on the Merger.

Transactions between DowDuPont, DuPont, Dow and their affiliates and other associated companies are reflected in the Successor consolidated financial statements and disclosed as related party transactions when material. Related party transactions with DowDuPont are included in Note 6. Related party transactions with Dow and their affiliates were not material as of December 31, 2017 and for the period September 1 through December 31, 2017.

As a condition of the regulatory approval for the Merger Transaction, the company was required to divest certain assets related to its crop protection business and research and development ("R&D") organization, specifically the company’s Cereal Broadleaf Herbicides and Chewing Insecticides portfolios, including Rynaxypyr^®, Cyazypyr^® and Indoxacarb as well as the crop protection R&D pipeline and organization, excluding seed treatment, nematicides, and late-stage R&D programs. On March 31, 2017, the company entered into a definitive agreement (the "FMC Transaction Agreement") with FMC Corporation ("FMC"). Under the FMC Transaction Agreement, FMC would acquire the crop protection business and R&D assets that DuPont was required to divest in order to obtain European Commission ("EC") approval of the Merger Transaction as described above, (the "Divested Ag Business") and DuPont agreed to acquire certain assets relating to FMC’s Health and Nutrition segment, excluding its Omega-3 products (the "H&N Business") (collectively, the "FMC Transactions").

On November 1, 2017, the company completed the FMC Transactions through the disposition of the Divested Ag Business and the acquisition of the H&N Business. The sale of the Divested Ag Business meets the criteria for discontinued operations and as such, results of operations are presented as discontinued operations and have been excluded from continuing operations for all periods presented. The sum of the individual earnings per share amounts from continuing operations and discontinued operations may not equal the total company earnings per share amounts due to rounding. The assets and liabilities related to the Divested Ag Business for all periods are presented as assets and liabilities held for sale in the Consolidated Balance Sheets. The comprehensive income and cash flows related to the Divested Ag Business have not been segregated and are included in the Consolidated Statements of Comprehensive Income and Consolidated Statements of Cash Flows, respectively, for all periods presented. Amounts related to the Divested Ag Business are consistently included or excluded from the Notes to the Consolidated Financial Statements based on the respective financial statement line item. See Note 4 for additional information.

On July 1, 2015, the company completed the separation of its Performance Chemicals segment through the spin-off of all of the issued and outstanding stock of The Chemours Company ("Chemours"). In accordance with GAAP, the results of operations of the Performance Chemicals segment are presented as discontinued operations and, as such, have been excluded from continuing operations in the Consolidated Statements of Operations for all periods presented. See Note 4 for additional information.

Certain reclassifications of prior year's data have been made to conform to current year's presentation. As described in Note 2, effective January 1, 2017, the company adopted the Financial Accounting Standards Board (“FASB”) Accounting Standards Update ("ASU") No. 2016-09, Compensation - Stock Compensation (Topic 718), Improvements to Employee Share-Based Payment Accounting. In conjunction with the adoption of this ASU, the company retrospectively reclassified cash flows related to income tax impacts associated with employee share-based payments in the Consolidated Statements of Cash Flows, as described in Note 2.

Basis of Consolidation

The Consolidated Financial Statements include the accounts of the company and subsidiaries in which a controlling interest is maintained. For those consolidated subsidiaries in which the company's ownership is less than 100 percent, the outside stockholders' interests are shown as noncontrolling interests. Investments in affiliates over which the company has significant influence but not a controlling interest are accounted for under the equity method.

The company is also involved with certain joint ventures accounted for under the equity method of accounting that are variable interest entities ("VIEs"). The company is not the primary beneficiary, as the nature of the company's involvement with the VIEs does not provide it the power to direct the VIEs significant activities. Future events may require these VIEs to be consolidated if the company becomes the primary beneficiary. At December 31, 2017 and 2016, the maximum exposure to loss related to the nonconsolidated VIEs is not considered material to the Consolidated Financial Statements.

Use of Estimates

Use of Estimates in Financial Statement Preparation

The preparation of financial statements in accordance with U.S. GAAP requires the use of estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenues and expenses during the reporting period. The company’s consolidated financial statements include amounts that are based on management’s best estimates and judgments. Actual results could differ from those estimates. In connection with the Merger, DowDuPont has performed a preliminary allocation of the total consideration exchanged for the DuPont assets and liabilities it acquired using preliminary estimates. The estimates are subject to change as discussed in Note 3.

Changes in Accounting and Reporting

Changes in Accounting and Reporting

Within the Successor period, DuPont made the following changes in accounting and reporting to harmonize its accounting and reporting with DowDuPont.

Within the Successor period of the Consolidated Statements of Operations:

• Included royalty income within net sales. In the Predecessor periods, royalty income is included within sundry income - net.

• Eliminated the other operating charges line item. In the Successor period, a majority of these costs are included within cost of goods sold. These costs are also included in selling, general and administrative expenses and amortization of intangibles in the Successor period.

• Presented amortization of intangibles as a separate line item. In the Predecessor periods, amortization is included within cost of goods sold, selling, general and administrative expenses, other operating charges, and research and development expenses.

• Presented integration and separation costs as a separate line item. In the Predecessor periods, these costs are included within selling, general and administrative expenses.

• Included interest accrued related to unrecognized tax benefits within the (benefit from) provision for income taxes on continuing operations. In the Predecessor period, interest accrued related to unrecognized tax benefits is included within sundry income - net.

Within the Successor period of the Consolidated Balance Sheets:

• Included loans to nonconsolidated affiliates within other assets. In the Predecessor period, loans are included within investment in nonconsolidated affiliates.

• Included accrued discounts and rebates within accounts payable. In the Predecessor period, accrued discounts and rebates are included within accrued and other current liabilities.

• Included non-current pension liabilities within pension and other post employment benefits - noncurrent. In the Predecessor period, non-current pension liabilities are included within other noncurrent obligations.

Within the Successor period of the Consolidated Statements of Cash Flows:

• Included foreign currency exchange contract settlements within cash flows from operating activities, regardless of hedge accounting qualification. In the Predecessor period, DuPont reflected non-qualified hedge programs, specifically forward contracts, options and cash collateral activity, within cash flows from investing activities. In the Predecessor period, DuPont reflected cash flows from qualified programs within the line item it related to (i.e., revenue hedge cash flows presented within changes from accounts receivable).

• Aligned the line items within "changes in assets and liabilities, net of effects of acquired and divested companies" to the DowDuPont presentation, including accounts and notes receivable, inventories, accounts payable, and other assets and liabilities. In the Predecessor period, the line item "changes in assets and liabilities, net of effects of acquired and divested companies" includes accounts and notes receivable, inventories and other operating assets, accounts payable and other operating liabilities, and accrued interest and income taxes.

Cash and Cash Equivalents

Cash and Cash Equivalents

Cash equivalents represent investments with maturities of three months or less from time of purchase. They are carried at cost plus accrued interest.

Restricted Cash

Restricted Cash

Restricted cash represents trust assets of $558 million as of December 31, 2017, and is included within other current assets on the Consolidated Balance Sheets. See Note 6 and Note 16 for further information.

Marketable Securities

Marketable Securities

Marketable securities represent investments in fixed and floating rate financial instruments with maturities greater than three months and up to twelve months at time of purchase. Investments classified as held-to-maturity are recorded at amortized cost. The carrying value approximates fair value due to the short-term nature of the investments. Investments classified as available-for-sale are carried at estimated fair value with unrealized gains and losses recorded as a component of accumulated other comprehensive income (loss). The cost of investments sold is determined by specific identification.

Fair Value Measurements

Fair Value Measurements

Under the accounting guidance for fair value measurements and disclosures, a fair value hierarchy was established that prioritizes the inputs to valuation techniques used to measure fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). A financial instrument's level within the fair value hierarchy is based on the lowest level of any input that is significant to the fair value measurement.

The company uses the following valuation techniques to measure fair value for its assets and liabilities:

Level 1	–	Quoted market prices in active markets for identical assets or liabilities;
Level 2	–	Significant other observable inputs (e.g. quoted prices for similar items in active markets, quoted prices for identical or similar items in markets that are not active, inputs other than quoted prices that are observable such as interest rate and yield curves, and market-corroborated inputs);
Level 3	–	Unobservable inputs for the asset or liability, which are valued based on management's estimates of assumptions that market participants would use in pricing the asset or liability.

Foreign Currency Translation

Foreign Currency Translation

The company's worldwide operations utilize the U.S. dollar (USD) or local currency as the functional currency, where applicable. The company identifies its separate and distinct foreign entities and groups the foreign entities into two categories: 1) extension of the parent or foreign subsidiaries operating in a hyper-inflationary environment (USD functional currency) and 2) self-contained (local functional currency). If a foreign entity does not align with either category, factors are evaluated and a judgment is made to determine the functional currency. 

For foreign entities where the USD is the functional currency, all foreign currency-denominated asset and liability amounts are re-measured into USD at end-of-period exchange rates, except for inventories, prepaid expenses, property, plant and equipment, goodwill and other intangible assets, which are re-measured at historical rates. Foreign currency income and expenses are re-measured at average exchange rates in effect during the year, except for expenses related to balance sheet amounts re-measured at historical exchange rates. Exchange gains and losses arising from re-measurement of foreign currency-denominated monetary assets and liabilities are included in income in the period in which they occur.

For foreign entities where the local currency is the functional currency, assets and liabilities denominated in local currencies are translated into USD at end-of-period exchange rates and the resultant translation adjustments are reported, net of their related tax effects, as a component of accumulated other comprehensive loss in equity. Assets and liabilities denominated in other than the local currency are re-measured into the local currency prior to translation into USD and the resultant exchange gains or losses are included in income in the period in which they occur. Income and expenses are translated into USD at average exchange rates in effect during the period.

The company changes the functional currency of its separate and distinct foreign entities only when significant changes in economic facts and circumstances indicate clearly that the functional currency has changed.

Inventories

Inventories

The company's inventories are valued at the lower of cost or net realizable value. Elements of cost in inventories include raw materials, direct labor and manufacturing overhead. Stores and supplies are valued at cost or net realizable value, whichever is lower; cost is generally determined by the average cost method.

As of December 31, 2017 approximately 60 percent, 30 percent, and 10 percent of the company's inventories were accounted for under the first-in, first-out ("FIFO"), average cost and the last-in, first-out ("LIFO") methods, respectively. As of December 31, 2016 approximately 55 percent, 30 percent, and 15 percent of the company's inventories were accounted for under the FIFO, average cost and LIFO methods, respectively. Inventories accounted for under the FIFO method are primarily comprised of products with shorter shelf lives such as seeds, certain food-ingredients and enzymes.

The company establishes allowances for obsolescence of inventory based upon quality considerations and assumptions about future demand and market conditions.

Property, Plant and Equipment

Property, Plant and Equipment

Property, plant and equipment are carried at cost less accumulated depreciation. In connection with the Merger, the preliminary estimated fair value of property, plant and equipment is determined using a market approach and a replacement cost approach. Refer to Note 3 for further information. Depreciation is based on the estimated service lives of depreciable assets and is calculated using the straight-line method. Fully depreciated assets are retained in property and accumulated depreciation accounts until they are removed from service. When assets are surrendered, retired, sold, or otherwise disposed of, their gross carrying values and related accumulated depreciation are removed from the Consolidated Balance Sheets and included in determining gain or loss on such disposals.

Goodwill and Other Intangible Assets

Goodwill and Other Intangible Assets

The company records goodwill when the purchase price of a business acquisition exceeds the estimated fair value of net identified tangible and intangible assets acquired. Goodwill is tested for impairment at the reporting unit level annually, or more frequently when events or changes in circumstances indicate that the fair value of a reporting unit has more likely than not declined below its carrying value. In connection with the Merger Transaction, the company adopted the policy of DowDuPont and performed an annual goodwill impairment test in the fourth quarter of 2017. In the Predecessor periods, the annual impairment test was performed in the third quarter.

When testing goodwill for impairment, the company has the option to first perform qualitative testing to determine whether it is more likely than not that the fair value of a reporting unit is less than its carrying value.  If the company chooses not to complete a qualitative assessment for a given reporting unit or if the initial assessment indicates that it is more likely than not that the carrying value of a reporting unit exceeds its estimated fair value, additional quantitative testing is required.  The company's fair value methodology is primarily based on discounted cash flow techniques.  See Note 12 for further information on goodwill.

Indefinite-lived intangible assets are tested for impairment at least annually; however, these tests are performed more frequently when events or changes in circumstances indicate that the asset may be impaired. Impairment exists when carrying value exceeds fair value. The company's fair value methodology is primarily based on discounted cash flow techniques.

Definite-lived intangible assets are amortized over their estimated useful lives, generally on a straight-line basis for periods ranging primarily from 1 to 23 years. The company continually evaluates the reasonableness of the useful lives of these assets. Once these assets are fully amortized, they are removed from the Consolidated Balance Sheets.

Impairment of Long-Lived Assets

Impairment of Long-Lived Assets

The company evaluates the carrying value of long-lived assets to be held and used when events or changes in circumstances indicate the carrying value may not be recoverable. The carrying value of a long-lived asset group is considered impaired when the total projected undiscounted cash flows from the assets are separately identifiable and are less than its carrying value. In that event, a loss is recognized based on the amount by which the carrying value exceeds the fair value of the long-lived asset. The company's fair value methodology is an estimate of fair market value which is made based on prices of similar assets or other valuation methodologies including present value techniques. Long-lived assets to be disposed of by sale, if material, are classified as held for sale and reported at the lower of carrying amount or fair value less cost to sell, and depreciation is ceased. Long-lived assets to be disposed of other than by sale are classified as held and used until they are disposed of and reported at the lower of carrying amount or fair value. Depreciation is recognized over the remaining useful life of the assets.

Derivative Instruments

Derivative Instruments

Derivative instruments are reported in the Consolidated Balance Sheets at their fair values. The company utilizes derivatives to manage exposures to foreign currency exchange rates and commodity prices. Changes in the fair values of derivative instruments that are not designated as hedges are recorded in current period earnings. For derivative instruments designated as cash flow hedges, the effective portion of any hedge is reported in accumulated other comprehensive loss until it is cleared to earnings during the same period in which the hedged item affects earnings. The ineffective portion of all hedges is recognized in current period earnings.

In the event that a derivative designated as a hedge of a firm commitment or an anticipated transaction is terminated prior to the maturation of the hedged transaction, gains or losses realized at termination are deferred and included in the measurement of the hedged transaction. If a hedged transaction matures, or is sold, extinguished, or terminated prior to the maturity of a derivative designated as a hedge of such transaction, gains or losses associated with the derivative through the date the transaction matured are included in the measurement of the hedged transaction and the derivative is reclassified as for trading purposes. Derivatives designated as hedges of anticipated transactions are reclassified as for trading purposes if the anticipated transaction is no longer probable.

In the Predecessor period, the company reflected non-qualified hedge programs, specifically forward contracts, options and cash collateral activity, within cash flows from investing activities. In the Predecessor period, the company reflected cash flows from qualified programs within the line item it related to (i.e., revenue hedge cash flows presented within changes from accounts receivable). In the Successor period, the company included foreign currency exchange contract settlements within cash flows from operating activities, regardless of hedge accounting qualification. See Note 18 for additional discussion regarding the company's objectives and strategies for derivative instruments.

Environmental Matters

Environmental Matters

Accruals for environmental matters are recorded when it is probable that a liability has been incurred and the amount of the liability can be reasonably estimated. These accruals are adjusted periodically as assessment and remediation efforts progress or as additional technical or legal information becomes available. Accruals for environmental liabilities are included in the Consolidated Balance Sheets in accrued and other current liabilities and other noncurrent obligations at undiscounted amounts. Accruals for related insurance or other third-party recoveries for environmental liabilities are recorded when it is probable that a recovery will be realized and are included in the consolidated balance sheets as accounts and notes receivable - net.

Environmental costs are capitalized if the costs extend the life of the property, increase its capacity, and/or mitigate or prevent contamination from future operations. Environmental costs are also capitalized in recognition of legal asset retirement obligations resulting from the acquisition, construction and/or normal operation of a long-lived asset. Costs related to environmental contamination treatment and cleanup are charged to expense. Estimated future incremental operations, maintenance and management costs directly related to remediation are accrued when such costs are probable and reasonably estimable.

Revenue Recognition

Revenue Recognition

The company recognizes revenue when it is realized or realizable, and the earnings process is complete. The company's revenues are from the sale of a wide range of products to a diversified base of customers around the world. Revenue for product sales is recognized when title and risk of loss have been transferred, collectability is reasonably assured and pricing is fixed or determinable. A majority of product sales are sold FOB (free on board) shipping point or, with respect to non-United States of America (U.S.) customers, an equivalent basis. Accruals are made for sales returns and other allowances based on the company's experience. The company accounts for cash sales incentives as a reduction in sales and noncash sales incentives as a charge to cost of goods sold or selling expense, depending on the nature of the incentive. Amounts billed to customers for shipping and handling fees are included in net sales and costs incurred by the company for the delivery of goods are classified as cost of goods sold in the Consolidated Statements of Operations. Taxes on revenue-producing transactions are excluded from net sales.

The company periodically enters into prepayment contracts with the agriculture product line's customers and receives advance payments for product to be delivered in future periods. These advance payments are recorded as deferred revenue (classified as accrued and other current liabilities) or debt, depending on the nature of the program. Revenue associated with advance payments is recognized as shipments are made and title, ownership and risk of loss pass to the customer.

Licensing and royalty income is recognized in accordance with agreed upon terms, when performance obligations are satisfied, the amount is fixed or determinable and collectability is reasonably assured.

Royalty Expense

Royalty Expense

The company’s agriculture product line currently has certain third party biotechnology trait license agreements, which require up-front and variable payments subject to the licensor meeting certain conditions. These payments are reflected as other current assets and other assets and are amortized to cost of goods sold as seeds containing the respective trait technology are utilized over the life of the license. The company evaluates the carrying value of the prepaid royalties when events or changes in circumstances indicate the carrying value may not be recoverable.

Cost of Goods Sold

Cost of Goods Sold

Successor periods - Cost of goods sold primarily includes the cost of manufacture and delivery, ingredients or raw materials, direct salaries, wages and benefits and overhead, non-capitalizable costs associated with capital projects and other operational expenses.  No amortization of intangibles is included within costs of goods sold.

Predecessor periods - Cost of goods sold primarily includes the cost of manufacture and delivery, ingredients or raw materials, direct salaries, wages and benefits and overhead.

Other Operating Charges

Other Operating Charges

Predecessor periods - Other operating charges includes product claim charges and recoveries, non-capitalizable costs associated with capital projects and other operational expenses. 

Research and Development

Research and Development

Research and development costs are expensed as incurred. Research and development expense includes costs (primarily consisting of employee costs, materials, contract services, research agreements, and other external spend) relating to the discovery and development of new products, enhancement of existing products and regulatory approval of new and existing products.

Selling, General and Administrative Expenses

Selling, General and Administrative Expenses

Successor periods - Selling, general and administrative expenses primarily include selling and marketing expenses, commissions, functional costs, and business management expenses.

Predecessor periods - Selling, general and administrative expenses primarily include selling and marketing expenses, commissions, functional costs, business management expenses and integration and separation costs.

Integration and Separation Costs

Integration and Separation Costs

Successor periods - Integration and separation costs includes costs incurred to prepare for and close the Merger, post-Merger integration expenses and costs incurred to prepare for the Intended Business Separations. These costs primarily consist of financial advisory, information technology, legal, accounting, consulting and other professional advisory fees associated with preparation and execution of these activities.

Litigation

Litigation

Accruals for legal matters are recorded when it is probable that a liability has been incurred and the amount of the liability can be reasonably estimated. Legal costs, such as outside counsel fees and expenses, are charged to expense in the period incurred.

Severance Costs

Severance Costs

Severance benefits are provided to employees under the company's ongoing benefit arrangements. Severance costs are accrued when management commits to a plan of termination and it becomes probable that employees will be entitled to benefits at amounts that can be reasonably estimated.

Insurance and Self Insurance

Insurance/Self-Insurance

The company self-insures certain risks where permitted by law or regulation, including workers' compensation, vehicle liability and employee related benefits. Liabilities associated with these risks are estimated in part by considering historical claims experience, demographic factors and other actuarial assumptions. For other risks, the company uses a combination of insurance and self-insurance, reflecting comprehensive reviews of relevant risks. A receivable for an insurance recovery is generally recognized when the loss has occurred and collection is considered probable.

Income Taxes

Income Taxes

The company accounts for income taxes using the asset and liability method. Under this method, deferred tax assets and liabilities are recognized for the future tax consequences of temporary differences between the carrying amounts and tax bases of assets and liabilities using enacted tax rates. The effect of a change in tax rates on deferred tax assets or liabilities is recognized in income in the period that includes the enactment date (see Note 7 for further information relating to the enactment of the Tax Cuts and Job Act).

The company recognizes the financial statement effects of an uncertain income tax position when it is more likely than not, based on the technical merits, that the position will be sustained upon examination. The company accrues for other tax contingencies when it is probable that a liability to a taxing authority has been incurred and the amount of the contingency can be reasonably estimated. The current portion of uncertain income tax positions is included in income taxes payable and the long-term portion is included in other noncurrent obligations in the Consolidated Balance Sheets.

Provision is made for taxes on undistributed earnings of foreign subsidiaries and related companies to the extent that such earnings are not deemed to be permanently invested. Income tax related penalties are included in the provision for income taxes in the Consolidated Statements of Operations. Interest accrued related to unrecognized tax benefits is included within the (benefit from) provision for income taxes from continuing operations in the Consolidated Statements of Operations in the Successor period. In the Predecessor period, interest accrued related to unrecognized tax benefits is included within sundry income - net in the Consolidated Statements of Operations.

Segment Reporting

Segments

Effective with the Merger, DuPont’s business activities are components of its parent company’s business operations. DuPont’s business activities, including the assessment of performance and allocation of resources, are reviewed and managed by DowDuPont. Information used by the chief operating decision maker of DuPont relates to the company in its entirety. Accordingly, there are no separate reportable business segments for DuPont under Accounting Standards Codification ("ASC") Topic 280 “Segment Reporting” and DuPont's business results are reported in this Form 10-K as a single operating segment. Prior year's segment information has been made to conform to the current presentation.

XML

Recent Accounting Guidance Recent Accounting Guidance (Policies)

12 Months Ended

Dec. 31, 2017

Accounting Policies [Abstract]

Recent Accounting Guidance

RECENT ACCOUNTING GUIDANCE

Recently Adopted Accounting Guidance

In March 2016, the FASB issued ASU No. 2016-09, Compensation - Stock Compensation (Topic 718), Improvements to Employee Share-Based Payment Accounting, which modifies the accounting for certain aspects of share-based payments to employees. The new guidance requires excess tax benefits and tax deficiencies to be recorded in the income statement when stock awards vest or are settled. In addition, cash flows related to excess tax benefits will no longer be separately classified as a financing activity apart from other income tax cash flows. The standard also allows the company to repurchase more of an employee’s vested shares for tax withholding purposes without triggering liability accounting, and clarifies that all cash payments made to tax authorities on an employee’s behalf for withheld shares should be presented as a financing activity on the statement of cash flows. The company adopted this standard as of January 1, 2017.

The primary impact of adoption was the recognition of excess tax benefits in the company's provision for income taxes rather than additional paid-in capital, which is applied prospectively in accordance with the guidance. Adoption of the new standard resulted in the recognition of $2 million and $30 million of excess tax benefits in the company's provision for income taxes rather than additional paid-in capital for the period September 1 through December 31, 2017 and the period January 1 through August 31, 2017, respectively.

The company elected to apply the presentation requirements for cash flows related to excess tax benefits retrospectively to all periods presented, which resulted in an increase to both net cash provided by operating activities and net cash used for financing activities of $27 million and $74 million for the years ended December 31, 2016 and 2015, respectively. The presentation requirements for cash flows related to employee taxes paid for withheld shares resulted in an increase to both net cash provided by operating activities and net cash used for financing activities of $30 million and $32 million for the years ended December 31, 2016 and 2015, respectively.

The remaining updates required by this standard did not have a material impact to the company’s Consolidated Financial Statements.

In January 2017, the FASB issued ASU No. 2017-04, Intangibles - Goodwill and Other (Topic 350), Simplifying the Test for Goodwill Impairment. The new guidance eliminates the requirement to determine the fair value of individual assets and liabilities of a reporting unit to measure goodwill impairment. Under the amendments in the new ASU, goodwill impairment testing will be performed by comparing the fair value of the reporting unit with its carrying amount and recognizing an impairment charge for the amount by which the carrying amount exceeds the reporting unit’s fair value. The new standard is effective for annual and interim goodwill impairment tests in fiscal years beginning after December 15, 2019, and should be applied on a prospective basis. Early adoption is permitted for annual or interim goodwill impairment testing performed after January 1, 2017. In connection with the Merger Transaction, the company adopted the policy of the parent company and performed its annual goodwill impairment test in the fourth quarter. Previously, the annual impairment test was performed in the third quarter. The company early adopted the new guidance for the annual goodwill impairment test that was performed in the fourth quarter of 2017. See Note 12 for additional information.

Accounting Guidance Issued But Not Adopted as of December 31, 2017

In August 2017, the FASB issued ASU No. 2017-12, Derivatives and Hedging (Topic 815), Targeted Improvements to Accounting for Hedging Activities. The new guidance expands and refines hedge accounting for both nonfinancial and financial risk components and aligns the recognition and presentation of the effects of the hedging instrument and the hedged items in the financial statements. For cash flow and net investment hedges existing as of the date of adoption, an entity should apply a cumulative-effect adjustment related to eliminating the separate measurement of ineffectiveness to accumulated other comprehensive income with a corresponding adjustment to the opening balance of retained earnings as of the beginning of the fiscal year in which an entity adopts. Presentation and disclosure guidance is required to be adopted prospectively. The new standard is effective for fiscal years beginning after December 15, 2018 and interim periods within those fiscal years. Early adoption is permitted in any interim period. All transition requirements and elections should be applied to hedging relationships existing (that is, hedging relationships in which the hedging instrument has not expired, been sold, terminated, or exercised or the entity has not removed the designation of the hedging relationship) on the date of adoption. The effect of adoption should be reflected as of the beginning of the fiscal year of adoption. The company is currently evaluating the impact this guidance will have on the Consolidated Financial Statements and related disclosures.

In March 2017, the FASB issued ASU No. 2017-07, Compensation - Retirement Benefits (Topic 715), Improving the Presentation of Net Periodic Pension Cost and Net Periodic Postretirement Benefit Cost. The new guidance requires registrants to present the service cost component of net periodic benefit cost in the same income statement line item or items as other employee compensation costs arising from services rendered during the period. In addition, only the service cost component will be eligible for capitalization in assets. Registrants will present the other components of net periodic benefit cost separately from the service cost component; and, the line item or items used in the income statement to present the other components of net periodic benefit cost must be disclosed. The guidance is effective for annual reporting periods beginning after December 15, 2017, including interim periods within those fiscal years. Early adoption is permitted as of the beginning of an annual period. The new standard must be adopted retrospectively for the presentation of the service cost component and the other components of net periodic benefit cost in the income statement, and prospectively for the capitalization of the service cost component of net periodic benefit cost in assets. The company plans to adopt this guidance in the first quarter of 2018 and is currently evaluating the impact on the Consolidated Financial Statements and related disclosures. The company anticipates approximately half the costs will be reclassified from cost of goods sold, with the remainder reclassified from selling, general and administrative expenses and research and development expense, to sundry income - net in the Consolidated Statements of Operations. See Note 16 for the components of net periodic benefit cost.

In January 2017, the FASB issued ASU No. 2017-01, Business Combinations (Topic 805), Clarifying the Definition of a Business. The new guidance narrows the existing definition of a business and provides a framework for evaluating whether a transaction should be accounted for as an acquisition (or disposal) of assets or a business. The guidance requires an entity to evaluate if substantially all of the fair value of the gross assets acquired is concentrated in a single identifiable asset or a group of similar identifiable assets; if so, the set of transferred assets and activities (collectively, the "set") is not a business. To be considered a business, the set would need to include an input and a substantive process that together significantly contribute to the ability to create outputs, as defined by the ASU. The guidance is effective for annual reporting periods beginning after December 15, 2017, including interim periods within those annual reporting periods, and should be applied prospectively. Early adoption is permitted. The company adopted this standard on January 1, 2018 and will apply it prospectively to all applicable transactions after the adoption date.

In November 2016, the FASB issued ASU 2016-18, Statement of Cash Flows (Topic 230): Restricted Cash (a consensus of the FASB Emerging Issues Task Force), which clarifies how entities should present restricted cash and restricted cash equivalents in the statement of cash flows, and, as a result, entities will no longer present transfers between cash and cash equivalents and restricted cash and restricted cash equivalents in the statement of cash flows. An entity with a material balance of restricted cash and restricted cash equivalents must disclose information about the nature of the restrictions. The new standard is effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2017. Early adoption is permitted and the new guidance must be applied retrospectively to all periods presented. The new guidance will change the presentation of restricted cash in the Consolidated Statements of Cash Flows and will be applied retrospectively in the first quarter of 2018.

In October 2016, the FASB issued ASU No. 2016-16, Income Taxes (Topic 740), Intra-Entity Transfers of Assets Other Than Inventory. The new guidance requires that entities recognize the income tax consequences of an intra-entity transfer of an asset other than inventory when the transfer occurs, rather than when the asset is sold to an outside party. The guidance is effective for annual reporting periods beginning after December 15, 2017, including interim periods within those annual reporting periods. Early adoption is permitted as of the beginning of an annual reporting period. The new guidance requires adoption on a modified retrospective basis through a cumulative-effect adjustment directly to retained earnings as of the beginning of the period of adoption. The company plans to adopt this guidance in the first quarter of 2018 with the expectation that this guidance will have an immaterial impact on the Consolidated Financial Statements and related disclosures.

In August 2016, the FASB issued ASU No. 2016-15, Statement of Cash Flows (Topic 230), Classification of Certain Cash Receipts and Cash Payments. The new guidance makes eight targeted changes to how cash receipts and cash payments are presented and classified in the statement of cash flows. The guidance is effective for fiscal years beginning after December 15, 2017, and interim periods within those fiscal years. The new guidance requires adoption on a retrospective basis unless it is impracticable to apply, in which case the company would be required to apply the amendments prospectively as of the earliest date practicable. The company is currently evaluating the impact this guidance will have on the Consolidated Financial Statements and related disclosures, but does not expect there to be a significant impact.

In February 2016, the FASB issued ASU No. 2016-02, Leases (Topic 842). The amendments under the new guidance will require lessees to recognize almost all leases on their balance sheet as a right-of-use asset and a lease liability, other than leases that meet the definition of a short-term lease. For income statement purposes, the FASB retained a dual model, requiring leases to be classified as either operating or finance. Classification will be based on criteria that are largely similar to those applied in current lease accounting. Lessor accounting is similar to the current model, but updated to align with certain changes to the lessee model and the new revenue recognition standard. The new leasing standard will be effective for fiscal years beginning after December 15, 2018, and interim periods within those fiscal years. Early adoption is permitted. The new standard must be adopted using a modified retrospective transition, requiring application at the beginning of the earliest comparative period presented. The company is currently evaluating the impact of adopting this guidance on the Consolidated Financial Statements and related disclosures. The company is the lessee under various agreements for facilities and equipment that are currently accounted for as operating leases. A discussion of these leases is included in Note 14, "Commitments and Contingent Liabilities."

In May 2014, the FASB issued ASU No. 2014-09, Revenue from Contracts with Customers (Topic 606), which was further updated in March, April, May and December 2016, as well as September and November 2017.  The new guidance clarifies the principles for recognizing revenue and develops a common revenue standard for GAAP.  The core principle of the guidance is that an entity should recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods and services.  The new standard also will result in additional disclosure requirements to describe the nature, amount, timing and uncertainty of revenue and cash flows arising from contracts with customers.  In July 2015, the FASB approved a deferral of the ASU effective date from annual and interim periods beginning after December 15, 2016 to annual and interim periods beginning after December 15, 2017. The standard permits the use of either the retrospective or modified retrospective (cumulative-effect) transition method of adoption.  The company will adopt the standard in the first quarter of 2018 under the modified retrospective transition method.  The company has substantially completed its evaluation of the impact of the new standard on the Consolidated Financial Statements and has determined that the transition adjustment to be recorded upon adoption is not material and the company does not expect material changes in the timing of revenue recognition.  The company continues to evaluate the impact of the new standard on its disclosures.

XML

Business Combinations (Tables)

12 Months Ended

Dec. 31, 2017

Merger with Dow [Member]

Business Acquisition [Line Items]

Schedule of Business Acquisitions, by Acquisition

(In millions, except exchange ratio)
DuPont Common Stock outstanding as of the Merger Effectiveness Time	868.3
DuPont exchange ratio	1.2820
DowDuPont Common Stock issued in exchange for DuPont Common Stock	1,113.2
Fair value of DowDuPont Common Stock issued 1	$	74,195
Fair value of DowDuPont equity awards issued in exchange for outstanding DuPont equity awards 2	485
Total consideration	$	74,680

1. Amount was determined based on the price per share of Dow Common Stock of $66.65 on August 31, 2017.

2. Represents the fair value of replacement awards issued for DuPont's equity awards outstanding immediately before the Merger and attributable to the service periods prior to the Merger. The previous DuPont equity awards were converted into the right to receive 1.2820 shares of DowDuPont Common Stock.

	Successor		Predecessor
(In millions)	For the Period September 1 through December 31, 2017		For the Period January 1 through August 31, 2017		For the Year Ended December 31, 2016		For the Year Ended December 31, 2015
Integration and separation costs	$	314
Selling, general and administrative expenses			$	581	$	386	$	10

Schedule of Recognized Identified Assets Acquired and Liabilities Assumed [Table Text Block]

	Estimated fair value as previously reported 1		Measurement period adjustments2			Estimated fair value adjusted
(In millions)
Fair Value of Assets as of the Merger Effectiveness Time
Cash and cash equivalents	$	4,005	$	—		$	4,005
Marketable securities	2,849		—			2,849
Accounts and notes receivable	7,851		—			7,851
Inventories	8,886		(79		)	8,807
Other current assets	360		—			360
Investment in nonconsolidated affiliates	1,685		(31		)	1,654
Assets held for sale - current	3,184		564			3,748
Property, plant and equipment	12,122		(181		)	11,941
Goodwill 3	45,501		(396		)	45,105
Other intangible assets 3	27,844		(623		)	27,221
Deferred income tax assets	487		(203		)	284
Other assets	2,076		—			2,076
Total Assets	$	116,850	$	(949	)	$	115,901
Fair Value of Liabilities
Short-term borrowings and capital lease obligations	$	5,319	$	—		$	5,319
Accounts payable	3,283		—			3,283
Income taxes payable	140		—			140
Accrued and other current liabilities	3,517		—			3,517
Liabilities held for sale - current	104		11			115
Long-term debt	9,878		—			9,878
Deferred income tax liabilities	9,408		(940		)	8,468
Pension and other post employment benefits - noncurrent	8,092		(36		)	8,056
Other noncurrent obligations	2,028		—			2,028
Total Liabilities	$	41,769	$	(965	)	$	40,804
Noncontrolling interests	162		16			178
Preferred stock	239		—			239
Fair Value of Net Assets (Consideration for the Merger)	$	74,680	$	—		$	74,680

1. As previously reported in the company’s Quarterly Report on Form 10-Q for the period ended September 30, 2017.

2. DuPont recorded measurement period adjustments in the fourth quarter of 2017 to reflect facts and circumstances in existence as of the Merger Effectiveness Time. These measurement period adjustments primarily related to changes in preliminary valuation assumptions, including market participant estimates of cash flows and estimates of asset useful lives, as well as other initial estimates. All measurement period adjustments were offset against goodwill.

3. See Note 12 for additional information.

H&N Acquisition [Member]

Business Acquisition [Line Items]

Schedule of Business Acquisitions, by Acquisition

(In millions)
Fair Value of Divested Ag Business 1	$	3,665
Less: Cash received 2	1,200
Less: Favorable contracts 3	495
Fair Value of H&N Business	$	1,970

1. Refer to Note 4 for additional information.

2. The FMC Transactions include a cash consideration payment to DuPont of approximately $1,200 million, which reflects the difference in value between the Divested Ag Business and the H&N Business, subject to certain customary inventory and net working capital adjustments.

3. Upon closing and pursuant to the terms of the FMC Transaction Agreement, DuPont entered into favorable supply contracts with FMC. DuPont recorded these contracts as intangible assets recognized at the fair value of off-market contracts. Refer to Notes 4 and 12 for additional information.

Schedule of Recognized Identified Assets Acquired and Liabilities Assumed [Table Text Block]

	Successor
(In millions)	November 1, 2017
Fair Value of Assets
Cash and cash equivalents	$	16
Accounts and notes receivable	144
Inventories	314
Property, plant and equipment	505
Goodwill	718
Other intangible assets	435
Other current and non-current assets	16
Total Assets	$	2,148
Fair Value of Liabilities
Accounts payable and other accrued liabilities	$	70
Deferred income tax liabilities	108
Total Liabilities	$	178
Fair Value of Net Assets (Consideration for the H&N Business)	$	1,970

Schedule of Results of Operations

	Successor
(In millions)	For the Period November 1 through December 31, 2017
Net sales	$	102
Loss from continuing operations before income taxes	$	(12	)

XML

Divestitures and Other Transactions (Tables)

12 Months Ended

Dec. 31, 2017

Income Statement [Member] | Divested Ag Business [Member]

Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]

Disposal Groups, Including Discontinued Operations [Table Text Block]

	Successor			Predecessor
(In millions)	For the Period September 1 through December 31, 20171			For the Period January 1 through August 31, 2017		For the Year Ended December 31, 2016			For the Year Ended December 31, 2015
Net sales	$	199		$	1,068	$	1,385		$	1,473
Cost of goods sold	194			412		514			521
Other operating charges				17		19			25
Research and development expenses	30			95		139			163
Selling, general and administrative expenses2	102			146		176			187
Restructuring and asset related charges - net	(1		)	—		(4		)	15
Sundry (expense) income - net	(1		)	7		1			7
(Loss) Income from discontinued operations before income taxes	(127		)	405		542			569
(Benefit from) Provision for income taxes	(50		)	79		103			121
(Loss) Income from discontinued operations after income taxes	$	(77	)	$	326	$	439		$	448

^1.  Includes results of operations for the period September 1 through October 31, 2017, as the Divested Ag Business was disposed of on November 1, 2017.

^2.  Successor period includes $44 million of transaction costs associated with the disposal of the Divested Ag Business.

Income Statement [Member] | Performance Chemicals [Member]

Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]

Disposal Groups, Including Discontinued Operations [Table Text Block]

	Predecessor
(In millions)	For the Period January 1 through August 31, 2017			For the Year Ended December 31, 2016			For the Year Ended December 31, 2015
Net sales	$	—		$	—		$	2,810
Cost of goods sold	—			—			2,215
Other operating charges	335			36			386
Research and development expense	—			—			40
Selling, general and administrative expenses	—			—			(87		)
Restructuring and asset related charges - net	—			—			59
Sundry income - net	3			3			27
Interest expense	—			—			32
(Loss) income from discontinued operations before income taxes	(332		)	(33		)	192
(Benefit from) provision for income taxes	(125		)	(28		)	106
(Loss) income from discontinued operations after income taxes	$	(207	)	$	(5	)	$	86

Cash Flow [Member] | Divested Ag Business [Member]

Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]

Disposal Groups, Including Discontinued Operations [Table Text Block]

	Successor		Predecessor
(In millions)	For the Period September 1 through December 31, 2017		For the Period January 1 through August 31, 2017		For the Year Ended December 31, 2016		For the Year Ended December 31, 2015
Depreciation	$	—	$	21	$	32	$	30
Capital expenditures	$	5	$	8	$	40	$	77

Cash Flow [Member] | Performance Chemicals [Member]

Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]

Disposal Groups, Including Discontinued Operations [Table Text Block]

(In millions)	Predecessor
For the year ended December 31,	2015
Depreciation	$	126
Amortization of intangible assets	2
Capital Expenditures	235

Balance Sheet [Member] | Divested Ag Business [Member]

Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]

Disposal Groups, Including Discontinued Operations [Table Text Block]

	Predecessor
(In millions)	December 31, 2016
Cash and cash equivalents	$	57
Accounts and notes receivable - net	12
Inventories	323
Other current assets	1
Property, plant and equipment - net	380
Goodwill	11
Other assets	5
Assets held for sale	$	789
Accounts payable	27
Accrued and other current liabilities	12
Deferred income tax liabilities	6
Other noncurrent obligations	29
Liabilities held for sale	$	74

XML

Restructuring and Asset Related Charges (Tables)

12 Months Ended

Dec. 31, 2017

DowDuPont Cost Synergy Program [Member]

Restructuring Cost and Reserve [Line Items]

Schedule of Restructuring Reserve by Type of Cost [Table Text Block]

(In millions)	Severance and Related Benefit Costs			Other Non-Personnel Charges1			Asset-Related Charges			Total
Charges to income from continuing operations for the period September 1 through December 31, 2017 (Successor)	$	153		$	31		$	3		$	187
Payments	(13		)	(3		)	—			(16		)
Asset write-offs	—			—			(3		)	(3		)
Non-cash compensation	(7		)	—			—			(7		)
Balance as of December 31, 2017	$	133		$	28		$	—		$	161

1. Other non-personnel charges consist of contractual obligation costs.

2017 Restructuring Program [Member]

Restructuring Cost and Reserve [Line Items]

Schedule of Restructuring Reserve by Type of Cost [Table Text Block]

(In millions)	Severance and Related Benefit Costs			Asset Related Charges1			Total
Charges to income from continuing operations for the period January 1 through August 31, 2017 (Predecessor)	$	34		$	279		$	313
Payments	(8		)	—			(8		)
Asset write-offs	—			(279		)	$	(279	)
Balance as of August 31, 2017	$	26		$	—		$	26
Charges to income from continuing operations for the period September 1 through December 31, 2017 (Successor)	$	—		$	—		$	—
Payments	(7		)	—			(7		)
Balance as of December 31, 2017	$	19		$	—		$	19

^1.  Includesaccelerated depreciation related to site closure. Charge for accelerated depreciation represents the difference between the depreciation expense to be recognized over the revised useful life of the site, based upon the anticipated date the site will be closed and depreciation expense as determined utilizing the useful life prior to the restructuring action.

2016 Global Cost Savings and Restructuring Plan [Member]

Restructuring Cost and Reserve [Line Items]

Schedule of Restructuring Reserve by Type of Cost [Table Text Block]

(In millions)	Severance and Related Benefit Costs			Other Non-Personnel Charges1			Total
Balance at December 31, 2016 (Predecessor)	$	100		$	22		$	122
Payments	(76		)	(11		)	(87		)
Net translation adjustment	2			—			2
Other adjustments	10			—			10
Balance as of August 31, 2017	$	36		$	11		$	47
Balance at September 1, 2017 (Successor)	$	36		$	11		$	47
Payments	(18		)	(2		)	(20		)
Other adjustments	(5		)	—			(5		)
Balance as of December 31, 2017	$	13		$	9		$	22

1. Other non-personnel charges consist of contractual obligation costs.

XML

Supplementary Information (Tables)

12 Months Ended

Dec. 31, 2017

Organization, Consolidation and Presentation of Financial Statements [Abstract]

Schedule of Other Nonoperating Income (Expense)

Sundry Income - Net	Successor		Predecessor
(In millions)	For the Period September 1 through December 31, 2017		For the Period January 1 through August 31, 2017			For the Year Ended December 31, 2016			For the Year Ended December 31, 2015
Royalty income1			$	84		$	170		$	138
Interest income	$	41	83			102			124
Equity in earnings of affiliates - net	1		55			99			49
Net gain on sales of businesses and other assets2,3	16		205			435			92
Net exchange gains (losses)	8		(394		)	(106		)	30
Miscellaneous income and expenses - net4	24		133			7			257
Sundry income - net	$	90	$	166		$	707		$	690

^1.  In the Successor period, royalty income of $60 million is included in Net Sales.

^2.   Includes a pre-tax gain of $162 million ($86 million net of tax) for the period January 1 through August 31, 2017 related to the sale of global food safety diagnostics. See Note 4 for additional information.

^3.   Includes a pre-tax gain of $369 million ($214 million net of tax) for the year ended December 31, 2016 related to the sale of DuPont (Shenzhen) Manufacturing Limited. See Note 4 for additional information.

^4.   Miscellaneous income and expenses - net, includes interest items (in the Predecessor period only), gains (losses) on available for sale securities, gains related to litigation settlements, licensing income, gains on purchases, and other items.

Foreign Currency Exchange Gain (Loss)

	Successor			Predecessor
(In millions)	For the Period September 1 through December 31, 2017			For the Period January 1 through August 31, 2017			For the Year Ended December 31, 2016			For the Year Ended December 31, 2015
Subsidiary Monetary Position (Loss) Gain
Pre-tax exchange (loss) gain	$	(83	)	$	37		$	198		$	(404	)
Local tax (expenses) benefits	(3		)	217			(126		)	(61		)
Net after-tax impact from subsidiary exchange (loss) gain	$	(86	)	$	254		$	72		$	(465	)
Hedging Program Gain (Loss)
Pre-tax exchange gain (loss)	$	91		$	(431	)	$	(304	)	$	434
Tax (expenses) benefits	(33		)	155			110			(157		)
Net after-tax impact from hedging program exchange gain (loss)	$	58		$	(276	)	$	(194	)	$	277
Total Exchange Gain (Loss)
Pre-tax exchange gain (loss)	$	8		$	(394	)	$	(106	)	$	30
Tax (expenses) benefits	(36		)	372			(16		)	(218		)
Net after-tax exchange (loss) gain	$	(28	)	$	(22	)	$	(122	)	$	(188	)

XML

Income Taxes (Tables)

12 Months Ended

Dec. 31, 2017

Income Tax Disclosure [Abstract]

Geographic Allocation of Income and Provision for Income Taxes

Geographic Allocation of Income and Provision for Income Taxes	Successor			Predecessor
(In millions)	For the Period September 1 through December 31, 2017			For the Period January 1 through August 31, 2017			Year Ended 2016			Year Ended 2015
(Loss) Income from continuing operations before income taxes
Domestic	$	(811	)	$	409		$	1,415		$	1,301
Foreign	(775		)	1,382			1,308			721
(Loss) Income from continuing operations before income taxes	$	(1,586	)	$	1,791		$	2,723		$	2,022
Current tax expense (benefit)
Federal	$	216		$	(563	)	$	4		$	155
State and local	22			(11		)	9			2
Foreign	187			282			539			420
Total current tax expense (benefit)	$	425		$	(292	)	$	552		$	577
Deferred tax (benefit) expense
Federal	$	(2,790	)	$	476		$	22		$	135
State and local	(48		)	(8		)	(29		)	4
Foreign	(260		)	(27		)	96			(141		)
Total deferred tax (benefit) expense	$	(3,098	)	$	441		$	89		$	(2	)
(Benefit from) Provision for income taxes on continuing operations	(2,673		)	149			641			575
Net Income from continuing operations	$	1,087		$	1,642		$	2,082		$	1,447

Reconciliation to US Statutory Rate

Reconciliation to U.S. Statutory Rate	Successor		Predecessor
	For the Period September 1 through December 31, 2017		For the Period January 1 through August 31, 2017		Year Ended 2016		Year Ended 2015
Statutory U.S. federal income tax rate	35.0	%	35.0	%	35.0	%	35.0	%
Equity earning effect	0.9		(0.5	)	(0.8	)	(0.7	)
Lower effective tax rates on international operations - net	(9.5	)	(11.4	)	(9.2	)	(9.7	)
Acquisitions, divestitures and ownership restructuring activities 1, 2	15.8		5.2		1.9		(0.2	)
U.S. research and development credit	0.4		(0.8	)	(0.7	)	(1.5	)
Exchange gains/losses 3	(1.8	)	(12.9	)	1.9		10.2
Impact of U.S. Tax Reform	126.1
Excess tax benefits from stock compensation4	0.1		(1.7	)
Tax settlements and expiration of statute of limitations5	—		(3.8	)	(1.1	)	(1.5	)
Other - net	1.5		(0.8	)	(3.5	)	(3.2	)
Effective tax rate	168.5	%	8.3	%	23.5	%	28.4	%

1. See Notes 3 and 4 for additional information.

2. Includes a net tax benefit of $261 million related to an internal legal entity restructuring associated with the Intended Business Separations.

3. Principally reflects the impact of foreign exchange gains and losses on net monetary assets for which no corresponding tax impact is realized. Further information about the company's foreign currency hedging program is included in Note 6 and Note 18 under the heading Foreign Currency Risk.

4. Reflects the impact of the adoption of Accounting Standards Update ("ASU") 2016-09, which resulted in the recognition of excess tax benefits related to equity compensation in the (benefit from) provision for income taxes on continuing operations. See Note 2 for additional information.

5. The period January 1 through August 31, 2017 includes a tax benefit of $53 million for accrued interest reversals (recorded in sundry income - net).

Deferred Tax Balances

Deferred Tax Balances at December 31	2017 (Successor)					2016 (Predecessor)
(In millions)	Assets			Liabilities		Assets			Liabilities
Property	$	—		$	1,160	$	—		$	742
Tax loss and credit carryforwards	1,690			—		1,808			—
Accrued employee benefits	1,988			68		4,529			410
Other accruals and reserves	333			39		617			222
Intangibles	284			6,286		210			1,345
Inventory	130			597		163			138
Long-term debt	109			—		—			—
Investments	23			453		126			230
Unrealized exchange gains/losses	—			71		—			346
Other – net	260			121		257			86
Subtotal	$	4,817		$	8,795	$	7,710		$	3,519
Valuation allowances	(1,378		)	—		(1,308		)	—
Total	$	3,439		$	8,795	$	6,402		$	3,519
Net Deferred Tax (Liability) Asset	$	(5,356	)			$	2,883

Operating Loss and Tax Credit Carryforwards [Table Text Block]

Operating Loss and Tax Credit Carryforwards	Deferred Tax Asset
(In millions)	2017 (Successor)		2016 (Predecessor)
Operating loss carryforwards
Expire within 5 years	$	42	$	41
Expire after 5 years or indefinite expiration	1,483		1,482
Total operating loss carryforwards	$	1,525	$	1,523
Tax credit carryforwards
Expire within 5 years	$	10	$	10
Expire after 5 years or indefinite expiration	155		275
Total tax credit carryforwards	$	165	$	285
Total Operating Loss and Tax Credit Carryforwards	$	1,690	$	1,808

Total Gross Unrecognized Tax Benefits

Total Gross Unrecognized Tax Benefits	Successor			Predecessor
	For the Period September 1 through December 31, 2017			For the Period January 1 through August 31, 2017			Year Ended 2016			Year Ended 2015
(In millions)
Total unrecognized tax benefits as of beginning of period	$	436		$	348		$	558		$	735
Decreases related to positions taken on items from prior years	(2		)	(19		)	(41		)	(98		)
Increases related to positions taken on items from prior years	9			3			32			13
Increases related to positions taken in the current year	19			19			32			32
Settlement of uncertain tax positions with tax authorities	1			(6		)	(205		)	(58		)
Decreases due to expiration of statutes of limitations	(5		)	(81		)	(30		)	(30		)
Exchange loss (gain)	1			1			2			(36		)
Total unrecognized tax benefits as of end of period	$	459		$	265		$	348		$	558
Total unrecognized tax benefits that, if recognized, would impact the effective tax rate	$	76		$	188		$	253		$	386
Total amount of interest and penalties (benefit) recognized in Provision for income taxes on continuing operations	$	1		$	(27	)	$	10		$	(14	)
Total accrual for interest and penalties associated with unrecognized tax benefits	$	25		$	22		$	71		$	88

Tax Year Subject to Examination

Tax Years Subject to Examination by Major Tax Jurisdiction at Dec 31,	Earliest Open Year
Jurisdiction
Brazil	2012
Canada	2011
China	2014
Denmark	2003
Germany	2006
India	2001
The Netherlands	2014
Switzerland	2012
United States:
Federal income tax	2012
State and local income tax	2004

XML

Earnings Per Share of Common Stock (Tables)

12 Months Ended

Dec. 31, 2017

Earnings Per Share [Abstract]

Earnings Per Share of Common Stock Reconciliation

	Predecessor
(In millions, except share amounts)	For the Period January 1 through August 31, 2017			For the Year Ended December 31, 2016			For the Year Ended December 31, 2015
Numerator:
Income from continuing operations after income taxes attributable to DuPont	$	1,624		$	2,072		$	1,443
Preferred dividends	(7		)	(10		)	(10		)
Income from continuing operations after income taxes available to DuPont common stockholders	$	1,617		$	2,062		$	1,433
Income from discontinued operations after income taxes available to DuPont common stockholders	117			441			510
Net income available to common stockholders	$	1,734		$	2,503		$	1,943
Denominator:
Weighted-average number of common shares outstanding - Basic	867,888,000			872,560,000			893,992,000
Dilutive effect of the company’s employee compensation plans1	4,532,000			4,476,000			5,535,000
Weighted-average number of common shares outstanding - Diluted1	872,420,000			877,036,000			899,527,000

^1.  Diluted earnings per share considers the impact of potentially dilutive securities except in periods in which there is a loss because the inclusion of the potential common shares would have an anti-dilutive effect.

Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]

	Predecessor
	For the Period January 1 through August 31, 2017	For the Year Ended December 31, 2016	For the Year Ended December 31, 2015
Average number of stock options	1,906	4,794,000	4,715,000

XML

Accounts and Notes Receivable, Net (Tables)

12 Months Ended

Dec. 31, 2017

Receivables [Abstract]

Schedule of Accounts and Notes Receivable

	Successor		Predecessor
(In millions)	December 31, 2017		December 31, 2016
Accounts receivable – trade1	$	3,777	$	3,601
Notes receivable – trade2	199		206
Other3	1,263		1,152
Total accounts and notes receivable - net	$	5,239	$	4,959

^1.  Accounts receivable – trade is net of allowances of $10 millionat December 31, 2017 and $287 million at December 31, 2016. Allowances are equal to the estimated uncollectible amounts. That estimate is based on historical collection experience, current economic and market conditions, and review of the current status of customers' accounts.

^2.  Notes receivable – trade primarily consists of receivables within the agriculture product line for deferred payment loan programs for the sale of seed products to customers. These loans have terms of one year or less and are primarily concentrated in North America. The company maintains a rigid pre-approval process for extending credit to customers in order to manage overall risk and exposure associated with credit losses. As of December 31, 2017 and 2016, there were no significant past due notes receivable, nor were there any significant impairments related to current loan agreements.

^3.  Other includes receivables in relation to fair value of derivative instruments, indemnification assets, value added tax, general sales tax and other taxes. No individual group represents more than ten percent of total receivables.

XML

Inventories (Tables)

12 Months Ended

Dec. 31, 2017

Inventory, Net [Abstract]

Schedule of Inventory, Current [Table Text Block]

	Successor		Predecessor
(In millions)	December 31, 2017		December 31, 2016
Finished products	$	4,500	$	2,961
Semi-finished products	2,769		1,877
Raw materials	371		292
Stores and supplies	447		398
Total	$	8,087	$	5,528
Adjustment of inventories to a LIFO basis	546		(178		)
Total inventories	$	8,633	$	5,350

XML

Property, Plant and Equipment (Tables)

12 Months Ended

Dec. 31, 2017

Property, Plant and Equipment [Abstract]

Property, Plant and Equipment [Table Text Block]

	Successor			Predecessor
(In millions)	December 31, 2017			December 31, 2016
Land and land improvements	$	913		$	501
Buildings	2,747			4,224
Machinery and equipment	8,104			16,909
Construction in progress	1,114			1,381
Total property, plant and equipment	12,878			23,015
Accumulated depreciation	(443		)	(14,164		)
Total property, plant and equipment - net	$	12,435		$	8,851

Property, Plant and Equipment - Depreciation Expense [Table Text Block]

	Successor		Predecessor
(In millions)	For the Period September 1 through December 31, 2017		For the Period January 1 through August 31, 2017		For the Year Ended December 31, 2016		For the Year Ended December 31, 2015
Depreciation expense	$	426	$	589	$	907	$	948

XML

Goodwill and Other Intangible Assets (Tables)

12 Months Ended

Dec. 31, 2017

Goodwill and Intangible Asset Disclosure [Abstract]

Schedule of Goodwill

(In millions)
Balance as of December 31, 2015 (Predecessor)	$	4,238
Currency Translation Adjustment	(68		)
Other Goodwill Adjustments and Acquisitions	(1		)
Balance as of December 31, 2016 (Predecessor)	4,169
Currency Translation Adjustment	176
Other Goodwill Adjustments and Acquisitions	198
Balance as of August 31, 2017 (Predecessor)	$	4,543
Balance at September 1, 2017 (Successor)	$	45,105
Currency Translation Adjustment	(234		)
Goodwill Recognized for H&N Acquisition	718
Balance as of December 31, 2017 (Successor)	$	45,589

Other Intangible Assets

	Successor							Predecessor
(In millions)	December 31, 2017							December 31, 2016
	Gross		Accumulated Amortization			Net		Gross		Accumulated Amortization			Net
Intangible assets subject to amortization (Definite-lived):
Customer-related	$	9,502	$	(186	)	$	9,316	$	1,574	$	(586	)	$	988
Developed technology	4,364		(144		)	4,220		1,410		(838		)	572
Trademarks/trade names	1,117		(26		)	1,091		53		(15		)	38
Favorable supply contracts1	495		(17		)	478
Microbial cell factories2	397		(6		)	391
Other3	459		(10		)	449		171		(82		)	89
Total other intangible assets with finite lives	16,334		(389		)	15,945		3,208		(1,521		)	1,687
Intangible assets not subject to amortization (Indefinite-lived):
In-process research and development ("IPR&D")	660		—			660		73		—			73
Microbial cell factories2								306		—			306
Germplasm4	6,265		—			6,265		1,053		—			1,053
Trademarks / trade names	4,856		—			4,856		545		—			545
Total other intangible assets	11,781		—			11,781		1,977		—			1,977
Total	$	28,115	$	(389	)	$	27,726	$	5,185	$	(1,521	)	$	3,664

^1.  Upon closing and pursuant to the terms of the FMC Transaction Agreement, DuPont entered into favorable supply contracts with FMC. DuPont recorded these contracts as intangible assets recognized at the fair value of off-market contracts. Refer to Notes 3 and 4 for additional information.

^2.  Microbial cell factories, derived from natural microbes, are used to sustainably produce enzymes, peptides and chemicals using natural metabolic processes. The company recognized the microbial cell factories as intangible assets upon the acquisition of Danisco. As a result of the valuation as part of the Merger, it was determined that this intangible asset now has a definite life and therefore it has been moved from indefinite-lived to definite-lived as of September 1, 2017.

^3.  Primarily consists of sales and farmer networks, marketing and manufacturing alliances and noncompetition agreements.

^4.  Pioneer germplasm is the pool of genetic source material and body of knowledge gained from the development and delivery stage of plant breeding. The company recognized germplasm as an intangible asset upon the acquisition of Pioneer. This intangible asset is expected to contribute to cash flows beyond the foreseeable future and there are no legal, regulatory, contractual, or other factors which limit its useful life.

Schedule of Acquired Intangible Assets

Intangible Assets	Gross Carrying Amount		Weighted-average Amortization Period (years)
(In millions)
Intangible assets with finite lives:
Customer-related	$	9,264	17
Developed technology	4,239		12
Trademarks/trade names	1,080		15
Microbial cell factories	400		23
Other	453		17
Total other intangible assets with finite lives	$	15,436
Intangible assets with indefinite lives:
IPR&D	$	660
Germplasm	6,263
Trademarks/trade names	4,862
Total intangible assets	$	27,221

Schedule of Finite-Lived Intangible Assets, Future Amortization Expense

(In millions)
2018	$	1,266
2019	$	1,254
2020	$	1,244
2021	$	1,228
2022	$	1,221

XML

Short-Term Borrowings, Long-Term Debt and Available Credit Facilities (Tables)

12 Months Ended

Dec. 31, 2017

Debt Disclosure [Abstract]

Short-Term Borrowings and Capital Lease Obligations

Short-term borrowings and capital lease obligations	Successor		Predecessor
(In millions)	December 31, 2017		December 31, 2016
Commercial paper	$	1,436	$	386
Other loans - various currencies	28		39
Long-term debt payable within one year	1,315		4
Total short-term borrowings and capital lease obligations	$	2,779	$	429

Long-Term Debt

Long Term Debt	Successor1				Predecessor
	December 31, 2017				December 31, 2016
(In millions)	Amount		Weighted Average Rate		Amount
Promissory notes and debentures:
Final maturity 2018	$	1,280	1.59	%	$	1,290
Final maturity 2019	521		2.23	%	500
Final maturity 2020	3,070		1.79	%	999
Final maturity 2021	1,580		2.07	%	1,498
Final maturity 2023 and thereafter	3,492		3.32	%	3,188
Other facilities:
Term loan due 2019	1,500		2.35	%	500
Other loans	18		4.32	%	22
Foreign currency loans, various rates and maturities	30		2.85	%	29
Medium-term notes, varying maturities through 2043	110		1.22	%	111
Capital lease obligations	5				9
Less: Unamortized debt discount and issuance costs	—				35
Less: Long-term debt due within one year	1,315				4
Total	$	10,291			$	8,107

^1.  The Successor period includes the reflection of debt at fair value at the date of the Merger. See Note 3 for additional information regarding the Merger.

Maturities of Long-term Debt

Maturities of Long-Term Debt For Next Five Years1
(In millions)
2018	$	1,286
2019	$	2,005
2020	$	3,005
2021	$	1,505
2022	$	2

Committed and Available Credit Facilities

Committed and Available Credit Facilities at December 31, 2017 (Successor)
(In millions)	Effective Date	Committed Credit		Credit Available		Maturity Date	Interest
Revolving Credit Facility	March 2016	$	3,000	$	2,950	May 2019	Floating Rate
Term Loan Facility	March 2016	4,500		3,000		March 2019	Floating Rate
Total Committed and Available Credit Facilities		$	7,500	$	5,950

XML

Commitments and Contingent Liabilities (Tables)

12 Months Ended

Dec. 31, 2017

Commitments and Contingencies Disclosure [Abstract]

Schedule of Guarantor Obligations [Table Text Block]

Guarantees at December 31, 2017 (Successor)	Final Expiration	Maximum Future Payments
(In millions)
Obligations for customers and suppliers1:
Bank borrowings	2022	$	89
Obligations for non-consolidated affiliates2:
Bank borrowings	2018	161
Obligations for Chemours3:
Chemours' purchase obligations	2018	10
Residual value guarantees4	2029	37
Total guarantees		$	297

1. Existing guarantees for customers and suppliers, as part of contractual agreements.

2.    Existing guarantees for non-consolidated affiliates' liquidity needs in normal operations.

3. Guarantee for Chemours' raw material purchase obligations under agreement with third party supplier.

4. The company provides guarantees related to leased assets specifying the residual value that will be available to the lessor at lease termination through sale of the assets to the lessee or third parties.

XML

Stockholders' Equity (Tables)

12 Months Ended

Dec. 31, 2017

Equity [Abstract]

Reconciliation of Common Stock Share Activity

Shares of common stock	Issued		Held In Treasury
Balance January 1, 2015 (Predecessor)	992,020,000		(87,041,000	)
Issued	5,932,000		—
Repurchased	—		(39,564,000	)
Retired	(39,564,000	)	39,564,000
Balance December 31, 2015 (Predecessor)	958,388,000		(87,041,000	)
Issued	4,808,000		—
Repurchased	—		(13,152,000	)
Retired	(13,152,000	)	13,152,000
Balance December 31, 2016 (Predecessor)	950,044,000		(87,041,000	)
Issued	5,335,000		—
Retired	(87,041,000	)	87,041,000
Balance August 31, 2017 (Predecessor)	868,338,000		—
Balance September 1 and December 31, 2017 (Successor)1	100		—

^1.  All of the company's issued and outstanding common stock at September 1, 2017 is held by the DowDuPont Inc.

Other Comprehensive Income (Loss)

(In millions)	Cumulative Translation Adjustment1			Derivative Instruments			Pension Benefit Plans2			Other Benefit Plans			Unrealized Gain (Loss) on Investments			Total
2015
Balance January 1, 2015 (Predecessor)	$	(919	)	$	(6	)	$	(7,895	)	$	262		$	2		$	(8,556	)
Other comprehensive (loss) income before reclassifications	(1,605		)	(25		)	39			3			(17		)	(1,605		)
Amounts reclassified from accumulated other comprehensive income (loss)	—			7			535			(243		)	(2		)	297
Net other comprehensive (loss) income	(1,605		)	(18		)	574			(240		)	(19		)	(1,308		)
Spin-off of Chemours	$	191		$	—		$	278		$	—		$	(1	)	$	468
Balance December 31, 2015 (Predecessor)	$	(2,333	)	$	(24	)	$	(7,043	)	$	22		$	(18	)	$	(9,396	)
2016
Other comprehensive (loss) income before reclassifications	(510		)	20			(271		)	(81		)	(8		)	(850		)
Amounts reclassified from accumulated other comprehensive income (loss)	—			11			594			(298		)	28			335
Net other comprehensive (loss) income	(510		)	31			323			(379		)	20			(515		)
Balance December 31, 2016 (Predecessor)	$	(2,843	)	$	7		$	(6,720	)	$	(357	)	$	2		$	(9,911	)
2017
Other comprehensive income (loss) before reclassifications	1,042			3			(78		)	—			1			968
Amounts reclassified from accumulated other comprehensive income (loss)	—			(13		)	325			10			(1		)	321
Net other comprehensive income (loss)	1,042			(10		)	247			10			—			1,289
Balance August 31, 2017 (Predecessor)	$	(1,801	)	$	(3	)	$	(6,473	)	$	(347	)	$	2		$	(8,622	)
Balance September 1, 2017 (Successor)3	$	—		$	—		$	—		$	—		$	—		$	—
Other comprehensive income (loss) before reclassifications	(454		)	(2		)	128			(53		)	—			(381		)
Amounts reclassified from accumulated other comprehensive income (loss)	—			—			—			—			—			—
Net other comprehensive (loss) income	(454		)	(2		)	128			(53		)	—			(381		)
Balance December 31, 2017 (Successor)	$	(454	)	$	(2	)	$	128		$	(53	)	$	—		$	(381	)

^1.  The cumulative translation adjustment loss for the period September 1 through December 31, 2017 is primarily driven by the strengthening of the U.S dollar (USD) against the European Euro (EUR) and the Brazilian real (BRL). The cumulative translation adjustment gain for the period January 1 through August 31, 2017 is primarily driven by the weakening of the USD against the EUR. The currency translation loss for the year ended December 31, 2016 is primarily driven by the strengthening of the USD against the EUR partially offset by the weakening of the USD against the BRL. The currency translation loss for the year ended December 31, 2015 is driven by the strengthening USD against primarily the EUR and BRL.

^2.  The Pension Benefit Plans loss recognized in other comprehensive (loss) income during the year ended December 31, 2016 includes the impact of the remeasurement of the principal U.S. pension plan as of June 30, 2016. See Note 16 for additional information.

^3.  In connection with the Merger, balances in accumulated other comprehensive loss at Merger Effectiveness Time were eliminated as a result of reflecting the balance sheet at fair value as of the date of the Merger. See Note 3 and 16 for further information regarding the Merger and pension and OPEB plans, respectively.

The tax (expense) benefit on the net activity related to each component of other comprehensive income (loss) were as follows:

	Successor			Predecessor
(In millions)	For the Period September 1 through December 31, 2017			For the Period January 1 through August 31, 2017			For the Year Ended December 31, 2016			For the Year Ended December 31, 2015
Derivative instruments	$	1		$	6		$	(19	)	$	7
Pension benefit plans - net	(37		)	(145		)	(163		)	(317		)
Other benefit plans - net	15			(5		)	194			135
(Provision for) benefit from income taxes related to other comprehensive income (loss) items	$	(21	)	$	(144	)	$	12		$	(175	)

Reclassification out of Accumulated Other Comprehensive Income [Table Text Block]

	Successor		Predecessor									Income Classification
(In millions)	For the Period September 1 through December 31, 2017		For the Period January 1 through August 31, 2017			For the Year Ended December 31, 2016			For the Year Ended December 31, 2015
Derivative Instruments:	$	—	$	(21	)	$	18		$	12		(1)
Tax expense (benefit)	—		8			(7		)	(5		)	(2)
After-tax	$	—	$	(13	)	$	11		$	7
Amortization of pension benefit plans:
Prior service benefit	—		(3		)	(6		)	(9		)	(3)
Actuarial losses	—		506			822			768			(3)
Curtailment gain (loss)	—		—			40			(6		)	(3)
Settlement loss	—		—			62			76			(3)
Total before tax	$	—	$	503		$	918		$	829
Tax benefit	—		(178		)	(324		)	(294		)	(2)
After-tax	$	—	$	325		$	594		$	535
Amortization of other benefit plans:
Prior service benefit	—		(46		)	(134		)	(182		)	(3)
Actuarial losses	—		61			78			78			(3)
Curtailment gain	—		—			(392		)	(274		)	(3)
Total before tax	$	—	$	15		$	(448	)	$	(378	)
Tax (benefit) expense	—		(5		)	150			135			(2)
After-tax	$	—	$	10		$	(298	)	$	(243	)
Net realized (losses) gains on investments, before tax:	—		(1		)	28			(2		)	(4)
Tax expense	—		—			—			—			(2)
After-tax	$	—	$	(1	)	$	28		$	(2	)
Total reclassifications for the period, after-tax	$	—	$	321		$	335		$	297

^1.  Cost of goods sold.

^2.  Provision for income taxes from continuing operations.

^3.  These accumulated other comprehensive loss components are included in the computation of net periodic benefit cost of the company's pension and other benefit plans. See Note 16 for additional information.

^4.  Sundry income - net.

XML

Pension Plans and Other Post Employment Benefit Plans (Tables)

12 Months Ended

Dec. 31, 2017

Retirement Benefits [Abstract]

Schedule of Assumptions Used [Table Text Block]

The weighted-average assumptions used to determine benefit obligations for OPEB plans are summarized in the table below:

Weighted-Average Assumptions used to Determine Benefit Obligations	Successor		Predecessor
	December 31, 2017		December 31, 2016
Discount rate	3.56	%	4.03	%

The weighted-average assumptions used to determine net periodic benefit costs for the OPEB plans are summarized in the two tables below:

Weighted-Average Assumptions used to Determine Net Periodic Benefit Cost	Successor		Predecessor
	For the Period September 1 through December 31, 2017		For the Period January 1 through August 31, 2017		For the Year Ended December 31, 2016		For the Year Ended December 31, 2015
Discount rate	3.62	%	4.03	%	3.87	%	4.13	%

Assumed Health Care Cost Trend Rates	Successor		Predecessor
	December 31, 2017		December 31, 2016
Health care cost trend rate assumed for next year	6.40	%	7.00	%
Rate to which the cost trend rate is assumed to decline (the ultimate health care trend rate)	5.00	%	5.00	%
Year that the rate reached the ultimate health care cost trend rate	2023		2023

The weighted-average assumptions used to determine pension plan obligations for all pension plans are summarized in the table below:

Weighted-Average Assumptions used to Determine Benefit Obligations	Successor		Predecessor
	December 31, 2017		December 31, 2016
Discount rate	3.37	%	3.80	%
Rate of increase in future compensation levels 1	4.04	%	3.80	%

1. The rate of compensation increase represents the single annual effective salary increase that an average plan participant would receive during the participant's entire career at the company.

The weighted-average assumptions used to determine net periodic benefit costs for all pension plans are summarized in the two tables below:

Weighted-Average Assumptions used to Determine Net Periodic Benefit Cost	Successor		Predecessor
	For the Period September 1 through December 31, 2017		For the Period January 1 through August 31, 2017		For the Year Ended December 31, 2016		For the Year Ended December 31, 2015
Discount rate	3.42	%	3.80	%	3.77	%	3.93	%
Rate of increase in future compensation levels	3.80	%	3.80	%	3.96	%	4.01	%
Expected long-term rate of return on plan assets	6.24	%	7.66	%	7.74	%	8.10	%

The weighted-average assumptions used to determine net periodic benefit costs for U.S. plans are summarized in the table below:

Weighted- Average Assumptions used to Determine Net Periodic Benefit Cost	Successor		Predecessor
	For the Period September 1 through December 31, 2017		For the Period January 1 through August 31, 2017		For the Year Ended December 31, 2016		For the Year Ended December 31, 2015
Discount rate	3.73	%	4.16	%	4.04	%	4.29	%
Rate of increase in future compensation levels	3.95	%	3.95	%	4.15	%	4.20	%
Expected long-term rate of return on plan assets	6.25	%	8.00	%	8.00	%	8.50	%

Schedule of Benefit Obligations in Excess of Fair Value of Plan Assets [Table Text Block]

Pension Plans with Projected Benefit Obligations in Excess of Plan Assets	Successor		Predecessor
(In millions)	December 31, 2017		December 31, 2016
Projected benefit obligations	$	25,254	$	24,779
Accumulated benefit obligations	24,864		24,297
Fair value of plan assets	19,941		16,601

Schedule of Accumulated Benefit Obligations in Excess of Fair Value of Plan Assets [Table Text Block]

Pension Plans with Accumulated Benefit Obligations in Excess of Plan Assets	Successor		Predecessor
(In millions)	December 31, 2017		December 31, 2016
Projected benefit obligations	$	24,625	$	23,946
Accumulated benefit obligations	24,315		23,591
Fair value of plan assets	19,335		15,838

Schedule of Net Benefit Costs [Table Text Block]

	Defined Benefit Pension Plans												Other Post Employment Benefits
(In millions)	Successor			Predecessor									Successor		Predecessor
Components of net periodic benefit cost (credit) and amounts recognized in other comprehensive loss	For the Period September 1 through December 31, 2017			For the Period January 1 through August 31, 2017			For the Year Ended December 31, 2016			For the Year Ended December 31, 2015			For the Period September 1 through December 31, 2017		For the Period January 1 through August 31, 2017			For the Year Ended December 31, 2016			For the Year Ended December 31, 2015
Net Periodic Benefit Cost:
Service cost	$	49		$	92		$	174		$	232		$	3	$	6		$	11		$	15
Interest cost	247			524			800			1,084			26		60			87			112
Expected return on plan assets	(407		)	(824		)	(1,320		)	(1,554		)	—		—			—			—
Amortization of unrecognized loss	—			506			822			768			—		61			78			78
Amortization of prior service benefit	—			(3		)	(6		)	(9		)	—		(46		)	(134		)	(182		)
Curtailment loss (gain)	—			—			40			(6		)	—		—			(392		)	(274		)
Settlement loss	—			—			62			76			—		—			—			—
Net periodic (credit) benefit cost - Total	$	(111	)	$	295		$	572		$	591		$	29	$	81		$	(350	)	$	(251	)
Less: Discontinued operations	1			3			—			—			—		—			—			(272		)
Net periodic (credit) benefit cost - Continuing operations	$	(112	)	$	292		$	572		$	591		$	29	$	81		$	(350	)	$	21
Changes in plan assets and benefit obligations recognized in other comprehensive (income) loss:
Net (gain) loss	$	(165	)	$	(22	)	$	570		$	57		$	68	$	—		$	153		$	(4	)
Amortization of unrecognized loss	—			(506		)	(822		)	(768		)	—		(61		)	(78		)	(78		)
Prior service benefit	—			—			—			—			—		—			(28		)	—
Amortization of prior service benefit	—			3			6			9			—		46			134			182
Curtailment (loss) gain	—			—			(40		)	6			—		—			392			274
Settlement loss	—			—			(62		)	(76		)	—		—			—			—
Effect of foreign exchange rates	—			133			(138		)	(119		)	—		—			—			1
Spin-off of Chemours	—			—			—			(382		)	—		—			—			—
Total (benefit) loss recognized in other comprehensive loss, attributable to DuPont	$	(165	)	$	(392	)	$	(486	)	$	(1,273	)	$	68	$	(15	)	$	573		$	375
Total recognized in net periodic benefit cost and other comprehensive (income) loss	$	(276	)	$	(97	)	$	86		$	(682	)	$	97	$	66		$	223		$	124

Schedule of Expected Benefit Payments [Table Text Block]

Estimated Future Benefit Payments at December 31, 2017 (Successor)	Defined Benefit Pension Plans		Other Post Employment Benefits
(In millions)
2018	$	1,636	$	250
2019	1,614		243
2020	1,600		236
2021	1,587		227
2022	1,568		218
Years 2023-2027	7,533		906
Total	15,538		2,080

Schedule of Allocation of Plan Assets [Table Text Block]

Target Allocation for Plan Assets	Successor		Predecessor
Asset Category	December 31, 2017		December 31, 2016
U.S. equity securities	17	%	27	%
Non-U.S. equity securities	18		24
Fixed income securities	50		33
Hedge funds	2		2
Private market securities	8		8
Real estate	3		4
Cash and cash equivalents	2		2
Total	100	%	100	%

Basis of Fair Value Measurements
For the year ended December 31, 2017 (Successor)
(In millions)	Total			Level 1		Level 2			Level 3
Cash and cash equivalents	$	3,057		$	3,057	$	—		$	—
U.S. equity securities 1	4,043			4,012		14			17
Non-U.S. equity securities	3,064			2,866		195			3
Debt – government-issued	3,263			497		2,766			—
Debt – corporate-issued	3,181			270		2,884			27
Debt – asset-backed	706			17		687			2
Hedge funds	85			—		83			2
Private market securities	14			—		—			14
Real estate	342			239		7			96
Derivatives – asset position	24			3		21			—
Derivatives – liability position	(16		)	—		(16		)	—
Other	2			—		2			—
Subtotal	$	17,765		$	10,961	$	6,643		$	161
Investments measured at net asset value
Hedge funds	747
Private market securities	1,383
Real estate funds	437
Total investments measured at net asset value	$	2,567
Other items to reconcile to fair value of plan assets
Pension trust receivables 2	127
Pension trust payables 3	(175		)
Total	$	20,284

1. The DuPont pension plans directly held $910 million (4 percent of total plan assets) of DowDuPont common stock at December 31, 2017.

2. Primarily receivables for investments securities sold.

3. Primarily payables for investment securities purchased

Basis of Fair Value Measurements
For the year ended December 31, 2016 (Predecessor)
(In millions)	Total			Level 1		Level 2			Level 3
Cash and cash equivalents	$	1,505		$	1,480	$	25		$	—
U.S. equity securities1	4,071			4,033		20			18
Non-U.S. equity securities	3,278			3,126		151			1
Debt – government-issued	2,067			864		1,203			—
Debt – corporate-issued	2,475			273		2,163			39
Debt – asset-backed	721			39		682			—
Hedge funds	1			—		1			—
Private market securities	67			—		25			42
Real estate	275			175		2			98
Derivatives – asset position	53			7		46			—
Derivatives – liability position	(47		)	—		(47		)	—
Other	4			—		4			—
Subtotal	$	14,470		$	9,997	$	4,275		$	198
Investments measured at net asset value
Hedge funds	434
Private market securities	1,416
Real estate funds	444
Total investments measured at net asset value	$	2,294
Other items to reconcile to fair value of plan assets
Pension trust receivables2	264
Pension trust payables3	(372		)
Total	$	16,656

1. The DuPont pension plans directly held $732 million (4 percent of total plan assets) of DuPont common stock at December 31, 2016.

2. Primarily receivables for investments securities sold.

3. Primarily payables for investment securities purchased.

Schedule of Effect of Significant Unobservable Inputs, Changes in Plan Assets [Table Text Block]

Fair Value Measurement of Level 3 Pension Plan Assets	U.S. equity securities			Non-U.S. equity securities			Debt – corporate-issued			Debt- asset- backed			Hedge funds		Private market securities			Real estate			Total
(In millions)
Predecessor
Balance at January 1, 2016	$	20		$	2		$	34		$	1		$	—	$	37		$	144		$	238
Actual return on assets:
Relating to assets sold during the year ended December 31, 2016	(3		)	—			(25		)	—			—		—			—			(28		)
Relating to assets held at December 31, 2016	1			(1		)	27			—			—		2			(10		)	19
Purchases, sales and settlements, net	—			—			(3		)	(1		)	—		3			(36		)	(37		)
Transfers in Level 3, net	—			—			6			—			—		—			—			6
Balance at December 31, 2016	$	18		$	1		$	39		$	—		$	—	$	42		$	98		$	198
Actual return on assets:
Relating to assets sold during the period January 1 through August 31, 2017	(1		)	2			(20		)	—			—		—			—			(19		)
Relating to assets held at August 31, 2017	(7		)	(2		)	22			—			—		(5		)	7			15
Purchases, sales and settlements, net	6			1			(1		)	—			—		1			(7		)	—
Transfers in (out) of Level 3, net	—			—			6			2			—		(21		)	—			(13		)
Balance at August 31, 2017	$	16		$	2		$	46		$	2		$	—	$	17		$	98		$	181
Successor
Balance at September 1, 2017	$	16		$	2		$	46		$	2		$	—	$	17		$	98		$	181
Actual return on assets:
Relating to assets sold during the period September 1 through December 31, 2017	—			—			(3		)	—			—		—			—			(3		)
Relating to assets held at December 31, 2017	1			(1		)	5			—			—		(3		)	4			6
Purchases, sales and settlements, net	—			2			(21		)	—			2		—			(6		)	(23		)
Balance at December 31, 2017	$	17		$	3		$	27		$	2		$	2	$	14		$	96		$	161

Schedule of Pension Plans and Other Postemployment Benefits [Table Text Block]

Change in Projected Benefit Obligations, Plan Assets and Funded Status
	Defined Benefit Pension Plans									Other Post Employment Benefits
	Successor			Predecessor						Successor			Predecessor
(In millions)	For the Period September 1 through December 31, 2017 1			For the Period January 1 through August 31, 2017			For the Year Ended December 31, 2016			For the Period September 1 through December 31, 2017 1			For the Period January 1 through August 31, 2017			For the Year Ended December 31, 2016
Change in benefit obligations:
Benefit obligation at beginning of the period	$	26,036		$	24,831		$	26,094		$	2,772		$	2,829		$	2,758
Service cost	49			92			174			3			6			11
Interest cost	247			524			800			26			60			87
Plan participants' contributions	6			8			18			12			26			36
Actuarial (gain) loss	(23		)	—			460			68			—			153
Benefits paid2	(730		)	(1,118		)	(2,374		)	(71		)	(192		)	(254		)
Plan amendments	—			—			—			—			—			(28		)
Net effects of acquisitions / divestitures / other	22			—			7			—			—			65
Effect of foreign exchange rates	(57		)	429			(348		)	—			2			1
Benefit obligations at end of the period	$	25,550		$	24,766		$	24,831		$	2,810		$	2,731		$	2,829
Change in plan assets:
Fair value of plan assets at beginning of the period	$	20,395		$	16,656		$	17,497		$	—		$	—		$	—
Actual return on plan assets	549			846			1,219			—			—			—
Employer contributions	68			3,024			535			59			166			218
Plan participants' contributions	6			8			18			12			26			36
Benefits paid2	(730		)	(1,118		)	(2,374		)	(71		)	(192		)	(254		)
Net effects of acquisitions / divestitures / other	29			—			—			—			—			—
Effect of foreign exchange rates	(33		)	269			(239		)	—			—			—
Fair value of plan assets at end of the period	$	20,284		$	19,685		$	16,656		$	—		$	—		$	—
Funded status
U.S. plan with plan assets	$	(3,628	)	$	(3,277	)	$	(6,391	)	$	—		$	—		$	—
Non-U.S. plans with plan assets	(447		)	(609		)	(674		)	—			—			—
All other plans 3, 4	(1,191		)	(1,187		)	(1,102		)	(2,810		)	(2,731		)	(2,829		)
Plans of discontinued operations	—			(8		)	(8		)	—			—			—
Funded status at end of the period	$	(5,266	)	$	(5,081	)	$	(8,175	)	$	(2,810	)	$	(2,731	)	$	(2,829	)

1. The benefit obligation and the fair value of plan assets at the beginning of the period September 1 through December 31, 2017, reflects the remeasurement of the plans at the Merger Effectiveness Time.

2. In the fourth quarter of 2016, about $550 million of lump-sum payments were made from the principal U.S. pension plan trust fund to a group of separated, vested plan participants who were extended a limited-time opportunity and voluntarily elected to receive their pension benefits in a single lump-sum payment. In the fourth quarter of 2017, about $140 million of lump-sum payments were made from the principal U.S. pension plan trust fund under a similar program.

3. As of December 31, 2017, $389 million of the benefit obligations are supported by funding under the Trust agreement, defined in the "Trust Assets" section below.

4. Includes pension plans maintained around the world where funding is not customary.

	Defined Benefit Pension Plans						Other Post Employment Benefits
(In millions)	Successor			Predecessor			Successor			Predecessor
	December 31, 2017			December 31, 2016			December 31, 2017			December 31, 2016
Amounts recognized in the Consolidated Balance Sheets:
Other Assets	$	47		$	3		$	—		$	—
Accrued and other current liabilities	(86		)	(78		)	(250		)	(275		)
Liabilities held for sale - current	—			(8		)	—			—
Pension and other post employment benefits - noncurrent 1	(5,227		)				(2,560		)
Other noncurrent obligations 1	—			(8,092		)	—			(2,554		)
Net amount recognized	$	(5,266	)	$	(8,175	)	$	(2,810	)	$	(2,829	)
Pretax amounts recognized in accumulated other comprehensive (income) loss:
Net (gain) loss	$	(165	)	$	10,280		$	68		$	830
Prior service benefit	—			(17		)	—			(281		)
Pretax balance in accumulated other comprehensive (income) loss at end of year	$	(165	)	$	10,263		$	68		$	549

1. In the Successor Period, non-current pension and OPEB liabilities are included within pension and other post employment benefits - noncurrent in the Consolidated Balance Sheets.  In the Predecessor period, these liabilities are included within other noncurrent obligations. 

(In millions)	Successor				Predecessor
	December 31, 2017				December 31, 2016
	Fair Value		Unfunded Commitments		Fair Value		Unfunded Commitments		Redemption Frequency	Redemption Notice Period Range
Hedge funds 1	747		—		434		—		Monthly, Quarterly	Ranges from 15-45 days monthly, 10-185 days quarterly
Private market securities 2	1,383		797		1,416		693		Not applicable	Not applicable
Real estate funds 2	437		371		444		244		Not applicable	Not applicable
Total	$	2,567	$	1,168	$	2,294	$	937

1. Less than 5 percent of hedge funds have gates in place at the investor level for year-end redemptions. Hedge funds also contain either no lock up or a lock up period of less than 1 year.

2. The remaining life of private market securities and real estate funds is an average of 15 years per investment.

XML

Stock-Based Compensation (Tables)

12 Months Ended

Dec. 31, 2017

Disclosure of Compensation Related Costs, Share-based Payments [Abstract]

Weighted Average Assumptions - Stock Option Awards

Weighted-Average Assumptions	Successor		Predecessor
	For the Period September 1 through December 31, 2017		For the Period January 1 through August 31, 2017		For the Year Ended December 31, 2016		For the Year Ended December 31, 2015
Dividend yield	2.2	%	2.0	%	2.6	%	2.5	%
Expected volatility	23.59	%	23.21	%	28.27	%	22.52	%
Risk-free interest rate	2.1	%	2.3	%	1.8	%	1.4	%
Expected life of stock options granted during period (years)	7.2		7.2		7.2		5.3

Stock Option Activity

Stock Options	2017
	Number of Shares (in thousands)		Weighted Average Exercise Price (per share)		Weighted Average Remaining Contractual Term (years)	Aggregate Intrinsic Value (in thousands)
Outstanding at January 1, 2017 (Predecessor)	15,696		$	58.11
Granted	1,626		76.18
Exercised	(4,356	)	54.52
Forfeited/Expired	(136	)	60.93
Outstanding at August 31, 20171	12,830		$	61.84	4.71	$	283,365
Exercisable at August 31, 2017	8,441		$	57.78	3.37	$	220,716
Outstanding at September 1, 2017 (Successor)1	16,447		$	48.24
Granted	174		45.29
Exercised	(702	)	43.07
Forfeited/Expired	(30	)	54.83
Outstanding at December 31, 2017	15,889		$	48.43	3.74	$	362,088
Exercisable at December 31, 2017	10,881		$	45.75	3.06	$	277,163

^1.  As a result of the Merger, all previous DuPont equity awards were converted into the right to receive 1.2820 shares of DowDuPont Common Stock, as discussed above. As a result, the number of shares outstanding at September 1, 2017 represents the shares as of August 31, 2017 multiplied by the conversion factor.

RSU and PSU Activity

	2017
	Number of Shares (in thousands)		Weighted Average Grant Date Fair Value (per share)
Nonvested at December 31, 2016 (Predecessor)	3,390		$	63.11
Granted	1,124		76.41
Vested	(1,332	)	63.08
Forfeited	(104	)	70.69
Nonvested at August 31, 20171	3,078		$	67.53
Nonvested at September 1, 2017 (Successor)1	3,948		$	67.06
Granted	412		70.02
Vested	(139	)	67.67
Forfeited	(23	)	66.65
Nonvested at December 31, 2017	4,198		$	68.28

XML

Financial Instruments (Tables)

12 Months Ended

Dec. 31, 2017

Investments, All Other Investments [Abstract]

Notional Amounts of Derivatives

Notional Amounts	Successor		Predecessor
(In millions)	December 31, 2017		December 31, 2016
Derivatives designated as hedging instruments:
Commodity contracts	$	587	$	422
Derivatives not designated as hedging instruments:
Foreign currency contracts	10,454		9,896
Commodity contracts	6		7

After-Tax Effect of Cash Flow Hedges Included in Accumulated Other Comprehensive Income (Loss)

	Successor			Predecessor
(In millions)	For the Period September 1 - December 31, 2017			For the Period Jan. 1 - August 31, 2017			Year Ended December 31, 2016
Beginning balance	$	—		$	7		$	(24	)
Additions and revaluations of derivatives designated as cash flow hedges	(2		)	3			20
Clearance of hedge results to earnings	—			(13		)	11
Ending balance	$	(2	)	$	(3	)	$	7

Fair Value of Derivatives Instruments

		Successor
		December 31, 2017
(In millions)	Balance Sheet Location	Gross		Counterparty and Cash Collateral Netting1			Net Amounts Included in the Condensed Consolidated Balance Sheet
Asset derivatives:
Derivatives not designated as hedging instruments:
Foreign currency contracts	Other current assets	$	46	$	(37	)	$	9
Total asset derivatives		$	46	$	(37	)	$	9
Liability derivatives:
Derivatives not designated as hedging instruments:
Foreign currency contracts	Accrued and other current liabilities	$	79	$	(32	)	$	47
Total liability derivatives		$	79	$	(32	)	$	47

^1.  Counterparty and cash collateral amounts represent the estimated net settlement amount when applying netting and set-off rights included in master netting arrangements between the company and its counterparties and the payable or receivable for cash collateral held or placed with the same counterparty. The company held cash collateral of $5 million as of December 31, 2017.

		Predecessor
(In millions)	Balance Sheet Location	December 31, 2016
Asset derivatives:
Derivatives not designated as hedging instruments:
Foreign currency contracts1	Accounts and notes receivable - net	$	182
Total asset derivatives2		$	182
Cash collateral1	Accrued and other current liabilities	$	52
Liability derivatives:
Derivatives not designated as hedging instruments:
Foreign currency contracts	Accrued and other current liabilities	$	121
Total liability derivatives2		$	121

^1.  Cash collateral held as of December 31, 2016 is related to foreign currency derivatives not designated as hedging instruments.

^2.  The company's derivative assets and liabilities subject to enforceable master netting arrangements totaled $114 million at December 31, 2016.

Effect of Derivative Instruments

	Amount of Gain (Loss) Recognized in OCI1 (Effective Portion) - Pre Tax
	Successor		Predecessor
(In millions)	For the Period September 1 - December 31, 2017		For the Period Jan. 1 - August 31, 2017		Year Ended December 31, 2016		Year Ended December 31, 2015
Derivatives designated as hedging instruments:
Cash flow hedges:
Foreign currency contracts	$	—	—		—		(2		)
Commodity contracts	3		5		32		(35		)
Total derivatives designated as hedging instruments	$	3	$	5	$	32	$	(37	)
Total derivatives	$	3	$	5	$	32	$	(37	)

1. OCI is defined as other comprehensive income (loss).

	Amount of Gain (Loss) Recognized in Income - Pre Tax1
	Successor		Predecessor
(In millions)	For the Period September 1 - December 31, 2017		For the Period Jan. 1 - August 31, 2017			Year Ended December 31, 2016			Year Ended December 31, 2015
Derivatives designated as hedging instruments:
Fair value hedges:
Interest rate swaps2	$	—	$	—		$	—		$	(1	)
Cash flow hedges:
Foreign currency contracts3	—		—			—			10
Commodity contracts2	—		21			(18		)	(22		)
Total derivatives designated as hedging instruments	$	—	$	21		$	(18	)	$	(13	)
Derivatives not designated as hedging instruments:
Foreign currency contracts4	91		(431		)	(304		)	434
Foreign currency contracts3	—		—			(12		)	(3		)
Commodity contracts2	—		2			(11		)	(2		)
Total derivatives not designated as hedging instruments	91		(429		)	(327		)	429
Total derivatives	$	91	$	(408	)	$	(345	)	$	416

1. For cash flow hedges, this represents the effective portion of the gain (loss) reclassified from accumulated OCI into income during the period. There was no material ineffectiveness with regard to the company's cash flow hedges during the period.

2. Recorded in cost of goods sold.

3. Recorded in net sales.

4. Gain recognized in sundry income - net was partially offset by the related gain on the foreign currency-denominated monetary assets and liabilities of the company's operations. See Note 6 for additional information.

XML

Fair Value Measurements (Tables)

12 Months Ended

Dec. 31, 2017

Fair Value Disclosures [Abstract]

Fair Value of Assets and Liabilities Measured on Recurring Basis

December 31, 2017 (Successor)	Significant Other Observable Inputs (Level 2)
(In millions)
Assets at fair value:
Cash equivalents1	$	5,205
Marketable securities	$	952
Derivatives relating to:2
Foreign currency	46
Total assets at fair value	$	6,203
Liabilities at fair value:
Long-term debt3	$	11,560
Derivatives relating to:2
Foreign currency	79
Total liabilities at fair value	$	11,639

1. Time deposits included in "Cash and cash equivalents" and money market funds included in "Other current assets" in the consolidated balance sheets are held at amortized cost, which approximates fair value.

2. See Note 18 for the classification of derivatives in the consolidated balance sheets.

3. See Note 13 for information on fair value measurements of long-term debt.

December 31, 2016 (Predecessor)	Significant Other Observable Inputs (Level 2)
(In millions)
Assets at fair value:
Cash equivalents1	$	2,713
Marketable securities	$	1,362
Derivatives relating to:2
Foreign currency	182
Total assets at fair value	$	4,257
Liabilities at fair value:
Long-term debt3	$	8,464
Derivatives relating to:2
Foreign currency	121
Total liabilities at fair value	$	8,585

1. Time deposits included in "Cash and cash equivalents" and money market funds included in "Other current assets" in the consolidated balance sheets are held at amortized cost, which approximates fair value.

2. See Note 18 for the classification of derivatives in the consolidated balance sheets.

3. See Note 13 for information on fair value measurements of long-term debt.

XML

Geographic and Product Line Information (Tables)

12 Months Ended

Dec. 31, 2017

Geographic Area, Revenues from External Customers [Abstract]

Net Sales by Geographic Area

	Net Sales
	Successor		Predecessor
(In millions)	Sept 1 - Dec 31, 2017		Jan 1 - Aug 31, 2017		Year Ended Dec 31, 2016		Year Ended Dec 31, 2015
United States	$	2,086	$	7,535	$	9,500	$	9,812
Canada	139		583		669		692
EMEA1	1,689		3,927		5,251		5,483
Asia Pacific2	2,047		3,844		5,407		5,292
Latin America	1,092		1,392		2,382		2,378
Total	$	7,053	$	17,281	$	23,209	$	23,657

^1.  Europe, Middle East, and Africa (EMEA).

^2.  Net sales for China in the Successor period were $818 million.

Net Property By Geographic Area

	Net Property
	Successor		Predecessor
(In millions)	2017		2016		2015
United States	$	7,708	$	5,951	$	6,458
Canada	170		124		128
EMEA1	2,867		1,550		1,582
Asia Pacific	1,120		797		854
Latin America	570		429		392
Total	$	12,435	$	8,851	$	9,414

^1.  Europe, Middle East, and Africa (EMEA).

Sales by Principal Product Group

Net Sales	Successor		Predecessor
(In millions)	For the Period September 1 through December 31, 2017		For the Period January 1 through August 31, 2017		For the Year Ended December 31, 2016		For the Year Ended December 31, 2015
Agriculture	$	1,596	$	6,894	$	8,131	$	8,327
Packaging and Specialty Plastics	544		1,072		1,651		1,715
Electronics and Imaging	743		1,422		1,960		2,070
Nutrition and Health	1,165		2,129		3,268		3,256
Industrial Biosciences	573		1,022		1,500		1,478
Transportation and Advanced Polymers	1,355		2,608		3,599		3,591
Safety and Construction	1,074		2,134		3,099		3,220
Other	3		—		1		—
Total	$	7,053	$	17,281	$	23,209	$	23,657

XML

Quaterly Financial Data (Tables)

12 Months Ended

Dec. 31, 2017

Quarterly Financial Data [Abstract]

Quarterly Financial Information

	2017
	Predecessor										Successor
In millions, except per share amounts (unaudited)	First			Second			July 1 - Aug 31				Sept 1 - Sept 30				Fourth
Net sales	$	7,319		$	6,971		$	2,991			$	1,735			$	5,318
Cost of goods sold	4,209			4,021			1,975				1,511			2	4,654		2
Restructuring and asset related charges - net1	152			160			11				40				140
Net income (loss)	1,121		3,4,5	869		3	(229		)	3	(295		)	1,3	1,305		1,3,6
Net income (loss) attributable to DuPont	1,113			862			(234		)		(293		)		1,303
Earnings per common share, continuing operations - basic9	1.35			0.82			(0.30		)
Earnings per common share, continuing operations - diluted9	1.34			0.82			(0.30		)

	2016
	Predecessor
In millions, except per share amounts (unaudited)	First			Second				Third				Fourth
Net sales	$	7,014		$	6,646			$	4,646			$	4,903
Cost of goods sold	4,103			3,823				2,997				3,032
Restructuring and asset related charges - net1	78			(88		)		172				394
Net income (loss)	1,232		7,8	1,024			7	6			7	263		7
Net income (loss) attributable to DuPont	1,226			1,020				2				265
Earnings per common share, continuing operations - basic9	1.23			1.03				(0.08		)		0.19
Earnings per common share, continuing operations - diluted9	1.22			1.02				(0.08		)		0.19

1. See Note 5 for additional information.

2. Includes charges of $(360) million and $(1,109) million during the period September 1 - September 30, 2017 and the fourth quarter 2017, respectively, related to the amortization of inventory step-up as a result of the Merger and the acquisition of the H&N Business, which was included in cost of goods sold. See Note 3 for additional information.

3. Includes charges of $(170) million, $(201) million, $(210) million, $(71) million, and $(243) million in the first quarter 2017, second quarter 2017, the period July 1 - August 31, 2017, the period September 1 - September 30, 2017, and the fourth quarter 2017, respectively, related to transaction costs associated with the Merger. Predecessor costs are recorded in selling, general and administrative expenses; Successor costs are recoded in integration and separation costs. See Note 3 for additional information.

4. First quarter 2017 included a gain of $162 million recorded in sundry income - net associated with the sale of the company's global food safety diagnostic business. See Note 4 for additional information.

5. First quarter 2017 included a tax benefit of $53 million, as well as a $47 million benefit on associated accrued interest reversals (recorded in sundry income - net), related to a reduction in the company’s unrecognized tax benefits due to the closure of various tax statutes of limitations.

6. Includes a tax benefit of $2,262 million in the fourth quarter 2017 related to the Tax Cuts and Jobs Act and a benefit related to an internal entity restructuring associated with the Intended Business Separations. See Note 7 for additional information.

7. First, second, third and fourth quarter 2016 included charges of $(24) million, $(76) million, $(122) million, and $(164) million, respectively, recorded in selling, general and administrative expenses related to transaction costs associated with the Merger. See Note 3 for additional information.

8. First quarter 2016 included a gain of $369 million recorded in sundry income - net associated with the sale of the DuPont (Shenzhen) Manufacturing Limited entity, which held certain buildings and other assets. See Note 4 for additional information.

9. Due to quarterly changes in the share count and the allocation of income to participating securities, the sum of the four quarters may not equal the earnings per share amount calculated for the year.

XML

Summary of Significant Accounting Policies (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2017	Dec. 31, 2016
Successor [Member]
Restricted Cash	$ 558
Percentage of FIFO Inventory	60.00%
Percentage of Weighted Average Cost Inventory	30.00%
Percentage of LIFO Inventory	10.00%
Successor [Member] | Minimum [Member]
Definite-Lived Intangible Asset, Useful Life	1 year
Successor [Member] | Maximum [Member]
Definite-Lived Intangible Asset, Useful Life	23 years
Predecessor [Member]
Percentage of FIFO Inventory		55.00%
Percentage of Weighted Average Cost Inventory		30.00%
Percentage of LIFO Inventory		15.00%

XML

Recent Accounting Guidance (Details) - Accounting Standards Update 2016-09 [Member] - USD ($) $ in Millions	4 Months Ended	8 Months Ended	12 Months Ended
	Dec. 31, 2017	Aug. 31, 2017	Dec. 31, 2016	Dec. 31, 2015
Successor [Member]
Excess Tax Benefits Recognized	$ 2
Predecessor [Member]
Excess Tax Benefits Recognized		$ 30
Excess Tax Benefit from Share-based Compensation, Operating Activities			$ 27	$ 74
Excess Tax Benefit from Share-based Compensation, Financing Activities			27	74
Cash Flows from Operating Activities [Member] | Predecessor [Member]
Payments Related to Tax Withholding for Share-based Compensation			30	32
Cash Flows from Financing Activities [Member] | Predecessor [Member]
Payments Related to Tax Withholding for Share-based Compensation			$ 30	$ 32

XML

Business Combinations Granular Acquisition (Details) $ in Millions	8 Months Ended
	Aug. 31, 2017 USD ($)
Predecessor [Member] | Granular Acquisition [Member]
Business Acquisition [Line Items]
Payments to Acquire Businesses, Gross	$ 250

XML

Business Combinations Merger with Dow Narrative (Details) - USD ($) $ / shares in Units, $ in Millions			1 Months Ended	2 Months Ended	3 Months Ended							4 Months Ended	8 Months Ended	12 Months Ended
		Aug. 31, 2017	Sep. 30, 2017	Aug. 31, 2017	Dec. 31, 2017	Jun. 30, 2017	Mar. 31, 2017	Dec. 31, 2016	Sep. 30, 2016	Jun. 30, 2016	Mar. 31, 2016	Dec. 31, 2017	Aug. 31, 2017	Dec. 31, 2016	Dec. 31, 2015	Aug. 30, 2017
Merger with Dow [Member]
Business Acquisition [Line Items]
Business Combination, Consideration Transferred		$ 74,680
Equity Awards converted but not yet earned		144
Business Combination, Recognized Identifiable Assets Acquired And Liabilities Assumed, Inventory, Finished Goods		4,929		$ 4,929									$ 4,929
Business Combination, Recognized Identifiable Assets Acquired And Liabilities Assumed, Inventory, Semi-finished goods		3,055		3,055									3,055
Business Combination, Recognized Identifiable Assets Acquired And Liabilities Assumed, Raw Materials and stores and supplies		823		823									823
Property, plant and equipment		11,941		11,941									11,941
Goodwill	[1]	45,105		$ 45,105									$ 45,105
Deferred Taxes, Business Combination, Adjustment To Derecognize Valuation Allowance		172
Deferred Taxes, Business Combination, Adjustment For Reinvestment Strategy		$ 546
DuPont [Member]
Business Acquisition [Line Items]
Common Stock, Par or Stated Value Per Share																$ 0.30
DuPont [Member] | $4.50 Series Preferred Stock [Member]
Business Acquisition [Line Items]
Preferred Stock, Par or Stated Value Per Share																4.50
DuPont [Member] | $3.50 Series Preferred Stock [Member]
Business Acquisition [Line Items]
Preferred Stock, Par or Stated Value Per Share																$ 3.50
DowDuPont [Member]
Business Acquisition [Line Items]
Common Stock, Par or Stated Value Per Share		$ 0.01		$ 0.01									$ 0.01
Common Stock [Member] | Merger with Dow [Member]
Business Acquisition [Line Items]
Share exchange ratio, DuPont to DowDuPont		1.2820
Machinery and Equipment [Member] | Merger with Dow [Member]
Business Acquisition [Line Items]
Property, plant and equipment		$ 7,466		$ 7,466									$ 7,466
Building [Member] | Merger with Dow [Member]
Business Acquisition [Line Items]
Property, plant and equipment		2,583		2,583									2,583
Construction in Progress [Member] | Merger with Dow [Member]
Business Acquisition [Line Items]
Property, plant and equipment		980		980									980
Land and Land Improvements [Member] | Merger with Dow [Member]
Business Acquisition [Line Items]
Property, plant and equipment		912		912									912
Successor [Member]
Business Acquisition [Line Items]
Common Stock, Par or Stated Value Per Share					$ 0.30							$ 0.30
Business Combination, Fair Value Step-Up Of Acquired Inventory, Amount recognized in Cost of Goods sold			$ 360		$ 1,109							$ 1,469
Goodwill		45,105		45,105	45,589							45,589	45,105
Integration and Separation Costs			$ (71)		$ (243)							314
Successor [Member] | Merger with Dow [Member]
Business Acquisition [Line Items]
Business Combination, Fair Value Step-Up Of Acquired Inventory Recognized Including Discontinued Operations												1,538
Business Combination, Fair Value Step-Up Of Acquired Inventory, Amount recognized in Cost of Goods sold												1,434
Disposal Group, Including Discontinued Operations, Fair Value Step-Up Of Acquired Inventory Recognized												$ 104
Predecessor [Member]
Business Acquisition [Line Items]
Common Stock, Par or Stated Value Per Share								$ 0.30						$ 0.30
Goodwill		$ 4,543		4,543				$ 4,169					4,543	$ 4,169	$ 4,238
Integration and Separation Costs						$ (201)	$ (170)	$ (164)	$ (122)	$ (76)	$ (24)		$ 581	$ 386	$ 10
Predecessor [Member] | Merger with Dow [Member]
Business Acquisition [Line Items]
Integration and Separation Costs				$ (210)

[1] See Note 12 for additional information.

XML

Business Combinations Fair Value of Consideration Exchanged (Details) - Merger with Dow [Member] $ / shares in Units, $ in Millions	Aug. 31, 2017 USD ($) $ / shares shares
Business Acquisition [Line Items]
Business Combination, Consideration Transferred, Equity Interests Issued and Issuable | $	$ 485	[1]
Business Combination, Consideration Transferred | $	$ 74,680
Common Stock [Member]
Business Acquisition [Line Items]
Share exchange ratio, DuPont to DowDuPont | shares	1.2820
Common Stock [Member] | DuPont [Member]
Business Acquisition [Line Items]
Common Stock, Shares, Outstanding | shares	868,300,000
Common Stock [Member] | DowDuPont [Member]
Business Acquisition [Line Items]
Stock Issued During Period, Shares, New Issues | shares	1,113,200,000
Business Combination, Consideration Transferred, Equity Interests Issued and Issuable | $	$ 74,195	[2]
Common Stock [Member] | Dow [Member]
Business Acquisition [Line Items]
Share Price | $ / shares	$ 66.65

[1] Represents the fair value of replacement awards issued for DuPont's equity awards outstanding immediately before the Merger and attributable to the service periods prior to the Merger. The previous DuPont equity awards were converted into the right to receive 1.2820 shares of DowDuPont Common Stock.

[2] Amount was determined based on the price per share of Dow Common Stock of $66.65 on August 31, 2017.

XML

Business Combinations Fair Value of Assets and Liabilities (Details) - Merger with Dow [Member] - USD ($) $ in Millions		4 Months Ended
		Dec. 31, 2017	Aug. 31, 2017
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets [Abstract]
Cash and Equivalents			$ 4,005
Marketable Securities			2,849
Accounts and Notes Receivable			7,851
Inventories			8,807
Other current assets			360
Inventory Measurement Period Adjustment	[1]	$ (79)
Investment in nonconsolidated affiliates			1,654
Investment in nonconsolidated affiliates measurement period adjustments	[1]	(31)
Assets held for sale - current			3,748
Assets held for sale - current measurement period adjustments	[1]	564
Property, plant and equipment			11,941
Property, plant and equipment measurement period adjustments	[1]	(181)
Goodwill	[2]		45,105
Goodwill, Measurement Period Adjustments	[1],[2]	(396)
Other intangible assets	[2]		27,221
Other intangible assets measurement period adjustments	[1],[2]	(623)
Deferred income taxes			284
Deferred income taxes, measurement period adjustments	[1]	(203)
Other assets			2,076
Total assets			115,901
Total assets, measurement period adjustments	[1]	(949)
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Liabilities [Abstract]
Short Term Borrowings and capital lease obligations			5,319
Accounts Payable			3,283
Income Taxes Payable			140
Accrued and other current liabilities			3,517
Liabilities Held For Sale Current			115
Liabilities Held For Sale Current measurement period adjustments	[1]	11
Long-term Debt			9,878
Deferred Tax Liabilities			8,468
Deferred Tax Liabilities measurement period adjustments	[1]	(940)
Pension And Other Postretirement Benefits Noncurrent			8,056
Pension And Other Postretirement Benefits Noncurrent measurement period adjustments	[1]	(36)
Other Noncurrent Obligations			2,028
Total Liabilities			40,804
Total liabilities measurement period adjustments	[1]	(965)
Noncontrolling interest			178
Noncontrolling interest measurement period adjustments	[1]	$ 16
Preferred Stock			239
Fair value of net assets			74,680
Scenario, Previously Reported [Member]
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets [Abstract]
Cash and Equivalents	[3]		4,005
Marketable Securities	[3]		2,849
Accounts and Notes Receivable	[3]		7,851
Inventories	[3]		8,886
Other current assets	[3]		360
Investment in nonconsolidated affiliates	[3]		1,685
Assets held for sale - current	[3]		3,184
Property, plant and equipment	[3]		12,122
Goodwill	[2],[3]		45,501
Other intangible assets	[2],[3]		27,844
Deferred income taxes	[3]		487
Other assets	[3]		2,076
Total assets	[3]		116,850
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Liabilities [Abstract]
Short Term Borrowings and capital lease obligations	[3]		5,319
Accounts Payable	[3]		3,283
Income Taxes Payable	[3]		140
Accrued and other current liabilities	[3]		3,517
Liabilities Held For Sale Current	[3]		104
Long-term Debt	[3]		9,878
Deferred Tax Liabilities	[3]		9,408
Pension And Other Postretirement Benefits Noncurrent	[3]		8,092
Other Noncurrent Obligations	[3]		2,028
Total Liabilities	[3]		41,769
Noncontrolling interest	[3]		162
Preferred Stock	[3]		239
Fair value of net assets	[3]		$ 74,680

[1] DuPont recorded measurement period adjustments in the fourth quarter of 2017 to reflect facts and circumstances in existence as of the Merger Effectiveness Time. These measurement period adjustments primarily related to changes in preliminary valuation assumptions, including market participant estimates of cash flows and estimates of asset useful lives, as well as other initial estimates. All measurement period adjustments were offset against goodwill.

[2] See Note 12 for additional information.

[3] As previously reported in the company’s Quarterly Report on Form 10-Q for the period ended September 30, 2017.

XML

Business Combinations Summary of H&N Business Consideration (Details) - Successor [Member] $ in Millions	Nov. 01, 2017 USD ($)
H&N Business [Member]
Business Acquisition [Line Items]
Favorable Contracts	$ 495	[1]
Fair Value of H&N Business	1,970
Divested Ag Business [Member] | Discontinued Operations, Disposed of by Sale [Member]
Business Acquisition [Line Items]
Fair Value of Divested Ag Business	3,665	[2]
Cash Received	$ 1,200

[1] Upon closing and pursuant to the terms of the FMC Transaction Agreement, DuPont entered into favorable supply contracts with FMC. DuPont recorded these contracts as intangible assets recognized at the fair value of off-market contracts. Refer to Notes 4 and 12 for additional information.

[2] Refer to Note 4 for additional information.

XML

Business Combinations H&N Acquisition - Fair Value of Assets and Liabilities (Details) - Successor [Member] - USD ($) $ in Millions	Dec. 31, 2017	Nov. 01, 2017	Aug. 31, 2017
Business Acquisition [Line Items]
Goodwill	$ 45,589		$ 45,105
H&N Business [Member]
Business Acquisition [Line Items]
Cash and Equivalents		$ 16
Accounts and Notes Receivable		144
Inventories		314
Property, plant and equipment		505
Goodwill		718
Other intangible assets		435
Other current and non-current assets		16
Total assets		2,148
Accounts payable and other accrued liabilities		70
Deferred Tax Liabilities		108
Total Liabilities		178
Fair value of net assets		$ 1,970

XML

Business Combinations H&N Acquisition Narrative (Details) - Successor [Member] - USD ($) $ in Millions	1 Months Ended	2 Months Ended	3 Months Ended	4 Months Ended
	Sep. 30, 2017	Dec. 31, 2017	Dec. 31, 2017	Dec. 31, 2017	Nov. 01, 2017	Aug. 31, 2017
Business Acquisition [Line Items]
Net Sales	$ 1,735		$ 5,318	$ 7,053
(Loss) Income from Continuing Operations before Income Taxes				(1,586)
Business Combination, Fair Value Step-Up Of Acquired Inventory, Amount recognized in Cost of Goods sold	$ 360		1,109	1,469
Goodwill		$ 45,589	$ 45,589	$ 45,589		$ 45,105
H&N Business [Member]
Business Acquisition [Line Items]
Net Sales		102
(Loss) Income from Continuing Operations before Income Taxes		(12)
Business Combination, Recognized Identifiable Assets Acquired And Liabilities Assumed, Inventory, Finished Goods					$ 153
Business Combination, Recognized Identifiable Assets Acquired And Liabilities Assumed, Inventory, Semi-finished goods					85
Business Combination, Recognized Identifiable Assets Acquired And Liabilities Assumed, Raw Materials and stores and supplies					76
Business Combination, Fair Value Step Up Of Acquired Inventory					100
Business Combination, Fair Value Step-Up Of Acquired Inventory, Amount recognized in Cost of Goods sold		$ 35
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment					505
Goodwill					718
Business Acquisition, Goodwill, Expected Tax Deductible Amount					208
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Other than Goodwill					435
H&N Business [Member] | Machinery and Equipment [Member]
Business Acquisition [Line Items]
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment					372
H&N Business [Member] | Building [Member]
Business Acquisition [Line Items]
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment					63
H&N Business [Member] | Land and Land Improvements [Member]
Business Acquisition [Line Items]
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment					39
H&N Business [Member] | Construction in Progress [Member]
Business Acquisition [Line Items]
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment					31
H&N Business [Member] | Customer-Related Intangible Assets [Member]
Business Acquisition [Line Items]
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Other than Goodwill					268
H&N Business [Member] | Developed Technology Rights [Member]
Business Acquisition [Line Items]
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Other than Goodwill					130
H&N Business [Member] | Trademarks and Trade Names [Member]
Business Acquisition [Line Items]
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Other than Goodwill					$ 37

XML

Divestitures and Other Transactions Divestitures and Other Transactions - Narrative (Details) - Successor [Member] - USD ($) $ in Millions		Nov. 01, 2017	Dec. 31, 2017
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Favorable Supply Agreement Intangible			$ 16,334
H&N Business [Member]
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Preliminary Fair Value		$ 1,970
Favorable Supply Contract [Member]
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Favorable Supply Agreement Intangible	[1]		$ 495
Favorable Supply Contract [Member] | Divested Ag Business [Member]
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Definite-Lived Intangible Asset, Useful Life		5 years
Discontinued Operations, Disposed of by Sale [Member] | Divested Ag Business [Member]
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Cash Consideration		$ 1,200

[1] Upon closing and pursuant to the terms of the FMC Transaction Agreement, DuPont entered into favorable supply contracts with FMC. DuPont recorded these contracts as intangible assets recognized at the fair value of off-market contracts. Refer to Notes 3 and 4 for additional information.

XML

Divestitures and Other Transactions Divestitures and Other Transactions - Divested Ag Business Results of Operations (Details) - USD ($) $ in Millions		4 Months Ended	8 Months Ended	12 Months Ended
		Dec. 31, 2017	Aug. 31, 2017	Dec. 31, 2016	Dec. 31, 2015
Successor [Member]
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
(Loss) Income from discontinued operations after income taxes		$ (77)
Successor [Member] | Divested Ag Business [Member]
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Disposal Group, Including Discontinued Operation, Transaction Costs		44
Net Sales, Discontinued Operations	[1]	199
Cost of Goods Sold, Discontinued Operations	[1]	194
Research and Development Expense, Discontinued Operations	[1]	30
Selling, General and Administrative, Discontinued Operations	[1],[2]	102
Restructuring and Asset Related Charges - Net, Discontinued Operations	[1]	(1)
Sundry Income (Expense) - Net, Discontinued Operations	[1]	(1)
(Loss) Income from Discontinued Operation, before Income Taxes	[1]	(127)
(Benefit from) Provision for Income Taxes, Discontinued Operation	[1]	(50)
(Loss) Income from discontinued operations after income taxes	[1]	$ (77)
Predecessor [Member]
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
(Loss) Income from discontinued operations after income taxes			$ 119	$ 443	$ 512
Predecessor [Member] | Divested Ag Business [Member]
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Net Sales, Discontinued Operations			1,068	1,385	1,473
Cost of Goods Sold, Discontinued Operations			412	514	521
Other Operating Charges, Discontinued Operations			17	19	25
Research and Development Expense, Discontinued Operations			95	139	163
Selling, General and Administrative, Discontinued Operations			146	176	187
Restructuring and Asset Related Charges - Net, Discontinued Operations			0	(4)	15
Sundry Income (Expense) - Net, Discontinued Operations			7	1	7
(Loss) Income from Discontinued Operation, before Income Taxes			405	542	569
(Benefit from) Provision for Income Taxes, Discontinued Operation			79	103	121
(Loss) Income from discontinued operations after income taxes			$ 326	$ 439	$ 448

[1] Includes results of operations for the period September 1 through October 31, 2017, as the Divested Ag Business was disposed of on November 1, 2017.

[2] Successor period includes $44 million of transaction costs associated with the disposal of the Divested Ag Business.

XML

Divestitures and Other Transactions Divestitures and Other Transactions - Divested Ag Business Depreciation and Capital Expenditures (Details) - Divested Ag Business [Member] - USD ($) $ in Millions	4 Months Ended	8 Months Ended	12 Months Ended
	Dec. 31, 2017	Aug. 31, 2017	Dec. 31, 2016	Dec. 31, 2015
Successor [Member]
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Depreciation, Discontinued Operations	$ 0
Capital Expenditures, Discontinued Operations	$ 5
Predecessor [Member]
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Depreciation, Discontinued Operations		$ 21	$ 32	$ 30
Capital Expenditures, Discontinued Operations		$ 8	$ 40	$ 77

XML

Divestitures and Other Transactions Divestitures and Other Transactions - Divested Ag Business Assets and Liabilities (Details) - Predecessor [Member] - USD ($) $ in Millions	Aug. 31, 2017	Dec. 31, 2016	Dec. 31, 2015
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Disposal Group, Including Discontinued Operation, Cash and Cash Equivalents	$ (31)	$ 15	$ 22
Divested Ag Business [Member]
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Disposal Group, Including Discontinued Operation, Cash and Cash Equivalents		57
Disposal Group, Including Discontinued Operation, Accounts, Accounts and Notes Receivable, Net		12
Disposal Group, Including Discontinued Operation, Inventories		323
Disposal Group, Including Discontinued Operation, Other Current Assets		1
Disposal Group, Including Discontinued Operation, Property, Plant and Equipment, Net		380
Disposal Group, Including Discontinued Operation, Goodwill		11
Disposal Group, Including Discontinued Operation, Other Assets		5
Disposal Group, Including Discontinued Operation, Assets		789
Disposal Group, Including Discontinued Operation, Accounts Payable		27
Disposal Group, Including Discontinued Operation, Accrued and Other Current Liabilities		12
Disposal Group, Including Discontinued Operation, Deferred Income Tax Liabilities		6
Disposal Group, Including Discontinued Operation, Other Noncurrent Obligations		29
Disposal Group, Including Discontinued Operation, Liabilities		$ 74

XML

Divestitures and Other Transactions Divestitures and Other Transactions - Food Safety Diagnostic Business (Details) - Predecessor [Member] - Food Safety Diagnostic Business [Member] $ in Millions	8 Months Ended
	Aug. 31, 2017 USD ($)
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Pre-tax gain on disposal	$ 162
Gain on disposal, net of tax	$ 86

XML

Divestitures and Other Transactions Divestitures and Other Transactions - Shenzhen (Details) - Predecessor [Member] - DuPont (Shenzhen) Manufacturing Limited [Member] $ in Millions	12 Months Ended
	Dec. 31, 2016 USD ($)
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Ownership interest in an entity	100.00%
Gain on sale of entity	$ 369
Gain on sale of entity, after tax	$ 214

XML

Divestitures and Other Transactions Divestitures and Other Transactions - PChem Narrative (Details) - USD ($) $ in Millions	1 Months Ended	8 Months Ended	12 Months Ended
	May 31, 2015	Aug. 31, 2017	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2017	Jul. 01, 2015	May 12, 2015
Predecessor [Member]
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Separation Related Transaction Costs			$ 35	$ 306
Dividend received from Chemours	$ 3,923
Cash distribution received from Chemours	3,416
Net assets transferred at spin-off						$ 431
Predecessor [Member] | Performance Chemicals [Member]
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Restructuring and Related Cost, Incurred Cost		$ 0	0	59
Predecessor [Member] | Chemours' Debt [Member]
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Proceeds from Issuance of Debt	$ 4,000
Predecessor [Member] | Senior Notes 7 Percent Due 2025 [Member] | Chemours Notes Received [Member]
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Senior Notes Payable							$ 507
Debt Instrument, Interest Rate							7.00%
Predecessor [Member] | Discontinued Operations [Member]
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Separation Related Transaction Costs			$ 35	260
Pension & OPEB, Net Periodic Benefit Cost, Gain Due to Curtailment				281
Predecessor [Member] | Discontinued Operations [Member] | PFOA Matters: Multi-District Litigation [Member]
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Gain (Loss) Related to Litigation Settlement		335
Gain (Loss) Related To Litigation Settlement, Net Of Tax		$ 214
Predecessor [Member] | Continuing Operations [Member]
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Separation Related Transaction Costs				26
Predecessor [Member] | Continuing Operations [Member] | Loss on extinguishment of debt [Member]
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Separation Related Transaction Costs				$ 20
Accounts and Notes Receivable [Member] | Successor [Member]
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Indemnification Assets					$ 80
Other Assets [Member] | Successor [Member]
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Indemnification Assets					340
Accrued and Other Current Liabilities [Member] | Successor [Member]
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Indemnification Liabilities					80
Other Noncurrent Obligations [Member] | Successor [Member]
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Indemnification Liabilities					$ 340

XML

Divestitures and Other Transactions Divestitures and Other Transactions - PChem Results of Operations (Details) - Predecessor [Member] - USD ($) $ in Millions	8 Months Ended	12 Months Ended
	Aug. 31, 2017	Dec. 31, 2016	Dec. 31, 2015
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
(Loss) Income from discontinued operations after income taxes	$ 119	$ 443	$ 512
Performance Chemicals [Member]
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Net Sales, Discontinued Operations	0	0	2,810
Cost of Goods Sold, Discontinued Operations	0	0	2,215
Other Operating Charges, Discontinued Operations	335	36	386
Research and Development Expense, Discontinued Operations	0	0	40
Selling, General and Administrative, Discontinued Operations	0	0	(87)
Restructuring and Asset Related Charges - Net, Discontinued Operations	0	0	59
Sundry Income (Expense) - Net, Discontinued Operations	3	3	27
Interest Expense, Discontinued Operations	0	0	32
(Loss) Income from Discontinued Operation, before Income Taxes	(332)	(33)	192
(Benefit from) Provision for Income Taxes, Discontinued Operation	(125)	(28)	106
(Loss) Income from discontinued operations after income taxes	$ (207)	$ (5)	$ 86

XML

Divestitures and Other Transactions Divestitures and Other Transactions - PChem Depreciation, Capital Expenditures and Amortization (Details) - Predecessor [Member] - Performance Chemicals [Member] $ in Millions	12 Months Ended
	Dec. 31, 2015 USD ($)
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Depreciation, Discontinued Operations	$ 126
Amortization Expense, Discontinued Operations	2
Capital Expenditures, Discontinued Operations	$ 235

XML

Restructuring and Asset Related Charges DowDuPont Cost Synergy Program (Details) - Successor [Member] - USD ($) $ in Millions		1 Months Ended		3 Months Ended		4 Months Ended
		Sep. 30, 2017	[1]	Dec. 31, 2017		Dec. 31, 2017	Nov. 01, 2017
Restructuring Cost and Reserve [Line Items]
Restructuring and Asset Related Charges - Net		$ 40		$ 140	[1]	$ 180
DowDuPont Cost Synergy Program [Member]
Restructuring Cost and Reserve [Line Items]
Restructuring and Asset Related Charges - Net						187
Payments for Restructuring						(16)
Asset write-offs						(3)
Non-Cash Compensation						(7)
Restructuring Reserve				161		161
Employee Severance [Member] | DowDuPont Cost Synergy Program [Member]
Restructuring Cost and Reserve [Line Items]
Restructuring and Asset Related Charges - Net						153
Payments for Restructuring						(13)
Asset write-offs						0
Non-Cash Compensation						(7)
Restructuring Reserve				133		133
Other Non-Personnel Charges | DowDuPont Cost Synergy Program [Member]
Restructuring Cost and Reserve [Line Items]
Restructuring and Asset Related Charges - Net	[2]					31
Payments for Restructuring	[2]					(3)
Asset write-offs	[2]					0
Non-Cash Compensation	[2]					0
Restructuring Reserve	[2]			28		28
Asset Related Charges [Member] | DowDuPont Cost Synergy Program [Member]
Restructuring Cost and Reserve [Line Items]
Restructuring and Asset Related Charges - Net						3
Payments for Restructuring						0
Asset write-offs						(3)
Non-Cash Compensation						0
Restructuring Reserve				$ 0		$ 0
Minimum [Member] | DowDuPont Cost Synergy Program [Member]
Restructuring Cost and Reserve [Line Items]
Restructuring and Related Cost, Expected Cost							$ 430
Minimum [Member] | Employee Severance [Member] | DowDuPont Cost Synergy Program [Member]
Restructuring Cost and Reserve [Line Items]
Restructuring and Related Cost, Expected Cost							320
Minimum [Member] | Other Non-Personnel Charges | DowDuPont Cost Synergy Program [Member]
Restructuring Cost and Reserve [Line Items]
Restructuring and Related Cost, Expected Cost							110
Maximum [Member] | DowDuPont Cost Synergy Program [Member]
Restructuring Cost and Reserve [Line Items]
Restructuring and Related Cost, Expected Cost							600
Maximum [Member] | Employee Severance [Member] | DowDuPont Cost Synergy Program [Member]
Restructuring Cost and Reserve [Line Items]
Restructuring and Related Cost, Expected Cost							360
Maximum [Member] | Other Non-Personnel Charges | DowDuPont Cost Synergy Program [Member]
Restructuring Cost and Reserve [Line Items]
Restructuring and Related Cost, Expected Cost							140
Maximum [Member] | Asset Related Charges [Member] | DowDuPont Cost Synergy Program [Member]
Restructuring Cost and Reserve [Line Items]
Restructuring and Related Cost, Expected Cost							$ 100

[1] See Note 5 for additional information.

[2] Other non-personnel charges consist of contractual obligation costs.

XML

Restructuring and Asset Related Charges 2017 Restructuring Program (Details) - USD ($) $ in Millions		1 Months Ended		2 Months Ended		3 Months Ended														4 Months Ended	8 Months Ended	12 Months Ended
		Sep. 30, 2017	[1]	Aug. 31, 2017		Dec. 31, 2017		Jun. 30, 2017	[1]	Mar. 31, 2017	[1]	Dec. 31, 2016	[1]	Sep. 30, 2016	[1]	Jun. 30, 2016	[1]	Mar. 31, 2016	[1]	Dec. 31, 2017	Aug. 31, 2017	Dec. 31, 2016	Dec. 31, 2015
Predecessor [Member]
Restructuring Cost and Reserve [Line Items]
Restructuring and Asset Related Charges - Net				$ 11	[1]			$ 160		$ 152		$ 394		$ 172		$ (88)		$ 78			$ 323	$ 556	$ 795
Predecessor [Member] | 2017 Restructuring Program [Member]
Restructuring Cost and Reserve [Line Items]
Restructuring and Asset Related Charges - Net																					313
Payments for Restructuring																					(8)
Asset write-offs																					(279)
Restructuring Reserve				26																	26
Predecessor [Member] | Employee Severance [Member] | 2017 Restructuring Program [Member]
Restructuring Cost and Reserve [Line Items]
Restructuring and Asset Related Charges - Net																					34
Payments for Restructuring																					(8)
Asset write-offs																					0
Restructuring Reserve				26																	26
Predecessor [Member] | Asset Related Charges [Member] | 2017 Restructuring Program [Member]
Restructuring Cost and Reserve [Line Items]
Restructuring and Asset Related Charges - Net	[2]																				279
Payments for Restructuring																					0
Asset write-offs	[2]																				(279)
Restructuring Reserve				$ 0																	$ 0
Successor [Member]
Restructuring Cost and Reserve [Line Items]
Restructuring and Asset Related Charges - Net		$ 40				$ 140	[1]													$ 180
Successor [Member] | 2017 Restructuring Program [Member]
Restructuring Cost and Reserve [Line Items]
Restructuring and Asset Related Charges - Net																				0
Payments for Restructuring																				(7)
Restructuring Reserve						19														19
Successor [Member] | Employee Severance [Member] | 2017 Restructuring Program [Member]
Restructuring Cost and Reserve [Line Items]
Restructuring and Asset Related Charges - Net																				0
Payments for Restructuring																				(7)
Restructuring Reserve						19														19
Successor [Member] | Asset Related Charges [Member] | 2017 Restructuring Program [Member]
Restructuring Cost and Reserve [Line Items]
Restructuring and Asset Related Charges - Net																				0
Payments for Restructuring																				0
Restructuring Reserve						$ 0														$ 0

[1] See Note 5 for additional information.

[2] Includes accelerated depreciation related to site closure. Charge for accelerated depreciation represents the difference between the depreciation expense to be recognized over the revised useful life of the site, based upon the anticipated date the site will be closed and depreciation expense as determined utilizing the useful life prior to the restructuring action.

XML

Restructuring and Asset Related Charges La Porte (Details) - Predecessor [Member] - USD ($) $ in Millions	2 Months Ended		3 Months Ended												8 Months Ended	12 Months Ended
	Aug. 31, 2017	[1]	Jun. 30, 2017	[1]	Mar. 31, 2017	[1]	Dec. 31, 2016	[1]	Sep. 30, 2016	[1]	Jun. 30, 2016	[1]	Mar. 31, 2016	[1]	Aug. 31, 2017	Dec. 31, 2016	Dec. 31, 2015
Restructuring Cost and Reserve [Line Items]
Restructuring and Asset Related Charges - Net	$ 11		$ 160		$ 152		$ 394		$ 172		$ (88)		$ 78		$ 323	$ 556	$ 795
La Porte [Member]
Restructuring Cost and Reserve [Line Items]
Restructuring and Asset Related Charges - Net																68
Asset Related Charges [Member] | La Porte [Member]
Restructuring Cost and Reserve [Line Items]
Restructuring and Asset Related Charges - Net																41
Employee Severance [Member] | La Porte [Member]
Restructuring Cost and Reserve [Line Items]
Restructuring and Asset Related Charges - Net																16
Contract Termination [Member] | La Porte [Member]
Restructuring Cost and Reserve [Line Items]
Restructuring and Asset Related Charges - Net																$ 11

[1] See Note 5 for additional information.

XML

Restructuring and Asset Related Charges 2016 Global Cost Savings and Restructuring Plan (Details) - USD ($) $ in Millions		1 Months Ended		2 Months Ended		3 Months Ended														4 Months Ended	8 Months Ended	12 Months Ended
		Sep. 30, 2017		Aug. 31, 2017		Dec. 31, 2017		Jun. 30, 2017	[1]	Mar. 31, 2017		Dec. 31, 2016		Sep. 30, 2016	[1]	Jun. 30, 2016	[1]	Mar. 31, 2016	[1]	Dec. 31, 2017	Aug. 31, 2017	Dec. 31, 2016	Dec. 31, 2015
Predecessor [Member]
Restructuring Cost and Reserve [Line Items]
Restructuring and Asset Related Charges - Net				$ 11	[1]			$ 160		$ 152	[1]	$ 394	[1]	$ 172		$ (88)		$ 78			$ 323	$ 556	$ 795
Predecessor [Member] | 2016 Restructuring Program [Member]
Restructuring Cost and Reserve [Line Items]
Restructuring and Asset Related Charges - Net																					10	(81)	783
Restructuring Reserve, Beginning Balance		$ 47								122										$ 47	122
Payments for Restructuring																					(87)
Restructuring Reserve, Net Translation Adjustment																					2
Restructuring Reserve, Other Adjustment																					10
Restructuring Reserve, Ending Balance				47								122									47	122
Predecessor [Member] | 2016 Restructuring Program [Member] | Sundry Income (Expense) - net
Restructuring Cost and Reserve [Line Items]
Restructuring and Asset Related Charges - Net																						3	5
Predecessor [Member] | 2016 Restructuring Program [Member] | Restructuring and Asset Related Charges - Net [Member]
Restructuring Cost and Reserve [Line Items]
Restructuring and Asset Related Charges - Net																						(84)	778
Predecessor [Member] | Employee Severance [Member] | 2016 Restructuring Program [Member]
Restructuring Cost and Reserve [Line Items]
Restructuring and Asset Related Charges - Net																						(150)	641
Restructuring Reserve, Beginning Balance		36								100										36	100
Payments for Restructuring																					(76)
Restructuring Reserve, Net Translation Adjustment																					2
Restructuring Reserve, Other Adjustment																					10
Restructuring Reserve, Ending Balance				36								100									36	100
Predecessor [Member] | Asset Related Charges [Member] | 2016 Restructuring Program [Member]
Restructuring Cost and Reserve [Line Items]
Restructuring and Asset Related Charges - Net																						53	109
Predecessor [Member] | Contract Termination [Member] | 2016 Restructuring Program [Member]
Restructuring Cost and Reserve [Line Items]
Restructuring and Asset Related Charges - Net																						16	$ 33
Restructuring Reserve, Beginning Balance	[2]	11								$ 22										11	22
Payments for Restructuring	[2]																				(11)
Restructuring Reserve, Net Translation Adjustment	[2]																				0
Restructuring Reserve, Other Adjustment	[2]																				0
Restructuring Reserve, Ending Balance	[2]			11								$ 22									11	$ 22
Successor [Member]
Restructuring Cost and Reserve [Line Items]
Restructuring and Asset Related Charges - Net		40	[1]			$ 140	[1]													180
Successor [Member] | 2016 Restructuring Program [Member]
Restructuring Cost and Reserve [Line Items]
Restructuring and Asset Related Charges - Net																				(5)
Restructuring Reserve, Beginning Balance		47																		47
Payments for Restructuring																				(20)
Restructuring Reserve, Other Adjustment																				(5)
Restructuring Reserve, Ending Balance				47		22														22	47
Successor [Member] | Employee Severance [Member] | 2016 Restructuring Program [Member]
Restructuring Cost and Reserve [Line Items]
Restructuring Reserve, Beginning Balance		36																		36
Payments for Restructuring																				(18)
Restructuring Reserve, Other Adjustment																				(5)
Restructuring Reserve, Ending Balance				36		13														13	36
Successor [Member] | Contract Termination [Member] | 2016 Restructuring Program [Member]
Restructuring Cost and Reserve [Line Items]
Restructuring Reserve, Beginning Balance	[2]	$ 11																		11
Payments for Restructuring	[2]																			(2)
Restructuring Reserve, Other Adjustment	[2]																			0
Restructuring Reserve, Ending Balance	[2]			$ 11		$ 9														$ 9	$ 11

[1] See Note 5 for additional information.

[2] Other non-personnel charges consist of contractual obligation costs.

XML

Restructuring and Asset Related Charges 2014 Restructuring Program (Details) - 2014 Restructuring Program [Member] - USD ($) $ in Millions	4 Months Ended	12 Months Ended
	Dec. 31, 2017	Dec. 31, 2016	Dec. 31, 2015
Successor [Member]
Restructuring Cost and Reserve [Line Items]
Restructuring Reserve, Other Adjustment	$ (2)
Predecessor [Member]
Restructuring Cost and Reserve [Line Items]
Restructuring Reserve, Other Adjustment		$ (21)	$ (21)

XML

Restructuring and Asset Related Charges Asset Impairments (Details) - Predecessor [Member] - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2016	Dec. 31, 2015
Restructuring Cost and Reserve [Line Items]
Capitalized Computer Software, Gross	$ 435
Property, Plant, and Equipment, Fair Value Disclosure	0
Asset Impairment Charges	435	$ 38
Cost basis investment ownership		6.00%
Cost-method Investments, Other than Temporary Impairment [Member]
Restructuring Cost and Reserve [Line Items]
Cost-Method Investments Impairment		$ 37
Trade Names [Member]
Restructuring Cost and Reserve [Line Items]
Asset Impairment Charges	158
Remaining Net Book Value, Trade Name	$ 28

XML

Supplementary Information Sundry Income (Expense) - Net (Details) - USD ($) $ in Millions		4 Months Ended	8 Months Ended		12 Months Ended
		Dec. 31, 2017	Aug. 31, 2017		Dec. 31, 2016		Dec. 31, 2015
Successor [Member]
Schedule of Sundry Income (Expense) - Net [Line Items]
Royalty income		$ 60
Interest income		41
Equity in earnings of affiliates - net		1
Net gain on sales of businesses and other assets		16
Net exchange gains (losses)		8
Miscellaneous income and expenses, net	[1]	24
Sundry income - net		$ 90
Predecessor [Member]
Schedule of Sundry Income (Expense) - Net [Line Items]
Royalty income			$ 84		$ 170		$ 138
Interest income			83		102		124
Equity in earnings of affiliates - net			55		99		49
Net gain on sales of businesses and other assets			205	[2]	435	[3]	92
Net exchange gains (losses)			(394)		(106)		30
Miscellaneous income and expenses, net	[1]		133		7		257
Sundry income - net			166		707		$ 690
Food Safety Diagnostic Business [Member] | Predecessor [Member]
Schedule of Sundry Income (Expense) - Net [Line Items]
Pre-tax gain on disposal			162
Gain on disposal, net of tax			$ 86
DuPont (Shenzhen) Manufacturing Limited [Member] | Predecessor [Member]
Schedule of Sundry Income (Expense) - Net [Line Items]
Gain on sale of entity					369
Gain on sale of entity, after tax					$ 214

[1] Miscellaneous income and expenses - net, includes interest items (in the Predecessor period only), gains (losses) on available for sale securities, gains related to litigation settlements, licensing income, gains on purchases, and other items.

[2] Includes a pre-tax gain of $162 million ($86 million net of tax) for the period January 1 through August 31, 2017 related to the sale of global food safety diagnostics. See Note 4 for additional information.

[3] Includes a pre-tax gain of $369 million ($214 million net of tax) for the year ended December 31, 2016 related to the sale of DuPont (Shenzhen) Manufacturing Limited. See Note 4 for additional information.

XML

Supplementary Information Foreign Currency Exchange Gain (Loss) (Details) - USD ($) $ in Millions	4 Months Ended	8 Months Ended	12 Months Ended
	Dec. 31, 2017	Aug. 31, 2017	Dec. 31, 2016	Dec. 31, 2015
Successor [Member]
Foreign Currency Exchange Gain (Loss) [Line Items]
Foreign Currency Transaction Gain (Loss), before Tax	$ 8
Foreign Currency Transaction Gain (Loss) Tax	(36)
Foreign Currency Transaction Gain (Loss) After Tax	(28)
Predecessor [Member]
Foreign Currency Exchange Gain (Loss) [Line Items]
Foreign Currency Transaction Gain (Loss), before Tax		$ (394)	$ (106)	$ 30
Foreign Currency Transaction Gain (Loss) Tax		372	(16)	(218)
Foreign Currency Transaction Gain (Loss) After Tax		(22)	(122)	(188)
Subsidiary Monetary Position | Successor [Member]
Foreign Currency Exchange Gain (Loss) [Line Items]
Foreign Currency Transaction Gain (Loss), before Tax	(83)
Foreign Currency Transaction Gain (Loss) Tax	(3)
Foreign Currency Transaction Gain (Loss) After Tax	(86)
Subsidiary Monetary Position | Predecessor [Member]
Foreign Currency Exchange Gain (Loss) [Line Items]
Foreign Currency Transaction Gain (Loss), before Tax		37	198	(404)
Foreign Currency Transaction Gain (Loss) Tax		217	(126)	(61)
Foreign Currency Transaction Gain (Loss) After Tax		254	72	(465)
Hedging Program [Member] | Successor [Member]
Foreign Currency Exchange Gain (Loss) [Line Items]
Foreign Currency Transaction Gain (Loss), before Tax	91
Foreign Currency Transaction Gain (Loss) Tax	(33)
Foreign Currency Transaction Gain (Loss) After Tax	$ 58
Hedging Program [Member] | Predecessor [Member]
Foreign Currency Exchange Gain (Loss) [Line Items]
Foreign Currency Transaction Gain (Loss), before Tax		(431)	(304)	434
Foreign Currency Transaction Gain (Loss) Tax		155	110	(157)
Foreign Currency Transaction Gain (Loss) After Tax		$ (276)	$ (194)	$ 277

XML

Supplementary Information Supplementary Information (Narrative) (Details) - USD ($) $ in Millions	3 Months Ended	4 Months Ended
	Dec. 31, 2017	Dec. 31, 2017	Nov. 02, 2017	Dec. 31, 2016
Successor [Member]
Restricted Cash	$ 558	$ 558
Accrued and other current liabilities	4,384	4,384
Deferred Revenue	2,014	2,014
Compensation and other employee-related costs	857	857
Other noncurrent obligations	1,975	1,975
Accrued benefit costs	7,787	7,787
Stock Repurchase Program, Authorized Amount			$ 4,000
Distributions to DowDuPont	829	(829)
Successor [Member] | DowDuPont [Member]
Accounts Payable, Related Parties	354	354
Successor [Member] | Other Current Assets [Member]
Restricted Cash	$ 558	$ 558
Predecessor [Member]
Accrued and other current liabilities				$ 4,650
Deferred Revenue				2,217
Compensation and other employee-related costs				807
Other noncurrent obligations				12,304
Predecessor [Member] | Pension Plan
Accrued benefit costs				8,092
Predecessor [Member] | Other Post Employment Benefits Plan
Accrued benefit costs				$ 2,554

XML

Income Taxes Income Taxes - Narrative (Details) - USD ($) $ in Millions	1 Months Ended	3 Months Ended	4 Months Ended	8 Months Ended	12 Months Ended
	Sep. 30, 2017	Dec. 31, 2017	Dec. 31, 2017	Aug. 31, 2017	Dec. 31, 2016	Dec. 31, 2015
Successor [Member]
Operating Loss Carryforwards [Line Items]
Tax Cuts and Jobs Act of 2017, Incomplete Accounting, Change in Tax Rate, Provisional Income Tax Benefit			$ (2,716)
Tax Cuts and Jobs Act of 2017, Incomplete Accounting, Transition Tax for Accumulated Foreign Earnings, Provisional Income Tax Expense			715
Undistributed Earnings of Foreign Subsidiaries		$ 15,408	15,408
(Loss) Income from Continuing Operations before Income Taxes, Foreign			(775)
Business Combination, Fair Value Step-Up Of Acquired Inventory, Amount recognized in Cost of Goods sold	$ 360	$ 1,109	$ 1,469
Predecessor [Member]
Operating Loss Carryforwards [Line Items]
Undistributed Earnings of Foreign Subsidiaries					$ 17,380	$ 16,053
(Loss) Income from Continuing Operations before Income Taxes, Foreign				$ 1,382	$ 1,308	$ 721

XML

Income Taxes Income Taxes - Geographic Allocation of Income and Provision for Income Taxes (Details) - USD ($) $ in Millions	1 Months Ended		2 Months Ended		3 Months Ended														4 Months Ended	8 Months Ended	12 Months Ended
	Sep. 30, 2017	[1],[2]	Aug. 31, 2017	[1]	Dec. 31, 2017	[1],[2],[3]	Jun. 30, 2017	[1]	Mar. 31, 2017	[1],[4],[5]	Dec. 31, 2016	[6]	Sep. 30, 2016	[6]	Jun. 30, 2016	[6]	Mar. 31, 2016	[6],[7]	Dec. 31, 2017	Aug. 31, 2017	Dec. 31, 2016	Dec. 31, 2015
Successor [Member]
(Loss) Income from Continuing Operations before Income Taxes, Domestic																			$ (811)
(Loss) Income from Continuing Operations before Income Taxes, Foreign																			(775)
(Loss) Income from Continuing Operations before Income Taxes																			(1,586)
(Benefit from) provision for income taxes on continuing operations																			(2,673)
Net income (loss)	$ (295)				$ 1,305														1,010
Predecessor [Member]
(Loss) Income from Continuing Operations before Income Taxes, Domestic																				$ 409	$ 1,415	$ 1,301
(Loss) Income from Continuing Operations before Income Taxes, Foreign																				1,382	1,308	721
(Loss) Income from Continuing Operations before Income Taxes																				1,791	2,723	2,022
(Benefit from) provision for income taxes on continuing operations																				149	641	575
Net income (loss)			$ (229)				$ 869		$ 1,121		$ 263		$ 6		$ 1,024		$ 1,232			1,761	2,525	1,959
Continuing Operations [Member] | Successor [Member]
Current Federal Tax Expense (Benefit)																			216
Current State and Local Tax Expense (Benefit)																			22
Current Foreign Tax Expense (Benefit)																			187
Current Income Tax Expense (Benefit)																			425
Deferred Federal Income Tax (Benefit) Expense																			(2,790)
Deferred State and Local Income Tax (Benefit) Expense																			(48)
Deferred Foreign Income Tax (Benefit) Expense																			(260)
Deferred Income Tax (Benefit) Expense																			(3,098)
(Benefit from) provision for income taxes on continuing operations																			(2,673)
Net income (loss)																			$ 1,087
Continuing Operations [Member] | Predecessor [Member]
Current Federal Tax Expense (Benefit)																				(563)	4	155
Current State and Local Tax Expense (Benefit)																				(11)	9	2
Current Foreign Tax Expense (Benefit)																				282	539	420
Current Income Tax Expense (Benefit)																				(292)	552	577
Deferred Federal Income Tax (Benefit) Expense																				476	22	135
Deferred State and Local Income Tax (Benefit) Expense																				(8)	(29)	4
Deferred Foreign Income Tax (Benefit) Expense																				(27)	96	(141)
Deferred Income Tax (Benefit) Expense																				441	89	(2)
(Benefit from) provision for income taxes on continuing operations																				149	641	575
Net income (loss)																				$ 1,642	$ 2,082	$ 1,447

[1] Includes charges of $(170) million, $(201) million, $(210) million, $(71) million, and $(243) million in the first quarter 2017, second quarter 2017, the period July 1 - August 31, 2017, the period September 1 - September 30, 2017, and the fourth quarter 2017, respectively, related to transaction costs associated with the Merger. Predecessor costs are recorded in selling, general and administrative expenses; Successor costs are recoded in integration and separation costs. See Note 3 for additional information.

[2] Includes charges of $(360) million and $(1,109) million during the period September 1 - September 30, 2017 and the fourth quarter 2017, respectively, related to the amortization of inventory step-up as a result of the Merger and the acquisition of the H&N Business, which was included in cost of goods sold. See Note 3 for additional information.

[3] Includes a tax benefit of $2,262 million in the fourth quarter 2017 related to the Tax Cuts and Jobs Act and a benefit related to an internal entity restructuring associated with the Intended Business Separations. See Note 7 for additional information.

[4] First quarter 2017 included a gain of $162 million recorded in sundry income - net associated with the sale of the company's global food safety diagnostic business. See Note 4 for additional information.

[5] First quarter 2017 included a tax benefit of $53 million, as well as a $47 million benefit on associated accrued interest reversals (recorded in sundry income - net), related to a reduction in the company’s unrecognized tax benefits due to the closure of various tax statutes of limitations.

[6] First, second, third and fourth quarter 2016 included charges of $(24) million, $(76) million, $(122) million, and $(164) million, respectively, recorded in selling, general and administrative expenses related to transaction costs associated with the Merger. See Note 3 for additional information.

[7] First quarter 2016 included a gain of $369 million recorded in sundry income - net associated with the sale of the DuPont (Shenzhen) Manufacturing Limited entity, which held certain buildings and other assets. See Note 4 for additional information

XML

Income Taxes Income Taxes - Reconciliation to US Statutory Rate (Details) - USD ($) $ in Millions		3 Months Ended	4 Months Ended	8 Months Ended		12 Months Ended
		Mar. 31, 2017	Dec. 31, 2017	Aug. 31, 2017		Dec. 31, 2016	Dec. 31, 2015
Successor [Member]
Statutory U.S. federal income tax rate			35.00%
Equity earning effect			0.90%
Lower effective tax rates on international operations - net			(9.50%)
Acquisitions, divestitures, and ownership restructuring activities	[1],[2]		15.80%
U.S. research and development credit			0.40%
Exchange gains/losses	[3]		(1.80%)
Impact of U.S. Tax Reform			126.10%
Excess tax benefits from stock-compensation			0.10%
Tax settlements and expiration of statue of limitations			0.00%
Other, net			1.50%
Effective Income Tax Rate			168.50%
Benefit related to internal legal entity restructuring			$ 261
Predecessor [Member]
Statutory U.S. federal income tax rate				35.00%		35.00%	35.00%
Equity earning effect				(0.50%)		(0.80%)	(0.70%)
Lower effective tax rates on international operations - net				(11.40%)		(9.20%)	(9.70%)
Acquisitions, divestitures, and ownership restructuring activities	[2]			5.20%		1.90%	(0.20%)
U.S. research and development credit				(0.80%)		(0.70%)	(1.50%)
Exchange gains/losses	[3]			(12.90%)		1.90%	10.20%
Excess tax benefits from stock-compensation	[4]			(1.70%)
Tax settlements and expiration of statue of limitations				(3.80%)	[5]	(1.10%)	(1.50%)
Other, net				(0.80%)		(3.50%)	(3.20%)
Effective Income Tax Rate				8.30%		23.50%	28.40%
Continuing Operations [Member] | Predecessor [Member]
Tax benefit related to reduction in company's unrecognized tax benefits		$ 53		$ 53

[1] Includes a net tax benefit of $261 million related to an internal legal entity restructuring associated with the Intended Business Separations.

[2] See Notes 3 and 4 for additional information.

[3] Principally reflects the impact of foreign exchange gains and losses on net monetary assets for which no corresponding tax impact is realized. Further information about the company's foreign currency hedging program is included in Note 6 and Note 18 under the heading Foreign Currency Risk.

[4] Reflects the impact of the adoption of Accounting Standards Update ("ASU") 2016-09, which resulted in the recognition of excess tax benefits related to equity compensation in the (benefit from) provision for income taxes on continuing operations. See Note 2 for additional information.

[5] The period January 1 through August 31, 2017 includes a tax benefit of $53 million for accrued interest reversals (recorded in sundry income - net).

XML

Income Taxes Income Taxes - Deferred Tax Balances (Details) - USD ($) $ in Millions	Dec. 31, 2017	Dec. 31, 2016
Successor [Member]
Assets
Deferred Tax Assets, Tax Loss And Tax Credit Carryforwards	$ 1,690
Deferred Tax Assets, Tax Deferred Expense, Accrued Employee Benefits	1,988
Deferred Tax Assets, Tax Deferred Expense, Other Accruals and Reversals	333
Deferred Tax Assets, Intangible Assets	284
Deferred Tax Assets, Inventory	130
Deferred Tax Assets, Long-Term Debt	109
Deferred Tax Assets, Investments	23
Deferred Tax Assets, Other	260
Deferred Tax Assets, Gross	4,817
Deferred Tax Assets, Valuation Allowance	(1,378)
Deferred Tax Assets, Net of Valuation Allowance	3,439
Liabilities
Deferred Tax Liabilities, Property	1,160
Deferred Tax Liabilities, Tax Deferred Expense, Accrued Employee Benefits	68
Deferred Tax Liabilities, Tax Deferred Expense, Other Accruals and Reversals	39
Deferred Tax Liabilities, Intangible Assets	6,286
Deferred Tax Liabilities, Inventory	597
Deferred Tax Liabilities, Investments	453
Deferred Tax Liabilities, Unrealized Exchange Gains/Losses	71
Deferred Tax Liabilities, Other	121
Deferred Tax Liabilities, Gross	8,795
Deferred Tax Liabilities, Net	$ (5,356)
Predecessor [Member]
Assets
Deferred Tax Assets, Tax Loss And Tax Credit Carryforwards		$ 1,808
Deferred Tax Assets, Tax Deferred Expense, Accrued Employee Benefits		4,529
Deferred Tax Assets, Tax Deferred Expense, Other Accruals and Reversals		617
Deferred Tax Assets, Intangible Assets		210
Deferred Tax Assets, Inventory		163
Deferred Tax Assets, Investments		126
Deferred Tax Assets, Other		257
Deferred Tax Assets, Gross		7,710
Deferred Tax Assets, Valuation Allowance		(1,308)
Deferred Tax Assets, Net of Valuation Allowance		6,402
Deferred Tax Assets, Net		2,883
Liabilities
Deferred Tax Liabilities, Property		742
Deferred Tax Liabilities, Tax Deferred Expense, Accrued Employee Benefits		410
Deferred Tax Liabilities, Tax Deferred Expense, Other Accruals and Reversals		222
Deferred Tax Liabilities, Intangible Assets		1,345
Deferred Tax Liabilities, Inventory		138
Deferred Tax Liabilities, Investments		230
Deferred Tax Liabilities, Unrealized Exchange Gains/Losses		346
Deferred Tax Liabilities, Other		86
Deferred Tax Liabilities, Gross		$ 3,519

XML

Income Taxes Income Taxes - Operating Loss and Tax Credit Carryforwards (Details) - USD ($) $ in Millions	Dec. 31, 2017	Dec. 31, 2016
Predecessor [Member]
Operating Loss Carryforwards [Line Items]
Deferred Tax Assets, Operating Loss Carryforwards		$ 1,523
Deferred Tax Assets, Tax Credit Carryforwards		285
Total Operating Loss and Tax Credit Carryforwards		1,808
Successor [Member]
Operating Loss Carryforwards [Line Items]
Deferred Tax Assets, Operating Loss Carryforwards	$ 1,525
Deferred Tax Assets, Tax Credit Carryforwards	165
Total Operating Loss and Tax Credit Carryforwards	1,690
Expiring within Five Years [Member] | Predecessor [Member]
Operating Loss Carryforwards [Line Items]
Deferred Tax Assets, Operating Loss Carryforwards		41
Deferred Tax Assets, Tax Credit Carryforwards		10
Expiring within Five Years [Member] | Successor [Member]
Operating Loss Carryforwards [Line Items]
Deferred Tax Assets, Operating Loss Carryforwards	42
Deferred Tax Assets, Tax Credit Carryforwards	10
Expiring After Five Years Or Having Indefinite Expiration [Member] | Predecessor [Member]
Operating Loss Carryforwards [Line Items]
Deferred Tax Assets, Operating Loss Carryforwards		1,482
Deferred Tax Assets, Tax Credit Carryforwards		$ 275
Expiring After Five Years Or Having Indefinite Expiration [Member] | Successor [Member]
Operating Loss Carryforwards [Line Items]
Deferred Tax Assets, Operating Loss Carryforwards	1,483
Deferred Tax Assets, Tax Credit Carryforwards	$ 155

XML

Income Taxes Income Taxes - Gross Unrecognized Tax Benefits (Details) - USD ($) $ in Millions	4 Months Ended	8 Months Ended	12 Months Ended
	Dec. 31, 2017	Aug. 31, 2017	Dec. 31, 2016	Dec. 31, 2015
Successor [Member]
Income Tax Contingency [Line Items]
Unrecognized Tax Benefits, Beginning Balance	$ 436
Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions	(2)
Unrecognized Tax Benefits, Increase Resulting from Prior Period Tax Positions	9
Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions	19
Unrecognized Tax Benefits, Decrease Resulting from Settlements with Taxing Authorities	1
Unrecognized Tax Benefits, Reduction Resulting from Lapse of Applicable Statute of Limitations	(5)
Unrecognized Tax Benefits, Increase Resulting from Foreign Currency Translation	1
Unrecognized Tax Benefits, Ending Balance	459	$ 436
Unrecognized Tax Benefits that Would Impact Effective Tax Rate	76
Unrecognized Tax Benefits, Income Tax Penalties and Interest Expense	1
Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued	25
Predecessor [Member]
Income Tax Contingency [Line Items]
Unrecognized Tax Benefits, Beginning Balance	$ 265	348	$ 558	$ 735
Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions		(19)	(41)	(98)
Unrecognized Tax Benefits, Increase Resulting from Prior Period Tax Positions		3	32	13
Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions		19	32	32
Unrecognized Tax Benefits, Decrease Resulting from Settlements with Taxing Authorities		(6)	(205)	(58)
Unrecognized Tax Benefits, Reduction Resulting from Lapse of Applicable Statute of Limitations		(81)	(30)	(30)
Unrecognized Tax Benefits, Increase Resulting from Foreign Currency Translation		1	2	(36)
Unrecognized Tax Benefits, Ending Balance		265	348	558
Unrecognized Tax Benefits that Would Impact Effective Tax Rate		188	253	386
Unrecognized Tax Benefits, Income Tax Penalties and Interest Expense		(27)	10	(14)
Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued		$ 22	$ 71	$ 88

XML

Earnings Per Share of Common Stock Earnings Per Share Reconciliation (Details) - USD ($) $ in Millions			8 Months Ended	12 Months Ended
		Aug. 31, 2017	Aug. 31, 2017	Dec. 31, 2016	Dec. 31, 2015
Predecessor [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Income from Continuing Operations after Income Taxes, attributable to DuPont			$ 1,624	$ 2,072	$ 1,443
Preferred Dividends			(7)	(10)	(10)
Income from continuing operations after income taxes available to DuPont common stockholders			1,617	2,062	1,433
Income from Discontinued Operations after income taxes available to DuPont common stockholders			117	441	510
Net Income Available to Common Stockholders			$ 1,734	$ 2,503	$ 1,943
Weighted Average Number of Shares Outstanding, Basic			868,000,000	873,000,000	894,000,000
Dilutive effect of the company's employee compensation plans	[1]		5,000,000	4,000,000	6,000,000
Weighted Average Number of Shares Outstanding, Diluted	[1]		872,000,000	877,000,000	900,000,000
Common Stock [Member] | Merger with Dow [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Share exchange ratio, DuPont to DowDuPont		1.2820

[1] Diluted earnings per share considers the impact of potentially dilutive securities except in periods in which there is a loss because the inclusion of the potential common shares would have an anti-dilutive effect.

XML

Earnings Per Share of Common Stock Average Number of Antidilutive Stock Options (Details) - shares	8 Months Ended	12 Months Ended
	Aug. 31, 2017	Dec. 31, 2016	Dec. 31, 2015
Predecessor [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Average number of stock options excluded from diluted calculation	1,906	4,794,000	4,715,000

XML

Accounts and Notes Receivable, Net (Schedule of Accounts and Notes Receivable, Net) (Details) - USD ($) $ in Millions		Dec. 31, 2017	Dec. 31, 2016
Successor [Member]
Accounts and Notes Receivable, Net [Line Items]
Accounts receivable - trade	[1]	$ 3,777
Notes receivable - trade	[2]	199
Other	[3]	1,263
Total accounts and notes receivable - net		5,239
Accounts and notes receivable - trade, allowance		$ 10
Predecessor [Member]
Accounts and Notes Receivable, Net [Line Items]
Accounts receivable - trade	[1]		$ 3,601
Notes receivable - trade	[2]		206
Other	[3]		1,152
Total accounts and notes receivable - net			4,959
Accounts and notes receivable - trade, allowance			$ 287

[1] Accounts receivable – trade is net of allowances of $10 million at December 31, 2017 and $287 million at December 31, 2016. Allowances are equal to the estimated uncollectible amounts. That estimate is based on historical collection experience, current economic and market conditions, and review of the current status of customers' accounts.

[2] Notes receivable – trade primarily consists of receivables within the agriculture product line for deferred payment loan programs for the sale of seed products to customers. These loans have terms of one year or less and are primarily concentrated in North America. The company maintains a rigid pre-approval process for extending credit to customers in order to manage overall risk and exposure associated with credit losses. As of December 31, 2017 and 2016, there were no significant past due notes receivable, nor were there any significant impairments related to current loan agreements.

[3] Other includes receivables in relation to fair value of derivative instruments, indemnification assets, value added tax, general sales tax and other taxes. No individual group represents more than ten percent of total receivables.

XML

Inventories Schedule of Inventory (Details) - USD ($) $ in Millions	Dec. 31, 2017	Dec. 31, 2016
Successor [Member]
Inventory [Line Items]
Finished Products	$ 4,500
Semi-finished Products	2,769
Raw Materials	371
Stores and Supplies	447
Total	8,087
Adjustment of inventories to a LIFO basis	546
Total inventories	$ 8,633
Predecessor [Member]
Inventory [Line Items]
Finished Products		$ 2,961
Semi-finished Products		1,877
Raw Materials		292
Stores and Supplies		398
Total		5,528
Adjustment of inventories to a LIFO basis		(178)
Total inventories		$ 5,350

XML

Inventories Narrative (Details) - Successor [Member] - USD ($) $ in Millions	1 Months Ended	3 Months Ended	4 Months Ended
	Sep. 30, 2017	Dec. 31, 2017	Dec. 31, 2017	Sep. 01, 2017
Inventory [Line Items]
Business Combination, Fair Value Step-Up Of Acquired Inventory, Amount recognized in Cost of Goods sold	$ (360)	$ (1,109)	$ (1,469)
Merger with Dow [Member]
Inventory [Line Items]
Business Combination, Fair Value Step Up Of Acquired Inventory				$ 3,842
Business Combination, Fair Value Step-Up Of Acquired Inventory, Amount recognized in Cost of Goods sold			$ (1,434)

XML

Property, Plant and Equipment (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2017	Sep. 01, 2017
Land Improvements [Member] | Minimum [Member]
Property, Plant and Equipment [Line Items]
Property, Plant and Equipment, Useful Life	1 year
Land Improvements [Member] | Maximum [Member]
Property, Plant and Equipment [Line Items]
Property, Plant and Equipment, Useful Life	25 years
Building [Member] | Minimum [Member]
Property, Plant and Equipment [Line Items]
Property, Plant and Equipment, Useful Life	1 year
Building [Member] | Maximum [Member]
Property, Plant and Equipment [Line Items]
Property, Plant and Equipment, Useful Life	25 years
Machinery and Equipment [Member] | Minimum [Member]
Property, Plant and Equipment [Line Items]
Property, Plant and Equipment, Useful Life	1 year
Machinery and Equipment [Member] | Maximum [Member]
Property, Plant and Equipment [Line Items]
Property, Plant and Equipment, Useful Life	25 years
Computer Software, Intangible Asset [Member] | Minimum [Member]
Property, Plant and Equipment [Line Items]
Property, Plant and Equipment, Useful Life	1 year
Computer Software, Intangible Asset [Member] | Maximum [Member]
Property, Plant and Equipment [Line Items]
Property, Plant and Equipment, Useful Life	8 years
Merger with Dow [Member] | Successor [Member]
Property, Plant and Equipment [Line Items]
Business Combination, Fair Value Step Up Of Acquired Property		$ 3,200

XML

Property, Plant and Equipment Schedule of Property, Plant and Equipment (Details) - USD ($) $ in Millions	Dec. 31, 2017	Dec. 31, 2016	Dec. 31, 2015
Successor [Member]
Property, Plant and Equipment [Line Items]
Property, Plant and Equipment, Gross	$ 12,878
Accumulated Depreciation	(443)
Property, Plant and Equipment, Net	12,435
Successor [Member] | Land and Land Improvements [Member]
Property, Plant and Equipment [Line Items]
Property, Plant and Equipment, Gross	913
Successor [Member] | Building [Member]
Property, Plant and Equipment [Line Items]
Property, Plant and Equipment, Gross	2,747
Successor [Member] | Machinery and Equipment [Member]
Property, Plant and Equipment [Line Items]
Property, Plant and Equipment, Gross	8,104
Successor [Member] | Construction in Progress [Member]
Property, Plant and Equipment [Line Items]
Property, Plant and Equipment, Gross	$ 1,114
Predecessor [Member]
Property, Plant and Equipment [Line Items]
Property, Plant and Equipment, Gross		$ 23,015
Accumulated Depreciation		(14,164)
Property, Plant and Equipment, Net		8,851	$ 9,414
Predecessor [Member] | Land and Land Improvements [Member]
Property, Plant and Equipment [Line Items]
Property, Plant and Equipment, Gross		501
Predecessor [Member] | Building [Member]
Property, Plant and Equipment [Line Items]
Property, Plant and Equipment, Gross		4,224
Predecessor [Member] | Machinery and Equipment [Member]
Property, Plant and Equipment [Line Items]
Property, Plant and Equipment, Gross		16,909
Predecessor [Member] | Construction in Progress [Member]
Property, Plant and Equipment [Line Items]
Property, Plant and Equipment, Gross		$ 1,381

XML

Property, Plant and Equipment Schedule of Depreciation (Details) - USD ($) $ in Millions	4 Months Ended	8 Months Ended	12 Months Ended
	Dec. 31, 2017	Aug. 31, 2017	Dec. 31, 2016	Dec. 31, 2015
Successor [Member]
Property, Plant and Equipment [Line Items]
Depreciation expense	$ 426
Predecessor [Member]
Property, Plant and Equipment [Line Items]
Depreciation expense		$ 589	$ 907	$ 948

XML

Goodwill and Other Intangible Assets Goodwill (Details) - USD ($) $ in Millions	4 Months Ended	8 Months Ended	12 Months Ended
	Dec. 31, 2017	Aug. 31, 2017	Dec. 31, 2016
Predecessor [Member]
Goodwill [Line Items]
Goodwill, Beginning Balance	$ 4,543	$ 4,169	$ 4,238
Currency Translation Adjustment		176	(68)
Other Goodwill Adjustments and Acquisitions		198	(1)
Goodwill, Ending Balance		4,543	$ 4,169
Successor [Member]
Goodwill [Line Items]
Goodwill, Beginning Balance	45,105
Currency Translation Adjustment	(234)
Goodwill, Ending Balance	45,589	$ 45,105
Successor [Member] | H&N Business [Member]
Goodwill [Line Items]
Goodwill Recognized for H&N Acquisition	$ 718

XML

Goodwill and Other Intangible Assets Other Intangible Assets (Details) - USD ($) $ in Millions		Dec. 31, 2017	Dec. 31, 2016
Successor [Member]
Acquired Finite-Lived Intangible Assets [Line Items]
Finite-Lived Intangible Assets, Gross		$ 16,334
Finite-Lived Intangible Assets, Accumulated Amortization		(389)
Finite-Lived Intangible Assets, Net		15,945
Indefinite-Lived Intangible Assets (Excluding Goodwill)		11,781
Intangible Assets, Gross (Excluding Goodwill)		28,115
Total other intangible assets		27,726
Successor [Member] | In Process Research and Development [Member]
Acquired Finite-Lived Intangible Assets [Line Items]
Indefinite-Lived Intangible Assets (Excluding Goodwill)		660
Successor [Member] | Germplasm [Member]
Acquired Finite-Lived Intangible Assets [Line Items]
Indefinite-Lived Intangible Assets (Excluding Goodwill)	[1]	6,265
Successor [Member] | Trademarks and Trade Names [Member]
Acquired Finite-Lived Intangible Assets [Line Items]
Indefinite-Lived Intangible Assets (Excluding Goodwill)		4,856
Successor [Member] | Customer-Related Intangible Assets [Member]
Acquired Finite-Lived Intangible Assets [Line Items]
Finite-Lived Intangible Assets, Gross		9,502
Finite-Lived Intangible Assets, Accumulated Amortization		(186)
Finite-Lived Intangible Assets, Net		9,316
Successor [Member] | Developed Technology Rights [Member]
Acquired Finite-Lived Intangible Assets [Line Items]
Finite-Lived Intangible Assets, Gross		4,364
Finite-Lived Intangible Assets, Accumulated Amortization		(144)
Finite-Lived Intangible Assets, Net		4,220
Successor [Member] | Trademarks and Trade Names [Member]
Acquired Finite-Lived Intangible Assets [Line Items]
Finite-Lived Intangible Assets, Gross		1,117
Finite-Lived Intangible Assets, Accumulated Amortization		(26)
Finite-Lived Intangible Assets, Net		1,091
Successor [Member] | Favorable Supply Contract [Member]
Acquired Finite-Lived Intangible Assets [Line Items]
Finite-Lived Intangible Assets, Gross	[2]	495
Finite-Lived Intangible Assets, Accumulated Amortization	[2]	(17)
Finite-Lived Intangible Assets, Net	[2]	478
Successor [Member] | Microbial Cell Factories [Member]
Acquired Finite-Lived Intangible Assets [Line Items]
Finite-Lived Intangible Assets, Gross	[3]	397
Finite-Lived Intangible Assets, Accumulated Amortization	[3]	(6)
Finite-Lived Intangible Assets, Net	[3]	391
Successor [Member] | Other Intangible Assets [Member]
Acquired Finite-Lived Intangible Assets [Line Items]
Finite-Lived Intangible Assets, Gross	[4]	459
Finite-Lived Intangible Assets, Accumulated Amortization	[4]	(10)
Finite-Lived Intangible Assets, Net	[4]	$ 449
Predecessor [Member]
Acquired Finite-Lived Intangible Assets [Line Items]
Finite-Lived Intangible Assets, Gross			$ 3,208
Finite-Lived Intangible Assets, Accumulated Amortization			(1,521)
Finite-Lived Intangible Assets, Net			1,687
Indefinite-Lived Intangible Assets (Excluding Goodwill)			1,977
Intangible Assets, Gross (Excluding Goodwill)			5,185
Total other intangible assets			3,664
Predecessor [Member] | In Process Research and Development [Member]
Acquired Finite-Lived Intangible Assets [Line Items]
Indefinite-Lived Intangible Assets (Excluding Goodwill)			73
Predecessor [Member] | Microbial Cell Factories [Member]
Acquired Finite-Lived Intangible Assets [Line Items]
Indefinite-Lived Intangible Assets (Excluding Goodwill)	[3]		306
Predecessor [Member] | Germplasm [Member]
Acquired Finite-Lived Intangible Assets [Line Items]
Indefinite-Lived Intangible Assets (Excluding Goodwill)	[1]		1,053
Predecessor [Member] | Trademarks and Trade Names [Member]
Acquired Finite-Lived Intangible Assets [Line Items]
Indefinite-Lived Intangible Assets (Excluding Goodwill)			545
Predecessor [Member] | Customer-Related Intangible Assets [Member]
Acquired Finite-Lived Intangible Assets [Line Items]
Finite-Lived Intangible Assets, Gross			1,574
Finite-Lived Intangible Assets, Accumulated Amortization			(586)
Finite-Lived Intangible Assets, Net			988
Predecessor [Member] | Developed Technology Rights [Member]
Acquired Finite-Lived Intangible Assets [Line Items]
Finite-Lived Intangible Assets, Gross			1,410
Finite-Lived Intangible Assets, Accumulated Amortization			(838)
Finite-Lived Intangible Assets, Net			572
Predecessor [Member] | Trademarks and Trade Names [Member]
Acquired Finite-Lived Intangible Assets [Line Items]
Finite-Lived Intangible Assets, Gross			53
Finite-Lived Intangible Assets, Accumulated Amortization			(15)
Finite-Lived Intangible Assets, Net			38
Predecessor [Member] | Other Intangible Assets [Member]
Acquired Finite-Lived Intangible Assets [Line Items]
Finite-Lived Intangible Assets, Gross	[4]		171
Finite-Lived Intangible Assets, Accumulated Amortization	[4]		(82)
Finite-Lived Intangible Assets, Net	[4]		$ 89

[1] Pioneer germplasm is the pool of genetic source material and body of knowledge gained from the development and delivery stage of plant breeding. The company recognized germplasm as an intangible asset upon the acquisition of Pioneer. This intangible asset is expected to contribute to cash flows beyond the foreseeable future and there are no legal, regulatory, contractual, or other factors which limit its useful life.

[2] Upon closing and pursuant to the terms of the FMC Transaction Agreement, DuPont entered into favorable supply contracts with FMC. DuPont recorded these contracts as intangible assets recognized at the fair value of off-market contracts. Refer to Notes 3 and 4 for additional information.

[3] Microbial cell factories, derived from natural microbes, are used to sustainably produce enzymes, peptides and chemicals using natural metabolic processes. The company recognized the microbial cell factories as intangible assets upon the acquisition of Danisco. As a result of the valuation as part of the Merger, it was determined that this intangible asset now has a definite life and therefore it has been moved from indefinite-lived to definite-lived as of September 1, 2017.

[4] Primarily consists of sales and farmer networks, marketing and manufacturing alliances and noncompetition agreements.

XML

Goodwill and Other Intangible Assets Acquired Intangible Assets (Details) - Merger with Dow [Member] $ in Millions	Aug. 31, 2017 USD ($)
Acquired Finite-Lived Intangible Assets [Line Items]
Finite-lived Intangible Assets Acquired	$ 15,436
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Other than Goodwill	27,221	[1]
In Process Research and Development [Member]
Acquired Finite-Lived Intangible Assets [Line Items]
Indefinite-lived Intangible Assets Acquired	660
Germplasm [Member]
Acquired Finite-Lived Intangible Assets [Line Items]
Indefinite-lived Intangible Assets Acquired	6,263
Trademarks and Trade Names [Member]
Acquired Finite-Lived Intangible Assets [Line Items]
Indefinite-lived Intangible Assets Acquired	4,862
Customer-Related Intangible Assets [Member]
Acquired Finite-Lived Intangible Assets [Line Items]
Finite-lived Intangible Assets Acquired	$ 9,264
Acquired Finite-lived Intangible Assets, Weighted Average Useful Life	17 years
Developed Technology Rights [Member]
Acquired Finite-Lived Intangible Assets [Line Items]
Finite-lived Intangible Assets Acquired	$ 4,239
Acquired Finite-lived Intangible Assets, Weighted Average Useful Life	12 years
Trademarks and Trade Names [Member]
Acquired Finite-Lived Intangible Assets [Line Items]
Finite-lived Intangible Assets Acquired	$ 1,080
Acquired Finite-lived Intangible Assets, Weighted Average Useful Life	15 years
Microbial Cell Factories [Member]
Acquired Finite-Lived Intangible Assets [Line Items]
Finite-lived Intangible Assets Acquired	$ 400
Acquired Finite-lived Intangible Assets, Weighted Average Useful Life	23 years
Other Intangible Assets [Member]
Acquired Finite-Lived Intangible Assets [Line Items]
Finite-lived Intangible Assets Acquired	$ 453
Acquired Finite-lived Intangible Assets, Weighted Average Useful Life	17 years

[1] See Note 12 for additional information.

XML

Goodwill and Other Intangible Assets Future Amortization Expense (Details) - USD ($) $ in Millions	4 Months Ended	8 Months Ended	12 Months Ended
	Dec. 31, 2017	Aug. 31, 2017	Dec. 31, 2016	Dec. 31, 2015
Finite-Lived Intangible Assets [Line Items]
Pre-tax amortization expense, 2018	$ 1,266
Pre-tax amortization expense, 2019	1,254
Pre-tax amortization expense, 2020	1,244
Pre-tax amortization expense, 2021	1,228
Pre-tax amortization expense, 2022	1,221
Successor [Member]
Finite-Lived Intangible Assets [Line Items]
Amortization expense	$ 389
Predecessor [Member]
Finite-Lived Intangible Assets [Line Items]
Amortization expense		$ 139	$ 319	$ 362

XML

Short-Term Borrowings, Long-Term Debt and Available Credit Facilities Short-Term Borrowings (Narrative) (Details) - USD ($) $ in Millions	Dec. 31, 2017	Dec. 31, 2016
Successor [Member]
Short-term Debt [Line Items]
Unused bank credit lines	$ 5,950
Line Of Credit Facility, Remaining Borrowing Capacity, Uncommitted Amount	731
Letters of Credit Outstanding, Amount	$ 177
Short-term Debt, Weighted Average Interest Rate	1.80%
Predecessor [Member]
Short-term Debt [Line Items]
Short-term Debt, Weighted Average Interest Rate		2.20%
Fair Value, Inputs, Level 2 [Member] | Successor [Member]
Short-term Debt [Line Items]
Short-term Debt, Fair Value	$ 2,780
Fair Value, Inputs, Level 2 [Member] | Predecessor [Member]
Short-term Debt [Line Items]
Short-term Debt, Fair Value		$ 430

XML

Short-Term Borrowings, Long-Term Debt and Available Credit Facilities Short-Term Borrowings and Capital Lease Obligations (Details) - USD ($) $ in Millions		Dec. 31, 2017	Dec. 31, 2016
Successor [Member]
Short-term Debt [Line Items]
Long-term Debt, Current Maturities	[1]	$ 1,315
Total short-term borrowings and capital lease obligations		2,779
Successor [Member] | Commercial Paper [Member]
Short-term Debt [Line Items]
Short-term Debt		1,436
Successor [Member] | Notes Payable to Banks [Member]
Short-term Debt [Line Items]
Short-term Debt		$ 28
Predecessor [Member]
Short-term Debt [Line Items]
Long-term Debt, Current Maturities			$ 4
Total short-term borrowings and capital lease obligations			429
Predecessor [Member] | Commercial Paper [Member]
Short-term Debt [Line Items]
Short-term Debt			386
Predecessor [Member] | Notes Payable to Banks [Member]
Short-term Debt [Line Items]
Short-term Debt			$ 39

[1] The Successor period includes the reflection of debt at fair value at the date of the Merger. See Note 3 for additional information regarding the Merger.

XML

Short-Term Borrowings, Long-Term Debt and Available Credit Facilities Long Term Debt (Details) - USD ($) $ in Millions		Dec. 31, 2017	Dec. 31, 2016
Successor [Member]
Debt Instrument [Line Items]
Capital Lease Obligations	[1]	$ 5
Unamortized debt discount and issuance costs	[1]	0
Long-term Debt, Current Maturities	[1]	1,315
Long-term Debt and Capital Lease Obligations	[1]	10,291
Predecessor [Member]
Debt Instrument [Line Items]
Capital Lease Obligations			$ 9
Unamortized debt discount and issuance costs			35
Long-term Debt, Current Maturities			4
Long-term Debt and Capital Lease Obligations			8,107
Loans Payable [Member] | Successor [Member] | Final Maturity 2018
Debt Instrument [Line Items]
Long-term Debt, Gross	[1]	$ 1,280
Long-term Debt, Weighted Average Interest Rate		1.59%
Loans Payable [Member] | Successor [Member] | Final Maturity 2019
Debt Instrument [Line Items]
Long-term Debt, Gross	[1]	$ 521
Long-term Debt, Weighted Average Interest Rate		2.23%
Loans Payable [Member] | Successor [Member] | Final Maturity 2020
Debt Instrument [Line Items]
Long-term Debt, Gross	[1]	$ 3,070
Long-term Debt, Weighted Average Interest Rate		1.79%
Loans Payable [Member] | Successor [Member] | Final Maturity 2021
Debt Instrument [Line Items]
Long-term Debt, Gross	[1]	$ 1,580
Long-term Debt, Weighted Average Interest Rate		2.07%
Loans Payable [Member] | Successor [Member] | Final Maturity 2023 and thereafter
Debt Instrument [Line Items]
Long-term Debt, Gross	[1]	$ 3,492
Long-term Debt, Weighted Average Interest Rate		3.32%
Loans Payable [Member] | Successor [Member] | Term Loan Facility due 2019 [Member]
Debt Instrument [Line Items]
Long-term Debt, Gross	[1]	$ 1,500
Long-term Debt, Weighted Average Interest Rate		2.35%
Loans Payable [Member] | Successor [Member] | Other Loans [Member]
Debt Instrument [Line Items]
Long-term Debt, Gross	[1]	$ 18
Long-term Debt, Weighted Average Interest Rate		4.32%
Loans Payable [Member] | Successor [Member] | Foreign Currency Loans [Member]
Debt Instrument [Line Items]
Long-term Debt, Gross	[1]	$ 30
Long-term Debt, Weighted Average Interest Rate		2.85%
Loans Payable [Member] | Predecessor [Member] | Final Maturity 2018
Debt Instrument [Line Items]
Long-term Debt, Gross			1,290
Loans Payable [Member] | Predecessor [Member] | Final Maturity 2019
Debt Instrument [Line Items]
Long-term Debt, Gross			500
Loans Payable [Member] | Predecessor [Member] | Final Maturity 2020
Debt Instrument [Line Items]
Long-term Debt, Gross			999
Loans Payable [Member] | Predecessor [Member] | Final Maturity 2021
Debt Instrument [Line Items]
Long-term Debt, Gross			1,498
Loans Payable [Member] | Predecessor [Member] | Final Maturity 2023 and thereafter
Debt Instrument [Line Items]
Long-term Debt, Gross			3,188
Loans Payable [Member] | Predecessor [Member] | Term Loan Facility due 2019 [Member]
Debt Instrument [Line Items]
Long-term Debt, Gross			500
Loans Payable [Member] | Predecessor [Member] | Other Loans [Member]
Debt Instrument [Line Items]
Long-term Debt, Gross			22
Loans Payable [Member] | Predecessor [Member] | Foreign Currency Loans [Member]
Debt Instrument [Line Items]
Long-term Debt, Gross			29
Medium-term Notes [Member] | Successor [Member]
Debt Instrument [Line Items]
Long-term Debt, Gross	[1]	$ 110
Long-term Debt, Weighted Average Interest Rate		1.22%
Medium-term Notes [Member] | Predecessor [Member]
Debt Instrument [Line Items]
Long-term Debt, Gross			$ 111

[1] The Successor period includes the reflection of debt at fair value at the date of the Merger. See Note 3 for additional information regarding the Merger.

XML

Short-Term Borrowings, Long-Term Debt and Available Credit Facilities Maturities of Long-Term Debt (Details) - Successor [Member] $ in Millions	Dec. 31, 2017 USD ($)	[1]
Debt Instrument [Line Items]
Repayments of Principal 2018	$ 1,286
Repayments of Principal 2019	2,005
Repayments of Principal 2020	3,005
Repayments of Principal 2021	1,505
Repayments of Principal 2022	$ 2

[1] Excludes unamortized debt step-up premium.

XML

Short-Term Borrowings, Long-Term Debt and Available Credit Facilities Long Term Debt Narrative (Details) - Fair Value, Inputs, Level 2 [Member] - USD ($) $ in Millions	Dec. 31, 2017	Dec. 31, 2016
Successor [Member]
Debt Instrument [Line Items]
Long-term Debt, Fair Value	$ 10,250
Predecessor [Member]
Debt Instrument [Line Items]
Long-term Debt, Fair Value		$ 8,460

XML

Short-Term Borrowings, Long-Term Debt and Available Credit Facilities Committed and Available Credit Facilities (Details) - USD ($) $ in Millions	Dec. 31, 2017	Mar. 22, 2016
Term Loan Facility due 2019 [Member]
Line of Credit Facility [Line Items]
Line of Credit Facility, Maximum Borrowing Capacity		$ 4,500
Successor [Member]
Line of Credit Facility [Line Items]
Line of Credit Facility, Maximum Borrowing Capacity	$ 7,500
Line of Credit Facility, Remaining Borrowing Capacity	5,950
Successor [Member] | Revolving Credit Facility [Member]
Line of Credit Facility [Line Items]
Line of Credit Facility, Maximum Borrowing Capacity	3,000
Line of Credit Facility, Remaining Borrowing Capacity	2,950
Successor [Member] | Term Loan Facility due 2019 [Member]
Line of Credit Facility [Line Items]
Line of Credit Facility, Maximum Borrowing Capacity	4,500
Line of Credit Facility, Remaining Borrowing Capacity	$ 3,000

XML

Short-Term Borrowings, Long-Term Debt and Available Credit Facilities Available Committed Credit Facilities (Narrative) (Details) $ in Millions	36 Months Ended
	Mar. 22, 2019	Dec. 31, 2017 USD ($)	May 02, 2017 USD ($)	Mar. 22, 2016 USD ($)
Successor [Member]
Line of Credit Facility [Line Items]
Line of Credit Facility, Maximum Borrowing Capacity		$ 7,500
Line of Credit Facility, Remaining Borrowing Capacity		5,950
Senior Note Floating Rate Due 2020 [Member]
Line of Credit Facility [Line Items]
Debt Instrument, Face Amount			$ 750
Senior Note 2.20 Percent Due 2020 [Member]
Line of Credit Facility [Line Items]
Debt Instrument, Face Amount			$ 1,250
Debt Instrument, Interest Rate, Stated Percentage			2.20%
Term Loan Facility due 2019 [Member]
Line of Credit Facility [Line Items]
Line of Credit Facility, Maximum Borrowing Capacity				$ 4,500
Line of Credit Facility, Number of Borrowings				7
Term Loan Facility due 2019 [Member] | Scenario, Forecast [Member]
Line of Credit Facility [Line Items]
Debt Instrument, Term	3 years
Term Loan Facility due 2019 [Member] | Successor [Member]
Line of Credit Facility [Line Items]
Line of Credit Facility, Maximum Borrowing Capacity		4,500
Line of Credit Facility, Remaining Borrowing Capacity		3,000
Borrowings under Term Loan Facility		$ 1,500

XML

Commitments and Contingent Liabilities Guarantee Narrative (Details) - USD ($) $ in Millions		12 Months Ended
		Dec. 31, 2017	Dec. 31, 2016
Successor [Member]
Guarantor Obligations [Line Items]
Guarantee Obligations		$ 297
Predecessor [Member]
Guarantor Obligations [Line Items]
Guarantee Obligations			$ 388
Customer and Supplier Guarantee, Bank Borrowings [Member] | Successor [Member]
Guarantor Obligations [Line Items]
Guarantee Obligations	[1]	$ 89
Guarantor Obligations, Liquidation Proceeds, Percentage		23.00%

[1] Existing guarantees for customers and suppliers, as part of contractual agreements.

XML

Commitments and Contingent Liabilities Guarantees (Details) $ in Millions	Dec. 31, 2017 USD ($)
Successor [Member]
Guarantor Obligations [Line Items]
Guarantee Obligations	$ 297
Customer and Supplier Guarantee, Bank Borrowings [Member]
Guarantor Obligations [Line Items]
Guaranteed Obligations, Maximum Term, Years	5 years
Customer and Supplier Guarantee, Bank Borrowings [Member] | Successor [Member]
Guarantor Obligations [Line Items]
Guarantee Obligations	$ 89	[1]
Equity Affiliates Guarantee, Bank Borrowings [Member]
Guarantor Obligations [Line Items]
Guaranteed Obligations, Maximum Term, Months	12 months
Equity Affiliates Guarantee, Bank Borrowings [Member] | Successor [Member]
Guarantor Obligations [Line Items]
Guarantee Obligations	$ 161	[2]
Chemours Purchase Obligations [Member]
Guarantor Obligations [Line Items]
Guaranteed Obligations, Maximum Term, Months	12 months
Chemours Purchase Obligations [Member] | Successor [Member]
Guarantor Obligations [Line Items]
Guarantee Obligations	$ 10	[3]
Residual Value Guarantee [Member]
Guarantor Obligations [Line Items]
Guaranteed Obligations, Maximum Term, Years	12 years
Residual Value Guarantee [Member] | Successor [Member]
Guarantor Obligations [Line Items]
Guarantee Obligations	$ 37	[4]

[1] Existing guarantees for customers and suppliers, as part of contractual agreements.

[2] Existing guarantees for non-consolidated affiliates' liquidity needs in normal operations.

[3] Guarantee for Chemours' raw material purchase obligations under agreement with third party supplier.

[4] The company provides guarantees related to leased assets specifying the residual value that will be available to the lessor at lease termination through sale of the assets to the lessee or third parties.

XML

Commitments and Contingent Liabilities Operating Leases (Details) - USD ($) $ in Millions	4 Months Ended	8 Months Ended	12 Months Ended
	Dec. 31, 2017	Aug. 31, 2017	Dec. 31, 2016	Dec. 31, 2015
Future Minimum Lease Payments 2018	$ 264
Future Minimum Lease Payments 2019	190
Future Minimum Lease Payments 2020	137
Future Minimum Lease Payments 2021	104
Future Minimum Lease Payments 2022	81
Future Minimum Lease Payments Thereafter	268
Non-cancelable minimum sublease rentals	3
Successor [Member]
Net rental expense	$ 105
Predecessor [Member]
Net rental expense		$ 179	$ 242	$ 266

XML

Commitments and Contingent Liabilities Litigation (Details)		3 Months Ended		12 Months Ended
	Dec. 31, 2017 USD ($) lawsuits	Dec. 31, 2017 USD ($) lawsuits	Mar. 31, 2017 USD ($)	Dec. 31, 2017 USD ($) lawsuits	Dec. 31, 2004 USD ($)	Jan. 01, 2012
PFOA Matters: Multi-District Litigation [Member]
Loss Contingencies [Line Items]
Loss Contingency, Limited Sharing of Potential Future Liabilities, Period	5 years
Period for sharing for PFOA liabilities	5 years
Loss Contingency, Limited Sharing of Potential Future Liabilities, Third-Party Annual Liability Threshold	$ 25,000,000	$ 25,000,000		$ 25,000,000
PFOA Matters: Drinking Water Actions [Member]
Loss Contingencies [Line Items]
Loss Contingency, Number Of Water Districts Receiving Water Treatment						6
PFOA Matters: Multi-District Litigation [Member]
Loss Contingencies [Line Items]
Disease Categories for MDL	6	6		6
Lawsuits alleging personal injury filed | lawsuits	3,550	3,550		3,550
Litigation Settlement, Amount Awarded to Other Party			$ 670,700,000
Successor [Member] | PFOA Matters: Multi-District Litigation [Member]
Loss Contingencies [Line Items]
Indemnification Assets	$ 15,000,000	$ 15,000,000		$ 15,000,000
Accrual balance	15,000,000	15,000,000		15,000,000
Successor [Member] | PFOA Matters: Drinking Water Actions [Member]
Loss Contingencies [Line Items]
Escrow Deposit	$ 1,000,000	$ 1,000,000		$ 1,000,000
Predecessor [Member] | PFOA Matters: Drinking Water Actions [Member]
Loss Contingencies [Line Items]
Binding Settlement Agreement Class Size					80,000
Litigation Settlement, Liability For Medical Monitoring Program, Threshold					$ 235,000,000
Predecessor [Member] | Payment for Plaintiffs Attorney Fees [Member] | PFOA Matters: Drinking Water Actions [Member]
Loss Contingencies [Line Items]
Plaintiffs' attorneys' fees and expenses					23,000,000
Predecessor [Member] | Payment to fund community health project [Member] | PFOA Matters: Drinking Water Actions [Member]
Loss Contingencies [Line Items]
Payments to fund community health project					$ 70,000,000
WEST VIRGINIA | PFOA Matters: Drinking Water Actions [Member]
Loss Contingencies [Line Items]
Loss Contingency, Pending Claims, Number	5	5		5
OHIO | PFOA Matters: Drinking Water Actions [Member]
Loss Contingencies [Line Items]
Loss Contingency, Pending Claims, Number	4	4		4
NEW YORK | PFOA Matters: Drinking Water Actions [Member]
Loss Contingencies [Line Items]
Loss Contingency, Number of Plaintiffs				5
Loss Contingency, Pending Claims, Number	3	3		3
NORTH CAROLINA | PFOA Matters: Drinking Water Actions [Member]
Loss Contingencies [Line Items]
Loss Contingency, Pending Claims, Number	3	3		3
Loss Contingency, Number of Additional Plaintiffs		2
Chemours [Member] | PFOA Matters: Multi-District Litigation [Member]
Loss Contingencies [Line Items]
Additional annual PFOA liabilities for the next five years paid by Chemours	$ 25,000,000	$ 25,000,000		$ 25,000,000

XML

Commitments and Contingent Liabilities Environmental (Details) $ in Millions	Dec. 31, 2017 USD ($)
Successor [Member]
Loss Contingencies [Line Items]
Accrual for Environmental Loss Contingencies	$ 433
Accrual for Environmental Loss Contingencies, Potential Exposure in Excess of Accrual	920
Predecessor [Member]
Loss Contingencies [Line Items]
Accrual for Environmental Loss Contingencies	457
Superfund Sites [Member] | Successor [Member]
Loss Contingencies [Line Items]
Accrual for Environmental Loss Contingencies	67
Superfund Sites [Member] | Predecessor [Member]
Loss Contingencies [Line Items]
Accrual for Environmental Loss Contingencies	50
Chemours [Member] | Successor [Member]
Loss Contingencies [Line Items]
Accrual for Environmental Loss Contingencies	242
Accrual for Environmental Loss Contingencies, Potential Exposure in Excess of Accrual	430
Indemnification Agreement [Member] | Chemours [Member] | Successor [Member]
Loss Contingencies [Line Items]
Indemnification Assets	242
Indemnification Agreement [Member] | Chemours [Member] | Superfund Sites [Member] | Successor [Member]
Loss Contingencies [Line Items]
Indemnification Assets	$ 47

XML

Stockholders' Equity Share Buyback Program (Details) - Predecessor [Member] - USD ($) $ in Millions	6 Months Ended	8 Months Ended	12 Months Ended		23 Months Ended	43 Months Ended
	Dec. 31, 2016	Aug. 31, 2017	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2016	Aug. 31, 2017	Jan. 21, 2015	Jan. 31, 2014
Equity, Class of Treasury Stock [Line Items]
Shares Repurchased and Retired During Period			(13,152,000)	(39,564,000)
Payments for Repurchase of Common Stock		$ 0	$ 916	$ 2,353
2015 Share Buyback Plan [Member]
Equity, Class of Treasury Stock [Line Items]
2015 Share Buy Back Announcement							$ 4,000
Shares Repurchased and Retired During Period	13,200,000		48,200,000
Payments for Repurchase of Common Stock	$ 916				$ 2,916
2014 Share Buyback Plan [Member]
Equity, Class of Treasury Stock [Line Items]
Stock Repurchase Program, Authorized Amount								$ 5,000
Shares Repurchased and Retired During Period						34,700,000
Payments for Repurchase of Common Stock						$ 2,353
Year ended December 31, 2015 [Member] | 2015 Share Buyback Plan [Member]
Equity, Class of Treasury Stock [Line Items]
Stock Repurchase Program, Authorized Amount							$ 2,000
Year ended December 31, 2015 [Member] | 2014 Share Buyback Plan [Member]
Equity, Class of Treasury Stock [Line Items]
Shares Repurchased and Retired During Period				4,600,000
Payments for Repurchase of Common Stock				$ 353

XML

Stockholders' Equity Stockholders' Equity (Narrative) (Details) - USD ($) $ in Millions		8 Months Ended	12 Months Ended
	Aug. 30, 2017	Aug. 31, 2017	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2017	Dec. 31, 2014
Predecessor [Member]
Class of Stock [Line Items]
Treasury Stock, Shares	87,041,000	0	87,041,000	87,041,000		87,041,000
Excess of Cost of Treasury Stock over Par Value		$ 0	$ 0	$ 0
Tax benefit (expense) recorded in Stockholders' Equity			33	(138)
Tax benefits			21	37
Successor [Member]
Class of Stock [Line Items]
Treasury Stock, Shares		0			0
Retained Earnings [Member] | Predecessor [Member]
Class of Stock [Line Items]
Excess of Cost of Treasury Stock over Par Value	$ 5,657	$ 5,657	758	1,890
Additional Paid-in Capital [Member] | Predecessor [Member]
Class of Stock [Line Items]
Excess of Cost of Treasury Stock over Par Value	$ 1,044	$ 1,044	$ 154	$ 451

XML

Stockholders' Equity Reconciliation of Common Stock Share Activity (Details) - shares		4 Months Ended	8 Months Ended	12 Months Ended
		Dec. 31, 2017	Aug. 31, 2017	Dec. 31, 2016	Dec. 31, 2015
Predecessor [Member]
Class of Stock [Line Items]
Common Stock, Shares, Outstanding, Beginning Balance		868,338,000	950,044,000	958,388,000	992,020,000
Shares Issued During Period		0	5,335,000	4,808,000	5,932,000
Shares Repurchased and Retired During Period				(13,152,000)	(39,564,000)
Shares Retired During the Period			(87,041,000)
Common Stock, Shares, Outstanding, Ending Balance			868,338,000	950,044,000	958,388,000
Treasury Stock Shares, Beginning of Period		0	(87,041,000)	(87,041,000)	(87,041,000)
Treasury Stock Shares Repurchased During Period				(13,152,000)	(39,564,000)
Treasury Stock Shares Retired During Period			87,041,000	13,152,000	39,564,000
Treasury Stock Shares, End of Period			0	(87,041,000)	(87,041,000)
Successor [Member]
Class of Stock [Line Items]
Common Stock, Shares, Outstanding, Beginning Balance	[1]	100
Common Stock, Shares, Outstanding, Ending Balance	[1]	100	100
Treasury Stock Shares, Beginning of Period		0
Treasury Stock Shares, End of Period		0	0

[1] All of the company's issued and outstanding common stock at September 1, 2017 is held by the DowDuPont Inc.

XML

Stockholders' Equity Other Comprehensive Income (Loss) (Details) - USD ($) $ in Millions		4 Months Ended	8 Months Ended		12 Months Ended
		Dec. 31, 2017	Aug. 31, 2017		Dec. 31, 2016		Dec. 31, 2015
Predecessor [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Beginning Balance		$ 12,517	$ 10,196		$ 10,200		$ 13,378
Amounts Reclassified from Accumulated Other Comprehensive Income, Net of Tax			321		335		297
Net other comprehensive income (loss)			1,289		(515)		(1,308)
Ending Balance			12,517		10,196		10,200
Predecessor [Member] | Cumulative Translation Adjustment
Accumulated Other Comprehensive Income (Loss) [Line Items]
Beginning Balance		(1,801)	(2,843)		(2,333)		(919)
Other Comprehensive Income (Loss), before Reclassifications, Net of Tax	[1]		1,042		(510)		(1,605)
Amounts Reclassified from Accumulated Other Comprehensive Income, Net of Tax			0		0		0
Net other comprehensive income (loss)			1,042		(510)		(1,605)
Spin-off of Chemours							191
Ending Balance			(1,801)		(2,843)		(2,333)
Predecessor [Member] | Derivative Instruments
Accumulated Other Comprehensive Income (Loss) [Line Items]
Beginning Balance		(3)	7		(24)		(6)
Other Comprehensive Income (Loss), before Reclassifications, Net of Tax			3		20		(25)
Amounts Reclassified from Accumulated Other Comprehensive Income, Net of Tax			(13)		11		7
Net other comprehensive income (loss)			(10)		31		(18)
Spin-off of Chemours							0
Ending Balance			(3)		7		(24)
Predecessor [Member] | Unrealized gain (loss) on investments
Accumulated Other Comprehensive Income (Loss) [Line Items]
Beginning Balance		2	2		(18)		2
Other Comprehensive Income (Loss), before Reclassifications, Net of Tax			1		(8)		(17)
Amounts Reclassified from Accumulated Other Comprehensive Income, Net of Tax			(1)		28		(2)
Net other comprehensive income (loss)			0		20		(19)
Spin-off of Chemours							(1)
Ending Balance			2		2		(18)
Predecessor [Member] | Total
Accumulated Other Comprehensive Income (Loss) [Line Items]
Beginning Balance		(8,622)	(9,911)		(9,396)		(8,556)
Other Comprehensive Income (Loss), before Reclassifications, Net of Tax			968		(850)		(1,605)
Amounts Reclassified from Accumulated Other Comprehensive Income, Net of Tax			321		335		297
Net other comprehensive income (loss)			1,289		(515)		(1,308)
Spin-off of Chemours							468
Ending Balance			(8,622)		(9,911)		(9,396)
Successor [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Beginning Balance		75,081
Amounts Reclassified from Accumulated Other Comprehensive Income, Net of Tax		0
Net other comprehensive income (loss)		(381)
Ending Balance		74,932	75,081
Successor [Member] | Cumulative Translation Adjustment
Accumulated Other Comprehensive Income (Loss) [Line Items]
Beginning Balance	[2]	0
Other Comprehensive Income (Loss), before Reclassifications, Net of Tax	[1]	(454)
Amounts Reclassified from Accumulated Other Comprehensive Income, Net of Tax		0
Net other comprehensive income (loss)		(454)
Ending Balance		(454)	0	[2]
Successor [Member] | Derivative Instruments
Accumulated Other Comprehensive Income (Loss) [Line Items]
Beginning Balance	[2]	0
Other Comprehensive Income (Loss), before Reclassifications, Net of Tax		(2)
Amounts Reclassified from Accumulated Other Comprehensive Income, Net of Tax		0
Net other comprehensive income (loss)		(2)
Ending Balance		(2)	0	[2]
Successor [Member] | Unrealized gain (loss) on investments
Accumulated Other Comprehensive Income (Loss) [Line Items]
Beginning Balance	[2]	0
Other Comprehensive Income (Loss), before Reclassifications, Net of Tax		0
Amounts Reclassified from Accumulated Other Comprehensive Income, Net of Tax		0
Net other comprehensive income (loss)		0
Ending Balance		0	0	[2]
Successor [Member] | Total
Accumulated Other Comprehensive Income (Loss) [Line Items]
Beginning Balance	[2]	0
Other Comprehensive Income (Loss), before Reclassifications, Net of Tax		(381)
Amounts Reclassified from Accumulated Other Comprehensive Income, Net of Tax		0
Net other comprehensive income (loss)		(381)
Ending Balance		(381)	0	[2]
Other Benefit Plans | Predecessor [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Beginning Balance		(347)	(357)		22		262
Other Comprehensive Income (Loss), before Reclassifications, Net of Tax			0		(81)		3
Amounts Reclassified from Accumulated Other Comprehensive Income, Net of Tax			10		(298)		(243)
Net other comprehensive income (loss)			10		(379)		(240)
Spin-off of Chemours							0
Ending Balance			(347)		(357)		22
Other Benefit Plans | Successor [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Beginning Balance	[2]	0
Other Comprehensive Income (Loss), before Reclassifications, Net of Tax		(53)
Amounts Reclassified from Accumulated Other Comprehensive Income, Net of Tax		0
Net other comprehensive income (loss)		(53)
Ending Balance		(53)	0	[2]
Pension Plan | Predecessor [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Beginning Balance		(6,473)	(6,720)		(7,043)		(7,895)
Other Comprehensive Income (Loss), before Reclassifications, Net of Tax			(78)		(271)	[3]	39
Amounts Reclassified from Accumulated Other Comprehensive Income, Net of Tax			325		594		535
Net other comprehensive income (loss)			247		323		574
Spin-off of Chemours							278
Ending Balance			(6,473)		$ (6,720)		$ (7,043)
Pension Plan | Successor [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Beginning Balance	[2]	0
Other Comprehensive Income (Loss), before Reclassifications, Net of Tax		128
Amounts Reclassified from Accumulated Other Comprehensive Income, Net of Tax		0
Net other comprehensive income (loss)		128
Ending Balance		$ 128	$ 0	[2]

[1] The cumulative translation adjustment loss for the period September 1 through December 31, 2017 is primarily driven by the strengthening of the U.S dollar (USD) against the European Euro (EUR) and the Brazilian real (BRL). The cumulative translation adjustment gain for the period January 1 through August 31, 2017 is primarily driven by the weakening of the USD against the EUR. The currency translation loss for the year ended December 31, 2016 is primarily driven by the strengthening of the USD against the EUR partially offset by the weakening of the USD against the BRL. The currency translation loss for the year ended December 31, 2015 is driven by the strengthening USD against primarily the EUR and BRL.

[2] In connection with the Merger, balances in accumulated other comprehensive loss at Merger Effectiveness Time were eliminated as a result of reflecting the balance sheet at fair value as of the date of the Merger. See Note 3 and 16 for further information regarding the Merger and pension and OPEB plans, respectively.

[3] The Pension Benefit Plans loss recognized in other comprehensive (loss) income during the year ended December 31, 2016 includes the impact of the remeasurement of the principal U.S. pension plan as of June 30, 2016. See Note 16 for additional information.

XML

Stockholders' Equity Tax Benefit (Expense) on Net Activity (Details) - USD ($) $ in Millions	4 Months Ended	8 Months Ended	12 Months Ended
	Dec. 31, 2017	Aug. 31, 2017	Dec. 31, 2016	Dec. 31, 2015
Successor [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Other Comprehensive Income (Loss), Tax	$ (21)
Successor [Member] | Derivative Instruments
Accumulated Other Comprehensive Income (Loss) [Line Items]
Other Comprehensive Income (Loss), Tax	1
Predecessor [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Other Comprehensive Income (Loss), Tax		$ (144)	$ 12	$ (175)
Predecessor [Member] | Derivative Instruments
Accumulated Other Comprehensive Income (Loss) [Line Items]
Other Comprehensive Income (Loss), Tax		6	(19)	7
Pension Plan | Successor [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Other Comprehensive Income (Loss), Tax	(37)
Pension Plan | Predecessor [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Other Comprehensive Income (Loss), Tax		(145)	(163)	(317)
Other Benefit Plans | Successor [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Other Comprehensive Income (Loss), Tax	$ 15
Other Benefit Plans | Predecessor [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Other Comprehensive Income (Loss), Tax		$ (5)	$ 194	$ 135

XML

Stockholders' Equity Reclassifications out of AOCI (Details) - USD ($) $ in Millions		1 Months Ended		2 Months Ended	3 Months Ended								4 Months Ended	8 Months Ended	12 Months Ended
		Sep. 30, 2017	[1]	Aug. 31, 2017	Dec. 31, 2017	[1]	Jun. 30, 2017	Mar. 31, 2017	Dec. 31, 2016	Sep. 30, 2016	Jun. 30, 2016	Mar. 31, 2016	Dec. 31, 2017	Aug. 31, 2017	Dec. 31, 2016	Dec. 31, 2015
Successor [Member]
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Cost of Goods Sold		$ 1,511			$ 4,654								$ 6,165
Income Tax Expense (Benefit)													(2,673)
Income from continuing operations after income taxes													1,087
Reclassification from Accumulated Other Comprehensive Income, Current Period, Net of Tax													0
Successor [Member] | Derivative Instruments
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Cost of Goods Sold	[2]												0
Income Tax Expense (Benefit)	[3]												0
Income from continuing operations after income taxes													0
Reclassification from Accumulated Other Comprehensive Income, Current Period, Net of Tax													0
Successor [Member] | Unrealized gain (loss) on investments
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Reclassification from Accumulated Other Comprehensive Income, Current Period, before Tax	[4]												0
Reclassification from AOCI, Current Period, Tax	[3]												0
Reclassification from Accumulated Other Comprehensive Income, Current Period, Net of Tax													0
Predecessor [Member]
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Cost of Goods Sold				$ 1,975			$ 4,021	$ 4,209	$ 3,032	$ 2,997	$ 3,823	$ 4,103		$ 10,205	$ 13,955	$ 14,591
Income Tax Expense (Benefit)														149	641	575
Income from continuing operations after income taxes														1,642	2,082	1,447
Reclassification from Accumulated Other Comprehensive Income, Current Period, Net of Tax														321	335	297
Predecessor [Member] | Derivative Instruments
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Cost of Goods Sold	[2]													(21)	18	12
Income Tax Expense (Benefit)	[3]													8	(7)	(5)
Income from continuing operations after income taxes														(13)	11	7
Reclassification from Accumulated Other Comprehensive Income, Current Period, Net of Tax														(13)	11	7
Predecessor [Member] | Unrealized gain (loss) on investments
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Reclassification from Accumulated Other Comprehensive Income, Current Period, before Tax	[4]													(1)	28	(2)
Reclassification from AOCI, Current Period, Tax	[3]													0	0	0
Reclassification from Accumulated Other Comprehensive Income, Current Period, Net of Tax														(1)	28	(2)
Pension Plan | Successor [Member]
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Reclassification from Accumulated Other Comprehensive Income, Current Period, Net of Tax													0
Pension Plan | Successor [Member] | Prior Service Benefit
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Reclassification from Accumulated Other Comprehensive Income, Current Period, before Tax	[5]												0
Pension Plan | Successor [Member] | Actuarial Losses
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Reclassification from Accumulated Other Comprehensive Income, Current Period, before Tax	[5]												0
Pension Plan | Successor [Member] | Curtailment (loss) gain
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Reclassification from Accumulated Other Comprehensive Income, Current Period, before Tax	[5]												0
Pension Plan | Successor [Member] | Settlement loss
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Reclassification from Accumulated Other Comprehensive Income, Current Period, before Tax	[5]												0
Pension Plan | Successor [Member] | Accumulated Defined Benefit Plans Adjustment Attributable to Parent
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Reclassification from Accumulated Other Comprehensive Income, Current Period, before Tax													0
Reclassification from AOCI, Current Period, Tax	[3]												0
Reclassification from Accumulated Other Comprehensive Income, Current Period, Net of Tax													0
Pension Plan | Predecessor [Member]
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Reclassification from Accumulated Other Comprehensive Income, Current Period, Net of Tax														325	594	535
Pension Plan | Predecessor [Member] | Prior Service Benefit
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Reclassification from Accumulated Other Comprehensive Income, Current Period, before Tax	[5]													(3)	(6)	(9)
Pension Plan | Predecessor [Member] | Actuarial Losses
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Reclassification from Accumulated Other Comprehensive Income, Current Period, before Tax	[5]													506	822	768
Pension Plan | Predecessor [Member] | Curtailment (loss) gain
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Reclassification from Accumulated Other Comprehensive Income, Current Period, before Tax	[5]													0	40	(6)
Pension Plan | Predecessor [Member] | Settlement loss
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Reclassification from Accumulated Other Comprehensive Income, Current Period, before Tax	[5]													0	62	76
Pension Plan | Predecessor [Member] | Accumulated Defined Benefit Plans Adjustment Attributable to Parent
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Reclassification from Accumulated Other Comprehensive Income, Current Period, before Tax														503	918	829
Reclassification from AOCI, Current Period, Tax	[3]													(178)	(324)	(294)
Reclassification from Accumulated Other Comprehensive Income, Current Period, Net of Tax														325	594	535
Other Benefit Plans | Successor [Member]
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Reclassification from Accumulated Other Comprehensive Income, Current Period, Net of Tax													0
Other Benefit Plans | Successor [Member] | Prior Service Benefit
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Reclassification from Accumulated Other Comprehensive Income, Current Period, before Tax	[5]												0
Other Benefit Plans | Successor [Member] | Actuarial Losses
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Reclassification from Accumulated Other Comprehensive Income, Current Period, before Tax	[5]												0
Other Benefit Plans | Successor [Member] | Curtailment (loss) gain
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Reclassification from Accumulated Other Comprehensive Income, Current Period, before Tax	[5]												0
Other Benefit Plans | Successor [Member] | Accumulated Defined Benefit Plans Adjustment Attributable to Parent
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Reclassification from Accumulated Other Comprehensive Income, Current Period, before Tax													0
Reclassification from AOCI, Current Period, Tax	[3]												0
Reclassification from Accumulated Other Comprehensive Income, Current Period, Net of Tax													$ 0
Other Benefit Plans | Predecessor [Member]
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Reclassification from Accumulated Other Comprehensive Income, Current Period, Net of Tax														10	(298)	(243)
Other Benefit Plans | Predecessor [Member] | Prior Service Benefit
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Reclassification from Accumulated Other Comprehensive Income, Current Period, before Tax	[5]													(46)	(134)	(182)
Other Benefit Plans | Predecessor [Member] | Actuarial Losses
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Reclassification from Accumulated Other Comprehensive Income, Current Period, before Tax	[5]													61	78	78
Other Benefit Plans | Predecessor [Member] | Curtailment (loss) gain
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Reclassification from Accumulated Other Comprehensive Income, Current Period, before Tax	[5]													0	(392)	(274)
Other Benefit Plans | Predecessor [Member] | Accumulated Defined Benefit Plans Adjustment Attributable to Parent
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Reclassification from Accumulated Other Comprehensive Income, Current Period, before Tax														15	(448)	(378)
Reclassification from AOCI, Current Period, Tax	[3]													(5)	150	135
Reclassification from Accumulated Other Comprehensive Income, Current Period, Net of Tax														$ 10	$ (298)	$ (243)

[1] Includes charges of $(360) million and $(1,109) million during the period September 1 - September 30, 2017 and the fourth quarter 2017, respectively, related to the amortization of inventory step-up as a result of the Merger and the acquisition of the H&N Business, which was included in cost of goods sold. See Note 3 for additional information.

[2] Cost of goods sold.

[3] Provision for income taxes from continuing operations.

[4] Sundry income - net.

[5] These accumulated other comprehensive loss components are included in the computation of net periodic benefit cost of the company's pension and other benefit plans. See Note 16 for additional information.

XML

Pension Plans and Other Post Employment Benefit Plans Additional Information (Details) $ in Millions	1 Months Ended	3 Months Ended		4 Months Ended	8 Months Ended	12 Months Ended
	Nov. 30, 2017 USD ($)	Dec. 31, 2017 USD ($)	Dec. 31, 2016 USD ($)	Dec. 31, 2017 USD ($)	Aug. 31, 2017 USD ($)	Dec. 31, 2016 USD ($)	Dec. 31, 2015 USD ($)	Nov. 30, 2016
U.S. Retirement Savings Plan [Member]
Defined Benefit and Contribution Disclosures [Line Items]
Employer Matching Contribution, Percent of Match				100.00%
Employer Matching Contribution, Percent of Employees' Gross Pay				6.00%
Employer Discretionary Contribution Percent				3.00%
Employers Discretionary Contribution, Vesting Period				3 years
Pension Plan | Funded Pension Plans other than Principal U.S. Plan and Remaining Plans with no Plan Assets [Member]
Defined Benefit and Contribution Disclosures [Line Items]
Expected Future Employer Contributions, Next Fiscal Year		$ 200		$ 200
Other Post Employment Benefits Plan
Defined Benefit and Contribution Disclosures [Line Items]
Expected Amortization of Gain (Loss), Next Fiscal Year		1		1
Expected Future Employer Contributions, Next Fiscal Year		250		250
Predecessor [Member] | Remaining Plans with no Plan Assets [Member]
Defined Benefit and Contribution Disclosures [Line Items]
Employer contributions					$ 57	$ 184	$ 144
Predecessor [Member] | U.S. Retirement Savings Plan [Member]
Defined Benefit and Contribution Disclosures [Line Items]
Defined Contribution Plan, Employer Contribution					129	187	219
Predecessor [Member] | DuPont Other Contribution Plans [Member]
Defined Benefit and Contribution Disclosures [Line Items]
Defined Contribution Plan, Employer Contribution					33	33	57
Predecessor [Member] | Pension Plan
Defined Benefit and Contribution Disclosures [Line Items]
Remeasurement Impact Benefit Obligation						527
Curtailment loss (gain)			$ (25)		0	40	$ (6)
Employer contributions					$ 3,024	$ 535
Discount Rate			3.80%		3.42%	3.80%
Expected long-term rate of return on plan assets					7.66%	7.74%	8.10%
Predecessor [Member] | Pension Plan | Principal U.S. Pension Plan [Member]
Defined Benefit and Contribution Disclosures [Line Items]
Curtailment loss (gain)						$ 63
Employer contributions					$ 2,900	$ 230
Lump-Sum Payments			$ 550
Expected long-term rate of return on plan assets					8.00%	8.00%	8.50%
Predecessor [Member] | Pension Plan | Other Pension Plan [Member]
Defined Benefit and Contribution Disclosures [Line Items]
Employer contributions					$ 67	$ 121	$ 164
Predecessor [Member] | Other Post Employment Benefits Plan
Defined Benefit and Contribution Disclosures [Line Items]
Eligible Employee Age Threshold								50
Curtailment loss (gain)			$ (357)		0	(392)	(274)
Pre-tax cash requirements to cover actual net claims costs and related administrative expenses					166	218	237
Employer contributions					$ 166	$ 218
Discount Rate			4.03%		3.62%	4.03%
Successor [Member]
Defined Benefit and Contribution Disclosures [Line Items]
Trust Asset		$ 558		558
Successor [Member] | Other Pension Plan [Member]
Defined Benefit and Contribution Disclosures [Line Items]
Employer contributions				34
Successor [Member] | Remaining Plans with no Plan Assets [Member]
Defined Benefit and Contribution Disclosures [Line Items]
Employer contributions				34
Successor [Member] | U.S. Retirement Savings Plan [Member]
Defined Benefit and Contribution Disclosures [Line Items]
Defined Contribution Plan, Employer Contribution				53
Successor [Member] | DuPont Other Contribution Plans [Member]
Defined Benefit and Contribution Disclosures [Line Items]
Defined Contribution Plan, Employer Contribution				17
Successor [Member] | Pension Plan
Defined Benefit and Contribution Disclosures [Line Items]
Curtailment loss (gain)				0
Employer contributions				68
Remeasurement Impact Underfunded Status				$ 560
Discount Rate		3.37%		3.37%
Expected long-term rate of return on plan assets				6.24%
Successor [Member] | Pension Plan | Principal U.S. Pension Plan [Member]
Defined Benefit and Contribution Disclosures [Line Items]
Lump-Sum Payments		$ 140
Expected long-term rate of return on plan assets				6.25%
Successor [Member] | Other Post Employment Benefits Plan
Defined Benefit and Contribution Disclosures [Line Items]
Remeasurement Impact Benefit Obligation				$ 41
Curtailment loss (gain)				0
Pre-tax cash requirements to cover actual net claims costs and related administrative expenses				59
Employer contributions				$ 59
Discount Rate		3.56%		3.56%
Nonqualified Plan [Member] | Successor [Member] | Trust Agreement [Member]
Defined Benefit and Contribution Disclosures [Line Items]
Contributions to Trust	$ 571
Trust Asset Distribution		$ 13
Trust Asset		$ 558		$ 558
Discontinued Operations [Member] | Predecessor [Member] | DuPont Other Contribution Plans [Member]
Defined Benefit and Contribution Disclosures [Line Items]
Defined Contribution Plan, Employer Contribution					$ 5	$ 6	$ 39
Discontinued Operations [Member] | Successor [Member] | DuPont Other Contribution Plans [Member]
Defined Benefit and Contribution Disclosures [Line Items]
Defined Contribution Plan, Employer Contribution				$ 1
2016 Global Cost Savings and Restructuring Plan [Member] | Predecessor [Member] | Other Post Employment Benefits Plan
Defined Benefit and Contribution Disclosures [Line Items]
Curtailment loss (gain)						$ (35)

XML

Pension Plans and Other Post Employment Benefit Plans Weighted Average Assumptions used to Determine Benefit Obligations - Pension (Details) - Pension Plan		Dec. 31, 2017	Aug. 31, 2017	Dec. 31, 2016
Successor [Member]
Defined Benefit Plan Disclosure [Line Items]
Discount Rate		3.37%
Rate of increase in future compensation levels	[1]	4.04%
Predecessor [Member]
Defined Benefit Plan Disclosure [Line Items]
Discount Rate			3.42%	3.80%
Rate of increase in future compensation levels	[1]			3.80%

[1] The rate of compensation increase represents the single annual effective salary increase that an average plan participant would receive during the participant's entire career at the company.

XML

Pension Plans and Other Post Employment Benefit Plans Weighted Average Assumptions used to Determine Net Periodic Benefit Cost - Pension (Details) - Pension Plan	4 Months Ended	8 Months Ended	12 Months Ended
	Dec. 31, 2017	Aug. 31, 2017	Dec. 31, 2016	Dec. 31, 2015
Successor [Member]
Defined Benefit Plan Disclosure [Line Items]
Net Periodic Benefit, Discount Rate	3.42%
Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Rate of Compensation Increase	3.80%
Expected long-term rate of return on plan assets	6.24%
Successor [Member] | Principal U.S. Pension Plan [Member]
Defined Benefit Plan Disclosure [Line Items]
Net Periodic Benefit, Discount Rate	3.73%
Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Rate of Compensation Increase	3.95%
Expected long-term rate of return on plan assets	6.25%
Predecessor [Member]
Defined Benefit Plan Disclosure [Line Items]
Net Periodic Benefit, Discount Rate		3.80%	3.77%	3.93%
Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Rate of Compensation Increase		3.80%	3.96%	4.01%
Expected long-term rate of return on plan assets		7.66%	7.74%	8.10%
Predecessor [Member] | Principal U.S. Pension Plan [Member]
Defined Benefit Plan Disclosure [Line Items]
Net Periodic Benefit, Discount Rate		4.16%	4.04%	4.29%
Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Rate of Compensation Increase		3.95%	4.15%	4.20%
Expected long-term rate of return on plan assets		8.00%	8.00%	8.50%

XML

Pension Plans and Other Post Employment Benefit Plans Weighted Average Assumptions used to Determine Benefit Obligations and Periodic Benefit Cost - OPEB (Details) - Other Post Employment Benefits Plan	4 Months Ended	8 Months Ended	12 Months Ended
	Dec. 31, 2017	Aug. 31, 2017	Dec. 31, 2016	Dec. 31, 2015
Successor [Member]
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]
Net Periodic Benefit, Discount Rate	3.62%
Discount Rate	3.56%
Predecessor [Member]
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]
Net Periodic Benefit, Discount Rate		4.03%	3.87%	4.13%
Discount Rate		3.62%	4.03%

XML

Pension Plans and Other Post Employment Benefit Plans Assumed Health Care Cost Trend Rates (Details) - Other Post Employment Benefits Plan	4 Months Ended	12 Months Ended
	Dec. 31, 2017	Dec. 31, 2016
Successor [Member]
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]
Health care cost trend rate assumed for next year	6.40%
Defined Benefit Plan, Ultimate Health Care Cost Trend Rate	5.00%
Year that the rate reached the ultimate health care cost trend rate	2023
Predecessor [Member]
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]
Health care cost trend rate assumed for next year		7.00%
Defined Benefit Plan, Ultimate Health Care Cost Trend Rate		5.00%
Year that the rate reached the ultimate health care cost trend rate		2023

XML

Pension Plans and Other Post Employment Benefit Plans Change in Projected Benefit Obligations, Plan Assets and Funded Status (Details) - USD ($) $ in Millions		3 Months Ended		4 Months Ended	8 Months Ended		12 Months Ended
		Dec. 31, 2017	Dec. 31, 2016	Dec. 31, 2017	Aug. 31, 2017		Dec. 31, 2016		Dec. 31, 2015
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]
Benefit obligation at end of the period		$ 389		$ 389
Successor [Member] | Pension Plan
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]
Benefit obligation at beginning of the period	[1]			26,036
Service Cost				49
Interest Cost				247
Plan participants' contributions				6
Actuarial (gain) loss				(23)
Benefits Paid				(730)
Plan amendments				0
Net effects of acquisitions / divestitures / other				22
Effect of foreign exchange rates				(57)
Benefit obligation at end of the period		25,550		25,550	$ 26,036	[1]
Fair value of plan assets at beginning of period	[1]			20,395
Actual return on plan assets				549
Employer contributions				68
Plan participants' contributions				6
Benefits paid	[2]			(730)
Net effects of acquisitions / divestitures / other				29
Effect of foreign exchange rates				(33)
Fair value of plan assets at end of the period		20,284		20,284	20,395	[1]
Funded (unfunded) status of plan		(5,266)		(5,266)
Successor [Member] | Pension Plan | Principal U.S. Pension Plan [Member]
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]
Lump-Sum Payments		140
Successor [Member] | Pension Plan | U.S. Plans with Plan Assets [Member]
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]
Funded (unfunded) status of plan		(3,628)		(3,628)
Successor [Member] | Pension Plan | Non-U.S. plans with plan assets [Member]
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]
Funded (unfunded) status of plan		(447)		(447)
Successor [Member] | Pension Plan | All other plans [Member]
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]
Funded (unfunded) status of plan	[3],[4]	(1,191)		(1,191)
Successor [Member] | Pension Plan | Plans of Discontinued Operations [Member]
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]
Funded (unfunded) status of plan		0		0
Successor [Member] | Other Post Employment Benefits Plan
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]
Benefit obligation at beginning of the period	[1]			2,772
Service Cost				3
Interest Cost				26
Plan participants' contributions				12
Actuarial (gain) loss				68
Benefits Paid				(71)
Plan amendments				0
Net effects of acquisitions / divestitures / other				0
Effect of foreign exchange rates				0
Benefit obligation at end of the period		2,810		2,810	2,772	[1]
Fair value of plan assets at beginning of period	[1]			0
Actual return on plan assets				0
Employer contributions				59
Plan participants' contributions				12
Benefits paid				(71)
Net effects of acquisitions / divestitures / other				0
Effect of foreign exchange rates				0
Fair value of plan assets at end of the period		0		0	0	[1]
Funded (unfunded) status of plan		(2,810)		(2,810)
Successor [Member] | Other Post Employment Benefits Plan | U.S. Plans with Plan Assets [Member]
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]
Funded (unfunded) status of plan		0		0
Successor [Member] | Other Post Employment Benefits Plan | Non-U.S. plans with plan assets [Member]
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]
Funded (unfunded) status of plan		0		0
Successor [Member] | Other Post Employment Benefits Plan | All other plans [Member]
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]
Funded (unfunded) status of plan		(2,810)		(2,810)
Successor [Member] | Other Post Employment Benefits Plan | Plans of Discontinued Operations [Member]
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]
Funded (unfunded) status of plan		$ 0		0
Predecessor [Member] | Pension Plan
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]
Benefit obligation at beginning of the period				24,766	24,831		$ 26,094
Service Cost					92		174		$ 232
Interest Cost					524		800		1,084
Plan participants' contributions					8		18
Actuarial (gain) loss					0		460
Benefits Paid					(1,118)		(2,374)
Plan amendments					0		0
Net effects of acquisitions / divestitures / other					0		7
Effect of foreign exchange rates					429		(348)
Benefit obligation at end of the period			$ 24,831		24,766		24,831		26,094
Fair value of plan assets at beginning of period				19,685	16,656		17,497
Actual return on plan assets					846		1,219
Employer contributions					3,024		535
Plan participants' contributions					8		18
Benefits paid					(1,118)		(2,374)	[2]
Net effects of acquisitions / divestitures / other					0		0
Effect of foreign exchange rates					269		(239)
Fair value of plan assets at end of the period			16,656		19,685		16,656		17,497
Funded (unfunded) status of plan			(8,175)		(5,081)		(8,175)
Predecessor [Member] | Pension Plan | Principal U.S. Pension Plan [Member]
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]
Employer contributions					2,900		230
Lump-Sum Payments			550
Predecessor [Member] | Pension Plan | U.S. Plans with Plan Assets [Member]
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]
Funded (unfunded) status of plan			(6,391)		(3,277)		(6,391)
Predecessor [Member] | Pension Plan | Non-U.S. plans with plan assets [Member]
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]
Funded (unfunded) status of plan			(674)		(609)		(674)
Predecessor [Member] | Pension Plan | All other plans [Member]
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]
Funded (unfunded) status of plan			(1,102)		(1,187)		(1,102)
Predecessor [Member] | Pension Plan | Plans of Discontinued Operations [Member]
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]
Funded (unfunded) status of plan			(8)		(8)		(8)
Predecessor [Member] | Other Post Employment Benefits Plan
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]
Benefit obligation at beginning of the period				2,731	2,829		2,758
Service Cost					6		11		15
Interest Cost					60		87		112
Plan participants' contributions					26		36
Actuarial (gain) loss					0		153
Benefits Paid					(192)		(254)
Plan amendments					0		(28)
Net effects of acquisitions / divestitures / other					0		65
Effect of foreign exchange rates					2		1
Benefit obligation at end of the period			2,829		2,731		2,829		2,758
Fair value of plan assets at beginning of period				$ 0	0		0
Actual return on plan assets					0		0
Employer contributions					166		218
Plan participants' contributions					26		36
Benefits paid					(192)		(254)
Net effects of acquisitions / divestitures / other					0		0
Effect of foreign exchange rates					0		0
Fair value of plan assets at end of the period			0		0		0		$ 0
Funded (unfunded) status of plan			(2,829)		(2,731)		(2,829)
Predecessor [Member] | Other Post Employment Benefits Plan | U.S. Plans with Plan Assets [Member]
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]
Funded (unfunded) status of plan			0		0		0
Predecessor [Member] | Other Post Employment Benefits Plan | Non-U.S. plans with plan assets [Member]
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]
Funded (unfunded) status of plan			0		0		0
Predecessor [Member] | Other Post Employment Benefits Plan | All other plans [Member]
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]
Funded (unfunded) status of plan			(2,829)		(2,731)		(2,829)
Predecessor [Member] | Other Post Employment Benefits Plan | Plans of Discontinued Operations [Member]
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]
Funded (unfunded) status of plan			$ 0		$ 0		$ 0

[1] The benefit obligation and the fair value of plan assets at the beginning of the period September 1 through December 31, 2017, reflects the remeasurement of the plans at the Merger Effectiveness Time.

[2] In the fourth quarter of 2016, about $550 million of lump-sum payments were made from the principal U.S. pension plan trust fund to a group of separated, vested plan participants who were extended a limited-time opportunity and voluntarily elected to receive their pension benefits in a single lump-sum payment. In the fourth quarter of 2017, about $140 million of lump-sum payments were made from the principal U.S. pension plan trust fund under a similar program.

[3] As of December 31, 2017, $389 million of the benefit obligations are supported by funding under the Trust agreement, defined in the "Trust Assets" section below.

[4] Includes pension plans maintained around the world where funding is not customary.

XML

Pension Plans and Other Post Employment Benefit Plans Amounts Recognized in Consolidated Balance Sheets (Details) - USD ($) $ in Millions		Dec. 31, 2017	Dec. 31, 2016
Successor [Member]
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]
Defined Benefit Plan, Accumulated Benefit Obligation		$ 25,100
Noncurrent liabilities		(7,787)
Successor [Member] | Pension Plan
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]
Other Assets		47
Net amount recognized		(5,266)
Net (gain) loss		(165)
Prior service benefit		0
Pretax balance in accumulated other comprehensive (income) loss at end of year		(165)
Successor [Member] | Other Post Employment Benefits Plan
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]
Other Assets		0
Net amount recognized		(2,810)
Net (gain) loss		68
Prior service benefit		0
Pretax balance in accumulated other comprehensive (income) loss at end of year		68
Predecessor [Member]
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]
Defined Benefit Plan, Accumulated Benefit Obligation			$ 24,300
Predecessor [Member] | Pension Plan
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]
Other Assets			3
Net amount recognized			(8,175)
Net (gain) loss			10,280
Prior service benefit			(17)
Pretax balance in accumulated other comprehensive (income) loss at end of year			10,263
Predecessor [Member] | Other Post Employment Benefits Plan
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]
Other Assets			0
Net amount recognized			(2,829)
Net (gain) loss			830
Prior service benefit			(281)
Pretax balance in accumulated other comprehensive (income) loss at end of year			549
Accrued and Other Current Liabilities [Member] | Successor [Member] | Pension Plan
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]
Current liabilities		(86)
Accrued and Other Current Liabilities [Member] | Successor [Member] | Other Post Employment Benefits Plan
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]
Current liabilities		(250)
Accrued and Other Current Liabilities [Member] | Predecessor [Member] | Pension Plan
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]
Current liabilities			(78)
Accrued and Other Current Liabilities [Member] | Predecessor [Member] | Other Post Employment Benefits Plan
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]
Current liabilities			(275)
Liabilities held for sale - current [Member] | Successor [Member] | Pension Plan
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]
Current liabilities		0
Liabilities held for sale - current [Member] | Successor [Member] | Other Post Employment Benefits Plan
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]
Current liabilities		0
Liabilities held for sale - current [Member] | Predecessor [Member] | Pension Plan
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]
Current liabilities			(8)
Liabilities held for sale - current [Member] | Predecessor [Member] | Other Post Employment Benefits Plan
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]
Current liabilities			0
Pension and other post employment benefits - noncurrent [Member] | Successor [Member] | Pension Plan
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]
Noncurrent liabilities	[1]	(5,227)
Pension and other post employment benefits - noncurrent [Member] | Successor [Member] | Other Post Employment Benefits Plan
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]
Noncurrent liabilities	[1]	(2,560)
Other Noncurrent Obligations [Member] | Successor [Member] | Pension Plan
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]
Noncurrent liabilities	[1]	0
Other Noncurrent Obligations [Member] | Successor [Member] | Other Post Employment Benefits Plan
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]
Noncurrent liabilities	[1]	$ 0
Other Noncurrent Obligations [Member] | Predecessor [Member] | Pension Plan
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]
Noncurrent liabilities	[1]		(8,092)
Other Noncurrent Obligations [Member] | Predecessor [Member] | Other Post Employment Benefits Plan
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]
Noncurrent liabilities	[1]		$ (2,554)

[1] In the Successor Period, non-current pension and OPEB liabilities are included within pension and other post employment benefits - noncurrent in the Consolidated Balance Sheets. In the Predecessor period, these liabilities are included within other noncurrent obligations.

XML

Pension Plans and Other Post Employment Benefit Plans Pension Plans with Projected Benefit Obligations in Excess of Plan Assets (Details) - Pension Plan - USD ($) $ in Millions	Dec. 31, 2017	Dec. 31, 2016
Successor [Member]
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]
Projected benefit obligations	$ 25,254
Accumulated benefit obligations	24,864
Fair value of plan assets	$ 19,941
Predecessor [Member]
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]
Projected benefit obligations		$ 24,779
Accumulated benefit obligations		24,297
Fair value of plan assets		$ 16,601

XML

Pension Plans and Other Post Employment Benefit Plans Pension Plans with Accumulated Benefit Obligations in Excess of Plan Assets (Details) - Pension Plan - USD ($) $ in Millions	Dec. 31, 2017	Dec. 31, 2016
Successor [Member]
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]
Defined Benefit Plan, Pension Plan with Accumulated Benefit Obligation in Excess of Plan Assets, Projected Benefit Obligation	$ 24,625
Defined Benefit Plan, Pension Plan with Accumulated Benefit Obligation in Excess of Plan Assets, Accumulated Benefit Obligation	24,315
Defined Benefit Plan, Pension Plan with Accumulated Benefit Obligation in Excess of Plan Assets, Fair Value of Plan Assets	$ 19,335
Predecessor [Member]
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]
Defined Benefit Plan, Pension Plan with Accumulated Benefit Obligation in Excess of Plan Assets, Projected Benefit Obligation		$ 23,946
Defined Benefit Plan, Pension Plan with Accumulated Benefit Obligation in Excess of Plan Assets, Accumulated Benefit Obligation		23,591
Defined Benefit Plan, Pension Plan with Accumulated Benefit Obligation in Excess of Plan Assets, Fair Value of Plan Assets		$ 15,838

XML

Pension Plans and Other Post Employment Benefit Plans Components of net periodic benefit cost (credit) and amounts recognized in other comprehensive loss (Details) - USD ($) $ in Millions	3 Months Ended	4 Months Ended	8 Months Ended	12 Months Ended
	Dec. 31, 2016	Dec. 31, 2017	Aug. 31, 2017	Dec. 31, 2016	Dec. 31, 2015
Successor [Member] | Pension Plan
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]
Service Cost		$ 49
Interest Cost		247
Expected return on plan assets		(407)
Amortization of unrecognized loss		0
Amortization of prior service benefit		0
Curtailment loss (gain)		0
Settlement loss		0
Net periodic benefit cost (credit)		(111)
Net (gain) loss		(165)
Amortization of unrecognized loss		0
Prior service benefit		0
Amortization of prior service benefit		0
Curtailment (loss) gain		0
Settlement loss		0
Effect of foreign exchange rates		0
Spin-off of Chemours		0
Total (benefit) loss recognized in other comprehensive loss, attributable to DuPont		(165)
Total recognized in net periodic benefit cost and other comprehensive (income) loss		(276)
Successor [Member] | Other Post Employment Benefits Plan
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]
Service Cost		3
Interest Cost		26
Expected return on plan assets		0
Amortization of unrecognized loss		0
Amortization of prior service benefit		0
Curtailment loss (gain)		0
Settlement loss		0
Net periodic benefit cost (credit)		29
Net (gain) loss		68
Amortization of unrecognized loss		0
Prior service benefit		0
Amortization of prior service benefit		0
Curtailment (loss) gain		0
Settlement loss		0
Effect of foreign exchange rates		0
Spin-off of Chemours		0
Total (benefit) loss recognized in other comprehensive loss, attributable to DuPont		68
Total recognized in net periodic benefit cost and other comprehensive (income) loss		97
Predecessor [Member] | Pension Plan
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]
Service Cost			$ 92	$ 174	$ 232
Interest Cost			524	800	1,084
Expected return on plan assets			(824)	(1,320)	(1,554)
Amortization of unrecognized loss			506	822	768
Amortization of prior service benefit			(3)	(6)	(9)
Curtailment loss (gain)	$ 25		0	(40)	6
Settlement loss			0	62	76
Net periodic benefit cost (credit)			295	572	591
Net (gain) loss			(22)	570	57
Amortization of unrecognized loss			(506)	(822)	(768)
Prior service benefit			0	0	0
Amortization of prior service benefit			3	6	9
Curtailment (loss) gain			0	(40)	6
Settlement loss			0	(62)	(76)
Effect of foreign exchange rates			133	(138)	(119)
Spin-off of Chemours			0	0	(382)
Total (benefit) loss recognized in other comprehensive loss, attributable to DuPont			(392)	(486)	(1,273)
Total recognized in net periodic benefit cost and other comprehensive (income) loss			(97)	86	(682)
Predecessor [Member] | Other Post Employment Benefits Plan
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]
Service Cost			6	11	15
Interest Cost			60	87	112
Expected return on plan assets			0	0	0
Amortization of unrecognized loss			61	78	78
Amortization of prior service benefit			(46)	(134)	(182)
Curtailment loss (gain)	$ 357		0	392	274
Settlement loss			0	0	0
Net periodic benefit cost (credit)			81	(350)	(251)
Net (gain) loss			0	153	(4)
Amortization of unrecognized loss			(61)	(78)	(78)
Prior service benefit			0	(28)	0
Amortization of prior service benefit			46	134	182
Curtailment (loss) gain			0	392	274
Settlement loss			0	0	0
Effect of foreign exchange rates			0	0	1
Spin-off of Chemours			0	0	0
Total (benefit) loss recognized in other comprehensive loss, attributable to DuPont			(15)	573	375
Total recognized in net periodic benefit cost and other comprehensive (income) loss			66	223	124
Discontinued Operations [Member] | Successor [Member] | Pension Plan
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]
Net periodic benefit cost (credit)		1
Discontinued Operations [Member] | Successor [Member] | Other Post Employment Benefits Plan
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]
Net periodic benefit cost (credit)		0
Discontinued Operations [Member] | Predecessor [Member] | Pension Plan
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]
Net periodic benefit cost (credit)			3	0	0
Discontinued Operations [Member] | Predecessor [Member] | Other Post Employment Benefits Plan
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]
Net periodic benefit cost (credit)			0	0	(272)
Continuing Operations [Member] | Successor [Member] | Pension Plan
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]
Net periodic benefit cost (credit)		(112)
Continuing Operations [Member] | Successor [Member] | Other Post Employment Benefits Plan
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]
Net periodic benefit cost (credit)		$ 29
Continuing Operations [Member] | Predecessor [Member] | Pension Plan
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]
Net periodic benefit cost (credit)			292	572	591
Continuing Operations [Member] | Predecessor [Member] | Other Post Employment Benefits Plan
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]
Net periodic benefit cost (credit)			$ 81	$ (350)	$ 21

XML

Pension Plans and Other Post Employment Benefit Plans Estimated Future Benefit Payments (Details) - Successor [Member] $ in Millions	Dec. 31, 2017 USD ($)
Pension Plan
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]
2018	$ 1,636
2019	1,614
2020	1,600
2021	1,587
2022	1,568
2023-2027	7,533
Total	15,538
Postemployment Retirement Benefits [Member]
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]
2018	250
2019	243
2020	236
2021	227
2022	218
2023-2027	906
Total	$ 2,080

XML

Pension Plans and Other Post Employment Benefit Plans Target Allocation for Plan Assets (Details) - Pension Plan	Dec. 31, 2017	Dec. 31, 2016
Successor [Member]
Defined Benefit Plan Disclosure [Line Items]
Target Allocation for plan assets	100.00%
Successor [Member] | Fixed Income Securities [Member]
Defined Benefit Plan Disclosure [Line Items]
Target Allocation for plan assets	50.00%
Successor [Member] | Hedge Funds [Member]
Defined Benefit Plan Disclosure [Line Items]
Target Allocation for plan assets	2.00%
Successor [Member] | Private Market Securities [Member]
Defined Benefit Plan Disclosure [Line Items]
Target Allocation for plan assets	8.00%
Successor [Member] | Real Estate [Member]
Defined Benefit Plan Disclosure [Line Items]
Target Allocation for plan assets	3.00%
Successor [Member] | Cash and Cash Equivalents [Member]
Defined Benefit Plan Disclosure [Line Items]
Target Allocation for plan assets	2.00%
Successor [Member] | UNITED STATES | Equity Securities [Member]
Defined Benefit Plan Disclosure [Line Items]
Target Allocation for plan assets	17.00%
Successor [Member] | Non-US [Member] | Equity Securities [Member]
Defined Benefit Plan Disclosure [Line Items]
Target Allocation for plan assets	18.00%
Predecessor [Member]
Defined Benefit Plan Disclosure [Line Items]
Target Allocation for plan assets		100.00%
Predecessor [Member] | Fixed Income Securities [Member]
Defined Benefit Plan Disclosure [Line Items]
Target Allocation for plan assets		33.00%
Predecessor [Member] | Hedge Funds [Member]
Defined Benefit Plan Disclosure [Line Items]
Target Allocation for plan assets		2.00%
Predecessor [Member] | Private Market Securities [Member]
Defined Benefit Plan Disclosure [Line Items]
Target Allocation for plan assets		8.00%
Predecessor [Member] | Real Estate [Member]
Defined Benefit Plan Disclosure [Line Items]
Target Allocation for plan assets		4.00%
Predecessor [Member] | Cash and Cash Equivalents [Member]
Defined Benefit Plan Disclosure [Line Items]
Target Allocation for plan assets		2.00%
Predecessor [Member] | UNITED STATES | Equity Securities [Member]
Defined Benefit Plan Disclosure [Line Items]
Target Allocation for plan assets		27.00%
Predecessor [Member] | Non-US [Member] | Equity Securities [Member]
Defined Benefit Plan Disclosure [Line Items]
Target Allocation for plan assets		24.00%

XML

Pension Plans and Other Post Employment Benefit Plans Basis of Fair Value Measurement (Details) - Pension Plan - USD ($) $ in Millions		Dec. 31, 2017	Aug. 31, 2017		Dec. 31, 2016	Dec. 31, 2015
Successor [Member]
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets		$ 20,284	$ 20,395	[1]
Fair Value of Plan Assets, Excluding Trust Receivables and payables and assets measured at NAV		17,765
Investments Measured at Net Asset Value		2,567
Pension Trust Receivables	[2]	127
Pension Trust Payables	[3]	(175)
Successor [Member] | Fair Value, Inputs, Level 1 [Member]
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets		10,961
Successor [Member] | Fair Value, Inputs, Level 2 [Member]
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets		6,643
Successor [Member] | Fair Value, Inputs, Level 3 [Member]
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets		161	181
Successor [Member] | Cash and Cash Equivalents [Member]
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets		3,057
Successor [Member] | Cash and Cash Equivalents [Member] | Fair Value, Inputs, Level 1 [Member]
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets		3,057
Successor [Member] | Cash and Cash Equivalents [Member] | Fair Value, Inputs, Level 2 [Member]
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets		0
Successor [Member] | Cash and Cash Equivalents [Member] | Fair Value, Inputs, Level 3 [Member]
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets		0
Successor [Member] | US Treasury and Government [Member]
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets		3,263
Successor [Member] | US Treasury and Government [Member] | Fair Value, Inputs, Level 1 [Member]
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets		497
Successor [Member] | US Treasury and Government [Member] | Fair Value, Inputs, Level 2 [Member]
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets		2,766
Successor [Member] | US Treasury and Government [Member] | Fair Value, Inputs, Level 3 [Member]
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets		0
Successor [Member] | Corporate Debt Securities [Member]
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets		3,181
Successor [Member] | Corporate Debt Securities [Member] | Fair Value, Inputs, Level 1 [Member]
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets		270
Successor [Member] | Corporate Debt Securities [Member] | Fair Value, Inputs, Level 2 [Member]
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets		2,884
Successor [Member] | Corporate Debt Securities [Member] | Fair Value, Inputs, Level 3 [Member]
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets		27	46
Successor [Member] | Asset-backed Securities [Member]
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets		706
Successor [Member] | Asset-backed Securities [Member] | Fair Value, Inputs, Level 1 [Member]
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets		17
Successor [Member] | Asset-backed Securities [Member] | Fair Value, Inputs, Level 2 [Member]
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets		687
Successor [Member] | Asset-backed Securities [Member] | Fair Value, Inputs, Level 3 [Member]
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets		2	2
Successor [Member] | Hedge Funds [Member]
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets		85
Investments Measured at Net Asset Value		747
Successor [Member] | Hedge Funds [Member] | Fair Value, Inputs, Level 1 [Member]
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets		0
Successor [Member] | Hedge Funds [Member] | Fair Value, Inputs, Level 2 [Member]
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets		83
Successor [Member] | Hedge Funds [Member] | Fair Value, Inputs, Level 3 [Member]
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets		2	0
Successor [Member] | Private Market Securities [Member]
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets		14
Investments Measured at Net Asset Value		1,383
Successor [Member] | Private Market Securities [Member] | Fair Value, Inputs, Level 1 [Member]
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets		0
Successor [Member] | Private Market Securities [Member] | Fair Value, Inputs, Level 2 [Member]
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets		0
Successor [Member] | Private Market Securities [Member] | Fair Value, Inputs, Level 3 [Member]
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets		14	17
Successor [Member] | Real Estate [Member]
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets		342
Investments Measured at Net Asset Value		437
Successor [Member] | Real Estate [Member] | Fair Value, Inputs, Level 1 [Member]
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets		239
Successor [Member] | Real Estate [Member] | Fair Value, Inputs, Level 2 [Member]
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets		7
Successor [Member] | Real Estate [Member] | Fair Value, Inputs, Level 3 [Member]
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets		96	98
Successor [Member] | Derivative, Asset [Member]
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets		24
Successor [Member] | Derivative, Asset [Member] | Fair Value, Inputs, Level 1 [Member]
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets		3
Successor [Member] | Derivative, Asset [Member] | Fair Value, Inputs, Level 2 [Member]
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets		21
Successor [Member] | Derivative, Asset [Member] | Fair Value, Inputs, Level 3 [Member]
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets		0
Successor [Member] | Derivative, Liability [Member]
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets		(16)
Successor [Member] | Derivative, Liability [Member] | Fair Value, Inputs, Level 1 [Member]
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets		0
Successor [Member] | Derivative, Liability [Member] | Fair Value, Inputs, Level 2 [Member]
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets		(16)
Successor [Member] | Derivative, Liability [Member] | Fair Value, Inputs, Level 3 [Member]
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets		0
Successor [Member] | Other Investments [Member]
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets		2
Successor [Member] | Other Investments [Member] | Fair Value, Inputs, Level 1 [Member]
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets		0
Successor [Member] | Other Investments [Member] | Fair Value, Inputs, Level 2 [Member]
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets		2
Successor [Member] | Other Investments [Member] | Fair Value, Inputs, Level 3 [Member]
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets		0
Successor [Member] | UNITED STATES | Equity Securities [Member]
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	[4]	4,043
Successor [Member] | UNITED STATES | Equity Securities [Member] | Fair Value, Inputs, Level 1 [Member]
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets		4,012
Successor [Member] | UNITED STATES | Equity Securities [Member] | Fair Value, Inputs, Level 2 [Member]
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets		14
Successor [Member] | UNITED STATES | Equity Securities [Member] | Fair Value, Inputs, Level 3 [Member]
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets		17	16
Successor [Member] | Non-US [Member] | Equity Securities [Member]
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets		3,064
Successor [Member] | Non-US [Member] | Equity Securities [Member] | Fair Value, Inputs, Level 1 [Member]
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets		2,866
Successor [Member] | Non-US [Member] | Equity Securities [Member] | Fair Value, Inputs, Level 2 [Member]
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets		195
Successor [Member] | Non-US [Member] | Equity Securities [Member] | Fair Value, Inputs, Level 3 [Member]
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets		3	2
Predecessor [Member]
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets			19,685		$ 16,656	$ 17,497
Fair Value of Plan Assets, Excluding Trust Receivables and payables and assets measured at NAV					14,470
Investments Measured at Net Asset Value					2,294
Pension Trust Receivables	[5]				264
Pension Trust Payables	[6]				(372)
Predecessor [Member] | Fair Value, Inputs, Level 1 [Member]
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets					9,997
Predecessor [Member] | Fair Value, Inputs, Level 2 [Member]
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets					4,275
Predecessor [Member] | Fair Value, Inputs, Level 3 [Member]
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets			181		198	238
Predecessor [Member] | Cash and Cash Equivalents [Member]
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets					1,505
Predecessor [Member] | Cash and Cash Equivalents [Member] | Fair Value, Inputs, Level 1 [Member]
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets					1,480
Predecessor [Member] | Cash and Cash Equivalents [Member] | Fair Value, Inputs, Level 2 [Member]
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets					25
Predecessor [Member] | Cash and Cash Equivalents [Member] | Fair Value, Inputs, Level 3 [Member]
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets					0
Predecessor [Member] | US Treasury and Government [Member]
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets					2,067
Predecessor [Member] | US Treasury and Government [Member] | Fair Value, Inputs, Level 1 [Member]
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets					864
Predecessor [Member] | US Treasury and Government [Member] | Fair Value, Inputs, Level 2 [Member]
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets					1,203
Predecessor [Member] | US Treasury and Government [Member] | Fair Value, Inputs, Level 3 [Member]
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets					0
Predecessor [Member] | Corporate Debt Securities [Member]
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets					2,475
Predecessor [Member] | Corporate Debt Securities [Member] | Fair Value, Inputs, Level 1 [Member]
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets					273
Predecessor [Member] | Corporate Debt Securities [Member] | Fair Value, Inputs, Level 2 [Member]
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets					2,163
Predecessor [Member] | Corporate Debt Securities [Member] | Fair Value, Inputs, Level 3 [Member]
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets			46		39	34
Predecessor [Member] | Asset-backed Securities [Member]
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets					721
Predecessor [Member] | Asset-backed Securities [Member] | Fair Value, Inputs, Level 1 [Member]
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets					39
Predecessor [Member] | Asset-backed Securities [Member] | Fair Value, Inputs, Level 2 [Member]
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets					682
Predecessor [Member] | Asset-backed Securities [Member] | Fair Value, Inputs, Level 3 [Member]
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets			2		0	1
Predecessor [Member] | Hedge Funds [Member]
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets					1
Investments Measured at Net Asset Value					434
Predecessor [Member] | Hedge Funds [Member] | Fair Value, Inputs, Level 1 [Member]
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets					0
Predecessor [Member] | Hedge Funds [Member] | Fair Value, Inputs, Level 2 [Member]
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets					1
Predecessor [Member] | Hedge Funds [Member] | Fair Value, Inputs, Level 3 [Member]
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets			0		0	0
Predecessor [Member] | Private Market Securities [Member]
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets					67
Investments Measured at Net Asset Value					1,416
Predecessor [Member] | Private Market Securities [Member] | Fair Value, Inputs, Level 1 [Member]
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets					0
Predecessor [Member] | Private Market Securities [Member] | Fair Value, Inputs, Level 2 [Member]
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets					25
Predecessor [Member] | Private Market Securities [Member] | Fair Value, Inputs, Level 3 [Member]
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets			17		42	37
Predecessor [Member] | Real Estate [Member]
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets					275
Investments Measured at Net Asset Value					444
Predecessor [Member] | Real Estate [Member] | Fair Value, Inputs, Level 1 [Member]
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets					175
Predecessor [Member] | Real Estate [Member] | Fair Value, Inputs, Level 2 [Member]
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets					2
Predecessor [Member] | Real Estate [Member] | Fair Value, Inputs, Level 3 [Member]
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets			98		98	144
Predecessor [Member] | Derivative, Asset [Member]
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets					53
Predecessor [Member] | Derivative, Asset [Member] | Fair Value, Inputs, Level 1 [Member]
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets					7
Predecessor [Member] | Derivative, Asset [Member] | Fair Value, Inputs, Level 2 [Member]
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets					46
Predecessor [Member] | Derivative, Asset [Member] | Fair Value, Inputs, Level 3 [Member]
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets					0
Predecessor [Member] | Derivative, Liability [Member]
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets					(47)
Predecessor [Member] | Derivative, Liability [Member] | Fair Value, Inputs, Level 1 [Member]
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets					0
Predecessor [Member] | Derivative, Liability [Member] | Fair Value, Inputs, Level 2 [Member]
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets					(47)
Predecessor [Member] | Derivative, Liability [Member] | Fair Value, Inputs, Level 3 [Member]
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets					0
Predecessor [Member] | Other Investments [Member]
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets					4
Predecessor [Member] | Other Investments [Member] | Fair Value, Inputs, Level 1 [Member]
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets					0
Predecessor [Member] | Other Investments [Member] | Fair Value, Inputs, Level 2 [Member]
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets					4
Predecessor [Member] | Other Investments [Member] | Fair Value, Inputs, Level 3 [Member]
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets					0
Predecessor [Member] | UNITED STATES | Equity Securities [Member]
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	[7]				4,071
Predecessor [Member] | UNITED STATES | Equity Securities [Member] | Fair Value, Inputs, Level 1 [Member]
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets					4,033
Predecessor [Member] | UNITED STATES | Equity Securities [Member] | Fair Value, Inputs, Level 2 [Member]
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets					20
Predecessor [Member] | UNITED STATES | Equity Securities [Member] | Fair Value, Inputs, Level 3 [Member]
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets			16		18	20
Predecessor [Member] | Non-US [Member] | Equity Securities [Member]
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets					3,278
Predecessor [Member] | Non-US [Member] | Equity Securities [Member] | Fair Value, Inputs, Level 1 [Member]
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets					3,126
Predecessor [Member] | Non-US [Member] | Equity Securities [Member] | Fair Value, Inputs, Level 2 [Member]
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets					151
Predecessor [Member] | Non-US [Member] | Equity Securities [Member] | Fair Value, Inputs, Level 3 [Member]
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets			$ 2		1	$ 2
DowDuPont [Member] | Common Stock [Member] | Successor [Member] | UNITED STATES | Equity Securities [Member]
Defined Benefit Plan Disclosure [Line Items]
Amount of Employer and Related Party Securities Included in Plan Assets		$ 910
Amount of Employer and Related Party Securities Included in Plan Assets, Percent		4.00%
DuPont [Member] | Common Stock [Member] | Predecessor [Member] | UNITED STATES | Equity Securities [Member]
Defined Benefit Plan Disclosure [Line Items]
Amount of Employer and Related Party Securities Included in Plan Assets					$ 732
Amount of Employer and Related Party Securities Included in Plan Assets, Percent		4.00%

[1] The benefit obligation and the fair value of plan assets at the beginning of the period September 1 through December 31, 2017, reflects the remeasurement of the plans at the Merger Effectiveness Time.

[2] Primarily receivables for investments securities sold.

[3] Primarily payables for investment securities purchased

[4] The DuPont pension plans directly held $910 million (4 percent of total plan assets) of DowDuPont common stock at December 31, 2017.

[5] Primarily receivables for investments securities sold.

[6] Primarily payables for investment securities purchased.

[7] The DuPont pension plans directly held $732 million (4 percent of total plan assets) of DuPont common stock at December 31, 2016.

XML

Pension Plans and Other Post Employment Benefit Plans Summary of Fair Value Measurement of Level 3 Pension Plan Assets (Details) - Pension Plan - USD ($) $ in Millions		4 Months Ended	8 Months Ended		12 Months Ended
		Dec. 31, 2017	Aug. 31, 2017		Dec. 31, 2016	Dec. 31, 2015
Predecessor [Member]
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets			$ 19,685		$ 16,656	$ 17,497
Predecessor [Member] | Fair Value, Inputs, Level 3 [Member]
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets			181		198	238
Actual Return (Loss) on Plan Assets Sold			(19)		(28)
Actual Return (Loss) on Plan Assets Still Held			15		19
Purchases, Sales, and Settlements			0		(37)
Assets Transferred into (out of) Level 3			(13)		6
Predecessor [Member] | Corporate Debt Securities [Member]
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets					2,475
Predecessor [Member] | Corporate Debt Securities [Member] | Fair Value, Inputs, Level 3 [Member]
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets			46		39	34
Actual Return (Loss) on Plan Assets Sold			(20)		(25)
Actual Return (Loss) on Plan Assets Still Held			22		27
Purchases, Sales, and Settlements			(1)		(3)
Assets Transferred into (out of) Level 3			6		6
Predecessor [Member] | Asset-backed Securities [Member]
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets					721
Predecessor [Member] | Asset-backed Securities [Member] | Fair Value, Inputs, Level 3 [Member]
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets			2		0	1
Actual Return (Loss) on Plan Assets Sold			0		0
Actual Return (Loss) on Plan Assets Still Held			0		0
Purchases, Sales, and Settlements			0		(1)
Assets Transferred into (out of) Level 3			2		0
Predecessor [Member] | Hedge Funds [Member]
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets					1
Predecessor [Member] | Hedge Funds [Member] | Fair Value, Inputs, Level 3 [Member]
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets			0		0	0
Actual Return (Loss) on Plan Assets Sold			0		0
Actual Return (Loss) on Plan Assets Still Held			0		0
Purchases, Sales, and Settlements			0		0
Assets Transferred into (out of) Level 3			0		0
Predecessor [Member] | Private Market Securities [Member]
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets					67
Predecessor [Member] | Private Market Securities [Member] | Fair Value, Inputs, Level 3 [Member]
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets			17		42	37
Actual Return (Loss) on Plan Assets Sold			0		0
Actual Return (Loss) on Plan Assets Still Held			(5)		2
Purchases, Sales, and Settlements			1		3
Assets Transferred into (out of) Level 3			(21)		0
Predecessor [Member] | Real Estate [Member]
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets					275
Predecessor [Member] | Real Estate [Member] | Fair Value, Inputs, Level 3 [Member]
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets			98		98	144
Actual Return (Loss) on Plan Assets Sold			0		0
Actual Return (Loss) on Plan Assets Still Held			7		(10)
Purchases, Sales, and Settlements			(7)		(36)
Assets Transferred into (out of) Level 3			0		0
Successor [Member]
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets		$ 20,284	20,395	[1]
Successor [Member] | Fair Value, Inputs, Level 3 [Member]
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets		161	181
Actual Return (Loss) on Plan Assets Sold		(3)
Actual Return (Loss) on Plan Assets Still Held		6
Purchases, Sales, and Settlements		(23)
Successor [Member] | Corporate Debt Securities [Member]
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets		3,181
Successor [Member] | Corporate Debt Securities [Member] | Fair Value, Inputs, Level 3 [Member]
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets		27	46
Actual Return (Loss) on Plan Assets Sold		(3)
Actual Return (Loss) on Plan Assets Still Held		5
Purchases, Sales, and Settlements		(21)
Successor [Member] | Asset-backed Securities [Member]
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets		706
Successor [Member] | Asset-backed Securities [Member] | Fair Value, Inputs, Level 3 [Member]
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets		2	2
Actual Return (Loss) on Plan Assets Sold		0
Actual Return (Loss) on Plan Assets Still Held		0
Purchases, Sales, and Settlements		0
Successor [Member] | Hedge Funds [Member]
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets		85
Successor [Member] | Hedge Funds [Member] | Fair Value, Inputs, Level 3 [Member]
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets		2	0
Actual Return (Loss) on Plan Assets Sold		0
Actual Return (Loss) on Plan Assets Still Held		0
Purchases, Sales, and Settlements		2
Successor [Member] | Private Market Securities [Member]
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets		14
Successor [Member] | Private Market Securities [Member] | Fair Value, Inputs, Level 3 [Member]
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets		14	17
Actual Return (Loss) on Plan Assets Sold		0
Actual Return (Loss) on Plan Assets Still Held		(3)
Purchases, Sales, and Settlements		0
Successor [Member] | Real Estate [Member]
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets		342
Successor [Member] | Real Estate [Member] | Fair Value, Inputs, Level 3 [Member]
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets		96	98
Actual Return (Loss) on Plan Assets Sold		0
Actual Return (Loss) on Plan Assets Still Held		4
Purchases, Sales, and Settlements		(6)
UNITED STATES | Predecessor [Member] | Equity Securities [Member]
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	[2]				4,071
UNITED STATES | Predecessor [Member] | Equity Securities [Member] | Fair Value, Inputs, Level 3 [Member]
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets			16		18	20
Actual Return (Loss) on Plan Assets Sold			(1)		(3)
Actual Return (Loss) on Plan Assets Still Held			(7)		1
Purchases, Sales, and Settlements			6		0
Assets Transferred into (out of) Level 3			0		0
UNITED STATES | Successor [Member] | Equity Securities [Member]
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	[3]	4,043
UNITED STATES | Successor [Member] | Equity Securities [Member] | Fair Value, Inputs, Level 3 [Member]
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets		17	16
Actual Return (Loss) on Plan Assets Sold		0
Actual Return (Loss) on Plan Assets Still Held		1
Purchases, Sales, and Settlements		0
Non-US [Member] | Predecessor [Member] | Equity Securities [Member]
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets					3,278
Non-US [Member] | Predecessor [Member] | Equity Securities [Member] | Fair Value, Inputs, Level 3 [Member]
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets			2		1	$ 2
Actual Return (Loss) on Plan Assets Sold			2		0
Actual Return (Loss) on Plan Assets Still Held			(2)		(1)
Purchases, Sales, and Settlements			1		0
Assets Transferred into (out of) Level 3			0		$ 0
Non-US [Member] | Successor [Member] | Equity Securities [Member]
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets		3,064
Non-US [Member] | Successor [Member] | Equity Securities [Member] | Fair Value, Inputs, Level 3 [Member]
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets		3	$ 2
Actual Return (Loss) on Plan Assets Sold		0
Actual Return (Loss) on Plan Assets Still Held		(1)
Purchases, Sales, and Settlements		$ 2

[1] The benefit obligation and the fair value of plan assets at the beginning of the period September 1 through December 31, 2017, reflects the remeasurement of the plans at the Merger Effectiveness Time.

[2] The DuPont pension plans directly held $732 million (4 percent of total plan assets) of DuPont common stock at December 31, 2016.

[3] The DuPont pension plans directly held $910 million (4 percent of total plan assets) of DowDuPont common stock at December 31, 2017.

XML

Pension Plans and Other Post Employment Benefit Plans Net Asset Value as a Practical Expedient (Details) - Pension Plan - USD ($) $ in Millions	4 Months Ended
	Dec. 31, 2017	Dec. 31, 2016
Hedge Funds [Member]
Defined Benefit Plan Disclosure [Line Items]
Percentage of funds with gates in place for year-end redemptions (less than 5 percent)	5.00%
Lock Up Period	1 year
Private Market Securities [Member]
Defined Benefit Plan Disclosure [Line Items]
Average Remaining Life per Investment	15 years
Real Estate [Member]
Defined Benefit Plan Disclosure [Line Items]
Average Remaining Life per Investment	15 years
Successor [Member]
Defined Benefit Plan Disclosure [Line Items]
Investments Measured at Net Asset Value	$ 2,567
Fair Value, Investments, Entities that Calculate Net Asset Value Per Share, Unfunded Commitments	1,168
Successor [Member] | Hedge Funds [Member]
Defined Benefit Plan Disclosure [Line Items]
Investments Measured at Net Asset Value	747
Fair Value, Investments, Entities that Calculate Net Asset Value Per Share, Unfunded Commitments	0
Successor [Member] | Private Market Securities [Member]
Defined Benefit Plan Disclosure [Line Items]
Investments Measured at Net Asset Value	1,383
Fair Value, Investments, Entities that Calculate Net Asset Value Per Share, Unfunded Commitments	797
Successor [Member] | Real Estate [Member]
Defined Benefit Plan Disclosure [Line Items]
Investments Measured at Net Asset Value	437
Fair Value, Investments, Entities that Calculate Net Asset Value Per Share, Unfunded Commitments	$ 371
Predecessor [Member]
Defined Benefit Plan Disclosure [Line Items]
Investments Measured at Net Asset Value		$ 2,294
Fair Value, Investments, Entities that Calculate Net Asset Value Per Share, Unfunded Commitments		937
Predecessor [Member] | Hedge Funds [Member]
Defined Benefit Plan Disclosure [Line Items]
Investments Measured at Net Asset Value		434
Fair Value, Investments, Entities that Calculate Net Asset Value Per Share, Unfunded Commitments		0
Predecessor [Member] | Private Market Securities [Member]
Defined Benefit Plan Disclosure [Line Items]
Investments Measured at Net Asset Value		1,416
Fair Value, Investments, Entities that Calculate Net Asset Value Per Share, Unfunded Commitments		693
Predecessor [Member] | Real Estate [Member]
Defined Benefit Plan Disclosure [Line Items]
Investments Measured at Net Asset Value		444
Fair Value, Investments, Entities that Calculate Net Asset Value Per Share, Unfunded Commitments		$ 244
Redemption Frequency, Monthly [Member] | Minimum [Member] | Hedge Funds [Member]
Defined Benefit Plan Disclosure [Line Items]
Redemption Notice Period Range	15 days
Redemption Frequency, Monthly [Member] | Maximum [Member] | Hedge Funds [Member]
Defined Benefit Plan Disclosure [Line Items]
Redemption Notice Period Range	45 days
Redemption Frequency, Quarterly [Member] | Minimum [Member] | Hedge Funds [Member]
Defined Benefit Plan Disclosure [Line Items]
Redemption Notice Period Range	10 days
Redemption Frequency, Quarterly [Member] | Maximum [Member] | Hedge Funds [Member]
Defined Benefit Plan Disclosure [Line Items]
Redemption Notice Period Range	185 days

XML

Stock-Based Compensation Stock Compensation (Narrative) (Details) - USD ($) $ in Millions			4 Months Ended	8 Months Ended	12 Months Ended
		Aug. 31, 2017	Dec. 31, 2017	Aug. 31, 2017	Dec. 31, 2016	Dec. 31, 2015
Merger with Dow [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Fair value of DuPont equity awards converted		$ 629
Business Combination, Consideration Transferred, Equity Interests Issued and Issuable	[1]	485
Equity Awards converted but not yet earned		144
Incremental expense		$ 23
Common Stock [Member] | Merger with Dow [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share exchange ratio, DuPont to DowDuPont		1.2820
Successor [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Shares Reserved for Future Issuance		110,000,000		110,000,000
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized			34,000,000
Shares in excess must be counted against maximum number of shares granted		30,000,000
Stock-based compensation cost included in income from continuing operations			$ 33
Tax Benefit from Compensation Expense			11
Successor [Member] | Employee Stock Option [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Tax Benefit from Compensation Expense			$ 6
Predecessor [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock-based compensation cost included in income from continuing operations				$ 85	$ 118	$ 127
Tax Benefit from Compensation Expense				29	$ 39	$ 42
Predecessor [Member] | Employee Stock Option [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Tax Benefit from Compensation Expense				$ 36

[1] Represents the fair value of replacement awards issued for DuPont's equity awards outstanding immediately before the Merger and attributable to the service periods prior to the Merger. The previous DuPont equity awards were converted into the right to receive 1.2820 shares of DowDuPont Common Stock.

XML

Stock-Based Compensation Stock Options (Narrative) (Details) - USD ($) $ / shares in Units, $ in Millions		4 Months Ended	8 Months Ended	12 Months Ended
	Aug. 31, 2017	Dec. 31, 2017	Aug. 31, 2017	Dec. 31, 2017	Dec. 31, 2016	Dec. 31, 2015
Employee Stock Option [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock Option Award Vesting Period	3 years
Stock Option Award Requisite Service Period	6 months
Grants between 2010 and 2015 [Member] | Employee Stock Option [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock Option, Expiration Period	7 years
Grants in 2016 and 2017 [Member] | Employee Stock Option [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock Option, Expiration Period	10 years
Successor [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Tax Benefit from Compensation Expense		$ 11
Unrecognized Pretax Compensation Expense Related to Stock Options		$ 24		$ 24
Successor [Member] | Employee Stock Option [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Weighted-Average Grant Date Fair Value, Stock Options		$ 28.56
Total Intrinsic Value of Stock Options Exercised		$ 19
Tax Benefit from Compensation Expense		$ 6
Remaining Weighted-Average Recognition Period				1 year 314 days
Predecessor [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Tax Benefit from Compensation Expense			$ 29		$ 39	$ 42
Predecessor [Member] | Employee Stock Option [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Weighted-Average Grant Date Fair Value, Stock Options			$ 16.65		$ 13.40	$ 11.57
Total Intrinsic Value of Stock Options Exercised			$ 108		$ 86	$ 160
Tax Benefit from Compensation Expense			$ 36

XML

Stock-Based Compensation Weighted Average Assumptions - Stock Options (Details) - Employee Stock Option [Member]	4 Months Ended	8 Months Ended	12 Months Ended
	Dec. 31, 2017	Aug. 31, 2017	Dec. 31, 2016	Dec. 31, 2015
Predecessor [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Dividend Yield		2.00%	2.60%	2.50%
Expected Volatility		23.21%	28.27%	22.52%
Risk Free Interest Rate		2.30%	1.80%	1.40%
Expected life of stock options granted during period		7 years 73 days	7 years 73 days	5 years 110 days
Successor [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Dividend Yield	2.20%
Expected Volatility	23.59%
Risk Free Interest Rate	2.10%
Expected life of stock options granted during period	7 years 73 days

XML

Stock-Based Compensation Stock Option Activity Rollforward (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands		4 Months Ended	8 Months Ended
		Dec. 31, 2017	Aug. 31, 2017
Predecessor [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Options outstanding, beginning of period		12,830	15,696
Stock options granted during period			1,626
Options exercised during period			(4,356)
Option forfeited/expired during period			(136)
Options outstanding, end of period			12,830
Options Exercisable at End of Period			8,441
Options Outstanding at beginning of period, Weighted Average Exercise Price		$ 61.84	$ 58.11
Options Granted during period, Weighted Average Exercise Price			76.18
Options Exercised during period, Weighted Average Exercise Price			54.52
Options Forfeited/Expired during period, Weighted Average Exercise Price			60.93
Options Outstanding at end of period, Weighted Average Exercise Price			61.84
Options Exercisable at End of Period, Weighted Average Exercise Price			$ 57.78
Weighted Average Remaining Contractual Term			4 years 259 days
Options Exercisable at End of Period, Weighted Average Remaining Contractual Term			3 years 135 days
Aggregate Intrinsic Value			$ 283,365
Options Exercisable at End of Period, Aggregate Intrinsic Value			$ 220,716
Successor [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Options outstanding, beginning of period	[1]	16,447
Stock options granted during period		174
Options exercised during period		(702)
Option forfeited/expired during period		(30)
Options outstanding, end of period		15,889	16,447	[1]
Options Exercisable at End of Period		10,881
Options Outstanding at beginning of period, Weighted Average Exercise Price		$ 48.24
Options Granted during period, Weighted Average Exercise Price		45.29
Options Exercised during period, Weighted Average Exercise Price		43.07
Options Forfeited/Expired during period, Weighted Average Exercise Price		54.83
Options Outstanding at end of period, Weighted Average Exercise Price		48.43	$ 48.24
Options Exercisable at End of Period, Weighted Average Exercise Price		$ 45.75
Weighted Average Remaining Contractual Term		3 years 270 days
Options Exercisable at End of Period, Weighted Average Remaining Contractual Term		3 years 22 days
Aggregate Intrinsic Value		$ 362,088
Options Exercisable at End of Period, Aggregate Intrinsic Value		$ 277,163

[1] As a result of the Merger, all previous DuPont equity awards were converted into the right to receive 1.2820 shares of DowDuPont Common Stock, as discussed above. As a result, the number of shares outstanding at September 1, 2017 represents the shares as of August 31, 2017 multiplied by the conversion factor.

XML

Stock-Based Compensation RSU and PSU (Narrative) (Details) - USD ($) $ / shares in Units, $ in Millions			4 Months Ended	8 Months Ended	12 Months Ended
	Nov. 30, 2017	Aug. 31, 2017	Dec. 31, 2017	Aug. 31, 2017	Dec. 31, 2017	Dec. 31, 2016	Dec. 31, 2015
Restricted Stock Units (RSUs) [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
RSU and PSU Award Vesting Period		3 years
Conversion Ratio - DuPont RSUs to DowDuPont Common Stock		1
RSU Requisite Service Period		6 months
Performance Deferred Stock Units [Member] | Minimum [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
PSU, percentage of performance target		0.00%
Performance Deferred Stock Units [Member] | Maximum [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
PSU, percentage of performance target		200.00%
Management [Member] | Restricted Stock Units (RSUs) [Member] | Minimum [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
RSU and PSU Award Vesting Period		2 years
Management [Member] | Restricted Stock Units (RSUs) [Member] | Maximum [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
RSU and PSU Award Vesting Period		5 years
Successor [Member] | Performance Deferred Stock Units [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Weighted Average Grant Date Fair Value, Granted during Period	$ 71.16
Successor [Member] | Performance Deferred Stock Units [Member] | Minimum [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
PSU, percentage of performance target	0.00%
Successor [Member] | Performance Deferred Stock Units [Member] | Maximum [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
PSU, percentage of performance target	200.00%
Successor [Member] | Restricted Stock Units and Performance Deferred Stock Units [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Weighted Average Grant Date Fair Value, Granted during Period			$ 70.02
Fair value of stock units vested			$ 9
Unrecognized Pretax Compensation Expense Related to RSUs			$ 113		$ 113
Remaining Weighted-Average Recognition Period					1 year 266 days
Predecessor [Member] | Performance Deferred Stock Units [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Weighted Average Grant Date Fair Value, Granted during Period				$ 91.56
Predecessor [Member] | Restricted Stock Units and Performance Deferred Stock Units [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Weighted Average Grant Date Fair Value, Granted during Period				$ 76.41		$ 59.50	$ 71.66
Fair value of stock units vested				$ 84		$ 83	$ 64

XML

Stock-Based Compensation RSU and PSU Activity Rollforward (Details) - Restricted Stock Units and Performance Deferred Stock Units [Member] - $ / shares shares in Thousands		4 Months Ended		8 Months Ended		12 Months Ended
		Dec. 31, 2017		Aug. 31, 2017		Dec. 31, 2016	Dec. 31, 2015
Predecessor [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Nonvested Shares, Beginning of Period		3,078	[1]	3,390
Shares Granted during the Period				1,124
Shares Vested during the Period				(1,332)
Shares Forfeited during the Period				(104)
Nonvested Shares, End of Period				3,078	[1]	3,390
Weighted Average Grant Date Fair Value, Beginning of Period		$ 67.53		$ 63.11
Weighted Average Grant Date Fair Value, Granted during Period				76.41		$ 59.50	$ 71.66
Weighted Average Grant Date Fair Value, Vested during Period				63.08
Weighted Average Grant Date Fair Value, Forfeited during Period				70.69
Weighted Average Grant Date Fair Value, End of Period				$ 67.53		$ 63.11
Successor [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Nonvested Shares, Beginning of Period	[1]	3,948
Shares Granted during the Period		412
Shares Vested during the Period		(139)
Shares Forfeited during the Period		(23)
Nonvested Shares, End of Period		4,198		3,948	[1]
Weighted Average Grant Date Fair Value, Beginning of Period		$ 67.06
Weighted Average Grant Date Fair Value, Granted during Period		70.02
Weighted Average Grant Date Fair Value, Vested during Period		67.67
Weighted Average Grant Date Fair Value, Forfeited during Period		66.65
Weighted Average Grant Date Fair Value, End of Period		$ 68.28		$ 67.06

[1] As a result of the Merger, all previous DuPont equity awards were converted into the right to receive 1.2820 shares of DowDuPont Common Stock, as discussed above. As a result, the number of shares outstanding at September 1, 2017 represents the shares as of August 31, 2017 multiplied by the conversion factor.

XML

Stock-Based Compensation Other Cash Based Awards (Narrative) (Details) - USD ($) $ in Millions	4 Months Ended	8 Months Ended	12 Months Ended
	Dec. 31, 2017	Aug. 31, 2017	Dec. 31, 2016	Dec. 31, 2015
Successor [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Compensation Expense	$ 83
Predecessor [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Compensation Expense		$ 264	$ 295	$ 179

XML

Financial Instruments Financial Instruments (Narrative) (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2016	Dec. 31, 2017
Predecessor [Member]
Schedule of Held-to-maturity Securities [Line Items]
Proceeds from Sale of Available-for-sale Securities	$ 788
Cash Equivalents [Member] | Successor [Member]
Schedule of Held-to-maturity Securities [Line Items]
Held-to-maturity Securities		$ 5,205
Cash Equivalents [Member] | Predecessor [Member]
Schedule of Held-to-maturity Securities [Line Items]
Held-to-maturity Securities	2,713
Marketable Securities [Member] | Successor [Member]
Schedule of Held-to-maturity Securities [Line Items]
Held-to-maturity Securities		$ 952
Marketable Securities [Member] | Predecessor [Member]
Schedule of Held-to-maturity Securities [Line Items]
Held-to-maturity Securities	$ 1,362

XML

Financial Instruments Notional Amounts (Details) - USD ($) $ in Millions	Dec. 31, 2017	Dec. 31, 2016
Designated as Hedging Instrument [Member] | Commodity Contract [Member] | Successor [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Derivative, Notional Amount	$ 587
Designated as Hedging Instrument [Member] | Commodity Contract [Member] | Predecessor [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Derivative, Notional Amount		$ 422
Not Designated as Hedging Instrument [Member] | Foreign Exchange Contract [Member] | Successor [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Derivative, Notional Amount	10,454
Not Designated as Hedging Instrument [Member] | Foreign Exchange Contract [Member] | Predecessor [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Derivative, Notional Amount		9,896
Not Designated as Hedging Instrument [Member] | Commodity Contract [Member] | Successor [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Derivative, Notional Amount	$ 6
Not Designated as Hedging Instrument [Member] | Commodity Contract [Member] | Predecessor [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Derivative, Notional Amount		$ 7

XML

Financial Instruments Cash Flow Hedges Included in AOCI (Details) - USD ($) $ in Millions	4 Months Ended	8 Months Ended	12 Months Ended
	Dec. 31, 2017	Aug. 31, 2017	Dec. 31, 2017	Dec. 31, 2016	Dec. 31, 2015
Derivative Instruments, Gain (Loss) [Line Items]
Derivative, Remaining Maturity			2 years
Successor [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Additions and revaluations of derivatives designated as cash flow hedges	$ 3
Predecessor [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Additions and revaluations of derivatives designated as cash flow hedges		$ 5		$ 32	$ (37)
Scenario, Forecast [Member]
Derivative Instruments, Gain (Loss) [Line Items]
After-tax net loss to be reclassified from AOCL into earnings over the next twelve months	(6)
Cash Flow Hedging [Member] | Successor [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Cash Flow Hedges Derivative Instruments at Fair Value, Beginning Balance	0
Additions and revaluations of derivatives designated as cash flow hedges	(2)
Clearance of hedge results to earnings	0
Cash Flow Hedges Derivative Instruments at Fair Value, Ending Balance	(2)	0	$ (2)
Cash Flow Hedging [Member] | Predecessor [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Cash Flow Hedges Derivative Instruments at Fair Value, Beginning Balance	$ (3)	7	$ 7	(24)
Additions and revaluations of derivatives designated as cash flow hedges		3		20
Clearance of hedge results to earnings		(13)		11
Cash Flow Hedges Derivative Instruments at Fair Value, Ending Balance		$ (3)		$ 7	$ (24)

XML

Financial Instruments Fair Value of Derivatives (Details) - USD ($) $ in Millions		Dec. 31, 2017	Dec. 31, 2016
Successor [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Derivative Asset, Gross		$ 46
Derivative Asset, Fair Value, Gross Liability and Obligation to Return Cash, Offset	[1]	(37)
Derivative Asset		9
Derivative Liability, Gross		79
Derivative Liability, Fair Value, Gross Asset and Right to Reclaim Cash, Offset	[1]	(32)
Derivative Liability		47
Derivative Liability, Collateral, Right to Reclaim Cash, Offset		5
Predecessor [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Derivative Asset, Gross	[2]		$ 182
Derivative Liability, Gross	[2]		121
Derivatives Subject to Enforceable Master Netting Arrangements			114
Other Current Assets [Member] | Not Designated as Hedging Instrument [Member] | Successor [Member] | Foreign Exchange Contract [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Derivative Asset, Gross		46
Derivative Asset, Fair Value, Gross Liability and Obligation to Return Cash, Offset	[1]	(37)
Derivative Asset		9
Accrued and Other Current Liabilities [Member] | Predecessor [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Derivative, Collateral, Obligation to Return Cash	[3]		52
Accrued and Other Current Liabilities [Member] | Not Designated as Hedging Instrument [Member] | Successor [Member] | Foreign Exchange Contract [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Derivative Liability, Gross		79
Derivative Liability, Fair Value, Gross Asset and Right to Reclaim Cash, Offset	[1]	(32)
Derivative Liability		$ 47
Accrued and Other Current Liabilities [Member] | Not Designated as Hedging Instrument [Member] | Predecessor [Member] | Foreign Exchange Contract [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Derivative Liability, Gross			121
Accounts and Notes Receivable [Member] | Not Designated as Hedging Instrument [Member] | Predecessor [Member] | Foreign Exchange Contract [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Derivative Asset, Gross	[3]		$ 182

[1] Counterparty and cash collateral amounts represent the estimated net settlement amount when applying netting and set-off rights included in master netting arrangements between the company and its counterparties and the payable or receivable for cash collateral held or placed with the same counterparty. The company held cash collateral of $5 million as of December 31, 2017.

[2] The company's derivative assets and liabilities subject to enforceable master netting arrangements totaled $114 million at December 31, 2016.

[3] Cash collateral held as of December 31, 2016 is related to foreign currency derivatives not designated as hedging instruments.

XML

Financial Instruments Effect of Derivative Instruments (Details) - USD ($) $ in Millions		4 Months Ended	8 Months Ended	12 Months Ended
		Dec. 31, 2017	Aug. 31, 2017	Dec. 31, 2016	Dec. 31, 2015
Successor [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Derivative Instruments, Gain (Loss) Recognized in Other Comprehensive Income (Loss), Effective Portion, Net		$ 3
Gain (Loss) on Derivative Instruments, Net, Pretax		91
Successor [Member] | Designated as Hedging Instrument [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Derivative Instruments, Gain (Loss) Recognized in Other Comprehensive Income (Loss), Effective Portion, Net		3
Gain (Loss) on Hedging Activity		0
Successor [Member] | Not Designated as Hedging Instrument [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Derivative Instruments Not Designated as Hedging Instruments, Gain (Loss), Net		91
Predecessor [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Derivative Instruments, Gain (Loss) Recognized in Other Comprehensive Income (Loss), Effective Portion, Net			$ 5	$ 32	$ (37)
Gain (Loss) on Derivative Instruments, Net, Pretax			(408)	(345)	416
Predecessor [Member] | Designated as Hedging Instrument [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Derivative Instruments, Gain (Loss) Recognized in Other Comprehensive Income (Loss), Effective Portion, Net			5	32	(37)
Gain (Loss) on Hedging Activity			21	(18)	(13)
Predecessor [Member] | Not Designated as Hedging Instrument [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Derivative Instruments Not Designated as Hedging Instruments, Gain (Loss), Net			(429)	(327)	429
Foreign Exchange Contract [Member] | Successor [Member] | Designated as Hedging Instrument [Member] | Cash Flow Hedging [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Derivative Instruments, Gain (Loss) Recognized in Other Comprehensive Income (Loss), Effective Portion, Net		0
Foreign Exchange Contract [Member] | Predecessor [Member] | Designated as Hedging Instrument [Member] | Cash Flow Hedging [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Derivative Instruments, Gain (Loss) Recognized in Other Comprehensive Income (Loss), Effective Portion, Net			0	0	(2)
Foreign Exchange Contract [Member] | Net sales | Successor [Member] | Designated as Hedging Instrument [Member] | Cash Flow Hedging [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Gain (Loss) on Hedging Activity	[1],[2]	0
Foreign Exchange Contract [Member] | Net sales | Successor [Member] | Not Designated as Hedging Instrument [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Derivative Instruments Not Designated as Hedging Instruments, Gain (Loss), Net	[2]	0
Foreign Exchange Contract [Member] | Net sales | Predecessor [Member] | Designated as Hedging Instrument [Member] | Cash Flow Hedging [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Gain (Loss) on Hedging Activity	[1],[2]		0	0	10
Foreign Exchange Contract [Member] | Net sales | Predecessor [Member] | Not Designated as Hedging Instrument [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Derivative Instruments Not Designated as Hedging Instruments, Gain (Loss), Net	[2]		0	(12)	(3)
Foreign Exchange Contract [Member] | Sundry Income (Expense) | Successor [Member] | Not Designated as Hedging Instrument [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Derivative Instruments Not Designated as Hedging Instruments, Gain (Loss), Net	[3]	91
Foreign Exchange Contract [Member] | Sundry Income (Expense) | Predecessor [Member] | Not Designated as Hedging Instrument [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Derivative Instruments Not Designated as Hedging Instruments, Gain (Loss), Net	[3]		(431)	(304)	434
Commodity Contract [Member] | Successor [Member] | Designated as Hedging Instrument [Member] | Cash Flow Hedging [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Derivative Instruments, Gain (Loss) Recognized in Other Comprehensive Income (Loss), Effective Portion, Net		3
Commodity Contract [Member] | Predecessor [Member] | Designated as Hedging Instrument [Member] | Cash Flow Hedging [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Derivative Instruments, Gain (Loss) Recognized in Other Comprehensive Income (Loss), Effective Portion, Net			5	32	(35)
Commodity Contract [Member] | Cost of Goods Sold | Successor [Member] | Designated as Hedging Instrument [Member] | Cash Flow Hedging [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Gain (Loss) on Hedging Activity	[1],[4]	0
Commodity Contract [Member] | Cost of Goods Sold | Successor [Member] | Not Designated as Hedging Instrument [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Derivative Instruments Not Designated as Hedging Instruments, Gain (Loss), Net	[4]	0
Commodity Contract [Member] | Cost of Goods Sold | Predecessor [Member] | Designated as Hedging Instrument [Member] | Cash Flow Hedging [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Gain (Loss) on Hedging Activity	[1],[4]		21	(18)	(22)
Commodity Contract [Member] | Cost of Goods Sold | Predecessor [Member] | Not Designated as Hedging Instrument [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Derivative Instruments Not Designated as Hedging Instruments, Gain (Loss), Net	[4]		2	(11)	(2)
Interest Rate Swap [Member] | Cost of Goods Sold | Successor [Member] | Designated as Hedging Instrument [Member] | Fair Value Hedging [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Gain (Loss) on Hedging Activity	[4]	$ 0
Interest Rate Swap [Member] | Cost of Goods Sold | Predecessor [Member] | Designated as Hedging Instrument [Member] | Fair Value Hedging [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Gain (Loss) on Hedging Activity	[4]		$ 0	$ 0	$ (1)

[1] For cash flow hedges, this represents the effective portion of the gain (loss) reclassified from accumulated OCI into income during the period. There was no material ineffectiveness with regard to the company's cash flow hedges during the period.

[2] Recorded in net sales.

[3] Gain recognized in sundry income - net was partially offset by the related gain on the foreign currency-denominated monetary assets and liabilities of the company's operations. See Note 6 for additional information.

[4] Recorded in cost of goods sold.

XML

Fair Value Measurements Fair Value Tables (Details) - USD ($) $ in Millions		Dec. 31, 2017	Dec. 31, 2016
Predecessor [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative Asset	[1]		$ 182
Derivative Liability	[1]		121
Predecessor [Member] | Fair Value, Inputs, Level 2 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Long-term Debt, Fair Value			8,460
Predecessor [Member] | Fair Value, Measurements, Recurring [Member] | Fair Value, Inputs, Level 2 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash Equivalents	[2]		2,713
Marketable Securities			1,362
Assets at Fair Value			4,257
Long-term Debt, Fair Value	[3]		8,464
Liabilities at Fair Value			8,585
Predecessor [Member] | Foreign Exchange Contract [Member] | Fair Value, Measurements, Recurring [Member] | Fair Value, Inputs, Level 2 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative Asset	[4]		182
Derivative Liability	[4]		$ 121
Successor [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative Asset		$ 46
Derivative Liability		79
Successor [Member] | Fair Value, Inputs, Level 2 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Long-term Debt, Fair Value		10,250
Successor [Member] | Fair Value, Measurements, Recurring [Member] | Fair Value, Inputs, Level 2 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash Equivalents	[5]	5,205
Marketable Securities		952
Assets at Fair Value		6,203
Long-term Debt, Fair Value	[6]	11,560
Liabilities at Fair Value		11,639
Successor [Member] | Foreign Exchange Contract [Member] | Fair Value, Measurements, Recurring [Member] | Fair Value, Inputs, Level 2 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative Asset	[7]	46
Derivative Liability	[7]	$ 79

[1] The company's derivative assets and liabilities subject to enforceable master netting arrangements totaled $114 million at December 31, 2016.

[2] Time deposits included in "Cash and cash equivalents" and money market funds included in "Other current assets" in the consolidated balance sheets are held at amortized cost, which approximates fair value.

[3] See Note 13 for information on fair value measurements of long-term debt.

[4] See Note 18 for the classification of derivatives in the consolidated balance sheets.

[5] Time deposits included in "Cash and cash equivalents" and money market funds included in "Other current assets" in the consolidated balance sheets are held at amortized cost, which approximates fair value.

[6] See Note 13 for information on fair value measurements of long-term debt.

[7] See Note 18 for the classification of derivatives in the consolidated balance sheets.

XML

Geographic and Product Line Information Revenue by Country (Details) - USD ($) $ in Millions		1 Months Ended	2 Months Ended	3 Months Ended							4 Months Ended	8 Months Ended	12 Months Ended
		Sep. 30, 2017	Aug. 31, 2017	Dec. 31, 2017	Jun. 30, 2017	Mar. 31, 2017	Dec. 31, 2016	Sep. 30, 2016	Jun. 30, 2016	Mar. 31, 2016	Dec. 31, 2017	Aug. 31, 2017	Dec. 31, 2016	Dec. 31, 2015
Revenues from External Customers and Long-Lived Assets [Line Items]
Geographic Information Threshold				10.00%							10.00%
Predecessor [Member]
Revenues from External Customers and Long-Lived Assets [Line Items]
Net Sales			$ 2,991		$ 6,971	$ 7,319	$ 4,903	$ 4,646	$ 6,646	$ 7,014		$ 17,281	$ 23,209	$ 23,657
Predecessor [Member] | UNITED STATES
Revenues from External Customers and Long-Lived Assets [Line Items]
Net Sales												7,535	9,500	9,812
Predecessor [Member] | CANADA
Revenues from External Customers and Long-Lived Assets [Line Items]
Net Sales												583	669	692
Predecessor [Member] | EMEA
Revenues from External Customers and Long-Lived Assets [Line Items]
Net Sales	[1]											3,927	5,251	5,483
Predecessor [Member] | Asia Pacific
Revenues from External Customers and Long-Lived Assets [Line Items]
Net Sales												3,844	5,407	5,292
Predecessor [Member] | Latin America
Revenues from External Customers and Long-Lived Assets [Line Items]
Net Sales												$ 1,392	$ 2,382	$ 2,378
Successor [Member]
Revenues from External Customers and Long-Lived Assets [Line Items]
Net Sales		$ 1,735		$ 5,318							$ 7,053
Successor [Member] | UNITED STATES
Revenues from External Customers and Long-Lived Assets [Line Items]
Net Sales											2,086
Successor [Member] | CANADA
Revenues from External Customers and Long-Lived Assets [Line Items]
Net Sales											139
Successor [Member] | EMEA
Revenues from External Customers and Long-Lived Assets [Line Items]
Net Sales	[1]										1,689
Successor [Member] | Asia Pacific
Revenues from External Customers and Long-Lived Assets [Line Items]
Net Sales	[2]										2,047
Successor [Member] | Latin America
Revenues from External Customers and Long-Lived Assets [Line Items]
Net Sales											1,092
Successor [Member] | CHINA
Revenues from External Customers and Long-Lived Assets [Line Items]
Net Sales											$ 818

[1] Europe, Middle East, and Africa (EMEA).

[2] Net sales for China in the Successor period were $818 million. Net sales for China were less than 10 percent of consolidated net sales in all Predecessor periods.

XML

Geographic and Product Line Information Net Property by Country (Details) - USD ($) $ in Millions		Dec. 31, 2017	Dec. 31, 2016	Dec. 31, 2015
Successor [Member]
Revenues from External Customers and Long-Lived Assets [Line Items]
Net Property		$ 12,435
Successor [Member] | UNITED STATES
Revenues from External Customers and Long-Lived Assets [Line Items]
Net Property		7,708
Successor [Member] | CANADA
Revenues from External Customers and Long-Lived Assets [Line Items]
Net Property		170
Successor [Member] | EMEA
Revenues from External Customers and Long-Lived Assets [Line Items]
Net Property	[1]	2,867
Successor [Member] | Asia Pacific
Revenues from External Customers and Long-Lived Assets [Line Items]
Net Property		1,120
Successor [Member] | Latin America
Revenues from External Customers and Long-Lived Assets [Line Items]
Net Property		$ 570
Predecessor [Member]
Revenues from External Customers and Long-Lived Assets [Line Items]
Net Property			$ 8,851	$ 9,414
Predecessor [Member] | UNITED STATES
Revenues from External Customers and Long-Lived Assets [Line Items]
Net Property			5,951	6,458
Predecessor [Member] | CANADA
Revenues from External Customers and Long-Lived Assets [Line Items]
Net Property			124	128
Predecessor [Member] | EMEA
Revenues from External Customers and Long-Lived Assets [Line Items]
Net Property	[1]		1,550	1,582
Predecessor [Member] | Asia Pacific
Revenues from External Customers and Long-Lived Assets [Line Items]
Net Property			797	854
Predecessor [Member] | Latin America
Revenues from External Customers and Long-Lived Assets [Line Items]
Net Property			$ 429	$ 392

[1] Europe, Middle East, and Africa (EMEA).

XML

Geographic and Product Line Information Sales by Principal Product Group (Details) - USD ($) $ in Millions	1 Months Ended	2 Months Ended	3 Months Ended							4 Months Ended	8 Months Ended	12 Months Ended
	Sep. 30, 2017	Aug. 31, 2017	Dec. 31, 2017	Jun. 30, 2017	Mar. 31, 2017	Dec. 31, 2016	Sep. 30, 2016	Jun. 30, 2016	Mar. 31, 2016	Dec. 31, 2017	Aug. 31, 2017	Dec. 31, 2016	Dec. 31, 2015
Successor [Member]
Revenue from External Customer [Line Items]
Net Sales	$ 1,735		$ 5,318							$ 7,053
Successor [Member] | Agriculture [Member]
Revenue from External Customer [Line Items]
Net Sales										1,596
Successor [Member] | Packaging & Specialty Plastics [Member]
Revenue from External Customer [Line Items]
Net Sales										544
Successor [Member] | Electronics & Imaging [Member]
Revenue from External Customer [Line Items]
Net Sales										743
Successor [Member] | Nutrition & Health [Member]
Revenue from External Customer [Line Items]
Net Sales										1,165
Successor [Member] | Industrial Biosciences [Member]
Revenue from External Customer [Line Items]
Net Sales										573
Successor [Member] | Transportation & Advanced Polymers [Member]
Revenue from External Customer [Line Items]
Net Sales										1,355
Successor [Member] | Safety & Construction [Member]
Revenue from External Customer [Line Items]
Net Sales										1,074
Successor [Member] | Other
Revenue from External Customer [Line Items]
Net Sales										$ 3
Predecessor [Member]
Revenue from External Customer [Line Items]
Net Sales		$ 2,991		$ 6,971	$ 7,319	$ 4,903	$ 4,646	$ 6,646	$ 7,014		$ 17,281	$ 23,209	$ 23,657
Predecessor [Member] | Agriculture [Member]
Revenue from External Customer [Line Items]
Net Sales											6,894	8,131	8,327
Predecessor [Member] | Packaging & Specialty Plastics [Member]
Revenue from External Customer [Line Items]
Net Sales											1,072	1,651	1,715
Predecessor [Member] | Electronics & Imaging [Member]
Revenue from External Customer [Line Items]
Net Sales											1,422	1,960	2,070
Predecessor [Member] | Nutrition & Health [Member]
Revenue from External Customer [Line Items]
Net Sales											2,129	3,268	3,256
Predecessor [Member] | Industrial Biosciences [Member]
Revenue from External Customer [Line Items]
Net Sales											1,022	1,500	1,478
Predecessor [Member] | Transportation & Advanced Polymers [Member]
Revenue from External Customer [Line Items]
Net Sales											2,608	3,599	3,591
Predecessor [Member] | Safety & Construction [Member]
Revenue from External Customer [Line Items]
Net Sales											2,134	3,099	3,220
Predecessor [Member] | Other
Revenue from External Customer [Line Items]
Net Sales											$ 0	$ 1	$ 0

XML

Quaterly Financial Data Quarterly Financial Data (Details) - USD ($) $ / shares in Units, $ in Millions	1 Months Ended		2 Months Ended		3 Months Ended														4 Months Ended	8 Months Ended	12 Months Ended
	Sep. 30, 2017		Aug. 31, 2017		Dec. 31, 2017		Jun. 30, 2017		Mar. 31, 2017		Dec. 31, 2016		Sep. 30, 2016		Jun. 30, 2016		Mar. 31, 2016		Dec. 31, 2017	Aug. 31, 2017	Dec. 31, 2016	Dec. 31, 2015
Predecessor [Member]
Effect of Fourth Quarter Events [Line Items]
Net Sales			$ 2,991				$ 6,971		$ 7,319		$ 4,903		$ 4,646		$ 6,646		$ 7,014			$ 17,281	$ 23,209	$ 23,657
Cost of Goods Sold			1,975				4,021		4,209		3,032		2,997		3,823		4,103			10,205	13,955	14,591
Restructuring and Asset Related Charges - Net			11	[1]			160	[1]	152	[1]	394	[1]	172	[1]	(88)	[1]	78	[1]		323	556	795
Net income (loss)			(229)	[2]			869	[2]	1,121	[2],[3],[4]	263	[5]	6	[5]	1,024	[5]	1,232	[5],[6]		1,761	2,525	1,959
Net Income (Loss) Attributable to DuPont			$ (234)				$ 862		$ 1,113		$ 265		$ 2		$ 1,020		$ 1,226			$ 1,741	$ 2,513	$ 1,953
Earnings per common share, continuing operations - basic			$ (0.30)	[7]			$ 0.82	[7]	$ 1.35	[7]	$ 0.19	[7]	$ (0.08)	[7]	$ 1.03	[7]	$ 1.23	[7]		$ 1.86	$ 2.36	$ 1.60
Earnings per common share, continuing operations - diluted			$ (0.30)	[7]			$ 0.82	[7]	$ 1.34	[7]	$ 0.19	[7]	$ (0.08)	[7]	$ 1.02	[7]	$ 1.22	[7]		$ 1.85	$ 2.35	$ 1.59
Successor [Member]
Effect of Fourth Quarter Events [Line Items]
Net Sales	$ 1,735				$ 5,318														$ 7,053
Cost of Goods Sold	1,511	[8]			4,654	[8]													6,165
Restructuring and Asset Related Charges - Net	40	[1]			140	[1]													180
Net income (loss)	(295)	[2],[8]			1,305	[2],[8],[9]													1,010
Net Income (Loss) Attributable to DuPont	$ (293)				$ 1,303														$ 1,010

[1] See Note 5 for additional information.

[2] Includes charges of $(170) million, $(201) million, $(210) million, $(71) million, and $(243) million in the first quarter 2017, second quarter 2017, the period July 1 - August 31, 2017, the period September 1 - September 30, 2017, and the fourth quarter 2017, respectively, related to transaction costs associated with the Merger. Predecessor costs are recorded in selling, general and administrative expenses; Successor costs are recoded in integration and separation costs. See Note 3 for additional information.

[3] First quarter 2017 included a gain of $162 million recorded in sundry income - net associated with the sale of the company's global food safety diagnostic business. See Note 4 for additional information.

[4] First quarter 2017 included a tax benefit of $53 million, as well as a $47 million benefit on associated accrued interest reversals (recorded in sundry income - net), related to a reduction in the company’s unrecognized tax benefits due to the closure of various tax statutes of limitations.

[5] First, second, third and fourth quarter 2016 included charges of $(24) million, $(76) million, $(122) million, and $(164) million, respectively, recorded in selling, general and administrative expenses related to transaction costs associated with the Merger. See Note 3 for additional information.

[6] First quarter 2016 included a gain of $369 million recorded in sundry income - net associated with the sale of the DuPont (Shenzhen) Manufacturing Limited entity, which held certain buildings and other assets. See Note 4 for additional information

[7] Due to quarterly changes in the share count and the allocation of income to participating securities, the sum of the four quarters may not equal the earnings per share amount calculated for the year.

[8] Includes charges of $(360) million and $(1,109) million during the period September 1 - September 30, 2017 and the fourth quarter 2017, respectively, related to the amortization of inventory step-up as a result of the Merger and the acquisition of the H&N Business, which was included in cost of goods sold. See Note 3 for additional information.

[9] Includes a tax benefit of $2,262 million in the fourth quarter 2017 related to the Tax Cuts and Jobs Act and a benefit related to an internal entity restructuring associated with the Intended Business Separations. See Note 7 for additional information.

XML

Quaterly Financial Data Quarterly Financial Data (Parentheticals) (Details) - USD ($) $ in Millions	1 Months Ended	2 Months Ended	3 Months Ended							4 Months Ended	8 Months Ended	12 Months Ended
	Sep. 30, 2017	Aug. 31, 2017	Dec. 31, 2017	Jun. 30, 2017	Mar. 31, 2017	Dec. 31, 2016	Sep. 30, 2016	Jun. 30, 2016	Mar. 31, 2016	Dec. 31, 2017	Aug. 31, 2017	Dec. 31, 2016	Dec. 31, 2015
Predecessor [Member]
Effect of Fourth Quarter Events [Line Items]
Transaction Costs				$ (201)	$ (170)	$ (164)	$ (122)	$ (76)	$ (24)		$ 581	$ 386	$ 10
Predecessor [Member] | Continuing Operations [Member]
Effect of Fourth Quarter Events [Line Items]
Tax benefit related to reduction in company's unrecognized tax benefits					53						53
Pre tax benefit on associated accrued interest reversals					$ 47
Predecessor [Member] | Food Safety Diagnostic Business [Member]
Effect of Fourth Quarter Events [Line Items]
Pre-tax gain on disposal											$ 162
Predecessor [Member] | Ownership interest in DuPont (Shenzhen) Manufacturing Limited [Member]
Effect of Fourth Quarter Events [Line Items]
Gain on sale of entity												$ 369
Predecessor [Member] | Merger with Dow [Member]
Effect of Fourth Quarter Events [Line Items]
Transaction Costs		$ (210)
Successor [Member]
Effect of Fourth Quarter Events [Line Items]
Business Combination, Fair Value Step-Up Of Acquired Inventory	$ (360)		$ (1,109)							$ (1,469)
Transaction Costs	$ (71)		$ (243)							314
Successor [Member] | Tax benefit due to Tax Cuts and Jobs Act and an internal entity restructuring [Member]
Effect of Fourth Quarter Events [Line Items]
Income Tax Benefit										2,262
Successor [Member] | Merger with Dow [Member]
Effect of Fourth Quarter Events [Line Items]
Business Combination, Fair Value Step-Up Of Acquired Inventory										$ (1,434)

XML

Subsequent Events (Details) - Securities Sold under Agreements to Repurchase [Member] - Subsequent Event [Member] - Successor [Member] $ in Millions	Feb. 13, 2018 USD ($)
Subsequent Event [Line Items]
Short-term Debt	$ 1,300
Percentage of outstanding amounts borrowed utilized as collateral	105.00%
Interest rate in addition to LIBOR	0.75%

XML

Schedule II - Valuation and Qualifying Accounts (Details) - USD ($) $ in Millions		4 Months Ended	8 Months Ended	12 Months Ended
		Dec. 31, 2017	Aug. 31, 2017	Dec. 31, 2016	Dec. 31, 2015
Predecessor [Member] | Allowance for Doubtful Accounts [Member]
Valuation and Qualifying Accounts Disclosure [Line Items]
Balance at beginning of period		$ 305	$ 287	$ 225	$ 235
Additions charges to expenses			51	119	58
Deductions from reserves	[1]		(33)	(57)	(68)
Balance at end of period			305	287	225
Predecessor [Member] | Inventory Valuation Reserve [Member]
Valuation and Qualifying Accounts Disclosure [Line Items]
Balance at beginning of period		274	214	237	179
Additions charges to expenses			241	275	391
Deductions from reserves	[2]		(181)	(298)	(333)
Balance at end of period			274	214	237
Predecessor [Member] | Valuation Allowance of Deferred Tax Assets [Member]
Valuation and Qualifying Accounts Disclosure [Line Items]
Balance at beginning of period		1,383	1,308	1,529	1,704
Additions charges to expenses			95	74	40
Deductions from reserves			(20)	(295)	(215)
Balance at end of period			1,383	$ 1,308	$ 1,529
Successor [Member] | Allowance for Doubtful Accounts [Member]
Valuation and Qualifying Accounts Disclosure [Line Items]
Balance at beginning of period		0
Additions charges to expenses		10
Deductions from reserves	[1]	0
Balance at end of period			0
Successor [Member] | Inventory Valuation Reserve [Member]
Valuation and Qualifying Accounts Disclosure [Line Items]
Balance at beginning of period		0
Additions charges to expenses		89
Deductions from reserves	[2]	(34)
Balance at end of period		55	0
Successor [Member] | Valuation Allowance of Deferred Tax Assets [Member]
Valuation and Qualifying Accounts Disclosure [Line Items]
Balance at beginning of period		1,323
Additions charges to expenses		84
Deductions from reserves		(29)
Balance at end of period		$ 1,378	$ 1,323

[1] Deductions include write-offs, recoveries and currency translation adjustments.

[2] Deductions include disposals and currency translation adjustments.